<?xml version="1.0" encoding="UTF-8"?>

<rss version="2.0"
  xmlns:atom="http://www.w3.org/2005/Atom"
  xmlns:cc="http://web.resource.org/cc/"
  xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd"
  xmlns:media="http://search.yahoo.com/mrss/"
  xmlns:content="http://purl.org/rss/1.0/modules/content/"
  xmlns:podcast="https://podcastindex.org/namespace/1.0"
  xmlns:googleplay="http://www.google.com/schemas/play-podcasts/1.0"
  xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">

  <channel>
    <atom:link href="https://rss.libsyn.com/shows/35693/destinations/90171.xml" rel="self" type="application/rss+xml"/>
    <title>Healthy Dialogue</title>
    <pubDate>Fri, 17 Apr 2026 15:09:34 +0000</pubDate>
    <lastBuildDate>Fri, 17 Apr 2026 15:09:34 +0000</lastBuildDate>
    <generator>Libsyn RSSgen 1.0</generator>
    <link>https://jamanetwork.com/journals/jama/pages/healthy-dialogue</link>
    <language>en</language>
    <copyright><![CDATA[2026 American Medical Association. All rights reserved, including those for text and data mining, AI training, and similar technologies.]]></copyright>
    <docs>https://jamanetwork.com/journals/jama/pages/healthy-dialogue</docs>
    <itunes:summary><![CDATA[Go beyond the latest discoveries with nuanced, in-depth conversations in Healthy Dialogue, a podcast from the JAMA Network. Host and JAMA Senior Editor, Derek C. Angus, MD, MPH, sits down with the world's leading experts to explore the most pressing issues in health and health care.]]></itunes:summary>
    <image>
      <url>https://static.libsyn.com/p/assets/7/4/9/f/749f7791c7e9665516c3140a3186d450/Healthy_Dialogue_Podcast_Tile_3000-34000.png</url>
      <title>Healthy Dialogue</title>
      <link><![CDATA[https://jamanetwork.com/journals/jama/pages/healthy-dialogue]]></link>
    </image>
    <itunes:author>JAMA Network</itunes:author>
		<itunes:category text="Health &amp; Fitness">
  <itunes:category text="Medicine" />
</itunes:category>
<itunes:category text="Science" />
    <itunes:image href="https://static.libsyn.com/p/assets/7/4/9/f/749f7791c7e9665516c3140a3186d450/Healthy_Dialogue_Podcast_Tile_3000-34000.png" />
    <itunes:explicit>false</itunes:explicit>
    <itunes:owner>
      <itunes:name>American Medical Association</itunes:name>
      <itunes:email>support@jamanetwork.org</itunes:email>
    </itunes:owner>
    <description><![CDATA[Go beyond the latest discoveries with nuanced, in-depth conversations in Healthy Dialogue, a podcast from the JAMA Network. Host and JAMA Senior Editor, Derek C. Angus, MD, MPH, sits down with the world's leading experts to explore the most pressing issues in health and health care.]]></description>
    
    <itunes:type>episodic</itunes:type>
    

    <itunes:keywords />

    

    
    <podcast:locked owner="support@jamanetwork.org">no</podcast:locked>
    
    
    
    
    
    <item>
      <title>Introducing Healthy Dialogue</title>
      <itunes:title>Introducing Healthy Dialogue</itunes:title>
      <pubDate>Fri, 17 Apr 2026 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[33058971-9e8f-4e74-9eb0-fddcab271be0]]></guid>
      <link><![CDATA[https://jamanetwork.com/journals/jama/pages/healthy-dialogue]]></link>
      <description><![CDATA[<p>Go beyond the latest discoveries with nuanced, in-depth conversations in Healthy Dialogue, a podcast from the JAMA Network. Host and JAMA Senior Editor, Derek C. Angus, MD, MPH, sits down with the world's leading experts to explore the most pressing issues in health and health care.</p>]]></description>
      
      <content:encoded><![CDATA[<p>Go beyond the latest discoveries with nuanced, in-depth conversations in Healthy Dialogue, a podcast from the JAMA Network. Host and JAMA Senior Editor, Derek C. Angus, MD, MPH, sits down with the world's leading experts to explore the most pressing issues in health and health care.</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Introducing_Healthy_Dialogue.mp3?dest-id=90171" length="3210636" type="audio/mpeg" />
      <itunes:duration>01:35</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/7/7/2/1772a12cbf758b50d959afa2a1bf1c87/Healthy_Dialogue_Podcast_Tile_3000-34000.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>From the JAMA Network: JAMA Research of the Year With Editor in Chief Kirsten Bibbins-Domingo</title>
      <itunes:title>From the JAMA Network: JAMA Research of the Year With Editor in Chief Kirsten Bibbins-Domingo</itunes:title>
      <pubDate>Fri, 26 Dec 2025 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[dbe43db6-c10d-4007-b82e-743beff8ea56]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2025.22412]]></link>
      <description><![CDATA[<p>In this episode, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, and Medical News Director Jennifer Abbasi discuss the journal's inaugural Research of the Year roundup.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.20503?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Research of the Year 2025</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>In this episode, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, and Medical News Director Jennifer Abbasi discuss the journal's inaugural Research of the Year roundup. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.20503?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Research of the Year 2025</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_Research_of_the_Year_With_Editor_in_Chief_Kirsten_Bibbins-Domingo.mp3?dest-id=90171" length="38781234" type="audio/mpeg" />
      <itunes:duration>16:08</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/1/5/6/115689625e6a8273d959afa2a1bf1c87/JSX250176_x450_thumbimg.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>The Sequential Organ Failure Assessment (SOFA)-2 Score</title>
      <itunes:title>The Sequential Organ Failure Assessment (SOFA)-2 Score</itunes:title>
      <pubDate>Wed, 29 Oct 2025 13:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[e834e880-e339-4986-b880-972945771df8]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2025.20881]]></link>
      <description><![CDATA[<p>SOFA-2, validated in more than 3 million intensive care unit (ICU) patients, incorporates contemporary organ support treatments, showing strong predictive validity for ICU mortality in diverse international settings. Coauthor Mervyn Singer, MD, joins JAMA Associate Editor Christopher W. Seymour, MD, MSc, to discuss.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2025.45040?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Rationale and Methodological Approach Underlying the Development of the Sequential Organ Failure Assessment (SOFA)–2 Score</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.20516?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Development and Validation of the Sequential Organ Failure Assessment (SOFA)-2 Score</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.20255?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">A Revision to Organ Failure Assessment in Critically Ill Patients</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>SOFA-2, validated in more than 3 million intensive care unit (ICU) patients, incorporates contemporary organ support treatments, showing strong predictive validity for ICU mortality in diverse international settings. Coauthor Mervyn Singer, MD, joins JAMA Associate Editor Christopher W. Seymour, MD, MSc, to discuss. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2025.45040?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Rationale and Methodological Approach Underlying the Development of the Sequential Organ Failure Assessment (SOFA)–2 Score</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.20516?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Development and Validation of the Sequential Organ Failure Assessment (SOFA)-2 Score</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.20255?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">A Revision to Organ Failure Assessment in Critically Ill Patients</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/The_Sequential_Organ_Failure_Assessment_SOFA-2_Score.mp3?dest-id=90171" length="37501833" type="audio/mpeg" />
      <itunes:duration>15:33</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/1/7/9/9179a43f5772133cd959afa2a1bf1c87/jsx250159audio_thumb_x3000.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>From the JAMA Network: Acetaminophen Use in Pregnancy and Risk of Autism</title>
      <itunes:title>From the JAMA Network: Acetaminophen Use in Pregnancy and Risk of Autism</itunes:title>
      <pubDate>Tue, 30 Sep 2025 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[20e86799-a5af-4399-8653-278de930e7ea]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2025.19347]]></link>
      <description><![CDATA[<p>Epidemiologist Brian Lee, PhD, discusses his study on acetaminophen use during pregnancy and children's risk of autism and other neurodevelopmental disorders in this interview with JAMA Deputy Editor Linda Brubaker, MD.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.19345?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Acetaminophen Use in Pregnancy—Study Author Explains the Data</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Epidemiologist Brian Lee, PhD, discusses his study on acetaminophen use during pregnancy and children's risk of autism and other neurodevelopmental disorders in this interview with JAMA Deputy Editor Linda Brubaker, MD. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.19345?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Acetaminophen Use in Pregnancy—Study Author Explains the Data</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/CP2509-JAI-250929-jama-news-lee.mp3?dest-id=90171" length="40693160" type="audio/mpeg" />
      <itunes:duration>16:58</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/b/c/4/1bc49a356ef5dc7d16c3140a3186d450/JSX250149_thumbimg.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>From the JAMA Network: AI-Based Analysis for Parkinsonism</title>
      <itunes:title>From the JAMA Network: AI-Based Analysis for Parkinsonism</itunes:title>
      <pubDate>Sat, 30 Aug 2025 11:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[c123604e-3570-4c22-aef5-c6775252db9e]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2025.3267]]></link>
      <description><![CDATA[<p>Delaying diagnosis of parkinsonism can mean delaying care. In a study recently published in JAMA Neurology, David Vaillancourt, PhD, and colleagues tested the ability of an AI model to differentiate between Parkinson disease and other neurodegenerative disorders when paired with MRI. He joins JAMA and JAMA+ AI Associate Editor Yulin Hswen, ScD, MPH to discuss.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.3276?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">A Large Proportion of Parkinson Disease Diagnoses Are Wrong—Here's How AI Could Help</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2025.0112?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Automated Imaging Differentiation for Parkinsonism</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Delaying diagnosis of parkinsonism can mean delaying care. In a study recently published in JAMA Neurology, David Vaillancourt, PhD, and colleagues tested the ability of an AI model to differentiate between Parkinson disease and other neurodegenerative disorders when paired with MRI. He joins JAMA and JAMA+ AI Associate Editor Yulin Hswen, ScD, MPH to discuss. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.3276?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">A Large Proportion of Parkinson Disease Diagnoses Are Wrong—Here's How AI Could Help</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2025.0112?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Automated Imaging Differentiation for Parkinsonism</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/CP-JAI-250613-jama-ai-vaillancourt.mp3?dest-id=90171" length="28813484" type="audio/mpeg" />
      <itunes:duration>12:01</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/5/d/a/e/5dae51c3c2e4b39b16c3140a3186d450/JSX250039_x3000_thumbimg.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Treatment of Complicated Staphylococcus aureus Bacteremia</title>
      <itunes:title>Treatment of Complicated Staphylococcus aureus Bacteremia</itunes:title>
      <pubDate>Wed, 13 Aug 2025 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[240d4467-de69-4b13-ae3c-3d861446ae37]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2025.13067]]></link>
      <description><![CDATA[<p>Dalbavancin, a long-acting IV lipoglycopeptide, may be an option for the treatment of complicated Staphylococcus aureus bacteremia without requiring long-term IV access. Author Thomas L. Holland, MD, MSc, from Duke University School of Medicine discusses key points of the DOTS randomized clinical trial and more with JAMA Deputy Editor Preeti Malani, MD, MSJ.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.12543?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Dalbavancin for Treatment of Staphylococcus aureus Bacteremia</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.4288?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Management of Staphylococcus aureus Bacteremia</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Dalbavancin, a long-acting IV lipoglycopeptide, may be an option for the treatment of complicated Staphylococcus aureus bacteremia without requiring long-term IV access. Author Thomas L. Holland, MD, MSc, from Duke University School of Medicine discusses key points of the DOTS randomized clinical trial and more with JAMA Deputy Editor Preeti Malani, MD, MSJ. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.12543?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Dalbavancin for Treatment of Staphylococcus aureus Bacteremia</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.4288?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Management of Staphylococcus aureus Bacteremia</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Treatment_of_Complicated_Staphylococcus_aureus_Bacteremia.mp3?dest-id=90171" length="27835385" type="audio/mpeg" />
      <itunes:duration>11:35</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/a/f/9/0af985f458fe5237d959afa2a1bf1c87/jsx250111audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>From the JAMA Network: Incidence and Nature of Antidepressant Discontinuation Symptoms</title>
      <itunes:title>From the JAMA Network: Incidence and Nature of Antidepressant Discontinuation Symptoms</itunes:title>
      <pubDate>Tue, 05 Aug 2025 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[fd0d0c8f-42e8-4b34-9bda-a51b0ed9ad43]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jamapsychiatry.2025.1752]]></link>
      <description><![CDATA[<p>Interview with Sameer Jauhar, PhD, author of Incidence and Nature of Antidepressant Discontinuation Symptoms: A Systematic Review and Meta-Analysis. Hosted by John Torous, MD.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jamapsychiatry/fullarticle/10.1001/jamapsychiatry.2025.1362?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Incidence and Nature of Antidepressant Discontinuation Symptoms</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Sameer Jauhar, PhD, author of Incidence and Nature of Antidepressant Discontinuation Symptoms: A Systematic Review and Meta-Analysis. Hosted by John Torous, MD. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jamapsychiatry/fullarticle/10.1001/jamapsychiatry.2025.1362?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Incidence and Nature of Antidepressant Discontinuation Symptoms</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/CP-JAI-250709-psy-sai-jauhar-v1.mp3?dest-id=90171" length="39523880" type="audio/mpeg" />
      <itunes:duration>16:29</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/3/e/f/e3ef9e1ebb9f441c16c3140a3186d450/YSX250004_x3000_thumbimg.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>From the JAMA Network: GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension</title>
      <itunes:title>From the JAMA Network: GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension</itunes:title>
      <pubDate>Mon, 28 Jul 2025 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[de6bdb14-82cc-4729-a27b-937d2f2fadc8]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jamaneurol.2025.2895]]></link>
      <description><![CDATA[<p>Interview with Dennis J. Rivet II, MD, author of GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension. Hosted by Cynthia E. Armand, MD.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2025.2020?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Dennis J. Rivet II, MD, author of GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension. Hosted by Cynthia E. Armand, MD. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2025.2020?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/CP-JAI-250714-neu-sai-rivet-v1.mp3?dest-id=90171" length="53421608" type="audio/mpeg" />
      <itunes:duration>22:16</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/f/0/0/2f00deedaf995da716c3140a3186d450/NSX250005_x450_thumbimg.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Life Support and Outcomes in Patients Admitted to Intensive Care Units</title>
      <itunes:title>Life Support and Outcomes in Patients Admitted to Intensive Care Units</itunes:title>
      <pubDate>Mon, 14 Apr 2025 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[7f69b152-3e10-4649-9d4e-841f563050ea]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2025.4003]]></link>
      <description><![CDATA[<p>Nationwide data are unavailable regarding changes in intensive care unit (ICU) outcomes over the past 10 years, limiting understanding of practice changes. Authors Emily Moin, MD, MBE, and Scott D. Halpern, MD, PhD, MBE, of the University of Pennsylvania join JAMA Associate Editor Christopher W. Seymour, MD, MSc, to discuss how ICU care and outcomes have changed in the US over the past decade.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.2163?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Use of Life Support and Outcomes Among Patients Admitted to Intensive Care Units</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Nationwide data are unavailable regarding changes in intensive care unit (ICU) outcomes over the past 10 years, limiting understanding of practice changes. Authors Emily Moin, MD, MBE, and Scott D. Halpern, MD, PhD, MBE, of the University of Pennsylvania join JAMA Associate Editor Christopher W. Seymour, MD, MSc, to discuss how ICU care and outcomes have changed in the US over the past decade. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.2163?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Use of Life Support and Outcomes Among Patients Admitted to Intensive Care Units</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Life_Support_and_Outcomes_in_Patients_Admitted_to_Intensive_Care_Units.mp3?dest-id=90171" length="45604136" type="audio/mpeg" />
      <itunes:duration>19:01</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/5/b/6/25b6c981f71daec4d959afa2a1bf1c87/jsx250046audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Increases in Invasive Group A Streptococcal Infections</title>
      <itunes:title>Increases in Invasive Group A Streptococcal Infections</itunes:title>
      <pubDate>Mon, 07 Apr 2025 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[a22123c5-8dac-4ff8-af1e-dd6c8ecb541e]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2025.4535]]></link>
      <description><![CDATA[<p>The incidence of invasive group A streptococcal infections has risen in the US. Similar observations have been reported in other parts of the world. Authors Joshua Osowicki, MBBS, PhD, of Murdoch Children's Research Institute and Theresa L. Lamagni, MSc, PhD, of the United Kingdom Health Security Agency join JAMA Deputy Editor Preeti Malani, MD, MSJ, to discuss the public health challenge posed by group A strep.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.3257?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Invasive Group A Streptococcal Disease in the US</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.0910?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Invasive Group A Streptococcal Infections in 10 US States</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>The incidence of invasive group A streptococcal infections has risen in the US. Similar observations have been reported in other parts of the world. Authors Joshua Osowicki, MBBS, PhD, of Murdoch Children's Research Institute and Theresa L. Lamagni, MSc, PhD, of the United Kingdom Health Security Agency join JAMA Deputy Editor Preeti Malani, MD, MSJ, to discuss the public health challenge posed by group A strep. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.3257?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Invasive Group A Streptococcal Disease in the US</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.0910?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Invasive Group A Streptococcal Infections in 10 US States</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Increases_in_Invasive_Group_A_Streptococcal_Infections.mp3?dest-id=90171" length="33354552" type="audio/mpeg" />
      <itunes:duration>13:53</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/f/d/1/0/fd108dd709a91023d959afa2a1bf1c87/jsx250055audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Preventive Health Care Among Adults Eligible for Lung Cancer Screening</title>
      <itunes:title>Preventive Health Care Among Adults Eligible for Lung Cancer Screening</itunes:title>
      <pubDate>Wed, 02 Apr 2025 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[179d425f-5fbc-4576-b775-906accafe740]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2025.4527]]></link>
      <description><![CDATA[<p>Less than 20% of patients eligible for lung cancer screening get screened in the US. A recent study examined whether adults eligible for lung cancer screening engage in screening for other types of cancer. Coauthor Chi-Fu Jeffrey Yang, MD, of Harvard Medical School joins JAMA Deputy Editor Tracy Lieu, MD, to discuss.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.2157?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Preventive Health Care Use Among Adults Eligible for Lung Cancer Screening in the US</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Less than 20% of patients eligible for lung cancer screening get screened in the US. A recent study examined whether adults eligible for lung cancer screening engage in screening for other types of cancer. Coauthor Chi-Fu Jeffrey Yang, MD, of Harvard Medical School joins JAMA Deputy Editor Tracy Lieu, MD, to discuss. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.2157?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Preventive Health Care Use Among Adults Eligible for Lung Cancer Screening in the US</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Preventive_Health_Care_Among_Adults_Eligible_for_Lung_Cancer_Screening.mp3?dest-id=90171" length="21971345" type="audio/mpeg" />
      <itunes:duration>09:09</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/d/1/a/2d1a14fd23fda61d16c3140a3186d450/jsx250054audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Cardiac Arrests During Long-Distance Running: What's Changed?</title>
      <itunes:title>Cardiac Arrests During Long-Distance Running: What's Changed?</itunes:title>
      <pubDate>Sun, 30 Mar 2025 22:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[14422eec-f747-4365-aa82-3d4df2e2aec8]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2025.3904]]></link>
      <description><![CDATA[<p>Despite increased participation in US long-distance running races, cardiac arrest incidence remains stable. Authors Jonathan Kim, MD, MSc, of Emory University, and Aaron Baggish, MD, of the University of Lausanne Switzerland, discuss the RACER 2 study and compare results with initial findings published in the RACER 1 study from 13 years ago, with JAMA Associate Editor Gregory Marcus, MD, MAS.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.3026?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Cardiac Arrest During Long-Distance Running Races</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Despite increased participation in US long-distance running races, cardiac arrest incidence remains stable. Authors Jonathan Kim, MD, MSc, of Emory University, and Aaron Baggish, MD, of the University of Lausanne Switzerland, discuss the RACER 2 study and compare results with initial findings published in the RACER 1 study from 13 years ago, with JAMA Associate Editor Gregory Marcus, MD, MAS. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.3026?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Cardiac Arrest During Long-Distance Running Races</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Cardiac_Arrests_During_Long-Distance_Running_Whats_Changed.mp3?dest-id=90171" length="36931872" type="audio/mpeg" />
      <itunes:duration>15:22</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/3/a/9/13a9a2a5e9a600dbd959afa2a1bf1c87/jsx250044audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Inhaled Sedation With Sevoflurane for Acute Respiratory Distress Syndrome (ARDS)</title>
      <itunes:title>Inhaled Sedation With Sevoflurane for Acute Respiratory Distress Syndrome (ARDS)</itunes:title>
      <pubDate>Tue, 18 Mar 2025 07:30:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[916ba0f9-e578-49a0-aa01-edd3a98da354]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2025.3350]]></link>
      <description><![CDATA[<p>ARDS, which is characterized by hypoxemic respiratory failure and inflammatory injury to the lungs, has a mortality rate of 30% to 40%. Balasubramanian Venkatesh, MD, of the George Institute for Global Health joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss the effects of inhaled sedation with sevoflurane for patients with moderate to severe ARDS.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.3023?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Sevoflurane Sedation in Acute Respiratory Distress Syndrome</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.3169?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Inhaled Sedation in Acute Respiratory Distress Syndrome</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>ARDS, which is characterized by hypoxemic respiratory failure and inflammatory injury to the lungs, has a mortality rate of 30% to 40%. Balasubramanian Venkatesh, MD, of the George Institute for Global Health joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss the effects of inhaled sedation with sevoflurane for patients with moderate to severe ARDS. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.3023?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Sevoflurane Sedation in Acute Respiratory Distress Syndrome</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.3169?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Inhaled Sedation in Acute Respiratory Distress Syndrome</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Inhaled_Sedation_With_Sevoflurane_for_Acute_Respiratory_Distress_Syndrome_ARDS.mp3?dest-id=90171" length="43518122" type="audio/mpeg" />
      <itunes:duration>18:08</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/b/8/6/1/b861d669cd4cd4c1d959afa2a1bf1c87/jsx250041audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>New FDA Pulse Oximetry Guidance: Strengths and Weaknesses</title>
      <itunes:title>New FDA Pulse Oximetry Guidance: Strengths and Weaknesses</itunes:title>
      <pubDate>Wed, 05 Mar 2025 16:15:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[726f5f1e-0a4a-4410-ac49-dc71ee46faa3]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2025.2338]]></link>
      <description><![CDATA[<p>The US Food and Drug Administration (FDA) issued new draft regulatory guidance for pulse oximeters related to skin pigment. The guidance is a step forward but it may have unintended consequences. Authors Michael Lipnick, MD, and Philip Bicker, MD, PhD, professors of anesthesia at University of California, San Francisco, discuss this and more with JAMA Executive Editor Gregory Curfman, MD.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.1959?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Pulse Oximetry and Skin Pigmentation—New Guidance From the FDA</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.26473?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Adherence to FDA Guidance on Pulse Oximetry Testing Among Diverse Individuals, 1996-2024</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.25443?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Addressing Racial and Ethnic Bias in Pulse Oximeters—A Wicked Problem</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2023.0071?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Evaluating the Accuracy of Pulse Oximetry in Children According to Race</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>The US Food and Drug Administration (FDA) issued new draft regulatory guidance for pulse oximeters related to skin pigment. The guidance is a step forward but it may have unintended consequences. Authors Michael Lipnick, MD, and Philip Bicker, MD, PhD, professors of anesthesia at University of California, San Francisco, discuss this and more with JAMA Executive Editor Gregory Curfman, MD. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.1959?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Pulse Oximetry and Skin Pigmentation—New Guidance From the FDA</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.26473?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Adherence to FDA Guidance on Pulse Oximetry Testing Among Diverse Individuals, 1996-2024</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.25443?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Addressing Racial and Ethnic Bias in Pulse Oximeters—A Wicked Problem</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2023.0071?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Evaluating the Accuracy of Pulse Oximetry in Children According to Race</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/New_FDA_Pulse_Oximetry_Guidance_Strengths_and_Weaknesses.mp3?dest-id=90171" length="40395415" type="audio/mpeg" />
      <itunes:duration>16:50</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/6/6/5/a6654efa25f2479fd959afa2a1bf1c87/jsx250027audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Combining CAC Score With Treatment on Plaque Progression in Familial Coronary Artery Disease</title>
      <itunes:title>Combining CAC Score With Treatment on Plaque Progression in Familial Coronary Artery Disease</itunes:title>
      <pubDate>Wed, 05 Mar 2025 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[29aadef3-2506-469f-89f9-7f3121761742]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2025.2106]]></link>
      <description><![CDATA[<p>The CAUGHT-CAD randomized clinical trial sought to determine whether a CAC score-informed strategy could slow the progression of coronary plaque volume. Author Thomas H. Marwick of the Baker Heart & Diabetes Institute joins JAMA Associate Editor Pradeep Natarajan to discuss "Effects of Combining Coronary Calcium Score With Treatment on Plaque Progression in Familial Coronary Artery Disease."<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.0584?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Effects of Combining Coronary Calcium Score With Treatment on Plaque Progression in Familial Coronary Artery Disease</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.0610?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Cardiac CT Calcium Score</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jamacardiology/fullarticle/10.1001/jamacardio.2024.5644?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Coronary Artery Calcium Testing—Too Early, Too Late, Too Often</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jamacardiology/fullarticle/10.1001/jamacardio.2025.0410?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Filling the Evidence Gaps Toward a Coronary Artery Calcium-Guided Primary Prevention Strategy</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>The CAUGHT-CAD randomized clinical trial sought to determine whether a CAC score-informed strategy could slow the progression of coronary plaque volume. Author Thomas H. Marwick of the Baker Heart & Diabetes Institute joins JAMA Associate Editor Pradeep Natarajan to discuss "Effects of Combining Coronary Calcium Score With Treatment on Plaque Progression in Familial Coronary Artery Disease." Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.0584?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Effects of Combining Coronary Calcium Score With Treatment on Plaque Progression in Familial Coronary Artery Disease</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.0610?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Cardiac CT Calcium Score</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jamacardiology/fullarticle/10.1001/jamacardio.2024.5644?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Coronary Artery Calcium Testing—Too Early, Too Late, Too Often</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jamacardiology/fullarticle/10.1001/jamacardio.2025.0410?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Filling the Evidence Gaps Toward a Coronary Artery Calcium-Guided Primary Prevention Strategy</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Combining_CAC_Score_With_Treatment_on_Plaque_Progression_in_Familial_Coronary_Artery_Disease.mp3?dest-id=90171" length="25383160" type="audio/mpeg" />
      <itunes:duration>10:23</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/4/9/8/3498f0f2bd11f41b16c3140a3186d450/jsx250025audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Evaluating Treatments for Amyotrophic Lateral Sclerosis</title>
      <itunes:title>Evaluating Treatments for Amyotrophic Lateral Sclerosis</itunes:title>
      <pubDate>Mon, 17 Feb 2025 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[a8998e94-0c75-4d4b-91ca-9946fc01f872]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2025.1084]]></link>
      <description><![CDATA[<p>The HEALEY ALS platform is an innovative first attempt at platform trials in ALS, looking to slow ALS disease progression. Author Sabrina Paganoni, MD, PhD, of Massachusetts General Hospital and Harvard Medical School, discusses results of the first 4 drug regimens from this platform trial and how this study design makes efficient use of resources, with JAMA Deputy Editor Christopher Muth, MD.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.27688?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Platform Clinical Trials for the Efficient Evaluation of Multiple Treatments</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.26429?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Pridopidine in Amyotrophic Lateral Sclerosis</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.0100?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Platform Trials in ALS</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2024.5249?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Verdiperstat in Amyotrophic Lateral Sclerosis</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.59058?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.27643?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">CNM-Au8 in Amyotrophic Lateral Sclerosis</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>The HEALEY ALS platform is an innovative first attempt at platform trials in ALS, looking to slow ALS disease progression. Author Sabrina Paganoni, MD, PhD, of Massachusetts General Hospital and Harvard Medical School, discusses results of the first 4 drug regimens from this platform trial and how this study design makes efficient use of resources, with JAMA Deputy Editor Christopher Muth, MD. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.27688?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Platform Clinical Trials for the Efficient Evaluation of Multiple Treatments</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.26429?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Pridopidine in Amyotrophic Lateral Sclerosis</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.0100?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Platform Trials in ALS</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2024.5249?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Verdiperstat in Amyotrophic Lateral Sclerosis</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.59058?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.27643?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">CNM-Au8 in Amyotrophic Lateral Sclerosis</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Evaluating_Treatments_for_Amyotrophic_Lateral_Sclerosis.mp3?dest-id=90171" length="54185880" type="audio/mpeg" />
      <itunes:duration>22:34</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/e/7/d/ae7da203652fabe216c3140a3186d450/jsx250020audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>US Health Care Spending by Health Condition and County—What Drives Variation?</title>
      <itunes:title>US Health Care Spending by Health Condition and County—What Drives Variation?</itunes:title>
      <pubDate>Fri, 14 Feb 2025 15:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[8f85bce6-f339-4459-9e74-449541b61e32]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2025.190]]></link>
      <description><![CDATA[<p>Understanding health conditions with the most spending and variation across locations and over time is important for identifying trends, inequalities, and strategies for lowering health spending. Joseph Dieleman, PhD, of the University of Washington speaks with JAMA Associate Editor Karen Joynt Maddox, MD, MPH, about county-level variation in health care spending across the US.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.26790?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Tracking US Health Care Spending by Health Condition and County</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Understanding health conditions with the most spending and variation across locations and over time is important for identifying trends, inequalities, and strategies for lowering health spending. Joseph Dieleman, PhD, of the University of Washington speaks with JAMA Associate Editor Karen Joynt Maddox, MD, MPH, about county-level variation in health care spending across the US. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.26790?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Tracking US Health Care Spending by Health Condition and County</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/US_Health_Care_Spending_by_Health_Condition_and_County_What_Drives_Variation.mp3?dest-id=90171" length="32327103" type="audio/mpeg" />
      <itunes:duration>13:28</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/4/1/9/14198eb5331b82ad16c3140a3186d450/jsx250003audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Supporting Children and Families in an Era With Abortion Restrictions</title>
      <itunes:title>Supporting Children and Families in an Era With Abortion Restrictions</itunes:title>
      <pubDate>Thu, 13 Feb 2025 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[bc9c6d15-6880-4f3d-a427-2bf5807acf92]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2025.1023]]></link>
      <description><![CDATA[<p>Two recent studies published in JAMA provide evidence about the effects of state-level abortion restrictions on birth rates and infant mortality. Author Alyssa Bilinski, PhD, MSc, of Brown University School of Public Health joins JAMA Deputy Editor Tracy Lieu, MD, to discuss her related Editorial "Abortion May Be Controversial—Supporting Children and Families Need Not Be."<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.0854?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Abortion May Be Controversial—Supporting Children and Families Need Not Be</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Two recent studies published in JAMA provide evidence about the effects of state-level abortion restrictions on birth rates and infant mortality. Author Alyssa Bilinski, PhD, MSc, of Brown University School of Public Health joins JAMA Deputy Editor Tracy Lieu, MD, to discuss her related Editorial "Abortion May Be Controversial—Supporting Children and Families Need Not Be." Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.0854?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Abortion May Be Controversial—Supporting Children and Families Need Not Be</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Supporting_Children_and_Families_in_an_Era_With_Abortion_Restrictions.mp3?dest-id=90171" length="26904400" type="audio/mpeg" />
      <itunes:duration>11:12</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/4/5/f/a45fb35b6af7d628d959afa2a1bf1c87/jsx250019audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Evaluating Comprehensive Models–Challenges and Innovations in Dementia Care</title>
      <itunes:title>Evaluating Comprehensive Models–Challenges and Innovations in Dementia Care</itunes:title>
      <pubDate>Wed, 29 Jan 2025 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[b9fd9abf-3564-4dfc-907a-e8b02c8d9517]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.28253]]></link>
      <description><![CDATA[<p>Contemporary models of dementia care are multidisciplinary and aim to bridge medical and social services. Julie P. W. Bynum, MD, MPH, of the University of Michigan speaks with JAMA Deputy Editor Christopher C. Muth, MD, about 2 trials—the D-CARE and IN-PEACE trials—that evaluated care models to support people diagnosed with dementia and their caregivers.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.28066?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Challenges and Innovations in Dementia Care—Evaluating Comprehensive Models</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.25056?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Health System, Community-Based, or Usual Dementia Care for Persons With Dementia and Caregivers</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.25845?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Palliative Care Program for Community-Dwelling Individuals With Dementia and Caregivers</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Contemporary models of dementia care are multidisciplinary and aim to bridge medical and social services. Julie P. W. Bynum, MD, MPH, of the University of Michigan speaks with JAMA Deputy Editor Christopher C. Muth, MD, about 2 trials—the D-CARE and IN-PEACE trials—that evaluated care models to support people diagnosed with dementia and their caregivers. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.28066?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Challenges and Innovations in Dementia Care—Evaluating Comprehensive Models</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.25056?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Health System, Community-Based, or Usual Dementia Care for Persons With Dementia and Caregivers</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.25845?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Palliative Care Program for Community-Dwelling Individuals With Dementia and Caregivers</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Evaluating_Comprehensive_ModelsChallenges_and_Innovations_in_Dementia_Care.mp3?dest-id=90171" length="42795613" type="audio/mpeg" />
      <itunes:duration>17:50</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/c/b/d/1cbdfe75e8ca6df4d959afa2a1bf1c87/jsx240219audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Intra-Arterial Thrombolytics Following Thrombectomy for Ischemic Stroke</title>
      <itunes:title>Intra-Arterial Thrombolytics Following Thrombectomy for Ischemic Stroke</itunes:title>
      <pubDate>Mon, 13 Jan 2025 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[d321c758-c008-4e08-b113-c048e58f62b3]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.27319]]></link>
      <description><![CDATA[<p>Two new trials published in JAMA evaluate the efficacy of periprocedural intra-arterial thrombolytics after successful endovascular thrombectomy for patients with acute ischemic stroke. Diederik Dippel, MD, PhD, of Erasmus University Medical Center discusses this and more with JAMA Deputy Editor Christopher C. Muth, MD.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.27100?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Intra-Arterial Thrombolytics During Thrombectomy for Ischemic Stroke—End of the Story or a New Beginning?</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.23466?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Intra-Arterial Tenecteplase Following Endovascular Reperfusion for Large Vessel Occlusion Acute Ischemic Stroke</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.23480?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Intra-Arterial Urokinase After Endovascular Reperfusion for Acute Ischemic Stroke</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Two new trials published in JAMA evaluate the efficacy of periprocedural intra-arterial thrombolytics after successful endovascular thrombectomy for patients with acute ischemic stroke. Diederik Dippel, MD, PhD, of Erasmus University Medical Center discusses this and more with JAMA Deputy Editor Christopher C. Muth, MD. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.27100?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Intra-Arterial Thrombolytics During Thrombectomy for Ischemic Stroke—End of the Story or a New Beginning?</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.23466?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Intra-Arterial Tenecteplase Following Endovascular Reperfusion for Large Vessel Occlusion Acute Ischemic Stroke</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.23480?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Intra-Arterial Urokinase After Endovascular Reperfusion for Acute Ischemic Stroke</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Intra-Arterial_Thrombolytics_Following_Thrombectomy_for_Ischemic_Stroke.mp3?dest-id=90171" length="26684424" type="audio/mpeg" />
      <itunes:duration>11:07</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/d/8/e/0d8eb0f0e9959f1816c3140a3186d450/jsx240208audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Impact of Private Equity Acquisition on Patient Care Experience in US Hospitals</title>
      <itunes:title>Impact of Private Equity Acquisition on Patient Care Experience in US Hospitals</itunes:title>
      <pubDate>Thu, 09 Jan 2025 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[58c97f3f-5da8-4603-b617-2212e1a09f50]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.27459]]></link>
      <description><![CDATA[<p>Private equity acquisitions of health care facilities have rapidly increased over the past decade. However, little is known about the effects of these acquisitions on patient experience. Author Rishi K. Wadhera, MD, MPP, MPhil, of Harvard Medical School discusses this topic with JAMA Associate Editor Karen Joynt Maddox, MD, MPH.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.23450?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Changes in Patient Care Experience After Private Equity Acquisition of US Hospitals</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Private equity acquisitions of health care facilities have rapidly increased over the past decade. However, little is known about the effects of these acquisitions on patient experience. Author Rishi K. Wadhera, MD, MPP, MPhil, of Harvard Medical School discusses this topic with JAMA Associate Editor Karen Joynt Maddox, MD, MPH. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.23450?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Changes in Patient Care Experience After Private Equity Acquisition of US Hospitals</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Impact_of_Private_Equity_Acquisition_on_Patient_Care_Experience_in_US_Hospitals.mp3?dest-id=90171" length="31587110" type="audio/mpeg" />
      <itunes:duration>13:09</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/b/9/e/eb9eae742e53252816c3140a3186d450/jsx240209audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Asthma Endotypes Based on Nasal Epithelial Biopsies in School-Aged Youth</title>
      <itunes:title>Asthma Endotypes Based on Nasal Epithelial Biopsies in School-Aged Youth</itunes:title>
      <pubDate>Thu, 02 Jan 2025 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[7e4a3f0b-5c6d-47b5-a61b-2679f1ac909e]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.26305]]></link>
      <description><![CDATA[<p>Certain CD4+ T-cell subtypes play a role in asthma. Characterizing asthma endotypes in diverse groups is important to help develop effective therapies for youth with asthma. Author Juan C. Celedon, MD, DrPH, University of Pittsburgh, Department of Pediatrics, discusses this and more with JAMA Deputy Editor Kristin L. Walter, MD, MS.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.22684?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Transcriptomic Profiles in Nasal Epithelium and Asthma Endotypes in Youth</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Certain CD4+ T-cell subtypes play a role in asthma. Characterizing asthma endotypes in diverse groups is important to help develop effective therapies for youth with asthma. Author Juan C. Celedon, MD, DrPH, University of Pittsburgh, Department of Pediatrics, discusses this and more with JAMA Deputy Editor Kristin L. Walter, MD, MS. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.22684?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Transcriptomic Profiles in Nasal Epithelium and Asthma Endotypes in Youth</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Asthma_Endotypes_Based_on_Nasal_Epithelial_Biopsies_in_School-Aged_Youth.mp3?dest-id=90171" length="27730808" type="audio/mpeg" />
      <itunes:duration>11:33</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/5/e/e/a5ee7e96916c71c016c3140a3186d450/jsx240205audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Dental Benefits and Medicare Advantage Plans</title>
      <itunes:title>Dental Benefits and Medicare Advantage Plans</itunes:title>
      <pubDate>Thu, 26 Dec 2024 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[00f8b316-a8ec-4f83-8973-0ace8a0fc134]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.25728]]></link>
      <description><![CDATA[<p>Most Medicare Advantage (MA) plans offer dental care coverage as a supplemental benefit. However,few beneficiaries are enrolled in an MA plan that provides comprehensive dental benefits. Lisa Simon, MD, DMD, discusses this and more with JAMA Deputy Editor Kristin L. Walter, MD, MS.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.24814?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Availability of Dental Benefits Within Medicare Advantage Plans by Enrollment and County</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Most Medicare Advantage (MA) plans offer dental care coverage as a supplemental benefit. However,few beneficiaries are enrolled in an MA plan that provides comprehensive dental benefits. Lisa Simon, MD, DMD, discusses this and more with JAMA Deputy Editor Kristin L. Walter, MD, MS. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.24814?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Availability of Dental Benefits Within Medicare Advantage Plans by Enrollment and County</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Dental_Benefits_and_Medicare_Advantage_Plans.mp3?dest-id=90171" length="27233312" type="audio/mpeg" />
      <itunes:duration>11:20</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/f/3/5/af35b6f0825c7779d959afa2a1bf1c87/jsx240198audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>2024 Update on Long COVID Classification and Symptom List</title>
      <itunes:title>2024 Update on Long COVID Classification and Symptom List</itunes:title>
      <pubDate>Wed, 18 Dec 2024 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[356a2dae-831f-457c-a498-febaca82eb6e]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.26168]]></link>
      <description><![CDATA[<p>Long COVID is now defined as a heterogeneous, infection-associated chronic condition present for at least 3 months after SARS-CoV-2 infection. Author Leora Horwitz, MD, MHS, of NYU Grossman School of Medicine joins JAMA Executive Editor Gregory Curfman, MD, to discuss the JAMA article "2024 Update of the RECOVER-Adult Long COVID Research Index."<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.24184?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">2024 Update of the RECOVER-Adult Long COVID Research Index</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.12747?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Characterizing Long COVID in Children and Adolescents</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Long COVID is now defined as a heterogeneous, infection-associated chronic condition present for at least 3 months after SARS-CoV-2 infection. Author Leora Horwitz, MD, MHS, of NYU Grossman School of Medicine joins JAMA Executive Editor Gregory Curfman, MD, to discuss the JAMA article "2024 Update of the RECOVER-Adult Long COVID Research Index." Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.24184?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">2024 Update of the RECOVER-Adult Long COVID Research Index</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.12747?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Characterizing Long COVID in Children and Adolescents</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/2024_Update_on_Long_COVID_Classification_and_Symptom_List.mp3?dest-id=90171" length="29531161" type="audio/mpeg" />
      <itunes:duration>12:18</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/9/3/5/9935320f36ced1db16c3140a3186d450/jsx240203audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Camrelizumab vs Placebo With Chemotherapy as Neoadjuvant Treatment in Triple-Negative Breast Cancer</title>
      <itunes:title>Camrelizumab vs Placebo With Chemotherapy as Neoadjuvant Treatment in Triple-Negative Breast Cancer</itunes:title>
      <pubDate>Fri, 13 Dec 2024 16:15:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[5f946f29-fdb5-481e-92a5-b1090d2b0afb]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.25897]]></link>
      <description><![CDATA[<p>Triple-negative breast cancer accounts for around 15% of breast cancers. Zhi-Ming Shao, MD, of Fudon University, joins JAMA Oncology Editor in Chief and JAMA Deputy Editor Nora Disis, MD, to discuss "Camrelizumab vs Placebo in Combination With Chemotherapy as Neoadjuvant Treatment in Patients with Early or Locally Advanced Triple-Negative Breast Cancer: The CamRelief Randomized Clinical Trial."<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.23560?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Camrelizumab vs Placebo in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-Negative Breast Cancer</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Triple-negative breast cancer accounts for around 15% of breast cancers. Zhi-Ming Shao, MD, of Fudon University, joins JAMA Oncology Editor in Chief and JAMA Deputy Editor Nora Disis, MD, to discuss "Camrelizumab vs Placebo in Combination With Chemotherapy as Neoadjuvant Treatment in Patients with Early or Locally Advanced Triple-Negative Breast Cancer: The CamRelief Randomized Clinical Trial." Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.23560?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Camrelizumab vs Placebo in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-Negative Breast Cancer</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Camrelizumab_vs_Placebo_With_Chemotherapy_as_Neoadjuvant_Treatment_in_Triple-Negative_Breast_Cancer.mp3?dest-id=90171" length="36568539" type="audio/mpeg" />
      <itunes:duration>15:14</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/8/8/2/1882a4ee2bcf4c16d959afa2a1bf1c87/jsx240200audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>HIV Treatment and Prevention: Updated Recommendations</title>
      <itunes:title>HIV Treatment and Prevention: Updated Recommendations</itunes:title>
      <pubDate>Sun, 01 Dec 2024 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[e0d3667b-d29a-42bf-a2bb-082c1d0691e3]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.24732]]></link>
      <description><![CDATA[<p>New antiretroviral drugs and formulations continue to become available for the prevention and management of HIV infection. Author Rajesh T. Gandhi, MD, joins JAMA Deputy Editor Preeti Malani, MD, MSJ, to discuss these new approaches for HIV.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.24543?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society–USA Panel</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.24027?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Advances in Treatment and Prevention of HIV</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>New antiretroviral drugs and formulations continue to become available for the prevention and management of HIV infection. Author Rajesh T. Gandhi, MD, joins JAMA Deputy Editor Preeti Malani, MD, MSJ, to discuss these new approaches for HIV. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.24543?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society–USA Panel</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.24027?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Advances in Treatment and Prevention of HIV</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/HIV_Treatment_and_Prevention_Updated_Recommendations.mp3?dest-id=90171" length="36002806" type="audio/mpeg" />
      <itunes:duration>15:00</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/5/d/1/5/5d150c70782f063116c3140a3186d450/jsx240193audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>The Impacts of Severe Maternal Morbidity</title>
      <itunes:title>The Impacts of Severe Maternal Morbidity</itunes:title>
      <pubDate>Mon, 25 Nov 2024 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[d0bbf078-cbf9-438e-93a6-ff301b443ddb]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.24047]]></link>
      <description><![CDATA[<p>A new JAMA study examines the association between severe maternal morbidity in a first birth and the probability of a subsequent birth. Authors Neda Razaz, PhD, and Eleni Tsamantioti, MD, MMedSc, both from the Karolinska Institute in Sweden, discuss this and more with JAMA Associate Editor Melissa A. Simon, MD, MPH.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.20957?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Association of Severe Maternal Morbidity With Subsequent Birth</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.25308?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Severe Maternal Morbidity and Subsequent Birth—Understanding and Informing a Woman's Choice</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>A new JAMA study examines the association between severe maternal morbidity in a first birth and the probability of a subsequent birth. Authors Neda Razaz, PhD, and Eleni Tsamantioti, MD, MMedSc, both from the Karolinska Institute in Sweden, discuss this and more with JAMA Associate Editor Melissa A. Simon, MD, MPH. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.20957?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Association of Severe Maternal Morbidity With Subsequent Birth</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.25308?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Severe Maternal Morbidity and Subsequent Birth—Understanding and Informing a Woman's Choice</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/The_Impacts_of_Severe_Maternal_Morbidity.mp3?dest-id=90171" length="32241098" type="audio/mpeg" />
      <itunes:duration>13:25</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/d/8/6/f/d86fb63f18efe45e40be95ea3302a6a1/jsx240187audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Zerlasiran, a Small-Interfering RNA That Targets Lipoprotein(a)</title>
      <itunes:title>Zerlasiran, a Small-Interfering RNA That Targets Lipoprotein(a)</itunes:title>
      <pubDate>Mon, 18 Nov 2024 19:40:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[b2589647-8995-4372-9df8-f7e210490c3a]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.23752]]></link>
      <description><![CDATA[<p>Elevated lipoprotein(a) levels increase the risk of atherosclerotic cardiovascular disease (ASCVD) and aortic stenosis. Cleveland Clinic's Steven E. Nissen, MD, speaks with JAMA Executive Editor Gregory Curfman, MD, about how zerlasiran produced more than 80% reductions in time-averaged lipoprotein(a) concentration.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.21957?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Zerlasiran—A Small-Interfering RNA Targeting Lipoprotein(a)</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Elevated lipoprotein(a) levels increase the risk of atherosclerotic cardiovascular disease (ASCVD) and aortic stenosis. Cleveland Clinic's Steven E. Nissen, MD, speaks with JAMA Executive Editor Gregory Curfman, MD, about how zerlasiran produced more than 80% reductions in time-averaged lipoprotein(a) concentration. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.21957?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Zerlasiran—A Small-Interfering RNA Targeting Lipoprotein(a)</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Zerlasiran_a_Small-Interfering_RNA_That_Targets_Lipoproteina.mp3?dest-id=90171" length="34470337" type="audio/mpeg" />
      <itunes:duration>14:21</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/7/2/2/872290db3ae1de0427a2322813b393ee/jsx240183audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Intratracheal Budesonide for Extremely Preterm Infants</title>
      <itunes:title>Intratracheal Budesonide for Extremely Preterm Infants</itunes:title>
      <pubDate>Mon, 11 Nov 2024 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[e3a0b8a0-d884-47d1-959b-86f8e7610901]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.22763]]></link>
      <description><![CDATA[<p>Preterm birth is the greatest cause of neonatal mortality and morbidity, with infants born extremely preterm at highest risk. Author Brett J. Manley, PhD, the Royal Women's Hospital, Melbourne, Australia, discusses a new study of the effect of intratracheal corticosteroid administration on survival free of bronchopulmonary dysplasia in preterm infants, with JAMA Deputy Editor Tracy A. Lieu, MD, MPH.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.17380?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Intratracheal Budesonide Mixed With Surfactant for Extremely Preterm Infants</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Preterm birth is the greatest cause of neonatal mortality and morbidity, with infants born extremely preterm at highest risk. Author Brett J. Manley, PhD, the Royal Women's Hospital, Melbourne, Australia, discusses a new study of the effect of intratracheal corticosteroid administration on survival free of bronchopulmonary dysplasia in preterm infants, with JAMA Deputy Editor Tracy A. Lieu, MD, MPH. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.17380?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Intratracheal Budesonide Mixed With Surfactant for Extremely Preterm Infants</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Intratracheal_Budesonide_for_Extremely_Preterm_Infants.mp3?dest-id=90171" length="20320137" type="audio/mpeg" />
      <itunes:duration>08:27</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/d/b/8/adb8ae13edcb3fc127a2322813b393ee/jsx240174audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Digital Health Behavior Intervention to Prevent Childhood Obesity</title>
      <itunes:title>Digital Health Behavior Intervention to Prevent Childhood Obesity</itunes:title>
      <pubDate>Sun, 03 Nov 2024 22:30:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[9b2148d6-227d-480d-8bdb-f89233f3ca7c]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.22749]]></link>
      <description><![CDATA[<p>Preventing obesity in early childhood is challenging for clinicians and families. Authors Eliana M. Perrin, MD, MPH, of Johns Hopkins University, and William J. Heerman, MD, MPH, of Vanderbilt University, join JAMA Deputy Editor Tracy Lieu, MD, to discuss "A Digital Health Behavior Intervention to Prevent Childhood Obesity: The Greenlight Plus Randomized Clinical Trial."<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.22362?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">A Digital Health Behavior Intervention to Prevent Childhood Obesity</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Preventing obesity in early childhood is challenging for clinicians and families. Authors Eliana M. Perrin, MD, MPH, of Johns Hopkins University, and William J. Heerman, MD, MPH, of Vanderbilt University, join JAMA Deputy Editor Tracy Lieu, MD, to discuss "A Digital Health Behavior Intervention to Prevent Childhood Obesity: The Greenlight Plus Randomized Clinical Trial." Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.22362?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">A Digital Health Behavior Intervention to Prevent Childhood Obesity</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Digital_Health_Behavior_Intervention_to_Prevent_Childhood_Obesity.mp3?dest-id=90171" length="31394956" type="audio/mpeg" />
      <itunes:duration>13:05</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/4/4/8/6/44864eb00e63faade55e3c100dce7605/jsx240173audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Drug Shortages After Supply Chain Issues in the US vs Canada</title>
      <itunes:title>Drug Shortages After Supply Chain Issues in the US vs Canada</itunes:title>
      <pubDate>Thu, 31 Oct 2024 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[39c39999-36a6-4574-bec4-e9c308027886]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.21852]]></link>
      <description><![CDATA[<p>A new study published in JAMA found that drug-related supply chain issue reports were 40% less likely to result in meaningful drug shortages in Canada compared with the US. Authors Kate Suda, PharmD, MS, of University of Pittsburgh School of Medicine, and Mina Tadrous, PharmD, PhD, of University of Toronto, discuss this and more with JAMA Deputy Editor Joseph S. Ross, MD, MHS.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.17688?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Differences in Drug Shortages in the US and Canada</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.18682?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Understanding Drug Supply Shortages in the US and Canada</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>A new study published in JAMA found that drug-related supply chain issue reports were 40% less likely to result in meaningful drug shortages in Canada compared with the US. Authors Kate Suda, PharmD, MS, of University of Pittsburgh School of Medicine, and Mina Tadrous, PharmD, PhD, of University of Toronto, discuss this and more with JAMA Deputy Editor Joseph S. Ross, MD, MHS. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.17688?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Differences in Drug Shortages in the US and Canada</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.18682?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Understanding Drug Supply Shortages in the US and Canada</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Drug_Shortages_After_Supply_Chain_Issues_in_the_US_vs_Canada.mp3?dest-id=90171" length="28080391" type="audio/mpeg" />
      <itunes:duration>11:42</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/5/d/8/e/5d8ec3b56404307127a2322813b393ee/jsx240170audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Advanced Birth Centers Raise Safety Concerns for Obstetric Care</title>
      <itunes:title>Advanced Birth Centers Raise Safety Concerns for Obstetric Care</itunes:title>
      <pubDate>Mon, 21 Oct 2024 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[a0716111-79c1-4b5c-97c9-e1096d66967a]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.21127]]></link>
      <description><![CDATA[<p>In the US, childbirth typically occurs in hospitals or accredited birth centers. President of the American College of Obstetricians and Gynecologists Stella Marie Dantas, MD, speaks with JAMA Deputy Editor Linda Brubaker, MD, MS, about newly proposed advanced birth centers that would permit higher-risk births, with concerns for patient safety and rural obstetric care access.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.20539?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Advanced Birth Centers and the Effect on Maternity Care</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>In the US, childbirth typically occurs in hospitals or accredited birth centers. President of the American College of Obstetricians and Gynecologists Stella Marie Dantas, MD, speaks with JAMA Deputy Editor Linda Brubaker, MD, MS, about newly proposed advanced birth centers that would permit higher-risk births, with concerns for patient safety and rural obstetric care access. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.20539?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Advanced Birth Centers and the Effect on Maternity Care</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Advanced_Birth_Centers_Raise_Safety_Concerns_for_Obstetric_Care.mp3?dest-id=90171" length="24494893" type="audio/mpeg" />
      <itunes:duration>10:12</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/f/0/f/0/f0f043f397a921e227a2322813b393ee/jsx240162audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Declaration of Helsinki Addresses New Ethical Challenges</title>
      <itunes:title>Declaration of Helsinki Addresses New Ethical Challenges</itunes:title>
      <pubDate>Sat, 19 Oct 2024 17:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[f2906760-49a1-4a0b-a83f-57a95bce04ed]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.19395]]></link>
      <description><![CDATA[<p>The Declaration of Helsinki originated in 1964, developed by the World Medical Association (WMA). Process Chair Jack S. Resneck Jr, MD, discusses the 2024 updates to the Declaration of Helsinki with JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.21902?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Revisions to the Declaration of Helsinki on Its 60th Anniversary</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.21972?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">World Medical Association Declaration of Helsinki</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.0269?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Making the Ethical Oversight of All Clinical Trials Fit for Purpose</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.22074?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">The Revised Declaration of Helsinki—Considerations for the Future of Artificial Intelligence in Health and Medical Research</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.22077?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Revisiting the Declaration of Helsinki—A Patient-Centered Perspective</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.22254?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Future-Proofing Research Ethics—Key Revisions of the Declaration of Helsinki 2024</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.22270?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">The Revision of the Declaration of Helsinki Viewed From the Americas—Paving the Way to Better Research</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.22281?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Declaration of Helsinki—Revisions for the 21st Century</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.22126?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Facilitating Efficient and Ethical Trials at the Intersection of Research and Clinical Care</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.22530?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">The 2024 Revision to the Declaration of Helsinki</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>The Declaration of Helsinki originated in 1964, developed by the World Medical Association (WMA). Process Chair Jack S. Resneck Jr, MD, discusses the 2024 updates to the Declaration of Helsinki with JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.21902?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Revisions to the Declaration of Helsinki on Its 60th Anniversary</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.21972?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">World Medical Association Declaration of Helsinki</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.0269?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Making the Ethical Oversight of All Clinical Trials Fit for Purpose</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.22074?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">The Revised Declaration of Helsinki—Considerations for the Future of Artificial Intelligence in Health and Medical Research</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.22077?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Revisiting the Declaration of Helsinki—A Patient-Centered Perspective</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.22254?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Future-Proofing Research Ethics—Key Revisions of the Declaration of Helsinki 2024</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.22270?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">The Revision of the Declaration of Helsinki Viewed From the Americas—Paving the Way to Better Research</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.22281?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Declaration of Helsinki—Revisions for the 21st Century</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.22126?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Facilitating Efficient and Ethical Trials at the Intersection of Research and Clinical Care</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.22530?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">The 2024 Revision to the Declaration of Helsinki</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Declaration_of_Helsinki_Addresses_New_Ethical_Challenges.mp3?dest-id=90171" length="36327595" type="audio/mpeg" />
      <itunes:duration>15:08</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/4/1/7/a417b1957e2ebf3427a2322813b393ee/jsx240149audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>JAMA Critical Care Research at ESICM Congress 2024</title>
      <itunes:title>JAMA Critical Care Research at ESICM Congress 2024</itunes:title>
      <pubDate>Wed, 09 Oct 2024 11:45:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[38c9b49c-7df3-463f-831d-4e8c0ff787fd]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.21157]]></link>
      <description><![CDATA[<p>Transfusion strategy for patients with acute brain injury, telehealth care, acute kidney injury after cardiac surgery, and weaning ventilatory support are the topics of 4 trials published in JAMA and presented at the 2024 European Society of Intensive Care Medicine meeting. JAMA Associate Editor Christopher Seymour, MD, MSc, joins Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.20416?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Shifting Balance of the Risk-Benefit of Restrictive Transfusion Strategies in Neurocritically Ill Patients—Is Less Still More?</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.19854?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Evaluating Complex Technological Innovations in Critical Care—Current Challenges and Future Directions</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.20928?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Impact of Adsorptive Blood Purification on Kidney Outcomes</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.19853?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Ventilator Weaning Strategies—Managing Interaction Between Randomized Treatments</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.20424?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Restrictive vs Liberal Transfusion Strategy in Patients With Acute Brain Injury</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.20651?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Effect of Tele-ICU on Clinical Outcomes of Critically Ill Patients</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.20630?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Extracorporeal Blood Purification and Acute Kidney Injury in Cardiac Surgery</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.20631?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Frequency of Screening and Spontaneous Breathing Trial Techniques</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Transfusion strategy for patients with acute brain injury, telehealth care, acute kidney injury after cardiac surgery, and weaning ventilatory support are the topics of 4 trials published in JAMA and presented at the 2024 European Society of Intensive Care Medicine meeting. JAMA Associate Editor Christopher Seymour, MD, MSc, joins Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.20416?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Shifting Balance of the Risk-Benefit of Restrictive Transfusion Strategies in Neurocritically Ill Patients—Is Less Still More?</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.19854?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Evaluating Complex Technological Innovations in Critical Care—Current Challenges and Future Directions</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.20928?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Impact of Adsorptive Blood Purification on Kidney Outcomes</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.19853?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Ventilator Weaning Strategies—Managing Interaction Between Randomized Treatments</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.20424?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Restrictive vs Liberal Transfusion Strategy in Patients With Acute Brain Injury</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.20651?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Effect of Tele-ICU on Clinical Outcomes of Critically Ill Patients</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.20630?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Extracorporeal Blood Purification and Acute Kidney Injury in Cardiac Surgery</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.20631?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Frequency of Screening and Spontaneous Breathing Trial Techniques</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_Critical_Care_Research_at_ESICM_Congress_2024.mp3?dest-id=90171" length="37497306" type="audio/mpeg" />
      <itunes:duration>15:37</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/9/7/e/a97e6c6df502516b27a2322813b393ee/jsx240163audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Fecal Immunochemical Test (FIT) and Helicobacter pylori Stool Antigen Co-Testing for Gastric Cancer</title>
      <itunes:title>Fecal Immunochemical Test (FIT) and Helicobacter pylori Stool Antigen Co-Testing for Gastric Cancer</itunes:title>
      <pubDate>Mon, 30 Sep 2024 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[6da83e1f-6298-4a82-8396-429eeb9519b3]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.20006]]></link>
      <description><![CDATA[<p>Gastric cancer is a leading cause of cancer death globally. Chronic H pylori infection is the primary cause of gastric cancer, responsible for at least 80% of the new cases. Constanza Camargo, PhD, of the National Cancer Institute joins JAMA Associate Editor John M. Inadomi, MD, to discuss co-testing with FIT and H pylori stool antigen to help prevent gastric cancer.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.8611?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Fecal Immunochemical Test and Helicobacter pylori Stool Antigen Co-Testing</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.14887?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Screening for Helicobacter pylori to Prevent Gastric Cancer</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Gastric cancer is a leading cause of cancer death globally. Chronic H pylori infection is the primary cause of gastric cancer, responsible for at least 80% of the new cases. Constanza Camargo, PhD, of the National Cancer Institute joins JAMA Associate Editor John M. Inadomi, MD, to discuss co-testing with FIT and H pylori stool antigen to help prevent gastric cancer. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.8611?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Fecal Immunochemical Test and Helicobacter pylori Stool Antigen Co-Testing</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.14887?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Screening for Helicobacter pylori to Prevent Gastric Cancer</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Fecal_Immunochemical_Test_FIT_and_Helicobacter_pylori_Stool_Antigen_Co-Testing_for_Gastric_Cancer.mp3?dest-id=90171" length="27836269" type="audio/mpeg" />
      <itunes:duration>11:35</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/b/2/6/0b26ed250d7809a0e55e3c100dce7605/jsx240155audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Preventing Fever in Patients With Acute Vascular Brain Injury</title>
      <itunes:title>Preventing Fever in Patients With Acute Vascular Brain Injury</itunes:title>
      <pubDate>Wed, 25 Sep 2024 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[745243ee-1ca4-40f5-8f47-5254840796b3]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.18527]]></link>
      <description><![CDATA[<p>Fever is associated with worse outcomes in patients with stroke, but whether preventing fever improves outcomes is unclear. David M. Greer, MD, MA, speaks with JAMA Associate Editor Jeffrey L. Saver, MD, about fever prevention in patients with acute stroke and its impact on functional outcomes.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.14745?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Fever Prevention in Patients With Acute Vascular Brain Injury</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.16415?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Feasibility of Fever Prevention in Vascular Brain Injury</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Fever is associated with worse outcomes in patients with stroke, but whether preventing fever improves outcomes is unclear. David M. Greer, MD, MA, speaks with JAMA Associate Editor Jeffrey L. Saver, MD, about fever prevention in patients with acute stroke and its impact on functional outcomes. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.14745?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Fever Prevention in Patients With Acute Vascular Brain Injury</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.16415?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Feasibility of Fever Prevention in Vascular Brain Injury</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Preventing_Fever_in_Patients_With_Acute_Vascular_Brain_Injury.mp3?dest-id=90171" length="25453892" type="audio/mpeg" />
      <itunes:duration>10:37</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/f/2/4/a/f24a2df71f54eb77e55e3c100dce7605/jsx240146audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>The Discovery of Glucagon-Like Peptide 1 (GLP-1)</title>
      <itunes:title>The Discovery of Glucagon-Like Peptide 1 (GLP-1)</itunes:title>
      <pubDate>Thu, 19 Sep 2024 13:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[73393d54-5642-44a1-a515-0e2243a1b4b4]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.18624]]></link>
      <description><![CDATA[<p>The 2024 Lasker–DeBakey Clinical Medical Research Award has been presented for the discovery of GLP-1 and its application to the treatment of obesity. Lasker winner Svetlana Mojsov, PhD, discusses her role in this innovative discovery and more with JAMA Senior Editor Anne Rentoumis Cappola, MD, ScM.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.17571?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Chemistry Matters—From a Putative Peptide to Effective Treatments for Diabetes and Obesity</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.17873?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Discovery of cGAS as a DNA-Sensing Enzyme That Triggers Inflammation</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.18000?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">GLP-1 for Treating Obesity—Origin, History, and Evolution</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.18271?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">AIDS in Africa—Impact of Research</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>The 2024 Lasker–DeBakey Clinical Medical Research Award has been presented for the discovery of GLP-1 and its application to the treatment of obesity. Lasker winner Svetlana Mojsov, PhD, discusses her role in this innovative discovery and more with JAMA Senior Editor Anne Rentoumis Cappola, MD, ScM. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.17571?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Chemistry Matters—From a Putative Peptide to Effective Treatments for Diabetes and Obesity</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.17873?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Discovery of cGAS as a DNA-Sensing Enzyme That Triggers Inflammation</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.18000?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">GLP-1 for Treating Obesity—Origin, History, and Evolution</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.18271?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">AIDS in Africa—Impact of Research</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/The_Discovery_of_Glucagon-Like_Peptide_1_GLP-1.mp3?dest-id=90171" length="28213252" type="audio/mpeg" />
      <itunes:duration>11:45</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/f/3/7/ef37574fffb91e5be55e3c100dce7605/jsx240147audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Improving Access to Palliative Care for Patients With Cancer</title>
      <itunes:title>Improving Access to Palliative Care for Patients With Cancer</itunes:title>
      <pubDate>Wed, 11 Sep 2024 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[349843b9-2923-421b-bb03-0a6ff64465ed]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.16689]]></link>
      <description><![CDATA[<p>Palliative care is an essential component to high-quality care for patients with cancer. How can access to palliative care be expanded? Eduardo Bruera, MD, from MD Anderson Cancer Center speaks with JAMA Editor in Chief Kirsten Bibbins-Domingo about 2 new trials in JAMA that address access to care and what more it will take for executives, insurers, and regulators to support palliative care programs.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.14059?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Improving Palliative Care Access for Patients With Cancer</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.13964?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Telehealth vs In-Person Early Palliative Care for Patients With Advanced Lung Cancer</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Palliative care is an essential component to high-quality care for patients with cancer. How can access to palliative care be expanded? Eduardo Bruera, MD, from MD Anderson Cancer Center speaks with JAMA Editor in Chief Kirsten Bibbins-Domingo about 2 new trials in JAMA that address access to care and what more it will take for executives, insurers, and regulators to support palliative care programs. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.14059?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Improving Palliative Care Access for Patients With Cancer</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.13964?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Telehealth vs In-Person Early Palliative Care for Patients With Advanced Lung Cancer</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Improving_Access_to_Palliative_Care_for_Patients_With_Cancer.mp3?dest-id=90171" length="28545660" type="audio/mpeg" />
      <itunes:duration>11:53</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/d/2/1/3/d2135906b7e5c63a27a2322813b393ee/jsx240137audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Balloon Angioplasty for Intracranial Atherosclerotic Stenosis</title>
      <itunes:title>Balloon Angioplasty for Intracranial Atherosclerotic Stenosis</itunes:title>
      <pubDate>Thu, 05 Sep 2024 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[c421c636-fd91-47bc-b6dd-923cda22b762]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.17493]]></link>
      <description><![CDATA[<p>A new trial assessed whether balloon angioplasty plus aggressive medical management was superior to aggressive medical management alone for patients with symptomatic intracranial atherosclerotic stenosis. Author Zhongrong Miao, MD, PhD, from Beijing Tiantan Hospital, discusses the BASIS randomized clinical trial with JAMA Deputy Editor Christopher C. Muth, MD.<br /> <br /> <strong>Related Content:</strong></p> <ul> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.12829?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Balloon Angioplasty vs Medical Management for Intracranial Artery Stenosis</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.13547?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Is Balloon Angioplasty the Future for Intracranial Stenosis?</a></li> </ul> </ul> <p><a href= "https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.17493?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Read Transcript</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>A new trial assessed whether balloon angioplasty plus aggressive medical management was superior to aggressive medical management alone for patients with symptomatic intracranial atherosclerotic stenosis. Author Zhongrong Miao, MD, PhD, from Beijing Tiantan Hospital, discusses the BASIS randomized clinical trial with JAMA Deputy Editor Christopher C. Muth, MD. Related Content:</p> <ul> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.12829?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Balloon Angioplasty vs Medical Management for Intracranial Artery Stenosis</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.13547?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Is Balloon Angioplasty the Future for Intracranial Stenosis?</a></li> </ul> </ul> <p><a href= "https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.17493?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Read Transcript</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Balloon_Angioplasty_for_Intracranial_Atherosclerotic_Stenosis.mp3?dest-id=90171" length="33657540" type="audio/mpeg" />
      <itunes:duration>14:01</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/b/3/d/a/b3daee5dffa13d5727a2322813b393ee/jsx240140audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Concerning Mortality Rate Trends in the US</title>
      <itunes:title>Concerning Mortality Rate Trends in the US</itunes:title>
      <pubDate>Thu, 29 Aug 2024 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[455a88bc-1742-4199-9059-da7aff67bfbc]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.16672]]></link>
      <description><![CDATA[<p>The abating COVID-19 pandemic brings attention to rising mortality rates from non-COVID causes in the US, a trend that predates the COVID-19 pandemic. Viewpoint author Steven H. Woolf, MD, MPH, discusses this and more with JAMA Executive Editor Gregory Curfman, MD.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.13626?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Increasing Mortality Rates in the US, but Not From COVID-19</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>The abating COVID-19 pandemic brings attention to rising mortality rates from non-COVID causes in the US, a trend that predates the COVID-19 pandemic. Viewpoint author Steven H. Woolf, MD, MPH, discusses this and more with JAMA Executive Editor Gregory Curfman, MD. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.13626?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Increasing Mortality Rates in the US, but Not From COVID-19</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Concerning_Mortality_Rate_Trends_in_the_US.mp3?dest-id=90171" length="24959370" type="audio/mpeg" />
      <itunes:duration>10:24</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/8/0/9/680978ad17d8925fe55e3c100dce7605/jsx240136audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Menopause-Associated Vasomotor Symptom Treatment With Elinzanetant</title>
      <itunes:title>Menopause-Associated Vasomotor Symptom Treatment With Elinzanetant</itunes:title>
      <pubDate>Thu, 22 Aug 2024 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[715c042e-28af-4b9b-a30a-1dc7b437cfe0]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.15276]]></link>
      <description><![CDATA[<p>Nonhormonal treatments for menopausal vasomotor symptoms may benefit symptomatic patients who cannot take or prefer to avoid systemic hormones. Author JoAnn V. Pinkerton, MD, MSCP, discusses the efficacy and safety of elinzanetant for the treatment of moderate to severe vasomotor symptoms associated with menopause with JAMA Deputy Editor Linda Brubaker, MD, MS.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.14618?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.15118?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">A New Era in Menopause Management?</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Nonhormonal treatments for menopausal vasomotor symptoms may benefit symptomatic patients who cannot take or prefer to avoid systemic hormones. Author JoAnn V. Pinkerton, MD, MSCP, discusses the efficacy and safety of elinzanetant for the treatment of moderate to severe vasomotor symptoms associated with menopause with JAMA Deputy Editor Linda Brubaker, MD, MS. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.14618?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.15118?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">A New Era in Menopause Management?</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Menopause-Associated_Vasomotor_Symptom_Treatment_With_Elinzanetant.mp3?dest-id=90171" length="27398340" type="audio/mpeg" />
      <itunes:duration>11:25</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/5/c/c/a/5cca114de364b896e55e3c100dce7605/JSX240123_x3000_thumbimg.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Long COVID in Children</title>
      <itunes:title>Long COVID in Children</itunes:title>
      <pubDate>Wed, 21 Aug 2024 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[5137a009-5a15-4df2-b00a-5ddd87957a75]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.15264]]></link>
      <description><![CDATA[<p>To address the need to characterize long COVID in children and adolescents, the National Institutes of Health funded a pediatric program in the Researching COVID to Enhance Recovery (RECOVER) Initiative. Editorialist Suchitra Rao, MBBS, MSCS, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, discusses this and more with JAMA Senior Editor Tracy A. Lieu, MD, MPH.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.13551?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Uncovering Long COVID in Children</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.12747?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Characterizing Long COVID in Children and Adolescents</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>To address the need to characterize long COVID in children and adolescents, the National Institutes of Health funded a pediatric program in the Researching COVID to Enhance Recovery (RECOVER) Initiative. Editorialist Suchitra Rao, MBBS, MSCS, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, discusses this and more with JAMA Senior Editor Tracy A. Lieu, MD, MPH. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.13551?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Uncovering Long COVID in Children</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.12747?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Characterizing Long COVID in Children and Adolescents</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Long_COVID_in_Children.mp3?dest-id=90171" length="26474901" type="audio/mpeg" />
      <itunes:duration>11:01</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/f/9/5/0/f950f29056d06724e55e3c100dce7605/jsx240122audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Uterus Transplant: Innovation and Considerations</title>
      <itunes:title>Uterus Transplant: Innovation and Considerations</itunes:title>
      <pubDate>Thu, 15 Aug 2024 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[b0eaddab-76c0-40aa-9aa7-a60164b3b32a]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.14402]]></link>
      <description><![CDATA[<p>A new study looks at uterus transplant to determine if it is safe, feasible, and results in births of healthy infants. Editorialist Emily Jungheim, MD, MSCI, Northwestern University, discusses this innovative treatment with JAMA Deputy Editor Linda Brubaker, MD, MS.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.13548?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Uterus Transplant—The Frontier of Innovative Fertility Treatment</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.11679?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Uterus Transplant in Women With Absolute Uterine-Factor Infertility</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>A new study looks at uterus transplant to determine if it is safe, feasible, and results in births of healthy infants. Editorialist Emily Jungheim, MD, MSCI, Northwestern University, discusses this innovative treatment with JAMA Deputy Editor Linda Brubaker, MD, MS. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.13548?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Uterus Transplant—The Frontier of Innovative Fertility Treatment</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.11679?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Uterus Transplant in Women With Absolute Uterine-Factor Infertility</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Uterus_Transplant_Innovation_and_Considerations.mp3?dest-id=90171" length="21206209" type="audio/mpeg" />
      <itunes:duration>08:49</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/a/2/5/aa257bf5a07dce65e55e3c100dce7605/jsx240119audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>A Vaping Cessation Text Message Program for Adolescents</title>
      <itunes:title>A Vaping Cessation Text Message Program for Adolescents</itunes:title>
      <pubDate>Wed, 07 Aug 2024 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[82171020-63d0-4023-b812-81dfe7116bef]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.13923]]></link>
      <description><![CDATA[<p>Ten percent of US adolescents use e-cigarettes, and many want to quit. However, evidence on the effectiveness of vaping cessation interventions is lacking. Amanda L. Graham, PhD, of the Truth Initiative discusses with JAMA Senior Editor Tracy Lieu, MD, MPH, how a tailored, interactive text message intervention increased vaping cessation among adolescents recruited via social media channels.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.11057?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">A Vaping Cessation Text Message Program for Adolescent E-Cigarette Users</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.13142?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Supporting Adolescents' Desire to Quit E-Cigarettes</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.14334?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">What Are E-Cigarettes?</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.12408?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Variability in Constituents of E-Cigarette Products Containing Nicotine Analogues</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.8759?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">E-Cigarette Use in Adults</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.14243?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Controversial FDA Decision Authorizes Menthol-Flavored E-Cigarettes Despite Risks to Youth</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.13403?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Vaping in Youth</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.15912?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">E-Cigarette Use in Adolescents and Adults—A JAMA Collection</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Ten percent of US adolescents use e-cigarettes, and many want to quit. However, evidence on the effectiveness of vaping cessation interventions is lacking. Amanda L. Graham, PhD, of the Truth Initiative discusses with JAMA Senior Editor Tracy Lieu, MD, MPH, how a tailored, interactive text message intervention increased vaping cessation among adolescents recruited via social media channels. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.11057?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">A Vaping Cessation Text Message Program for Adolescent E-Cigarette Users</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.13142?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Supporting Adolescents' Desire to Quit E-Cigarettes</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.14334?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">What Are E-Cigarettes?</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.12408?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Variability in Constituents of E-Cigarette Products Containing Nicotine Analogues</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.8759?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">E-Cigarette Use in Adults</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.14243?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Controversial FDA Decision Authorizes Menthol-Flavored E-Cigarettes Despite Risks to Youth</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.13403?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Vaping in Youth</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.15912?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">E-Cigarette Use in Adolescents and Adults—A JAMA Collection</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/A_Vaping_Cessation_Text_Message_Program_for_Adolescents.mp3?dest-id=90171" length="26734996" type="audio/mpeg" />
      <itunes:duration>11:08</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/5/1/4/0/51407f211f9864abe55e3c100dce7605/jsx240113audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Diagnostic Accuracy of an Integrated AI Ultrasound Tool for Gestational Age Estimation</title>
      <itunes:title>Diagnostic Accuracy of an Integrated AI Ultrasound Tool for Gestational Age Estimation</itunes:title>
      <pubDate>Thu, 01 Aug 2024 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[a453dfd0-a08b-4dad-a511-3048899559f3]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.14122]]></link>
      <description><![CDATA[<p>Gestational age estimation is foundational for obstetric care. In resource-limited settings, an integrated AI tool allows novice users to improve gestational age estimates. Author Jeffrey Stringer, MD, University of North Carolina, joins JAMA Deputy Editor Linda Brubaker, MD, MS, to discuss Diagnostic Accuracy of an Integrated AI Tool to Estimate Gestational Age From Blind Ultrasound Sweeps.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.10770?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Diagnostic Accuracy of an Integrated AI Tool to Estimate Gestational Age From Blind Ultrasound Sweeps</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.14794?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Enhancing Obstetric Ultrasonography With Artificial Intelligence in Resource-Limited Settings</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Gestational age estimation is foundational for obstetric care. In resource-limited settings, an integrated AI tool allows novice users to improve gestational age estimates. Author Jeffrey Stringer, MD, University of North Carolina, joins JAMA Deputy Editor Linda Brubaker, MD, MS, to discuss Diagnostic Accuracy of an Integrated AI Tool to Estimate Gestational Age From Blind Ultrasound Sweeps. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.10770?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Diagnostic Accuracy of an Integrated AI Tool to Estimate Gestational Age From Blind Ultrasound Sweeps</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.14794?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Enhancing Obstetric Ultrasonography With Artificial Intelligence in Resource-Limited Settings</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Diagnostic_Accuracy_of_an_Integrated_AI_Ultrasound_Tool_for_Gestational_Age_Estimation.mp3?dest-id=90171" length="23477241" type="audio/mpeg" />
      <itunes:duration>09:46</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/d/4/4/5/d44518947f59864ce55e3c100dce7605/jsx240116audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Alzheimer Disease Blood Biomarkers</title>
      <itunes:title>Alzheimer Disease Blood Biomarkers</itunes:title>
      <pubDate>Sun, 28 Jul 2024 11:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[659826c4-1821-4f17-a29f-84cca1024aa5]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.13985]]></link>
      <description><![CDATA[<p>Biomarkers for Alzheimer disease (AD) provide insight into disease processes and may aid clinical diagnosis for individuals with cognitive impairment. Author Stephen Salloway, MD, MS, of Brown University joins JAMA Deputy Editor Christopher Muth, MD, to discuss 2 articles and an accompanying editorial about blood biomarkers for AD and potential implications for clinical practice.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.12814?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Are Blood Tests for Alzheimer Disease Ready for Prime Time?</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.13855?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.6619?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Changes in Alzheimer Disease Blood Biomarkers and Associations With Incident All-Cause Dementia</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Biomarkers for Alzheimer disease (AD) provide insight into disease processes and may aid clinical diagnosis for individuals with cognitive impairment. Author Stephen Salloway, MD, MS, of Brown University joins JAMA Deputy Editor Christopher Muth, MD, to discuss 2 articles and an accompanying editorial about blood biomarkers for AD and potential implications for clinical practice. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.12814?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Are Blood Tests for Alzheimer Disease Ready for Prime Time?</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.13855?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.6619?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Changes in Alzheimer Disease Blood Biomarkers and Associations With Incident All-Cause Dementia</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Alzheimer_Disease_Blood_Biomarkers.mp3?dest-id=90171" length="36110958" type="audio/mpeg" />
      <itunes:duration>15:02</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/d/9/1/3/d9130120f65857ffe55e3c100dce7605/jsx240114audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Risankizumab for Ulcerative Colitis</title>
      <itunes:title>Risankizumab for Ulcerative Colitis</itunes:title>
      <pubDate>Mon, 22 Jul 2024 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[f6c833a8-20c0-4d46-9b54-0abfeeabdbcc]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.13319]]></link>
      <description><![CDATA[<p>Ulcerative colitis can significantly decrease quality of life. A third of patients have persistent symptoms with tumor necrosis factor inhibitors and nearly 1 in 5 patients will be hospitalized within 5 years of diagnosis. Author Gilaad G. Kaplan, MD, MPH, of the University of Calgary joins JAMA Associate Editor John M. Inadomi, MD, to discuss Risankizumab for Ulcerative Colitis.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.8819?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Monoclonal Antibody Risankizumab for Ulcerative Colitis</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.12414?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Risankizumab for Ulcerative Colitis</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Ulcerative colitis can significantly decrease quality of life. A third of patients have persistent symptoms with tumor necrosis factor inhibitors and nearly 1 in 5 patients will be hospitalized within 5 years of diagnosis. Author Gilaad G. Kaplan, MD, MPH, of the University of Calgary joins JAMA Associate Editor John M. Inadomi, MD, to discuss Risankizumab for Ulcerative Colitis. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.8819?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Monoclonal Antibody Risankizumab for Ulcerative Colitis</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.12414?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Risankizumab for Ulcerative Colitis</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Risankizumab_for_Ulcerative_Colitis.mp3?dest-id=90171" length="37973707" type="audio/mpeg" />
      <itunes:duration>15:49</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/a/e/f/6aef82f3d3f36a8ae55e3c100dce7605/jsx240109audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Influence of Endometriosis Typology on Ovarian Cancer Risk</title>
      <itunes:title>Influence of Endometriosis Typology on Ovarian Cancer Risk</itunes:title>
      <pubDate>Wed, 17 Jul 2024 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[a2edf466-03f1-4ba9-a33d-d676032fff75]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.12722]]></link>
      <description><![CDATA[<p>What are the ovarian cancer risks associated with endometriosis subtypes? Author Karen C. Schliep, PhD, MSPH, of the University of Utah joins JAMA Deputy Editor Linda Brubaker, MD, MS, to discuss Endometriosis Typology and Ovarian Cancer Risk.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.9210?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Endometriosis Typology and Ovarian Cancer Risk</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.12357?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">New Insights in Endometriosis Subtypes and Ovarian Cancer Risk</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>What are the ovarian cancer risks associated with endometriosis subtypes? Author Karen C. Schliep, PhD, MSPH, of the University of Utah joins JAMA Deputy Editor Linda Brubaker, MD, MS, to discuss Endometriosis Typology and Ovarian Cancer Risk. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.9210?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Endometriosis Typology and Ovarian Cancer Risk</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.12357?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">New Insights in Endometriosis Subtypes and Ovarian Cancer Risk</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Influence_of_Endometriosis_Typology_on_Ovarian_Cancer_Risk.mp3?dest-id=90171" length="22646476" type="audio/mpeg" />
      <itunes:duration>09:26</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/8/e/1/08e15ddeee4c46e2e55e3c100dce7605/jsx240103audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Nicotine Pouch Use in the US</title>
      <itunes:title>Nicotine Pouch Use in the US</itunes:title>
      <pubDate>Wed, 10 Jul 2024 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[1d840825-aa39-4ed5-8cde-ae619765018f]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.12393]]></link>
      <description><![CDATA[<p>Oral nicotine pouches are becoming more popular in the US, based on a survey performed in 2022. Hongying Daisy Dai, PhD, from Nebraska Medical Center, Omaha, discusses nicotine pouches and more with JAMA Deputy Editor Kristin L. Walter, MD, MS.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.10686?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Prevalence of Nicotine Pouch Use Among US Adults</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Oral nicotine pouches are becoming more popular in the US, based on a survey performed in 2022. Hongying Daisy Dai, PhD, from Nebraska Medical Center, Omaha, discusses nicotine pouches and more with JAMA Deputy Editor Kristin L. Walter, MD, MS. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.10686?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Prevalence of Nicotine Pouch Use Among US Adults</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Nicotine_Pouch_Use_in_the_US.mp3?dest-id=90171" length="25489664" type="audio/mpeg" />
      <itunes:duration>10:36</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/3/c/1/63c11554b47571c1e55e3c100dce7605/jsx240102audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>The Future of Pediatrics in the US</title>
      <itunes:title>The Future of Pediatrics in the US</itunes:title>
      <pubDate>Wed, 03 Jul 2024 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[0476352c-68c3-4b42-bbf3-1aafb66605b8]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.12007]]></link>
      <description><![CDATA[<p>Availability of pediatric care is decreasing, despite the growing complexity of pediatric care needs. Match rates for pediatric residency continue to decline. The US risks a serious shortage of pediatricians. Julie Byerley, MD, MPH, executive vice president & chief academic officer, Geisinger, Pennsylvania, discusses this and more with JAMA Deputy Editor Linda Brubaker, MD, MS.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.8485?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Where Are All the Pediatricians?</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Availability of pediatric care is decreasing, despite the growing complexity of pediatric care needs. Match rates for pediatric residency continue to decline. The US risks a serious shortage of pediatricians. Julie Byerley, MD, MPH, executive vice president & chief academic officer, Geisinger, Pennsylvania, discusses this and more with JAMA Deputy Editor Linda Brubaker, MD, MS. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.8485?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Where Are All the Pediatricians?</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/The_Future_of_Pediatrics_in_the_US.mp3?dest-id=90171" length="21875406" type="audio/mpeg" />
      <itunes:duration>09:06</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/f/3/1/ef315336b3cd61e827a2322813b393ee/jsx240101audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Telehealth Abortion Safety and Effectiveness</title>
      <itunes:title>Telehealth Abortion Safety and Effectiveness</itunes:title>
      <pubDate>Mon, 24 Jun 2024 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[f1d1cf66-5f8f-4427-9024-9b3fe925bda9]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.11279]]></link>
      <description><![CDATA[<p>Facilitating safe and timely health care for individuals planning medication abortion is a reproductive health care priority. Lauren J. Ralph, PhD, MPH, and Daniel Grossman, MD, of University of California San Francisco join JAMA Deputy Editor Linda Brubaker, MD, MS, to discuss Comparison of Effectiveness of No-Test Telehealth and In-Person Medication Abortion.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.10680?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Comparison of No-Test Telehealth and In-Person Medication Abortion</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Facilitating safe and timely health care for individuals planning medication abortion is a reproductive health care priority. Lauren J. Ralph, PhD, MPH, and Daniel Grossman, MD, of University of California San Francisco join JAMA Deputy Editor Linda Brubaker, MD, MS, to discuss Comparison of Effectiveness of No-Test Telehealth and In-Person Medication Abortion. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.10680?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Comparison of No-Test Telehealth and In-Person Medication Abortion</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Telehealth_Abortion_Safety_and_Effectiveness.mp3?dest-id=90171" length="26366217" type="audio/mpeg" />
      <itunes:duration>10:59</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/d/d/1/8dd1c397a34e15c2e55e3c100dce7605/jsx240097audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Sudden Death, Calcium Release Deficiency Syndrome, and a New ECG Finding</title>
      <itunes:title>Sudden Death, Calcium Release Deficiency Syndrome, and a New ECG Finding</itunes:title>
      <pubDate>Thu, 20 Jun 2024 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[f7f3366f-8cc8-4fdf-b979-1efa71a5019f]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.10200]]></link>
      <description><![CDATA[<p>Can a new ECG finding identify individuals at risk for dying suddenly? Jason D. Roberts, MD, of McMaster University joins JAMA Associate Editor Gregory M. Marcus, MD, MAS, to discuss A Clinical Diagnostic Test for Calcium Release Deficiency Syndrome (CRDS). CRDS is a recently described cause of sudden arrhythmic death. Until now, no clinical test has existed to identify those with the disease.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.8599?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">A Clinical Diagnostic Test for Calcium Release Deficiency Syndrome</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.10230?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">The First Clinical Test for Calcium Release Deficiency Syndrome?</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Can a new ECG finding identify individuals at risk for dying suddenly? Jason D. Roberts, MD, of McMaster University joins JAMA Associate Editor Gregory M. Marcus, MD, MAS, to discuss A Clinical Diagnostic Test for Calcium Release Deficiency Syndrome (CRDS). CRDS is a recently described cause of sudden arrhythmic death. Until now, no clinical test has existed to identify those with the disease. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.8599?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">A Clinical Diagnostic Test for Calcium Release Deficiency Syndrome</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.10230?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">The First Clinical Test for Calcium Release Deficiency Syndrome?</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Sudden_Death_Calcium_Release_Deficiency_Syndrome_and_a_New_ECG_Finding.mp3?dest-id=90171" length="30437051" type="audio/mpeg" />
      <itunes:duration>12:40</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/0/8/e/908e0bda92658a01e55e3c100dce7605/jsx240092audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Continuous vs Intermittent β-Lactam Antibiotic Infusions in Patients With Sepsis</title>
      <itunes:title>Continuous vs Intermittent β-Lactam Antibiotic Infusions in Patients With Sepsis</itunes:title>
      <pubDate>Wed, 12 Jun 2024 08:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[2ae86d2e-a8f8-430e-b744-42a749c3be48]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.10180]]></link>
      <description><![CDATA[<p>Joel M. Dulhunty, MD, PhD, Royal Brisbane and Women's Hospital, and Jason A. Roberts, BPharm, PhD, University of Queensland Centre for Clinical Research, join JAMA Deputy Editor Preeti Malani, MD, MSJ, to discuss the BLING trial that assessed continuous vs intermittent β-lactam antibiotic infusions in patients with sepsis or septic shock.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.9779?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.9803?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Prolonged vs Intermittent Infusions of β-Lactam Antibiotics in Adults With Sepsis or Septic Shock</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Joel M. Dulhunty, MD, PhD, Royal Brisbane and Women's Hospital, and Jason A. Roberts, BPharm, PhD, University of Queensland Centre for Clinical Research, join JAMA Deputy Editor Preeti Malani, MD, MSJ, to discuss the BLING trial that assessed continuous vs intermittent β-lactam antibiotic infusions in patients with sepsis or septic shock. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.9779?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.9803?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Prolonged vs Intermittent Infusions of β-Lactam Antibiotics in Adults With Sepsis or Septic Shock</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Continuous_vs_Intermittent_-Lactam_Antibiotic_Infusions_in_Patients_With_Sepsis.mp3?dest-id=90171" length="23911256" type="audio/mpeg" />
      <itunes:duration>09:57</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/5/c/4/8/5c48658af22c037627a2322813b393ee/jsx240091audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Integrating Clinical Trials With the Practice of Medicine</title>
      <itunes:title>Integrating Clinical Trials With the Practice of Medicine</itunes:title>
      <pubDate>Mon, 03 Jun 2024 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[e94b8044-27c7-4322-a60c-52c55505a46f]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.9331]]></link>
      <description><![CDATA[<p>Randomized clinical trials (RCTs) frequently fail to generate knowledge relevant to practice, while practice patterns are frequently unsupported by RCT evidence. Derek C. Angus, MD, MPH, of the University of Pittsburgh, joins JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss The Integration of Clinical Trials With the Practice of Medicine: Repairing a House Divided.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.4088?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">The Integration of Clinical Trials With the Practice of Medicine</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Randomized clinical trials (RCTs) frequently fail to generate knowledge relevant to practice, while practice patterns are frequently unsupported by RCT evidence. Derek C. Angus, MD, MPH, of the University of Pittsburgh, joins JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss The Integration of Clinical Trials With the Practice of Medicine: Repairing a House Divided. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.4088?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">The Integration of Clinical Trials With the Practice of Medicine</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Integrating_Clinical_Trials_With_the_Practice_of_Medicine.mp3?dest-id=90171" length="44772685" type="audio/mpeg" />
      <itunes:duration>18:38</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/c/b/a/2cba490df488c1ed27a2322813b393ee/JSX240087_x450_thumbimg-v2.jpeg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Evidence Against Nitrogen's Use for the Death Penalty</title>
      <itunes:title>Evidence Against Nitrogen's Use for the Death Penalty</itunes:title>
      <pubDate>Wed, 29 May 2024 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[078a3eb7-5c52-430a-896f-007f9fd2060b]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.8786]]></link>
      <description><![CDATA[<p>Forced nitrogen inhalation was used by the state of Alabama to execute Kenneth Smith on January 25, 2024. Some politicians, attorneys general, and health care practitioners support its use for capital punishment in the US. Philip E. Bickler, MD, PhD, and Michael S. Lipnick, MD, discuss the evidence indicating that forced nitrogen inhalation is inhumane with JAMA Executive Editor Gregory Curfman, MD.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.6577?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Evidence Against Use of Nitrogen for the Death Penalty</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Forced nitrogen inhalation was used by the state of Alabama to execute Kenneth Smith on January 25, 2024. Some politicians, attorneys general, and health care practitioners support its use for capital punishment in the US. Philip E. Bickler, MD, PhD, and Michael S. Lipnick, MD, discuss the evidence indicating that forced nitrogen inhalation is inhumane with JAMA Executive Editor Gregory Curfman, MD. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.6577?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Evidence Against Use of Nitrogen for the Death Penalty</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Evidence_Against_Nitrogens_Use_for_the_Death_Penalty.mp3?dest-id=90171" length="30857765" type="audio/mpeg" />
      <itunes:duration>12:51</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/7/0/1/a/701ab1997eaa69ab27a2322813b393ee/jsx240083audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Outcomes After Living Kidney Donation</title>
      <itunes:title>Outcomes After Living Kidney Donation</itunes:title>
      <pubDate>Thu, 23 May 2024 14:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[8754ca08-412a-4c56-be9a-3c62cb3cfc6f]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.9322]]></link>
      <description><![CDATA[<p>Guidelines call for better evidence on the health outcomes after living kidney donation. Author Amit X. Garg, MD, PhD, London Health Sciences Centre, and editorialist Elizabeth C. Lorenz, MD, Baylor College of Medicine, discuss a new study that compares the risks of hypertension and other health outcomes in living kidney donors, with JAMA Associate Editor Wolfgang Winkelmayer, MD, ScD.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.8523?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Hypertension and Kidney Function After Living Kidney Donation</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.8733?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Prospectively Examining Outcomes After Living Kidney Donation</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.8469?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Kidney Transplant Outcomes From Deceased Donors Who Received Dialysis</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.8734?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Expanding the Overton Window in Deceased Kidney Donor Eligibility—Enough to Make a Difference?</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Guidelines call for better evidence on the health outcomes after living kidney donation. Author Amit X. Garg, MD, PhD, London Health Sciences Centre, and editorialist Elizabeth C. Lorenz, MD, Baylor College of Medicine, discuss a new study that compares the risks of hypertension and other health outcomes in living kidney donors, with JAMA Associate Editor Wolfgang Winkelmayer, MD, ScD. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.8523?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Hypertension and Kidney Function After Living Kidney Donation</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.8733?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Prospectively Examining Outcomes After Living Kidney Donation</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.8469?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Kidney Transplant Outcomes From Deceased Donors Who Received Dialysis</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.8734?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Expanding the Overton Window in Deceased Kidney Donor Eligibility—Enough to Make a Difference?</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Outcomes_After_Living_Kidney_Donation.mp3?dest-id=90171" length="28553685" type="audio/mpeg" />
      <itunes:duration>11:53</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/6/1/c/c61ce2c021bd94a9e55e3c100dce7605/JSX240086_x3000_thumbimg.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Cardiac Amyloidosis and the V142I Transthyretin Variant</title>
      <itunes:title>Cardiac Amyloidosis and the V142I Transthyretin Variant</itunes:title>
      <pubDate>Sun, 12 May 2024 07:30:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[24770183-0c61-4eff-9350-9372aa8867f1]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.7039]]></link>
      <description><![CDATA[<p>What is the natural history and cardiovascular burden of the V142I transthyretin variant among US Black individuals who carry this variant? Senthil Selvaraj, MD, MS, MA, from Duke University, and Scott D. Solomon, MD, from Brigham and Women's Hospital, discuss this and more with JAMA Executive Editor Gregory Curfman, MD.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.4467?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Cardiovascular Burden of the V142I Transthyretin Variant</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.2868?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Addressing Health Disparities—The Case for Variant Transthyretin Cardiac Amyloidosis Grows Stronger</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.5217?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Heart Failure in African American Individuals, Version 2.0</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.0442?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Cardiac Amyloidosis Due to Transthyretin Protein</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>What is the natural history and cardiovascular burden of the V142I transthyretin variant among US Black individuals who carry this variant? Senthil Selvaraj, MD, MS, MA, from Duke University, and Scott D. Solomon, MD, from Brigham and Women's Hospital, discuss this and more with JAMA Executive Editor Gregory Curfman, MD. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.4467?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Cardiovascular Burden of the V142I Transthyretin Variant</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.2868?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Addressing Health Disparities—The Case for Variant Transthyretin Cardiac Amyloidosis Grows Stronger</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.5217?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Heart Failure in African American Individuals, Version 2.0</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.0442?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Cardiac Amyloidosis Due to Transthyretin Protein</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Cardiac_Amyloidosis_and_the_V142I_Transthyretin_Variant.mp3?dest-id=90171" length="32195397" type="audio/mpeg" />
      <itunes:duration>13:24</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/0/e/a/80ea4d5ffe4d3c1be55e3c100dce7605/jsx240065audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Racial and Ethnic Disparities in All-Cause and Cause-Specific Mortality Among US Youth</title>
      <itunes:title>Racial and Ethnic Disparities in All-Cause and Cause-Specific Mortality Among US Youth</itunes:title>
      <pubDate>Sat, 04 May 2024 19:30:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[e7f3a093-1f13-45fe-a8ef-291229cc4c3d]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.6688]]></link>
      <description><![CDATA[<p>Between 2019 and 2021, pediatric mortality rates had the largest increases in at least half a century. Steven H. Woolf, MD, MPH, of Virginia Commonwealth University Center on Society and Health, joins JAMA Associate Editor Tracy A. Lieu, MD, MPH, to discuss how racial and ethnic disparities and specific causes have factored into these increases and what this means for policymakers and clinicians.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.3908?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Racial and Ethnic Disparities in All-Cause and Cause-Specific Mortality Among US Youth</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.4208?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Injury Prevention Science and Firearm Injury in Pediatric Health</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Between 2019 and 2021, pediatric mortality rates had the largest increases in at least half a century. Steven H. Woolf, MD, MPH, of Virginia Commonwealth University Center on Society and Health, joins JAMA Associate Editor Tracy A. Lieu, MD, MPH, to discuss how racial and ethnic disparities and specific causes have factored into these increases and what this means for policymakers and clinicians. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.3908?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Racial and Ethnic Disparities in All-Cause and Cause-Specific Mortality Among US Youth</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.4208?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Injury Prevention Science and Firearm Injury in Pediatric Health</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Racial_and_Ethnic_Disparities_in_All-Cause_and_Cause-Specific_Mortality_Among_US_Youth.mp3?dest-id=90171" length="28719752" type="audio/mpeg" />
      <itunes:duration>11:58</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/4/6/4/f/464f294be7247553e5bbc093207a2619/jsx240064audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Smoking Cessation After Initial Treatment Failure With Varenicline or Nicotine Replacement</title>
      <itunes:title>Smoking Cessation After Initial Treatment Failure With Varenicline or Nicotine Replacement</itunes:title>
      <pubDate>Thu, 02 May 2024 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[e5b5ae07-30ad-42ec-abf2-ec6821c33694]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.6154]]></link>
      <description><![CDATA[<p>When initial treatment with varenicline or nicotine replacement doesn't work, does increasing dosage improve smoking cessation rates? Paul Cinciripini, PhD, of MD Anderson Cancer Center's Department of Behavioral Science, joins JAMA Executive Editor Gregory Curfman, MD, to discuss guidance on the best strategies for smoking cessation following an initial quit attempt.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.4183?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Smoking Cessation After Initial Treatment Failure With Varenicline or Nicotine Replacement</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>When initial treatment with varenicline or nicotine replacement doesn't work, does increasing dosage improve smoking cessation rates? Paul Cinciripini, PhD, of MD Anderson Cancer Center's Department of Behavioral Science, joins JAMA Executive Editor Gregory Curfman, MD, to discuss guidance on the best strategies for smoking cessation following an initial quit attempt. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.4183?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Smoking Cessation After Initial Treatment Failure With Varenicline or Nicotine Replacement</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Smoking_Cessation_After_Initial_Treatment_Failure_With_Varenicline_or_Nicotine_Replacement.mp3?dest-id=90171" length="27189081" type="audio/mpeg" />
      <itunes:duration>11:19</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/5/0/d/5/50d5970339ba66a3e5bbc093207a2619/jsx240057audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Examining Mortality Disparities by Sexual Orientation Among Female Nurses</title>
      <itunes:title>Examining Mortality Disparities by Sexual Orientation Among Female Nurses</itunes:title>
      <pubDate>Thu, 25 Apr 2024 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[1dcf1b2b-5a88-4a21-839e-f4e7640710b5]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.5962]]></link>
      <description><![CDATA[<p>Extensive evidence documents health disparities for lesbian, gay, and bisexual (LGB) women, including worse physical, mental, and behavioral health than heterosexual women. Sarah McKetta, ScM, MD, PhD, discusses these factors and their link to premature mortality with JAMA Deputy Editor Linda Brubaker, MD, MS.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.4459?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Disparities in Mortality by Sexual Orientation in a Large, Prospective Cohort of Female Nurses</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Extensive evidence documents health disparities for lesbian, gay, and bisexual (LGB) women, including worse physical, mental, and behavioral health than heterosexual women. Sarah McKetta, ScM, MD, PhD, discusses these factors and their link to premature mortality with JAMA Deputy Editor Linda Brubaker, MD, MS. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.4459?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Disparities in Mortality by Sexual Orientation in a Large, Prospective Cohort of Female Nurses</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Examining_Mortality_Disparities_by_Sexual_Orientation_Among_Female_Nurses.mp3?dest-id=90171" length="18989554" type="audio/mpeg" />
      <itunes:duration>07:54</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/4/9/f/3/49f3726245f102fd88c4a68c3ddbc4f2/jsx240055audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Stewardship Prompts to Improve Antibiotic Selection for Pneumonia and Urinary Tract Infection</title>
      <itunes:title>Stewardship Prompts to Improve Antibiotic Selection for Pneumonia and Urinary Tract Infection</itunes:title>
      <pubDate>Fri, 19 Apr 2024 13:30:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[882ef312-c974-4d1b-ac8c-3caf008d5c87]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.7074]]></link>
      <description><![CDATA[<p>Can real-time EHR–generated recommendations safely reduce antibiotic use in hospitalized patients with pneumonia or UTI? Shruti K. Gohil, MD, MPH, of the University of California-Irvine, joins JAMA Deputy Editor Preeti Malani, MD, MSJ, to discuss the INSPIRE randomized clinical trial.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.6248?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Stewardship Prompts to Improve Antibiotic Selection for Pneumonia</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.6259?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Stewardship Prompts to Improve Antibiotic Selection for Urinary Tract Infection</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.6554?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Harnessing the Electronic Health Record to Improve Empiric Antibiotic Prescribing</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Can real-time EHR–generated recommendations safely reduce antibiotic use in hospitalized patients with pneumonia or UTI? Shruti K. Gohil, MD, MPH, of the University of California-Irvine, joins JAMA Deputy Editor Preeti Malani, MD, MSJ, to discuss the INSPIRE randomized clinical trial. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.6248?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Stewardship Prompts to Improve Antibiotic Selection for Pneumonia</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.6259?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Stewardship Prompts to Improve Antibiotic Selection for Urinary Tract Infection</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.6554?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Harnessing the Electronic Health Record to Improve Empiric Antibiotic Prescribing</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Stewardship_Prompts_to_Improve_Antibiotic_Selection_for_Pneumonia_and_Urinary_Tract_Infection.mp3?dest-id=90171" length="22076956" type="audio/mpeg" />
      <itunes:duration>09:12</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/9/5/6/6956b46fb48bf38c88c4a68c3ddbc4f2/jsx240066audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Advancing Climate Action Through Academic Health Systems</title>
      <itunes:title>Advancing Climate Action Through Academic Health Systems</itunes:title>
      <pubDate>Wed, 17 Apr 2024 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[84269447-4b7e-4cf3-84ab-eabb5640b3dc]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.5691]]></link>
      <description><![CDATA[<p>Climate action is an urgent public health imperative. Climate change is causing excess morbidity and mortality and posing an increasing threat to mental health and well-being. The US health care sector is a significant contributor to this problem. A. Eugene Washington, MD, of Duke University, discusses accelerating climate action with JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.4967?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Accelerating Climate Action Through Academic Health Systems</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Climate action is an urgent public health imperative. Climate change is causing excess morbidity and mortality and posing an increasing threat to mental health and well-being. The US health care sector is a significant contributor to this problem. A. Eugene Washington, MD, of Duke University, discusses accelerating climate action with JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.4967?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Accelerating Climate Action Through Academic Health Systems</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Advancing_Climate_Action_Through_Academic_Health_Systems.mp3?dest-id=90171" length="25976960" type="audio/mpeg" />
      <itunes:duration>10:49</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/c/b/7/0cb7ab027dfa9d8b88c4a68c3ddbc4f2/jsx240054audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>The Evolution of Screening Tools for Prostate Cancer</title>
      <itunes:title>The Evolution of Screening Tools for Prostate Cancer</itunes:title>
      <pubDate>Sat, 06 Apr 2024 08:15:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[b29c8f94-5574-4457-859d-cdc3374c11a0]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.5659]]></link>
      <description><![CDATA[<p>The utility of prostate-specific antigen (PSA) screening for prostate cancer detection is impacted by detection of cancers with low risk of mortality. Editorialist Jeffrey J. Tosoian, MD, MPH, discusses a pragmatic approach to prostate cancer screening with JAMA Deputy Editor Mary L. (Nora) Disis, MD.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.4089?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">A Pragmatic Approach to Prostate Cancer Screening</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.3841?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Prostate Cancer Screening With PSA, Kallikrein Panel, and MRI</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.4011?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>The utility of prostate-specific antigen (PSA) screening for prostate cancer detection is impacted by detection of cancers with low risk of mortality. Editorialist Jeffrey J. Tosoian, MD, MPH, discusses a pragmatic approach to prostate cancer screening with JAMA Deputy Editor Mary L. (Nora) Disis, MD. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.4089?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">A Pragmatic Approach to Prostate Cancer Screening</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.3841?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Prostate Cancer Screening With PSA, Kallikrein Panel, and MRI</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.4011?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/The_Evolution_of_Screening_Tools_for_Prostate_Cancer.mp3?dest-id=90171" length="29394157" type="audio/mpeg" />
      <itunes:duration>12:15</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/5/5/0/2/5502e42ec1c8a34488c4a68c3ddbc4f2/jsx240053audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Regional Interventions to Prevent Multidrug-Resistant Organisms</title>
      <itunes:title>Regional Interventions to Prevent Multidrug-Resistant Organisms</itunes:title>
      <pubDate>Mon, 01 Apr 2024 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[c19eb7dc-57b5-442e-9718-1359581a4ad3]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.3484]]></link>
      <description><![CDATA[<p>Infections due to multidrug-resistant organisms (MDROs) are difficult to treat with increased morbidity, mortality, length of hospitalization, and health care costs. Author Susan S. Huang, MD, MPH, from the University of California Irvine School of Medicine, joins JAMA Deputy Editor Preeti Malani, MD, MSJ, to discuss a new study that used a regional intervention to prevent MDROs.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.2759?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Reducing Hospitalizations and Multidrug-Resistant Organisms via Regional Decolonization in Hospitals and Nursing Homes</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Infections due to multidrug-resistant organisms (MDROs) are difficult to treat with increased morbidity, mortality, length of hospitalization, and health care costs. Author Susan S. Huang, MD, MPH, from the University of California Irvine School of Medicine, joins JAMA Deputy Editor Preeti Malani, MD, MSJ, to discuss a new study that used a regional intervention to prevent MDROs. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.2759?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Reducing Hospitalizations and Multidrug-Resistant Organisms via Regional Decolonization in Hospitals and Nursing Homes</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Regional_Interventions_to_Prevent_Multidrug-Resistant_Organisms.mp3?dest-id=90171" length="23359742" type="audio/mpeg" />
      <itunes:duration>09:44</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/3/0/d/130df97c5c9ac25c88c4a68c3ddbc4f2/jsx240048audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Mifepristone–Science, Abortion Care, and Politics</title>
      <itunes:title>Mifepristone–Science, Abortion Care, and Politics</itunes:title>
      <pubDate>Mon, 25 Mar 2024 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[ebf45005-9bb1-46a1-9548-97d4000f8095]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.3358]]></link>
      <description><![CDATA[<p>The US Supreme Court will soon decide a case challenging the US Food and Drug Administration's (FDA's) approval of mifepristone. Author Holly Fernandez Lynch, JD, MBE, University of Pennsylvania, joins JAMA Executive Editor Gregory Curfman, MD, to discuss the science and politics surrounding this significant case.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.2229?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">The FDA in the Crosshairs—Science, Politics, and Abortion</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.4266?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Provision of Medications for Self-Managed Abortion Before and After the Dobbs v Jackson Women's Health Organization Decision</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.5376?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Understanding the Impacts of the Supreme Court Case FDA v Alliance for Hippocratic Medicine</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>The US Supreme Court will soon decide a case challenging the US Food and Drug Administration's (FDA's) approval of mifepristone. Author Holly Fernandez Lynch, JD, MBE, University of Pennsylvania, joins JAMA Executive Editor Gregory Curfman, MD, to discuss the science and politics surrounding this significant case. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.2229?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">The FDA in the Crosshairs—Science, Politics, and Abortion</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.4266?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Provision of Medications for Self-Managed Abortion Before and After the Dobbs v Jackson Women's Health Organization Decision</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.5376?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Understanding the Impacts of the Supreme Court Case FDA v Alliance for Hippocratic Medicine</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/MifepristoneScience_Abortion_Care_and_Politics.mp3?dest-id=90171" length="46210549" type="audio/mpeg" />
      <itunes:duration>19:15</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/d/2/0/e/d20e928ef8f4e3f188c4a68c3ddbc4f2/jsx240046audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>How Do Multimodal Large Language Models Perform on Clinical Vignette Questions?</title>
      <itunes:title>How Do Multimodal Large Language Models Perform on Clinical Vignette Questions?</itunes:title>
      <pubDate>Mon, 18 Mar 2024 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[b7f8b053-100e-4cb9-837e-8efa2f2d642a]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.2837]]></link>
      <description><![CDATA[<p>How did GPT-4 Vision, a model that can work with images and text as input, perform when answering clinical challenge questions from medical journals? Daniel Truhn, MD, MSc, of the University Hospital Aachen in Germany, joins JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss this topic.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.27861?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Comparative Analysis of Multimodal Large Language Model Performance on Clinical Vignette Questions</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>How did GPT-4 Vision, a model that can work with images and text as input, perform when answering clinical challenge questions from medical journals? Daniel Truhn, MD, MSc, of the University Hospital Aachen in Germany, joins JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss this topic. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.27861?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Comparative Analysis of Multimodal Large Language Model Performance on Clinical Vignette Questions</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/How_Do_Multimodal_Large_Language_Models_Perform_on_Clinical_Vignette_Questions.mp3?dest-id=90171" length="22039076" type="audio/mpeg" />
      <itunes:duration>09:11</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/0/5/e/205e63cd0a78e773e5bbc093207a2619/jsx240043audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Does Treating Attention-Deficit/Hyperactivity Disorder Reduce Mortality?</title>
      <itunes:title>Does Treating Attention-Deficit/Hyperactivity Disorder Reduce Mortality?</itunes:title>
      <pubDate>Tue, 12 Mar 2024 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[530435e4-3432-45b7-85a9-e760f456ee57]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.2900]]></link>
      <description><![CDATA[<p>An observational study by Lin Li, PhD, and colleagues, published in JAMA, found that pharmacotherapy was associated with reduced mortality in individuals with ADHD. Frances R. Levin, MD, of the Columbia Vagelos College of Physicians and Surgeons, who wrote an accompanying editorial, joins JAMA Associate Editor Donald C. Goff, MD, to discuss the results of this article.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.1755?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Treating Attention-Deficit/Hyperactivity Disorder Matters</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>An observational study by Lin Li, PhD, and colleagues, published in JAMA, found that pharmacotherapy was associated with reduced mortality in individuals with ADHD. Frances R. Levin, MD, of the Columbia Vagelos College of Physicians and Surgeons, who wrote an accompanying editorial, joins JAMA Associate Editor Donald C. Goff, MD, to discuss the results of this article. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.1755?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Treating Attention-Deficit/Hyperactivity Disorder Matters</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Does_Treating_Attention-DeficitHyperactivity_Disorder_Reduce_Mortality.mp3?dest-id=90171" length="32592469" type="audio/mpeg" />
      <itunes:duration>13:35</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/d/b/6/adb643e027ff993988c4a68c3ddbc4f2/jsx240044audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Delivering Effective Messages in the Patient-Clinician Encounter</title>
      <itunes:title>Delivering Effective Messages in the Patient-Clinician Encounter</itunes:title>
      <pubDate>Tue, 05 Mar 2024 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[4edb0024-0e51-4b0a-b1bc-3cbe62e0bd26]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.1128]]></link>
      <description><![CDATA[<p>Introducing JAMA's new Communicating Medicine series, JAMA Associate Editor Anne Cappola, MD, ScM, discusses strategies for delivering effective messages in the patient encounter with authors Joseph Cappella, PhD, of the University of Pennsylvania, and Richard Street, PhD, of Texas A&M University and Baylor College of Medicine.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.0371?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Delivering Effective Messages in the Patient-Clinician Encounter</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Introducing JAMA's new Communicating Medicine series, JAMA Associate Editor Anne Cappola, MD, ScM, discusses strategies for delivering effective messages in the patient encounter with authors Joseph Cappella, PhD, of the University of Pennsylvania, and Richard Street, PhD, of Texas A&M University and Baylor College of Medicine. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.0371?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Delivering Effective Messages in the Patient-Clinician Encounter</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Delivering_Effective_Messages_in_the_Patient-Clinician_Encounter.mp3?dest-id=90171" length="31458224" type="audio/mpeg" />
      <itunes:duration>13:06</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/f/b/6/1fb67a1a1b1bcb5888c4a68c3ddbc4f2/jsx240022audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Why Does PrEP Use Lag in Cisgender Women?</title>
      <itunes:title>Why Does PrEP Use Lag in Cisgender Women?</itunes:title>
      <pubDate>Fri, 01 Mar 2024 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[38fd500f-56d6-4e90-93ac-5a05a616bddc]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.1855]]></link>
      <description><![CDATA[<p>How will new study results inform HIV prevention in the US and globally? JAMA Deputy Editor Preeti Malani, MD, MSJ, and author Jeanne Marrazzo, MD, MPH, director of NIAID, discuss these study findings and more.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.0464?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">HIV Preexposure Prophylaxis With Emtricitabine and Tenofovir Disoproxil Fumarate Among Cisgender Women</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>How will new study results inform HIV prevention in the US and globally? JAMA Deputy Editor Preeti Malani, MD, MSJ, and author Jeanne Marrazzo, MD, MPH, director of NIAID, discuss these study findings and more. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.0464?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">HIV Preexposure Prophylaxis With Emtricitabine and Tenofovir Disoproxil Fumarate Among Cisgender Women</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Why_Does_PrEP_Use_Lag_in_Cisgender_Women.mp3?dest-id=90171" length="27228336" type="audio/mpeg" />
      <itunes:duration>11:20</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/3/4/0/c340fc5e637cc98188c4a68c3ddbc4f2/jsx240039audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Updated Pediatric Sepsis Criteria—Transitioning From SIRS to Phoenix</title>
      <itunes:title>Updated Pediatric Sepsis Criteria—Transitioning From SIRS to Phoenix</itunes:title>
      <pubDate>Tue, 27 Feb 2024 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[b37a7994-e40c-49ea-9bbb-f023eed21032]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.783]]></link>
      <description><![CDATA[<p>JAMA Associate Editor Romain Pirracchio, MD, MPH, discusses context and implications of the new pediatric sepsis criteria with authors Hallie Prescott, MD, MSc, of the University of Michigan and Ann Arbor VA Hospital, and Roberto Jabornisky, MD, of Northeastern National Medical School in Argentina.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.27979?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Context and Implications of the New Pediatric Sepsis Criteria</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.27988?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Transitioning From SIRS to Phoenix With the Updated Pediatric Sepsis Criteria—The Difficult Task of Simplifying the Complex</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>JAMA Associate Editor Romain Pirracchio, MD, MPH, discusses context and implications of the new pediatric sepsis criteria with authors Hallie Prescott, MD, MSc, of the University of Michigan and Ann Arbor VA Hospital, and Roberto Jabornisky, MD, of Northeastern National Medical School in Argentina. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.27979?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Context and Implications of the New Pediatric Sepsis Criteria</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.27988?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Transitioning From SIRS to Phoenix With the Updated Pediatric Sepsis Criteria—The Difficult Task of Simplifying the Complex</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Updated_Pediatric_Sepsis_Criteria_Transitioning_From_SIRS_to_Phoenix.mp3?dest-id=90171" length="34188637" type="audio/mpeg" />
      <itunes:duration>14:14</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/0/6/8/a0684c73c37f76c788c4a68c3ddbc4f2/jsx240019audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Renter Eviction, Excess Mortality, and COVID-19</title>
      <itunes:title>Renter Eviction, Excess Mortality, and COVID-19</itunes:title>
      <pubDate>Tue, 20 Feb 2024 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[70f90f44-d33f-4e06-b615-54c4beca03e3]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.663]]></link>
      <description><![CDATA[<p>Renters who received eviction filings experienced excess mortality associated with the COVID-19 pandemic. JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, discusses a recent study that underscores the importance of studying health outcomes among marginalized populations with author Nick Graetz, PhD, from Princeton University.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.27005?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Examining Excess Mortality Associated With the COVID-19 Pandemic for Renters Threatened With Eviction</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Renters who received eviction filings experienced excess mortality associated with the COVID-19 pandemic. JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, discusses a recent study that underscores the importance of studying health outcomes among marginalized populations with author Nick Graetz, PhD, from Princeton University. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.27005?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Examining Excess Mortality Associated With the COVID-19 Pandemic for Renters Threatened With Eviction</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Renter_Eviction_Excess_Mortality_and_COVID-19.mp3?dest-id=90171" length="29811986" type="audio/mpeg" />
      <itunes:duration>12:25</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/b/1/a/a/b1aae3069d88e45be5bbc093207a2619/jsx240017audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Azithromycin to Prevent Childhood Mortality in Sub-Saharan Africa</title>
      <itunes:title>Azithromycin to Prevent Childhood Mortality in Sub-Saharan Africa</itunes:title>
      <pubDate>Tue, 13 Feb 2024 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[839ba1e0-9f08-47f1-8a4a-1ea063512813]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.53]]></link>
      <description><![CDATA[<p>Childhood death rates remain high in some areas of sub-Saharan Africa, despite global reductions in childhood mortality. JAMA Deputy Editor Preeti Malani, MD, MSJ, and author Thomas Lietman, MD, University of California, San Francisco, discuss twice-yearly azithromycin to reduce childhood mortality.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.27393?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Mass Azithromycin Distribution to Prevent Child Mortality in Burkina Faso</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Childhood death rates remain high in some areas of sub-Saharan Africa, despite global reductions in childhood mortality. JAMA Deputy Editor Preeti Malani, MD, MSJ, and author Thomas Lietman, MD, University of California, San Francisco, discuss twice-yearly azithromycin to reduce childhood mortality. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.27393?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Mass Azithromycin Distribution to Prevent Child Mortality in Burkina Faso</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Azithromycin_to_Prevent_Childhood_Mortality_in_Sub-Saharan_Africa.mp3?dest-id=90171" length="25275460" type="audio/mpeg" />
      <itunes:duration>10:31</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/2/9/3/3293c96072162b83e5bbc093207a2619/jsx240003audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Evaluating the Effectiveness of Bivalent COVID-19 Vaccines in Children and Adolescents</title>
      <itunes:title>Evaluating the Effectiveness of Bivalent COVID-19 Vaccines in Children and Adolescents</itunes:title>
      <pubDate>Tue, 06 Feb 2024 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[0d2a1859-78c2-4c40-83ee-00f73fe9be06]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2023.27495]]></link>
      <description><![CDATA[<p>Bivalent mRNA COVID-19 vaccines were recommended for children and adolescents aged 5 to 17 years in the US, but were they effective? JAMA Associate Editor Tracy A. Lieu, MD, MPH, spoke with author Leora R. Feldstein, PhD, US Centers for Disease Control and Prevention, about the effectiveness of bivalent COVID-19 vaccines in children and adolescents.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.27022?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing SARS-CoV-2 Infection in Children and Adolescents Aged 5 to 17 Years</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Bivalent mRNA COVID-19 vaccines were recommended for children and adolescents aged 5 to 17 years in the US, but were they effective? JAMA Associate Editor Tracy A. Lieu, MD, MPH, spoke with author Leora R. Feldstein, PhD, US Centers for Disease Control and Prevention, about the effectiveness of bivalent COVID-19 vaccines in children and adolescents. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.27022?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing SARS-CoV-2 Infection in Children and Adolescents Aged 5 to 17 Years</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Evaluating_the_Effectiveness_of_Bivalent_COVID-19_Vaccines_in_Children_and_Adolescents.mp3?dest-id=90171" length="29335520" type="audio/mpeg" />
      <itunes:duration>12:13</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/b/8/0/f/b80f72d4657b2ef888c4a68c3ddbc4f2/jsx230184audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Anxiety and Depression Symptoms After the Dobbs Abortion Rights Decision</title>
      <itunes:title>Anxiety and Depression Symptoms After the Dobbs Abortion Rights Decision</itunes:title>
      <pubDate>Tue, 23 Jan 2024 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[369eab85-8995-44f9-89b5-877b4d6be41e]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2023.27704]]></link>
      <description><![CDATA[<p>Following the Dobbs decision, females aged 18-45 years living in states with "trigger laws" that restricted access to abortion reported a greater increase in symptoms of anxiety and depression than those in states without trigger laws. JAMA Associate Editor Donald Goff, MD, speaks with editorialist Julia Steinberg, PhD, associate professor at the School of Public Health at the University of Maryland, about this topic.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.26816?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Mental Health Symptoms When Abortion Access Is Restricted</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.25599?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Anxiety and Depression Symptoms After the Dobbs Abortion Decision</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Following the Dobbs decision, females aged 18-45 years living in states with "trigger laws" that restricted access to abortion reported a greater increase in symptoms of anxiety and depression than those in states without trigger laws. JAMA Associate Editor Donald Goff, MD, speaks with editorialist Julia Steinberg, PhD, associate professor at the School of Public Health at the University of Maryland, about this topic. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.26816?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Mental Health Symptoms When Abortion Access Is Restricted</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.25599?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Anxiety and Depression Symptoms After the Dobbs Abortion Decision</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Anxiety_and_Depression_Symptoms_After_the_Dobbs_Abortion_Rights_Decision.mp3?dest-id=90171" length="34700267" type="audio/mpeg" />
      <itunes:duration>14:26</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/0/3/9/c039127518f4948f88c4a68c3ddbc4f2/JSX230185_x3000_thumbimg.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Patient-Centered Palliative Care</title>
      <itunes:title>Patient-Centered Palliative Care</itunes:title>
      <pubDate>Tue, 16 Jan 2024 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[e1c12d56-0bf8-4cad-8ee4-9bb757ac8e25]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2023.27462]]></link>
      <description><![CDATA[<p>JAMA Deputy Editor Preeti Malani, MD, MSJ, and author Alexander K. Smith, MD, MS, MPH, University of California, San Francisco, discuss the importance of 2 new palliative care trials that were recently published in JAMA.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.26815?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">A Tale of 2 Palliative Care Trials</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.14205?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Association of Receipt of Palliative Care Interventions With Health Care Use, Quality of Life, and Symptom Burden Among Adults With Chronic Noncancer Illness</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>JAMA Deputy Editor Preeti Malani, MD, MSJ, and author Alexander K. Smith, MD, MS, MPH, University of California, San Francisco, discuss the importance of 2 new palliative care trials that were recently published in JAMA. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.26815?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">A Tale of 2 Palliative Care Trials</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.14205?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Association of Receipt of Palliative Care Interventions With Health Care Use, Quality of Life, and Symptom Burden Among Adults With Chronic Noncancer Illness</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Patient-Centered_Palliative_Care.mp3?dest-id=90171" length="35957173" type="audio/mpeg" />
      <itunes:duration>14:58</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/9/d/5/39d5a061ece69654e5bbc093207a2619/jsx230183audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Dialysis Facility Performance and Social Risk in the First Year of the ESRD Treatment Choices Model</title>
      <itunes:title>Dialysis Facility Performance and Social Risk in the First Year of the ESRD Treatment Choices Model</itunes:title>
      <pubDate>Tue, 09 Jan 2024 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[bbd9ac5e-9b81-48a9-aa81-59a93aca862f]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2023.27417]]></link>
      <description><![CDATA[<p>Dialysis facilities in the US are financially rewarded for higher rates of home dialysis and kidney transplant, but facilities that serve patients with high social risk might have a harder time meeting these goals. JAMA Associate Editor Karen E. Joynt Maddox, MD, MPH, speaks with Amal N. Trivedi, MD, MPH, of Brown University, about how this plays out under the ESRD Treatment Choices Model.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.23649?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Social Risk and Dialysis Facility Performance in the First Year of the ESRD Treatment Choices Model</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Dialysis facilities in the US are financially rewarded for higher rates of home dialysis and kidney transplant, but facilities that serve patients with high social risk might have a harder time meeting these goals. JAMA Associate Editor Karen E. Joynt Maddox, MD, MPH, speaks with Amal N. Trivedi, MD, MPH, of Brown University, about how this plays out under the ESRD Treatment Choices Model. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.23649?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Social Risk and Dialysis Facility Performance in the First Year of the ESRD Treatment Choices Model</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Dialysis_Facility_Performance_and_Social_Risk_in_the_First_Year_of_the_ESRD_Treatment_Choices_Model.mp3?dest-id=90171" length="34155812" type="audio/mpeg" />
      <itunes:duration>14:14</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/4/f/c/0/4fc03ef7dcefb2f6e5bbc093207a2619/jsx230181audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Alpha-Gal Syndrome</title>
      <itunes:title>Alpha-Gal Syndrome</itunes:title>
      <pubDate>Tue, 02 Jan 2024 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[d2bf9226-8ca5-4bac-a229-4202040a22c1]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2023.26878]]></link>
      <description><![CDATA[<p>Alpha-gal syndrome is a food allergy to red meat products that develops after affected individuals are bitten by a tick. JAMA Deputy Editor Kristin Walter, MD, MS, discusses alpha-gal syndrome with author Mariel R. Benjamin, MD, assistant professor in the Division of Allergy and Clinical Immunology at Michigan Medicine.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.23097?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">What Is Alpha-Gal Syndrome?</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Alpha-gal syndrome is a food allergy to red meat products that develops after affected individuals are bitten by a tick. JAMA Deputy Editor Kristin Walter, MD, MS, discusses alpha-gal syndrome with author Mariel R. Benjamin, MD, assistant professor in the Division of Allergy and Clinical Immunology at Michigan Medicine. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.23097?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">What Is Alpha-Gal Syndrome?</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Alpha-Gal_Syndrome.mp3?dest-id=90171" length="21473585" type="audio/mpeg" />
      <itunes:duration>08:56</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/6/3/e/363e236111d73b7a88c4a68c3ddbc4f2/jsx230178audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Private Equity Acquisition and Hospital-Acquired Adverse Events in the US</title>
      <itunes:title>Private Equity Acquisition and Hospital-Acquired Adverse Events in the US</itunes:title>
      <pubDate>Tue, 26 Dec 2023 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[536ea20f-cae5-44c1-bade-87dc533d668c]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2023.24888]]></link>
      <description><![CDATA[<p>The effects of private equity acquisition of US hospitals on the quality of inpatient care and patient outcomes remain largely unknown. JAMA Associate Editor Karen E. Joynt Maddox, MD, MPH, spoke with author Zirui Song, MD, PHD, of Massachusetts General Hospital, about a recent study showing that private equity acquisition was associated with increased hospital-acquired adverse events.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.23147?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Changes in Hospital Adverse Events and Patient Outcomes Associated With Private Equity Acquisition</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>The effects of private equity acquisition of US hospitals on the quality of inpatient care and patient outcomes remain largely unknown. JAMA Associate Editor Karen E. Joynt Maddox, MD, MPH, spoke with author Zirui Song, MD, PHD, of Massachusetts General Hospital, about a recent study showing that private equity acquisition was associated with increased hospital-acquired adverse events. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.23147?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Changes in Hospital Adverse Events and Patient Outcomes Associated With Private Equity Acquisition</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Private_Equity_Acquisition_and_Hospital-Acquired_Adverse_Events_in_the_US.mp3?dest-id=90171" length="31458175" type="audio/mpeg" />
      <itunes:duration>13:06</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/c/e/3/ace38aea9737b175e5bbc093207a2619/JSX230173_x3000_thumbimg.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Effect of Dietary Sodium on Blood Pressure</title>
      <itunes:title>Effect of Dietary Sodium on Blood Pressure</itunes:title>
      <pubDate>Tue, 19 Dec 2023 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[006d2ee3-c7b5-4c5b-9d73-97394657d5c4]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2023.24278]]></link>
      <description><![CDATA[<p>Does reducing dietary sodium benefit patients already taking antihypertensive medication? JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, speaks with author Norrina Allen, PhD, MPH, from Northwestern University, about the effect of dietary sodium on blood pressure.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.23651?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Effect of Dietary Sodium on Blood Pressure</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Does reducing dietary sodium benefit patients already taking antihypertensive medication? JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, speaks with author Norrina Allen, PhD, MPH, from Northwestern University, about the effect of dietary sodium on blood pressure. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.23651?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Effect of Dietary Sodium on Blood Pressure</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Effect_of_Dietary_Sodium_on_Blood_Pressure.mp3?dest-id=90171" length="33716579" type="audio/mpeg" />
      <itunes:duration>14:03</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/8/a/8/a8a8a045bbc450e9e5bbc093207a2619/jsx230171audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Risks Associated With Cannabis Exposure During Pregnancy</title>
      <itunes:title>Risks Associated With Cannabis Exposure During Pregnancy</itunes:title>
      <pubDate>Tue, 12 Dec 2023 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[daef3363-5054-4f70-aa6b-e309095d2bfa]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2023.23573]]></link>
      <description><![CDATA[<p>Cannabis use is increasing among reproductive-age individuals. JAMA Deputy Editor Linda Brubaker, MD, MS, discusses the associated risks of cannabis exposure during pregnancy with Torri D. Metz, MD, MS, University of Utah Health.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.21146?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Cannabis Exposure and Adverse Pregnancy Outcomes Related to Placental Function</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Cannabis use is increasing among reproductive-age individuals. JAMA Deputy Editor Linda Brubaker, MD, MS, discusses the associated risks of cannabis exposure during pregnancy with Torri D. Metz, MD, MS, University of Utah Health. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.21146?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Cannabis Exposure and Adverse Pregnancy Outcomes Related to Placental Function</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Risks_Associated_With_Cannabis_Exposure_During_Pregnancy.mp3?dest-id=90171" length="24110013" type="audio/mpeg" />
      <itunes:duration>10:02</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/d/6/7/4/d674448dfb5af57b88c4a68c3ddbc4f2/jsx230162audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Neonatal Outcomes Following Serial Amnioinfusions for Bilateral Renal Agenesis</title>
      <itunes:title>Neonatal Outcomes Following Serial Amnioinfusions for Bilateral Renal Agenesis</itunes:title>
      <pubDate>Tue, 05 Dec 2023 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[9612ac8a-b797-47c0-a701-e9fc55b6adc0]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2023.23354]]></link>
      <description><![CDATA[<p>Bilateral renal agenesis results in lethal neonatal pulmonary hypoplasia. New evidence from an amnioinfusion trial is available. JAMA Deputy Editor Linda Brubaker, MD, MS, discusses the results from the Renal Anhydramnios Fetal Therapy Trial with Meredith A. Atkinson, MD, MHS, Johns Hopkins University, and Johnathan M. Davis, MD, Tufts University.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.21153?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Neonatal Survival After Serial Amnioinfusions for Bilateral Renal Agenesis</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Bilateral renal agenesis results in lethal neonatal pulmonary hypoplasia. New evidence from an amnioinfusion trial is available. JAMA Deputy Editor Linda Brubaker, MD, MS, discusses the results from the Renal Anhydramnios Fetal Therapy Trial with Meredith A. Atkinson, MD, MHS, Johns Hopkins University, and Johnathan M. Davis, MD, Tufts University. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.21153?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Neonatal Survival After Serial Amnioinfusions for Bilateral Renal Agenesis</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Neonatal_Outcomes_Following_Serial_Amnioinfusions_for_Bilateral_Renal_Agenesis.mp3?dest-id=90171" length="32220635" type="audio/mpeg" />
      <itunes:duration>13:24</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/f/6/a/0f6abb2c14533937e5bbc093207a2619/jsx230159audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Increasing Cervical Cancer Screening With Self-Sampling HPV Kits at Home</title>
      <itunes:title>Increasing Cervical Cancer Screening With Self-Sampling HPV Kits at Home</itunes:title>
      <pubDate>Tue, 28 Nov 2023 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[cdb09560-9c6d-486e-8a8b-f88cb4e6b9d3]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2023.22575]]></link>
      <description><![CDATA[<p>Cervical cancer screening is effective when done as recommended. JAMA Deputy Editor Linda Brubaker, MD, speaks with Rachel L. Winer, PhD, MPH, of the University of Washington, about a recent trial in JAMA that compared cervical cancer screening strategies, including direct-mail and opt-in approaches for human papillomavirus (HPV) self-sampling.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.21471?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Strategies to Increase Cervical Cancer Screening With Mailed Human Papillomavirus Self-Sampling Kits</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Cervical cancer screening is effective when done as recommended. JAMA Deputy Editor Linda Brubaker, MD, speaks with Rachel L. Winer, PhD, MPH, of the University of Washington, about a recent trial in JAMA that compared cervical cancer screening strategies, including direct-mail and opt-in approaches for human papillomavirus (HPV) self-sampling. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.21471?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Strategies to Increase Cervical Cancer Screening With Mailed Human Papillomavirus Self-Sampling Kits</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Increasing_Cervical_Cancer_Screening_With_Self-Sampling_HPV_Kits_at_Home.mp3?dest-id=90171" length="25081389" type="audio/mpeg" />
      <itunes:duration>10:26</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/7/d/8/17d87119b525b1d488c4a68c3ddbc4f2/jsx230149audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Small-Volume Blood Collection Tubes May Reduce Transfusions in Intensive Care</title>
      <itunes:title>Small-Volume Blood Collection Tubes May Reduce Transfusions in Intensive Care</itunes:title>
      <pubDate>Tue, 21 Nov 2023 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[19cd1739-5e92-4468-8497-112b7f84b11a]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2023.21928]]></link>
      <description><![CDATA[<p>Small-volume blood collection tubes may decrease red blood cell transfusions in intensive care units without affecting laboratory analysis. JAMA Associate Editor Christopher W. Seymour, MD, MSc, discusses the results and implications of the STRATUS trial with Deborah M. Siegal, MD, MSc, of Ottawa Hospital Research Institute.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.20820?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Small-Volume Blood Collection Tubes to Reduce Transfusions in Intensive Care</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Small-volume blood collection tubes may decrease red blood cell transfusions in intensive care units without affecting laboratory analysis. JAMA Associate Editor Christopher W. Seymour, MD, MSc, discusses the results and implications of the STRATUS trial with Deborah M. Siegal, MD, MSc, of Ottawa Hospital Research Institute. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.20820?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Small-Volume Blood Collection Tubes to Reduce Transfusions in Intensive Care</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Small-Volume_Blood_Collection_Tubes_May_Reduce_Transfusions_in_Intensive_Care.mp3?dest-id=90171" length="39760358" type="audio/mpeg" />
      <itunes:duration>16:33</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/b/8/4/c/b84cd45cbda271f1e5bbc093207a2619/jsx230145audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Fitness Trackers to Guide Advice on Activity Prescription</title>
      <itunes:title>Fitness Trackers to Guide Advice on Activity Prescription</itunes:title>
      <pubDate>Tue, 14 Nov 2023 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[f6d173bf-97ae-44bb-948b-aba2254c3a39]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2023.22043]]></link>
      <description><![CDATA[<p>Fitness trackers are a group of devices including watches, phones, and rings that track physical activity. JAMA Executive Editor Gregory Curfman, MD, speaks with I-Min Lee, MBBS, ScD, professor of medicine at Harvard Medical School and professor of epidemiology at Harvard T.H. Chan School of Public Health, about using fitness trackers to guide advice on activity prescription.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.19332?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Fitness Trackers to Guide Advice on Activity Prescription</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Fitness trackers are a group of devices including watches, phones, and rings that track physical activity. JAMA Executive Editor Gregory Curfman, MD, speaks with I-Min Lee, MBBS, ScD, professor of medicine at Harvard Medical School and professor of epidemiology at Harvard T.H. Chan School of Public Health, about using fitness trackers to guide advice on activity prescription. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.19332?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Fitness Trackers to Guide Advice on Activity Prescription</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Fitness_Trackers_to_Guide_Advice_on_Activity_Prescription.mp3?dest-id=90171" length="37145199" type="audio/mpeg" />
      <itunes:duration>15:27</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/7/b/3/d/7b3d377b6f245591e5bbc093207a2619/jsx230146audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Medicare's Historic Prescription Drug Price Negotiations</title>
      <itunes:title>Medicare's Historic Prescription Drug Price Negotiations</itunes:title>
      <pubDate>Tue, 07 Nov 2023 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[d4c378c3-469d-4728-937f-d00388ad199a]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2023.21824]]></link>
      <description><![CDATA[<p>JAMA Senior Editor Kristin Walter, MD, MS, and Lawrence O. Gostin, JD, JAMA Legal and Global Health Correspondent and Faculty Director of the O'Neill Institute for National and Global Health Law at Georgetown University, discuss the Inflation Reduction Act, which for the first time allows the Centers for Medicare & Medicaid Services to negotiate prescription drug prices with drug manufacturers.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.19506?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Medicare's Historic Prescription Drug Price Negotiations</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>JAMA Senior Editor Kristin Walter, MD, MS, and Lawrence O. Gostin, JD, JAMA Legal and Global Health Correspondent and Faculty Director of the O'Neill Institute for National and Global Health Law at Georgetown University, discuss the Inflation Reduction Act, which for the first time allows the Centers for Medicare & Medicaid Services to negotiate prescription drug prices with drug manufacturers. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.19506?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Medicare's Historic Prescription Drug Price Negotiations</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Medicares_Historic_Prescription_Drug_Price_Negotiations.mp3?dest-id=90171" length="36051022" type="audio/mpeg" />
      <itunes:duration>15:01</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/c/3/1/1c31176f41b83e82e55e3c100dce7605/jsx230144audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Traditional Chinese Medicine Meets Evidence-Based Medicine in the Acutely Infarcted Heart</title>
      <itunes:title>Traditional Chinese Medicine Meets Evidence-Based Medicine in the Acutely Infarcted Heart</itunes:title>
      <pubDate>Tue, 24 Oct 2023 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[c7a6fd6b-365a-4ade-9440-daaf6d139190]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2023.21816]]></link>
      <description><![CDATA[<p>JAMA Executive Editor Gregory Curfman, MD, speaks with Richard G. Bach, MD, professor of medicine and medical director of the cardiac intensive care unit at the Washington University School of Medicine in St Louis, about the use of traditional Chinese medicine to treat patients with acute ST-segment elevation myocardial infarction.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.20838?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Traditional Chinese Medicine Meets Evidence-Based Medicine in the Acutely Infarcted Heart</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>JAMA Executive Editor Gregory Curfman, MD, speaks with Richard G. Bach, MD, professor of medicine and medical director of the cardiac intensive care unit at the Washington University School of Medicine in St Louis, about the use of traditional Chinese medicine to treat patients with acute ST-segment elevation myocardial infarction. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.20838?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Traditional Chinese Medicine Meets Evidence-Based Medicine in the Acutely Infarcted Heart</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Traditional_Chinese_Medicine_Meets_Evidence-Based_Medicine_in_the_Acutely_Infarcted_Heart.mp3?dest-id=90171" length="46586096" type="audio/mpeg" />
      <itunes:duration>19:24</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/7/9/3/3793357a17f0ef3b88c4a68c3ddbc4f2/jsx230143audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Optical Coherence Tomography (OCT): Imaging Modalities in Clinical Practice</title>
      <itunes:title>Optical Coherence Tomography (OCT): Imaging Modalities in Clinical Practice</itunes:title>
      <pubDate>Tue, 17 Oct 2023 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[85163afc-51d1-4b4f-b1f5-f34fa2cebbe1]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2023.20600]]></link>
      <description><![CDATA[<p>Optical coherence tomography (OCT) is a powerful imaging tool used across multiple clinical disciplines. JAMA Executive Editor Gregory Curfman, MD, speaks with 2023 Lasker Award recipient James G. Fujimoto, PhD, professor of electrical engineering at MIT, about his role in developing OCT and OCT's advancements in clinical practice.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.16942?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Optical Coherence Tomography—History, Evolution, and Future Prospects</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Optical coherence tomography (OCT) is a powerful imaging tool used across multiple clinical disciplines. JAMA Executive Editor Gregory Curfman, MD, speaks with 2023 Lasker Award recipient James G. Fujimoto, PhD, professor of electrical engineering at MIT, about his role in developing OCT and OCT's advancements in clinical practice. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.16942?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Optical Coherence Tomography—History, Evolution, and Future Prospects</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Optical_Coherence_Tomography_OCT_Imaging_Modalities_in_Clinical_Practice.mp3?dest-id=90171" length="28103428" type="audio/mpeg" />
      <itunes:duration>11:42</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/b/3/c/0/b3c0478498bab09ae55e3c100dce7605/jsx230137audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Nasal Iodophor vs Nasal Mupirocin With Chlorhexidine Baths to Prevent Infections in Adult ICUs</title>
      <itunes:title>Nasal Iodophor vs Nasal Mupirocin With Chlorhexidine Baths to Prevent Infections in Adult ICUs</itunes:title>
      <pubDate>Tue, 10 Oct 2023 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[b8b31fa5-2488-41dd-bc90-6ad90101a381]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2023.19978]]></link>
      <description><![CDATA[<p>Nasal mupirocin plus chlorhexidine baths in ICUs prevents methicillin-resistant Staphylococcus aureus (MRSA) infections but raises concern about antibiotic resistance. JAMA Senior Editor Kristin Walter, MD, speaks with Susan Huang, MD, of University of California, Irvine, about a study comparing iodophor vs mupirocin with chlorhexidine bathing for ICU-attributable S aureus clinical cultures.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.17219?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Nasal Iodophor Antiseptic vs Nasal Mupirocin Antibiotic in the Setting of Chlorhexidine Bathing to Prevent Infections in Adult ICUs</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Nasal mupirocin plus chlorhexidine baths in ICUs prevents methicillin-resistant Staphylococcus aureus (MRSA) infections but raises concern about antibiotic resistance. JAMA Senior Editor Kristin Walter, MD, speaks with Susan Huang, MD, of University of California, Irvine, about a study comparing iodophor vs mupirocin with chlorhexidine bathing for ICU-attributable S aureus clinical cultures. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.17219?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Nasal Iodophor Antiseptic vs Nasal Mupirocin Antibiotic in the Setting of Chlorhexidine Bathing to Prevent Infections in Adult ICUs</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Nasal_Iodophor_vs_Nasal_Mupirocin_With_Chlorhexidine_Baths_to_Prevent_Infections_in_Adult_ICUs.mp3?dest-id=90171" length="32441490" type="audio/mpeg" />
      <itunes:duration>13:31</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/2/5/a/925ae5e61a15a9b840be95ea3302a6a1/jsx230133audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Is Remote Ischemic Conditioning (RIC) an Effective Treatment for Acute Stroke?</title>
      <itunes:title>Is Remote Ischemic Conditioning (RIC) an Effective Treatment for Acute Stroke?</itunes:title>
      <pubDate>Tue, 03 Oct 2023 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[b7de7990-669c-4d6d-9215-d28279f2547d]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2023.17928]]></link>
      <description><![CDATA[<p>It's been unclear whether remote ischemic conditioning (RIC) with transient cycles of limb ischemia and reperfusion is an effective treatment for acute stroke. JAMA Deputy Editor Chris Muth, MD, speaks with author Rolf Blauenfeldt, MD, Aarhus University Hospital, Denmark, about the RESIST randomized clinical trial, which looks at the effect of RIC when initiated in the prehospital setting.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.16893?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Remote Ischemic Conditioning for Acute Stroke</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>It's been unclear whether remote ischemic conditioning (RIC) with transient cycles of limb ischemia and reperfusion is an effective treatment for acute stroke. JAMA Deputy Editor Chris Muth, MD, speaks with author Rolf Blauenfeldt, MD, Aarhus University Hospital, Denmark, about the RESIST randomized clinical trial, which looks at the effect of RIC when initiated in the prehospital setting. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.16893?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Remote Ischemic Conditioning for Acute Stroke</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Is_Remote_Ischemic_Conditioning_RIC_an_Effective_Treatment_for_Acute_Stroke.mp3?dest-id=90171" length="26687749" type="audio/mpeg" />
      <itunes:duration>11:07</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/f/c/7/9/fc796371c1a2f74ebafc7308ab683e82/jsx230127audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>The Connection Between SARS-CoV-2 and Type 1 Diabetes Risk in Young Children</title>
      <itunes:title>The Connection Between SARS-CoV-2 and Type 1 Diabetes Risk in Young Children</itunes:title>
      <pubDate>Tue, 26 Sep 2023 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[915aa8c3-14b6-4a49-a4be-7b995d199453]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2023.18047]]></link>
      <description><![CDATA[<p>During the COVID-19 pandemic, the incidence of diabetes in childhood increased. JAMA Associate Editor Anne R. Cappola, MD, ScM, and Ezio Bonifacio, PhD, from the Center for Regenerative Therapies at the Dresden University of Technology, discuss SARS-CoV-2 infection and its association with islet autoimmunity in early childhood.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.16348?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">SARS-CoV-2 Infection and Development of Islet Autoimmunity in Early Childhood</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>During the COVID-19 pandemic, the incidence of diabetes in childhood increased. JAMA Associate Editor Anne R. Cappola, MD, ScM, and Ezio Bonifacio, PhD, from the Center for Regenerative Therapies at the Dresden University of Technology, discuss SARS-CoV-2 infection and its association with islet autoimmunity in early childhood. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.16348?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">SARS-CoV-2 Infection and Development of Islet Autoimmunity in Early Childhood</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/The_Connection_Between_SARS-CoV-2_and_Type_1_Diabetes_Risk_in_Young_Children.mp3?dest-id=90171" length="35455930" type="audio/mpeg" />
      <itunes:duration>14:45</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/7/4/9/4/7494014677fd745cbafc7308ab683e82/jsx230128audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Two-Year Outcomes After Minimally Invasive Surfactant Therapy</title>
      <itunes:title>Two-Year Outcomes After Minimally Invasive Surfactant Therapy</itunes:title>
      <pubDate>Tue, 19 Sep 2023 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[bd9b11ad-cd57-42f0-bf53-68f833920f17]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2023.16555]]></link>
      <description><![CDATA[<p>Many premature infants with respiratory distress are now supported with continuous positive airway pressure, or CPAP, rather than intubation and ventilation, and those with CPAP can receive surfactant via a minimally invasive approach. JAMA Associate Editor Tracy Lieu, MD, speaks with author Peter Dargaville, MD, from the Menzies Institute for Medical Research in Tasmania, Australia, about Two-Year Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants: Follow-Up of the OPTIMIST-A Randomized Clinical Trial.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.15694?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Two-Year Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Many premature infants with respiratory distress are now supported with continuous positive airway pressure, or CPAP, rather than intubation and ventilation, and those with CPAP can receive surfactant via a minimally invasive approach. JAMA Associate Editor Tracy Lieu, MD, speaks with author Peter Dargaville, MD, from the Menzies Institute for Medical Research in Tasmania, Australia, about Two-Year Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants: Follow-Up of the OPTIMIST-A Randomized Clinical Trial. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.15694?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Two-Year Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Two-Year_Outcomes_After_Minimally_Invasive_Surfactant_Therapy.mp3?dest-id=90171" length="37118365" type="audio/mpeg" />
      <itunes:duration>15:27</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/d/0/1/6/d0164951ac37d499a04421dee9605cbd/jsx230120audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Sedentary Behavior and Dementia</title>
      <itunes:title>Sedentary Behavior and Dementia</itunes:title>
      <pubDate>Tue, 12 Sep 2023 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[baceb9a7-df20-474b-802a-3e0f4741151c]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2023.16710]]></link>
      <description><![CDATA[<p>There is an established link between sedentary behavior and cardiovascular disease, but the association between sedentary behavior and dementia is unclear. JAMA Deputy Editor Christopher C. Muth, MD, speaks with David A. Raichlen, PhD, University of Southern California, about a new study that investigates the relationship between sedentary behavior and dementia in older adults.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.15231?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Sedentary Behavior and Incident Dementia Among Older Adults</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>There is an established link between sedentary behavior and cardiovascular disease, but the association between sedentary behavior and dementia is unclear. JAMA Deputy Editor Christopher C. Muth, MD, speaks with David A. Raichlen, PhD, University of Southern California, about a new study that investigates the relationship between sedentary behavior and dementia in older adults. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.15231?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Sedentary Behavior and Incident Dementia Among Older Adults</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Sedentary_Behavior_and_Dementia.mp3?dest-id=90171" length="26157051" type="audio/mpeg" />
      <itunes:duration>10:53</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/5/c/f/0/5cf0d4a2915b1df427a2322813b393ee/jsx230123audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Psilocybin for Major Depressive Disorder</title>
      <itunes:title>Psilocybin for Major Depressive Disorder</itunes:title>
      <pubDate>Thu, 31 Aug 2023 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[c289856c-22d0-47cd-9db0-d1c2e417b2df]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2023.15326]]></link>
      <description><![CDATA[<p>In a new study, psilocybin showed promise as a treatment for major depressive disorder (MDD). JAMA Associate Editor Donald C. Goff, MD, speaks with author Charles L. Raison, MD, from the Usona Institute, about the study, as well as Rachel Yehuda, PhD, Mount Sinai School of Medicine, who wrote an accompanying editorial about the potential benefits of psychedelic therapies.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.14530?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Single-Dose Psilocybin Treatment for Major Depressive Disorder</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.12900?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Psychedelic Therapy—A New Paradigm of Care for Mental Health</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>In a new study, psilocybin showed promise as a treatment for major depressive disorder (MDD). JAMA Associate Editor Donald C. Goff, MD, speaks with author Charles L. Raison, MD, from the Usona Institute, about the study, as well as Rachel Yehuda, PhD, Mount Sinai School of Medicine, who wrote an accompanying editorial about the potential benefits of psychedelic therapies. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.14530?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Single-Dose Psilocybin Treatment for Major Depressive Disorder</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.12900?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Psychedelic Therapy—A New Paradigm of Care for Mental Health</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Psilocybin_for_Major_Depressive_Disorder.mp3?dest-id=90171" length="68677251" type="audio/mpeg" />
      <itunes:duration>28:37</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/d/9/7/4/d9748e9e6a84c072d959afa2a1bf1c87/jsx230110audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Neurodevelopmental Effects of Antenatal IV Magnesium Sulfate Between 30-34 Weeks' Gestation</title>
      <itunes:title>Neurodevelopmental Effects of Antenatal IV Magnesium Sulfate Between 30-34 Weeks' Gestation</itunes:title>
      <pubDate>Tue, 15 Aug 2023 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[3b03224e-9a23-4f92-82b5-19d12d99bff3]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2023.12709]]></link>
      <description><![CDATA[<p>Magnesium sulfate is widely recommended for neuroprotection in pregnancies at risk of preterm delivery. However, the optimal gestational age for use is unclear. JAMA Associate Editor Melissa Simon, MD, MPH, and Caroline Crowther, MD, Liggins Institute, University of Auckland, discuss the use of magnesium sulfate at different gestational ages and potential benefit vs harms as reflected in the MAGENTA Trial.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.12357?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Prenatal Intravenous Magnesium at 30-34 Weeks' Gestation and Neurodevelopmental Outcomes in Offspring</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Magnesium sulfate is widely recommended for neuroprotection in pregnancies at risk of preterm delivery. However, the optimal gestational age for use is unclear. JAMA Associate Editor Melissa Simon, MD, MPH, and Caroline Crowther, MD, Liggins Institute, University of Auckland, discuss the use of magnesium sulfate at different gestational ages and potential benefit vs harms as reflected in the MAGENTA Trial. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.12357?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Prenatal Intravenous Magnesium at 30-34 Weeks' Gestation and Neurodevelopmental Outcomes in Offspring</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Neurodevelopmental_Effects_of_Antenatal_IV_Magnesium_Sulfate_Between_30-34_Weeks_Gestation.mp3?dest-id=90171" length="32503705" type="audio/mpeg" />
      <itunes:duration>13:31</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/a/c/1/2ac162877335a6b927a2322813b393ee/jsx230090audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Atorvastatin to Reduce Risk of Anthracycline-Associated Cardiac Dysfunction</title>
      <itunes:title>Atorvastatin to Reduce Risk of Anthracycline-Associated Cardiac Dysfunction</itunes:title>
      <pubDate>Tue, 08 Aug 2023 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[6e9a1e47-9a83-412a-990c-430eca0bf5f8]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2023.13054]]></link>
      <description><![CDATA[<p>Anthracyclines are used to treat a variety of cancers, but treatment may be limited by cardiac toxicity. JAMA Executive Editor Gregory Curfman, MD, discusses a new clinical trial on the use of atorvastatin to prevent anthracycline-induced cardiac toxicity with authors Tomas Neilan, MD, MPH, and Marielle Scherrer-Crosbie, MD, PhD.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.11887?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Atorvastatin for Anthracycline-Associated Cardiac Dysfunction</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Anthracyclines are used to treat a variety of cancers, but treatment may be limited by cardiac toxicity. JAMA Executive Editor Gregory Curfman, MD, discusses a new clinical trial on the use of atorvastatin to prevent anthracycline-induced cardiac toxicity with authors Tomas Neilan, MD, MPH, and Marielle Scherrer-Crosbie, MD, PhD. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.11887?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Atorvastatin for Anthracycline-Associated Cardiac Dysfunction</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Atorvastatin_to_Reduce_Risk_of_Anthracycline-Associated_Cardiac_Dysfunction.mp3?dest-id=90171" length="44500121" type="audio/mpeg" />
      <itunes:duration>18:31</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/1/7/7/8177e2feb644db7da04421dee9605cbd/jsx230092audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Cardiovascular Health Counseling in Pregnant and Postpartum Individuals</title>
      <itunes:title>Cardiovascular Health Counseling in Pregnant and Postpartum Individuals</itunes:title>
      <pubDate>Tue, 25 Jul 2023 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[20ef32c6-619d-4980-9889-2997d136b90c]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2023.12282]]></link>
      <description><![CDATA[<p>Cardiovascular health is essential to everyone, but especially important to address in individuals who can become or who are pregnant or postpartum. JAMA Associate Editor Melissa Simon, MD, MPH, and Sadiya S. Khan, MD, MSc, Northwestern University, discuss the importance of cardiovascular health in pregnancy-capable, pregnant, and postpartum persons, how to counsel such individuals, issues of access to care and health equity, and their impact on cardiovascular health.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.11210?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Trends in Cardiovascular Health Counseling Among Postpartum Individuals</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Cardiovascular health is essential to everyone, but especially important to address in individuals who can become or who are pregnant or postpartum. JAMA Associate Editor Melissa Simon, MD, MPH, and Sadiya S. Khan, MD, MSc, Northwestern University, discuss the importance of cardiovascular health in pregnancy-capable, pregnant, and postpartum persons, how to counsel such individuals, issues of access to care and health equity, and their impact on cardiovascular health. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.11210?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Trends in Cardiovascular Health Counseling Among Postpartum Individuals</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Cardiovascular_Health_Counseling_in_Pregnant_and_Postpartum_Individuals.mp3?dest-id=90171" length="43872951" type="audio/mpeg" />
      <itunes:duration>18:16</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/2/1/f/321fc25dc61a1150e5bbc093207a2619/jsx230086audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Bempedoic Acid in Statin-Intolerant Patients</title>
      <itunes:title>Bempedoic Acid in Statin-Intolerant Patients</itunes:title>
      <pubDate>Tue, 11 Jul 2023 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[175868af-eab5-4462-afb5-88db476d73da]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2023.11249]]></link>
      <description><![CDATA[<p>Bempedoic acid is an effective option for some statin-intolerant patients with an elevated predicted risk of cardiovascular events. However, as JAMA Executive Editor Gregory Curfman, MD, discusses with editorialist Dhruv S. Kazi, MD, MSc, MS, bempedoic acid should not be considered a substitute for statins, which remain the first-line therapy for primary prevention.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.9696?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.9854?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Bempedoic Acid for High-Risk Primary Prevention of Cardiovascular Disease</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Bempedoic acid is an effective option for some statin-intolerant patients with an elevated predicted risk of cardiovascular events. However, as JAMA Executive Editor Gregory Curfman, MD, discusses with editorialist Dhruv S. Kazi, MD, MSc, MS, bempedoic acid should not be considered a substitute for statins, which remain the first-line therapy for primary prevention. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.9696?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.9854?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Bempedoic Acid for High-Risk Primary Prevention of Cardiovascular Disease</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Bempedoic_Acid_in_Statin-Intolerant_Patients.mp3?dest-id=90171" length="38993033" type="audio/mpeg" />
      <itunes:duration>16:14</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/d/3/5/0d35f0f7022a9cd988c4a68c3ddbc4f2/jsx230077audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Genomic Sequencing for Ill Newborns</title>
      <itunes:title>Genomic Sequencing for Ill Newborns</itunes:title>
      <pubDate>Tue, 11 Jul 2023 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[3aeae864-da4b-4498-91c4-c963a985b06c]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2023.9788]]></link>
      <description><![CDATA[<p>The performance of whole-genome sequencing in comparison with targeted genomic testing methods is not well understood. In this podcast, JAMA Associate Editor W. Gregory Feero, MD, PHD, interviews author Jill L. Maron, MD, MPH, of the Women and Infants Hospital of Rhode Island about a study of whole-genome sequencing vs a commercially available targeted genetic testing platform for diagnosing ill neonates with suspected genetic conditions.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.9350?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Rapid Whole-Genomic Sequencing and a Targeted Neonatal Gene Panel in Infants With a Suspected Genetic Disorder</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>The performance of whole-genome sequencing in comparison with targeted genomic testing methods is not well understood. In this podcast, JAMA Associate Editor W. Gregory Feero, MD, PHD, interviews author Jill L. Maron, MD, MPH, of the Women and Infants Hospital of Rhode Island about a study of whole-genome sequencing vs a commercially available targeted genetic testing platform for diagnosing ill neonates with suspected genetic conditions. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.9350?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Rapid Whole-Genomic Sequencing and a Targeted Neonatal Gene Panel in Infants With a Suspected Genetic Disorder</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Genomic_Sequencing_for_Ill_Newborns.mp3?dest-id=90171" length="46877451" type="audio/mpeg" />
      <itunes:duration>19:31</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/e/4/7/1e47b3ecb5d38d4088c4a68c3ddbc4f2/jsx230063audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus Disease in High-Risk Kidney Transplant Recipients</title>
      <itunes:title>Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus Disease in High-Risk Kidney Transplant Recipients</itunes:title>
      <pubDate>Mon, 03 Jul 2023 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[ca422d13-f2ef-47e6-8f72-c8ad21fe821d]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2023.9542]]></link>
      <description><![CDATA[<p>Valganciclovir is standard cytomegalovirus (CMV) prophylaxis in high-risk kidney transplant recipients, but its use is limited by myelosuppression. JAMA Deputy Editor Preeti Malani, MD, MSJ, interviews Ajit Limaye, MD, from the University of Washington, about a multinational randomized trial of letermovir vs valganciclovir for CMV prevention in CMV-negative patients receiving a kidney from a CMV-positive donor.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.9106?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Valganciclovir is standard cytomegalovirus (CMV) prophylaxis in high-risk kidney transplant recipients, but its use is limited by myelosuppression. JAMA Deputy Editor Preeti Malani, MD, MSJ, interviews Ajit Limaye, MD, from the University of Washington, about a multinational randomized trial of letermovir vs valganciclovir for CMV prevention in CMV-negative patients receiving a kidney from a CMV-positive donor. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.9106?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Letermovir_vs_Valganciclovir_for_Prophylaxis_of_Cytomegalovirus_Disease_in_High-Risk_Kidney_Transplant_Recipients.mp3?dest-id=90171" length="43141075" type="audio/mpeg" />
      <itunes:duration>17:57</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/7/f/8/4/7f840ded067887cad959afa2a1bf1c87/jsx230062audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>The Costs of Quality Reporting</title>
      <itunes:title>The Costs of Quality Reporting</itunes:title>
      <pubDate>Tue, 27 Jun 2023 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[5d439372-a075-4969-a970-718b8cd139db]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2023.8150]]></link>
      <description><![CDATA[<p>US hospitals report data on numerous quality metrics to government and independent rating organizations, but the cost of doing so is not well known. JAMA Associate Editor Karen E. Joynt Maddox, MD, discusses a new study that examines just how many quality metrics hospitals have to report, and attempts to quantify how much data collection and reporting costs in hours and dollars, with corresponding author Stephen A. Berry MD, PhD, Johns Hopkins University, Baltimore, Maryland.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.7271?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">The Volume and Cost of Quality Metric Reporting</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>US hospitals report data on numerous quality metrics to government and independent rating organizations, but the cost of doing so is not well known. JAMA Associate Editor Karen E. Joynt Maddox, MD, discusses a new study that examines just how many quality metrics hospitals have to report, and attempts to quantify how much data collection and reporting costs in hours and dollars, with corresponding author Stephen A. Berry MD, PhD, Johns Hopkins University, Baltimore, Maryland. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.7271?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">The Volume and Cost of Quality Metric Reporting</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/The_Costs_of_Quality_Reporting.mp3?dest-id=90171" length="56691117" type="audio/mpeg" />
      <itunes:duration>23:36</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/b/2/0/4/b204a4747d6d260d40be95ea3302a6a1/jsx230056audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendations: Screening for Depression and Suicide Risk in Adults, and Screening for Anxiety Disorders in Adults</title>
      <itunes:title>USPSTF Recommendations: Screening for Depression and Suicide Risk in Adults, and Screening for Anxiety Disorders in Adults</itunes:title>
      <pubDate>Fri, 23 Jun 2023 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[5de81041-ab04-4780-a988-36d612300fd4]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2023.7414]]></link>
      <description><![CDATA[<p>Interview with Michael Silverstein, MD, MPH, USPSTF chair and coauthor of Screening for Depression and Suicide Risk in Adults, and Screening for Anxiety Disorders in Adults: US Preventive Services Task Force Recommendation Statements. Hosted by JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.6369?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Anxiety Screening</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.7787?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Depression and Suicide Risk Screening</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.9297?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Screening for Depression and Suicide Risk in Adults</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.9301?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Screening for Anxiety Disorders in Adults</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.9449?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Screening for Depression and Suicide Risk in Adults</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.9446?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Screening for Anxiety Disorders in Adults</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.7239?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Are There Reasons to Fear Anxiety Screening?</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.7241?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Reframing the Key Questions Regarding Screening for Suicide Risk</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Michael Silverstein, MD, MPH, USPSTF chair and coauthor of Screening for Depression and Suicide Risk in Adults, and Screening for Anxiety Disorders in Adults: US Preventive Services Task Force Recommendation Statements. Hosted by JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.6369?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Anxiety Screening</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.7787?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Depression and Suicide Risk Screening</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.9297?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Screening for Depression and Suicide Risk in Adults</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.9301?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Screening for Anxiety Disorders in Adults</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.9449?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Screening for Depression and Suicide Risk in Adults</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.9446?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Screening for Anxiety Disorders in Adults</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.7239?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Are There Reasons to Fear Anxiety Screening?</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.7241?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Reframing the Key Questions Regarding Screening for Suicide Risk</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendations-Screening_for_Depression_and_Suicide_Risk_in_Adults_and_Screening_for_Anxiety_Disorders_in_Adults.mp3?dest-id=90171" length="58548225" type="audio/mpeg" />
      <itunes:duration>24:22</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/5/4/1/a/541aa0b2c25c4902d959afa2a1bf1c87/JSX230026_x3000_thumbimg.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Mortality and Years of Potential Life Lost in the US Black Population</title>
      <itunes:title>Mortality and Years of Potential Life Lost in the US Black Population</itunes:title>
      <pubDate>Thu, 22 Jun 2023 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[d857727a-8115-42f3-84ed-9ac72cc425e9]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2023.11813]]></link>
      <description><![CDATA[<p>The US Black population experienced more than 80 million excess years of life lost compared with the White population over a recent 22-year period. JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, discusses the research that quantified this disparity with authors César Caraballo, MD, Harlan M. Krumholz, MD, SM, and Clyde W. Yancy, MD, MSc.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.7022?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Excess Mortality and Years of Potential Life Lost Among the Black Population in the US, 1999-2020</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>The US Black population experienced more than 80 million excess years of life lost compared with the White population over a recent 22-year period. JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, discusses the research that quantified this disparity with authors César Caraballo, MD, Harlan M. Krumholz, MD, SM, and Clyde W. Yancy, MD, MSc. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.7022?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Excess Mortality and Years of Potential Life Lost Among the Black Population in the US, 1999-2020</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Mortality_and_Years_of_Potential_Life_Lost_in_the_US_Black_Population.mp3?dest-id=90171" length="55619785" type="audio/mpeg" />
      <itunes:duration>23:09</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/7/1/e/871e5ab0c93522eca04421dee9605cbd/jsx230080audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Legal Risks of Abortion Miscoding</title>
      <itunes:title>Legal Risks of Abortion Miscoding</itunes:title>
      <pubDate>Tue, 13 Jun 2023 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[3fba90c8-4f61-4920-bb43-3d8c5017fb8f]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2023.8218]]></link>
      <description><![CDATA[<p>Intentional miscoding of abortion services may put clinicians and hospital systems at legal risk. JAMA Senior Editor Linda Brubaker, MD, MS, and Carmel Shachar, JD, MPH, from the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, Harvard Law School, discuss the risks of intentional miscoding practices and possible penalties.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.6278?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Abortion Miscoding—Legal Risks for Clinicians and Hospital Systems</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Intentional miscoding of abortion services may put clinicians and hospital systems at legal risk. JAMA Senior Editor Linda Brubaker, MD, MS, and Carmel Shachar, JD, MPH, from the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, Harvard Law School, discuss the risks of intentional miscoding practices and possible penalties. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.6278?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Abortion Miscoding—Legal Risks for Clinicians and Hospital Systems</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Legal_Risks_of_Abortion_Miscoding.mp3?dest-id=90171" length="19647250" type="audio/mpeg" />
      <itunes:duration>20:24</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/3/e/b/83eb7b248410b060e55e3c100dce7605/jsx230057audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Physician as Writer:  Abraham Verghese Reflects on the Art of the Craft of Writing Fiction</title>
      <itunes:title>Physician as Writer:  Abraham Verghese Reflects on the Art of the Craft of Writing Fiction</itunes:title>
      <pubDate>Fri, 26 May 2023 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[64208f40-e26a-4341-921e-6f3a7cffd769]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2023.10112]]></link>
      <description><![CDATA[<p>The Covenant of Water, Stanford University professor Dr Abraham Verghese's long-awaited follow-up to his 2009 novel Cutting for Stone, traces the lives of a family in southern India negotiating forces of history, fate, and a genetic condition that takes the life of a member in each generation by drowning. In part 2, JAMA Arts and Medicine Section Editor Michael Berkwits, MD, MSCE, talks with Dr Verghese about the craft of writing fiction, the role of the humanities in medicine, of artificial intelligence in literature, and more.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.5899?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">"The Art of the Craft," From The Covenant of Water</a></li> <li><a class="related-article" href= "https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2023.6669?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">The Covenant of Water – Reflections on Fiction, the Humanities, and Medicine</a> (Part 1 of this interview)</li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>The Covenant of Water, Stanford University professor Dr Abraham Verghese's long-awaited follow-up to his 2009 novel Cutting for Stone, traces the lives of a family in southern India negotiating forces of history, fate, and a genetic condition that takes the life of a member in each generation by drowning. In part 2, JAMA Arts and Medicine Section Editor Michael Berkwits, MD, MSCE, talks with Dr Verghese about the craft of writing fiction, the role of the humanities in medicine, of artificial intelligence in literature, and more. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.5899?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">"The Art of the Craft," From The Covenant of Water</a></li> <li><a class="related-article" href= "https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2023.6669?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">The Covenant of Water – Reflections on Fiction, the Humanities, and Medicine</a> (Part 1 of this interview)</li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Physician_as_Writer__Abraham_Verghese_Reflects_on_the_Art_of_the_Craft_of_Writing_Fiction.mp3?dest-id=90171" length="47940095" type="audio/mpeg" />
      <itunes:duration>19:58</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/d/2/a/1d2ac1997b10887c5f2e77a3093c12a1/jsx230064audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>The Continued Legal Battle to Undercut the ACA</title>
      <itunes:title>The Continued Legal Battle to Undercut the ACA</itunes:title>
      <pubDate>Tue, 23 May 2023 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[4e3d2324-957e-4139-8a24-da3637c25969]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2023.7599]]></link>
      <description><![CDATA[<p>The ACA's preventive services mandate requires insurers to cover, without charge, nearly 200 basic primary care services. But now, a federal judge has issued a nationwide injunction preventing the Biden administration from enforcing this cost-free care for a significant number of these services. JAMA Executive Editor Gregory Curfman, MD, discusses this and more with Abbe R. Gluck, JD, Solomon Center for Health Law & Policy, Yale Law School.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.6584?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Cost-Free Preventive Care Under the ACA Faces Legal Challenge</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>The ACA's preventive services mandate requires insurers to cover, without charge, nearly 200 basic primary care services. But now, a federal judge has issued a nationwide injunction preventing the Biden administration from enforcing this cost-free care for a significant number of these services. JAMA Executive Editor Gregory Curfman, MD, discusses this and more with Abbe R. Gluck, JD, Solomon Center for Health Law & Policy, Yale Law School. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.6584?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Cost-Free Preventive Care Under the ACA Faces Legal Challenge</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/The_Continued_Legal_Battle_to_Undercut_the_ACA.mp3?dest-id=90171" length="17167646" type="audio/mpeg" />
      <itunes:duration>17:49</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/6/b/c/66bcb06cc8277fd2e5bbc093207a2619/jsx230055audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Global Trends in Heart Failure Etiology, Management, and Outcomes</title>
      <itunes:title>Global Trends in Heart Failure Etiology, Management, and Outcomes</itunes:title>
      <pubDate>Tue, 16 May 2023 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[dfa8f4c9-e756-4f57-9d4f-3f711e9c87b2]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2023.6524]]></link>
      <description><![CDATA[<p>Most epidemiological studies of heart failure have been conducted in high-income countries. JAMA Senior Editor Kristin L. Walter, MD, MS, interviews Philip George Joseph, MD, from the Population Health Research Institute, Ontario, Canada, about a study of more than 23 000 patients with heart failure in 40 countries.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.5942?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Global Variations in Heart Failure Etiology, Management, and Outcomes</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Most epidemiological studies of heart failure have been conducted in high-income countries. JAMA Senior Editor Kristin L. Walter, MD, MS, interviews Philip George Joseph, MD, from the Population Health Research Institute, Ontario, Canada, about a study of more than 23 000 patients with heart failure in 40 countries. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.5942?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Global Variations in Heart Failure Etiology, Management, and Outcomes</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Global_Trends_in_Heart_Failure_Etiology_Management_and_Outcomes.mp3?dest-id=90171" length="16509404" type="audio/mpeg" />
      <itunes:duration>17:08</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/f/8/9/a/f89aca167b3d4c4ed959afa2a1bf1c87/jsx230049audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Screening for Latent Tuberculosis Infection in Adults</title>
      <itunes:title>USPSTF Recommendation: Screening for Latent Tuberculosis Infection in Adults</itunes:title>
      <pubDate>Fri, 05 May 2023 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[c9b9eef3-9367-4001-96da-16b7687b0e7b]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2023.4364]]></link>
      <description><![CDATA[<p>Interview with Gbenga Ogedegbe, MD, MPH, USPSTF member and coauthor of Screening for Latent Tuberculosis Infection in Adults: US Preventive Services Task Force Recommendation Statement. Hosted by JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.3954?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Screening for Latent Tuberculosis Infection in Adults</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.4967?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Screening for Latent Tuberculosis Infection Among Non–US-Born Adults in the US</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.4899?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Screening for Latent Tuberculosis Infection in Adults</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.6495?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Screening for Latent Tuberculosis</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Gbenga Ogedegbe, MD, MPH, USPSTF member and coauthor of Screening for Latent Tuberculosis Infection in Adults: US Preventive Services Task Force Recommendation Statement. Hosted by JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.3954?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Screening for Latent Tuberculosis Infection in Adults</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.4967?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Screening for Latent Tuberculosis Infection Among Non–US-Born Adults in the US</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.4899?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Screening for Latent Tuberculosis Infection in Adults</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.6495?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Screening for Latent Tuberculosis</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation_Screening_for_Latent_Tuberculosis_Infection_in_Adults-jai.mp3?dest-id=90171" length="33122459" type="audio/mpeg" />
      <itunes:duration>13:47</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/4/c/d/9/4cd9f3ea10c078ee16c3140a3186d450/JSX220147_x3000_thumbimg.jpeg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Trends in Mental Health–Related Emergency Department Visits Among Children, Adolescents, and Young Adults in the US, 2011-2020</title>
      <itunes:title>Trends in Mental Health–Related Emergency Department Visits Among Children, Adolescents, and Young Adults in the US, 2011-2020</itunes:title>
      <pubDate>Tue, 02 May 2023 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[e8131fdb-a7bc-4f6e-a577-38f6361e8bd8]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2023.5719]]></link>
      <description><![CDATA[<p>The mental health of young people in the US has been an issue of increased concern in recent years. In this podcast, author Tanner Bommersbach, MD, MPH, assistant professor in the Department of Psychiatry and Psychology at the Mayo Clinic in Rochester, Minnesota, and Greg Rhee, PhD, a health services researcher and pharmacoepidemiologist at the University of Connecticut, join JAMA Senior Editor Kristin Walter, MD, MS, in a discussion about mental health-related emergency department visits in the US among children, adolescents, and young adults from 2011-2020.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.4809?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">National Trends in Mental Health–Related Emergency Department Visits Among Youth, 2011-2020</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>The mental health of young people in the US has been an issue of increased concern in recent years. In this podcast, author Tanner Bommersbach, MD, MPH, assistant professor in the Department of Psychiatry and Psychology at the Mayo Clinic in Rochester, Minnesota, and Greg Rhee, PhD, a health services researcher and pharmacoepidemiologist at the University of Connecticut, join JAMA Senior Editor Kristin Walter, MD, MS, in a discussion about mental health-related emergency department visits in the US among children, adolescents, and young adults from 2011-2020. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.4809?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">National Trends in Mental Health–Related Emergency Department Visits Among Youth, 2011-2020</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Trends_in_Mental_HealthRelated_Emergency_Department_Visits_Among_Children_Adolescents_and_Young_Adults_in_the_US_2011-2020.mp3?dest-id=90171" length="31034137" type="audio/mpeg" />
      <itunes:duration>12:55</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/7/0/e/6/70e60759b84f7e87e55e3c100dce7605/jsx230036audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>The Covenant of Water – Reflections on Fiction, the Humanities, and Medicine</title>
      <itunes:title>The Covenant of Water – Reflections on Fiction, the Humanities, and Medicine</itunes:title>
      <pubDate>Tue, 02 May 2023 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[c8ba77e7-4d73-4ef9-99d7-69f4f606f24a]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2023.6669]]></link>
      <description><![CDATA[<p>The Covenant of Water, Stanford University professor Dr Abraham Verghese's long-awaited follow-up to his 2009 novel Cutting for Stone, traces the lives of a family in southern India negotiating forces of history, fate, and a genetic condition that takes the life of a member in each generation by drowning. JAMA Arts and Medicine Section Editor Michael Berkwits, MD, MSCE, talks with Dr Verghese about the novel's clinical insights, the craft of writing fiction, the role of the humanities in medicine, of artificial intelligence in literature, and more.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.5899?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">"The Art of the Craft," From The Covenant of Water</a></li> <li><a class="related-article" href= "https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2023.10112?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Physician as Writer: Abraham Verghese Reflects on the Art of the Craft of Writing Fiction</a> (Part 2 of this interview)</li> <li> </li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>The Covenant of Water, Stanford University professor Dr Abraham Verghese's long-awaited follow-up to his 2009 novel Cutting for Stone, traces the lives of a family in southern India negotiating forces of history, fate, and a genetic condition that takes the life of a member in each generation by drowning. JAMA Arts and Medicine Section Editor Michael Berkwits, MD, MSCE, talks with Dr Verghese about the novel's clinical insights, the craft of writing fiction, the role of the humanities in medicine, of artificial intelligence in literature, and more. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.5899?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">"The Art of the Craft," From The Covenant of Water</a></li> <li><a class="related-article" href= "https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2023.10112?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Physician as Writer: Abraham Verghese Reflects on the Art of the Craft of Writing Fiction</a> (Part 2 of this interview)</li> <li> </li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/The_Covenant_of_Water__Reflections_on_Fiction_the_Humanities_and_Medicine.mp3?dest-id=90171" length="68612351" type="audio/mpeg" />
      <itunes:duration>28:35</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/c/0/4/3c04f2ba76c7d3aa27a2322813b393ee/jsx230051audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Medical Education: Is Medical School Ranking the Best Assessment of Quality?</title>
      <itunes:title>Medical Education: Is Medical School Ranking the Best Assessment of Quality?</itunes:title>
      <pubDate>Tue, 25 Apr 2023 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[3f0ca60f-4146-46d1-9bb0-828fd4fd7654]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2023.5778]]></link>
      <description><![CDATA[<p>Major medical schools are no longer contributing data to the US News & World Report (USNWR) including more than half the schools that are currently ranked in the top 10 medical schools by the survey. In this podcast, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, speaks with author Holly J. Humphrey, MD, from the Josiah Macy Jr Foundation in New York, about the recently published Viewpoint "Medical School Rankings—Bad for the Health of the Profession and the Public."<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.2815?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Medical School Rankings—Bad for the Health of the Profession and the Public</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Major medical schools are no longer contributing data to the US News & World Report (USNWR) including more than half the schools that are currently ranked in the top 10 medical schools by the survey. In this podcast, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, speaks with author Holly J. Humphrey, MD, from the Josiah Macy Jr Foundation in New York, about the recently published Viewpoint "Medical School Rankings—Bad for the Health of the Profession and the Public." Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.2815?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Medical School Rankings—Bad for the Health of the Profession and the Public</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Medical_Education_Is_Medical_School_Ranking_the_Best_Assessment_of_Quality.mp3?dest-id=90171" length="14925996" type="audio/mpeg" />
      <itunes:duration>15:29</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/7/8/6/4/78648cb37912f3aea04421dee9605cbd/jsx230037audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Income-Based Disparities for Patients With Acute Myocardial Infarction Across 6 Countries</title>
      <itunes:title>Income-Based Disparities for Patients With Acute Myocardial Infarction Across 6 Countries</itunes:title>
      <pubDate>Tue, 04 Apr 2023 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[3fa00b40-4a9d-4593-8fc6-e5c14583ee2d]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2023.3783]]></link>
      <description><![CDATA[<p>Differences among countries in how health care is organized could have implications for health equity. JAMA Associate Editor Karen Joynt Maddox, MD, MPH, and Bruce E. Landon, MD, MBA, MSc, professor of health care policy, Harvard Medical School, discuss whether treatment patterns and outcomes for patients presenting with acute myocardial infarction differ for patients with higher vs lower incomes across 6 countries.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.1699?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Differences in Treatment Patterns and Outcomes of Acute Myocardial Infarction for Low- and High-Income Patients in 6 Countries</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Differences among countries in how health care is organized could have implications for health equity. JAMA Associate Editor Karen Joynt Maddox, MD, MPH, and Bruce E. Landon, MD, MBA, MSc, professor of health care policy, Harvard Medical School, discuss whether treatment patterns and outcomes for patients presenting with acute myocardial infarction differ for patients with higher vs lower incomes across 6 countries. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.1699?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Differences in Treatment Patterns and Outcomes of Acute Myocardial Infarction for Low- and High-Income Patients in 6 Countries</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Income-Based_Disparities_for_Patients_With_Acute_Myocardial_Infarction_Across_6_Countries.mp3?dest-id=90171" length="22293446" type="audio/mpeg" />
      <itunes:duration>23:09</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/d/8/a/cd8a169bf24961caa04421dee9605cbd/jsx230026audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>The Uncertain Future of the Determination of Brain Death</title>
      <itunes:title>The Uncertain Future of the Determination of Brain Death</itunes:title>
      <pubDate>Wed, 29 Mar 2023 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[d2211b4b-4228-417d-affa-cae1e22cbbe8]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2023.3763]]></link>
      <description><![CDATA[<p>JAMA Executive Editor Greg Curfman, MD, speaks with Robert D. Truog, MD, MA, director of the Harvard Center for Bioethics, who describes the 2 approaches to the determination of death (cardiovascular death and brain death) and discusses the possibility that the determination of brain death may soon undergo substantial change, with important implications for organ transplantation.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.1472?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">The Uncertain Future of the Determination of Brain Death</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>JAMA Executive Editor Greg Curfman, MD, speaks with Robert D. Truog, MD, MA, director of the Harvard Center for Bioethics, who describes the 2 approaches to the determination of death (cardiovascular death and brain death) and discusses the possibility that the determination of brain death may soon undergo substantial change, with important implications for organ transplantation. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.1472?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">The Uncertain Future of the Determination of Brain Death</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/The_Uncertain_Future_of_the_Determination_of_Brain_Death.mp3?dest-id=90171" length="54440158" type="audio/mpeg" />
      <itunes:duration>22:40</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/5/f/3/c/5f3c0b4e602fd273bafc7308ab683e82/jsx230025audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Trends in Pediatric Mental Health Hospitalizations</title>
      <itunes:title>Trends in Pediatric Mental Health Hospitalizations</itunes:title>
      <pubDate>Tue, 28 Mar 2023 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[6223cc76-7347-454c-8e5b-41cf7f9f8410]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2023.2875]]></link>
      <description><![CDATA[<p>Mary Arakelyan, MPH, and JoAnna Leyenaar, MD, PhD, MPH, vice chair of Research in Pediatrics at Dartmouth, discuss increases in pediatric mental health hospitalizations and suicide-related diagnoses over the past decade. Hosted by JAMA Associate Editor Tracy Lieu, MD, MPH. Related Content: Pediatric Mental Health Hospitalizations at Acute Care Hospitals in the US, 2009-2019.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.1992?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Pediatric Mental Health Hospitalizations at Acute Care Hospitals in the US, 2009-2019</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Mary Arakelyan, MPH, and JoAnna Leyenaar, MD, PhD, MPH, vice chair of Research in Pediatrics at Dartmouth, discuss increases in pediatric mental health hospitalizations and suicide-related diagnoses over the past decade. Hosted by JAMA Associate Editor Tracy Lieu, MD, MPH. Related Content: Pediatric Mental Health Hospitalizations at Acute Care Hospitals in the US, 2009-2019. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.1992?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Pediatric Mental Health Hospitalizations at Acute Care Hospitals in the US, 2009-2019</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Trends_in_Pediatric_Mental_Health_Hospitalizations.mp3?dest-id=90171" length="40071564" type="audio/mpeg" />
      <itunes:duration>16:41</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/d/d/1/9/dd19c5ed067e7cc85f2e77a3093c12a1/jsx230019audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Limiting Acetaminophen in Prescription Combination Opioid Products</title>
      <itunes:title>Limiting Acetaminophen in Prescription Combination Opioid Products</itunes:title>
      <pubDate>Tue, 07 Mar 2023 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[6776fa1f-6214-4367-9865-e1c1548ca579]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2023.1980]]></link>
      <description><![CDATA[<p>In 2011, the US Food and Drug Administration (FDA) announced a mandate to limit acetaminophen (paracetamol) to 325 mg/tablet in combination acetaminophen and opioid medications, with manufacturer compliance required by early 2014. In this podcast, JAMA Deputy Editor Mary M. McDermott, MD, interviews Jayme E. Locke, MD, MPH, and Babak J. Orandi, MD, PhD, about their JAMA study describing results of the FDA announcement on subsequent rates of hospitalizations for acute liver failure due to toxicity from acetaminophen-containing opioid drugs.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.1080?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Association of FDA Mandate Limiting Acetaminophen (Paracetamol) in Prescription Combination Opioid Products and Subsequent Hospitalizations and Acute Liver Failure</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.1002?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Moving the Needle to Reduce Acetaminophen (Paracetamol) Hepatotoxicity</a></li> <li><a class="related-article" href= "https://edhub.ama-assn.org/jn-learning/video-player/10.1001/jama.2023.1968?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Acetaminophen (Paracetamol) and Acute Liver Failure</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>In 2011, the US Food and Drug Administration (FDA) announced a mandate to limit acetaminophen (paracetamol) to 325 mg/tablet in combination acetaminophen and opioid medications, with manufacturer compliance required by early 2014. In this podcast, JAMA Deputy Editor Mary M. McDermott, MD, interviews Jayme E. Locke, MD, MPH, and Babak J. Orandi, MD, PhD, about their JAMA study describing results of the FDA announcement on subsequent rates of hospitalizations for acute liver failure due to toxicity from acetaminophen-containing opioid drugs. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.1080?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Association of FDA Mandate Limiting Acetaminophen (Paracetamol) in Prescription Combination Opioid Products and Subsequent Hospitalizations and Acute Liver Failure</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.1002?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Moving the Needle to Reduce Acetaminophen (Paracetamol) Hepatotoxicity</a></li> <li><a class="related-article" href= "https://edhub.ama-assn.org/jn-learning/video-player/10.1001/jama.2023.1968?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Acetaminophen (Paracetamol) and Acute Liver Failure</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Limiting_Acetaminophen_in_Prescription_Combination_Opioid_Products.mp3?dest-id=90171" length="43243472" type="audio/mpeg" />
      <itunes:duration>18:01</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/2/1/5/12153fa5f869d871d959afa2a1bf1c87/jsx230012audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Diagnostic Errors in the Emergency Department: A System Solution Is Needed</title>
      <itunes:title>Diagnostic Errors in the Emergency Department: A System Solution Is Needed</itunes:title>
      <pubDate>Tue, 28 Feb 2023 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[e79dfb45-42b1-47ca-a0b7-009f325d4ce4]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2023.2440]]></link>
      <description><![CDATA[<p>In this JAMA author interview, Peter J. Pronovost, MD, PhD, Chief Quality & Clinical Transformation Officer, University Hospitals, Cleveland, and an internationally recognized expert in patient safety, discusses his recent article in JAMA on "Misdiagnosis in the Emergency Department." A new report from AHRQ underscores the seriousness of this problem.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.0577?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Misdiagnosis in the Emergency Department</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>In this JAMA author interview, Peter J. Pronovost, MD, PhD, Chief Quality & Clinical Transformation Officer, University Hospitals, Cleveland, and an internationally recognized expert in patient safety, discusses his recent article in JAMA on "Misdiagnosis in the Emergency Department." A new report from AHRQ underscores the seriousness of this problem. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.0577?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Misdiagnosis in the Emergency Department</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Diagnostic_Errors_in_the_Emergency_Department_A_System_Solution_Is_Needed.mp3?dest-id=90171" length="49476960" type="audio/mpeg" />
      <itunes:duration>20:36</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/b/e/1/4/be1427949032a1b9a04421dee9605cbd/jsx230016audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Serologic Screening for Genital Herpes Infection</title>
      <itunes:title>USPSTF Recommendation: Serologic Screening for Genital Herpes Infection</itunes:title>
      <pubDate>Tue, 14 Feb 2023 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[2ae86052-7e0b-41ba-8990-a4cb6277a9f7]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2022.24143]]></link>
      <description><![CDATA[<p>Interview with James Stevermer, MD, MSPH, USPSTF member and coauthor of Serologic Screening for Genital Herpes Infection: US Preventive Services Task Force Reaffirmation Recommendation Statement. Hosted by JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.0057?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Serologic Screening for Genital Herpes Infection: US Preventive Services Task Force Reaffirmation Recommendation Statement</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.24870?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Reducing HSV-2 Morbidity and Mortality</a></li> <li><a href= "https://jamanetwork.com/journals/jamadermatology/fullarticle/10.1001/jamadermatol.2022.6236?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Reaffirmed USPSTF Recommendation Against Serologic Screening for Genital Herpes: Empowering Clinicians and Reducing Potential Harm</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.20356?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Serologic Screening for Genital Herpes: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.0454?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Screening for Genital Herpes (Patient Page)</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with James Stevermer, MD, MSPH, USPSTF member and coauthor of Serologic Screening for Genital Herpes Infection: US Preventive Services Task Force Reaffirmation Recommendation Statement. Hosted by JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.0057?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Serologic Screening for Genital Herpes Infection: US Preventive Services Task Force Reaffirmation Recommendation Statement</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.24870?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Reducing HSV-2 Morbidity and Mortality</a></li> <li><a href= "https://jamanetwork.com/journals/jamadermatology/fullarticle/10.1001/jamadermatol.2022.6236?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Reaffirmed USPSTF Recommendation Against Serologic Screening for Genital Herpes: Empowering Clinicians and Reducing Potential Harm</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.20356?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Serologic Screening for Genital Herpes: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.0454?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Screening for Genital Herpes (Patient Page)</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation_Serologic_Screening_for_Genital_Herpes_Infection-2.mp3?dest-id=90171" length="34044468" type="audio/mpeg" />
      <itunes:duration>14:10</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/0/1/6/10163502730a098f5f2e77a3093c12a1/JSX220148_x450_thumbimg.jpeg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Fluvoxamine vs Placebo and Time to Sustained Recovery From Mild or Moderate COVID-19</title>
      <itunes:title>Fluvoxamine vs Placebo and Time to Sustained Recovery From Mild or Moderate COVID-19</itunes:title>
      <pubDate>Thu, 12 Jan 2023 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[78a960f4-77e1-411d-8582-43b6fc269c49]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2023.73]]></link>
      <description><![CDATA[<p>Susanna Naggie, MD, vice dean for research at Duke University's School of Medicine, discusses the ACTIV-6 trial of fluvoxamine for outpatient treatment of COVID-19 and outlines the role of platform trials during the pandemic. Hosted by JAMA Deputy Editor and Editorial Director for Equity Preeti Malani, MD, MSJ.</p> <p>Related Content:</p> <p><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.24100?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Susanna Naggie, MD, vice dean for research at Duke University's School of Medicine, discusses the ACTIV-6 trial of fluvoxamine for outpatient treatment of COVID-19 and outlines the role of platform trials during the pandemic. Hosted by JAMA Deputy Editor and Editorial Director for Equity Preeti Malani, MD, MSJ.</p> <p>Related Content:</p> <p><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.24100?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Fluvoxamine_vs_Placebo_and_Time_to_Sustained_Recovery_From_Mild_or_Moderate_COVID-19.mp3?dest-id=90171" length="36078300" type="audio/mpeg" />
      <itunes:duration>15:01</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/4/d/7/6/4d76705ee4a5d43ee55e3c100dce7605/JSX230001_posterimg.jpeg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Challenges to Racial and Ethnic Diversity Policies in Undergraduate and Medical School Admissions</title>
      <itunes:title>Challenges to Racial and Ethnic Diversity Policies in Undergraduate and Medical School Admissions</itunes:title>
      <pubDate>Tue, 10 Jan 2023 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[0f0f1c4b-57b7-45ce-a5b3-a2a5da6f1a11]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2022.24218]]></link>
      <description><![CDATA[<p>In the wake of new legal challenges to race-conscious admission policies, JAMA Interim Executive Editor Gregory Curfman, MD, discusses racial and ethnic diversity in undergraduate and medical school admission policies with Roy H. Hamilton, MD, MS, from the Perelman School of Medicine, University of Pennsylvania.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.23124?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Defending Racial and Ethnic Diversity in Undergraduate and Medical School Admission Policies</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>In the wake of new legal challenges to race-conscious admission policies, JAMA Interim Executive Editor Gregory Curfman, MD, discusses racial and ethnic diversity in undergraduate and medical school admission policies with Roy H. Hamilton, MD, MS, from the Perelman School of Medicine, University of Pennsylvania. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.23124?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Defending Racial and Ethnic Diversity in Undergraduate and Medical School Admission Policies</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Challenges_to_Racial_and_Ethnic_Diversity_Policies_in_Undergraduate_and_Medical_School_Admissions.mp3?dest-id=90171" length="18929728" type="audio/mpeg" />
      <itunes:duration>19:39</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/9/2/e/c92e1fd5ca1e237588c4a68c3ddbc4f2/jsx220149audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Urgent Need for Next-Generation COVID-19 Vaccines</title>
      <itunes:title>Urgent Need for Next-Generation COVID-19 Vaccines</itunes:title>
      <pubDate>Tue, 03 Jan 2023 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[ef828d7e-f736-470e-9f2a-eeb9fdf9746c]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2022.23471]]></link>
      <description><![CDATA[<p>JAMA Deputy Editor Preeti Malani, MD, MSJ, discusses potential next-generation COVID-19 vaccines with Peter Marks, MD, PhD, director of the Center for Biologics Evaluation and Research at the US Food and Drug Administration.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.22759?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Urgent Need for Next-Generation COVID-19 Vaccines</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>JAMA Deputy Editor Preeti Malani, MD, MSJ, discusses potential next-generation COVID-19 vaccines with Peter Marks, MD, PhD, director of the Center for Biologics Evaluation and Research at the US Food and Drug Administration. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.22759?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Urgent Need for Next-Generation COVID-19 Vaccines</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Urgent_Need_for_Next-Generation_COVID-19_Vaccines.mp3?dest-id=90171" length="33588016" type="audio/mpeg" />
      <itunes:duration>13:58</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/d/c/e/6/dce6ad6c9735652040be95ea3302a6a1/jsx220147audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Over-the-Counter Hearing Aids</title>
      <itunes:title>Over-the-Counter Hearing Aids</itunes:title>
      <pubDate>Tue, 20 Dec 2022 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[9f575fc0-2d71-4fee-b29c-f06dc5fd2b19]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2022.23386]]></link>
      <description><![CDATA[<p>In this JAMA author interview, we speak with Robert M. Califf, MD, Commissioner of the FDA, about a remarkable advance in the technology of hearing aids. Dr Califf has done important work to secure the entry of over-the-counter hearing aids into the market, providing a less expensive alternative to traditional hearing aids. In this interview, Dr Califf tells the story of how this technology has finally been made available to the public.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.22123?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Over-the-counter Hearing Aids: From Research to Policy to Practice</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>In this JAMA author interview, we speak with Robert M. Califf, MD, Commissioner of the FDA, about a remarkable advance in the technology of hearing aids. Dr Califf has done important work to secure the entry of over-the-counter hearing aids into the market, providing a less expensive alternative to traditional hearing aids. In this interview, Dr Califf tells the story of how this technology has finally been made available to the public. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.22123?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Over-the-counter Hearing Aids: From Research to Policy to Practice</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Over-the-Counter_Hearing_Aids.mp3?dest-id=90171" length="36318468" type="audio/mpeg" />
      <itunes:duration>15:07</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/0/c/c/80ccb5818f62f42988c4a68c3ddbc4f2/jsx220146audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>COP27 Climate Change Conference—Urgent Action Needed for Africa and the World</title>
      <itunes:title>COP27 Climate Change Conference—Urgent Action Needed for Africa and the World</itunes:title>
      <pubDate>Wed, 16 Nov 2022 16:10:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[eefff58e-2f14-4d8d-8277-f9481ef7738c]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2022.21720]]></link>
      <description><![CDATA[<p>Interview with Chris Zielinski, Visiting Research Fellow and Faculty of Health and Wellbeing at the University of Winchester, UK, James Kigera, Editor-in-Chief, Annals of African Surgery, and James Tumwine, Editor-in-Chief, African Health Sciences, authors of COP27 Climate Change Conference—Urgent Action Needed for Africa and the World. Hosted by JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.20637" target="_blank" rel="noopener">COP27 Climate Change Conference—Urgent Action Needed for Africa and the World</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.19235" target="_blank" rel="noopener">Conflict and Climate Collide to Create an Acute Hunger Crisis for an Unprecedented 345 Million People</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.21104" target="_blank" rel="noopener">Climate Justice and Health</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2022.5143" target="_blank" rel="noopener">Children, Climate Justice, and Lessons From Puerto Rico</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Chris Zielinski, Visiting Research Fellow and Faculty of Health and Wellbeing at the University of Winchester, UK, James Kigera, Editor-in-Chief, Annals of African Surgery, and James Tumwine, Editor-in-Chief, African Health Sciences, authors of COP27 Climate Change Conference—Urgent Action Needed for Africa and the World. Hosted by JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.20637" target="_blank" rel="noopener">COP27 Climate Change Conference—Urgent Action Needed for Africa and the World</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.19235" target="_blank" rel="noopener">Conflict and Climate Collide to Create an Acute Hunger Crisis for an Unprecedented 345 Million People</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.21104" target="_blank" rel="noopener">Climate Justice and Health</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2022.5143" target="_blank" rel="noopener">Children, Climate Justice, and Lessons From Puerto Rico</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/COP27_Climate_Change_Conference_Urgent_Action_Needed_for_Africa_and_the_World.mp3?dest-id=90171" length="23288986" type="audio/mpeg" />
      <itunes:duration>24:11</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/b/e/c/3bec1b5cd19fc85588c4a68c3ddbc4f2/jsx220134audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Screening for Obstructive Sleep Apnea in Adults</title>
      <itunes:title>USPSTF Recommendation: Screening for Obstructive Sleep Apnea in Adults</itunes:title>
      <pubDate>Tue, 15 Nov 2022 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[bb8987c1-c0fc-4915-b3f1-aad41a65903a]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2022.18092]]></link>
      <description><![CDATA[<p>Interview with Gbenga Ogedegbe, MD, MPH, USPSTF member and coauthor of Screening for Obstructive Sleep Apnea in Adults: US Preventive Services Task Force Recommendation Statement. Hosted by JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.20304" target="_blank" rel="noopener">Screening for Obstructive Sleep Apnea in Adults</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.18357" target="_blank" rel="noopener">Screening for Obstructive Sleep Apnea in Adults</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.20670" target="_blank" rel="noopener">Screening for Obstructive Sleep Apnea in Adults</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.20142" target="_blank" rel="noopener">Screening for Obstructive Sleep Apnea</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jamaotolaryngology%E2%80%93head&necksurgery/fullarticle/10.1001/jamaoto.2022.3844" target="_blank" rel="noopener">USPSTF Updates Recommendation for Obstructive Sleep Apnea Screening in Adults</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Gbenga Ogedegbe, MD, MPH, USPSTF member and coauthor of Screening for Obstructive Sleep Apnea in Adults: US Preventive Services Task Force Recommendation Statement. Hosted by JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.20304" target="_blank" rel="noopener">Screening for Obstructive Sleep Apnea in Adults</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.18357" target="_blank" rel="noopener">Screening for Obstructive Sleep Apnea in Adults</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.20670" target="_blank" rel="noopener">Screening for Obstructive Sleep Apnea in Adults</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.20142" target="_blank" rel="noopener">Screening for Obstructive Sleep Apnea</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jamaotolaryngology%E2%80%93head&necksurgery/fullarticle/10.1001/jamaoto.2022.3844" target="_blank" rel="noopener">USPSTF Updates Recommendation for Obstructive Sleep Apnea Screening in Adults</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation_Screening_for_Obstructive_Sleep_Apnea_in_Adults.mp3?dest-id=90171" length="19924489" type="audio/mpeg" />
      <itunes:duration>20:41</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/2/7/2/e272ca9ac7bb97055f2e77a3093c12a1/jsx220112audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Hormone Therapy for Prevention of Postmenopausal Chronic Conditions</title>
      <itunes:title>USPSTF Recommendation: Hormone Therapy for Prevention of Postmenopausal Chronic Conditions</itunes:title>
      <pubDate>Tue, 01 Nov 2022 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[7c2087ce-72a5-4ee9-be23-6ce01fcccc24]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2022.17345]]></link>
      <description><![CDATA[<p>Interview with Carol Mangione, MD, MSPH, USPSTF chair and coauthor of Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons: US Preventive Services Task Force Recommendation Statement. Hosted by JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.18625?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.18324?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.19855?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Menopausal Hormone Therapy for Prevention of Chronic Conditions</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Carol Mangione, MD, MSPH, USPSTF chair and coauthor of Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons: US Preventive Services Task Force Recommendation Statement. Hosted by JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.18625?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.18324?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.19855?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Menopausal Hormone Therapy for Prevention of Chronic Conditions</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation_Hormone_Therapy_for_Prevention_of_Postmenopausal_Chronic_Conditions.mp3?dest-id=90171" length="50617424" type="audio/mpeg" />
      <itunes:duration>21:06</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/7/f/f/b/7ffb6b44e21548fe27a2322813b393ee/jsx220106audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendations: Screening for Anxiety in Children and Adolescents, and Depression and Suicide Risk Screening in Children and Adolescents</title>
      <itunes:title>USPSTF Recommendations: Screening for Anxiety in Children and Adolescents, and Depression and Suicide Risk Screening in Children and Adolescents</itunes:title>
      <pubDate>Tue, 11 Oct 2022 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[b3c26779-cf37-4e41-aafd-15f42114c9cf]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2022.15257]]></link>
      <description><![CDATA[<p>Interview with Martha Kubik, PhD, RN, USPSTF member and coauthor of Screening for Anxiety in Children and Adolescents: US Preventive Services Task Force Recommendation Statement, and Screening for Depression and Suicide Risk in Children and Adolescents: US Preventive Services Task Force Recommendation Statement. Hosted by JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.16936" target="_blank" rel="noopener">Screening for Anxiety in Children and Adolescents</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.16303" target="_blank" rel="noopener">Screening for Anxiety in Children and Adolescents</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.16310" target="_blank" rel="noopener">Screening for Depression and Suicide Risk in Children and Adolescents</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.16946" target="_blank" rel="noopener">Screening for Depression and Suicide Risk in Children and Adolescents</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.18184" target="_blank" rel="noopener">Screening for Anxiety in Children and Adolescents</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.15224" target="_blank" rel="noopener">Screening for Pediatric Anxiety Disorders</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Martha Kubik, PhD, RN, USPSTF member and coauthor of Screening for Anxiety in Children and Adolescents: US Preventive Services Task Force Recommendation Statement, and Screening for Depression and Suicide Risk in Children and Adolescents: US Preventive Services Task Force Recommendation Statement. Hosted by JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.16936" target="_blank" rel="noopener">Screening for Anxiety in Children and Adolescents</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.16303" target="_blank" rel="noopener">Screening for Anxiety in Children and Adolescents</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.16310" target="_blank" rel="noopener">Screening for Depression and Suicide Risk in Children and Adolescents</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.16946" target="_blank" rel="noopener">Screening for Depression and Suicide Risk in Children and Adolescents</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.18184" target="_blank" rel="noopener">Screening for Anxiety in Children and Adolescents</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.15224" target="_blank" rel="noopener">Screening for Pediatric Anxiety Disorders</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTFRecommendations_Screening_for_Anxiety_in_Children_and_Adolescents_and_Depression_and_Suicide_Risk_Screening_in_Children_and_Adolescents.mp3?dest-id=90171" length="19598928" type="audio/mpeg" />
      <itunes:duration>20:21</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/5/0/3/b/503b0e4ebf756f3dd959afa2a1bf1c87/JSX220101_x3000_thumbimg.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Treatment of Peripheral Artery Disease</title>
      <itunes:title>Treatment of Peripheral Artery Disease</itunes:title>
      <pubDate>Tue, 04 Oct 2022 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[27c19185-c09f-4389-bd6d-13546dc5a2b3]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2022.18313]]></link>
      <description><![CDATA[<p>In this JAMA Author Interview, JAMA Interim Executive Editor Greg Curfman, MD, speaks with Mary M. McDermott, MD, professor of medicine at Northwestern University Feinberg School of Medicine, on current therapies for peripheral artery disease and a new clinical trial she directed on the use of telmisartan, an angiotensin receptor blocker, for patients with peripheral artery disease.</p> <p>Related Content:</p> <p><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.16797?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Effect of Telmisartan on Walking Performance in Patients With Lower Extremity Peripheral Artery Disease</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>In this JAMA Author Interview, JAMA Interim Executive Editor Greg Curfman, MD, speaks with Mary M. McDermott, MD, professor of medicine at Northwestern University Feinberg School of Medicine, on current therapies for peripheral artery disease and a new clinical trial she directed on the use of telmisartan, an angiotensin receptor blocker, for patients with peripheral artery disease.</p> <p>Related Content:</p> <p><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.16797?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Effect of Telmisartan on Walking Performance in Patients With Lower Extremity Peripheral Artery Disease</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Treatment_of_Peripheral_Artery_Disease.mp3?dest-id=90171" length="36927133" type="audio/mpeg" />
      <itunes:duration>15:22</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/d/2/f/ad2f0674f40f5f905f2e77a3093c12a1/JSX220113_x3000_thumbimg.jpeg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Approaches to Reducing Firearm Violence</title>
      <itunes:title>Approaches to Reducing Firearm Violence</itunes:title>
      <pubDate>Tue, 27 Sep 2022 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[480a2b50-41b2-4394-8e51-2d7e1630352b]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2022.18040]]></link>
      <description><![CDATA[<p>JAMA Network Open Editor Frederick Rivara, MD, MPH, discusses approaches to reducing firearm violence with several JAMA Viewpoint authors: Sandro Galea, MD, DrPH (Boston University), Elinore J. Kaufman, MD, MSHP (University of Pennsylvania), and Roger A. Mitchell Jr, MD (Howard University). Topics include the state-level response to firearm-related harms, the paucity of data on firearm violence, and the pervasive health effects of firearm violence on neighborhoods and in the carceral system.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.16894?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">The Epidemiology of Firearm Injuries in the US: The Need for Comprehensive, Real-time, Actionable Data</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.17144?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Violence and the Carceral State: A Public Health Continuum</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.16648?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">State Firearm Laws and Firearm-Related Mortality and Morbidity</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.13660?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Examining the Impact of Firearm Safety Laws on Suicides</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.13671?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Physicians and EMS Who Responded to Mass Shootings Develop Consensus Recommendations for Improving Care</a></li> <li><a href= "https://edhub.ama-assn.org/jn-learning/video-player/10.1001/jama.2022.18420?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Approaches to Reducing Firearm Violence</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>JAMA Network Open Editor Frederick Rivara, MD, MPH, discusses approaches to reducing firearm violence with several JAMA Viewpoint authors: Sandro Galea, MD, DrPH (Boston University), Elinore J. Kaufman, MD, MSHP (University of Pennsylvania), and Roger A. Mitchell Jr, MD (Howard University). Topics include the state-level response to firearm-related harms, the paucity of data on firearm violence, and the pervasive health effects of firearm violence on neighborhoods and in the carceral system.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.16894?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">The Epidemiology of Firearm Injuries in the US: The Need for Comprehensive, Real-time, Actionable Data</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.17144?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Violence and the Carceral State: A Public Health Continuum</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.16648?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">State Firearm Laws and Firearm-Related Mortality and Morbidity</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.13660?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Examining the Impact of Firearm Safety Laws on Suicides</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.13671?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Physicians and EMS Who Responded to Mass Shootings Develop Consensus Recommendations for Improving Care</a></li> <li><a href= "https://edhub.ama-assn.org/jn-learning/video-player/10.1001/jama.2022.18420?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Approaches to Reducing Firearm Violence</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Approaches_to_Reducing_Firearm_Violence.mp3?dest-id=90171" length="20908555" type="audio/mpeg" />
      <itunes:duration>21:40</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/9/0/2/0902aca1af0ff54e16c3140a3186d450/JSX220111_x3000_thumbimg.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Syphilis Screening in Nonpregnant Adolescents and Adults</title>
      <itunes:title>USPSTF Recommendation: Syphilis Screening in Nonpregnant Adolescents and Adults</itunes:title>
      <pubDate>Tue, 27 Sep 2022 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[c0be629d-a1d1-416a-8a35-b051e85f64b5]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2022.14904]]></link>
      <description><![CDATA[<p>Interview with Katrina E. Donahue, MD, MPH, USPSTF member and coauthor of Screening for Syphilis Infection in Nonpregnant Adolescents and Adults: US Preventive Services Task Force Reaffirmation Recommendation Statement. Hosted by JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.15227?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">The Critical Need to Modernize Syphilis Screening</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.15322?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Screening for Syphilis Infection in Nonpregnant Adolescents and Adults</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.8612?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Screening for Syphilis Infection in Nonpregnant Adults and Adolescents</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.16887?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Screening for Syphilis</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Katrina E. Donahue, MD, MPH, USPSTF member and coauthor of Screening for Syphilis Infection in Nonpregnant Adolescents and Adults: US Preventive Services Task Force Reaffirmation Recommendation Statement. Hosted by JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.15227?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">The Critical Need to Modernize Syphilis Screening</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.15322?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Screening for Syphilis Infection in Nonpregnant Adolescents and Adults</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.8612?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Screening for Syphilis Infection in Nonpregnant Adults and Adolescents</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.16887?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Screening for Syphilis</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation_Syphilis_Screening_in_Nonpregnant_Adolescents_and_Adults.mp3?dest-id=90171" length="25950407" type="audio/mpeg" />
      <itunes:duration>10:48</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/f/2/b/6/f2b65561435463cc16c3140a3186d450/JSX220097_x3000_thumbimg.jpeg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Achieving Diagnostic Excellence</title>
      <itunes:title>Achieving Diagnostic Excellence</itunes:title>
      <pubDate>Tue, 20 Sep 2022 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[27593f3e-5deb-4abb-8657-bcf25babd548]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2022.15343]]></link>
      <description><![CDATA[<p>Arguably, a clinician's most important role is providing an accurate and actionable diagnosis for patients. But challenges stand in the way, including tool limitations, inequitable access, and discontinuity of care. In this roundtable Q&A discussion, Urmimala Sarkar, MD, MPH (Zuckerberg San Francisco General Hospital and Trauma Center, UCSF), Jonathan H. Chen, MD, PhD (Stanford Center for Biomedical Informatics Research, Stanford University), and Harvey V. Fineberg, MD, PhD (Gordon and Betty Moore Foundation), discuss issues affecting diagnostic excellence, the emergence of artificial intelligence–driven tools, and ways to make the diagnostic process patient-focused. Hosted by JAMA Editor in Chief Kirsten Bibbins-Domingo, MD, PhD.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.13735" target="_blank" rel="noopener">Decoding Artificial Intelligence to Achieve Diagnostic Excellence</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.19493" target="_blank" rel="noopener">Diagnostic Excellence</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.14424" target="_blank" rel="noopener">Achieving Diagnostic Equity in Cardiovascular Disease</a></li> <li><a class="related-article" href= "https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2021.19824" target="_blank" rel="noopener">Achieving Diagnostic Excellence in the 21st Century</a></li> <li><a class="related-article" href= "https://edhub.ama-assn.org/jn-learning/video-player/10.1001/jama.2022.15383" target="_blank" rel="noopener">Achieving Diagnostic Excellence</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Arguably, a clinician's most important role is providing an accurate and actionable diagnosis for patients. But challenges stand in the way, including tool limitations, inequitable access, and discontinuity of care. In this roundtable Q&A discussion, Urmimala Sarkar, MD, MPH (Zuckerberg San Francisco General Hospital and Trauma Center, UCSF), Jonathan H. Chen, MD, PhD (Stanford Center for Biomedical Informatics Research, Stanford University), and Harvey V. Fineberg, MD, PhD (Gordon and Betty Moore Foundation), discuss issues affecting diagnostic excellence, the emergence of artificial intelligence–driven tools, and ways to make the diagnostic process patient-focused. Hosted by JAMA Editor in Chief Kirsten Bibbins-Domingo, MD, PhD. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.13735" target="_blank" rel="noopener">Decoding Artificial Intelligence to Achieve Diagnostic Excellence</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.19493" target="_blank" rel="noopener">Diagnostic Excellence</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.14424" target="_blank" rel="noopener">Achieving Diagnostic Equity in Cardiovascular Disease</a></li> <li><a class="related-article" href= "https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2021.19824" target="_blank" rel="noopener">Achieving Diagnostic Excellence in the 21st Century</a></li> <li><a class="related-article" href= "https://edhub.ama-assn.org/jn-learning/video-player/10.1001/jama.2022.15383" target="_blank" rel="noopener">Achieving Diagnostic Excellence</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Achieving_Diagnostic_Excellence.mp3?dest-id=90171" length="28115519" type="audio/mpeg" />
      <itunes:duration>29:18</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/e/c/8/2ec878c6c85cf33f27a2322813b393ee/jsx220102audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>CRISPR, Genome Editing, and Human Health</title>
      <itunes:title>CRISPR, Genome Editing, and Human Health</itunes:title>
      <pubDate>Tue, 20 Sep 2022 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[17296331-19f0-4eea-a99c-a49a100b124f]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2022.17436]]></link>
      <description><![CDATA[<p>CRISPR genome editing is a revolutionary technology that can be used to make highly targeted changes in DNA in living cells. JAMA Associate Editor W. Gregory Feero, MD, PhD, Maine Dartmouth Family Medicine Residency, and Matthew J. Kan, MD, PhD, University of California San Francisco, discuss how CRISPR works and how CRISPR-based technologies are being used in ongoing trials to treat a wide variety of medical conditions.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.13468" target="_blank" rel="noopener">Treatment of Genetic Diseases With CRISPR Genome Editing</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.3438" target="_blank" rel="noopener">With First CRISPR Trials, Gene Editing Moves Toward the Clinic</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>CRISPR genome editing is a revolutionary technology that can be used to make highly targeted changes in DNA in living cells. JAMA Associate Editor W. Gregory Feero, MD, PhD, Maine Dartmouth Family Medicine Residency, and Matthew J. Kan, MD, PhD, University of California San Francisco, discuss how CRISPR works and how CRISPR-based technologies are being used in ongoing trials to treat a wide variety of medical conditions. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.13468" target="_blank" rel="noopener">Treatment of Genetic Diseases With CRISPR Genome Editing</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.3438" target="_blank" rel="noopener">With First CRISPR Trials, Gene Editing Moves Toward the Clinic</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/CRISPR_Genome_Editing_and_Human_Health.mp3?dest-id=90171" length="22504341" type="audio/mpeg" />
      <itunes:duration>23:23</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/7/6/7/6/7676b5bf9fdff2f2d959afa2a1bf1c87/jsx220107audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Screening for Prediabetes and Diabetes in Children and Adolescents</title>
      <itunes:title>USPSTF Recommendation: Screening for Prediabetes and Diabetes in Children and Adolescents</itunes:title>
      <pubDate>Tue, 13 Sep 2022 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[f12fd7d2-6094-4b29-9b6d-ff17aeb4d054]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2022.11200]]></link>
      <description><![CDATA[<p>Interview with Michael D. Cabana, MD, MA, MPH, USPSTF member and coauthor of Screening for Prediabetes and Type 2 Diabetes in Children and Adolescents: US Preventive Services Task Force Recommendation Statement. Hosted by JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.7957?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Screening for Prediabetes and Type 2 Diabetes in Children and Adolescents</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.14543?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Screening for Prediabetes and Type 2 Diabetes in Children and Adolescents</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.15240?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Screening for Type 2 Diabetes in Children and Adolescents</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Michael D. Cabana, MD, MA, MPH, USPSTF member and coauthor of Screening for Prediabetes and Type 2 Diabetes in Children and Adolescents: US Preventive Services Task Force Recommendation Statement. Hosted by JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.7957?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Screening for Prediabetes and Type 2 Diabetes in Children and Adolescents</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.14543?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Screening for Prediabetes and Type 2 Diabetes in Children and Adolescents</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.15240?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Screening for Type 2 Diabetes in Children and Adolescents</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation_Screening_for_Prediabetes_and_Diabetes_in_Children_and_Adolescents.mp3?dest-id=90171" length="39143439" type="audio/mpeg" />
      <itunes:duration>16:17</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/e/0/8/ee08abb9c593a8a35f2e77a3093c12a1/JSX220071_x3000_thumbimg.jpeg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Dr Anthony Fauci—Communicating Science in a Polarized Era</title>
      <itunes:title>Dr Anthony Fauci—Communicating Science in a Polarized Era</itunes:title>
      <pubDate>Fri, 09 Sep 2022 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[82fd7f4f-f9e1-4bdb-aaf7-8aa30017ce76]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2022.15733]]></link>
      <description><![CDATA[<p>Over a nearly 40-year career at the head of the National Institute of Allergy and Infectious Diseases, Anthony Fauci, MD, has seen a seismic shift in the way that science is communicated to and received by the public. In conversation with JAMA Network Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, Fauci reflects on his career at NIAID, the joys and challenges of advising 7 presidents, and shares his strategies for communicating scientific information in an ever-changing environment.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.16280?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Dr Fauci and the Art of Science Communication</a></li> <li><a class="related-article" href= "https://edhub.ama-assn.org/jn-learning/video-player/10.1001/jama.2022.16255?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Dr Anthony Fauci—Communicating Science in a Polarized Era</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Over a nearly 40-year career at the head of the National Institute of Allergy and Infectious Diseases, Anthony Fauci, MD, has seen a seismic shift in the way that science is communicated to and received by the public. In conversation with JAMA Network Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, Fauci reflects on his career at NIAID, the joys and challenges of advising 7 presidents, and shares his strategies for communicating scientific information in an ever-changing environment. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.16280?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Dr Fauci and the Art of Science Communication</a></li> <li><a class="related-article" href= "https://edhub.ama-assn.org/jn-learning/video-player/10.1001/jama.2022.16255?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Dr Anthony Fauci—Communicating Science in a Polarized Era</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Dr_Anthony_Fauci_Communicating_Science_in_a_Polarized_Era.mp3?dest-id=90171" length="55906832" type="audio/mpeg" />
      <itunes:duration>23:16</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/d/d/c/6/ddc69915e7422b5127a2322813b393ee/jsx220103audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults</title>
      <itunes:title>USPSTF Recommendation: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults</itunes:title>
      <pubDate>Tue, 23 Aug 2022 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[0eb2a08e-abf9-42b5-a3ff-fa01fdd576f0]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2022.11315]]></link>
      <description><![CDATA[<p>Interview with John B. Wong, MD, USPSTF member and coauthor of Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement. Hosted by JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.12138" target="_blank" rel="noopener">Statin Use for the Primary Prevention of Cardiovascular Disease in Adults</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.13044" target="_blank" rel="noopener">Statin Use for the Primary Prevention of Cardiovascular Disease in Adults</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.13493" target="_blank" rel="noopener">Statins for the Prevention of Cardiovascular Disease</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jamacardiology/fullarticle/10.1001/jamacardio.2022.2851" target="_blank" rel="noopener">Statin Usage in Primary Prevention—Comparing the USPSTF Recommendations With the AHA/ACC/Multisociety Guidelines</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2022.3204" target="_blank" rel="noopener">Statins for Primary Cardiovascular Disease Prevention</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.28538" target="_blank" rel="noopener">Statins and Primary Atherosclerotic Cardiovascular Disease Prevention—What We Know, Where We Need to Go, and Why Are We Not There Already?</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with John B. Wong, MD, USPSTF member and coauthor of Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement. Hosted by JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.12138" target="_blank" rel="noopener">Statin Use for the Primary Prevention of Cardiovascular Disease in Adults</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.13044" target="_blank" rel="noopener">Statin Use for the Primary Prevention of Cardiovascular Disease in Adults</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.13493" target="_blank" rel="noopener">Statins for the Prevention of Cardiovascular Disease</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jamacardiology/fullarticle/10.1001/jamacardio.2022.2851" target="_blank" rel="noopener">Statin Usage in Primary Prevention—Comparing the USPSTF Recommendations With the AHA/ACC/Multisociety Guidelines</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2022.3204" target="_blank" rel="noopener">Statins for Primary Cardiovascular Disease Prevention</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.28538" target="_blank" rel="noopener">Statins and Primary Atherosclerotic Cardiovascular Disease Prevention—What We Know, Where We Need to Go, and Why Are We Not There Already?</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation_Statin_Use_for_the_Primary_Prevention_of_Cardiovascular_Disease_in_Adults.mp3?dest-id=90171" length="24489287" type="audio/mpeg" />
      <itunes:duration>25:31</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/2/9/2/0292424ebfecfdb0e55e3c100dce7605/jsx220073audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Prescription Drug Cost Provisions of the Inflation Reduction Act</title>
      <itunes:title>Prescription Drug Cost Provisions of the Inflation Reduction Act</itunes:title>
      <pubDate>Fri, 19 Aug 2022 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[e14dd13f-8573-4f46-9cc6-f42704764e8f]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2022.15233]]></link>
      <description><![CDATA[<p>President Biden has signed into law the Inflation Reduction Act containing important provisions related to prescription drug costs. JAMA Health Forum Editor John Z. Ayanian, MD, MPP, and Deputy Editor Melinda B. Buntin, PhD, discuss the effects of these provisions on patients with Aaron S. Kesselheim, MD, JD, MPH, of Harvard Medical School and Brigham and Women's Hospital.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.15268?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">New Reforms to Prescription Drug Pricing in the US</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jamahealthforum.2021.0626?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Estimating Rebates and Other Discounts Received by Medicare Part D</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jamahealthforum.2021.3409?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Estimation of the Share of Net Expenditures on Insulin Captured by US Manufacturers, Wholesalers, Pharmacy Benefit Managers, Pharmacies, and Health Plans From 2014 to 2018</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jamahealthforum.2022.1158?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Spending by the Centers for Medicare & Medicaid Services Before and After Confirmation of Benefit for Drugs Granted US Food and Drug Administration Accelerated Approval, 2012 to 2017</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jamahealthforum.2022.3180?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Improving Prescription Drug Affordability Through Regulatory Action</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>President Biden has signed into law the Inflation Reduction Act containing important provisions related to prescription drug costs. JAMA Health Forum Editor John Z. Ayanian, MD, MPP, and Deputy Editor Melinda B. Buntin, PhD, discuss the effects of these provisions on patients with Aaron S. Kesselheim, MD, JD, MPH, of Harvard Medical School and Brigham and Women's Hospital.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.15268?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">New Reforms to Prescription Drug Pricing in the US</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jamahealthforum.2021.0626?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Estimating Rebates and Other Discounts Received by Medicare Part D</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jamahealthforum.2021.3409?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Estimation of the Share of Net Expenditures on Insulin Captured by US Manufacturers, Wholesalers, Pharmacy Benefit Managers, Pharmacies, and Health Plans From 2014 to 2018</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jamahealthforum.2022.1158?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Spending by the Centers for Medicare & Medicaid Services Before and After Confirmation of Benefit for Drugs Granted US Food and Drug Administration Accelerated Approval, 2012 to 2017</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jamahealthforum.2022.3180?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Improving Prescription Drug Affordability Through Regulatory Action</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Prescription_Drug_Cost_Provisions_of_the_Inflation_Reduction_Act.mp3?dest-id=90171" length="37272729" type="audio/mpeg" />
      <itunes:duration>15:31</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/7/2/8/d/728d5139456a361ad959afa2a1bf1c87/JSX220099_x3000_thumbimg.jpeg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Making Electronic Health Records More Supportive for Clinicians</title>
      <itunes:title>Making Electronic Health Records More Supportive for Clinicians</itunes:title>
      <pubDate>Tue, 09 Aug 2022 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[a95688cc-8d00-405c-84ab-2c3614943640]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2022.14248]]></link>
      <description><![CDATA[<p>Electronic health records (EHRs) hold great promise to assist clinicians, but current versions are less user-friendly than ideal. JAMA Associate Editor Tracy Lieu, MD, MPH, spoke with Kevin B. Johnson, MD, MS, University of Pennsylvania, and William W. Stead, MD, Vanderbilt University Medical Center, about how to improve EHRs to protect cognitive attention and optimize their potential to provide cognitive support to health care professionals.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.12243?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Making Electronic Health Records Both SAFER and SMARTER</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Electronic health records (EHRs) hold great promise to assist clinicians, but current versions are less user-friendly than ideal. JAMA Associate Editor Tracy Lieu, MD, MPH, spoke with Kevin B. Johnson, MD, MS, University of Pennsylvania, and William W. Stead, MD, Vanderbilt University Medical Center, about how to improve EHRs to protect cognitive attention and optimize their potential to provide cognitive support to health care professionals.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.12243?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Making Electronic Health Records Both SAFER and SMARTER</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Making_Electronic_Health_Records_More_Supportive_for_Clinicians.mp3?dest-id=90171" length="19320777" type="audio/mpeg" />
      <itunes:duration>20:04</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/5/8/4/7/5847a57c677e55eed959afa2a1bf1c87/JSX220094_x3000_thumbimg.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronary Artery Bypass Surgery in 2022</title>
      <itunes:title>Coronary Artery Bypass Surgery in 2022</itunes:title>
      <pubDate>Tue, 09 Aug 2022 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[504affa8-ed2e-4492-9e2e-7b7d61cc06ab]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2022.14160]]></link>
      <description><![CDATA[<p>In this Author Interview, JAMA Deputy Editor Gregory Curfman, MD, discusses the state of coronary artery bypass surgery in 2022 with E. Magnus Ohman, MD, from Duke University. The conversation emphasizes methods to preserve patency of saphenous vein bypass grafts, the subject of an article in the August 9, 2022, issue of JAMA. Dr Ohman wrote the accompanying Editorial.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.11966" target="_blank" rel="noopener">Association of Dual Antiplatelet Therapy With Ticagrelor With Vein Graft Failure After Coronary Artery Bypass Graft Surgery</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.12444" target="_blank" rel="noopener">Balancing the Risks and Benefits of Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>In this Author Interview, JAMA Deputy Editor Gregory Curfman, MD, discusses the state of coronary artery bypass surgery in 2022 with E. Magnus Ohman, MD, from Duke University. The conversation emphasizes methods to preserve patency of saphenous vein bypass grafts, the subject of an article in the August 9, 2022, issue of JAMA. Dr Ohman wrote the accompanying Editorial. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.11966" target="_blank" rel="noopener">Association of Dual Antiplatelet Therapy With Ticagrelor With Vein Graft Failure After Coronary Artery Bypass Graft Surgery</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.12444" target="_blank" rel="noopener">Balancing the Risks and Benefits of Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronary_Artery_Bypass_Surgery_in_2022.mp3?dest-id=90171" length="18505754" type="audio/mpeg" />
      <itunes:duration>19:17</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/b/9/2/1/b921207fa54f0ef0bafc7308ab683e82/jsx220093audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Long COVID: The US Federal Response</title>
      <itunes:title>Long COVID: The US Federal Response</itunes:title>
      <pubDate>Wed, 03 Aug 2022 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[9c83c577-a0d3-47ef-a6ea-9e65db171b13]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2022.14292]]></link>
      <description><![CDATA[<p>On August 3, 2022, the US Department of Health and Human Services released 2 major reports in response to a presidential memo calling for a whole-of-government response to the SARS-CoV-2 sequelae known as "Long COVID." JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, discusses these new reports and the research and support needed to address this pervasive health concern with HHS Assistant Secretary for Health Rachel Levine, MD. Recorded July 29, 2022.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.14089?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Addressing the Long-term Effects of COVID-19</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.11691?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Association Between BNT162b2 Vaccination and Long COVID After Infections Not Requiring Hospitalization in Health Care Workers</a></li> <li><a href= "https://edhub.ama-assn.org/jn-learning/video-player/10.1001/jama.2022.14190"> Long COVID: The US Federal Response (Video)</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>On August 3, 2022, the US Department of Health and Human Services released 2 major reports in response to a presidential memo calling for a whole-of-government response to the SARS-CoV-2 sequelae known as "Long COVID." JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, discusses these new reports and the research and support needed to address this pervasive health concern with HHS Assistant Secretary for Health Rachel Levine, MD. Recorded July 29, 2022.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.14089?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Addressing the Long-term Effects of COVID-19</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.11691?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Association Between BNT162b2 Vaccination and Long COVID After Infections Not Requiring Hospitalization in Health Care Workers</a></li> <li><a href= "https://edhub.ama-assn.org/jn-learning/video-player/10.1001/jama.2022.14190"> Long COVID: The US Federal Response (Video)</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Long_COVID_The_US_Federal_Response.mp3?dest-id=90171" length="39975783" type="audio/mpeg" />
      <itunes:duration>16:38</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/4/4/f/4/44f4f4c862264c52bafc7308ab683e82/JSX220096_x3000_thumbimg.jpeg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Behavioral Counseling Interventions to Promote Healthy Behaviors for CVD Prevention</title>
      <itunes:title>USPSTF Recommendation: Behavioral Counseling Interventions to Promote Healthy Behaviors for CVD Prevention</itunes:title>
      <pubDate>Tue, 26 Jul 2022 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[7e757557-228f-4905-b1f4-7fc76df69197]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2022.10938]]></link>
      <description><![CDATA[<p>Interview with Lori Pbert, PhD, USPSTF member and coauthor of Behavioral Counseling Interventions to Promote a Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: US Preventive Services Task Force Recommendation Statement. Hosted by JAMA Senior Editor Kristin L. Walter, MD, MS.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.7408?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Behavioral Counseling Interventions to Promote a Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Known Cardiovascular Disease Risk Factors</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.10951?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Behavioral Counseling Interventions to Promote a Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.11667?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Behavioral Counseling Interventions to Promote a Healthy Diet and Physical Activity to Prevent CVD in Adults Without Risk Factors</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.10801?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Implications of the New Recommendation on Behavioral Counseling Interventions to Promote Healthy Eating and Physical Activity</a></li> <li><a href= "https://jamanetwork.com/journals/jamacardiology/fullarticle/10.1001/jamacardio.2022.2259?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Improving Behavioral Counseling for Primary Cardiovascular Disease Prevention</a></li> <li><a href= "https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2022.2015?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Updated USPSTF Recommendations for Behavioral Counseling Interventions</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Lori Pbert, PhD, USPSTF member and coauthor of Behavioral Counseling Interventions to Promote a Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: US Preventive Services Task Force Recommendation Statement. Hosted by JAMA Senior Editor Kristin L. Walter, MD, MS.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.7408?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Behavioral Counseling Interventions to Promote a Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Known Cardiovascular Disease Risk Factors</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.10951?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Behavioral Counseling Interventions to Promote a Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.11667?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Behavioral Counseling Interventions to Promote a Healthy Diet and Physical Activity to Prevent CVD in Adults Without Risk Factors</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.10801?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Implications of the New Recommendation on Behavioral Counseling Interventions to Promote Healthy Eating and Physical Activity</a></li> <li><a href= "https://jamanetwork.com/journals/jamacardiology/fullarticle/10.1001/jamacardio.2022.2259?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Improving Behavioral Counseling for Primary Cardiovascular Disease Prevention</a></li> <li><a href= "https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2022.2015?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Updated USPSTF Recommendations for Behavioral Counseling Interventions</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation_Behavioral_Counseling_to_Promote_Healthy_Behaviors_for_CVD_Prevention.mp3?dest-id=90171" length="47986477" type="audio/mpeg" />
      <itunes:duration>19:55</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/d/8/7/3d87f53cdd850a70a04421dee9605cbd/JSX220069_x3000_thumbimg.jpeg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Can Omecamtiv Mecarbil Improve Peak Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction (HFrEF)?</title>
      <itunes:title>Can Omecamtiv Mecarbil Improve Peak Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction (HFrEF)?</itunes:title>
      <pubDate>Tue, 19 Jul 2022 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[618fabea-b9b1-4927-a21c-20fd7e3d6ae1]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2022.12447]]></link>
      <description><![CDATA[<p>Exercise limitation is a cardinal manifestation of heart failure with reduced ejection fraction (HFrEF), but it is not consistently improved by any of the current guideline-directed medical therapies. JAMA Deputy Editor Gregory Curfman, MD, discusses whether omecamtiv mecarbil can improve peak exercise capacity in patients with HFrEF with Gregory D. Lewis, MD, from Massachusetts General Hospital, and Mark H. Drazner, MD, MSc, from University of Texas Southwestern Medical Center.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.11016"> Effect of Omecamtiv Mecarbil on Exercise Capacity in Chronic Heart Failure With Reduced Ejection Fraction: The METEORIC-HF Randomized Clinical Trial</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.6805"> Omecamtiv Mecarbil as a Therapy for Heart Failure With Low Ejection Fraction</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Exercise limitation is a cardinal manifestation of heart failure with reduced ejection fraction (HFrEF), but it is not consistently improved by any of the current guideline-directed medical therapies. JAMA Deputy Editor Gregory Curfman, MD, discusses whether omecamtiv mecarbil can improve peak exercise capacity in patients with HFrEF with Gregory D. Lewis, MD, from Massachusetts General Hospital, and Mark H. Drazner, MD, MSc, from University of Texas Southwestern Medical Center.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.11016"> Effect of Omecamtiv Mecarbil on Exercise Capacity in Chronic Heart Failure With Reduced Ejection Fraction: The METEORIC-HF Randomized Clinical Trial</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.6805"> Omecamtiv Mecarbil as a Therapy for Heart Failure With Low Ejection Fraction</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Can_Omecamtiv_Mecarbil_Improve_Peak_Exercise_Capacity_in_Patients_With_Heart_Failure_With_Reduced_Ejection_Fraction_HFrEF.mp3?dest-id=90171" length="19867636" type="audio/mpeg" />
      <itunes:duration>20:38</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/5/e/6/c5e6f0ecfcb0281ce55e3c100dce7605/JSX220078_x3000_thumbimg.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Diagnosis, Prevention, and Treatment of Monkeypox</title>
      <itunes:title>Diagnosis, Prevention, and Treatment of Monkeypox</itunes:title>
      <pubDate>Fri, 15 Jul 2022 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[a390e46f-dfbd-40c7-9c94-e7e0285863a5]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2022.12387]]></link>
      <description><![CDATA[<p>JAMA Associate Editor Preeti Malani, MD, MSJ, discusses the transmission, diagnosis, and treatment of monkeypox and the 2022 outbreak with Jeannette Guarner, MD, and Carlos del Rio, MD, both of the Division of Infectious Diseases at Emory University's School of Medicine. <a href= "https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2022.12387"> Read Transcript</a></p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.10802?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Monkeypox in 2022—What Clinicians Need to Know</a></li> </ul> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.10259?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">What Is Monkeypox?</a></li> </ul> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.9499?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">What to Know About Monkeypox</a></li> </ul> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.11224?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Global Monkeypox Outbreaks Spur Drug Research for the Neglected Disease</a></li> </ul> <p> </p>]]></description>
      
      <content:encoded><![CDATA[<p>JAMA Associate Editor Preeti Malani, MD, MSJ, discusses the transmission, diagnosis, and treatment of monkeypox and the 2022 outbreak with Jeannette Guarner, MD, and Carlos del Rio, MD, both of the Division of Infectious Diseases at Emory University's School of Medicine. <a href= "https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2022.12387"> Read Transcript</a></p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.10802?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Monkeypox in 2022—What Clinicians Need to Know</a></li> </ul> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.10259?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">What Is Monkeypox?</a></li> </ul> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.9499?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">What to Know About Monkeypox</a></li> </ul> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.11224?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Global Monkeypox Outbreaks Spur Drug Research for the Neglected Disease</a></li> </ul> <p> </p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Diagnosis_Prevention_and_Treatment_of_Monkeypox.mp3?dest-id=90171" length="17162400" type="audio/mpeg" />
      <itunes:duration>17:49</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/0/e/0/90e0a515bafae02727a2322813b393ee/JSX220077_x3000_thumbimg.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Progress in Adverse Event Rates in US Hospitalized Patients</title>
      <itunes:title>Progress in Adverse Event Rates in US Hospitalized Patients</itunes:title>
      <pubDate>Tue, 12 Jul 2022 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[79e5a965-06cf-45a0-92d2-abb999536f4e]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2022.11924]]></link>
      <description><![CDATA[<p>Patient safety is a national priority, but adverse events during hospitalization are hard to track and whether progress has been made over the past decade is unknown. JAMA Associate Editor Karen E. Joynt Maddox, MD, MPH, Washington University School of Medicine, discusses recent findings demonstrating decreases in hospital chart-abstracted adverse events and what's next in patient safety in the wake of COVID-19, with Mark Metersky, MD, University of Connecticut Health Center, and Peter Pronovost, MD, PhD, University Hospitals, Shaker Heights, Ohio.</p> <p>Related Content:</p> <ul> <li> <p><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.9600?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Trends in Adverse Event Rates in Hospitalized Patients, 2010-2019</a></p> </li> </ul> <ul> <li> <p><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.10281?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Improvements in Hospital Adverse Event Rates: Achieving Statistically Significant and Clinically Meaningful Results</a></p> </li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Patient safety is a national priority, but adverse events during hospitalization are hard to track and whether progress has been made over the past decade is unknown. JAMA Associate Editor Karen E. Joynt Maddox, MD, MPH, Washington University School of Medicine, discusses recent findings demonstrating decreases in hospital chart-abstracted adverse events and what's next in patient safety in the wake of COVID-19, with Mark Metersky, MD, University of Connecticut Health Center, and Peter Pronovost, MD, PhD, University Hospitals, Shaker Heights, Ohio.</p> <p>Related Content:</p> <ul> <li> <p><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.9600?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Trends in Adverse Event Rates in Hospitalized Patients, 2010-2019</a></p> </li> </ul> <ul> <li> <p><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.10281?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Improvements in Hospital Adverse Event Rates: Achieving Statistically Significant and Clinically Meaningful Results</a></p> </li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Progress_in_Adverse_Event_Rates_in_US_Hospitalized_Patients.mp3?dest-id=90171" length="15057970" type="audio/mpeg" />
      <itunes:duration>15:37</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/5/c/3/2/5c32c0db9c44689bbafc7308ab683e82/JSX220075_x3000_thumbimg.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>A Conversation With Dr Kirsten Bibbins-Domingo, JAMA's New Editor in Chief</title>
      <itunes:title>A Conversation With Dr Kirsten Bibbins-Domingo, JAMA's New Editor in Chief</itunes:title>
      <pubDate>Tue, 05 Jul 2022 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[3ba1ebcb-8d2e-40d5-81e5-018d62c145db]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2022.11289]]></link>
      <description><![CDATA[<p>In July 2022, Kirsten Bibbins-Domingo, PhD, MD, MAS, took on a new role as the 17th editor in chief of JAMA and the JAMA Network. In conversation with Nobel laureate Harold Varmus, MD, Bibbins-Domingo discusses her research background, approaches to leadership in health care, and the critical role that journals play in communication about public health and science.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.11108" target="_blank" rel="noopener">The Urgency of Now and the Responsibility to Do More—My Commitment for JAMA and the JAMA Network</a></li> <li><a class="related-article" href= "https://edhub.ama-assn.org/jn-learning/video-player/10.1001/jama.2022.11300" target="_blank" rel="noopener">A Conversation With Dr Kirsten Bibbins-Domingo, JAMA's New Editor in Chief (video)</a></li> <li><a class="related-article" href= "https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2022.11289" target="_blank" rel="noopener">A Conversation With Dr Kirsten Bibbins-Domingo, JAMA's New Editor in Chief (audio)</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>In July 2022, Kirsten Bibbins-Domingo, PhD, MD, MAS, took on a new role as the 17th editor in chief of JAMA and the JAMA Network. In conversation with Nobel laureate Harold Varmus, MD, Bibbins-Domingo discusses her research background, approaches to leadership in health care, and the critical role that journals play in communication about public health and science. Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.11108" target="_blank" rel="noopener">The Urgency of Now and the Responsibility to Do More—My Commitment for JAMA and the JAMA Network</a></li> <li><a class="related-article" href= "https://edhub.ama-assn.org/jn-learning/video-player/10.1001/jama.2022.11300" target="_blank" rel="noopener">A Conversation With Dr Kirsten Bibbins-Domingo, JAMA's New Editor in Chief (video)</a></li> <li><a class="related-article" href= "https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2022.11289" target="_blank" rel="noopener">A Conversation With Dr Kirsten Bibbins-Domingo, JAMA's New Editor in Chief (audio)</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/A_Conversation_With_Dr_Kirsten_Bibbins-Domingo_JAMAs_New_Editor_in_Chief.mp3?dest-id=90171" length="21329314" type="audio/mpeg" />
      <itunes:duration>22:07</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/9/4/e/a94ed5245a27fd16e5bbc093207a2619/jsx220072audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>The Association of Bariatric Surgery With Risk of Cancer in Adults With Obesity</title>
      <itunes:title>The Association of Bariatric Surgery With Risk of Cancer in Adults With Obesity</itunes:title>
      <pubDate>Tue, 28 Jun 2022 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[00a3a8be-43af-40fd-9f6f-370f11dd1f9a]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2022.9991]]></link>
      <description><![CDATA[<p>Observational data suggest that the risk of certain types of cancer may be increased in individuals with obesity and that this risk may be lower after bariatric surgery. JAMA Deputy Editor Gregory Curfman, MD, explores this in detail with Steven Nissen, MD, an author of a JAMA study on this topic, and Anita Courcoulas, MD, MPH, author of an accompanying editorial.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.9009?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Association of Bariatric Surgery With Cancer Risk and Mortality in Adults With Obesity</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.9166?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Bariatric Surgery and Cancer Risk</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Observational data suggest that the risk of certain types of cancer may be increased in individuals with obesity and that this risk may be lower after bariatric surgery. JAMA Deputy Editor Gregory Curfman, MD, explores this in detail with Steven Nissen, MD, an author of a JAMA study on this topic, and Anita Courcoulas, MD, MPH, author of an accompanying editorial.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.9009?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Association of Bariatric Surgery With Cancer Risk and Mortality in Adults With Obesity</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.9166?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Bariatric Surgery and Cancer Risk</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/The_Association_of_Bariatric_Surgery_With_Risk_of_Cancer_in_Adults_With_Obesity.mp3?dest-id=90171" length="47696037" type="audio/mpeg" />
      <itunes:duration>19:51</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/e/2/5/0e25dc29241b404d40be95ea3302a6a1/JSX220066_x3000_thumbimg.jpeg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Vitamin and Mineral Supplementation to Prevent CVD and Cancer</title>
      <itunes:title>USPSTF Recommendation: Vitamin and Mineral Supplementation to Prevent CVD and Cancer</itunes:title>
      <pubDate>Tue, 21 Jun 2022 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[7777c94f-5be1-4e66-a0ed-d78aa98d8375]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2022.7006]]></link>
      <description><![CDATA[<p>Interview with John B Wong, MD, USPSTF member and coauthor of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.8970?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: US Preventive Services Task Force Recommendation Statement</a>. Hosted by JAMA Deputy Editor Mary M. McDermott, MD.</p> <p>Related Content:</p> <ul> <li><a style= "font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Open Sans', 'Helvetica Neue', sans-serif;" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.9167?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Multivitamins and Supplements—Benign Prevention or Potentially Harmful Distraction?</a></li> </ul> <ul> <li><a style= "font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Open Sans', 'Helvetica Neue', sans-serif;" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.10009?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Patient Information: Vitamins and Minerals to Prevent Cardiovascular Disease and Cancer</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with John B Wong, MD, USPSTF member and coauthor of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.8970?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: US Preventive Services Task Force Recommendation Statement</a>. Hosted by JAMA Deputy Editor Mary M. McDermott, MD.</p> <p>Related Content:</p> <ul> <li><a style= "font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Open Sans', 'Helvetica Neue', sans-serif;" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.9167?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Multivitamins and Supplements—Benign Prevention or Potentially Harmful Distraction?</a></li> </ul> <ul> <li><a style= "font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Open Sans', 'Helvetica Neue', sans-serif;" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.10009?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Patient Information: Vitamins and Minerals to Prevent Cardiovascular Disease and Cancer</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation_Vitamin_and_Mineral_Supplementation_to_Prevent_CVD_and_Cancer.mp3?dest-id=90171" length="10065130" type="audio/mpeg" />
      <itunes:duration>10:25</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/5/7/2/25727b92db875761e5bbc093207a2619/JSX220051_x3000_thumbimg.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Occupational Well-being Among Clinicians</title>
      <itunes:title>Occupational Well-being Among Clinicians</itunes:title>
      <pubDate>Tue, 07 Jun 2022 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[1d61514c-782f-4b05-9e04-a4260f164f1a]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2022.8236]]></link>
      <description><![CDATA[<p>Interview with Lisa Rotenstein, MD, MBA, author of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.7461"> A Learning Health System Agenda for Organizational Approaches to Enhancing Occupational Well-being Among Clinicians</a>, and Clyde W. Yancy, MD, author of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.7424"> Resident Physician Wellness Postpandemic: How Does Healing Occur?</a>. Hosted by JAMA Associate Editor Anne Cappola, MD.</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Lisa Rotenstein, MD, MBA, author of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.7461"> A Learning Health System Agenda for Organizational Approaches to Enhancing Occupational Well-being Among Clinicians</a>, and Clyde W. Yancy, MD, author of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.7424"> Resident Physician Wellness Postpandemic: How Does Healing Occur?</a>. Hosted by JAMA Associate Editor Anne Cappola, MD.</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Occupational_Well-being_Among_Clinicians.mp3?dest-id=90171" length="28069232" type="audio/mpeg" />
      <itunes:duration>29:15</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/7/4/8/17481ef8aeaea16527a2322813b393ee/jsx220060audio_thumb_x3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendations: Screening for Primary Open-Angle Glaucoma and Screening for Impaired Visual Acuity in Older Adults</title>
      <itunes:title>USPSTF Recommendations: Screening for Primary Open-Angle Glaucoma and Screening for Impaired Visual Acuity in Older Adults</itunes:title>
      <pubDate>Tue, 24 May 2022 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[2945dbef-a3ec-44a0-a8ed-1eb2c5dea654]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2022.6552]]></link>
      <description><![CDATA[<p>Interview with Katrina Erika Donahue, MD, MPH, coauthor of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.7013?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Screening for Primary Open-Angle Glaucoma: US Preventive Services Task Force Recommendation Statement</a>, and <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.7015?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Screening for Impaired Visual Acuity in Older Adults: US Preventive Services Task Force Recommendation Statement</a>. Hosted by JAMA Deputy Editor Mary M. McDermott, MD.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.6290?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">USPSTF Review: Screening for Glaucoma in Adults</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.6381?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">USPSTF Review: Screening for Impaired Visual Acuity in Older Adults</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.7531?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Patient Information: Screening for Primary Open-Angle Glaucoma</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.6688?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Screening for Impaired Visual Acuity in Older Adults</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.7534?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Patient Information: Screening for Impaired Visual Acuity in Older Adults</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.6400?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Screening for Glaucoma</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Katrina Erika Donahue, MD, MPH, coauthor of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.7013?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Screening for Primary Open-Angle Glaucoma: US Preventive Services Task Force Recommendation Statement</a>, and <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.7015?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Screening for Impaired Visual Acuity in Older Adults: US Preventive Services Task Force Recommendation Statement</a>. Hosted by JAMA Deputy Editor Mary M. McDermott, MD.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.6290?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">USPSTF Review: Screening for Glaucoma in Adults</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.6381?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">USPSTF Review: Screening for Impaired Visual Acuity in Older Adults</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.7531?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Patient Information: Screening for Primary Open-Angle Glaucoma</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.6688?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Screening for Impaired Visual Acuity in Older Adults</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.7534?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Patient Information: Screening for Impaired Visual Acuity in Older Adults</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.6400?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Screening for Glaucoma</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendations_Screening_for_Primary_Open-Angle_Glaucoma_and_Screening_for_Impaired_Visual_Acuity_in_Older_Adults.mp3?dest-id=90171" length="11009743" type="audio/mpeg" />
      <itunes:duration>11:24</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/a/d/8/9ad8745f5f1c2a7d27a2322813b393ee/JSX220047_x3000_thumbimg.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Q&amp;A With White House COVID-19 Response Coordinator Ashish Jha</title>
      <itunes:title>Q&amp;A With White House COVID-19 Response Coordinator Ashish Jha</itunes:title>
      <pubDate>Wed, 18 May 2022 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[76c2006f-7e91-4992-a944-61b1cdf68136]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2022.8357]]></link>
      <description><![CDATA[<p>As the White House's COVID-19 Response Coordinator, Ashish Jha, MD, MPH, plays a critical role in the federal government's continued response to the pandemic. In this Q&A with JAMA Associate Editor Preeti Malani, MD, Jha details current thinking and federal planning around additional boosters, testing trends, and treatment for COVID-19.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.8541?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">New White House COVID-19 Leader on What's Next</a></li> <li><a href= "https://edhub.ama-assn.org/jn-learning/video-player/10.1001/jama.2022.8373" target="_blank" rel="noopener">Q&A With White House COVID-19 Response Coordinator Ashish Jha</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>As the White House's COVID-19 Response Coordinator, Ashish Jha, MD, MPH, plays a critical role in the federal government's continued response to the pandemic. In this Q&A with JAMA Associate Editor Preeti Malani, MD, Jha details current thinking and federal planning around additional boosters, testing trends, and treatment for COVID-19.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.8541?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">New White House COVID-19 Leader on What's Next</a></li> <li><a href= "https://edhub.ama-assn.org/jn-learning/video-player/10.1001/jama.2022.8373" target="_blank" rel="noopener">Q&A With White House COVID-19 Response Coordinator Ashish Jha</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/QA_With_White_House_COVID-19_Response_Coordinator_Ashish_Jha.mp3?dest-id=90171" length="56983785" type="audio/mpeg" />
      <itunes:duration>23:42</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/6/7/9/3679fc0b2d613aa716c3140a3186d450/JSX220062_x3000_thumbimg.jpeg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Screening for Chronic Obstructive Pulmonary Disease</title>
      <itunes:title>USPSTF Recommendation: Screening for Chronic Obstructive Pulmonary Disease</itunes:title>
      <pubDate>Tue, 10 May 2022 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[67bf943e-37df-4035-bb80-674b01040ce2]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2022.4916]]></link>
      <description><![CDATA[<p>Interview with Katrina E. Donahue, MD, MPH, USPSTF member and coauthor of Screening for Chronic Obstructive Pulmonary Disease: US Preventive Services Task Force Reaffirmation Recommendation Statement. Hosted by JAMA Senior Editor Kristin Walter, MD.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.4708?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">USPSTF Review: Screening for Chronic Obstructive Pulmonary Disease</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.3823?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Screening for Chronic Obstructive Pulmonary Disease: Challenges and Opportunities</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.5692?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">USPSTF Recommendation: Screening for Chronic Obstructive Pulmonary Disease</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.6110?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Patient Information: Screening for Chronic Obstructive Pulmonary Disease</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Katrina E. Donahue, MD, MPH, USPSTF member and coauthor of Screening for Chronic Obstructive Pulmonary Disease: US Preventive Services Task Force Reaffirmation Recommendation Statement. Hosted by JAMA Senior Editor Kristin Walter, MD.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.4708?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">USPSTF Review: Screening for Chronic Obstructive Pulmonary Disease</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.3823?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Screening for Chronic Obstructive Pulmonary Disease: Challenges and Opportunities</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.5692?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">USPSTF Recommendation: Screening for Chronic Obstructive Pulmonary Disease</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.6110?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Patient Information: Screening for Chronic Obstructive Pulmonary Disease</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation_Screening_for_Chronic_Obstructive_Pulmonary_Disease.mp3?dest-id=90171" length="21704567" type="audio/mpeg" />
      <itunes:duration>09:01</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/5/f/4/5/5f45e4aa7a27ab1a40be95ea3302a6a1/JSX220040_x3000_thumbimg.jpeg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Q&amp;A With FDA Commissioner Robert Califf</title>
      <itunes:title>Q&amp;A With FDA Commissioner Robert Califf</itunes:title>
      <pubDate>Wed, 04 May 2022 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[20786bb5-7032-489c-bef1-fa1943eda70e]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2022.6975]]></link>
      <description><![CDATA[<p>After serving as commissioner of the US Food and Drug Administration (FDA) under President Obama, Robert M. Califf, MD, recently returned to the role, overseeing a critical federal agency that regulates food, drugs, therapeutics, and medical devices in the US. In a wide-ranging discussion with JAMA Deputy Editor Gregory Curfman, MD, Califf discusses COVID-19 vaccine modifications, the FDA's approach to evaluating evidence, and efforts to combat health misinformation. Recorded April 26, 2022.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.7941?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links"" target="_blank" rel="noopener">"Unfinished Business" Brings Robert Califf, MD, Back for a Second Stint as FDA Commissioner</a></li> <li><a href= "https://edhub.ama-assn.org/jn-learning/video-player/10.1001/jama.2022.7943?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Q&A With FDA Commissioner Robert Califf</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>After serving as commissioner of the US Food and Drug Administration (FDA) under President Obama, Robert M. Califf, MD, recently returned to the role, overseeing a critical federal agency that regulates food, drugs, therapeutics, and medical devices in the US. In a wide-ranging discussion with JAMA Deputy Editor Gregory Curfman, MD, Califf discusses COVID-19 vaccine modifications, the FDA's approach to evaluating evidence, and efforts to combat health misinformation. Recorded April 26, 2022.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.7941?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links"" target="_blank" rel="noopener">"Unfinished Business" Brings Robert Califf, MD, Back for a Second Stint as FDA Commissioner</a></li> <li><a href= "https://edhub.ama-assn.org/jn-learning/video-player/10.1001/jama.2022.7943?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Q&A With FDA Commissioner Robert Califf</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/QA_With_FDA_Commissioner_Robert_Califf.mp3?dest-id=90171" length="22652074" type="audio/mpeg" />
      <itunes:duration>23:29</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/f/b/b/1fbba250a28558b9e55e3c100dce7605/JSX220049_x3000_thumbimg.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Aspirin Use for Cardiovascular Disease</title>
      <itunes:title>USPSTF Recommendation: Aspirin Use for Cardiovascular Disease</itunes:title>
      <pubDate>Tue, 26 Apr 2022 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[6756b5bf-849f-4d28-9d4a-a5dece302023]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2022.2735]]></link>
      <description><![CDATA[<p>Interview with John B. Wong, MD, USPSTF member and coauthor of Aspirin Use for Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement. Hosted by JAMA Deputy Editor Gregory Curfman, MD.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.4983?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement</a></li> </ul> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.2460?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Should Patients Take Aspirin for Primary Cardiovascular Prevention?</a></li> </ul> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.3337?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">USPSTF Review: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer</a></li> </ul> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.3385?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Updated Modeling Study for the US Preventive Services Task Force</a></li> </ul> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.5564?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Patient Information: Use of Aspirin to Prevent Cardiovascular Disease</a></li> </ul> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jamainternmed.2022.1365?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Whom to Treat for Primary Prevention of Atherosclerotic Cardiovascular Disease</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with John B. Wong, MD, USPSTF member and coauthor of Aspirin Use for Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement. Hosted by JAMA Deputy Editor Gregory Curfman, MD.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.4983?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement</a></li> </ul> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.2460?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Should Patients Take Aspirin for Primary Cardiovascular Prevention?</a></li> </ul> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.3337?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">USPSTF Review: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer</a></li> </ul> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.3385?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Updated Modeling Study for the US Preventive Services Task Force</a></li> </ul> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.5564?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Patient Information: Use of Aspirin to Prevent Cardiovascular Disease</a></li> </ul> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jamainternmed.2022.1365?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Whom to Treat for Primary Prevention of Atherosclerotic Cardiovascular Disease</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation_Aspirin_Use_for_Cardiovascular_Disease.mp3?dest-id=90171" length="13777543" type="audio/mpeg" />
      <itunes:duration>14:17</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/d/9/b/6/d9b6722a74a0ff6f40be95ea3302a6a1/JSX220026_x3000_thumbimg.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Reducing "COVID-19 Misinformation" While Preserving Free Speech</title>
      <itunes:title>Reducing "COVID-19 Misinformation" While Preserving Free Speech</itunes:title>
      <pubDate>Tue, 19 Apr 2022 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[fb637900-ecaa-43c9-9779-36127c73331b]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2022.5815]]></link>
      <description><![CDATA[<p>Misinformation about COVID-19 (such as around vaccines, masks, and ineffective drugs) has circulated widely during the pandemic, and much of this misinformation is protected by the Free Speech Clause of the First Amendment. Professor of Surgery and Perioperative Care and Professor of Law William M. Sage, MD, JD, from the University of Texas at Austin, is interviewed in this JAMA podcast.</p> <p>Related Content:</p> <p><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.4231?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Reducing "COVID-19 Misinformation" While Preserving Free Speech</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Misinformation about COVID-19 (such as around vaccines, masks, and ineffective drugs) has circulated widely during the pandemic, and much of this misinformation is protected by the Free Speech Clause of the First Amendment. Professor of Surgery and Perioperative Care and Professor of Law William M. Sage, MD, JD, from the University of Texas at Austin, is interviewed in this JAMA podcast.</p> <p>Related Content:</p> <p><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.4231?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Reducing "COVID-19 Misinformation" While Preserving Free Speech</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Reducing_COVID-19_Misinformation_While_Preserving_Free_Speech.mp3?dest-id=90171" length="59496518" type="audio/mpeg" />
      <itunes:duration>24:45</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/d/c/7/edc7c0f561964ebb5f2e77a3093c12a1/JSX220044_x3000_thumbimg.jpeg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Examining the Association of Left Atrial Function and Size With Incident Dementia</title>
      <itunes:title>Examining the Association of Left Atrial Function and Size With Incident Dementia</itunes:title>
      <pubDate>Tue, 22 Mar 2022 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[7e034f3f-f1ee-45bb-9b40-aeea4447d68d]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2022.3955]]></link>
      <description><![CDATA[<p>Electrocardiographic markers of atrial myopathy are associated with dementia, but it is unclear whether 2-dimensional echocardiographic––defined LA function and size are associated with dementia. JAMA Senior Editor Philip Greenland, MD, discusses study findings with Wendy Wang, MPH, and Lin Yee Chen, MD, authors of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.2518?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Association of Echocardiographic Measures of Left Atrial Function and Size With Incident Dementia</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Electrocardiographic markers of atrial myopathy are associated with dementia, but it is unclear whether 2-dimensional echocardiographic––defined LA function and size are associated with dementia. JAMA Senior Editor Philip Greenland, MD, discusses study findings with Wendy Wang, MPH, and Lin Yee Chen, MD, authors of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.2518?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Association of Echocardiographic Measures of Left Atrial Function and Size With Incident Dementia</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Examining_the_Association_of_Left_Atrial_Function_and_Size_With_Incident_Dementia.mp3?dest-id=90171" length="12540163" type="audio/mpeg" />
      <itunes:duration>12:57</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/4/4/e/a/44ea199115a42f52e55e3c100dce7605/JSX220029_x3000_thumbimg.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Leading Medicare: Q&amp;A With Medicare Director Meena Seshamani</title>
      <itunes:title>Leading Medicare: Q&amp;A With Medicare Director Meena Seshamani</itunes:title>
      <pubDate>Wed, 16 Mar 2022 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[ad612bdd-fa79-40e3-bb01-865d87736784]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2022.3733]]></link>
      <description><![CDATA[<p>As the largest public insurance program in the US, Medicare has an outsize influence in how many people in the US access and receive health care. Recently appointed Director of Center for Medicare Meena Seshamani, MD, PhD, joins JAMA Associate Editor Karen Joynt Maddox, MD, for a discussion of equitable, patient-centered approaches to health care delivery, and how her own experiences as a physician have illuminated how she leads the program.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.4289?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Center for Medicare Director Envisions Holistic Approach to Health Care</a></li> <li><a href= "https://edhub.ama-assn.org/jn-learning/video-player/10.1001/jama.2022.3808?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Leading Medicare: Q&A With Medicare Director Meena Seshamani</a></li> <li><a href= "https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jamahealthforum.2021.4938?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Health System Factors Related to Overuse of Health Services in Medicare</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.6613?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Leveraging Medicare to Advance Health Equity</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>As the largest public insurance program in the US, Medicare has an outsize influence in how many people in the US access and receive health care. Recently appointed Director of Center for Medicare Meena Seshamani, MD, PhD, joins JAMA Associate Editor Karen Joynt Maddox, MD, for a discussion of equitable, patient-centered approaches to health care delivery, and how her own experiences as a physician have illuminated how she leads the program.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.4289?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Center for Medicare Director Envisions Holistic Approach to Health Care</a></li> <li><a href= "https://edhub.ama-assn.org/jn-learning/video-player/10.1001/jama.2022.3808?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Leading Medicare: Q&A With Medicare Director Meena Seshamani</a></li> <li><a href= "https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jamahealthforum.2021.4938?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Health System Factors Related to Overuse of Health Services in Medicare</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.6613?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Leveraging Medicare to Advance Health Equity</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Leading_Medicare_QA_With_Medicare_Director_Meena_Seshamani.mp3?dest-id=90171" length="64055350" type="audio/mpeg" />
      <itunes:duration>26:39</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/d/e/b/8/deb8d3fe1965f629bafc7308ab683e82/JSX220027_x3000_thumbimg.jpeg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Screening for Eating Disorders in Adolescents and Adults</title>
      <itunes:title>USPSTF Recommendation: Screening for Eating Disorders in Adolescents and Adults</itunes:title>
      <pubDate>Tue, 15 Mar 2022 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[84b282e1-3741-4903-a31a-587110ec94cc]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2022.589]]></link>
      <description><![CDATA[<p>Interview with Lori Pbert, PhD, USPSTF member and coauthor of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.1806"> Screening for Eating Disorders in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Lori Pbert, PhD, USPSTF member and coauthor of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.1806"> Screening for Eating Disorders in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation_Screening_for_Eating_Disorders_in_Adolescents_and_Adults.mp3?dest-id=90171" length="11939751" type="audio/mpeg" />
      <itunes:duration>12:23</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/7/5/d/175d0c4c70be31eee5bbc093207a2619/JSX220008_x3000_thumbimg.jpeg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Screening for Atrial Fibrillation</title>
      <itunes:title>USPSTF Recommendation: Screening for Atrial Fibrillation</itunes:title>
      <pubDate>Tue, 25 Jan 2022 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[edd41d03-88eb-4b80-a76b-f36f512dcc4e]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2021.22008]]></link>
      <description><![CDATA[<p>Interview with Gbenga Ogedegbe, MD, MPH, USPSTF member and coauthor of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.21811?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Screening for Atrial Fibrillation: US Preventive Services Task Force Recommendation Statement</a>. Hosted by Gregory Curfman, MD.</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Gbenga Ogedegbe, MD, MPH, USPSTF member and coauthor of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.21811?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Screening for Atrial Fibrillation: US Preventive Services Task Force Recommendation Statement</a>. Hosted by Gregory Curfman, MD.</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation_Screening_for_Atrial_Fibrillation.mp3?dest-id=90171" length="40063249" type="audio/mpeg" />
      <itunes:duration>16:41</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/1/4/3/e143266ad7a6d7a188c4a68c3ddbc4f2/JSX210058_x3000_thumbimg.jpeg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Public Health in an Era of Endemic COVID-19</title>
      <itunes:title>Public Health in an Era of Endemic COVID-19</itunes:title>
      <pubDate>Tue, 18 Jan 2022 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[99a17711-b29c-4ac2-be4f-f7b11cc0d11b]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2022.140]]></link>
      <description><![CDATA[<p>Three members of President Biden's former COVID-19 Advisory Board—Luciana Borio, MD, Ezekiel Emanuel, MD, PhD, and Mike Osterholm, PhD—discuss their recent JAMA Viewpoints, providing their ideas on strategies for public health as COVID-19 transitions from pandemic to endemic. Hosted by JAMA Associate Editor Preeti Malani, MD.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.24282"> A National Strategy for the "New Normal" of Life With COVID</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.24168"> A National Strategy for COVID-19—Testing, Surveillance, and Mitigation Strategies</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.24165"> A National Strategy for COVID-19 Medical Countermeasures</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.0216"> Former Biden-Harris Transition Advisors Propose a New National Strategy for COVID-19</a></li> <li><a href= "https://edhub.ama-assn.org/jn-learning/video-player/10.1001/jama.2022.311"> Public Health in an Era of Endemic COVID-19 (video)</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Three members of President Biden's former COVID-19 Advisory Board—Luciana Borio, MD, Ezekiel Emanuel, MD, PhD, and Mike Osterholm, PhD—discuss their recent JAMA Viewpoints, providing their ideas on strategies for public health as COVID-19 transitions from pandemic to endemic. Hosted by JAMA Associate Editor Preeti Malani, MD.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.24282"> A National Strategy for the "New Normal" of Life With COVID</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.24168"> A National Strategy for COVID-19—Testing, Surveillance, and Mitigation Strategies</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.24165"> A National Strategy for COVID-19 Medical Countermeasures</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.0216"> Former Biden-Harris Transition Advisors Propose a New National Strategy for COVID-19</a></li> <li><a href= "https://edhub.ama-assn.org/jn-learning/video-player/10.1001/jama.2022.311"> Public Health in an Era of Endemic COVID-19 (video)</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Public_Health_in_an_Era_of_Endemic_COVID-19.mp3?dest-id=90171" length="30854935" type="audio/mpeg" />
      <itunes:duration>32:04</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/4/8/2/9/4829ca0dedc0b11d40be95ea3302a6a1/JSX220003_x3000_thumbimg.jpeg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>COVID-19 CDC Update – Early January 2022</title>
      <itunes:title>COVID-19 CDC Update – Early January 2022</itunes:title>
      <pubDate>Tue, 11 Jan 2022 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[e3063fbc-e220-44b8-824c-579e3e6c611d]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2021.24215]]></link>
      <description><![CDATA[<p>Former CDC Executive Secretariat of the Advisory Committee on Immunization Practices Amanda Cohn, MD, joins JAMA Associate Editor Preeti Malani, MD, for the latest on the need for vaccination and boosters, vaccine misinformation, and tackling the pandemic from a global perspective. Recorded January 6, 2022.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.23962?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">One Year of COVID-19 Vaccines: A Shot of Hope, a Dose of Reality</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.0106?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">COVID-19 Vaccines Have Been Available in the US for More Than a Year—What's Been Learned and What's Next?</a></li> <li><a href= "https://edhub.ama-assn.org/jn-learning/video-player/10.1001/jama.2021.24428?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">COVID-19 CDC Update – Early January 2022</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Former CDC Executive Secretariat of the Advisory Committee on Immunization Practices Amanda Cohn, MD, joins JAMA Associate Editor Preeti Malani, MD, for the latest on the need for vaccination and boosters, vaccine misinformation, and tackling the pandemic from a global perspective. Recorded January 6, 2022.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.23962?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">One Year of COVID-19 Vaccines: A Shot of Hope, a Dose of Reality</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.0106?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">COVID-19 Vaccines Have Been Available in the US for More Than a Year—What's Been Learned and What's Next?</a></li> <li><a href= "https://edhub.ama-assn.org/jn-learning/video-player/10.1001/jama.2021.24428?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">COVID-19 CDC Update – Early January 2022</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/COVID-19_CDC_Update__Early_January_2022.mp3?dest-id=90171" length="30938704" type="audio/mpeg" />
      <itunes:duration>32:11</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/0/f/c/30fcd066d9de6f6ad959afa2a1bf1c87/JSX210072_x3000_thumbimg.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Screening and Interventions to Prevent Dental Caries in Children</title>
      <itunes:title>USPSTF Recommendation: Screening and Interventions to Prevent Dental Caries in Children</itunes:title>
      <pubDate>Tue, 07 Dec 2021 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[f4d26c3c-66f1-451d-a0ce-30904936ef35]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2021.20914]]></link>
      <description><![CDATA[<p>Interview with Michael Cabana, MD, USPSTF member and coauthor of Screening and Interventions to Prevent Dental Caries in Children Younger Than 5 Years: US Preventive Services Task Force Recommendation Statement.</p> <p>Related Content:</p> <p><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.20007?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank"">Screening and Interventions to Prevent Dental Caries in Children Younger Than 5 Years</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Michael Cabana, MD, USPSTF member and coauthor of Screening and Interventions to Prevent Dental Caries in Children Younger Than 5 Years: US Preventive Services Task Force Recommendation Statement.</p> <p>Related Content:</p> <p><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.20007?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank"">Screening and Interventions to Prevent Dental Caries in Children Younger Than 5 Years</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation_Screening_and_Interventions_to_Prevent_Dental_Caries_in_Children.mp3?dest-id=90171" length="13688205" type="audio/mpeg" />
      <itunes:duration>14:14</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/4/b/a/c/4baca5b7774c506540be95ea3302a6a1/JSX210052_x3000_thumbimg.jpeg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>COVID-19 Update: Omicron Variant</title>
      <itunes:title>COVID-19 Update: Omicron Variant</itunes:title>
      <pubDate>Mon, 06 Dec 2021 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[863c9de6-63bd-4e09-8f4e-8d08a629aca1]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2021.22587]]></link>
      <description><![CDATA[<p>Infectious disease experts Adam Lauring, MD, PhD, and Carlos del Rio, MD, join JAMA Associate Editor Preeti Malani, MD, MSJ, for a discussion of the newly emerged Omicron variant, the potential for a 2021-2022 "twindemic" with flu, and the latest COVID-19 clinical updates. Recorded December 1, 2021.</p> <p>Related content:</p> <p><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.22619"> Omicron Has Reached the US—Here's What Infectious Disease Experts Know About the Variant</a></p> <p><a href= "https://edhub.ama-assn.org/jn-learning/video-player/10.1001/jama.2021.22720"> COVID-19 Update: Omicron Variant</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Infectious disease experts Adam Lauring, MD, PhD, and Carlos del Rio, MD, join JAMA Associate Editor Preeti Malani, MD, MSJ, for a discussion of the newly emerged Omicron variant, the potential for a 2021-2022 "twindemic" with flu, and the latest COVID-19 clinical updates. Recorded December 1, 2021.</p> <p>Related content:</p> <p><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.22619"> Omicron Has Reached the US—Here's What Infectious Disease Experts Know About the Variant</a></p> <p><a href= "https://edhub.ama-assn.org/jn-learning/video-player/10.1001/jama.2021.22720"> COVID-19 Update: Omicron Variant</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/COVID-19_Update__Omicron_Variant.mp3?dest-id=90171" length="36573318" type="audio/mpeg" />
      <itunes:duration>38:04</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/4/d/0/f/4d0f4b1caf88490d27a2322813b393ee/JSX210060_x3000_thumbimg.jpeg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Achieving Diagnostic Excellence in the 21st Century</title>
      <itunes:title>Achieving Diagnostic Excellence in the 21st Century</itunes:title>
      <pubDate>Thu, 28 Oct 2021 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[c9015678-e8b7-4eb1-9b82-6e44d39ce2e1]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2021.19824]]></link>
      <description><![CDATA[<p>Phil Fontanarosa, MD, MBA, interim editor in chief of JAMA, interviews Harvey V. Fineberg, MD, PhD, from the Gordon and Betty Moore Foundation, and Abraham Verghese, MD, from Stanford University School of Medicine, about diagnostic excellence and a new series on this topic in JAMA.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.19493?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Diagnostic Excellence</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.19496?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Diagnosis and the Illness Experience: Ways of Knowing</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Phil Fontanarosa, MD, MBA, interim editor in chief of JAMA, interviews Harvey V. Fineberg, MD, PhD, from the Gordon and Betty Moore Foundation, and Abraham Verghese, MD, from Stanford University School of Medicine, about diagnostic excellence and a new series on this topic in JAMA.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.19493?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Diagnostic Excellence</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.19496?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Diagnosis and the Illness Experience: Ways of Knowing</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Achieving_Diagnostic_Excellence_in_the_21st_Century.mp3?dest-id=90171" length="19837102" type="audio/mpeg" />
      <itunes:duration>20:34</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/9/9/4/c9944d56a5765f7d27a2322813b393ee/JSX210051_3000_thumbimg.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>A Continued Focus on Equity Through Pharmacoequity and Digital Health Equity: Two Current Viewpoints</title>
      <itunes:title>A Continued Focus on Equity Through Pharmacoequity and Digital Health Equity: Two Current Viewpoints</itunes:title>
      <pubDate>Fri, 22 Oct 2021 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[b98d1d56-eb98-480a-ba75-1bfce9a2fe2c]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2021.19181]]></link>
      <description><![CDATA[<p>Individuals who experience systemic, structural, institutional, and social barriers within society deserve better and more convenient health care access. This idea should be central when advancing efforts to achieve health equity. JAMA Editorial Board member Raina M. Merchant, MD, speaks with Courtney R. Lyles, PhD, and Urmimala Sarkar, MD, about approaches toward improving digital health equity and with Utibe R. Essien, MD, about enhancing targeted efforts toward realizing pharmacoequity.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.17764?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">A Policy Prescription for Reducing Health Disparities—Achieving Pharmacoequity</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.18459?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Focusing on Digital Health Equity</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Individuals who experience systemic, structural, institutional, and social barriers within society deserve better and more convenient health care access. This idea should be central when advancing efforts to achieve health equity. JAMA Editorial Board member Raina M. Merchant, MD, speaks with Courtney R. Lyles, PhD, and Urmimala Sarkar, MD, about approaches toward improving digital health equity and with Utibe R. Essien, MD, about enhancing targeted efforts toward realizing pharmacoequity.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.17764?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">A Policy Prescription for Reducing Health Disparities—Achieving Pharmacoequity</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.18459?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Focusing on Digital Health Equity</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/A_Continued_Focus_on_Equity_Through_Pharmacoequity_and_Digital_Health_Equity_Two_Current_Viewpoints.mp3?dest-id=90171" length="23044849" type="audio/mpeg" />
      <itunes:duration>23:53</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/5/3/b/853b28228656118840be95ea3302a6a1/JSX210050_3000_thumbimg.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Administrative Costs in US Health Care: A Quarter-Trillion-Dollar Opportunity</title>
      <itunes:title>Administrative Costs in US Health Care: A Quarter-Trillion-Dollar Opportunity</itunes:title>
      <pubDate>Wed, 20 Oct 2021 10:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[cd4163e3-ac1a-4fce-a3ec-12ae26543880]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2021.19043]]></link>
      <description><![CDATA[<p>Health care expenses that arise from largely nonclinical functions, such as coding and billing and administration, cost the US health care system almost $1 trillion annually. Michael Chernew, PhD, from Harvard Medical School Department of Health Care Policy, and David Cutler, PhD, from Harvard University Department of Economics, join JAMA Associate Editor Karen Joynt Maddox, MD, MPH, from Washington University School of Medicine to discuss some basic fixes and simplifications that could reduce administrative spending by an estimated $265 billion.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.13978?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Waste in the US Health Care System: Estimated Costs and Potential for Savings</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.17318?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Administrative Expenses in the US Health Care System: Why So High?</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.17315?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Administrative Simplification and the Potential for Saving a Quarter-Trillion Dollars in Health Care</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.18292?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Economic Incentives for Administrative Simplification</a></li> <li><a href= "https://edhub.ama-assn.org/jn-learning/video-player/10.1001/jama.2019.14980?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Waste in the US Health Care System</a></li> <li><a href= "https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2019.14987?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Waste in the US Health Care System</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Health care expenses that arise from largely nonclinical functions, such as coding and billing and administration, cost the US health care system almost $1 trillion annually. Michael Chernew, PhD, from Harvard Medical School Department of Health Care Policy, and David Cutler, PhD, from Harvard University Department of Economics, join JAMA Associate Editor Karen Joynt Maddox, MD, MPH, from Washington University School of Medicine to discuss some basic fixes and simplifications that could reduce administrative spending by an estimated $265 billion.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.13978?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Waste in the US Health Care System: Estimated Costs and Potential for Savings</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.17318?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Administrative Expenses in the US Health Care System: Why So High?</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.17315?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Administrative Simplification and the Potential for Saving a Quarter-Trillion Dollars in Health Care</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.18292?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Economic Incentives for Administrative Simplification</a></li> <li><a href= "https://edhub.ama-assn.org/jn-learning/video-player/10.1001/jama.2019.14980?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Waste in the US Health Care System</a></li> <li><a href= "https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2019.14987?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Waste in the US Health Care System</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Administrative_Costs_in_US_Health_Care_A_Quarter-Trillion-Dollar_Opportunity.mp3?dest-id=90171" length="21442339" type="audio/mpeg" />
      <itunes:duration>22:15</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/5/2/4/8/5248c432fbb1fe545f2e77a3093c12a1/JSX210049_3000_thumbimg.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Effect of Carbon Dioxide Laser vs Sham Therapy on Women With Postmenopausal Vaginal Symptoms</title>
      <itunes:title>Effect of Carbon Dioxide Laser vs Sham Therapy on Women With Postmenopausal Vaginal Symptoms</itunes:title>
      <pubDate>Tue, 12 Oct 2021 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[47f4ab02-0efe-41a0-9d9d-564d7f55e219]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2021.17489]]></link>
      <description><![CDATA[<p>Interview with Jason A. Abbott, and Fiona G Li, authors of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.14892?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Effect of Fractional Carbon Dioxide Laser vs Sham Treatment on Symptom Severity in Women With Postmenopausal Vaginal Symptoms: A Randomized Clinical Trial</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Jason A. Abbott, and Fiona G Li, authors of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.14892?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Effect of Fractional Carbon Dioxide Laser vs Sham Treatment on Symptom Severity in Women With Postmenopausal Vaginal Symptoms: A Randomized Clinical Trial</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Effect_of_Carbon_Dioxide_Laser_vs_Sham_Therapy_on_Women_With_Postmenopausal_Vaginal_Symptoms.mp3?dest-id=90171" length="49538302" type="audio/mpeg" />
      <itunes:duration>20:36</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/f/f/a/8/ffa8bd3dab009b535f2e77a3093c12a1/JSX210037_x3000_thumbimg.jpeg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Scopolamine Butylbromide for Preventing End-of-Life Death Rattle</title>
      <itunes:title>Scopolamine Butylbromide for Preventing End-of-Life Death Rattle</itunes:title>
      <pubDate>Tue, 05 Oct 2021 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[5f819388-b61d-4cef-a041-2be0db66b353]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2021.17433]]></link>
      <description><![CDATA[<p>Death rattle, defined as noisy breathing caused by the presence of mucus in the respiratory tract, is common among dying patients. Harriette van Esch, MD, from the Erasmus Medical Center, the Netherlands, and Jared R. Lowe, MD, from the University of North Carolina, join JAMA Associate Editor Ethan Basch, MD, to discuss evidence about use of prophylactic scopolamine butylbromide to reduce the death rattle.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.14785?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Effect of Prophylactic Subcutaneous Scopolamine Butylbromide on Death Rattle</a></li> </ul> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.9846?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Preventing Death Rattle With Prophylactic Subcutaneous Scopolamine Butylbromide</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Death rattle, defined as noisy breathing caused by the presence of mucus in the respiratory tract, is common among dying patients. Harriette van Esch, MD, from the Erasmus Medical Center, the Netherlands, and Jared R. Lowe, MD, from the University of North Carolina, join JAMA Associate Editor Ethan Basch, MD, to discuss evidence about use of prophylactic scopolamine butylbromide to reduce the death rattle.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.14785?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Effect of Prophylactic Subcutaneous Scopolamine Butylbromide on Death Rattle</a></li> </ul> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.9846?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Preventing Death Rattle With Prophylactic Subcutaneous Scopolamine Butylbromide</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Scopolamine_Butylbromide_for_Preventing_End-of-Life_Death_Rattle.mp3?dest-id=90171" length="14756322" type="audio/mpeg" />
      <itunes:duration>15:16</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/2/f/d/22fd83caa218817e27a2322813b393ee/JSX210036_x3000_thumbimg.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>COVID-19 in Canada—Experience and Response to Waves 2 and 3</title>
      <itunes:title>COVID-19 in Canada—Experience and Response to Waves 2 and 3</itunes:title>
      <pubDate>Tue, 28 Sep 2021 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[05e79df3-85ba-4d64-be29-651b6fee0005]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2021.15864]]></link>
      <description><![CDATA[<p>Canadian law gives the country's individual provinces and territories primary responsibility for coronavirus containment and mitigation. JAMA Associate Editor Preeti Malani, MD, MSJ, from the University of Michigan and Allan S. Detsky, MD, PhD, from the University of Toronto, Ontario, Canada, discuss the national pandemic experience, including public health responses to infection and vaccine allocation, from fall 2020 through summer 2021.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.14797?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">COVID-19 in Canada: Experience and Response to Waves 2 and 3</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Canadian law gives the country's individual provinces and territories primary responsibility for coronavirus containment and mitigation. JAMA Associate Editor Preeti Malani, MD, MSJ, from the University of Michigan and Allan S. Detsky, MD, PhD, from the University of Toronto, Ontario, Canada, discuss the national pandemic experience, including public health responses to infection and vaccine allocation, from fall 2020 through summer 2021.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.14797?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">COVID-19 in Canada: Experience and Response to Waves 2 and 3</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/COVID-19_in_CanadaExperience_and_Response_to_Waves_2_and_3.mp3?dest-id=90171" length="22758649" type="audio/mpeg" />
      <itunes:duration>23:35</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/0/3/b/003b1187f00f05b488c4a68c3ddbc4f2/JSX210029_thumbimgx3000.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality</title>
      <itunes:title>USPSTF Recommendation: Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality</itunes:title>
      <pubDate>Tue, 28 Sep 2021 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[074becfc-9191-40fd-b83f-04ff4579a021]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2021.13003]]></link>
      <description><![CDATA[<p>Interview with Aaron B. Caughey, MD, USPSTF member and coauthor of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.8551?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force</a></p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.14646?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Low-Dose Aspirin for the Prevention of Preeclampsia</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.14781?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">USPSTF Recommendation: Aspirin Use to Prevent Preeclampsia</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.15900?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Patient Information: Use of Aspirin During Pregnancy to Prevent Preeclampsia</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Aaron B. Caughey, MD, USPSTF member and coauthor of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.8551?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force</a></p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.14646?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Low-Dose Aspirin for the Prevention of Preeclampsia</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.14781?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">USPSTF Recommendation: Aspirin Use to Prevent Preeclampsia</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.15900?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Patient Information: Use of Aspirin During Pregnancy to Prevent Preeclampsia</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation__Aspirin_Use_to_Prevent_Preeclampsia_and_Related_Morbidity_and_Mortality.mp3?dest-id=90171" length="15929953" type="audio/mpeg" />
      <itunes:duration>16:22</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/b/d/4/a/bd4a080d9c60b156e55e3c100dce7605/JSX210015_3000px_thumbimg.jpeg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Screening for Chlamydia and Gonorrhea</title>
      <itunes:title>USPSTF Recommendation: Screening for Chlamydia and Gonorrhea</itunes:title>
      <pubDate>Tue, 14 Sep 2021 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[a6ea4529-e31c-48fd-a129-607773dea5c6]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2021.13284]]></link>
      <description><![CDATA[<p>Interview with Martha Kubik, PhD, RN, USPSTF member and coauthor of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.14081"> Screening for Chlamydia and Gonorrhea: US Preventive Services Task Force Recommendation Statement</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Martha Kubik, PhD, RN, USPSTF member and coauthor of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.14081"> Screening for Chlamydia and Gonorrhea: US Preventive Services Task Force Recommendation Statement</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation__Screening_for_Chlamydia_and_Gonorrhea.mp3?dest-id=90171" length="14206977" type="audio/mpeg" />
      <itunes:duration>14:45</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/6/6/1/8661575b056296b788c4a68c3ddbc4f2/JSX210016_thumbimg.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Addressing Diversity, Equity, and Inclusion in Health Care and Medicine</title>
      <itunes:title>Addressing Diversity, Equity, and Inclusion in Health Care and Medicine</itunes:title>
      <pubDate>Tue, 17 Aug 2021 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[c089b33a-9127-437d-9a6d-0aaf400b6e3f]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2021.13555]]></link>
      <description><![CDATA[<p>While health disparities have gained growing attention in recent years, much work is still needed, as inequities continue to have a direct and measurable negative influence on patients in historically disadvantaged communities. David Satcher, MD, PhD, Francisco Cigarroa, MD, and Howard Koh, MD, MPH, join moderator Ebony Boulware, MD, MPH, to discuss the vital importance of the visibility of all races and ethnicities in research, medical schools, and health care. They propose potential solutions, including the recruitment of and support for more physicians who look like their patients, who care enough, know enough, have the courage to make a difference, and who will persevere until changes are made.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.9441?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Healing and Health Equity for Asian American, Native Hawaiian, and Pacific Islander Populations</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.11997?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Uplifting the Latino Population From Obscurity to the Forefront of Health Care</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.10464?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Does Race Interfere With the Doctor-Patient Relationship? (published 1973)</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.12454?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Race and the Patient-Physician Relationship in 2021</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>While health disparities have gained growing attention in recent years, much work is still needed, as inequities continue to have a direct and measurable negative influence on patients in historically disadvantaged communities. David Satcher, MD, PhD, Francisco Cigarroa, MD, and Howard Koh, MD, MPH, join moderator Ebony Boulware, MD, MPH, to discuss the vital importance of the visibility of all races and ethnicities in research, medical schools, and health care. They propose potential solutions, including the recruitment of and support for more physicians who look like their patients, who care enough, know enough, have the courage to make a difference, and who will persevere until changes are made.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.9441?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Healing and Health Equity for Asian American, Native Hawaiian, and Pacific Islander Populations</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.11997?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Uplifting the Latino Population From Obscurity to the Forefront of Health Care</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.10464?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Does Race Interfere With the Doctor-Patient Relationship? (published 1973)</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.12454?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Race and the Patient-Physician Relationship in 2021</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Addressing_Diversity_Equity_and_Inclusion_in_Health_Care_and_Medicine.mp3?dest-id=90171" length="41385294" type="audio/mpeg" />
      <itunes:duration>43:05</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/b/4/9/ab49e3405964123cbafc7308ab683e82/JSX210019_thumbimg.jpeg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Noninvasive Ventilation of COVID-19 Patients</title>
      <itunes:title>Noninvasive Ventilation of COVID-19 Patients</itunes:title>
      <pubDate>Mon, 29 Mar 2021 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[d41fae37-f9cd-4852-9bc7-d4b7eb34e082]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2021.614]]></link>
      <description><![CDATA[<p>Noninvasive ventilation (NIV) may help COVID-19 patients in respiratory failure avoid invasive mechanical ventilation but may also lead to delays in intubation with potential for worse clinical outcomes.</p> <p>Domenico L. Grieco, MD, of Fondazione Policlinico Agostino Gemelli IRCCS in Rome, Jesse B. Hall, MD, of the University of Chicago, and Laveena Munshi, MD, MSc, of Sinai Health System/University Health Network of the University of Toronto join JAMA's live Q&A series to discuss helmet NIV, high-flow nasal oxygen, and other NIV modalities in the management of hypoxic coronavirus patients. Recorded March 25, 2021.</p> <p>Related Content:</p> <p><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.4682"> Effect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of Respiratory Support in Patients With COVID-19 and Moderate to Severe Hypoxemic Respiratory Failure</a></p> <p><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.4975"> Respiratory Support During the COVID-19 Pandemic: Is It Time to Consider Using a Helmet?</a></p> <p><a href= "https://edhub.ama-assn.org/jn-learning/video-player/18596411">Noninvasive Ventilation of COVID-19 Patients</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Noninvasive ventilation (NIV) may help COVID-19 patients in respiratory failure avoid invasive mechanical ventilation but may also lead to delays in intubation with potential for worse clinical outcomes.</p> <p>Domenico L. Grieco, MD, of Fondazione Policlinico Agostino Gemelli IRCCS in Rome, Jesse B. Hall, MD, of the University of Chicago, and Laveena Munshi, MD, MSc, of Sinai Health System/University Health Network of the University of Toronto join JAMA's live Q&A series to discuss helmet NIV, high-flow nasal oxygen, and other NIV modalities in the management of hypoxic coronavirus patients. Recorded March 25, 2021.</p> <p>Related Content:</p> <p><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.4682"> Effect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of Respiratory Support in Patients With COVID-19 and Moderate to Severe Hypoxemic Respiratory Failure</a></p> <p><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.4975"> Respiratory Support During the COVID-19 Pandemic: Is It Time to Consider Using a Helmet?</a></p> <p><a href= "https://edhub.ama-assn.org/jn-learning/video-player/18596411">Noninvasive Ventilation of COVID-19 Patients</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Noninvasive_Ventilation_of_COVID-19_Patients.mp3?dest-id=90171" length="38754016" type="audio/mpeg" />
      <itunes:duration>32:15</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/7/b/1/07b1a671e83330d1/JMI210031.jpeg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Precision Dosing—A Clinical and Public Health Imperative</title>
      <itunes:title>Precision Dosing—A Clinical and Public Health Imperative</itunes:title>
      <pubDate>Wed, 24 Mar 2021 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[882979d5-3f2c-4833-91ef-7f2f1d1e6c38]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2021.2563]]></link>
      <description><![CDATA[<p>Interview with Kimberly Maxfield, PhD, author of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.1004"> Precision Dosing—A Clinical and Public Health Imperative</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Kimberly Maxfield, PhD, author of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.1004"> Precision Dosing—A Clinical and Public Health Imperative</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Precision_DosingA_Clinical_and_Public_Health_Imperative.mp3?dest-id=90171" length="16180590" type="audio/mpeg" />
      <itunes:duration>16:47</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/5/1/1/2511ab55c7df6e6f/JVP210018.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Screening for Hearing Loss in Older Adults</title>
      <itunes:title>USPSTF Recommendation: Screening for Hearing Loss in Older Adults</itunes:title>
      <pubDate>Tue, 23 Mar 2021 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[dc834cb0-261a-436f-a8d9-995d8a560f0c]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2021.367]]></link>
      <description><![CDATA[<p>Interview with Chien-Wen W. Tseng, MD, USPSTF member and coauthor of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.0366"> USPSTF Recommendation: Screening for Hearing Loss in Older Adults</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Chien-Wen W. Tseng, MD, USPSTF member and coauthor of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.0366"> USPSTF Recommendation: Screening for Hearing Loss in Older Adults</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation__Screening_for_Hearing_Loss_in_Older_Adults.mp3?dest-id=90171" length="23616879" type="audio/mpeg" />
      <itunes:duration>19:39</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/b/2/b/6b2b33694c2cbfc0/JMI210023.jpeg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus Update With Carlos del Rio and Preeti Malani</title>
      <itunes:title>Coronavirus Update With Carlos del Rio and Preeti Malani</itunes:title>
      <pubDate>Thu, 18 Mar 2021 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[b4d16147-6697-45b5-9615-7f3f95d62934]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2021.3975]]></link>
      <description><![CDATA[<p>Coronavirus trends, variants, vaccines, treatment, and more. JAMA Associate Editor Preeti Malani, MD, MSJ, also from the University of Michigan, and Emory University School of Medicine's Carlos del Rio, MD, return to JAMA's Q&A series to discuss the latest in COVID-19 medicine and public health. Recorded March 15, 2021.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.3760"> COVID-19 in 2021—Continuing Uncertainty</a></li> <li><a href= "https://edhub.ama-assn.org/jn-learning/video-player/10.1001/jama.2021.3973"> Coronavirus Update With Carlos del Rio and Preeti Malani</a></li> <li><a href= "https://edhub.ama-assn.org/jn-learning/video-player/10.1001/jama.2021.3986"> Frequently Asked COVID Vaccine Questions</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Coronavirus trends, variants, vaccines, treatment, and more. JAMA Associate Editor Preeti Malani, MD, MSJ, also from the University of Michigan, and Emory University School of Medicine's Carlos del Rio, MD, return to JAMA's Q&A series to discuss the latest in COVID-19 medicine and public health. Recorded March 15, 2021.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.3760"> COVID-19 in 2021—Continuing Uncertainty</a></li> <li><a href= "https://edhub.ama-assn.org/jn-learning/video-player/10.1001/jama.2021.3973"> Coronavirus Update With Carlos del Rio and Preeti Malani</a></li> <li><a href= "https://edhub.ama-assn.org/jn-learning/video-player/10.1001/jama.2021.3986"> Frequently Asked COVID Vaccine Questions</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_Update_With_Carlos_del_Rio_and_Preeti_Malani.mp3?dest-id=90171" length="31525920" type="audio/mpeg" />
      <itunes:duration>32:46</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/6/6/6/266679dd3d401a77/JMI210073.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>A Conversation About Structural Racism in Medicine and Health Care</title>
      <itunes:title>A Conversation About Structural Racism in Medicine and Health Care</itunes:title>
      <pubDate>Thu, 18 Mar 2021 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[9b468cac-9382-44dd-bc3a-92ab5b8ac8c2]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/a-conversation-about-structural-racism-in-medicine-and-health-care]]></link>
      <description><![CDATA[<p>Lisa A. Cooper, MD, MPH, of Johns Hopkins University School of Medicine; Clyde W. Yancy, MD, MSc, of Northwestern University, and David R. Williams, PhD, MPH, of Harvard T.H. Chan School of Public Health, join JAMA Editor in Chief Howard Bauchner, MD, to discuss racism and structural racism in health care and medicine. Recorded March 16, 2021.</p>]]></description>
      
      <content:encoded><![CDATA[<p>Lisa A. Cooper, MD, MPH, of Johns Hopkins University School of Medicine; Clyde W. Yancy, MD, MSc, of Northwestern University, and David R. Williams, PhD, MPH, of Harvard T.H. Chan School of Public Health, join JAMA Editor in Chief Howard Bauchner, MD, to discuss racism and structural racism in health care and medicine. Recorded March 16, 2021.</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/A_Conversation_About_Structural_Racism_in_Medicine_and_Health_Care.mp3?dest-id=90171" length="35167814" type="audio/mpeg" />
      <itunes:duration>36:36</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/7/7/8/6778cb0ae6881227/JMI210061.jpeg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>National Initiatives to Prevent Myocardial Infarction and Stroke</title>
      <itunes:title>National Initiatives to Prevent Myocardial Infarction and Stroke</itunes:title>
      <pubDate>Fri, 12 Mar 2021 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[9f286624-c74b-4e76-8baf-660bbc90ab8a]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2021.2561]]></link>
      <description><![CDATA[<p>Interview with Thomas R. Frieden, MD, MPH, author of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.0905"> National Initiatives to Prevent Myocardial Infarction and Stroke</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Thomas R. Frieden, MD, MPH, author of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.0905"> National Initiatives to Prevent Myocardial Infarction and Stroke</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/National_Initiatives_to_Prevent_Myocardial_Infarction_and_Stroke.mp3?dest-id=90171" length="24995965" type="audio/mpeg" />
      <itunes:duration>20:47</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/f/3/2/3/f323fe7c7dbd1947/JVP210015.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation—Screening for Lung Cancer</title>
      <itunes:title>USPSTF Recommendation—Screening for Lung Cancer</itunes:title>
      <pubDate>Thu, 11 Mar 2021 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[f1be6afd-e612-4aa0-aed8-abe412c368ba]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2021.365]]></link>
      <description><![CDATA[<p>Interview with Michael J. Barry, MD, author of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.0364"> USPSTF Recommendation—Screening for Lung Cancer</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Michael J. Barry, MD, author of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.0364"> USPSTF Recommendation—Screening for Lung Cancer</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_RecommendationScreening_for_Lung_Cancer.mp3?dest-id=90171" length="27202597" type="audio/mpeg" />
      <itunes:duration>28:17</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/5/3/e/9/53e952acbe88fbff/JMI210022.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus Variants With John P. Moore</title>
      <itunes:title>Coronavirus Variants With John P. Moore</itunes:title>
      <pubDate>Mon, 08 Mar 2021 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[c4821629-eb81-4ee3-b527-522b80260bf7]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2021.3444]]></link>
      <description><![CDATA[<p>Genetic variants of the SARS-CoV-2 virus are emerging but so far do not seem to have caused breakthrough infections in people with previous infection or in those who have been vaccinated. John P. Moore, PhD, of Weill Medical College of Cornell University in New York, joins JAMA's Q&A series for an update on the latest variants and what you need to know. Recorded March 4, 2021.</p> <p>Related Article:</p> <p><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.3465"> Approaches for Optimal Use of Different COVID-19 Vaccines</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Genetic variants of the SARS-CoV-2 virus are emerging but so far do not seem to have caused breakthrough infections in people with previous infection or in those who have been vaccinated. John P. Moore, PhD, of Weill Medical College of Cornell University in New York, joins JAMA's Q&A series for an update on the latest variants and what you need to know. Recorded March 4, 2021.</p> <p>Related Article:</p> <p><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.3465"> Approaches for Optimal Use of Different COVID-19 Vaccines</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_Variants_With_John_P._Moore.mp3?dest-id=90171" length="40621158" type="audio/mpeg" />
      <itunes:duration>33:49</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/f/b/0/efb0c299baa5067d/JMI210069.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Will COVID-19 Become a Recurrent Seasonal Disease?</title>
      <itunes:title>Will COVID-19 Become a Recurrent Seasonal Disease?</itunes:title>
      <pubDate>Wed, 03 Mar 2021 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[f5b9708a-7541-4715-8078-d404746ec7de]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2021.2914]]></link>
      <description><![CDATA[<p>Interview with Christopher J.L. Murray, MD, DPhil, author of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.2828"> The Potential Future of the COVID-19 Pandemic: Will SARS-CoV-2 Become a Recurrent Seasonal Infection?</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Christopher J.L. Murray, MD, DPhil, author of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.2828"> The Potential Future of the COVID-19 Pandemic: Will SARS-CoV-2 Become a Recurrent Seasonal Infection?</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Will_COVID-19_Become_a_Recurrent_Seasonal_Disease_.mp3?dest-id=90171" length="34418851" type="audio/mpeg" />
      <itunes:duration>28:38</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/5/3/2/153253f1c27ccb49/JVP210033.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Funding of Pharmaceutical Innovation During and After the COVID-19 Pandemic</title>
      <itunes:title>Funding of Pharmaceutical Innovation During and After the COVID-19 Pandemic</itunes:title>
      <pubDate>Tue, 02 Mar 2021 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[65525401-2777-4b85-ab11-e9e659f7236b]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.27947]]></link>
      <description><![CDATA[<p>Interview with James C. Robinson, PhD, author of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.25384"> Funding of Pharmaceutical Innovation During and After the COVID-19 Pandemic</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with James C. Robinson, PhD, author of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.25384"> Funding of Pharmaceutical Innovation During and After the COVID-19 Pandemic</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Funding_of_Pharmaceutical_Innovation_During_and_After_the_COVID-19_Pandemic.mp3?dest-id=90171" length="20877678" type="audio/mpeg" />
      <itunes:duration>21:41</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/c/b/5/8cb56d5f81bf2328/JVP200255.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus Vaccine Update From the CDC With Nancy E. Messonnier, MD</title>
      <itunes:title>Coronavirus Vaccine Update From the CDC With Nancy E. Messonnier, MD</itunes:title>
      <pubDate>Tue, 02 Mar 2021 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[83310aa2-49ee-42ff-8af5-c5458d12aea0]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2021.3294]]></link>
      <description><![CDATA[<p>Nancy E. Messonnier, MD is director of the National Center for Immunization and Respiratory Diseases (NCIRD) at the Centers for Disease Control and Prevention (CDC) and leads the CDC's efforts on COVID-19 vaccination. She joins JAMA's Q&A series to discuss the agency's response to emerging coronavirus variants, the FDA advisory hearings on the new Johnson & Johnson vaccine, and other agency activities and priorities related to COVID-19 control. Recorded February 26, 2021.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.27124"> Genetic Variants of SARS-CoV-2—What Do They Mean?</a></li> <li><a href= "https://edhub.ama-assn.org/jn-learning/video-player/10.1001/jama.2021.3291"> Coronavirus Vaccine Update From the CDC With Nancy E. Messonnier, MD</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.1114"> SARS-CoV-2 Vaccines and the Growing Threat of Viral Variants</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.1101"> Experts Discuss COVID-19—Vaccine Doses, Virus Variants, and More</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.1612"> Emergence of a Novel SARS-CoV-2 Variant in Southern California</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.2294"> SARS-CoV-2 Variants of Concern in the United States</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.2264"> Pregnant People Getting Mixed Messages About COVID-19 Vaccines</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.2927"> The Johnson & Johnson Vaccine for COVID-19</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.2088"> SARS-CoV-2 Viral Variants—Tackling a Moving Target</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.1205"> Vaccine Distribution—Equity Left Behind?</a></li> <li><a href= "https://jamanetwork.com/channels/health-forum/fullarticle/10.1001/jamahealthforum.2021.0213"> Taking Vaccine to Where the Virus Is—Equity and Effectiveness in Coronavirus Vaccinations?</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Nancy E. Messonnier, MD is director of the National Center for Immunization and Respiratory Diseases (NCIRD) at the Centers for Disease Control and Prevention (CDC) and leads the CDC's efforts on COVID-19 vaccination. She joins JAMA's Q&A series to discuss the agency's response to emerging coronavirus variants, the FDA advisory hearings on the new Johnson & Johnson vaccine, and other agency activities and priorities related to COVID-19 control. Recorded February 26, 2021.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.27124"> Genetic Variants of SARS-CoV-2—What Do They Mean?</a></li> <li><a href= "https://edhub.ama-assn.org/jn-learning/video-player/10.1001/jama.2021.3291"> Coronavirus Vaccine Update From the CDC With Nancy E. Messonnier, MD</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.1114"> SARS-CoV-2 Vaccines and the Growing Threat of Viral Variants</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.1101"> Experts Discuss COVID-19—Vaccine Doses, Virus Variants, and More</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.1612"> Emergence of a Novel SARS-CoV-2 Variant in Southern California</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.2294"> SARS-CoV-2 Variants of Concern in the United States</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.2264"> Pregnant People Getting Mixed Messages About COVID-19 Vaccines</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.2927"> The Johnson & Johnson Vaccine for COVID-19</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.2088"> SARS-CoV-2 Viral Variants—Tackling a Moving Target</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.1205"> Vaccine Distribution—Equity Left Behind?</a></li> <li><a href= "https://jamanetwork.com/channels/health-forum/fullarticle/10.1001/jamahealthforum.2021.0213"> Taking Vaccine to Where the Virus Is—Equity and Effectiveness in Coronavirus Vaccinations?</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_Vaccine_Update_From_the_CDC_With_Nancy_E._Messonnier_MD.mp3?dest-id=90171" length="32507564" type="audio/mpeg" />
      <itunes:duration>33:49</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/6/d/3/86d30803cdf8787a/JMI210066.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Removing One Barrier to Opioid Use Disorder Treatment—Is It Enough?</title>
      <itunes:title>Removing One Barrier to Opioid Use Disorder Treatment—Is It Enough?</itunes:title>
      <pubDate>Thu, 25 Feb 2021 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[455f7ed7-cb01-4889-846b-045d5e9680b7]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2021.1927]]></link>
      <description><![CDATA[<p>Interview with Richard Saitz, MD, author of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.0958"> Removing One Barrier to Opioid Use Disorder Treatment: Is It Enough</a> and with Yngvild Olsen, MD, author of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.1741"> Overcoming Barriers to Treatment of Opioid Use Disorder</a></p> <p> </p> <p> </p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Richard Saitz, MD, author of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.0958"> Removing One Barrier to Opioid Use Disorder Treatment: Is It Enough</a> and with Yngvild Olsen, MD, author of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.1741"> Overcoming Barriers to Treatment of Opioid Use Disorder</a></p> <p> </p> <p> </p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Removing_One_Barrier_to_Opioid_Use_Disorder_TreatmentIs_It_Enough_.mp3?dest-id=90171" length="28437472" type="audio/mpeg" />
      <itunes:duration>29:33</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/f/2/6/9/f26940bc91eeb791/JMI210053.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>New Insights Into Plaque Erosion as a Mechanism of Acute Coronary Syndromes</title>
      <itunes:title>New Insights Into Plaque Erosion as a Mechanism of Acute Coronary Syndromes</itunes:title>
      <pubDate>Mon, 22 Feb 2021 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[8e644cdc-88ac-493c-af49-8623d61b2c96]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2021.527]]></link>
      <description><![CDATA[<p>Interview with Ik-Kyung Jang, MD, PhD, author of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.0069"> New Insights Into Plaque Erosion as a Mechanism of Acute Coronary Syndromes</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Ik-Kyung Jang, MD, PhD, author of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.0069"> New Insights Into Plaque Erosion as a Mechanism of Acute Coronary Syndromes</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/New_Insights_Into_Plaque_Erosion_as_a_Mechanism_of_Acute_Coronary_Syndromes.mp3?dest-id=90171" length="18637550" type="audio/mpeg" />
      <itunes:duration>19:21</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/d/b/3/0/db3030e0917e7dfc/JVP210006.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus Update With CDC Director Rochelle Walensky - February 17, 2021</title>
      <itunes:title>Coronavirus Update With CDC Director Rochelle Walensky - February 17, 2021</itunes:title>
      <pubDate>Fri, 19 Feb 2021 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[767e1ff2-7a34-490f-9a69-3f636aab2744]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2021.2340]]></link>
      <description><![CDATA[<p>CDC Director Rochelle P. Walensky, MD, MPH, returns to JAMA's Q&A series to discuss the agency's response to emerging SARS-CoV-2 variants, implications for the planned vaccine mobilization strategy, the upcoming Johnson & Johnson vaccine FDA advisory hearings, strategies for reopening K-12 schools, and other agency activities and priorities related to COVID-19 control. Recorded February 17, 2021.</p> <p>Related Article(s):</p> <ul> <li><a href= "https://edhub.ama-assn.org/jn-learning/video-player/10.1001/jama.2021.2338"> Coronavirus Update With CDC Director Rochelle Walensky - February 17, 2021</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.2294"> SARS-CoV-2 Variants of Concern in the United States—Challenges and Opportunities</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.2088"> SARS-CoV-2 Viral Variants—Tackling a Moving Target</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>CDC Director Rochelle P. Walensky, MD, MPH, returns to JAMA's Q&A series to discuss the agency's response to emerging SARS-CoV-2 variants, implications for the planned vaccine mobilization strategy, the upcoming Johnson & Johnson vaccine FDA advisory hearings, strategies for reopening K-12 schools, and other agency activities and priorities related to COVID-19 control. Recorded February 17, 2021.</p> <p>Related Article(s):</p> <ul> <li><a href= "https://edhub.ama-assn.org/jn-learning/video-player/10.1001/jama.2021.2338"> Coronavirus Update With CDC Director Rochelle Walensky - February 17, 2021</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.2294"> SARS-CoV-2 Variants of Concern in the United States—Challenges and Opportunities</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.2088"> SARS-CoV-2 Viral Variants—Tackling a Moving Target</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_Update_With_CDC_Director_Rochelle_Walensky_-_February_17_2021.mp3?dest-id=90171" length="29203796" type="audio/mpeg" />
      <itunes:duration>30:23</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/2/9/0/c2900e917ec35e04/JMI210058.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus Vaccine Update With Paul Offit – February 11, 2021</title>
      <itunes:title>Coronavirus Vaccine Update With Paul Offit – February 11, 2021</itunes:title>
      <pubDate>Mon, 15 Feb 2021 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[1da28250-7594-4d1c-a691-62417037bbbb]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2021.1827]]></link>
      <description><![CDATA[<p>Paul A. Offit, MD, of The Children's Hospital of Philadelphia returns to JAMA's Q&A series to provide an update on the emergence of COVID-19 variants and their implications for vaccine development, including the Johnson & Johnson vaccine, scheduled for a US Food and Drug Administration VRBPAC hearing on February 26, 2021. Recorded February 11, 2021.</p> <p>Related Article:</p> <p><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.1114"> SARS-CoV-2 Vaccines and the Growing Threat of Viral Variants</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Paul A. Offit, MD, of The Children's Hospital of Philadelphia returns to JAMA's Q&A series to provide an update on the emergence of COVID-19 variants and their implications for vaccine development, including the Johnson & Johnson vaccine, scheduled for a US Food and Drug Administration VRBPAC hearing on February 26, 2021. Recorded February 11, 2021.</p> <p>Related Article:</p> <p><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.1114"> SARS-CoV-2 Vaccines and the Growing Threat of Viral Variants</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_Vaccine_Update_With_Paul_Offit__February_11_2021.mp3?dest-id=90171" length="39149797" type="audio/mpeg" />
      <itunes:duration>32:35</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/b/2/9/b/b29b175fc2de3b4b/JMI210052.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus Vaccination in Pregnant and Breastfeeding Individuals</title>
      <itunes:title>Coronavirus Vaccination in Pregnant and Breastfeeding Individuals</itunes:title>
      <pubDate>Wed, 10 Feb 2021 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[cab91d37-7db1-4d00-8982-087daa03d6ea]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2021.1748]]></link>
      <description><![CDATA[<p>As US vaccine distribution expands to include younger healthier populations, questions about vaccine safety in women of childbearing age have become more urgent. University of Texas Southwestern Medical Center's Catherine Y. Spong, MD, and Emory University School of Medicine's Denise J. Jamieson, MD, MPH, both eminent obstetrician/gynecologists, join JAMA's Q&A series to discuss the safety of the Pfizer-BioNTech and Moderna vaccines in pregnant and nursing mothers, and in individuals trying to get pregnant. Recorded February 8, 2021.</p> <p>Related Article(s):</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.1683"> Pregnancy, Postpartum Care, and COVID-19 Vaccination in 2021</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.1658"> COVID-19 Vaccination in Pregnant and Lactating Women</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.1865"> Involving Pregnant Individuals in Clinical Research on COVID-19 Vaccines</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>As US vaccine distribution expands to include younger healthier populations, questions about vaccine safety in women of childbearing age have become more urgent. University of Texas Southwestern Medical Center's Catherine Y. Spong, MD, and Emory University School of Medicine's Denise J. Jamieson, MD, MPH, both eminent obstetrician/gynecologists, join JAMA's Q&A series to discuss the safety of the Pfizer-BioNTech and Moderna vaccines in pregnant and nursing mothers, and in individuals trying to get pregnant. Recorded February 8, 2021.</p> <p>Related Article(s):</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.1683"> Pregnancy, Postpartum Care, and COVID-19 Vaccination in 2021</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.1658"> COVID-19 Vaccination in Pregnant and Lactating Women</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.1865"> Involving Pregnant Individuals in Clinical Research on COVID-19 Vaccines</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_Vaccination_in_Pregnant_and_Breastfeeding_Individuals.mp3?dest-id=90171" length="32775174" type="audio/mpeg" />
      <itunes:duration>34:05</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/f/8/3/a/f83a2f2c122e91a0/JMI210050.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Mandating COVID-19 Vaccines—Ethical and Legal Considerations</title>
      <itunes:title>Mandating COVID-19 Vaccines—Ethical and Legal Considerations</itunes:title>
      <pubDate>Tue, 09 Feb 2021 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[fe89fb8d-38b3-4db8-9e77-6f50f4bd67e4]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.27441]]></link>
      <description><![CDATA[<p>Interview with Lawrence O. Gostin, JD, author of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.26553"> Mandating COVID-19 Vaccines</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Lawrence O. Gostin, JD, author of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.26553"> Mandating COVID-19 Vaccines</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Mandating_COVID-19_VaccinesEthical_and_Legal_Considerations.mp3?dest-id=90171" length="22699549" type="audio/mpeg" />
      <itunes:duration>23:35</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/2/9/c/e29c087277106edf/JVP200267.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus Variants - What They Mean</title>
      <itunes:title>Coronavirus Variants - What They Mean</itunes:title>
      <pubDate>Mon, 08 Feb 2021 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[53deea41-9d93-439f-be0a-720eb7c3ab11]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2021.1301]]></link>
      <description><![CDATA[<p>2021 has brought news of emerging SARS-CoV-2 genetic variants that increase transmissibility. Will they diminish vaccine efficacy and lead us to lose pandemic control? University of Michigan's Adam Lauring, MD, PhD, a molecular virologist who uses evolutionary theory to study viral transmission and pathogenesis, joins JAMA's Q&A series to explain the variants and what they mean for public health. Recorded February 4, 2021.</p> <p>Related Article(s):</p> <p><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.27124"> Genetic Variants of SARS-CoV-2—What Do They Mean?</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>2021 has brought news of emerging SARS-CoV-2 genetic variants that increase transmissibility. Will they diminish vaccine efficacy and lead us to lose pandemic control? University of Michigan's Adam Lauring, MD, PhD, a molecular virologist who uses evolutionary theory to study viral transmission and pathogenesis, joins JAMA's Q&A series to explain the variants and what they mean for public health. Recorded February 4, 2021.</p> <p>Related Article(s):</p> <p><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.27124"> Genetic Variants of SARS-CoV-2—What Do They Mean?</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_Variants_-_What_They_Mean.mp3?dest-id=90171" length="26642214" type="audio/mpeg" />
      <itunes:duration>27:42</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/d/4/0/1d40747a213f506e/JMI210044.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>The Triple Aim Applied to Correctional Health Systems</title>
      <itunes:title>The Triple Aim Applied to Correctional Health Systems</itunes:title>
      <pubDate>Mon, 08 Feb 2021 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[ad5d2520-7df9-42aa-9c78-56d12e481177]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2021.524]]></link>
      <description><![CDATA[<p>Interview with Donald Berwick, MD, author of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.0263"> The Triple Aim Applied to Correctional Health Systems</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Donald Berwick, MD, author of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.0263"> The Triple Aim Applied to Correctional Health Systems</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/The_Triple_Aim_Applied_to_Correctional_Health_Systems.mp3?dest-id=90171" length="15276944" type="audio/mpeg" />
      <itunes:duration>15:51</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/f/c/2/e/fc2e371c3d27bbd5/JVP210011.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus Update With Anthony Fauci – February 3, 2021</title>
      <itunes:title>Coronavirus Update With Anthony Fauci – February 3, 2021</itunes:title>
      <pubDate>Fri, 05 Feb 2021 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[a6677607-e980-47b8-aece-09b45748b5f5]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2021.957]]></link>
      <description><![CDATA[<p>NIAID Director Anthony S. Fauci, MD, returns to JAMA's Q&A series to discuss</p> <ul> <li>Shifts in the US pandemic response under the Biden administration</li> <li>Emerging genetic variants and implications for vaccine efficacy</li> <li>Prospects for new vaccine approvals and more.</li> </ul> <p>Related Article:</p> <p><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.21946"> Preventing the Spread of SARS-CoV-2 With Masks and Other "Low-tech" Interventions</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>NIAID Director Anthony S. Fauci, MD, returns to JAMA's Q&A series to discuss</p> <ul> <li>Shifts in the US pandemic response under the Biden administration</li> <li>Emerging genetic variants and implications for vaccine efficacy</li> <li>Prospects for new vaccine approvals and more.</li> </ul> <p>Related Article:</p> <p><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.21946"> Preventing the Spread of SARS-CoV-2 With Masks and Other "Low-tech" Interventions</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_Update_With_Anthony_Fauci__February_3_2021.mp3?dest-id=90171" length="28010189" type="audio/mpeg" />
      <itunes:duration>23:19</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/0/2/a/e02a56662ef77e58/JMI210039.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>When Physicians Engage in Practices That Threaten the Nation's Health</title>
      <itunes:title>When Physicians Engage in Practices That Threaten the Nation's Health</itunes:title>
      <pubDate>Thu, 04 Feb 2021 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[bc178db5-d01d-493b-89cb-d8ae1a26e330]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2021.472]]></link>
      <description><![CDATA[<p>Interview with Philip A. Pizzo, MD, author of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.0122"> When Physicians Engage in Practices That Threaten the Nation's Health</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Philip A. Pizzo, MD, author of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.0122"> When Physicians Engage in Practices That Threaten the Nation's Health</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/When_Physicians_Engage_in_Practices_That_Threaten_the_Nation_s_Health.mp3?dest-id=90171" length="22828812" type="audio/mpeg" />
      <itunes:duration>23:43</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/b/0/e/1/b0e10053b5612abd/JVP210008.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Ensuring Quality in the Era of Virtual Care</title>
      <itunes:title>Ensuring Quality in the Era of Virtual Care</itunes:title>
      <pubDate>Tue, 02 Feb 2021 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[a5f25f67-adf7-471e-9dec-150ea3e22681]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2021.25]]></link>
      <description><![CDATA[<p>Interview with Peter Pronovost, MD, PhD, author of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.24955"> Ensuring Quality in the Era of Virtual Care</a> and Abraham Verghese, MD, author of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.27304"> Virtual Care and Real Connection in the Era of COVID-19</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Peter Pronovost, MD, PhD, author of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.24955"> Ensuring Quality in the Era of Virtual Care</a> and Abraham Verghese, MD, author of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.27304"> Virtual Care and Real Connection in the Era of COVID-19</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Ensuring_Quality_in_the_Era_of_Virtual_Care.mp3?dest-id=90171" length="24644851" type="audio/mpeg" />
      <itunes:duration>25:36</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/4/3/4/5/4345b21e9ed88683/JMI210002.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Carotid Artery Stenosis</title>
      <itunes:title>USPSTF Recommendation: Carotid Artery Stenosis</itunes:title>
      <pubDate>Tue, 02 Feb 2021 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[be4f80a2-0fd1-4987-8ffb-4a9942e6187f]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.23695]]></link>
      <description><![CDATA[<p>Interview with Michael J. Barry, MD, USPSTF member and coauthor of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.23694"> USPSTF Recommendation: Carotid Artery Stenosis</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Michael J. Barry, MD, USPSTF member and coauthor of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.23694"> USPSTF Recommendation: Carotid Artery Stenosis</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation__Carotid_Artery_Stenosis.mp3?dest-id=90171" length="25404791" type="audio/mpeg" />
      <itunes:duration>21:08</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/a/7/2/8a72f801c7e693b5/JMI200264.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus Update With Peter Piot, MD, PhD</title>
      <itunes:title>Coronavirus Update With Peter Piot, MD, PhD</itunes:title>
      <pubDate>Mon, 01 Feb 2021 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[493fb35b-ca0c-445a-8179-04d28aaa3082]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2021.1108]]></link>
      <description><![CDATA[<p>Peter Piot, MD, PhD, director of The London School of Hygiene and Tropical Medicine, is a legend in global health, having been involved in identification of HIV and Ebola virus in Africa. He was founding executive director of UNAIDS and Under Secretary-General of the United Nations from 1995 to 2008. He joins JAMA's Q&A series to discuss the global public health response to COVID-19 past, present, and future. Recorded January 28, 2021.</p> <p>Related Article(s):</p> <p><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.21872"> The Challenges Ahead With Monoclonal Antibodies</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Peter Piot, MD, PhD, director of The London School of Hygiene and Tropical Medicine, is a legend in global health, having been involved in identification of HIV and Ebola virus in Africa. He was founding executive director of UNAIDS and Under Secretary-General of the United Nations from 1995 to 2008. He joins JAMA's Q&A series to discuss the global public health response to COVID-19 past, present, and future. Recorded January 28, 2021.</p> <p>Related Article(s):</p> <p><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.21872"> The Challenges Ahead With Monoclonal Antibodies</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_Update_With_Peter_Piot_MD_PhD.mp3?dest-id=90171" length="36929458" type="audio/mpeg" />
      <itunes:duration>38:26</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/e/8/9/9e894249293665d1/JMI210041.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Three Interventions to Address the US Pandemic of Firearm Injury and Death</title>
      <itunes:title>Three Interventions to Address the US Pandemic of Firearm Injury and Death</itunes:title>
      <pubDate>Tue, 26 Jan 2021 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[f00c172a-961b-4638-a7ca-e591a40d7528]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.25031]]></link>
      <description><![CDATA[<p>Interview with Frederick P. Rivara, MD, author of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.24206"> Three Interventions to Address the Other Pandemic—Firearm Injury and Death</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Frederick P. Rivara, MD, author of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.24206"> Three Interventions to Address the Other Pandemic—Firearm Injury and Death</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Three_Interventions_to_Address_the_US_Pandemic_of_Firearm_Injury_and_Death.mp3?dest-id=90171" length="19257214" type="audio/mpeg" />
      <itunes:duration>19:59</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/6/8/d/c68d61261085f3e2/JVP200246.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Recalibrating the Use of Race in Medical Research</title>
      <itunes:title>Recalibrating the Use of Race in Medical Research</itunes:title>
      <pubDate>Mon, 25 Jan 2021 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[8f8905ab-0588-405d-b54c-90bd1080c6fb]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2021.733]]></link>
      <description><![CDATA[<p>Interview with John P A Ioannidis, MD, DSC, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.0003"> Recalibrating the Use of Race in Medical Research</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with John P A Ioannidis, MD, DSC, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.0003"> Recalibrating the Use of Race in Medical Research</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Recalibrating_the_Use_of_Race_in_Medical_Research.mp3?dest-id=90171" length="24126087" type="audio/mpeg" />
      <itunes:duration>20:03</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/4/8/f/5/48f5c32742b94ee2/JVP210001.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Health Care Reform in the Biden Era</title>
      <itunes:title>Health Care Reform in the Biden Era</itunes:title>
      <pubDate>Mon, 25 Jan 2021 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[645220bb-a735-48db-9e83-b87a694df259]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.25781]]></link>
      <description><![CDATA[<p>President Biden has released a health care plan that proposes reducing the age of eligibility for Medicare to 60 years and introducing a public option. Larry Levitt, MPP, Executive Vice President for Health Policy at the Kaiser Family Foundation, JAMA Associate Editor Karen Joynt Maddox, MD, MPH, Co-Director of the Center for Health Economics and Policy (CHEP) at Washington University School of Medicine, and Lawrence O. Gostin, JD, from the O'Neill Institute for National and Global Health Law at Georgetown University discuss prospects for health care reform under the new administration. Recorded January 21, 2021.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2021.0050"> Moving Patient Care Forward in the Biden Era</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>President Biden has released a health care plan that proposes reducing the age of eligibility for Medicare to 60 years and introducing a public option. Larry Levitt, MPP, Executive Vice President for Health Policy at the Kaiser Family Foundation, JAMA Associate Editor Karen Joynt Maddox, MD, MPH, Co-Director of the Center for Health Economics and Policy (CHEP) at Washington University School of Medicine, and Lawrence O. Gostin, JD, from the O'Neill Institute for National and Global Health Law at Georgetown University discuss prospects for health care reform under the new administration. Recorded January 21, 2021.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2021.0050"> Moving Patient Care Forward in the Biden Era</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Health_Care_Reform_in_the_Biden_Era.mp3?dest-id=90171" length="35316330" type="audio/mpeg" />
      <itunes:duration>36:45</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/6/5/d/165d94a5d25ac588/JMI200288.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus Vaccine Update with Paul Offit and Robert Wachter</title>
      <itunes:title>Coronavirus Vaccine Update with Paul Offit and Robert Wachter</itunes:title>
      <pubDate>Thu, 21 Jan 2021 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[e57d5154-c0d3-49d7-a601-d8dbc2d85af5]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2021.460]]></link>
      <description><![CDATA[<p>To get more vaccine to more people more efficiently, UCSF School of Medicine's Robert M. Wachter, MD, recently urged giving a single dose now and deferring the second dose until more vaccine is available. Paul A. Offit, MD, of The Children's Hospital of Philadelphia, disagrees. The two discuss the pros and the cons of the plan and alternative responses to road bumps in the US vaccine rollout, on JAMA's live Q&A series. Recorded January 19, 2021.</p> <p>Related Article:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.12190"> Developing a SARS-CoV-2 Vaccine at Warp Speed</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>To get more vaccine to more people more efficiently, UCSF School of Medicine's Robert M. Wachter, MD, recently urged giving a single dose now and deferring the second dose until more vaccine is available. Paul A. Offit, MD, of The Children's Hospital of Philadelphia, disagrees. The two discuss the pros and the cons of the plan and alternative responses to road bumps in the US vaccine rollout, on JAMA's live Q&A series. Recorded January 19, 2021.</p> <p>Related Article:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.12190"> Developing a SARS-CoV-2 Vaccine at Warp Speed</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_Vaccine_Update_with_Paul_Offit_and_Robert_Wachter.mp3?dest-id=90171" length="51628400" type="audio/mpeg" />
      <itunes:duration>43:00</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/f/3/6/b/f36b482a06b6240a/JMI210029.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus Update With CDC Director Rochelle Walensky</title>
      <itunes:title>Coronavirus Update With CDC Director Rochelle Walensky</itunes:title>
      <pubDate>Thu, 21 Jan 2021 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[3c234c1b-5a17-4747-9453-b54b3c8d5b87]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2021.444]]></link>
      <description><![CDATA[<p>Incoming Centers for Disease Control and Prevention (CDC) Director Rochelle P. Walensky, MD, MPH, returns to JAMA's Q&A series to discuss her vision and priorities for the agency and changes in its pandemic response strategies, when she takes the reins on January 20. Recorded January 19, 2021.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.24243"> All-Cause Excess Mortality and COVID-19–Related Mortality Among US Adults Aged 25-44 Years, March-July 2020</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Incoming Centers for Disease Control and Prevention (CDC) Director Rochelle P. Walensky, MD, MPH, returns to JAMA's Q&A series to discuss her vision and priorities for the agency and changes in its pandemic response strategies, when she takes the reins on January 20. Recorded January 19, 2021.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.24243"> All-Cause Excess Mortality and COVID-19–Related Mortality Among US Adults Aged 25-44 Years, March-July 2020</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_Update_With_CDC_Director_Rochelle_Walensky.mp3?dest-id=90171" length="20599825" type="audio/mpeg" />
      <itunes:duration>21:26</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/4/a/2/d/4a2dd7e6df9fbeb2/JMI210027.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Thrombolysis Before Thrombectomy for Stroke</title>
      <itunes:title>Thrombolysis Before Thrombectomy for Stroke</itunes:title>
      <pubDate>Tue, 19 Jan 2021 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[416c28c4-c1dc-4c82-93d9-0dc3b4ae57bc]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2021.276]]></link>
      <description><![CDATA[<p>Intravenous thrombolysis (IVT) and endovascular thrombectomy (EVT) both improve outcomes for patients with acute ischemic stroke. Jeffrey L. Saver, MD, director of UCLA's Comprehensive Stroke and Vascular Neurology Program and a JAMA Associate Editor, discusses 2 randomized trials comparing outcomes for stroke patients treated with IVT prior to EVT vs EVT alone.</p> <p>Related Article:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.22388"> Intravenous Thrombolysis Before Endovascular Thrombectomy for Acute Ischemic Stroke</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Intravenous thrombolysis (IVT) and endovascular thrombectomy (EVT) both improve outcomes for patients with acute ischemic stroke. Jeffrey L. Saver, MD, director of UCLA's Comprehensive Stroke and Vascular Neurology Program and a JAMA Associate Editor, discusses 2 randomized trials comparing outcomes for stroke patients treated with IVT prior to EVT vs EVT alone.</p> <p>Related Article:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.22388"> Intravenous Thrombolysis Before Endovascular Thrombectomy for Acute Ischemic Stroke</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Thrombolysis_Before_Thrombectomy_for_Stroke.mp3?dest-id=90171" length="26189975" type="audio/mpeg" />
      <itunes:duration>21:48</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/a/c/1/6ac134d11c63e28d/JMI210016.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Public Health Messaging in an Era of Social Media</title>
      <itunes:title>Public Health Messaging in an Era of Social Media</itunes:title>
      <pubDate>Tue, 19 Jan 2021 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[0e729cc7-6067-4aa6-acc7-31ec99fff7a2]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.25029]]></link>
      <description><![CDATA[<p>Interview with Raina M. Merchant, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.24514"> Public Health Messaging in an Era of Social Media</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Raina M. Merchant, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.24514"> Public Health Messaging in an Era of Social Media</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Public_Health_Messaging_in_an_Era_of_Social_Media.mp3?dest-id=90171" length="22970595" type="audio/mpeg" />
      <itunes:duration>23:52</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/8/e/f/68ef7c4e2cd307f2/JVP200248.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Tobacco Cessation in Adults</title>
      <itunes:title>USPSTF Recommendation: Tobacco Cessation in Adults</itunes:title>
      <pubDate>Tue, 19 Jan 2021 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[1af7bda4-0d7d-43a5-a8f9-aecd43a65a30]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.23693]]></link>
      <description><![CDATA[<p>Interview with Michael Silverstein, MD, MPH, USPSTF member and coauthor of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.23692"> USPSTF Recommendation: Tobacco Cessation in Adults</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Michael Silverstein, MD, MPH, USPSTF member and coauthor of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.23692"> USPSTF Recommendation: Tobacco Cessation in Adults</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation__Tobacco_Cessation_in_Adults.mp3?dest-id=90171" length="20538478" type="audio/mpeg" />
      <itunes:duration>17:06</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/8/a/b/68ab8d5f81769e5d/JMI200263.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus Critical Care Update With Lennie Derde and Christopher Seymour</title>
      <itunes:title>Coronavirus Critical Care Update With Lennie Derde and Christopher Seymour</itunes:title>
      <pubDate>Fri, 15 Jan 2021 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[b9fd1187-9e5d-4da0-b151-4a6f9e1f3c93]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2021.96]]></link>
      <description><![CDATA[<p>The COVID-19 pandemic has prompted scientists to use adaptive research designs to evaluate potential treatments simultaneously and efficiently, increasing the likelihood that patients will receive treatments most likely to be effective for them. Lennie Derde, MD, of University Medical Center Utrecht in the Netherlands and JAMA Associate Editor Christopher W. Seymour, MD, of University of Pittsburgh Medical Center join JAMA's Q&A series to discuss the latest in critical care management of COVID-19 patients and emerging treatment strategies and therapies. Recorded January 13, 2021.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.20271"> Sensible Medicine-Optimizing the Trade-off Between Learning and Doing in a Pandemic</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>The COVID-19 pandemic has prompted scientists to use adaptive research designs to evaluate potential treatments simultaneously and efficiently, increasing the likelihood that patients will receive treatments most likely to be effective for them. Lennie Derde, MD, of University Medical Center Utrecht in the Netherlands and JAMA Associate Editor Christopher W. Seymour, MD, of University of Pittsburgh Medical Center join JAMA's Q&A series to discuss the latest in critical care management of COVID-19 patients and emerging treatment strategies and therapies. Recorded January 13, 2021.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.20271"> Sensible Medicine-Optimizing the Trade-off Between Learning and Doing in a Pandemic</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_Critical_Care_Update_With_Lennie_Derde_and_Christopher_Seymour.mp3?dest-id=90171" length="31457623" type="audio/mpeg" />
      <itunes:duration>32:43</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/d/5/2/7/d52737156f132f4b/JMI210010.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus Vaccine Update With Arnold S. Monto, MD</title>
      <itunes:title>Coronavirus Vaccine Update With Arnold S. Monto, MD</itunes:title>
      <pubDate>Wed, 13 Jan 2021 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[f7fdd9e1-405e-4784-bc94-b4be3816b87d]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2021.152]]></link>
      <description><![CDATA[<p>Arnold S. Monto, MD, chaired the US Food and Drug Administration's Vaccines and Related Biological Products Advisory Committee (VRBPAC) meetings in December that led to Emergency Use Authorization (EUA) of the Pfizer/BioNTech and Moderna vaccines. He joins JAMA's Q&A series from the University of Michigan School of Public Health to discuss experience to date with the 2 products and what's next in vaccine development. Recorded January 11, 2021.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.24075"> Experts Discuss COVID-19: Vaccine Allocation, Placebo Groups, and More</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Arnold S. Monto, MD, chaired the US Food and Drug Administration's Vaccines and Related Biological Products Advisory Committee (VRBPAC) meetings in December that led to Emergency Use Authorization (EUA) of the Pfizer/BioNTech and Moderna vaccines. He joins JAMA's Q&A series from the University of Michigan School of Public Health to discuss experience to date with the 2 products and what's next in vaccine development. Recorded January 11, 2021.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.24075"> Experts Discuss COVID-19: Vaccine Allocation, Placebo Groups, and More</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_Vaccine_Update_With_Arnold_S._Monto_MD.mp3?dest-id=90171" length="29290656" type="audio/mpeg" />
      <itunes:duration>30:29</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/8/0/2/6802a0a97df7adbe/JMI210014.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Diversifying Medical Education</title>
      <itunes:title>Diversifying Medical Education</itunes:title>
      <pubDate>Fri, 08 Jan 2021 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[0cb0d019-c4b2-4b27-b7e2-658a6d4e55de]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.24024]]></link>
      <description><![CDATA[<p>Increasing the number of physicians who are Black, Hispanic/Latinx, and Indigenous benefits everyone in the US, but it cannot be the sole responsibility of historically Black colleges and universities (HBCUs). Valerie Montgomery Rice, MD, president and dean of Morehouse School of Medicine (MSM), and Clyde W. Yancy, MD, of Northwestern Medicine, join JAMA Editor in Chief Howard Bauchner, MD, to discuss options for developing training pipelines of underrepresented minority health science students, and how academic medicine can make racial justice a part of its work and mission. Recorded January 5, 2021.</p> <p>Related Article:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.12532"> Academic Medicine and Black Lives Matter</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Increasing the number of physicians who are Black, Hispanic/Latinx, and Indigenous benefits everyone in the US, but it cannot be the sole responsibility of historically Black colleges and universities (HBCUs). Valerie Montgomery Rice, MD, president and dean of Morehouse School of Medicine (MSM), and Clyde W. Yancy, MD, of Northwestern Medicine, join JAMA Editor in Chief Howard Bauchner, MD, to discuss options for developing training pipelines of underrepresented minority health science students, and how academic medicine can make racial justice a part of its work and mission. Recorded January 5, 2021.</p> <p>Related Article:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.12532"> Academic Medicine and Black Lives Matter</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Diversifying_Medical_Education.mp3?dest-id=90171" length="47434143" type="audio/mpeg" />
      <itunes:duration>39:30</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/b/7/9/3b796b1ab80d46f7/JMI200267.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>To Err Is Human: 20 Years of Health Care Quality</title>
      <itunes:title>To Err Is Human: 20 Years of Health Care Quality</itunes:title>
      <pubDate>Thu, 31 Dec 2020 18:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[a5e82aab-20f7-4fcd-a2d3-dd187c54f794]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.23360]]></link>
      <description><![CDATA[<p>The National Academy of Medicine's 2000 report "To Err Is Human" launched the health care quality movement in the US. Victor Dzau, MD, president of the National Academy of Medicine, and Don Berwick, MD, MPP, from the Institute for Healthcare Improvement, discuss progress to date in advancing quality and prospects for improving outcomes and reducing harms, errors, and cost in the next 20 years. Recorded December 22, 2020.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.23151"> Two Decades Since To Err Is Human</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>The National Academy of Medicine's 2000 report "To Err Is Human" launched the health care quality movement in the US. Victor Dzau, MD, president of the National Academy of Medicine, and Don Berwick, MD, MPP, from the Institute for Healthcare Improvement, discuss progress to date in advancing quality and prospects for improving outcomes and reducing harms, errors, and cost in the next 20 years. Recorded December 22, 2020.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.23151"> Two Decades Since To Err Is Human</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/To_Err_Is_Human__20_Years_of_Health_Care_Quality.mp3?dest-id=90171" length="28149376" type="audio/mpeg" />
      <itunes:duration>29:17</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/7/d/b/8/7db81a4bd7043470/JMI200253.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Digital Health—The Need to Assess Benefits, Risks, and Value</title>
      <itunes:title>Digital Health—The Need to Assess Benefits, Risks, and Value</itunes:title>
      <pubDate>Mon, 28 Dec 2020 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[93a3e16a-5459-4305-88f2-34b74527977e]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.25023]]></link>
      <description><![CDATA[<p>Interview with Geoffrey S. Ginsburg, MD, PhD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.22919"> Digital Health—The Need to Assess Benefits, Risks, and Value</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Geoffrey S. Ginsburg, MD, PhD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.22919"> Digital Health—The Need to Assess Benefits, Risks, and Value</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Digital_HealthThe_Need_to_Assess_Benefits_Risks_and_Value.mp3?dest-id=90171" length="19393569" type="audio/mpeg" />
      <itunes:duration>20:08</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/f/4/2/e/f42efd5aa7a458f1/JVP200240.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>COVID-19 Vaccines and Herd Immunity</title>
      <itunes:title>COVID-19 Vaccines and Herd Immunity</itunes:title>
      <pubDate>Mon, 21 Dec 2020 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[49bc55cc-a37d-40f4-8c6b-9e5a4446ef83]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.25414]]></link>
      <description><![CDATA[<p>With coronavirus vaccines now available, what are the timeline and prospects for "herd immunity" and return to a new normal? Marc Lipsitch, DPhil, of Harvard T.H. Chan School of Public Health returns to JAMA's Q&A series with Paul D. Biddinger, MD, director of Massachusetts General Hospital's Center for Disaster Medicine, to discuss. Recorded December 17, 2020.</p> <p>Related Article(s):</p> <ul> <li><a href= "https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.25412"> COVID-19 Vaccines and Herd Immunity</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.25053"> The Ethics of Continuing Placebo in SARS-CoV-2 Vaccine Trials</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.25127"> Evaluating SARS-CoV-2 Vaccines After Emergency Use Authorization or Licensing of Initial Candidate Vaccines</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.20892"> Herd Immunity and Implications for SARS-CoV-2 Control</a></li> <li><a href= "https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.22332"> Herd Immunity as a Coronavirus Pandemic Strategy</a></li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>With coronavirus vaccines now available, what are the timeline and prospects for "herd immunity" and return to a new normal? Marc Lipsitch, DPhil, of Harvard T.H. Chan School of Public Health returns to JAMA's Q&A series with Paul D. Biddinger, MD, director of Massachusetts General Hospital's Center for Disaster Medicine, to discuss. Recorded December 17, 2020.</p> <p>Related Article(s):</p> <ul> <li><a href= "https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.25412"> COVID-19 Vaccines and Herd Immunity</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.25053"> The Ethics of Continuing Placebo in SARS-CoV-2 Vaccine Trials</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.25127"> Evaluating SARS-CoV-2 Vaccines After Emergency Use Authorization or Licensing of Initial Candidate Vaccines</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.20892"> Herd Immunity and Implications for SARS-CoV-2 Control</a></li> <li><a href= "https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.22332"> Herd Immunity as a Coronavirus Pandemic Strategy</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/COVID-19_Vaccines_and_Herd_Immunity.mp3?dest-id=90171" length="58102104" type="audio/mpeg" />
      <itunes:duration>48:17</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/7/0/1/2/701277334a8fd6c6/JMI200283.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus Vaccine FDA Update</title>
      <itunes:title>Coronavirus Vaccine FDA Update</itunes:title>
      <pubDate>Wed, 16 Dec 2020 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[5193749f-6469-4b90-b7d7-21289755412a]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.25582]]></link>
      <description><![CDATA[<p>Peter W. Marks, MD, PhD, and Stephen M. Hahn, MD, return to JAMA's Q&A series to discuss the Pfizer/BioNTech and Moderna vaccines: the data, the weekend's EUA designation (Pfizer/BioNTech), and the process for future full licensure and postmarketing safety surveillance.</p> <p>Dr Marks directs the US FDA's Center for Biologics Evaluation and Research (CBER).<br /> <br /> Dr Hahn is commissioner of the US Food and Drug Administration.<br /> <br /> Recorded December 14, 2020.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.24036"> Behaviorally Informed Strategies for a National COVID-19 Vaccine Promotion Program</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Peter W. Marks, MD, PhD, and Stephen M. Hahn, MD, return to JAMA's Q&A series to discuss the Pfizer/BioNTech and Moderna vaccines: the data, the weekend's EUA designation (Pfizer/BioNTech), and the process for future full licensure and postmarketing safety surveillance.</p> <p>Dr Marks directs the US FDA's Center for Biologics Evaluation and Research (CBER). Dr Hahn is commissioner of the US Food and Drug Administration. Recorded December 14, 2020.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.24036"> Behaviorally Informed Strategies for a National COVID-19 Vaccine Promotion Program</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_Vaccine_FDA_Update.mp3?dest-id=90171" length="24557055" type="audio/mpeg" />
      <itunes:duration>25:33</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/7/3/5/1/73513fd8b6653ac6/JMI200286.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Trust in Health Care in the Time of COVID-19</title>
      <itunes:title>Trust in Health Care in the Time of COVID-19</itunes:title>
      <pubDate>Tue, 15 Dec 2020 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[ef5f0279-6155-46f2-80e7-a29d880f7f6e]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.24963]]></link>
      <description><![CDATA[<p>Interview with David W. Baker, MD, MPH, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.23343"> Trust in Health Care in the Time of COVID-19</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with David W. Baker, MD, MPH, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.23343"> Trust in Health Care in the Time of COVID-19</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Trust_in_Health_Care_in_the_Time_of_COVID-19.mp3?dest-id=90171" length="20544486" type="audio/mpeg" />
      <itunes:duration>21:20</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/b/1/f/6/b1f6a7ec1f065dae/-CDB450x.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus Vaccine Update With Anthony Fauci</title>
      <itunes:title>Coronavirus Vaccine Update With Anthony Fauci</itunes:title>
      <pubDate>Tue, 15 Dec 2020 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[a7281625-b691-4c2d-ad93-5f2cbfaf513f]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.25111]]></link>
      <description><![CDATA[<p>Anthony S. Fauci, MD, returns to JAMA's Q&A series to discuss the Pfizer/BioNTech and Moderna vaccines: the public data, deliberations at Thursday's FDA Advisory Committee meeting, and prospects for an agency Emergency Use Authorization designation, licensure, and rollout. Recorded December 11, 2020.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.0757"> Coronavirus Infections—More Than Just the Common Cold</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Anthony S. Fauci, MD, returns to JAMA's Q&A series to discuss the Pfizer/BioNTech and Moderna vaccines: the public data, deliberations at Thursday's FDA Advisory Committee meeting, and prospects for an agency Emergency Use Authorization designation, licensure, and rollout. Recorded December 11, 2020.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.0757"> Coronavirus Infections—More Than Just the Common Cold</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_Vaccine_Update_With_Anthony_Fauci.mp3?dest-id=90171" length="29664693" type="audio/mpeg" />
      <itunes:duration>30:50</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/7/0/9/67093029417af390/JMI200277.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Screening for Hepatitis B Virus Infection in Adolescents and Adults</title>
      <itunes:title>USPSTF Recommendation: Screening for Hepatitis B Virus Infection in Adolescents and Adults</itunes:title>
      <pubDate>Tue, 15 Dec 2020 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[e84895b2-7b36-45c8-aaaa-096cefacdc57]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.18955]]></link>
      <description><![CDATA[<p>Interview with Chyke A. Doubeni, MD, MPH, USPSTF member and coauthor of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.18954"> USPSTF Recommendation: Screening for Hepatitis B Virus Infection in Adolescents and Adults</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Chyke A. Doubeni, MD, MPH, USPSTF member and coauthor of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.18954"> USPSTF Recommendation: Screening for Hepatitis B Virus Infection in Adolescents and Adults</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation__Screening_for_Hepatitis_B_Virus_Infection_in_Adolescents_and_Adults.mp3?dest-id=90171" length="20212429" type="audio/mpeg" />
      <itunes:duration>16:49</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/7/b/c/d/7bcdc2be5da2eb0e/JMI200203.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>The COVID Tracking Project</title>
      <itunes:title>The COVID Tracking Project</itunes:title>
      <pubDate>Fri, 11 Dec 2020 23:35:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[385e7ecb-3f94-4a88-ba7a-fa11a2359a74]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.25274]]></link>
      <description><![CDATA[<p>The COVID Tracking Project, launched by The Atlantic, collects and publishes data required to understand the COVID-19 outbreak in the US, including data on race and ethnicity needed to understand health inequities in the outbreak.</p> <p>Atlantic Monthly journalists Alexis C. Madrigal and Erin Kissane join JAMA's Q&A series to describe the project and their experience developing a database for fact-based health reporting on the pandemic.</p> <p>Recorded December 10, 2020.</p>]]></description>
      
      <content:encoded><![CDATA[<p>The COVID Tracking Project, launched by The Atlantic, collects and publishes data required to understand the COVID-19 outbreak in the US, including data on race and ethnicity needed to understand health inequities in the outbreak.</p> <p>Atlantic Monthly journalists Alexis C. Madrigal and Erin Kissane join JAMA's Q&A series to describe the project and their experience developing a database for fact-based health reporting on the pandemic.</p> <p>Recorded December 10, 2020.</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/The_COVID_Tracking_Project.mp3?dest-id=90171" length="39936492" type="audio/mpeg" />
      <itunes:duration>33:16</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/1/6/1/216194cd6eee43c0/JMI200280.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Asthma Guidelines Update 2020 - Diagnosis and Management</title>
      <itunes:title>Asthma Guidelines Update 2020 - Diagnosis and Management</itunes:title>
      <pubDate>Thu, 10 Dec 2020 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[733c4cdb-b3e6-4e53-af80-ba1da5d89039]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.23509]]></link>
      <description><![CDATA[<p>The National Asthma Education and Prevention Program (NAEPP) of the NIH has updated its guideline recommendations for diagnosis and treatment of asthma patients. Michelle M. Cloutier, MD, from UConn Health, Stephanie Lovinsky-Desir, MD, of Columbia University Irving Medical Center, and JAMA Associate Editor George O'Connor, MD, MS, from Boston Medical Center join JAMA's Q&A series to discuss what's new, including revised advice about</p> <p>• Use of intermittent inhaled corticosteroids (ICSs)</p> <p>• Use of add-on long-acting muscarinic antagonists (LAMAs)</p> <p>• Use of fractional exhaled nitric oxide (FeNO) measurement as a diagnostic biomarker</p> <p>• Monitoring response to therapy</p> <p>• Indoor allergen mitigation strategies</p> <p>• Safety and efficacy of subcutaneous and sublingual immunotherapy</p> <p>• Use of bronchial thermoplasty</p> <p>Recorded December 8, 2020</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.21974"> Managing Asthma in Adolescents and Adults</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>The National Asthma Education and Prevention Program (NAEPP) of the NIH has updated its guideline recommendations for diagnosis and treatment of asthma patients. Michelle M. Cloutier, MD, from UConn Health, Stephanie Lovinsky-Desir, MD, of Columbia University Irving Medical Center, and JAMA Associate Editor George O'Connor, MD, MS, from Boston Medical Center join JAMA's Q&A series to discuss what's new, including revised advice about</p> <p>• Use of intermittent inhaled corticosteroids (ICSs)</p> <p>• Use of add-on long-acting muscarinic antagonists (LAMAs)</p> <p>• Use of fractional exhaled nitric oxide (FeNO) measurement as a diagnostic biomarker</p> <p>• Monitoring response to therapy</p> <p>• Indoor allergen mitigation strategies</p> <p>• Safety and efficacy of subcutaneous and sublingual immunotherapy</p> <p>• Use of bronchial thermoplasty</p> <p>Recorded December 8, 2020</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.21974"> Managing Asthma in Adolescents and Adults</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Asthma_Guidelines_Update_2020_-_Diagnosis_and_Management.mp3?dest-id=90171" length="39356519" type="audio/mpeg" />
      <itunes:duration>40:56</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/f/3/3/ef3368f324c8cb3d/JMI200257.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus Vaccine Update With Paul Offit</title>
      <itunes:title>Coronavirus Vaccine Update With Paul Offit</itunes:title>
      <pubDate>Fri, 04 Dec 2020 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[156ec342-1312-4c0d-8435-8e4cd15d41f2]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.24370]]></link>
      <description><![CDATA[<p>With the Pfizer and Moderna coronavirus vaccines reportedly under review at the US FDA for Emergency Use Authorization (EUA), Paul A. Offit, MD, of the Children's Hospital of Philadelphia, returns to JAMA's Q&A series to provide an update on what to expect, prospects for vaccine rollout and distribution in the coming months, and ongoing safety surveillance. Recorded December 2, 2020.</p> <p>Related Article:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.12190"> Developing a SARS-CoV-2 Vaccine at Warp Speed</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>With the Pfizer and Moderna coronavirus vaccines reportedly under review at the US FDA for Emergency Use Authorization (EUA), Paul A. Offit, MD, of the Children's Hospital of Philadelphia, returns to JAMA's Q&A series to provide an update on what to expect, prospects for vaccine rollout and distribution in the coming months, and ongoing safety surveillance. Recorded December 2, 2020.</p> <p>Related Article:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.12190"> Developing a SARS-CoV-2 Vaccine at Warp Speed</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_Vaccine_Update_With_Paul_Offit.mp3?dest-id=90171" length="35700184" type="audio/mpeg" />
      <itunes:duration>29:44</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/9/4/9/1949e2af4ecb27b5/JMI200270pia_prod.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Health Policy in the Supreme Court and a New Conservative Majority</title>
      <itunes:title>Health Policy in the Supreme Court and a New Conservative Majority</itunes:title>
      <pubDate>Tue, 01 Dec 2020 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[9266174f-34af-48b2-9afc-7ee7b4af0ec1]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.23052]]></link>
      <description><![CDATA[<p>Interview with Lawrence O. Gostin, JD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.21987"> Health Policy in the Supreme Court and a New Conservative Majority</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Lawrence O. Gostin, JD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.21987"> Health Policy in the Supreme Court and a New Conservative Majority</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Health_Policy_in_the_Supreme_Court_and_a_New_Conservative_Majority.mp3?dest-id=90171" length="37627733" type="audio/mpeg" />
      <itunes:duration>31:18</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/9/6/0/a96031638689063c/JVP200234.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus Update with Nicholas Christakis</title>
      <itunes:title>Coronavirus Update with Nicholas Christakis</itunes:title>
      <pubDate>Wed, 25 Nov 2020 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[0213f1cf-4baa-4e0d-9de6-e35ac5da1a03]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.23631]]></link>
      <description><![CDATA[<p>Yale Sterling Professor Nicholas A. Christakis, MD, PhD, MPH, returns to JAMA's Q&A series to discuss the surge in US cases and other recent pandemic developments. Dr Christakis is author of the recently published book "Apollo's Arrow: The Profound and Enduring Impact of Coronavirus on the Way We Live." Recorded November 23, 2020.</p> <p> </p>]]></description>
      
      <content:encoded><![CDATA[<p>Yale Sterling Professor Nicholas A. Christakis, MD, PhD, MPH, returns to JAMA's Q&A series to discuss the surge in US cases and other recent pandemic developments. Dr Christakis is author of the recently published book "Apollo's Arrow: The Profound and Enduring Impact of Coronavirus on the Way We Live." Recorded November 23, 2020.</p> <p> </p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_Update_with_Nicholas_Christakis.mp3?dest-id=90171" length="43870532" type="audio/mpeg" />
      <itunes:duration>45:40</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/a/b/c/2abcf3308e1602ed/JMI200262.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors</title>
      <itunes:title>Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors</itunes:title>
      <pubDate>Tue, 24 Nov 2020 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[fd829fe6-08de-4219-84b5-6db6f1a9160c]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.18949]]></link>
      <description><![CDATA[<p>Interview with Martha Y. Kubik, PhD, RN, USPSTF member and coauthor of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.18948"> Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Martha Y. Kubik, PhD, RN, USPSTF member and coauthor of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.18948"> Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Healthy_Diet_and_Physical_Activity_for_Cardiovascular_Disease_Prevention_in_Adults_With_Cardiovascular_Risk_Factors.mp3?dest-id=90171" length="17847379" type="audio/mpeg" />
      <itunes:duration>14:50</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/e/c/a/0eca132dac2bca06/JMI200202.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>COVID-19 Update—Critical Care and Pandemic Response</title>
      <itunes:title>COVID-19 Update—Critical Care and Pandemic Response</itunes:title>
      <pubDate>Mon, 23 Nov 2020 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[0081e2c1-e245-44e0-bdc9-e3ba16740cd1]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.23468]]></link>
      <description><![CDATA[<p>In the midst of rising COVID-19 case rates globally, Derek C. Angus, MD, MPH, and Rochelle P. Walensky, MD, MPH, return to JAMA's Q&A series to update viewers on developments in the pandemic and the critical care management of COVID-19 patients. Dr Angus is Chief Health Care Innovation Officer at the University of Pittsburgh Medical Center, professor and chair of Critical Care Medicine, and a senior JAMA editor. Dr Walensky is Chief of Infectious Diseases at Massachusetts General Hospital and a professor at Harvard Medical School. Recorded November 19, 2020.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.4984"> Optimizing the Trade-off Between Learning and Doing in a Pandemic</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>In the midst of rising COVID-19 case rates globally, Derek C. Angus, MD, MPH, and Rochelle P. Walensky, MD, MPH, return to JAMA's Q&A series to update viewers on developments in the pandemic and the critical care management of COVID-19 patients. Dr Angus is Chief Health Care Innovation Officer at the University of Pittsburgh Medical Center, professor and chair of Critical Care Medicine, and a senior JAMA editor. Dr Walensky is Chief of Infectious Diseases at Massachusetts General Hospital and a professor at Harvard Medical School. Recorded November 19, 2020.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.4984"> Optimizing the Trade-off Between Learning and Doing in a Pandemic</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/COVID-19_UpdateCritical_Care_and_Pandemic_Response.mp3?dest-id=90171" length="33062293" type="audio/mpeg" />
      <itunes:duration>34:24</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/f/4/a/6f4a6ab8c494d928/JMI200255.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Older Adults and the Mental Health Effects of COVID-19</title>
      <itunes:title>Older Adults and the Mental Health Effects of COVID-19</itunes:title>
      <pubDate>Fri, 20 Nov 2020 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[39c726fd-c2f8-428f-81ae-ec2742622f6f]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.23313]]></link>
      <description><![CDATA[<p>Interview with Ipsit V. Vahia, MD, author of Older Adults and the Mental Health Effects of COVID-19</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.21753"> Older Adults and the Mental Health Effects of COVID-19</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Ipsit V. Vahia, MD, author of Older Adults and the Mental Health Effects of COVID-19</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.21753"> Older Adults and the Mental Health Effects of COVID-19</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Older_Adults_and_the_Mental_Health_Effects_of_COVID-19.mp3?dest-id=90171" length="21859050" type="audio/mpeg" />
      <itunes:duration>22:42</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/b/c/1/2bc1138d2059a327/JVP200231.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Heritable Human Genome Editing (HHGE)—The International Commission Report</title>
      <itunes:title>Heritable Human Genome Editing (HHGE)—The International Commission Report</itunes:title>
      <pubDate>Tue, 17 Nov 2020 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[22ee3e64-637d-41f9-a84a-dac293b6c6a5]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.21549]]></link>
      <description><![CDATA[<p>Interview with Eli Y. Adashi, MD, MS, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.19059"> Heritable Human Genome Editing: The International Commission Report</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Eli Y. Adashi, MD, MS, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.19059"> Heritable Human Genome Editing: The International Commission Report</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Heritable_Human_Genome_Editing_HHGEThe_International_Commission_Report.mp3?dest-id=90171" length="21617845" type="audio/mpeg" />
      <itunes:duration>22:27</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/b/c/3/e/bc3e46e93177d70c/JVP200205.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Herd Immunity as a Coronavirus Pandemic Strategy</title>
      <itunes:title>Herd Immunity as a Coronavirus Pandemic Strategy</itunes:title>
      <pubDate>Wed, 11 Nov 2020 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[14bf1a7c-9c1d-4035-92ca-09eafd95ee5d]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.22334]]></link>
      <description><![CDATA[<p>Would letting coronavirus infect the broad US and global population be a safe and effective means of ending the COVID-19 pandemic? Jay Bhattacharya, MD, PhD, of Stanford University's Center for Primary Care and Outcomes Research is a signatory of the "Great Barrington Declaration," which proposes to "allow those at minimal risk of death to live their lives normally to build up immunity to the virus through natural infection, while better protecting those who are at highest risk." Marc Lipsitch, PhD, of the Harvard T.H. Chan School of Public Health, a signatory of the "John Snow Memorandum," which refutes the argument, responds.</p> <p>Related Article:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.20892"> Herd Immunity and Implications for SARS-CoV-2 Control</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Would letting coronavirus infect the broad US and global population be a safe and effective means of ending the COVID-19 pandemic? Jay Bhattacharya, MD, PhD, of Stanford University's Center for Primary Care and Outcomes Research is a signatory of the "Great Barrington Declaration," which proposes to "allow those at minimal risk of death to live their lives normally to build up immunity to the virus through natural infection, while better protecting those who are at highest risk." Marc Lipsitch, PhD, of the Harvard T.H. Chan School of Public Health, a signatory of the "John Snow Memorandum," which refutes the argument, responds.</p> <p>Related Article:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.20892"> Herd Immunity and Implications for SARS-CoV-2 Control</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Herd_Immunity_as_a_Coronavirus_Pandemic_Strategy.mp3?dest-id=90171" length="63570049" type="audio/mpeg" />
      <itunes:duration>52:51</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/4/c/1/84c10a480b4a3a3a/JMI200244.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus and US State Departments of Health</title>
      <itunes:title>Coronavirus and US State Departments of Health</itunes:title>
      <pubDate>Wed, 11 Nov 2020 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[80c07972-dbbc-4ffc-acb0-43488c5a8626]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.22904]]></link>
      <description><![CDATA[<p>Ngozi O. Ezike, MD, director of the Illinois Department of Public Health, discusses state and regional management of the COVID-19 pandemic. Recorded November 9, 2020.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.15271"> Universal Masking in the United States</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Ngozi O. Ezike, MD, director of the Illinois Department of Public Health, discusses state and regional management of the COVID-19 pandemic. Recorded November 9, 2020.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.15271"> Universal Masking in the United States</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_and_US_State_Departments_of_Health.mp3?dest-id=90171" length="27371477" type="audio/mpeg" />
      <itunes:duration>28:30</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/a/d/d/8addf8286eb8d82a/JMI200247.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Screening for Hypertension in Children and Adolescents</title>
      <itunes:title>USPSTF Recommendation: Screening for Hypertension in Children and Adolescents</itunes:title>
      <pubDate>Tue, 10 Nov 2020 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[da256625-86d5-4b89-ac6c-a2822fcc265b]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.18950]]></link>
      <description><![CDATA[<p>Interview with Michael Silverstein, MD, USPSTF member and coauthor of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.11119"> Screening for Hypertension in Children and Adolescents</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Michael Silverstein, MD, USPSTF member and coauthor of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.11119"> Screening for Hypertension in Children and Adolescents</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation__Screening_for_Hypertension_in_Children_and_Adolescents.mp3?dest-id=90171" length="19086650" type="audio/mpeg" />
      <itunes:duration>19:49</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/d/5/7/2/d572a20134402d33/-CDB450x.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Long-term Health Consequences of COVID-19</title>
      <itunes:title>Long-term Health Consequences of COVID-19</itunes:title>
      <pubDate>Tue, 03 Nov 2020 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[d48018b2-eb9b-4868-be0d-0713da140e6a]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.20677]]></link>
      <description><![CDATA[<p>Interview with Carlos del Rio, MD, author of Long-term Health Consequences of COVID-19</p> <p>Related Article:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.19719"> Long-term Health Consequences of COVID-19</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Carlos del Rio, MD, author of Long-term Health Consequences of COVID-19</p> <p>Related Article:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.19719"> Long-term Health Consequences of COVID-19</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Long-term_Health_Consequences_of_COVID-19.mp3?dest-id=90171" length="30988451" type="audio/mpeg" />
      <itunes:duration>25:46</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/8/9/7/38975d8499b95f6d/JVP200214.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus Update With Anthony Fauci - October 28, 2020</title>
      <itunes:title>Coronavirus Update With Anthony Fauci - October 28, 2020</itunes:title>
      <pubDate>Fri, 30 Oct 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[3aee82f7-808f-438b-ac6e-f87800576930]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.21692]]></link>
      <description><![CDATA[<p>Anthony S. Fauci, MD, returns to JAMA's Q&A series to discuss the latest developments in the COVID-19 pandemic, including the continued importance of nonpharmaceutical interventions (masking, handwashing, physical distancing) for managing rising case numbers in the US and globally. Recorded October 28, 2020.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.21946"> Preventing the Spread of SARS-CoV-2 With Masks and Other "Low-tech" Interventions</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Anthony S. Fauci, MD, returns to JAMA's Q&A series to discuss the latest developments in the COVID-19 pandemic, including the continued importance of nonpharmaceutical interventions (masking, handwashing, physical distancing) for managing rising case numbers in the US and globally. Recorded October 28, 2020.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.21946"> Preventing the Spread of SARS-CoV-2 With Masks and Other "Low-tech" Interventions</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_Update_With_Anthony_Fauci_-_October_28_2020.mp3?dest-id=90171" length="26990559" type="audio/mpeg" />
      <itunes:duration>28:05</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/1/3/f/313f0a5177a2c46e/JMI200238.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus Vaccine Update With Paul A. Offit, MD</title>
      <itunes:title>Coronavirus Vaccine Update With Paul A. Offit, MD</itunes:title>
      <pubDate>Thu, 29 Oct 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[b2ebd8ce-73c1-4409-a68f-6d84f4134576]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.22274]]></link>
      <description><![CDATA[<p>Paul A. Offit, MD, of the Children's Hospital of Philadelphia, returns to JAMA's Q&A series to provide an update on progress in COVID-19 vaccine development. Recorded October 27, 2020.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.12190"> Developing a SARS-CoV-2 Vaccine at Warp Speed</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Paul A. Offit, MD, of the Children's Hospital of Philadelphia, returns to JAMA's Q&A series to provide an update on progress in COVID-19 vaccine development. Recorded October 27, 2020.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.12190"> Developing a SARS-CoV-2 Vaccine at Warp Speed</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_Vaccine_Update_With_Paul_A._Offit_MD.mp3?dest-id=90171" length="24974527" type="audio/mpeg" />
      <itunes:duration>25:59</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus Update With Rochelle Walensky, MD, MPH</title>
      <itunes:title>Coronavirus Update With Rochelle Walensky, MD, MPH</itunes:title>
      <pubDate>Mon, 26 Oct 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[93c8a923-b755-4e33-b314-56dece736a8e]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.21960]]></link>
      <description><![CDATA[<p>Rochelle P. Walensky, MD, MPH, of Harvard Medical School and Massachusetts General Hospital returns to JAMA's COVID-19 Q&A to provide an update on developments in the pandemic. She is a signatory of the recent John Snow Memorandum emphasizing the importance of public health interventions to manage the spread of COVID-19. Recorded October 22, 2020.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.21946"> Preventing the Spread of SARS-CoV-2 With Masks and Other "Low-tech" Interventions</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Rochelle P. Walensky, MD, MPH, of Harvard Medical School and Massachusetts General Hospital returns to JAMA's COVID-19 Q&A to provide an update on developments in the pandemic. She is a signatory of the recent John Snow Memorandum emphasizing the importance of public health interventions to manage the spread of COVID-19. Recorded October 22, 2020.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.21946"> Preventing the Spread of SARS-CoV-2 With Masks and Other "Low-tech" Interventions</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_Update_With_Rochelle_Walensky_MD_MPH.mp3?dest-id=90171" length="31770705" type="audio/mpeg" />
      <itunes:duration>32:58</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/f/1/c/a/f1cae6dd3af9a6f9/JMI200240.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Clinical Genome Sequencing—The Importance of Implementation Data</title>
      <itunes:title>Clinical Genome Sequencing—The Importance of Implementation Data</itunes:title>
      <pubDate>Mon, 26 Oct 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[739af384-4441-45ee-9345-201f05200c64]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.21047]]></link>
      <description><![CDATA[<p>Interview with Kathryn A. Phillips, PhD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.19933"> Expanding Use of Clinical Genome Sequencing and the Need for More Data on Implementation</a></p> <p> </p> <p>Related content:</p> <p><a href="https://www.fndsociety.org/" target="_blank" rel= "noopener">Functional Neurological Disorder Society</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Kathryn A. Phillips, PhD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.19933"> Expanding Use of Clinical Genome Sequencing and the Need for More Data on Implementation</a></p> <p> </p> <p>Related content:</p> <p><a href="https://www.fndsociety.org/" target="_blank" rel= "noopener">Functional Neurological Disorder Society</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Clinical_Genome_SequencingThe_Importance_of_Implementation_Data.mp3?dest-id=90171" length="17929482" type="audio/mpeg" />
      <itunes:duration>18:36</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/1/f/3/91f3d9f29be47860/JVP200216.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>The Costs of Coronavirus</title>
      <itunes:title>The Costs of Coronavirus</itunes:title>
      <pubDate>Thu, 22 Oct 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[65f6da34-2bc2-4043-82ba-e221ffeb094a]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.19671]]></link>
      <description><![CDATA[<p>The costs of the coronavirus pandemic are unprecedented in their dimensions:</p> <p>David M. Cutler, PhD, of Harvard University discusses financial costs: the $16 trillion virus.</p> <p>Lisa Cooper, MD, MPH, of Johns Hopkins University discusses the costs to communities of color in excess deaths and bereavement.</p> <p>Charles R. Marmar, MD, of NYU Grossman School of Medicine discusses the mental health costs. Recorded October 20, 2020.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.19759"> The COVID-19 Pandemic and the $16 Trillion Virus</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>The costs of the coronavirus pandemic are unprecedented in their dimensions:</p> <p>David M. Cutler, PhD, of Harvard University discusses financial costs: the $16 trillion virus.</p> <p>Lisa Cooper, MD, MPH, of Johns Hopkins University discusses the costs to communities of color in excess deaths and bereavement.</p> <p>Charles R. Marmar, MD, of NYU Grossman School of Medicine discusses the mental health costs. Recorded October 20, 2020.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.19759"> The COVID-19 Pandemic and the $16 Trillion Virus</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/The_Costs_of_Coronavirus.mp3?dest-id=90171" length="32855750" type="audio/mpeg" />
      <itunes:duration>34:05</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/3/a/b/a3abd79b10d9675c/JMI200211.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus Q&amp;A With Andy Slavitt, MBA</title>
      <itunes:title>Coronavirus Q&amp;A With Andy Slavitt, MBA</itunes:title>
      <pubDate>Wed, 21 Oct 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[ad8b9d5c-3226-42a5-b369-80f124869520]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.20979]]></link>
      <description><![CDATA[<p>Andy Slavitt, MBA, discusses recent developments in the COVID-19 pandemic and the US response. Slavitt is former Acting CMS Administrator in the Obama administration, board director at the United States of Care in Washington, DC, and a Distinguished Health Policy Fellow at the Leonard Davis Institute of Health Economics at the University of Pennsylvania in Philadelphia. Recorded October 16, 2020.</p> <p>Related Article:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jamahealthforum.2020.0839"> The COVID-19 Pandemic Underscores the Need to Address Structural Challenges of the US Health Care System</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Andy Slavitt, MBA, discusses recent developments in the COVID-19 pandemic and the US response. Slavitt is former Acting CMS Administrator in the Obama administration, board director at the United States of Care in Washington, DC, and a Distinguished Health Policy Fellow at the Leonard Davis Institute of Health Economics at the University of Pennsylvania in Philadelphia. Recorded October 16, 2020.</p> <p>Related Article:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jamahealthforum.2020.0839"> The COVID-19 Pandemic Underscores the Need to Address Structural Challenges of the US Health Care System</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_QA_With_Andy_Slavitt_MBA.mp3?dest-id=90171" length="43903302" type="audio/mpeg" />
      <itunes:duration>45:37</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/2/7/6/e2763d0841f808e3/JMI200227.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Prioritizing Racial and Ethnic Minority Populations for Coronavirus Vaccination</title>
      <itunes:title>Prioritizing Racial and Ethnic Minority Populations for Coronavirus Vaccination</itunes:title>
      <pubDate>Fri, 16 Oct 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[99771876-a775-42c8-bb59-2cb430b7d970]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.20527]]></link>
      <description><![CDATA[<p>The National Academy of Medicine has recommended that racial minority populations receive priority for vaccination because they have been hard hit by the pandemic and are "worse off" socioeconomically. US law is inconsistent on whether race/ethnicity can be an explicit criterion for achieving equity and diversity. Lawrence O. Gostin, JD, of Georgetown University and Michelle A. Williams, ScD, of Harvard T.H. Chan School of Public Health discuss ways to achieve the public health objective of protecting vulnerable communities while adhering to law and ethics. Recorded October 14, 2020.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.20571"> Is It Lawful and Ethical to Prioritize Racial Minorities for COVID-19 Vaccines?</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>The National Academy of Medicine has recommended that racial minority populations receive priority for vaccination because they have been hard hit by the pandemic and are "worse off" socioeconomically. US law is inconsistent on whether race/ethnicity can be an explicit criterion for achieving equity and diversity. Lawrence O. Gostin, JD, of Georgetown University and Michelle A. Williams, ScD, of Harvard T.H. Chan School of Public Health discuss ways to achieve the public health objective of protecting vulnerable communities while adhering to law and ethics. Recorded October 14, 2020.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.20571"> Is It Lawful and Ethical to Prioritize Racial Minorities for COVID-19 Vaccines?</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Prioritizing_Racial_and_Ethnic_Minority_Populations_for_Coronavirus_Vaccination.mp3?dest-id=90171" length="30178059" type="audio/mpeg" />
      <itunes:duration>31:20</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/a/a/0/1aa0fcabe388cf41/JMI200219.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Sensible Medicine—Balancing Intervention and Inaction During the COVID-19 Pandemic</title>
      <itunes:title>Sensible Medicine—Balancing Intervention and Inaction During the COVID-19 Pandemic</itunes:title>
      <pubDate>Thu, 15 Oct 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[490b06af-1f8a-42c7-9f96-6709256eaefb]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.20679]]></link>
      <description><![CDATA[<p>Interview with Christopher W. Seymour, MD, MSc, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.20271"> Sensible Medicine—Balancing Intervention and Inaction During the COVID-19 Pandemic</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Christopher W. Seymour, MD, MSc, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.20271"> Sensible Medicine—Balancing Intervention and Inaction During the COVID-19 Pandemic</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Sensible_MedicineBalancing_Intervention_and_Inaction_During_the_COVID-19_Pandemic.mp3?dest-id=90171" length="20499876" type="audio/mpeg" />
      <itunes:duration>21:17</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/7/b/9/37b9f0027d236ec4/JVP200218.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>The Surgeon General's Call to Action to Control Hypertension</title>
      <itunes:title>The Surgeon General's Call to Action to Control Hypertension</itunes:title>
      <pubDate>Fri, 09 Oct 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[16938e0c-0214-4fc7-8db4-273e79024555]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.20698]]></link>
      <description><![CDATA[<p>The US Surgeon General's office has released a report emphasizing the importance of making hypertension control a national public health priority. Vice Admiral Jerome Adams, MD, MPH, the 20th US Surgeon General, discusses the report's background and recommendations. Recorded October 7, 2020.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.20356"> A National Commitment to Improve the Care of Patients With Hypertension in the US</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>The US Surgeon General's office has released a report emphasizing the importance of making hypertension control a national public health priority. Vice Admiral Jerome Adams, MD, MPH, the 20th US Surgeon General, discusses the report's background and recommendations. Recorded October 7, 2020.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.20356"> A National Commitment to Improve the Care of Patients With Hypertension in the US</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/The_Surgeon_Generals_Call_to_Action_to_Control_Hypertension.mp3?dest-id=90171" length="22663532" type="audio/mpeg" />
      <itunes:duration>23:31</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/5/d/5/35d59506bdadce31/JMI200223.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus Vaccine Update From the FDA</title>
      <itunes:title>Coronavirus Vaccine Update From the FDA</itunes:title>
      <pubDate>Wed, 07 Oct 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[8d6fa641-0f8c-45b6-94ff-2cca8a57be2b]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.20694]]></link>
      <description><![CDATA[<p>Peter Marks, MD, PhD, directs the US FDA's Center for Biologics Evaluation and Research (CBER) and will "call the balls and strikes" on any COVID-19 vaccine, according to FDA Commissioner Stephen Hahn. He joins JAMA Editor Howard Bauchner, MD, for an update on vaccine progress to date and prospects for pre-election political interference in the FDA approval process. Recorded October 5, 2020.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.15725"> Unwavering Regulatory Safeguards for COVID-19 Vaccines</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Peter Marks, MD, PhD, directs the US FDA's Center for Biologics Evaluation and Research (CBER) and will "call the balls and strikes" on any COVID-19 vaccine, according to FDA Commissioner Stephen Hahn. He joins JAMA Editor Howard Bauchner, MD, for an update on vaccine progress to date and prospects for pre-election political interference in the FDA approval process. Recorded October 5, 2020.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.15725"> Unwavering Regulatory Safeguards for COVID-19 Vaccines</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_Vaccine_Update_From_the_FDA.mp3?dest-id=90171" length="31259330" type="audio/mpeg" />
      <itunes:duration>32:26</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/d/f/f/adfff3af20c10b73/JMI200221.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Who Gets Coronavirus Vaccine First?</title>
      <itunes:title>Who Gets Coronavirus Vaccine First?</itunes:title>
      <pubDate>Wed, 07 Oct 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[d1015639-5848-4ecd-a0dd-b254d3ef45b2]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.20743]]></link>
      <description><![CDATA[<p>On October 2 the US National Academies of Science, Engineering, and Medicine issued its consensus Framework for Equitable Allocation of a COVID-19 Vaccine. William H. Foege, MD, MPH, emeritus distinguished professor of International Health at the Rollins School of Public Health at Emory University, cochaired the committee that authored the report and discusses its recommendations. Recorded October 2, 2020.</p> <p>Related Article:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.18513"> Fairly Prioritizing Groups for Access to COVID-19 Vaccines</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>On October 2 the US National Academies of Science, Engineering, and Medicine issued its consensus Framework for Equitable Allocation of a COVID-19 Vaccine. William H. Foege, MD, MPH, emeritus distinguished professor of International Health at the Rollins School of Public Health at Emory University, cochaired the committee that authored the report and discusses its recommendations. Recorded October 2, 2020.</p> <p>Related Article:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.18513"> Fairly Prioritizing Groups for Access to COVID-19 Vaccines</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Who_Gets_Coronavirus_Vaccine_First_.mp3?dest-id=90171" length="34206967" type="audio/mpeg" />
      <itunes:duration>35:32</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/4/6/f/946f5f2642c5a652/JMI200225.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>De-Adopting Low-Value Care—Evidence, Eminence, and Economics</title>
      <itunes:title>De-Adopting Low-Value Care—Evidence, Eminence, and Economics</itunes:title>
      <pubDate>Fri, 02 Oct 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[ce099bec-732a-4991-8e6b-8b4fc64a7c4f]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.17636]]></link>
      <description><![CDATA[<p>Interview with William H. Shrank, MD, author of De-adopting Low-Value Care: Evidence, Eminence, and Economics</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.17534"> De-adopting Low-Value Care</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with William H. Shrank, MD, author of De-adopting Low-Value Care: Evidence, Eminence, and Economics</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.17534"> De-adopting Low-Value Care</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/De-Adopting_Low-Value_CareEvidence_Eminence_and_Economics.mp3?dest-id=90171" length="24332560" type="audio/mpeg" />
      <itunes:duration>25:17</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/3/6/d/936dfece21e91f09/JVP200195.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus Q&amp;A With Anthony Fauci, MD – September 25, 2020</title>
      <itunes:title>Coronavirus Q&amp;A With Anthony Fauci, MD – September 25, 2020</itunes:title>
      <pubDate>Tue, 29 Sep 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[cc0d8209-1b7e-45af-bd8e-a8dfb3266541]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.19516]]></link>
      <description><![CDATA[<p>Anthony S. Fauci, MD, returns to JAMA's Q&A series to discuss the latest developments in the COVID-19 pandemic. Recorded September 25, 2020.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.18860"> Reassuring the Public and Clinical Community About the Scientific Review and Approval of a COVID-19 Vaccine</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Anthony S. Fauci, MD, returns to JAMA's Q&A series to discuss the latest developments in the COVID-19 pandemic. Recorded September 25, 2020.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.18860"> Reassuring the Public and Clinical Community About the Scientific Review and Approval of a COVID-19 Vaccine</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_QA_With_Anthony_Fauci_MD__September_25_2020.mp3?dest-id=90171" length="35881938" type="audio/mpeg" />
      <itunes:duration>37:15</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/0/0/9/80097749374ea3b8/JMI200207.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus Update With Michael T. Osterholm, PhD, MPH</title>
      <itunes:title>Coronavirus Update With Michael T. Osterholm, PhD, MPH</itunes:title>
      <pubDate>Fri, 25 Sep 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[d6ce26df-fd06-4769-857e-db35edc30990]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.19764]]></link>
      <description><![CDATA[<p>Michael T. Osterholm, PhD, MPH, returns to JAMA's Coronavirus Q&A series to discuss the latest developments in the COVID-19 pandemic. He is director of the Center for Infectious Disease Research and Policy (CIDRAP) at University of Minnesota and a veteran of pandemic planning. Recorded September 23, 2020.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.18513"> Fairly Prioritizing Groups for Access to COVID-19 Vaccines</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Michael T. Osterholm, PhD, MPH, returns to JAMA's Coronavirus Q&A series to discuss the latest developments in the COVID-19 pandemic. He is director of the Center for Infectious Disease Research and Policy (CIDRAP) at University of Minnesota and a veteran of pandemic planning. Recorded September 23, 2020.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.18513"> Fairly Prioritizing Groups for Access to COVID-19 Vaccines</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_Update_With_Michael_T._Osterholm_PhD_MPH.mp3?dest-id=90171" length="28913144" type="audio/mpeg" />
      <itunes:duration>30:01</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/c/d/f/9cdff49f701d9051/JMI200213.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>COVID-19 Vaccine Approval and the FDA</title>
      <itunes:title>COVID-19 Vaccine Approval and the FDA</itunes:title>
      <pubDate>Wed, 23 Sep 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[6d876a3c-fd62-4bde-9e66-20a6258480ee]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.18991]]></link>
      <description><![CDATA[<p>Hydroxychloroquine and convalescent plasma approvals by the FDA under Emergency Use Authorization (EUA) protocols have raised concerns the agency is under withering political pressure to fast-track a COVID-19 vaccine before it is proven safe and effective. Joshua Sharfstein, MD, Johns Hopkins Bloomberg School of Public Health, and JAMA Associate Editor Preeti Malani, MD, University of Michigan, discuss implications for public health and policy responses to ensure vaccine safety. Recorded September 18, 2020.</p> <p>Related Article:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.18860"> Reassuring the Public and Clinical Community About the Scientific Review and Approval of a COVID-19 Vaccine</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Hydroxychloroquine and convalescent plasma approvals by the FDA under Emergency Use Authorization (EUA) protocols have raised concerns the agency is under withering political pressure to fast-track a COVID-19 vaccine before it is proven safe and effective. Joshua Sharfstein, MD, Johns Hopkins Bloomberg School of Public Health, and JAMA Associate Editor Preeti Malani, MD, University of Michigan, discuss implications for public health and policy responses to ensure vaccine safety. Recorded September 18, 2020.</p> <p>Related Article:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.18860"> Reassuring the Public and Clinical Community About the Scientific Review and Approval of a COVID-19 Vaccine</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/COVID-19_Vaccine_Approval_and_the_FDA.mp3?dest-id=90171" length="34596157" type="audio/mpeg" />
      <itunes:duration>35:55</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/f/e/c/2/fec2fc6cf5dafa32/JMI200205.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Regulatory Decision-making on COVID-19 Vaccines During a Public Health Emergency</title>
      <itunes:title>Regulatory Decision-making on COVID-19 Vaccines During a Public Health Emergency</itunes:title>
      <pubDate>Tue, 15 Sep 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[fb5dd75f-b2b0-4dc2-93b1-a7c30b90f830]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.17570]]></link>
      <description><![CDATA[<p>Interview with Aaron S. Kesselheim, MD, author of Regulatory Decision-making on COVID-19 Vaccines During a Public Health Emergency</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.17101"> Regulatory Decision-making on COVID-19 Vaccines During a Public Health Emergency</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Aaron S. Kesselheim, MD, author of Regulatory Decision-making on COVID-19 Vaccines During a Public Health Emergency</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.17101"> Regulatory Decision-making on COVID-19 Vaccines During a Public Health Emergency</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Regulatory_Decision-making_on_COVID-19_Vaccines_During_a_Public_Health_Emergency.mp3?dest-id=90171" length="20748821" type="audio/mpeg" />
      <itunes:duration>21:33</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/0/f/4/80f4ce1a97462b57/JVP200191.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Hypertension, Obesity, and COVID-19</title>
      <itunes:title>Hypertension, Obesity, and COVID-19</itunes:title>
      <pubDate>Mon, 14 Sep 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[4e573a3e-3950-4fb9-9944-f94ad14e8f89]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.17689]]></link>
      <description><![CDATA[<p>New data show unfavorable US trends in hypertension and obesity, with communities of color doing worse. National Institute of Diabetes and Digestive and Kidney Diseases Director Griffin P. Rodgers, MD, and National Heart, Lung, and Blood Institute Director Gary H. Gibbons, MD, discuss the implications for COVID-19 outcomes and public health. Recorded September 10, 2020.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.14545"> Trends in Blood Pressure Control Among US Adults With Hypertension, 1999-2000 to 2017-2018</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>New data show unfavorable US trends in hypertension and obesity, with communities of color doing worse. National Institute of Diabetes and Digestive and Kidney Diseases Director Griffin P. Rodgers, MD, and National Heart, Lung, and Blood Institute Director Gary H. Gibbons, MD, discuss the implications for COVID-19 outcomes and public health. Recorded September 10, 2020.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.14545"> Trends in Blood Pressure Control Among US Adults With Hypertension, 1999-2000 to 2017-2018</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Hypertension_Obesity_and_COVID-19.mp3?dest-id=90171" length="32943990" type="audio/mpeg" />
      <itunes:duration>33:28</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/3/1/0/3310ba113348d43b/JMI200199_4.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Algorithmic Stewardship for Artificial Intelligence and Machine Learning Technologies</title>
      <itunes:title>Algorithmic Stewardship for Artificial Intelligence and Machine Learning Technologies</itunes:title>
      <pubDate>Mon, 14 Sep 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[5b5e73f3-77cf-4e84-84f0-e58945005456]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.15991]]></link>
      <description><![CDATA[<p>Interview with Atul J Butte, MD, PhD, author of The Case for Algorithmic Stewardship for Artificial Intelligence and Machine Learning Technologies</p> <p>Related Article:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.9371"> The Case for Algorithmic Stewardship for Artificial Intelligence and Machine Learning Technologies</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Atul J Butte, MD, PhD, author of The Case for Algorithmic Stewardship for Artificial Intelligence and Machine Learning Technologies</p> <p>Related Article:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.9371"> The Case for Algorithmic Stewardship for Artificial Intelligence and Machine Learning Technologies</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Algorithmic_Stewardship_for_Artificial_Intelligence_and_Machine_Learning_Technologies.mp3?dest-id=90171" length="21441533" type="audio/mpeg" />
      <itunes:duration>22:16</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/5/a/c/c/5acc1f6da7e8f224/JVP200118.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Changing Language to Improve Physician Communication About Treatment Decisions</title>
      <itunes:title>Changing Language to Improve Physician Communication About Treatment Decisions</itunes:title>
      <pubDate>Tue, 08 Sep 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[36ee92c5-8a0b-41ad-ac18-427bde3abf5b]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.14135]]></link>
      <description><![CDATA[<p>Interview with Deborah Korenstein, MD, and Daniel J. Morgan, MD, author of Improving Physician Communication About Treatment Decisions: Reconsideration of "Risks vs Benefits"</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.0354"> Improving Physician Communication About Treatment Decisions</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Deborah Korenstein, MD, and Daniel J. Morgan, MD, author of Improving Physician Communication About Treatment Decisions: Reconsideration of "Risks vs Benefits"</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.0354"> Improving Physician Communication About Treatment Decisions</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Changing_Language_to_Improve_Physician_Communication_About_Treatment_Decisions.mp3?dest-id=90171" length="57453771" type="audio/mpeg" />
      <itunes:duration>23:55</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/0/e/a/c0ea92317fac318f/JVP200004.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Corticosteroids for COVID-19: New Evidence of Benefit</title>
      <itunes:title>Corticosteroids for COVID-19: New Evidence of Benefit</itunes:title>
      <pubDate>Fri, 04 Sep 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[02259cd0-3fa9-40f5-88c0-2883922bcf49]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.17046]]></link>
      <description><![CDATA[<p>A conversation with Jonathan A. C. Sterne, MA, MSc, PhD, of the University of Bristol, Todd W. Rice, MD, MSc, of Vanderbilt University, and Janet V. Diaz, MD, of the World Health Organization (WHO) on the latest research supporting the use of hydrocortisone and dexamethasone for treatment of COVID-19 ARDS. Recorded September 2, 2020.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.16761"> Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>A conversation with Jonathan A. C. Sterne, MA, MSc, PhD, of the University of Bristol, Todd W. Rice, MD, MSc, of Vanderbilt University, and Janet V. Diaz, MD, of the World Health Organization (WHO) on the latest research supporting the use of hydrocortisone and dexamethasone for treatment of COVID-19 ARDS. Recorded September 2, 2020.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.16761"> Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Corticosteroids_for_COVID-19__New_Evidence_of_Benefit.mp3?dest-id=90171" length="30325757" type="audio/mpeg" />
      <itunes:duration>31:25</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/a/d/d/0add7b7099dbfec2/JMI200196.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>The Transformational Effects of COVID-19 on Medical Education</title>
      <itunes:title>The Transformational Effects of COVID-19 on Medical Education</itunes:title>
      <pubDate>Wed, 26 Aug 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[d5d2d0fd-d1dc-4aaa-99df-45b8317c6f15]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.15982]]></link>
      <description><![CDATA[<p>Interview with Catherine Lucey, MD, FACP, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.14136"> The Transformational Effects of COVID-19 on Medical Education</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Catherine Lucey, MD, FACP, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.14136"> The Transformational Effects of COVID-19 on Medical Education</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/The_Transformational_Effects_of_COVID-19_on_Medical_Education.mp3?dest-id=90171" length="32512436" type="audio/mpeg" />
      <itunes:duration>33:48</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/1/8/0/c180aaa7c07f045f/JVP200160.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus Vaccine Update</title>
      <itunes:title>Coronavirus Vaccine Update</itunes:title>
      <pubDate>Wed, 26 Aug 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[40f6cb59-df21-4f5f-9e7e-4ddd788f7248]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.16931]]></link>
      <description><![CDATA[<p>Paul A. Offit, MD, of the Children's Hospital of Philadelphia provides an update on COVID-19 vaccine development. Recorded August 24, 2020.</p> <p>Related Article:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.12190"> Developing a SARS-CoV-2 Vaccine at Warp Speed</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Paul A. Offit, MD, of the Children's Hospital of Philadelphia provides an update on COVID-19 vaccine development. Recorded August 24, 2020.</p> <p>Related Article:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.12190"> Developing a SARS-CoV-2 Vaccine at Warp Speed</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_Vaccine_Update.mp3?dest-id=90171" length="37725233" type="audio/mpeg" />
      <itunes:duration>39:07</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/b/8/2/ab82def3300a0f87/JMI200190.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus Update From the CDC – August 20, 2020</title>
      <itunes:title>Coronavirus Update From the CDC – August 20, 2020</itunes:title>
      <pubDate>Mon, 24 Aug 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[6f14e5a5-6734-48ce-be84-f79229cc7a06]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.16410]]></link>
      <description><![CDATA[<p>CDC Director Robert Redfield, MD, discusses recent developments in the COVID-19 pandemic and US response, including prospects for dual outbreaks of COVID-19 and influenza in the fall and winter.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.15845"> Addressing Influenza Vaccination Disparities During the COVID-19 Pandemic</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>CDC Director Robert Redfield, MD, discusses recent developments in the COVID-19 pandemic and US response, including prospects for dual outbreaks of COVID-19 and influenza in the fall and winter.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.15845"> Addressing Influenza Vaccination Disparities During the COVID-19 Pandemic</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_Update_From_the_CDC__August_20_2020.mp3?dest-id=90171" length="29685770" type="audio/mpeg" />
      <itunes:duration>30:47</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/d/3/6/d/d36d4b782815a196/JMI200185.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus Update With Ezekiel J. Emanuel, MD, PhD</title>
      <itunes:title>Coronavirus Update With Ezekiel J. Emanuel, MD, PhD</itunes:title>
      <pubDate>Fri, 21 Aug 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[bea3e19e-6cd5-4ae3-8f18-57c27bbd4d49]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.16420]]></link>
      <description><![CDATA[<p>Ezekiel Emanuel, MD, PhD, of the University of Pennsylvania's Perelman School of Medicine, Department of Medical Ethics and Health Policy, discusses recent developments in the COVID-19 pandemic. Recorded August 19, 2020.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.8102"> The Ethics of COVID-19 Immunity-Based Licenses ("Immunity Passports")</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Ezekiel Emanuel, MD, PhD, of the University of Pennsylvania's Perelman School of Medicine, Department of Medical Ethics and Health Policy, discusses recent developments in the COVID-19 pandemic. Recorded August 19, 2020.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.8102"> The Ethics of COVID-19 Immunity-Based Licenses ("Immunity Passports")</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_Update_With_Ezekiel_J._Emanuel_MD_PhD.mp3?dest-id=90171" length="35192526" type="audio/mpeg" />
      <itunes:duration>36:33</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/e/2/6/8e268603086b3f88/JMI200187.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Behavioral Counseling Interventions to Prevent Sexually Transmitted Infections</title>
      <itunes:title>USPSTF Recommendation: Behavioral Counseling Interventions to Prevent Sexually Transmitted Infections</itunes:title>
      <pubDate>Tue, 18 Aug 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[e3c75c2e-8e19-4445-95d3-1f1b34091a02]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.13097]]></link>
      <description><![CDATA[<p>Interview with Melissa A Simon, MD, USPSTF member and coauthor of Behavioral Counseling Interventions to Prevent Sexually Transmitted Infections: US Preventive Services Task Force Recommendation Statement</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.13095"> Behavioral Counseling Interventions to Prevent Sexually Transmitted Infections</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Melissa A Simon, MD, USPSTF member and coauthor of Behavioral Counseling Interventions to Prevent Sexually Transmitted Infections: US Preventive Services Task Force Recommendation Statement</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.13095"> Behavioral Counseling Interventions to Prevent Sexually Transmitted Infections</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation__Behavioral_Counseling_Interventions_to_Prevent_Sexually_Transmitted_Infections.mp3?dest-id=90171" length="13783049" type="audio/mpeg" />
      <itunes:duration>14:07</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/6/f/5/86f54224f4165e3c/JMI200141.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>The Convergence of Neurology and Psychiatry</title>
      <itunes:title>The Convergence of Neurology and Psychiatry</itunes:title>
      <pubDate>Tue, 11 Aug 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[d19d032b-c631-479a-89d6-ac47cab5e810]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.12328]]></link>
      <description><![CDATA[<p>Interview with Matcheri S. Keshavan, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.0062"> The Convergence of Neurology and Psychiatry: The Importance of Cross-Disciplinary Education</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Matcheri S. Keshavan, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.0062"> The Convergence of Neurology and Psychiatry: The Importance of Cross-Disciplinary Education</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/The_Convergence_of_Neurology_and_Psychiatry.mp3?dest-id=90171" length="27569382" type="audio/mpeg" />
      <itunes:duration>28:39</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/1/8/c/c18cde1f88c55727/JVP200156.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus Update From the WHO</title>
      <itunes:title>Coronavirus Update From the WHO</itunes:title>
      <pubDate>Fri, 07 Aug 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[dec42d30-7f24-4692-83c3-7280d515264c]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.14752]]></link>
      <description><![CDATA[<p>Soumya Swaminathan, MD, DNB, chief scientist at the World Health Organization (WHO), discusses the global coronavirus pandemic and the WHO response. Recorded August 5, 2020.</p> <p>Related Article:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.8486"> COVID-19 Reveals Urgent Need to Strengthen the World Health Organization</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Soumya Swaminathan, MD, DNB, chief scientist at the World Health Organization (WHO), discusses the global coronavirus pandemic and the WHO response. Recorded August 5, 2020.</p> <p>Related Article:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.8486"> COVID-19 Reveals Urgent Need to Strengthen the World Health Organization</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_Update_From_the_WHO.mp3?dest-id=90171" length="40765249" type="audio/mpeg" />
      <itunes:duration>42:20</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/7/1/b/3/71b30649ab32928c/JMI200161.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus Q&amp;A With Anthony Fauci, MD – August 3, 2020</title>
      <itunes:title>Coronavirus Q&amp;A With Anthony Fauci, MD – August 3, 2020</itunes:title>
      <pubDate>Wed, 05 Aug 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[40c08de3-9762-480b-bc28-721130e9945a]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.15285]]></link>
      <description><![CDATA[<p>Anthony Fauci, MD, White House Coronavirus Task Force member and director of the National Institute of Allergy and Infectious Diseases, discusses latest developments in the COVID-19 pandemic. Recorded August 3, 2020.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.9222"> Anthony Fauci, MD, on COVID-19 Vaccines, Larry Kramer, and Dealing With Criticism</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Anthony Fauci, MD, White House Coronavirus Task Force member and director of the National Institute of Allergy and Infectious Diseases, discusses latest developments in the COVID-19 pandemic. Recorded August 3, 2020.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.9222"> Anthony Fauci, MD, on COVID-19 Vaccines, Larry Kramer, and Dealing With Criticism</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_QA_With_Anthony_Fauci_MD__August_3_2020.mp3?dest-id=90171" length="28015676" type="audio/mpeg" />
      <itunes:duration>29:04</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/5/2/6/6526d8b363c4af28/JMI200165.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>COVID-19 and the FDA</title>
      <itunes:title>COVID-19 and the FDA</itunes:title>
      <pubDate>Mon, 03 Aug 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[3463bf0a-8a46-43f0-a5d2-e0945ddd10e2]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.15108]]></link>
      <description><![CDATA[<p>US Food and Drug Administration (FDA) Commissioner Stephen Hahn, MD, discusses the agency's role in responding to the COVID-19 pandemic. Recorded July 30, 2020.</p> <p>Related Article:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.8920"> Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>US Food and Drug Administration (FDA) Commissioner Stephen Hahn, MD, discusses the agency's role in responding to the COVID-19 pandemic. Recorded July 30, 2020.</p> <p>Related Article:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.8920"> Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/COVID-19_and_the_FDA.mp3?dest-id=90171" length="37416632" type="audio/mpeg" />
      <itunes:duration>38:53</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/5/0/b/350b9d97a61568fa/JMI200163.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Determination of Brain Death/Death by Neurologic Criteria–The World Brain Death Project</title>
      <itunes:title>Determination of Brain Death/Death by Neurologic Criteria–The World Brain Death Project</itunes:title>
      <pubDate>Mon, 03 Aug 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[5859b711-70c0-4aa7-accb-89f7a2a4181d]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.14167]]></link>
      <description><![CDATA[<p>The World Brain Death Project was undertaken to establish minimum standards for diagnosing brain death/death by neurologic criteria (BD/DNC) in children and adults across a broad range of settings and clinical circumstances. In this Q&A, senior authors of the 2020 report join an editorialist and bioethicist to discuss the project. Featuring interviews with Gene Sung, MD, of the University of Southern California; Ariane Lewis, MD, of NYU Langone Medical Center; Robert Tasker, MD, of the University of Cambridge; and Robert D. Truog, MD, of Harvard University.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.11665"> Brain Death—Moving Beyond Consistency in the Diagnostic Criteria</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>The World Brain Death Project was undertaken to establish minimum standards for diagnosing brain death/death by neurologic criteria (BD/DNC) in children and adults across a broad range of settings and clinical circumstances. In this Q&A, senior authors of the 2020 report join an editorialist and bioethicist to discuss the project. Featuring interviews with Gene Sung, MD, of the University of Southern California; Ariane Lewis, MD, of NYU Langone Medical Center; Robert Tasker, MD, of the University of Cambridge; and Robert D. Truog, MD, of Harvard University.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.11665"> Brain Death—Moving Beyond Consistency in the Diagnostic Criteria</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Determination_of_Brain_Death_Death_by_Neurologic_CriteriaThe_World_Brain_Death_Project.mp3?dest-id=90171" length="31083371" type="audio/mpeg" />
      <itunes:duration>32:11</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/b/1/2/cb12cba69864ecde/JMI200149.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Exome Sequencing and Clinical Diagnosis</title>
      <itunes:title>Exome Sequencing and Clinical Diagnosis</itunes:title>
      <pubDate>Fri, 31 Jul 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[4f03e251-74f7-4c3f-9162-c2cbb6875b5a]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.11631]]></link>
      <description><![CDATA[<p>Interview with Jan M. Friedman, MD, PhD, author of Exome Sequencing and Clinical Diagnosis</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.11126"> Exome Sequencing and Clinical Diagnosis</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Jan M. Friedman, MD, PhD, author of Exome Sequencing and Clinical Diagnosis</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.11126"> Exome Sequencing and Clinical Diagnosis</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Exome_Sequencing_and_Clinical_Diagnosis.mp3?dest-id=90171" length="26936793" type="audio/mpeg" />
      <itunes:duration>27:59</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/2/1/0/e21015fb455b093f/JVP200134.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>COVID-19 and School Reopenings</title>
      <itunes:title>COVID-19 and School Reopenings</itunes:title>
      <pubDate>Fri, 31 Jul 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[31d65dbc-de2f-410a-9d04-4a625174aa1e]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.14688]]></link>
      <description><![CDATA[<p>Katherine Auger, MD, MSc, of Cincinnati Children's Hospital and Julie Donohue, PhD, of University of Pittsburgh's Graduate School of Public Health discuss K-12 school reopening policy options and the way forward for the 2020-21 school year. Recorded July 29, 2020.</p> <p>Related Article:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.14348"> Association Between Statewide School Closure and COVID-19 Incidence and Mortality in the US</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Katherine Auger, MD, MSc, of Cincinnati Children's Hospital and Julie Donohue, PhD, of University of Pittsburgh's Graduate School of Public Health discuss K-12 school reopening policy options and the way forward for the 2020-21 school year. Recorded July 29, 2020.</p> <p>Related Article:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.14348"> Association Between Statewide School Closure and COVID-19 Incidence and Mortality in the US</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/COVID-19_and_School_Reopenings.mp3?dest-id=90171" length="29577188" type="audio/mpeg" />
      <itunes:duration>30:38</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/f/9/d/cf9de7d618215fee/JMI200159.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>COVID-19 and Health Justice</title>
      <itunes:title>COVID-19 and Health Justice</itunes:title>
      <pubDate>Thu, 30 Jul 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[c883264c-8679-4e68-b676-e0082a6351ab]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.14682]]></link>
      <description><![CDATA[<p>Ford Foundation President Darren Walker discusses the role of philanthropic organizations in responding to the COVID-19 pandemic and to health inequities. Recorded July 28, 2020.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.12904"> The Work of Philanthropy in Responding to COVID-19 and Addressing Inequality</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Ford Foundation President Darren Walker discusses the role of philanthropic organizations in responding to the COVID-19 pandemic and to health inequities. Recorded July 28, 2020.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.12904"> The Work of Philanthropy in Responding to COVID-19 and Addressing Inequality</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/COVID-19_and_Health_Justice.mp3?dest-id=90171" length="27450938" type="audio/mpeg" />
      <itunes:duration>28:32</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/4/2/1/24218dbe6ef0033e/JMI200157.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Black Kidney Function Matters: Use or Misuse of Race?</title>
      <itunes:title>Black Kidney Function Matters: Use or Misuse of Race?</itunes:title>
      <pubDate>Wed, 29 Jul 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[0d92562a-f17b-4270-ac49-b8520ef39530]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.14134]]></link>
      <description><![CDATA[<p>Interview with Neil R. Powe, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.13378"> Black Kidney Function Matters: Use or Misuse of Race?</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Neil R. Powe, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.13378"> Black Kidney Function Matters: Use or Misuse of Race?</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Black_Kidney_Function_Matters__Use_or_Misuse_of_Race_.mp3?dest-id=90171" length="23780937" type="audio/mpeg" />
      <itunes:duration>24:42</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/a/6/e/8a6e21805b659e96/JVP200156.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Improving the Value of Information in Hospital Rating Systems</title>
      <itunes:title>Improving the Value of Information in Hospital Rating Systems</itunes:title>
      <pubDate>Mon, 27 Jul 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[2e8238c6-4172-46a0-9b64-dfa5482f7646]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.14580]]></link>
      <description><![CDATA[<p>Interview with Adrian F. Hernandez, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.11165"> National Hospital Quality Rankings: Improving the Value of Information in Hospital Rating Systems</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Adrian F. Hernandez, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.11165"> National Hospital Quality Rankings: Improving the Value of Information in Hospital Rating Systems</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Improving_the_Value_of_Information_in_Hospital_Rating_Systems.mp3?dest-id=90171" length="17739858" type="audio/mpeg" />
      <itunes:duration>18:25</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/e/1/8/2e181896881bb2c8/JVP200137.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus Update With Eric Topol, MD</title>
      <itunes:title>Coronavirus Update With Eric Topol, MD</itunes:title>
      <pubDate>Mon, 27 Jul 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[ffc2c9cf-c85e-4009-913f-aa0bea638eaa]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.14520]]></link>
      <description><![CDATA[<p>Eric Topol, MD, Scripps Research EVP and omnivorous science health care and tech commentator, discusses the evolving COVID-19 pandemic. Recorded July 23, 2020.</p> <p>Related Article:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.12897"> Association Between Universal Masking in a Health Care System and SARS-CoV-2 Positivity Among Health Care Workers</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Eric Topol, MD, Scripps Research EVP and omnivorous science health care and tech commentator, discusses the evolving COVID-19 pandemic. Recorded July 23, 2020.</p> <p>Related Article:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.12897"> Association Between Universal Masking in a Health Care System and SARS-CoV-2 Positivity Among Health Care Workers</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_Update_With_Eric_Topol_MD.mp3?dest-id=90171" length="37665028" type="audio/mpeg" />
      <itunes:duration>39:07</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/b/d/f/1bdf888c65b9235f/JMI200154.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus Update With CDC Director Robert R. Redfield, MD</title>
      <itunes:title>Coronavirus Update With CDC Director Robert R. Redfield, MD</itunes:title>
      <pubDate>Thu, 16 Jul 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[6f09821e-6c6e-4184-8ba3-622621be86d3]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.13815]]></link>
      <description><![CDATA[<p>CDC Director Robert R. Redfield, MD, discusses the ongoing COVID-19 pandemic and the agency's latest recommendations. Recorded July 14, 2020.</p> <p>Related Article:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.13107"> Universal Masking to Prevent SARS-CoV-2 Transmission—The Time Is Now</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>CDC Director Robert R. Redfield, MD, discusses the ongoing COVID-19 pandemic and the agency's latest recommendations. Recorded July 14, 2020.</p> <p>Related Article:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.13107"> Universal Masking to Prevent SARS-CoV-2 Transmission—The Time Is Now</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_Update_With_CDC_Director_Robert_R._Redfield_MD.mp3?dest-id=90171" length="33757251" type="audio/mpeg" />
      <itunes:duration>35:03</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/b/4/8/a/b48a05cdff20e075/JMI200148.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Assessing Quantitative Comparisons of Health and Social Care Between Countries</title>
      <itunes:title>Assessing Quantitative Comparisons of Health and Social Care Between Countries</itunes:title>
      <pubDate>Wed, 15 Jul 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[6293147d-a923-4ab7-aa00-41aa615619a5]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.5355]]></link>
      <description><![CDATA[<p>Interview with Michelle D. Carlson, MD, author of Assessing Quantitative Comparisons of Health and Social Care Between Countries</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.3813"> Assessing Quantitative Comparisons of Health and Social Care Between Countries</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Michelle D. Carlson, MD, author of Assessing Quantitative Comparisons of Health and Social Care Between Countries</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.3813"> Assessing Quantitative Comparisons of Health and Social Care Between Countries</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Assessing_Quantitative_Comparisons_of_Health_and_Social_Care_Between_Countries.mp3?dest-id=90171" length="14611524" type="audio/mpeg" />
      <itunes:duration>15:09</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/7/0/a/f/70afa2f0d16f47de/JVP200043.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus in Houston — Report From the Front Lines</title>
      <itunes:title>Coronavirus in Houston — Report From the Front Lines</itunes:title>
      <pubDate>Tue, 14 Jul 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[d9ac11f3-05b3-468b-ad3d-4614a720761c]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.13503]]></link>
      <description><![CDATA[<p>Kalpalatha K. Guntupalli, MD, of Baylor College of Medicine discusses the surge and ICU management of COVID-19 patients in Houston, Texas. Recorded July 10, 2020.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.6775"> Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Kalpalatha K. Guntupalli, MD, of Baylor College of Medicine discusses the surge and ICU management of COVID-19 patients in Houston, Texas. Recorded July 10, 2020.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.6775"> Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_in_Houston__Report_From_the_Front_Lines.mp3?dest-id=90171" length="26137481" type="audio/mpeg" />
      <itunes:duration>27:06</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/4/4/8/e/448eccd731181745/JMI200146.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus Update – July 2020</title>
      <itunes:title>Coronavirus Update – July 2020</itunes:title>
      <pubDate>Fri, 10 Jul 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[07a3a358-2987-4f2e-aca0-9dc35c87cb58]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.13120]]></link>
      <description><![CDATA[<p>Infectious disease physician Rochelle P. Walensky, MD, MPH, of Harvard University discusses the ongoing COVID-19 pandemic. Recorded July 8, 2020.</p> <p>Related Article:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.7603"> Airborne Spread of SARS-CoV-2 and a Potential Role for Air Disinfection</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Infectious disease physician Rochelle P. Walensky, MD, MPH, of Harvard University discusses the ongoing COVID-19 pandemic. Recorded July 8, 2020.</p> <p>Related Article:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.7603"> Airborne Spread of SARS-CoV-2 and a Potential Role for Air Disinfection</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_Update__July_2020.mp3?dest-id=90171" length="34462083" type="audio/mpeg" />
      <itunes:duration>35:47</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/f/5/f/6f5fac54c7cb17d0/JMI200143_1.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus Q&amp;A With Anthony Fauci, MD – July 2, 2020</title>
      <itunes:title>Coronavirus Q&amp;A With Anthony Fauci, MD – July 2, 2020</itunes:title>
      <pubDate>Fri, 03 Jul 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[edc6c9ff-bb3b-4f12-accf-0debddb44365]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.12820]]></link>
      <description><![CDATA[<p>Anthony Fauci, MD, White House Coronavirus Task Force member and Director of the National Institutes of Allergy and Infectious Diseases, discusses latest developments in the COVID-19 pandemic. Recorded on July 2, 2020.</p> <p><a href="https://www.youtube.com/watch?v=m5l5UGS9ngc">Watch the interview</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Anthony Fauci, MD, White House Coronavirus Task Force member and Director of the National Institutes of Allergy and Infectious Diseases, discusses latest developments in the COVID-19 pandemic. Recorded on July 2, 2020.</p> <p><a href="https://www.youtube.com/watch?v=m5l5UGS9ngc">Watch the interview</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_QA_With_Anthony_Fauci_MD__July_2_2020.mp3?dest-id=90171" length="31015690" type="audio/mpeg" />
      <itunes:duration>32:12</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/4/a/5/24a5973dd488a239/JMI200133.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Limited Evidence for the Health Effects and Safety of Intermittent Fasting in Type 2 Diabetes</title>
      <itunes:title>Limited Evidence for the Health Effects and Safety of Intermittent Fasting in Type 2 Diabetes</itunes:title>
      <pubDate>Thu, 02 Jul 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[e2771a45-2e8a-4b5b-a397-abfd84f3487a]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.10414]]></link>
      <description><![CDATA[<p>Interview with Benjamin D. Horne, PhD, author of Limited Evidence for the Health Effects and Safety of Intermittent Fasting Among Patients With Type 2 Diabetes</p> <p>Related Article:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.3908"> Limited Evidence for the Health Effects and Safety of Intermittent Fasting Among Patients With Type 2 Diabetes</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Benjamin D. Horne, PhD, author of Limited Evidence for the Health Effects and Safety of Intermittent Fasting Among Patients With Type 2 Diabetes</p> <p>Related Article:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.3908"> Limited Evidence for the Health Effects and Safety of Intermittent Fasting Among Patients With Type 2 Diabetes</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Limited_Evidence_for_the_Health_Effects_and_Safety_of_Intermittent_Fasting_in_Type_2_Diabetes.mp3?dest-id=90171" length="16405458" type="audio/mpeg" />
      <itunes:duration>17:01</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/4/6/7/846740df46aa347f/JVP200046.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Update From the CDC With Anne Schuchat, MD</title>
      <itunes:title>Update From the CDC With Anne Schuchat, MD</itunes:title>
      <pubDate>Wed, 01 Jul 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[573d5bfd-148b-4ab2-bcea-fce4e5b908e7]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.12397]]></link>
      <description><![CDATA[<p>Anne Schuchat, MD, Principal Deputy Director of the Centers for Disease Control and Prevention (CDC), discusses latest developments in the COVID-19 pandemic. Recorded on June 29, 2020.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.8259"> Interpreting Diagnostic Tests for SARS-CoV-2</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Anne Schuchat, MD, Principal Deputy Director of the Centers for Disease Control and Prevention (CDC), discusses latest developments in the COVID-19 pandemic. Recorded on June 29, 2020.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.8259"> Interpreting Diagnostic Tests for SARS-CoV-2</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Update_From_the_CDC_With_Anne_Schuchat_MD.mp3?dest-id=90171" length="30924842" type="audio/mpeg" />
      <itunes:duration>32:08</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/4/8/2/c48287e1efe9ee49/JMI200131.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus in Brazil: Report From the Front Lines</title>
      <itunes:title>Coronavirus in Brazil: Report From the Front Lines</itunes:title>
      <pubDate>Tue, 30 Jun 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[58eaf8b6-f877-49e2-9c00-d311e5961a3e]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.11892]]></link>
      <description><![CDATA[<p>Intensivists Flavia R. Machado, MD, PhD, of the Federal University of São Paulo, and Jorge Salluh, MD, PhD, of the D'OR Institute for Research and Education in Rio de Janeiro, discuss the surge of COVID-19 cases and ICU management of patients in Brazil. Recorded June 26, 2020.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.11182"> Latin America and Its Global Partners Toil to Procure Medical Supplies as COVID-19 Pushes the Region to Its Limit</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Intensivists Flavia R. Machado, MD, PhD, of the Federal University of São Paulo, and Jorge Salluh, MD, PhD, of the D'OR Institute for Research and Education in Rio de Janeiro, discuss the surge of COVID-19 cases and ICU management of patients in Brazil. Recorded June 26, 2020.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.11182"> Latin America and Its Global Partners Toil to Procure Medical Supplies as COVID-19 Pushes the Region to Its Limit</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_in_Brazil__Report_From_the_Front_Lines.mp3?dest-id=90171" length="41219025" type="audio/mpeg" />
      <itunes:duration>42:42</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/2/f/6/32f6d0b9875739f3/JMI200121.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>The Next COVID-19 Phase</title>
      <itunes:title>The Next COVID-19 Phase</itunes:title>
      <pubDate>Fri, 26 Jun 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[fed19011-8728-4c63-8e78-5cab69b41327]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.12034]]></link>
      <description><![CDATA[<p>Michael Osterholm, PhD, MPH, of UMN's Center for Infectious Disease Research and Policy, discusses the summer rise in US COVID-19 cases, prospects for school reopening, a "second wave" in the fall, and more. Recorded June 24, 2020.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.12966"> Vulnerability to Pandemic Flu Could Be Greater Today Than a Century Ago</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Michael Osterholm, PhD, MPH, of UMN's Center for Infectious Disease Research and Policy, discusses the summer rise in US COVID-19 cases, prospects for school reopening, a "second wave" in the fall, and more. Recorded June 24, 2020.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.12966"> Vulnerability to Pandemic Flu Could Be Greater Today Than a Century Ago</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/The_Next_COVID-19_Phase.mp3?dest-id=90171" length="35393667" type="audio/mpeg" />
      <itunes:duration>36:46</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/a/9/c/3a9cf3aae1fcf729/JMI200125.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Sustainability, Business, and Health</title>
      <itunes:title>Sustainability, Business, and Health</itunes:title>
      <pubDate>Wed, 17 Jun 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[f650959a-90bc-4b06-81e4-096c708780ab]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.10412]]></link>
      <description><![CDATA[<p>Interview with Howard K. Koh, MD, author of Sustainability, Business, and Health</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.8714"> Sustainability, Business, and Health</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Howard K. Koh, MD, author of Sustainability, Business, and Health</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.8714"> Sustainability, Business, and Health</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Sustainability_Business_and_Health.mp3?dest-id=90171" length="25045698" type="audio/mpeg" />
      <itunes:duration>26:01</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/a/2/1/9a2151a302daf7e6/JVP200108.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus Q&amp;A: Clinical Update With Carlos del Rio, MD</title>
      <itunes:title>Coronavirus Q&amp;A: Clinical Update With Carlos del Rio, MD</itunes:title>
      <pubDate>Wed, 17 Jun 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[ee233988-b96b-44b3-9a20-9cee8477944e]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.11381]]></link>
      <description><![CDATA[<p>Infectious disease and global health expert Carlos del Rio, MD, of Emory University provides an update on the status of the #COVID19 pandemic in summer 2020, prospects for effective treatment and prevention, communicating the ongoing risk to the public, and more. Recorded June 15, 2020.</p> <p>Related Article:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.9252"> Translating Science on COVID-19 to Improve Clinical Care and Support the Public Health Response</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Infectious disease and global health expert Carlos del Rio, MD, of Emory University provides an update on the status of the #COVID19 pandemic in summer 2020, prospects for effective treatment and prevention, communicating the ongoing risk to the public, and more. Recorded June 15, 2020.</p> <p>Related Article:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.9252"> Translating Science on COVID-19 to Improve Clinical Care and Support the Public Health Response</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_QA__Clinical_Update_With_Carlos_del_Rio_MD.mp3?dest-id=90171" length="32804812" type="audio/mpeg" />
      <itunes:duration>34:00</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/e/b/4/0eb4df4b87d35f39/JMI200118.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Hospice Carve-In—Aligning Benefits With Patient and Family Needs</title>
      <itunes:title>Hospice Carve-In—Aligning Benefits With Patient and Family Needs</itunes:title>
      <pubDate>Mon, 15 Jun 2020 18:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[6aa3f94d-f81e-4d28-8633-facf8b2f7ca5]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.11312]]></link>
      <description><![CDATA[<p>Interview with William H. Shrank, MD, author of Hospice Carve-In—Aligning Benefits With Patient and Family Needs</p> <p>Related Article:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.8459"> Hospice Carve-In—Aligning Benefits With Patient and Family Needs</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with William H. Shrank, MD, author of Hospice Carve-In—Aligning Benefits With Patient and Family Needs</p> <p>Related Article:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.8459"> Hospice Carve-In—Aligning Benefits With Patient and Family Needs</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Hospice_Carve-InAligning_Benefits_With_Patient_and_Family_Needs.mp3?dest-id=90171" length="21904020" type="audio/mpeg" />
      <itunes:duration>22:45</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/4/3/e/2/43e2b7651d6ec54a/JVP200102.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>COVID-19 Q&amp;A: Critical Care Update</title>
      <itunes:title>COVID-19 Q&amp;A: Critical Care Update</itunes:title>
      <pubDate>Wed, 10 Jun 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[70bdf69e-7e9c-4fef-bc95-da6c1663058d]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.11037]]></link>
      <description><![CDATA[<p>COVID-19 critical care update with Maurizio Cecconi, MD, of Humanitas University in Milan, Italy, and JAMA Associate Editor Derek C. Angus, MD, MPH, of the University of Pittsburgh. Recorded June 8, 2020.</p> <p>Related:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.6825"> Management of COVID-19 Respiratory Distress</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>COVID-19 critical care update with Maurizio Cecconi, MD, of Humanitas University in Milan, Italy, and JAMA Associate Editor Derek C. Angus, MD, MPH, of the University of Pittsburgh. Recorded June 8, 2020.</p> <p>Related:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.6825"> Management of COVID-19 Respiratory Distress</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/COVID-19_QA__Critical_Care_Update.mp3?dest-id=90171" length="48841229" type="audio/mpeg" />
      <itunes:duration>50:42</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/3/1/4/0314c86cc030a63e/JMI200114.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Screening for Unhealthy Drug Use</title>
      <itunes:title>USPSTF Recommendation: Screening for Unhealthy Drug Use</itunes:title>
      <pubDate>Tue, 09 Jun 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[2491217c-0c51-437f-86a1-e3dc7c147441]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.8023]]></link>
      <description><![CDATA[<p>Interview with Karina W. Davidson, PhD, USPSTF member and coauthor of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.8020"> Screening for Unhealthy Drug Use: US Preventive Services Task Force Recommendation Statement</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Karina W. Davidson, PhD, USPSTF member and coauthor of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.8020"> Screening for Unhealthy Drug Use: US Preventive Services Task Force Recommendation Statement</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation__Screening_for_Unhealthy_Drug_Use.mp3?dest-id=90171" length="15103328" type="audio/mpeg" />
      <itunes:duration>15:38</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/5/f/4/b/5f4bf0903f4f8022/JMI200095.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Can Infections Cause Alzheimer Disease?</title>
      <itunes:title>Can Infections Cause Alzheimer Disease?</itunes:title>
      <pubDate>Mon, 08 Jun 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[1f1ae1c4-404b-434b-becc-d1541d1ce952]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.5359]]></link>
      <description><![CDATA[<p>Interview with Anthony L. Komaroff, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.4085"> Can Infections Cause Alzheimer Disease?</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Anthony L. Komaroff, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.4085"> Can Infections Cause Alzheimer Disease?</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Can_Infections_Cause_Alzheimer_Disease_.mp3?dest-id=90171" length="20361950" type="audio/mpeg" />
      <itunes:duration>21:08</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/f/6/c/3f6cd008f87fd4eb/JVP200050.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus Q&amp;A: Opening School in the Fall</title>
      <itunes:title>Coronavirus Q&amp;A: Opening School in the Fall</itunes:title>
      <pubDate>Fri, 05 Jun 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[fda1b327-b45d-4e05-b8f3-84e5eab77e54]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.10709]]></link>
      <description><![CDATA[<p>Joshua M. Sharfstein, MD, and Christopher Morphew, PhD, of Johns Hopkins University discuss options for opening primary, middle, and high schools in fall 2020. Recorded June 3, 2020.</p> <p>Related Article:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.10175"> The Urgency and Challenge of Opening K-12 Schools in the Fall of 2020</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Joshua M. Sharfstein, MD, and Christopher Morphew, PhD, of Johns Hopkins University discuss options for opening primary, middle, and high schools in fall 2020. Recorded June 3, 2020.</p> <p>Related Article:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.10175"> The Urgency and Challenge of Opening K-12 Schools in the Fall of 2020</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_QA__Opening_School_in_the_Fall.mp3?dest-id=90171" length="33633917" type="audio/mpeg" />
      <itunes:duration>34:00</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/7/8/a/b/78ab2345dacd2ef6/JMI200112.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus Q&amp;A With Anthony Fauci, MD</title>
      <itunes:title>Coronavirus Q&amp;A With Anthony Fauci, MD</itunes:title>
      <pubDate>Thu, 04 Jun 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[96f755fd-e91b-440f-a85c-f77a82c25b74]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.9823]]></link>
      <description><![CDATA[<p>NIAID Director Anthony Fauci, MD, discusses recent developments in the global COVID-19 pandemic with JAMA Editor in Chief Howard Bauchner, MD. Recorded June 2, 2020.</p> <p>Related Article:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.9222"> Anthony Fauci, MD, on COVID-19 Vaccines, Larry Kramer, and Dealing With Criticism</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>NIAID Director Anthony Fauci, MD, discusses recent developments in the global COVID-19 pandemic with JAMA Editor in Chief Howard Bauchner, MD. Recorded June 2, 2020.</p> <p>Related Article:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.9222"> Anthony Fauci, MD, on COVID-19 Vaccines, Larry Kramer, and Dealing With Criticism</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_QA_With_Anthony_Fauci_MD.mp3?dest-id=90171" length="25865979" type="audio/mpeg" />
      <itunes:duration>26:46</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/f/7/9/5/f79579f850b80d8a/JMI200106.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus Vaccine Development</title>
      <itunes:title>Coronavirus Vaccine Development</itunes:title>
      <pubDate>Wed, 03 Jun 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[3c4bd934-2478-42a4-bf8d-d37d1578e211]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.10411]]></link>
      <description><![CDATA[<p>Paul Offit, MD, of the Children's Hospital of Philadelphia, discusses principles and progress to date in COVID-19 vaccine development. Recorded June 1, 2020.</p> <p>Related:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.8917"> Adverse Consequences of Rushing a SARS-CoV-2 Vaccine: Implications for Public Trust</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Paul Offit, MD, of the Children's Hospital of Philadelphia, discusses principles and progress to date in COVID-19 vaccine development. Recorded June 1, 2020.</p> <p>Related:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.8917"> Adverse Consequences of Rushing a SARS-CoV-2 Vaccine: Implications for Public Trust</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_Vaccine_Development.mp3?dest-id=90171" length="35110078" type="audio/mpeg" />
      <itunes:duration>36:27</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/b/c/f/0bcf21f4fc0deb39/JMI200110.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus Q&amp;A: Managing the Pandemic</title>
      <itunes:title>Coronavirus Q&amp;A: Managing the Pandemic</itunes:title>
      <pubDate>Mon, 01 Jun 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[6c9bf2fd-3276-4143-b95b-8dca56df89bf]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.10134]]></link>
      <description><![CDATA[<p>Paul Starr, PhD, Professor of Sociology and Public Affairs at Princeton University, discusses policy options for achieving a new normal in the COVID-19 pandemic. Recorded Thursday, May 28, 2020.</p> <p>Related Article: <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.8573" target="_blank" rel="noopener">Using Controlled Trials to Resolve Key Unknowns About Policy During the COVID-19 Pandemic</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Paul Starr, PhD, Professor of Sociology and Public Affairs at Princeton University, discusses policy options for achieving a new normal in the COVID-19 pandemic. Recorded Thursday, May 28, 2020.</p> <p>Related Article: <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.8573" target="_blank" rel="noopener">Using Controlled Trials to Resolve Key Unknowns About Policy During the COVID-19 Pandemic</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_QA__Managing_the_Pandemic.mp3?dest-id=90171" length="30296558" type="audio/mpeg" />
      <itunes:duration>31:23</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/7/6/1/1/76117264a50c3b7b/JMI200108.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Potential Implications of Lowering the Medicare Eligibility Age to 60</title>
      <itunes:title>Potential Implications of Lowering the Medicare Eligibility Age to 60</itunes:title>
      <pubDate>Fri, 29 May 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[18dbebc7-feee-436c-a318-f65710a49655]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.9451]]></link>
      <description><![CDATA[<p>Interview with Zirui Song, M.D., Ph.D., author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.7245"> Potential Implications of Lowering the Medicare Eligibility Age to 60</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Zirui Song, M.D., Ph.D., author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.7245"> Potential Implications of Lowering the Medicare Eligibility Age to 60</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Potential_Implications_of_Lowering_the_Medicare_Eligibility_Age_to_60.mp3?dest-id=90171" length="28212471" type="audio/mpeg" />
      <itunes:duration>29:19</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/6/3/7/663728d00bc13262/JVP200088.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Primary Care–Based Interventions to Prevent Illicit Drug Use in Children, Adolescents, and Young Adults</title>
      <itunes:title>USPSTF Recommendation: Primary Care–Based Interventions to Prevent Illicit Drug Use in Children, Adolescents, and Young Adults</itunes:title>
      <pubDate>Tue, 26 May 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[69322de1-f3b8-4a8b-8fdd-af64554f1a59]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.7445]]></link>
      <description><![CDATA[<p>Interview with Michael Silverstein, MD, MPH, USPSTF member and coauthor of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.6774"> Primary Care–Based Interventions to Prevent Illicit Drug Use in Children, Adolescents, and Young Adults: US Preventive Services Task Force Recommendation Statement</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Michael Silverstein, MD, MPH, USPSTF member and coauthor of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.6774"> Primary Care–Based Interventions to Prevent Illicit Drug Use in Children, Adolescents, and Young Adults: US Preventive Services Task Force Recommendation Statement</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation__Primary_CareBased_Interventions_to_Prevent_Illicit_Drug_Use_in_Children_Adolescents_and_Young_Adults.mp3?dest-id=90171" length="13879285" type="audio/mpeg" />
      <itunes:duration>14:26</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/4/9/b/5/49b5cc9e48f430f0/JMI200089.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Reporting USMLE Step 1 Scores as Pass/Fail: An Opportunity for Medical Education and Training</title>
      <itunes:title>Reporting USMLE Step 1 Scores as Pass/Fail: An Opportunity for Medical Education and Training</itunes:title>
      <pubDate>Tue, 26 May 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[33f7c0f7-c3fe-4074-be49-4a2465d38f3c]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.5334]]></link>
      <description><![CDATA[<p>Interview with Humayun J. Chaudhry, DO, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.3198"> The USMLE Step 1 Decision: An Opportunity for Medical Education and Training</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Humayun J. Chaudhry, DO, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.3198"> The USMLE Step 1 Decision: An Opportunity for Medical Education and Training</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Reporting_USMLE_Step_1_Scores_as_Pass_Fail__An_Opportunity_for_Medical_Education_and_Training.mp3?dest-id=90171" length="33015402" type="audio/mpeg" />
      <itunes:duration>34:19</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/5/d/c/e5dce753ed5541e8/JVP200036.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>The NIH Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Initiative</title>
      <itunes:title>The NIH Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Initiative</itunes:title>
      <pubDate>Thu, 21 May 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[1a5a8721-da42-4ee8-acf7-f69837b8c23b]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.9551]]></link>
      <description><![CDATA[<p>US National Institutes of Health (NIH) Director Francis S. Collins, MD, PhD, discusses the agency's new initiative to collaborate with other agencies and industry to accelerate development and testing of COVID-19 treatments and vaccines. Recorded May 19, 2020.</p> <p>Related: <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.8920"> Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV): An Unprecedented Partnership for Unprecedented Times</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>US National Institutes of Health (NIH) Director Francis S. Collins, MD, PhD, discusses the agency's new initiative to collaborate with other agencies and industry to accelerate development and testing of COVID-19 treatments and vaccines. Recorded May 19, 2020.</p> <p>Related: <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.8920"> Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV): An Unprecedented Partnership for Unprecedented Times</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/The_NIH_Accelerating_COVID-19_Therapeutic_Interventions_and_Vaccines_ACTIV_Initiative.mp3?dest-id=90171" length="36524028" type="audio/mpeg" />
      <itunes:duration>37:56</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/4/d/f/04dfd9e3860ad7b2/JMI200103.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Immunity Passports in the Time of COVID-19</title>
      <itunes:title>Immunity Passports in the Time of COVID-19</itunes:title>
      <pubDate>Wed, 13 May 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[6123428c-37cd-44f7-9887-186d08e772c3]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.8696]]></link>
      <description><![CDATA[<p>Ezekiel Emanuel, MD, PhD, of the Perelman School of Medicine's Department of Medical Ethics and Health Policy, discusses the use of immunity licensing (immunity passports) as a means to restore public travel, activity, and the economy following the first wave of the COVID-19 pandemic. Recorded May 11, 2020.</p> <p>Related:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.8102"> The Ethics of COVID-19 Immunity-Based Licenses ("Immunity Passports")</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Ezekiel Emanuel, MD, PhD, of the Perelman School of Medicine's Department of Medical Ethics and Health Policy, discusses the use of immunity licensing (immunity passports) as a means to restore public travel, activity, and the economy following the first wave of the COVID-19 pandemic. Recorded May 11, 2020.</p> <p>Related:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.8102"> The Ethics of COVID-19 Immunity-Based Licenses ("Immunity Passports")</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Immunity_Passports_in_the_Time_of_COVID-19.mp3?dest-id=90171" length="39074321" type="audio/mpeg" />
      <itunes:duration>40:29</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/8/d/6/38d6fe3e2130c592/JMI200100.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>When Should Physicians Act on Non–Statistically Significant Results From Clinical Trials?</title>
      <itunes:title>When Should Physicians Act on Non–Statistically Significant Results From Clinical Trials?</itunes:title>
      <pubDate>Fri, 08 May 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[8afb3eb0-497f-4874-803d-bfc99a733cb4]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.3711]]></link>
      <description><![CDATA[<p>Interview with Paul J. Young, PhD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.3508"> When Should Clinicians Act on Non–Statistically Significant Results From Clinical Trials?</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Paul J. Young, PhD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.3508"> When Should Clinicians Act on Non–Statistically Significant Results From Clinical Trials?</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/When_Should_Physicians_Act_on_NonStatistically_Significant_Results_From_Clinical_Trials_.mp3?dest-id=90171" length="28687776" type="audio/mpeg" />
      <itunes:duration>29:49</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/9/d/7/09d7b19bd9586472/JVP200039.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>COVID-19 and Health Care's New Normal</title>
      <itunes:title>COVID-19 and Health Care's New Normal</itunes:title>
      <pubDate>Wed, 06 May 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[fb724db6-ca03-41fe-88e1-c2a201aef05f]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.8247]]></link>
      <description><![CDATA[<p>Don Berwick, MD, MPP, of the Institute for Healthcare Improvement, discusses choices societies and the medical profession can make to improve health care and reduce inequities as we move out of the acute phase of the coronavirus pandemic.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.6949"> Choices for the "New Normal"</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Don Berwick, MD, MPP, of the Institute for Healthcare Improvement, discusses choices societies and the medical profession can make to improve health care and reduce inequities as we move out of the acute phase of the coronavirus pandemic.</p> <p>Related Article(s):</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.6949"> Choices for the "New Normal"</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/COVID-19_and_Health_Cares_New_Normal.mp3?dest-id=90171" length="32771513" type="audio/mpeg" />
      <itunes:duration>33:56</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/5/5/b/0/55b0d9ae5d84d295/JMI200098.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus Q&amp;A: Update From the CDC</title>
      <itunes:title>Coronavirus Q&amp;A: Update From the CDC</itunes:title>
      <pubDate>Tue, 05 May 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[74156aa7-80f5-4ff0-aa40-5434c7cf5f24]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.7888]]></link>
      <description><![CDATA[<p>Anne Schuchat, MD, Principal Deputy Director of the Centers for Disease Control and Prevention (CDC), discusses evolution of CDC guidance and latest developments in the COVID-19 pandemic. Recorded Friday May 1, 2020.</p>]]></description>
      
      <content:encoded><![CDATA[<p>Anne Schuchat, MD, Principal Deputy Director of the Centers for Disease Control and Prevention (CDC), discusses evolution of CDC guidance and latest developments in the COVID-19 pandemic. Recorded Friday May 1, 2020.</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_QA__Update_From_the_CDC.mp3?dest-id=90171" length="33894712" type="audio/mpeg" />
      <itunes:duration>35:03</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/5/2/3/1/5231473e2789e74a/JMI200094_1.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Understanding Brain Death</title>
      <itunes:title>Understanding Brain Death</itunes:title>
      <pubDate>Fri, 01 May 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[8e544080-512a-480f-9ae1-3b667da4c6a6]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.5352]]></link>
      <description><![CDATA[<p>Interview with Robert D. Truog, MD, MA, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.3593"> Understanding Brain Death</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Robert D. Truog, MD, MA, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.3593"> Understanding Brain Death</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Understanding_Brain_Death.mp3?dest-id=90171" length="22058440" type="audio/mpeg" />
      <itunes:duration>22:54</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/4/5/d/0/45d0a99689db6cf2/JVP200041.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>COVID-19 and US Health Care Spending</title>
      <itunes:title>COVID-19 and US Health Care Spending</itunes:title>
      <pubDate>Wed, 29 Apr 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[95a9007d-d9a0-4c08-927c-8e6e2360255a]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.7596]]></link>
      <description><![CDATA[<p>The US spends more on health care as a proportion of its GDP than any other nation. Will the COVID-19 pandemic reduce or accelerate that spending? Sherry Glied, PhD, Dean and Professor of Public Service at New York University, explains. Recorded Monday, April 27, 2020.</p> <p>Read the article</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.6644"> The Potential Effects of Coronavirus on National Health Expenditures</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>The US spends more on health care as a proportion of its GDP than any other nation. Will the COVID-19 pandemic reduce or accelerate that spending? Sherry Glied, PhD, Dean and Professor of Public Service at New York University, explains. Recorded Monday, April 27, 2020.</p> <p>Read the article</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.6644"> The Potential Effects of Coronavirus on National Health Expenditures</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/COVID-19_and_US_Health_Care_Spending.mp3?dest-id=90171" length="31419917" type="audio/mpeg" />
      <itunes:duration>32:27</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/4/0/b/a40b85c9819fcd58/JMI200091.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Tobacco Use Prevention and Cessation in Children and Adolescents</title>
      <itunes:title>USPSTF Recommendation: Tobacco Use Prevention and Cessation in Children and Adolescents</itunes:title>
      <pubDate>Tue, 28 Apr 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[106a2b3b-a86d-4d2c-925c-0c266d212e63]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.4922]]></link>
      <description><![CDATA[<p>Interview with Michael Silverstein, MD, MPH, USPSTF member and coauthor of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.4679"> Primary Care Interventions for Prevention and Cessation of Tobacco Use in Children and Adolescents: US Preventive Services Task Force Recommendation Statement</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Michael Silverstein, MD, MPH, USPSTF member and coauthor of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.4679"> Primary Care Interventions for Prevention and Cessation of Tobacco Use in Children and Adolescents: US Preventive Services Task Force Recommendation Statement</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation__Tobacco_Use_Prevention_and_Cessation_in_Children_and_Adolescents.mp3?dest-id=90171" length="18065424" type="audio/mpeg" />
      <itunes:duration>18:49</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/d/c/c/9/dcc9adaab543a90d/JMI200058.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Predicting the COVID-19 Pandemic</title>
      <itunes:title>Predicting the COVID-19 Pandemic</itunes:title>
      <pubDate>Fri, 24 Apr 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[5cd533cf-4f5b-4192-8230-64171b32298c]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.7265]]></link>
      <description><![CDATA[<p>Marc Lipsitch, DPhil, an infectious diseases epidemiologist developing biological and modeling approaches to pathogen transmission and outbreaks, discusses evolution of the COVID-19 pandemic in summer and fall 2020. Originally recorded April 22, 2020.</p>]]></description>
      
      <content:encoded><![CDATA[<p>Marc Lipsitch, DPhil, an infectious diseases epidemiologist developing biological and modeling approaches to pathogen transmission and outbreaks, discusses evolution of the COVID-19 pandemic in summer and fall 2020. Originally recorded April 22, 2020.</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Predicting_the_COVID-19_Pandemic.mp3?dest-id=90171" length="34705639" type="audio/mpeg" />
      <itunes:duration>35:57</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/5/1/4/151420715d5c2fe7/JMI200088.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Irregularities and Misconduct in Clinical Trials: Increasing Access to FDA Inspection Reports</title>
      <itunes:title>Irregularities and Misconduct in Clinical Trials: Increasing Access to FDA Inspection Reports</itunes:title>
      <pubDate>Thu, 23 Apr 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[5ecea5be-7b7b-4400-bf81-c5d7020b1c78]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.5335]]></link>
      <description><![CDATA[<p>Interview with Aaron S. Kesselheim, MD, JD, MPH, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.1631"> Increasing Access to FDA Inspection Reports on Irregularities and Misconduct in Clinical Trials</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Aaron S. Kesselheim, MD, JD, MPH, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.1631"> Increasing Access to FDA Inspection Reports on Irregularities and Misconduct in Clinical Trials</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Irregularities_and_Misconduct_in_Clinical_Trials__Increasing_Access_to_FDA_Inspection_Reports_1.mp3?dest-id=90171" length="17907909" type="audio/mpeg" />
      <itunes:duration>18:35</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/8/0/a/380a28d38dde722d/JVP200017.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>COVID-19: From Mitigation to Containment</title>
      <itunes:title>COVID-19: From Mitigation to Containment</itunes:title>
      <pubDate>Wed, 22 Apr 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[db5814a3-c765-4f13-bbb6-44a53b05e7d3]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.7056]]></link>
      <description><![CDATA[<p>Rochelle Walensky, MD, MPH, of Harvard University discusses public health strategies and policies for lifting shelter-in-place and quarantine and for returning the US to a new post-first-wave normal. Recorded Monday April 20, 2020.</p>]]></description>
      
      <content:encoded><![CDATA[<p>Rochelle Walensky, MD, MPH, of Harvard University discusses public health strategies and policies for lifting shelter-in-place and quarantine and for returning the US to a new post-first-wave normal. Recorded Monday April 20, 2020.</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/COVID-19__From_Mitigation_to_Containment.mp3?dest-id=90171" length="36954790" type="audio/mpeg" />
      <itunes:duration>38:25</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/5/5/5/85559211e3fdf395/JMI200085.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>The Need to Improve the Clinical Utility of Direct-to-Consumer Genetic Tests: Either Too Narrow or Too Broad</title>
      <itunes:title>The Need to Improve the Clinical Utility of Direct-to-Consumer Genetic Tests: Either Too Narrow or Too Broad</itunes:title>
      <pubDate>Tue, 21 Apr 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[167509e2-d182-4fce-98fe-c70e417b9727]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2019.23835]]></link>
      <description><![CDATA[<p>Interview with Madison Kilbride, PhD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.22504"> The Need to Improve the Clinical Utility of Direct-to-Consumer Genetic Tests: Either Too Narrow or Too Broad</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Madison Kilbride, PhD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.22504"> The Need to Improve the Clinical Utility of Direct-to-Consumer Genetic Tests: Either Too Narrow or Too Broad</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/The_Need_to_Improve_the_Clinical_Utility_of_Direct-to-Consumer_Genetic_Tests__Either_Too_Narrow_or_Too_Broad.mp3?dest-id=90171" length="16814921" type="audio/mpeg" />
      <itunes:duration>17:27</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/f/6/0/1f601cfad6636445/JVP190193.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus and Health Policy</title>
      <itunes:title>Coronavirus and Health Policy</itunes:title>
      <pubDate>Mon, 20 Apr 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[d21658d2-bfcc-4f49-a7f9-88369d363143]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.6746]]></link>
      <description><![CDATA[<p>JAMA Health Forum editors John Ayanian, MD, MPP, and Melinda Buntin, PhD, discuss changes in US health care and health policy driven by the coronavirus pandemic. Recorded April 16, 2020.</p>]]></description>
      
      <content:encoded><![CDATA[<p>JAMA Health Forum editors John Ayanian, MD, MPP, and Melinda Buntin, PhD, discuss changes in US health care and health policy driven by the coronavirus pandemic. Recorded April 16, 2020.</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_and_Health_Policy.mp3?dest-id=90171" length="26182571" type="audio/mpeg" />
      <itunes:duration>27:07</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/e/c/0/9ec0382563001b07/JMI200083.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Delayed Antibiotic Prescriptions in Ambulatory Care—Reconsidering a Problematic Practice</title>
      <itunes:title>Delayed Antibiotic Prescriptions in Ambulatory Care—Reconsidering a Problematic Practice</itunes:title>
      <pubDate>Thu, 16 Apr 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[eecaf4b0-20af-49bb-86b8-62c731f8f8ff]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.2413]]></link>
      <description><![CDATA[<p>Interview with Jeffrey A. Linder, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.2325"> Delayed Antibiotic Prescriptions in Ambulatory Care: Reconsidering a Problematic Practice</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Jeffrey A. Linder, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.2325"> Delayed Antibiotic Prescriptions in Ambulatory Care: Reconsidering a Problematic Practice</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Delayed_Antibiotic_Prescriptions_in_Ambulatory_CareReconsidering_a_Problematic_Practice.mp3?dest-id=90171" length="16701945" type="audio/mpeg" />
      <itunes:duration>17:20</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/5/c/0/a/5c0ab179110e8ab9/JVP200023.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>New York City Coronavirus (COVID-19) Update</title>
      <itunes:title>New York City Coronavirus (COVID-19) Update</itunes:title>
      <pubDate>Wed, 15 Apr 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[147ea881-6edf-49d8-bc0e-2bec71675490]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.6453]]></link>
      <description><![CDATA[<p>New York City coronavirus update from Mitchell Katz, MD, President and CEO of NYC Health + Hospitals, the largest municipal public health system in the United States. Recorded April 13, 2020.</p>]]></description>
      
      <content:encoded><![CDATA[<p>New York City coronavirus update from Mitchell Katz, MD, President and CEO of NYC Health + Hospitals, the largest municipal public health system in the United States. Recorded April 13, 2020.</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/New_York_City_Coronavirus_COVID-19_Update.mp3?dest-id=90171" length="29170441" type="audio/mpeg" />
      <itunes:duration>30:19</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/a/b/f/6abf74e9dc1947be/JMI200081.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus Q&amp;A: Former Utah Governor and HHS Secretary Mike Leavitt</title>
      <itunes:title>Coronavirus Q&amp;A: Former Utah Governor and HHS Secretary Mike Leavitt</itunes:title>
      <pubDate>Fri, 10 Apr 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[5bb8e06c-34fb-4754-8bd7-b4f723ca3671]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.5906]]></link>
      <description><![CDATA[<p>US states are taking the lead in managing the COVID-19 pandemic. What can state governors expect from the federal government and from the US Department of Health and Human Services? Governor Mike Leavitt from Leavitt Partners joins JAMA Editor Howard Bauchner, MD, in this live Q&A. Recorded April 8, 2020.</p>]]></description>
      
      <content:encoded><![CDATA[<p>US states are taking the lead in managing the COVID-19 pandemic. What can state governors expect from the federal government and from the US Department of Health and Human Services? Governor Mike Leavitt from Leavitt Partners joins JAMA Editor Howard Bauchner, MD, in this live Q&A. Recorded April 8, 2020.</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_QA__Former_Utah_Governor_and_HHS_Secretary_Mike_Leavitt.mp3?dest-id=90171" length="28962984" type="audio/mpeg" />
      <itunes:duration>30:07</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/4/e/9/64e9a3611c4244ea/JMI200074.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Q&amp;A With Anthony Fauci, MD</title>
      <itunes:title>Q&amp;A With Anthony Fauci, MD</itunes:title>
      <pubDate>Fri, 10 Apr 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[c67a1ba8-3941-47a5-8ecd-474f0ca32796]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.6291]]></link>
      <description><![CDATA[<p>NIAID Director and Presidential Coronavirus Task Force Advisor Anthony Fauci, MD, discusses recent developments in the global COVID-19 pandemic with JAMA Editor Howard Bauchner, MD. Recorded April 8, 2020.</p>]]></description>
      
      <content:encoded><![CDATA[<p>NIAID Director and Presidential Coronavirus Task Force Advisor Anthony Fauci, MD, discusses recent developments in the global COVID-19 pandemic with JAMA Editor Howard Bauchner, MD. Recorded April 8, 2020.</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/QA_With_Anthony_Fauci_MD.mp3?dest-id=90171" length="29968847" type="audio/mpeg" />
      <itunes:duration>31:11</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/d/5/4/ad54d159c65b2618/JMI200079.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus (COVID-19) Update: Clinical Review</title>
      <itunes:title>Coronavirus (COVID-19) Update: Clinical Review</itunes:title>
      <pubDate>Wed, 08 Apr 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[3d8d6419-e4bb-42b9-b54e-4359dfcc38b2]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.6014]]></link>
      <description><![CDATA[<p>Questions about testing, chloroquine toxicity, duration of immunity and reinfection, and what to expect next are gripping the US as the novel coronavirus spreads. JAMA Associate Editor Preeti Malani, MD, professor of medicine and Chief Health Officer at the University of Michigan, discusses recent developments in a live conversation with JAMA Editor in Chief Howard Bauchner. Recorded on April 6, 2020.</p>]]></description>
      
      <content:encoded><![CDATA[<p>Questions about testing, chloroquine toxicity, duration of immunity and reinfection, and what to expect next are gripping the US as the novel coronavirus spreads. JAMA Associate Editor Preeti Malani, MD, professor of medicine and Chief Health Officer at the University of Michigan, discusses recent developments in a live conversation with JAMA Editor in Chief Howard Bauchner. Recorded on April 6, 2020.</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_COVID-19_Update_Clinical_Review.mp3?dest-id=90171" length="34984591" type="audio/mpeg" />
      <itunes:duration>36:24</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/2/2/3/922398caac241c90/JMI200076.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Screening for Bacterial Vaginosis to Prevent Preterm Delivery</title>
      <itunes:title>USPSTF Recommendation: Screening for Bacterial Vaginosis to Prevent Preterm Delivery</itunes:title>
      <pubDate>Tue, 07 Apr 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[bec63ed8-8b6e-4efd-850a-a50c0c8b80e7]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.2686]]></link>
      <description><![CDATA[<p>Interview with Chien-Wen W Tseng, MD, MPH, USPSTF member and coauthor of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.2684"> Screening for Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: US Preventive Services Task Force Recommendation Statement</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Chien-Wen W Tseng, MD, MPH, USPSTF member and coauthor of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.2684"> Screening for Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: US Preventive Services Task Force Recommendation Statement</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation__Screening_for_Bacterial_Vaginosis_to_Prevent_Preterm_Delivery.mp3?dest-id=90171" length="13421044" type="audio/mpeg" />
      <itunes:duration>13:59</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/4/8/4/c/484c9dfe43208dad/JMI200036.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus Disease 2019 (COVID-19) Update: Epidemics in History</title>
      <itunes:title>Coronavirus Disease 2019 (COVID-19) Update: Epidemics in History</itunes:title>
      <pubDate>Mon, 06 Apr 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[4679d6d4-8c8c-4084-a8ae-21065389af66]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.5459]]></link>
      <description><![CDATA[<p>Infectious epidemics have always driven change and triggered discrimination in human societies. Frank Snowden, DPhil, Professor Emeritus of History and History of Medicine at Yale University and author of <em>Epidemics and Society: From the Black Death to the Present</em> (Yale University Press, 2019), puts the COVID-19 pandemic in historical context.</p>]]></description>
      
      <content:encoded><![CDATA[<p>Infectious epidemics have always driven change and triggered discrimination in human societies. Frank Snowden, DPhil, Professor Emeritus of History and History of Medicine at Yale University and author of <em>Epidemics and Society: From the Black Death to the Present</em> (Yale University Press, 2019), puts the COVID-19 pandemic in historical context.</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_Disease_2019_COVID-19_Update__Epidemics_in_History.mp3?dest-id=90171" length="31782471" type="audio/mpeg" />
      <itunes:duration>32:52</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/b/0/a/6b0ad28c77484ddb/JMI200068.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>The Role of Physicians in Addressing Social Determinants of Health</title>
      <itunes:title>The Role of Physicians in Addressing Social Determinants of Health</itunes:title>
      <pubDate>Fri, 03 Apr 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[d32ca63f-e1a9-46d7-96cf-84cb151ad335]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.2638]]></link>
      <description><![CDATA[<p>Interview with Sandro Galea, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.1637"> The Role of Physicians in Addressing Social Determinants of Health</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Sandro Galea, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.1637"> The Role of Physicians in Addressing Social Determinants of Health</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/The_Role_of_Physicians_in_Addressing_Social_Determinants_of_Health.mp3?dest-id=90171" length="16002633" type="audio/mpeg" />
      <itunes:duration>16:36</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/0/0/d/e00d35751bc2d216/JVP200019.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus (COVID-19) Update: Critical Care Management</title>
      <itunes:title>Coronavirus (COVID-19) Update: Critical Care Management</itunes:title>
      <pubDate>Thu, 02 Apr 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[d316ca64-d5ea-464a-8d4c-d807365acd9f]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.5749]]></link>
      <description><![CDATA[<p>Noninvasive ventilation (NIV), working with dying patients' families, use of experimental therapies, and more. JAMA Associate Editor Derek Angus, MD, MPH, Distinguished Professor and Chair of Critical Care Medicine at the University of Pittsburgh, provides a COVID-19 ICU management update.</p> <p><a href="https://www.youtube.com/watch?v=c7s3fS6RTlQ">Watch the recording of this livestream</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Noninvasive ventilation (NIV), working with dying patients' families, use of experimental therapies, and more. JAMA Associate Editor Derek Angus, MD, MPH, Distinguished Professor and Chair of Critical Care Medicine at the University of Pittsburgh, provides a COVID-19 ICU management update.</p> <p><a href="https://www.youtube.com/watch?v=c7s3fS6RTlQ">Watch the recording of this livestream</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_COVID-19_Update__Critical_Care_Management.mp3?dest-id=90171" length="44453292" type="audio/mpeg" />
      <itunes:duration>46:06</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/c/b/e/ccbed5051abf3699/JMI200070.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus (COVID-19) Update: The Near Future</title>
      <itunes:title>Coronavirus (COVID-19) Update: The Near Future</itunes:title>
      <pubDate>Wed, 01 Apr 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[4cef8071-ef1d-474b-93ae-1f02713cd8c3]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.5438]]></link>
      <description><![CDATA[<p>How does the current pandemic compare to historical infectious outbreaks and what can we expect in summer and fall of 2020? Nicholas Christakis, MD, PhD, MPH, director of the Human Nature Lab, Co-director of the Institute of Network Science, and Sterling Professor of Social and Natural Science at Yale University, discusses the epidemiology of COVID-19.</p>]]></description>
      
      <content:encoded><![CDATA[<p>How does the current pandemic compare to historical infectious outbreaks and what can we expect in summer and fall of 2020? Nicholas Christakis, MD, PhD, MPH, director of the Human Nature Lab, Co-director of the Institute of Network Science, and Sterling Professor of Social and Natural Science at Yale University, discusses the epidemiology of COVID-19.</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_COVID-19_Update__The_Near_Future.mp3?dest-id=90171" length="34568345" type="audio/mpeg" />
      <itunes:duration>35:48</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/f/0/8/9/f08912f48b02846f/JMI200066.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus (COVID-19) Update: Fairly Rationing ICU Care</title>
      <itunes:title>Coronavirus (COVID-19) Update: Fairly Rationing ICU Care</itunes:title>
      <pubDate>Mon, 30 Mar 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[9eb847ff-39fb-4294-b57c-e53ba0fcec88]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.5013]]></link>
      <description><![CDATA[<p>Hospitals need ways to make rational, fair decisions about who gets ICU beds and ventilators if COVID-19 patients overwhelm capacity. Douglas B. White, MD, MAS, Director of the Program on Ethics and Decision Making in Critical Illness at the University of Pittsburgh, discusses a framework for those decisions and a guideline he helped develop for allocation of scarce resources in public health emergencies.</p>]]></description>
      
      <content:encoded><![CDATA[<p>Hospitals need ways to make rational, fair decisions about who gets ICU beds and ventilators if COVID-19 patients overwhelm capacity. Douglas B. White, MD, MAS, Director of the Program on Ethics and Decision Making in Critical Illness at the University of Pittsburgh, discusses a framework for those decisions and a guideline he helped develop for allocation of scarce resources in public health emergencies.</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_COVID-19_Update__Fairly_Rationing_ICU_Care.mp3?dest-id=90171" length="33060384" type="audio/mpeg" />
      <itunes:duration>34:16</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/d/9/f/2d9f470f6a1a2498/JMI200063.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus (COVID-19) Update: Vaccines and Immunity</title>
      <itunes:title>Coronavirus (COVID-19) Update: Vaccines and Immunity</itunes:title>
      <pubDate>Thu, 26 Mar 2020 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[365774dc-61d4-4b44-b69e-ce0c725f9856]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.5082]]></link>
      <description><![CDATA[<p>As COVID-19 spreads globally, populations who survive their illness will become immune. Mayo Vaccine Research Group Director Gregory Poland, MD, discusses antibody responses, duration of immunity, vaccine safety, and the prospects for using convalescent serum to passively immunize people unexposed to SARS-CoV-2.</p>]]></description>
      
      <content:encoded><![CDATA[<p>As COVID-19 spreads globally, populations who survive their illness will become immune. Mayo Vaccine Research Group Director Gregory Poland, MD, discusses antibody responses, duration of immunity, vaccine safety, and the prospects for using convalescent serum to passively immunize people unexposed to SARS-CoV-2.</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_COVID-19_Update__Vaccines_and_Immunity.mp3?dest-id=90171" length="27265057" type="audio/mpeg" />
      <itunes:duration>28:18</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/3/9/d/639d4a655106c245/JMI200061.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus in New York - Report From the Front Lines</title>
      <itunes:title>Coronavirus in New York - Report From the Front Lines</itunes:title>
      <pubDate>Tue, 24 Mar 2020 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[5bd9ee9f-64ea-4c7e-b35f-855ec0477157]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.4858]]></link>
      <description><![CDATA[<p>The ARDS in COVID-19 patients appears more responsive to PEEP and prone ventilation, but seems to require prolonged ventilation and may be associated with myocardial injury. Michelle N. Gong, MD, MS, Chief of Critical Care Medicine at Montefiore Medical Center in the Bronx, discusses her department's experience managing critically ill coronavirus patients, procuring diagnostic tests and personal protective equipment (PPE) for her staff, and more.</p>]]></description>
      
      <content:encoded><![CDATA[<p>The ARDS in COVID-19 patients appears more responsive to PEEP and prone ventilation, but seems to require prolonged ventilation and may be associated with myocardial injury. Michelle N. Gong, MD, MS, Chief of Critical Care Medicine at Montefiore Medical Center in the Bronx, discusses her department's experience managing critically ill coronavirus patients, procuring diagnostic tests and personal protective equipment (PPE) for her staff, and more.</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_in_New_York_-_Report_From_the_Front_Lines.mp3?dest-id=90171" length="31221361" type="audio/mpeg" />
      <itunes:duration>32:25</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/7/b/f/2/7bf284b76fc23ddc/JMI200056.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus Disease 2019 (COVID-19) Mitigation: Preparing Hospitals and Health Systems</title>
      <itunes:title>Coronavirus Disease 2019 (COVID-19) Mitigation: Preparing Hospitals and Health Systems</itunes:title>
      <pubDate>Fri, 20 Mar 2020 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[29ffaa8e-69ed-4c8f-86c3-37c2db5665e3]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.4752]]></link>
      <description><![CDATA[<p>The strategy for managing the COVID-19 pandemic has shifted from containment to mitigation. What does that mean for US hospitals and health systems? Kaiser Permanente Executive Vice President Stephen M. Parodi, MD, discusses telemedicine, protecting health care workers, equipment allocation planning, and more.</p>]]></description>
      
      <content:encoded><![CDATA[<p>The strategy for managing the COVID-19 pandemic has shifted from containment to mitigation. What does that mean for US hospitals and health systems? Kaiser Permanente Executive Vice President Stephen M. Parodi, MD, discusses telemedicine, protecting health care workers, equipment allocation planning, and more.</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_Disease_2019_COVID-19_Mitigation__Preparing_Hospitals_and_Health_Systems.mp3?dest-id=90171" length="29337641" type="audio/mpeg" />
      <itunes:duration>30:21</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/0/3/a/e03a99ad4367e62b/JMI200054.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>COVID-19 Update with NIAID's Anthony Fauci, MD; March 18, 2020</title>
      <itunes:title>COVID-19 Update with NIAID's Anthony Fauci, MD; March 18, 2020</itunes:title>
      <pubDate>Thu, 19 Mar 2020 14:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[2b39e6c1-927c-4757-ae73-c65daab10e68]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.4587]]></link>
      <description><![CDATA[<p>Diagnostic testing, NSAIDs, ACE Inhibitors, antivirals, and more. Anthony Fauci, MD from NIAID discusses latest developments in the spread and clinical management of COVID-19 and the SARS-CoV-2 virus with JAMA Editor Howard Bauchner, MD.</p> <p><a href= "https://jamanetwork.com/journals/jama/pages/coronavirus-alert">JAMA Coronavirus Resource Center</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Diagnostic testing, NSAIDs, ACE Inhibitors, antivirals, and more. Anthony Fauci, MD from NIAID discusses latest developments in the spread and clinical management of COVID-19 and the SARS-CoV-2 virus with JAMA Editor Howard Bauchner, MD.</p> <p><a href= "https://jamanetwork.com/journals/jama/pages/coronavirus-alert">JAMA Coronavirus Resource Center</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/COVID-19_Update_with_NIAID_s_Anthony_Fauci_MD_March_18_2020.mp3?dest-id=90171" length="27971006" type="audio/mpeg" />
      <itunes:duration>28:48</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/5/c/8/c/5c8cfa5dcb64c35d/JMI200049.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus Testing – March 16 Q&amp;A with the CDC's Jay Butler, MD</title>
      <itunes:title>Coronavirus Testing – March 16 Q&amp;A with the CDC's Jay Butler, MD</itunes:title>
      <pubDate>Tue, 17 Mar 2020 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[2d274866-00c8-4125-b8cc-b56b05476b44]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.4421]]></link>
      <description><![CDATA[<p>Coronavirus testing will help countries manage coronavirus disease 2019 (COVID-19) but will raise questions about how to counsel patients about their test results. The CDC's Deputy Director for Infectious Diseases Jay C. Butler, MD, talks with JAMA Editor Howard Bauchner about what to advise healthy patients with positive PCR results, sick patients with negative test results, exposed health care workers, and more.</p>]]></description>
      
      <content:encoded><![CDATA[<p>Coronavirus testing will help countries manage coronavirus disease 2019 (COVID-19) but will raise questions about how to counsel patients about their test results. The CDC's Deputy Director for Infectious Diseases Jay C. Butler, MD, talks with JAMA Editor Howard Bauchner about what to advise healthy patients with positive PCR results, sick patients with negative test results, exposed health care workers, and more.</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_Testing__March_16_QA_with_the_CDC_s_Jay_Butler_MD.mp3?dest-id=90171" length="31485846" type="audio/mpeg" />
      <itunes:duration>32:44</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/4/3/7/b/437bbebe2dea917b/JVP200016.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus in Italy—Report From the Front Lines</title>
      <itunes:title>Coronavirus in Italy—Report From the Front Lines</itunes:title>
      <pubDate>Fri, 13 Mar 2020 18:45:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[eab76ab9-ee80-414e-8894-f097380c29d2]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.4093]]></link>
      <description><![CDATA[<p>Physicians in Lombardy, Italy, have been overwhelmed by COVID-19 patients requiring critical care. Based on an existing ECMO center network they developed an ICU network to rapidly identify, triage, and manage patients infected with SARS-2-CoV. Maurizio Cecconi, MD, of Humanitas University in Milan discusses the region's approach to the surge, including clinical and supply management, health care worker training and protection, and ventilation strategies, with JAMA Editor Howard Bauchner.</p> <p>Read the article:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.4031"> Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Physicians in Lombardy, Italy, have been overwhelmed by COVID-19 patients requiring critical care. Based on an existing ECMO center network they developed an ICU network to rapidly identify, triage, and manage patients infected with SARS-2-CoV. Maurizio Cecconi, MD, of Humanitas University in Milan discusses the region's approach to the surge, including clinical and supply management, health care worker training and protection, and ventilation strategies, with JAMA Editor Howard Bauchner.</p> <p>Read the article:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.4031"> Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_in_ItalyReport_From_the_Front_Lines.mp3?dest-id=90171" length="34605024" type="audio/mpeg" />
      <itunes:duration>36:00</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/2/c/9/c2c9fe25a521c496/200312-jama-cdb-cecconi-thumb.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>When Guidelines Recommend Shared Decision-Making</title>
      <itunes:title>When Guidelines Recommend Shared Decision-Making</itunes:title>
      <pubDate>Fri, 13 Mar 2020 13:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[c81ba337-75f4-434d-85ba-dad3f5db037e]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.2235]]></link>
      <description><![CDATA[<p>Interview with Victor M. Montori, MD, MSC, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.1525"> When Guidelines Recommend Shared Decision-making</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Victor M. Montori, MD, MSC, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.1525"> When Guidelines Recommend Shared Decision-making</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/When_Guidelines_Recommend_Shared_Decision-Making.mp3?dest-id=90171" length="26953998" type="audio/mpeg" />
      <itunes:duration>28:00</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/5/7/b/2/57b254766dd8b656/JVP200016.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>COVID-19 Update With NIAID's Anthony Fauci, MD; March 6, 2020</title>
      <itunes:title>COVID-19 Update With NIAID's Anthony Fauci, MD; March 6, 2020</itunes:title>
      <pubDate>Sat, 07 Mar 2020 19:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[cd559cf7-1c3e-465a-8265-af08d788ad4d]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.3466]]></link>
      <description><![CDATA[<p>Coronavirus testing, mortality, vaccine development, containment vs mitigation, and more. JAMA Editor Howard Bauchner, MD, interviews US NIAID Director Anthony Fauci, MD, about the latest developments in SARS-CoV-2 science and global spread of infection.</p> <p><a href= "https://jamanetwork.com/journals/jama/pages/coronavirus-alert">JAMA Coronavirus Resource Page</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Coronavirus testing, mortality, vaccine development, containment vs mitigation, and more. JAMA Editor Howard Bauchner, MD, interviews US NIAID Director Anthony Fauci, MD, about the latest developments in SARS-CoV-2 science and global spread of infection.</p> <p><a href= "https://jamanetwork.com/journals/jama/pages/coronavirus-alert">JAMA Coronavirus Resource Page</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/COVID-19_Update_With_NIAIDs_Anthony_Fauci_MD_March_6_2020.mp3?dest-id=90171" length="30816978" type="audio/mpeg" />
      <itunes:duration>32:02</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/8/4/2/9842e194a9ae3594/JVP200012.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Screening for Hepatitis C Virus Infection in Adolescents and Adults</title>
      <itunes:title>USPSTF Recommendation: Screening for Hepatitis C Virus Infection in Adolescents and Adults</itunes:title>
      <pubDate>Mon, 02 Mar 2020 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[67742369-59c7-44d9-bcac-5ec66a8b99eb]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.1000]]></link>
      <description><![CDATA[<p>Interview with Michael J. Barry, MD, Task Force member and coauthor of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.1123"> Screening for Hepatitis C Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Michael J. Barry, MD, Task Force member and coauthor of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.1123"> Screening for Hepatitis C Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation__Screening_for_Hepatitis_C_Virus_Infection_in_Adolescents_and_Adults.mp3?dest-id=90171" length="21965847" type="audio/mpeg" />
      <itunes:duration>22:36</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/5/d/b/7/5db7466a8d8bd1bd/JMI200022.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>A Low-Carbon Future Could Improve Global Health and Save Money</title>
      <itunes:title>A Low-Carbon Future Could Improve Global Health and Save Money</itunes:title>
      <pubDate>Fri, 28 Feb 2020 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[af07ab64-3658-40de-93e9-1aa43ff23b12]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.2277]]></link>
      <description><![CDATA[<p>Interview with Jonathan A. Patz, MD, MPH, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.1313"> A Low-Carbon Future Could Improve Global Health and Achieve Economic Benefits</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Jonathan A. Patz, MD, MPH, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.1313"> A Low-Carbon Future Could Improve Global Health and Achieve Economic Benefits</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/A_Low-Carbon_Future_Could_Improve_Global_Health_and_Save_Money.mp3?dest-id=90171" length="17023452" type="audio/mpeg" />
      <itunes:duration>17:40</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/c/3/1/ec312a10aa0e6209/JVP200012.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>The Inevitable Reimagining of Medical Education</title>
      <itunes:title>The Inevitable Reimagining of Medical Education</itunes:title>
      <pubDate>Thu, 27 Feb 2020 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[5a198518-29f6-4e33-a4f9-ad86a2985ca7]]></guid>
      <link><![CDATA[https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2020.1260]]></link>
      <description><![CDATA[<p>Interview with Ezekiel J. Emanuel, M.D., Ph.D., author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.1227"> The Inevitable Reimagining of Medical Education</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Ezekiel J. Emanuel, M.D., Ph.D., author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.1227"> The Inevitable Reimagining of Medical Education</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/The_Inevitable_Reimagining_of_Medical_Education.mp3?dest-id=90171" length="23799285" type="audio/mpeg" />
      <itunes:duration>24:43</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/7/7/2/87727b6e4947955a/JVP200009.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Screening for Cognitive Impairment</title>
      <itunes:title>USPSTF Recommendation: Screening for Cognitive Impairment</itunes:title>
      <pubDate>Tue, 25 Feb 2020 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[773a95a5-02b5-4e96-b204-d05876ba8b5b]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/uspstf-recommendation-screening-for-cognitive-impairment]]></link>
      <description><![CDATA[<p>Interview with Chyke A Doubeni, MD, MPH, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.0435"> Screening for Cognitive Impairment in Older Adults: US Preventive Services Task Force Recommendation Statement</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Chyke A Doubeni, MD, MPH, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.0435"> Screening for Cognitive Impairment in Older Adults: US Preventive Services Task Force Recommendation Statement</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation__Screening_for_Cognitive_Impairment.mp3?dest-id=90171" length="20849665" type="audio/mpeg" />
      <itunes:duration>21:39</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/1/2/e/612e52844e6f5b28/JMI190095.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>The Evolution of Schools of Thought in Medicine: Healthy Tensions</title>
      <itunes:title>The Evolution of Schools of Thought in Medicine: Healthy Tensions</itunes:title>
      <pubDate>Mon, 24 Feb 2020 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[2a4456d3-1e34-4138-ab9d-3e9d1064a037]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/the-evolution-of-schools-of-thought-in-medicine-healthy-tensions]]></link>
      <description><![CDATA[<p>Interview with David Naylor, MD DPhil, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.0748"> The Evolution of Schools of Thought in Medicine: Healthy Tensions</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with David Naylor, MD DPhil, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.0748"> The Evolution of Schools of Thought in Medicine: Healthy Tensions</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/The_Evolution_of_Schools_of_Thought_in_Medicine__Healthy_Tensions.mp3?dest-id=90171" length="35482873" type="audio/mpeg" />
      <itunes:duration>36:54</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/5/d/4/95d4ba4dcc34aacc/JVP200005.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>JAMA Author Interviews Becomes "Conversations with Dr Bauchner"</title>
      <itunes:title>JAMA Author Interviews Becomes "Conversations with Dr Bauchner"</itunes:title>
      <pubDate>Fri, 14 Feb 2020 18:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[a2be2fcf-d559-4ab7-8c50-9031080935b7]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/jama-author-interviews-becomes-conversations-with-dr-bauchner]]></link>
      <description><![CDATA[<p>JAMA Author Interviews is taking on a new look! Be sure to subscribe to Conversations with Dr Bauchner, a podcast that features the same insightful interviews with leading researchers and thinkers in health care. Covering a broad range of practice-changing research and important innovations, Conversations with Dr Bauchner is a convenient way to stay current with the most pressing issues facing medicine and healthcare. Listen and subscribe at <a href= "https://sites.jamanetwork.com/audio/">jamanetworkaudio.com</a>.</p>]]></description>
      
      <content:encoded><![CDATA[<p>JAMA Author Interviews is taking on a new look! Be sure to subscribe to Conversations with Dr Bauchner, a podcast that features the same insightful interviews with leading researchers and thinkers in health care. Covering a broad range of practice-changing research and important innovations, Conversations with Dr Bauchner is a convenient way to stay current with the most pressing issues facing medicine and healthcare. Listen and subscribe at <a href= "https://sites.jamanetwork.com/audio/">jamanetworkaudio.com</a>.</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_Author_Interviews_Becomes__Conversations_with_Dr_Bauchner_.mp3?dest-id=90171" length="881799" type="audio/mpeg" />
      <itunes:duration>51</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/4/e/1/5/4e15298591cc2608/Conversations-with-Dr-Bauchner-450px.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>COVID-19 Update From China</title>
      <itunes:title>COVID-19 Update From China</itunes:title>
      <pubDate>Fri, 14 Feb 2020 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[af44cfe0-de65-451a-8968-9e8903704b76]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/covid-19-update-from-china]]></link>
      <description><![CDATA[<p>By mid-February 2020 there were 60,000 confirmed cases of COVID-19, the vast majority diagnosed in Hubei Province (including Wuhan city) in mainland China. China CDC Chief Epidemiologist Zunyou Wu, MD, PhD discusses the latest COVID-19 developments in the country with JAMA Editor in Chief Howard Bauchner, MD.</p>]]></description>
      
      <content:encoded><![CDATA[<p>By mid-February 2020 there were 60,000 confirmed cases of COVID-19, the vast majority diagnosed in Hubei Province (including Wuhan city) in mainland China. China CDC Chief Epidemiologist Zunyou Wu, MD, PhD discusses the latest COVID-19 developments in the country with JAMA Editor in Chief Howard Bauchner, MD.</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/COVID-19_Update_From_China.mp3?dest-id=90171" length="24918662" type="audio/mpeg" />
      <itunes:duration>25:53</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/5/e/1/5/5e1527771cb55787/-CDB450x.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Potential Consequences of Changing Disease Classifications</title>
      <itunes:title>Potential Consequences of Changing Disease Classifications</itunes:title>
      <pubDate>Fri, 07 Feb 2020 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[398a1453-759a-4cba-9f42-17fefab6791b]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/potential-consequences-of-changing-disease-classifications]]></link>
      <description><![CDATA[<p>Interview with Jenny A. Doust, BMBS, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.22373"> Potential Consequences of Changing Disease Classifications</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Jenny A. Doust, BMBS, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.22373"> Potential Consequences of Changing Disease Classifications</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Potential_Consequences_of_Changing_Disease_Classifications.mp3?dest-id=90171" length="15128405" type="audio/mpeg" />
      <itunes:duration>15:41</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/f/0/3/6f0321a4f751009b/-CDB450x.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>The 2019 Novel Coronavirus Outbreak – Update From NIAID's Anthony Fauci, MD</title>
      <itunes:title>The 2019 Novel Coronavirus Outbreak – Update From NIAID's Anthony Fauci, MD</itunes:title>
      <pubDate>Fri, 07 Feb 2020 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[f002996a-1d99-4fbd-8148-630c3424d9c1]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/the-2019-novel-coronavirus-outbreak-update-from-niaids-anthony-fauci-md]]></link>
      <description><![CDATA[<p>In February 2020 the nature of the 2019-nCoV outbreak is still slowly coming into focus but it appears to be acting more like bad pandemic influenza (efficient spread, overall lower mortality) than like SARS (less efficient spread, overall higher mortality). Anthony Fauci, MD, of the US National Institute of Allergy and Infectious Diseases (NIAID) discusses the latest developments with JAMA Editor in Chief Howard Bauchner.</p> <p><a href= "https://jamanetwork.com/journals/jama/pages/coronavirus-alert">Coronavirus Resource Center</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>In February 2020 the nature of the 2019-nCoV outbreak is still slowly coming into focus but it appears to be acting more like bad pandemic influenza (efficient spread, overall lower mortality) than like SARS (less efficient spread, overall higher mortality). Anthony Fauci, MD, of the US National Institute of Allergy and Infectious Diseases (NIAID) discusses the latest developments with JAMA Editor in Chief Howard Bauchner.</p> <p><a href= "https://jamanetwork.com/journals/jama/pages/coronavirus-alert">Coronavirus Resource Center</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/The_2019_Novel_Coronavirus_Outbreak__Update_From_NIAID_s_Anthony_Fauci_MD.mp3?dest-id=90171" length="34432686" type="audio/mpeg" />
      <itunes:duration>35:48</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/a/0/9/ea091bad682b5902/-CDB450x.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Billing Quality Is Medical Quality</title>
      <itunes:title>Billing Quality Is Medical Quality</itunes:title>
      <pubDate>Tue, 04 Feb 2020 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[844d4ea5-1129-4ca2-8e68-5abbdd3913ae]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/billing-quality-is-medical-quality]]></link>
      <description><![CDATA[<p>Interview with Martin A. Makary, MD, MPH, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.19648"> Billing Quality Is Medical Quality</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Martin A. Makary, MD, MPH, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.19648"> Billing Quality Is Medical Quality</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Billing_Quality_Is_Medical_Quality.mp3?dest-id=90171" length="24213585" type="audio/mpeg" />
      <itunes:duration>25:09</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/e/6/e/ee6ea59abaed7dd2/-CDB450x.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Refocusing Medication Prior Authorization on Its Intended Purpose</title>
      <itunes:title>Refocusing Medication Prior Authorization on Its Intended Purpose</itunes:title>
      <pubDate>Mon, 03 Feb 2020 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[0ed44fae-371a-4969-951c-49fe4c6979bc]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/refocusing-medication-prior-authorization-on-its-intended-purpose]]></link>
      <description><![CDATA[<p>Interview with Jack Resneck, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.21428"> Refocusing Medication Prior Authorization on Its Intended Purpose</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Jack Resneck, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.21428"> Refocusing Medication Prior Authorization on Its Intended Purpose</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Refocusing_Medication_Prior_Authorization_on_Its_Intended_Purpose.mp3?dest-id=90171" length="24923617" type="audio/mpeg" />
      <itunes:duration>25:52</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/d/6/5/9/d6599509b36c9a4c/-CDB450x.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Coronavirus Infections—More Than Just the Common Cold</title>
      <itunes:title>Coronavirus Infections—More Than Just the Common Cold</itunes:title>
      <pubDate>Tue, 28 Jan 2020 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[4d0fc8d5-40a1-46b9-ac30-4a36675fc3ae]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/coronavirus-infectionsmore-than-just-the-common-cold]]></link>
      <description><![CDATA[<p>Interview with Anthony S. Fauci, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.0757"> Coronavirus Infections—More Than Just the Common Cold</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Anthony S. Fauci, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.0757"> Coronavirus Infections—More Than Just the Common Cold</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Coronavirus_InfectionsMore_Than_Just_the_Common_Cold.mp3?dest-id=90171" length="24729761" type="audio/mpeg" />
      <itunes:duration>25:41</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Ethical and Legal Aspects of Ambient Intelligence in Hospitals</title>
      <itunes:title>Ethical and Legal Aspects of Ambient Intelligence in Hospitals</itunes:title>
      <pubDate>Fri, 24 Jan 2020 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[c1da9dc0-0626-432f-81df-6f04b70973d5]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/ethical-and-legal-aspects-of-ambient-intelligence-in-hospitals]]></link>
      <description><![CDATA[<p>Interview with I Glenn. Cohen, JD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.21699"> Ethical and Legal Aspects of Ambient Intelligence in Hospitals</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with I Glenn. Cohen, JD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.21699"> Ethical and Legal Aspects of Ambient Intelligence in Hospitals</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Ethical_and_Legal_Aspects_of_Ambient_Intelligence_in_Hospitals.mp3?dest-id=90171" length="17279222" type="audio/mpeg" />
      <itunes:duration>17:56</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Improving the Residency Application and Selection Process</title>
      <itunes:title>Improving the Residency Application and Selection Process</itunes:title>
      <pubDate>Thu, 23 Jan 2020 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[cdba7bac-a84b-4b5c-ae11-2974c353fa18]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/improving-the-residency-application-and-selection-process]]></link>
      <description><![CDATA[<p>Interview with Maya M. Hammoud, MD, MBA, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.21212"> Improving the Residency Application and Selection Process: An Optional Early Result Acceptance Program</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Maya M. Hammoud, MD, MBA, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.21212"> Improving the Residency Application and Selection Process: An Optional Early Result Acceptance Program</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Improving_the_Residency_Application_and_Selection_Process.mp3?dest-id=90171" length="22338621" type="audio/mpeg" />
      <itunes:duration>23:12</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/f/4/2/8f425888670179be/-CDB450x.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Practices to Foster Physician Presence and Connection With Patients in the Clinical Encounter</title>
      <itunes:title>Practices to Foster Physician Presence and Connection With Patients in the Clinical Encounter</itunes:title>
      <pubDate>Tue, 07 Jan 2020 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[b85ed571-8d79-41f6-8e2b-2949b78074ba]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/practices-to-foster-physician-presence-and-connection-with-patients-in-the-clinical-encounter]]></link>
      <description><![CDATA[<p>Interview with Donna Michelle Zulman, MD, and Abraham Verghese, MD, authors of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.19003"> Practices to Foster Physician Presence and Connection With Patients in the Clinical Encounter</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Donna Michelle Zulman, MD, and Abraham Verghese, MD, authors of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.19003"> Practices to Foster Physician Presence and Connection With Patients in the Clinical Encounter</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Practices_to_Foster_Physician_Presence_and_Connection_With_Patients_in_the_Clinical_Encounter.mp3?dest-id=90171" length="23865947" type="audio/mpeg" />
      <itunes:duration>24:45</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/d/2/5/2/d252541be8a19feb/JMI190075.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Treatment Decisions for a Future Self</title>
      <itunes:title>Treatment Decisions for a Future Self</itunes:title>
      <pubDate>Thu, 02 Jan 2020 18:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[0b2665e6-e565-4bc4-8703-4e3d43d37b67]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/treatment-decisions-for-a-future-self]]></link>
      <description><![CDATA[<p>Interview with Claire J. Creutzfeldt, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.19652"> Treatment Decisions for a Future Self: Ethical Obligations to Guide Truly Informed Choices</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Claire J. Creutzfeldt, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.19652"> Treatment Decisions for a Future Self: Ethical Obligations to Guide Truly Informed Choices</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Treatment_Decisions_for_a_Future_Self.mp3?dest-id=90171" length="17603147" type="audio/mpeg" />
      <itunes:duration>18:16</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/4/f/c/a/4fcab6c0c8c78a0c/-CDB450x.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>The Potential of Manipulating the Human Microbiome to Manage Disease</title>
      <itunes:title>The Potential of Manipulating the Human Microbiome to Manage Disease</itunes:title>
      <pubDate>Thu, 26 Dec 2019 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[5cb9390b-787a-4b45-a01e-8447079012cd]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/the-potential-of-manipulating-the-human-microbiome-to-manage-disease]]></link>
      <description><![CDATA[<p>Interview with Julia A. Segre, Ph.D., author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.19602"> Manipulating the Human Microbiome to Manage Disease</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Julia A. Segre, Ph.D., author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.19602"> Manipulating the Human Microbiome to Manage Disease</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/The_Potential_of_Manipulating_the_Human_Microbiome_to_Manage_Disease.mp3?dest-id=90171" length="20181532" type="audio/mpeg" />
      <itunes:duration>20:57</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/6/8/d/068db2bb1966a754/-CDB450x.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Disparities Research, Disparities Researchers, and Health Equity</title>
      <itunes:title>Disparities Research, Disparities Researchers, and Health Equity</itunes:title>
      <pubDate>Mon, 16 Dec 2019 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[806230b4-2488-4b31-983b-55dcc55e66b0]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/disparities-research-disparities-researchers-and-health-equity]]></link>
      <description><![CDATA[<p>Interview with Mercedes R. Carnethon, PhD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.19329"> Disparities Research, Disparities Researchers, and Health Equity</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Mercedes R. Carnethon, PhD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.19329"> Disparities Research, Disparities Researchers, and Health Equity</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Disparities_Research_Disparities_Researchers_and_Health_Equity.mp3?dest-id=90171" length="23310378" type="audio/mpeg" />
      <itunes:duration>24:13</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/8/a/8/08a8f67a02bce6c8/-CDB450x.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Comorbidities in Persons With HIV</title>
      <itunes:title>Comorbidities in Persons With HIV</itunes:title>
      <pubDate>Wed, 11 Dec 2019 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[15303758-ac2c-4115-ad09-615102878b35]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/comorbidities-in-persons-with-hiv]]></link>
      <description><![CDATA[<p>Interview with Anthony S. Fauci, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.19775"> Comorbidities in Persons With HIV: The Lingering Challenge</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Anthony S. Fauci, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.19775"> Comorbidities in Persons With HIV: The Lingering Challenge</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Comorbidities_in_Persons_With_HIV.mp3?dest-id=90171" length="23350742" type="audio/mpeg" />
      <itunes:duration>24:15</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/a/1/c/3a1c901d7937a4ce/-CDB450x.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Screening for Abdominal Aortic Aneurysm</title>
      <itunes:title>USPSTF Recommendation: Screening for Abdominal Aortic Aneurysm</itunes:title>
      <pubDate>Tue, 10 Dec 2019 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[80ce8db1-8583-41f4-9f9a-73b4c6f507b2]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/uspstf-recommendation-screening-for-abdominal-aortic-aneurysm]]></link>
      <description><![CDATA[<p>Interview with Michael J. Barry, MD, USPSTF member and coauthor of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.18928"> Screening for Abdominal Aortic Aneurysm: US Preventive Services Task Force Recommendation Statement</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Michael J. Barry, MD, USPSTF member and coauthor of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.18928"> Screening for Abdominal Aortic Aneurysm: US Preventive Services Task Force Recommendation Statement</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation__Screening_for_Abdominal_Aortic_Aneurysm.mp3?dest-id=90171" length="26451372" type="audio/mpeg" />
      <itunes:duration>27:25</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/7/d/7/9/7d7934ab845a3429/JMI190073.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Implementation Strategies for Cardiovascular Polypills</title>
      <itunes:title>Implementation Strategies for Cardiovascular Polypills</itunes:title>
      <pubDate>Mon, 25 Nov 2019 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[3d7933e1-2ad1-43d4-805f-a4ff9a127bed]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/implementation-strategies-for-cardiovascular-polypills]]></link>
      <description><![CDATA[<p>Interview with Mark D. Huffman, MD, MPH, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.18102"> Implementation Strategies for Cardiovascular Polypills</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Mark D. Huffman, MD, MPH, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.18102"> Implementation Strategies for Cardiovascular Polypills</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Implementation_Strategies_for_Cardiovascular_Polypills.mp3?dest-id=90171" length="19851764" type="audio/mpeg" />
      <itunes:duration>20:36</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/6/2/2/9622e76096a3d0c1/-CDB450x.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Addressing Bias in Artificial Intelligence in Health Care</title>
      <itunes:title>Addressing Bias in Artificial Intelligence in Health Care</itunes:title>
      <pubDate>Fri, 22 Nov 2019 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[09325ee5-a163-4aeb-a871-f8cec43befa5]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/addressing-bias-in-artificial-intelligence-in-health-care]]></link>
      <description><![CDATA[<p>Interview with Amol S. Navathe, MD, PhD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.18058"> Addressing Bias in Artificial Intelligence in Health Care</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Amol S. Navathe, MD, PhD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.18058"> Addressing Bias in Artificial Intelligence in Health Care</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Addressing_Bias_in_Artificial_Intelligence_in_Health_Care.mp3?dest-id=90171" length="22332428" type="audio/mpeg" />
      <itunes:duration>23:12</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/f/d/2/2fd26118a9869a99/-CDB450x.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Vaping—Seeking Clarity in a Time of Uncertainty</title>
      <itunes:title>Vaping—Seeking Clarity in a Time of Uncertainty</itunes:title>
      <pubDate>Thu, 07 Nov 2019 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[e9346d110ec74373a0f0f588ee81d061]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/vapingseeking-clarity-in-a-time-of-uncertainty]]></link>
      <description><![CDATA[<p>Interview with Stephen Baldassarri, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.16493"> Vaping—Seeking Clarity in a Time of Uncertainty</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Stephen Baldassarri, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.16493"> Vaping—Seeking Clarity in a Time of Uncertainty</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/VapingSeeking_Clarity_in_a_Time_of_Uncertainty.mp3?dest-id=90171" length="26870975" type="audio/mpeg" />
      <itunes:duration>27:55</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/a/a/3/8aa35ff952c09c4a/-CDB450x.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Improving the System to Support Clinician Well-being and Provide Better Patient Care</title>
      <itunes:title>Improving the System to Support Clinician Well-being and Provide Better Patient Care</itunes:title>
      <pubDate>Wed, 23 Oct 2019 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[02308812d82b49c5b92f24dc2fa3552d]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/improving-the-system-to-support-clinician-well-being-and-provide-better-patient-care]]></link>
      <description><![CDATA[<p>Interview with Pascale Carayon, PhD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.17406"> Improving the System to Support Clinician Well-being and Provide Better Patient Care</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Pascale Carayon, PhD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.17406"> Improving the System to Support Clinician Well-being and Provide Better Patient Care</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Improving_the_System_to_Support_Clinician_Well-being_and_Provide_Better_Patient_Care.mp3?dest-id=90171" length="28088907" type="audio/mpeg" />
      <itunes:duration>29:11</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/e/a/a/9eaadea9f2156b60/-CDB450x.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Lifestyle Science and Health News: Neglecting Major Health Problems in Favor of Minor Uncertain Exposures</title>
      <itunes:title>Lifestyle Science and Health News: Neglecting Major Health Problems in Favor of Minor Uncertain Exposures</itunes:title>
      <pubDate>Fri, 18 Oct 2019 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[d1c212bbfb0c48fea185fb3844055aaa]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/lifestyle-science-and-health-news-neglecting-major-health-problems-in-favor-of-minor-uncertain-exposures]]></link>
      <description><![CDATA[<p>Interview with John P. A. Ioannidis, MD, DSc, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.17576"> Neglecting Major Health Problems and Broadcasting Minor, Uncertain Issues in Lifestyle Science</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with John P. A. Ioannidis, MD, DSc, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.17576"> Neglecting Major Health Problems and Broadcasting Minor, Uncertain Issues in Lifestyle Science</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Lifestyle_Science_and_Health_News__Neglecting_Major_Health_Problems_in_Favor_of_Minor_Uncertain_Exposures.mp3?dest-id=90171" length="21957128" type="audio/mpeg" />
      <itunes:duration>22:48</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>The HHS Guide to Patient-Centered Dose Reduction or Discontinuation of Long-term Opioids</title>
      <itunes:title>The HHS Guide to Patient-Centered Dose Reduction or Discontinuation of Long-term Opioids</itunes:title>
      <pubDate>Thu, 10 Oct 2019 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[a31b31a7220645a0abcbcf3f9bde9835]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/the-hhs-guide-to-patient-centered-dose-reduction-or-discontinuation-of-long-term-opioids]]></link>
      <description><![CDATA[<p>Interview with Deborah Dowell, M.D., M.P.H., author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.16409"> Patient-Centered Reduction or Discontinuation of Long-term Opioid Analgesics: The HHS Guide for Clinicians</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Deborah Dowell, M.D., M.P.H., author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.16409"> Patient-Centered Reduction or Discontinuation of Long-term Opioid Analgesics: The HHS Guide for Clinicians</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/The_HHS_Guide_to_Patient-Centered_Dose_Reduction_or_Discontinuation_of_Long-term_Opioids.mp3?dest-id=90171" length="22005510" type="audio/mpeg" />
      <itunes:duration>22:51</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/6/6/e/066e9a9449949251/-CDB450x.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Waste in the US Health Care System: Estimated Costs and Potential for Savings</title>
      <itunes:title>Waste in the US Health Care System: Estimated Costs and Potential for Savings</itunes:title>
      <pubDate>Mon, 07 Oct 2019 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[e16a5cc18e304bd0a73f04252d10702d]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/waste-in-the-us-health-care-system-estimated-costs-and-potential-for-savings]]></link>
      <description><![CDATA[<p>Interview with William H. Shrank, MD, MSHS, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.13978"> Waste in the US Health Care System: Estimated Costs and Potential for Savings</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with William H. Shrank, MD, MSHS, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.13978"> Waste in the US Health Care System: Estimated Costs and Potential for Savings</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Waste_in_the_US_Health_Care_System__Estimated_Costs_and_Potential_for_Savings.mp3?dest-id=90171" length="24977459" type="audio/mpeg" />
      <itunes:duration>25:57</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>The Risk and Cost of Limited Clinician and Patient Accountability in Health Care</title>
      <itunes:title>The Risk and Cost of Limited Clinician and Patient Accountability in Health Care</itunes:title>
      <pubDate>Mon, 30 Sep 2019 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[5755ffb6baaf42b38c4ed7c6a23da885]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/the-risk-and-cost-of-limited-clinician-and-patient-accountability-in-health-care]]></link>
      <description><![CDATA[<p>Interview with S Claiborne Johnston, MD, PhD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.14832"> The Risk and Cost of Limited Clinician and Patient Accountability in Health Care</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with S Claiborne Johnston, MD, PhD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.14832"> The Risk and Cost of Limited Clinician and Patient Accountability in Health Care</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/The_Risk_and_Cost_of_Limited_Clinician_and_Patient_Accountability_in_Health_Care.mp3?dest-id=90171" length="26865956" type="audio/mpeg" />
      <itunes:duration>27:55</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/d/5/e/8/d5e83cebaa09b08e/-CDB450x.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Screening for Asymptomatic Bacteriuria in Adults</title>
      <itunes:title>USPSTF Recommendation: Screening for Asymptomatic Bacteriuria in Adults</itunes:title>
      <pubDate>Tue, 24 Sep 2019 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[d5da8c23fa1b49afbd3474f6bca4a6af]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/uspstf-recommendation-screening-for-asymptomatic-bacteriuria-in-adults]]></link>
      <description><![CDATA[<p>Interview with Melissa A. Simon, MD, MPH, Task Force member and coauthor of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.13069"> Screening for Asymptomatic Bacteriuria in Adults: US Preventive Services Task Force Recommendation Statement</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Melissa A. Simon, MD, MPH, Task Force member and coauthor of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.13069"> Screening for Asymptomatic Bacteriuria in Adults: US Preventive Services Task Force Recommendation Statement</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation__Screening_for_Asymptomatic_Bacteriuria_in_Adults.mp3?dest-id=90171" length="12660638" type="audio/mpeg" />
      <itunes:duration>13:05</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/b/b/4/0bb4b6215e646fdf/JMI190055.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>The Advancing American Kidney Health Executive Order</title>
      <itunes:title>The Advancing American Kidney Health Executive Order</itunes:title>
      <pubDate>Fri, 20 Sep 2019 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[7b0d9a565c194a8399bae71a5716fd87]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/the-advancing-american-kidney-health-executive-order]]></link>
      <description><![CDATA[<p>Interview with Francisco G. Cigarroa, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.14500"> The Advancing American Kidney Health Executive Order: An Opportunity to Enhance Organ Donation</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Francisco G. Cigarroa, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.14500"> The Advancing American Kidney Health Executive Order: An Opportunity to Enhance Organ Donation</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/The_Advancing_American_Kidney_Health_Executive_Order.mp3?dest-id=90171" length="22705801" type="audio/mpeg" />
      <itunes:duration>23:35</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Can Plant-Based Meat Alternatives Be Part of a Healthy and Sustainable Diet?</title>
      <itunes:title>Can Plant-Based Meat Alternatives Be Part of a Healthy and Sustainable Diet?</itunes:title>
      <pubDate>Mon, 09 Sep 2019 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[758eef904b0e4877b1dd47ba3af73e39]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/can-plant-based-meat-alternatives-be-part-of-a-healthy-and-sustainable-diet]]></link>
      <description><![CDATA[<p>Interview with Frank B. Hu, MD, PhD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.13187"> Can Plant-Based Meat Alternatives Be Part of a Healthy and Sustainable Diet?</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Frank B. Hu, MD, PhD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.13187"> Can Plant-Based Meat Alternatives Be Part of a Healthy and Sustainable Diet?</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Can_Plant-Based_Meat_Alternatives_Be_Part_of_a_Healthy_and_Sustainable_Diet_.mp3?dest-id=90171" length="18898394" type="audio/mpeg" />
      <itunes:duration>19:37</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/4/f/f/a4ff4a99715ee86c/-CDB450x.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Medicaid Expansion and Health: Assessing the Evidence After Five Years</title>
      <itunes:title>Medicaid Expansion and Health: Assessing the Evidence After Five Years</itunes:title>
      <pubDate>Fri, 06 Sep 2019 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[3c46605209c3433484b64a29081d280f]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/medicaid-expansion-and-health-assessing-the-evidence-after-five-years]]></link>
      <description><![CDATA[<p>Interview with Benjamin Daniel Sommers, MD, PhD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.12345"> Medicaid Expansion and Health: Assessing the Evidence After Five Years</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Benjamin Daniel Sommers, MD, PhD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.12345"> Medicaid Expansion and Health: Assessing the Evidence After Five Years</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Medicaid_Expansion_and_Health__Assessing_the_Evidence_After_Five_Years.mp3?dest-id=90171" length="28606337" type="audio/mpeg" />
      <itunes:duration>29:44</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/b/1/2/9/b1294067d27be012/-CDB450x.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>What Is the Value of Market-Wide Health Care Price Transparency?</title>
      <itunes:title>What Is the Value of Market-Wide Health Care Price Transparency?</itunes:title>
      <pubDate>Thu, 05 Sep 2019 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[aa213c244c074cb6b53a828f6a5c4623]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/what-is-the-value-of-market-wide-health-care-price-transparency]]></link>
      <description><![CDATA[<p>Interview with Anna D. Sinaiko, Ph. D., author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.11578"> What Is the Value of Market-Wide Health Care Price Transparency?</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Anna D. Sinaiko, Ph. D., author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.11578"> What Is the Value of Market-Wide Health Care Price Transparency?</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/What_Is_the_Value_of_Market-Wide_Health_Care_Price_Transparency.mp3?dest-id=90171" length="24092378" type="audio/mpeg" />
      <itunes:duration>25:02</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/b/c/9/6bc925bf2919af9c/-CDB450x.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>The Lessons of the Opioid Epidemic</title>
      <itunes:title>The Lessons of the Opioid Epidemic</itunes:title>
      <pubDate>Tue, 03 Sep 2019 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[b32d8691770c431c8b8648d42dc4bf4f]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/the-lessons-of-the-opioid-epidemic]]></link>
      <description><![CDATA[<p>Interview with Yngvild Olsen, M.D., M.P.H., author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.9794"> Lessons Learned From the Opioid Epidemic</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Yngvild Olsen, M.D., M.P.H., author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.9794"> Lessons Learned From the Opioid Epidemic</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/The_Lessons_of_the_Opioid_Epidemic.mp3?dest-id=90171" length="22321901" type="audio/mpeg" />
      <itunes:duration>23:11</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/1/3/1/01312043a6437bb5/-CDB450x.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Medication Use to Reduce Risk of Breast Cancer</title>
      <itunes:title>USPSTF Recommendation: Medication Use to Reduce Risk of Breast Cancer</itunes:title>
      <pubDate>Tue, 03 Sep 2019 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[9363ff92f9cb4416881e5acd893b8867]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/uspstf-recommendation-medication-use-to-reduce-risk-of-breast-cancer]]></link>
      <description><![CDATA[<p>Interview with Michael J. Barry, MD, USPSTF member and coauthor of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.11885"> Medication Use to Reduce Risk of Breast Cancer: US Preventive Services Task Force Recommendation Statement</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Michael J. Barry, MD, USPSTF member and coauthor of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.11885"> Medication Use to Reduce Risk of Breast Cancer: US Preventive Services Task Force Recommendation Statement</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation__Medication_Use_to_Reduce_Risk_of_Breast_Cancer.mp3?dest-id=90171" length="26459831" type="audio/mpeg" />
      <itunes:duration>27:23</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/4/e/c/5/4ec5ca57cfb03e24/JMI190049.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Screening for Social Determinants of Health</title>
      <itunes:title>Screening for Social Determinants of Health</itunes:title>
      <pubDate>Thu, 29 Aug 2019 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[32f7812a57cb4cc4a4e0ce59c16950cf]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/screening-for-social-determinants-of-health]]></link>
      <description><![CDATA[<p>Interview with Karina W. Davidson, PhD, MASc, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.10915"> Screening for Social Determinants of Health: The Known and Unknown</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Karina W. Davidson, PhD, MASc, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.10915"> Screening for Social Determinants of Health: The Known and Unknown</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Screening_for_Social_Determinants_of_Health.mp3?dest-id=90171" length="17762108" type="audio/mpeg" />
      <itunes:duration>18:26</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/6/6/a/a66aa13b270169c7/-CDB450x.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer</title>
      <itunes:title>Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer</itunes:title>
      <pubDate>Tue, 20 Aug 2019 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[1bfc2cf4ce5c40fc9ec3a64919a64d5c]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/risk-assessment-genetic-counseling-and-genetic-testing-for-brca-related-cancer]]></link>
      <description><![CDATA[<p>Interview with Carol M Mangione, MD MSPH, USPSTF member and coauthor of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.10987"> Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement</a></p> <p>Audio at 5:55 was changed to reflect a revised risk increase statement.</p> <p> </p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Carol M Mangione, MD MSPH, USPSTF member and coauthor of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.10987"> Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement</a></p> <p>Audio at 5:55 was changed to reflect a revised risk increase statement.</p> <p> </p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation__Assessment_Counseling_and_Testing_for_BRCA-Related_Cancer.mp3?dest-id=90171" length="31420891" type="audio/mpeg" />
      <itunes:duration>32:38</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/e/9/6/9e96d0cf5d99c40f/JMI190045.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Communication Strategies for Sharing Prognostic Information With Patients: Beyond Survival Statistics</title>
      <itunes:title>Communication Strategies for Sharing Prognostic Information With Patients: Beyond Survival Statistics</itunes:title>
      <pubDate>Thu, 15 Aug 2019 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[3d83c1c3a7e14604b5ac02439a32fe3d]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/communication-strategies-for-sharing-prognostic-information-with-patients-beyond-survival-statistics]]></link>
      <description><![CDATA[<p>Interview with Joanna Paladino, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.11533"> Communication Strategies for Sharing Prognostic Information With Patients: Beyond Survival Statistics</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Joanna Paladino, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.11533"> Communication Strategies for Sharing Prognostic Information With Patients: Beyond Survival Statistics</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Communication_Strategies_for_Sharing_Prognostic_Information_With_Patients__Beyond_Survival_Statistics.mp3?dest-id=90171" length="22744007" type="audio/mpeg" />
      <itunes:duration>23:37</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/a/9/2/3a920722351ae5f3/-CDB450x.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Extracorporeal Life Support for Adults With Respiratory Failure and Related Indications</title>
      <itunes:title>Extracorporeal Life Support for Adults With Respiratory Failure and Related Indications</itunes:title>
      <pubDate>Tue, 13 Aug 2019 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[00d0b06e7ac54e778c321e74c939d2d8]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/extracorporeal-life-support-for-adults-with-respiratory-failure-and-related-indications]]></link>
      <description><![CDATA[<p>Interview with Daniel Brodie, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.9302"> Extracorporeal Life Support for Adults With Respiratory Failure and Related Indications: A Review</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Daniel Brodie, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.9302"> Extracorporeal Life Support for Adults With Respiratory Failure and Related Indications: A Review</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Extracorporeal_Life_Support_for_Adults_With_Respiratory_Failure_and_Related_Indications.mp3?dest-id=90171" length="35589599" type="audio/mpeg" />
      <itunes:duration>37:00</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/9/7/1/c971400ebcc50847/JRV190007.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Success of Opt-In Organ Donation Policy in the United States</title>
      <itunes:title>Success of Opt-In Organ Donation Policy in the United States</itunes:title>
      <pubDate>Thu, 08 Aug 2019 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[1b4da07de4394ce79caba1007136d05e]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/success-of-opt-in-organ-donation-policy-in-the-united-states]]></link>
      <description><![CDATA[<p>Interview with Alexandra K. Glazier, JD, MPH, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.9187"> Success of Opt-In Organ Donation Policy in the United States</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Alexandra K. Glazier, JD, MPH, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.9187"> Success of Opt-In Organ Donation Policy in the United States</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Success_of_Opt-In_Organ_Donation_Policy_in_the_United_States.mp3?dest-id=90171" length="24575121" type="audio/mpeg" />
      <itunes:duration>25:32</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/5/b/f/5/5bf502caa24ddaa2/JVP190094.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Accelerating the Science of Sickle Cell Disease Therapies—Is a Cure Possible?</title>
      <itunes:title>Accelerating the Science of Sickle Cell Disease Therapies—Is a Cure Possible?</itunes:title>
      <pubDate>Thu, 08 Aug 2019 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[e76af6f4bfa7420d8a5663d058525764]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/accelerating-the-science-of-sickle-cell-disease-therapiesis-a-cure-possible]]></link>
      <description><![CDATA[<p>Interview with Gary H. Gibbons, M.D., author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.11419"> Accelerating the Science of SCD Therapies—Is a Cure Possible?</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Gary H. Gibbons, M.D., author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.11419"> Accelerating the Science of SCD Therapies—Is a Cure Possible?</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Accelerating_the_Science_of_Sickle_Cell_Disease_TherapiesIs_a_Cure_Possible_.mp3?dest-id=90171" length="22050638" type="audio/mpeg" />
      <itunes:duration>22:54</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/b/7/8/9/b789c7f51524f44e/JVP190114.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Screening for Pancreatic Cancer</title>
      <itunes:title>USPSTF Recommendation: Screening for Pancreatic Cancer</itunes:title>
      <pubDate>Tue, 06 Aug 2019 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[0f5b00fdadc64d5883cc7a7744ea3081]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/uspstf-recommendation-screening-for-pancreatic-cancer]]></link>
      <description><![CDATA[<p>Interview with Chyke A Doubeni, MD, MPH, USPSTF member and coauthor of Screening for Pancreatic Cancer: US Preventive Services Task Force Reaffirmation Recommendation Statement</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Chyke A Doubeni, MD, MPH, USPSTF member and coauthor of Screening for Pancreatic Cancer: US Preventive Services Task Force Reaffirmation Recommendation Statement</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation__Screening_for_Pancreatic_Cancer.mp3?dest-id=90171" length="16946335" type="audio/mpeg" />
      <itunes:duration>17:06</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/9/a/2/e9a2aaed9e6a649f/JMI190041.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Relative Value Units and the Measurement of Physician Performance</title>
      <itunes:title>Relative Value Units and the Measurement of Physician Performance</itunes:title>
      <pubDate>Mon, 05 Aug 2019 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[d96f6a85fe844c89a17a4ff7ae698ed2]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/relative-value-units-and-the-measurement-of-physician-performance]]></link>
      <description><![CDATA[<p>Interview with Michael Nurok, MBChB, PhD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.11163"> Relative Value Units and the Measurement of Physician Performance</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Michael Nurok, MBChB, PhD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.11163"> Relative Value Units and the Measurement of Physician Performance</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Relative_Value_Units_and_the_Measurement_of_Physician_Performance.mp3?dest-id=90171" length="20709414" type="audio/mpeg" />
      <itunes:duration>21:30</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/f/e/5/efe5c91765bbd27f/JVP190109.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Reimagining Specialty Consultation in the Digital Age</title>
      <itunes:title>Reimagining Specialty Consultation in the Digital Age</itunes:title>
      <pubDate>Fri, 26 Jul 2019 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[195b2785a1854fdab1927e35de3fbc27]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/reimagining-specialty-consultation-in-the-digital-age]]></link>
      <description><![CDATA[<p>Interview with Robert M. Wachter, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.6607"> Reimagining Specialty Consultation in the Digital Age: The Potential Role of Targeted Automatic Electronic Consultations</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Robert M. Wachter, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.6607"> Reimagining Specialty Consultation in the Digital Age: The Potential Role of Targeted Automatic Electronic Consultations</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Reimagining_Specialty_Consultation_in_the_Digital_Age.mp3?dest-id=90171" length="28080963" type="audio/mpeg" />
      <itunes:duration>29:11</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/4/d/5/8/4d58bc31d8685ddb/JVP190072.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Implications of the United States Medical Licensing Examination (USMLE) Score Reporting Structure</title>
      <itunes:title>Implications of the United States Medical Licensing Examination (USMLE) Score Reporting Structure</itunes:title>
      <pubDate>Tue, 23 Jul 2019 19:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[f865bb68b1ea4c0185099a45927aaa8f]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/implications-of-the-united-states-medical-licensing-examination-usmle-score-reporting-structure]]></link>
      <description><![CDATA[<p>Interview with Jennifer L. Swails, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.9669"> The Conundrum of the United States Medical Licensing Examination Score Reporting Structure</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Jennifer L. Swails, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.9669"> The Conundrum of the United States Medical Licensing Examination Score Reporting Structure</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Implications_of_the_United_States_Medical_Licensing_Examination_USMLE_Score_Reporting_Structure.mp3?dest-id=90171" length="26470150" type="audio/mpeg" />
      <itunes:duration>27:30</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/4/3/5/943598fcdb4a47f7/JVP190096.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Screening for Hepatitis B Virus Infection in Pregnant Women</title>
      <itunes:title>Screening for Hepatitis B Virus Infection in Pregnant Women</itunes:title>
      <pubDate>Tue, 23 Jul 2019 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[63d36b779cb84a08862a6ff4358df089]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/screening-for-hepatitis-b-virus-infection-in-pregnant-women]]></link>
      <description><![CDATA[<p>Interview with Melissa A Simon, MD MPH, USPSTF member and coauthor of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.9365"> Screening for Hepatitis B Virus Infection in Pregnant Women: US Preventive Services Task Force Reaffirmation Recommendation Statement</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Melissa A Simon, MD MPH, USPSTF member and coauthor of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.9365"> Screening for Hepatitis B Virus Infection in Pregnant Women: US Preventive Services Task Force Reaffirmation Recommendation Statement</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Screening_for_Hepatitis_B_Virus_Infection_in_Pregnant_Women.mp3?dest-id=90171" length="13906751" type="audio/mpeg" />
      <itunes:duration>14:13</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/f/d/b/9fdbe1da5ec032a7/JMI190035.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>A Practical Approach to Low-Dose Aspirin for Primary Prevention</title>
      <itunes:title>A Practical Approach to Low-Dose Aspirin for Primary Prevention</itunes:title>
      <pubDate>Fri, 28 Jun 2019 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[8494eca8aa8a44e9b67e7cd63de008a8]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/a-practical-approach-to-low-dose-aspirin-for-primary-prevention]]></link>
      <description><![CDATA[<p>Interview with Randall S. Stafford, MD, PhD, MHS, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.8388"> A Practical Approach to Low-Dose Aspirin for Primary Prevention</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Randall S. Stafford, MD, PhD, MHS, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.8388"> A Practical Approach to Low-Dose Aspirin for Primary Prevention</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/A_Practical_Approach_to_Low-Dose_Aspirin_for_Primary_Prevention.mp3?dest-id=90171" length="21598731" type="audio/mpeg" />
      <itunes:duration>22:26</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/a/d/e/aade36ff9e7f5572/-CDB450x.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Academic Medical Centers—Too Large for Their Own Good?</title>
      <itunes:title>Academic Medical Centers—Too Large for Their Own Good?</itunes:title>
      <pubDate>Mon, 17 Jun 2019 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[3dacf6f2b9bd47979255193b34198230]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/academic-medical-centerstoo-large-for-their-own-good]]></link>
      <description><![CDATA[<p>Interview with S. Claiborne Johnston, MD, PhD, author of <a href="http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.6834"> Academic Medical Centers: Too Large for Their Own Health?</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with S. Claiborne Johnston, MD, PhD, author of <a href="http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.6834"> Academic Medical Centers: Too Large for Their Own Health?</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Academic_Medical_CentersToo_Large_for_Their_Own_Good_.mp3?dest-id=90171" length="28256843" type="audio/mpeg" />
      <itunes:duration>29:21</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/8/7/a/887a4c6d9cdafbdc/-CDB450x.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>HIV Screening and Preexposure Prophylaxis Guidelines</title>
      <itunes:title>HIV Screening and Preexposure Prophylaxis Guidelines</itunes:title>
      <pubDate>Tue, 11 Jun 2019 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[31d8e59c059d4396ab25c34feab53412]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/hiv-screening-and-preexposure-prophylaxis-guidelines]]></link>
      <description><![CDATA[<p>Interview with Paul A. Volberding, MD, and Hyman Scott, MD MPH, authors of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.2590"> HIV Screening and Preexposure Prophylaxis Guidelines: Following the Evidence</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Paul A. Volberding, MD, and Hyman Scott, MD MPH, authors of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.2590"> HIV Screening and Preexposure Prophylaxis Guidelines: Following the Evidence</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/HIV_Screening_and_Preexposure_Prophylaxis_Guidelines.mp3?dest-id=90171" length="26370656" type="audio/mpeg" />
      <itunes:duration>27:24</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/f/d/e/3fde645faab52cbe/JED190020.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Screening for HIV infection and Use of Preexposure Prophylaxis for Prevention of HIV Infection: US Preventive Services Task Force Recommendation Statements</title>
      <itunes:title>Screening for HIV infection and Use of Preexposure Prophylaxis for Prevention of HIV Infection: US Preventive Services Task Force Recommendation Statements</itunes:title>
      <pubDate>Tue, 11 Jun 2019 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[b0892b3ac3824652a3049d2b5eff723c]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/screening-for-hiv-infection-and-use-of-preexposure-prophylaxis-for-prevention-of-hiv-infection-us-preventive-services-task-force-recommendation-statements]]></link>
      <description><![CDATA[<p>Interview with John W Epling, MD, MSEd, Task Force member and co-author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.6390"> Preexposure Prophylaxis for the Prevention of HIV Infection: US Preventive Services Task Force Recommendation Statement</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with John W Epling, MD, MSEd, Task Force member and co-author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.6390"> Preexposure Prophylaxis for the Prevention of HIV Infection: US Preventive Services Task Force Recommendation Statement</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Screening_for_HIV_infection_and_Use_of_Preexposure_Prophylaxis_for_Prevention_of_HIV_Infection__US_Preventive_Services_Task_Force_Recommendation_Statements.mp3?dest-id=90171" length="24862663" type="audio/mpeg" />
      <itunes:duration>25:40</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/1/8/a/918aa6357ac2b0ba/JMI190029.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>The Review of Systems, the Electronic Health Record, and Billing</title>
      <itunes:title>The Review of Systems, the Electronic Health Record, and Billing</itunes:title>
      <pubDate>Fri, 07 Jun 2019 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[b9a78f0869884dccb2985a1f5e33d6db]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/the-review-of-systems-the-electronic-health-record-and-billing]]></link>
      <description><![CDATA[<p>Interview with Marissa A. Hendrickson, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.5667"> The Review of Systems, the Electronic Health Record, and Billing</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Marissa A. Hendrickson, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.5667"> The Review of Systems, the Electronic Health Record, and Billing</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/The_Review_of_Systems_the_Electronic_Health_Record_and_Billing.mp3?dest-id=90171" length="16632150" type="audio/mpeg" />
      <itunes:duration>17:14</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/d/7/e/0d7e0db7ba0ae2ce/-CDB450x.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Durable Control of HIV Infection in the Absence of Antiretroviral Therapy</title>
      <itunes:title>Durable Control of HIV Infection in the Absence of Antiretroviral Therapy</itunes:title>
      <pubDate>Thu, 06 Jun 2019 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[18e70cf15c6d45389353c726165f7a24]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/durable-control-of-hiv-infection-in-the-absence-of-antiretroviral-therapy]]></link>
      <description><![CDATA[<p>Interview with Anthony S. Fauci, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.5397"> Durable Control of HIV Infection in the Absence of Antiretroviral Therapy: Opportunities and Obstacles</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Anthony S. Fauci, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.5397"> Durable Control of HIV Infection in the Absence of Antiretroviral Therapy: Opportunities and Obstacles</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Durable_Control_of_HIV_Infection_in_the_Absence_of_Antiretroviral_Therapy.mp3?dest-id=90171" length="26742577" type="audio/mpeg" />
      <itunes:duration>27:46</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/7/3/d/d/73ddfa142022b810/-CDB450x.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Medication-Based Treatment for Opioid Use Disorder</title>
      <itunes:title>Medication-Based Treatment for Opioid Use Disorder</itunes:title>
      <pubDate>Tue, 04 Jun 2019 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[f8d1e2fddbea48ee8cf275e036cc7e8a]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/medication-based-treatment-for-opioid-use-disorder]]></link>
      <description><![CDATA[<p>Interview with Alan Leshner, PhD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.5523"> Medication-Based Treatment to Address Opioid Use Disorder</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Alan Leshner, PhD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.5523"> Medication-Based Treatment to Address Opioid Use Disorder</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Medication-Based_Treatment_for_Opioid_Use_Disorder.mp3?dest-id=90171" length="21689662" type="audio/mpeg" />
      <itunes:duration>22:30</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/3/d/b/33dbe89ea77ad6c8/jai_450px.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>New Approaches to Management of Depression</title>
      <itunes:title>New Approaches to Management of Depression</itunes:title>
      <pubDate>Fri, 24 May 2019 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[572bc8e588904b1ab137f157e8993b31]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/new-approaches-to-management-of-depression]]></link>
      <description><![CDATA[<p>Interview with Andrew A. Nierenberg, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.4990"> Evolving Issues in the Treatment of Depression</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Andrew A. Nierenberg, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.4990"> Evolving Issues in the Treatment of Depression</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/New_Approaches_to_Management_of_Depression.mp3?dest-id=90171" length="18946804" type="audio/mpeg" />
      <itunes:duration>19:39</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/f/8/5/cf85361dc9265575/1_jai_450px.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Restricting the Number of Open Patient Records in the Electronic Health Record</title>
      <itunes:title>Restricting the Number of Open Patient Records in the Electronic Health Record</itunes:title>
      <pubDate>Tue, 14 May 2019 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[e9cc9525ecff455cb7e7ccf0a97d167b]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/restricting-the-number-of-open-patient-records-in-the-electronic-health-record]]></link>
      <description><![CDATA[<p>Interview with Robert M. Wachter, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.3835"> Restricting the Number of Open Patient Records in the Electronic Health Record: Is the Record Half Open or Half Closed?</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Robert M. Wachter, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.3835"> Restricting the Number of Open Patient Records in the Electronic Health Record: Is the Record Half Open or Half Closed?</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Restricting_the_Number_of_Open_Patient_Records_in_the_Electronic_Health_Record.mp3?dest-id=90171" length="23554046" type="audio/mpeg" />
      <itunes:duration>24:28</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/c/a/1/6ca17c83da2387a5/JED190027.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Life and Death in Norway and the US</title>
      <itunes:title>Life and Death in Norway and the US</itunes:title>
      <pubDate>Mon, 13 May 2019 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[2b05fad4eb7d456f9f89fbbc3005405e]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/life-and-death-in-norway-and-the-us]]></link>
      <description><![CDATA[<p>Interview with David M. Cutler, PhD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.4891"> Life and Death in Norway and the United States</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with David M. Cutler, PhD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.4891"> Life and Death in Norway and the United States</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Life_and_Death_in_Norway_and_the_US.mp3?dest-id=90171" length="23079358" type="audio/mpeg" />
      <itunes:duration>23:57</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/f/e/5/2fe5ef51c1e047f8/jai_450px.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Federal Requirements to Inform Patients About Breast Density</title>
      <itunes:title>Federal Requirements to Inform Patients About Breast Density</itunes:title>
      <pubDate>Thu, 09 May 2019 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[d5e5e00233b74ae284dd6a2a84f442c1]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/federal-requirements-to-inform-patients-about-breast-density]]></link>
      <description><![CDATA[<p>Interview with Nancy L. Keating, MD, MPH, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.5919"> New Federal Requirements to Inform Patients About Breast Density: Will They Help Patients?</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Nancy L. Keating, MD, MPH, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.5919"> New Federal Requirements to Inform Patients About Breast Density: Will They Help Patients?</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Federal_Requirements_to_Inform_Patients_About_Breast_Density.mp3?dest-id=90171" length="20930017" type="audio/mpeg" />
      <itunes:duration>21:43</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/b/0/1/f/b01fae30c6686a7a/1_jai_450px.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Treatment of Patients With Psychogenic Nonepileptic Attacks</title>
      <itunes:title>Treatment of Patients With Psychogenic Nonepileptic Attacks</itunes:title>
      <pubDate>Fri, 26 Apr 2019 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[65581ac691e04f4b9f9f2c0cdee2d107]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/treatment-of-patients-with-psychogenic-nonepileptic-attacks]]></link>
      <description><![CDATA[<p>Interview with Benjamin Tolchin, MD, MS, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.3520"> Treatment of Patients With Psychogenic Nonepileptic Attacks</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Benjamin Tolchin, MD, MS, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.3520"> Treatment of Patients With Psychogenic Nonepileptic Attacks</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Treatment_of_Patients_With_Psychogenic_Nonepileptic_Attacks.mp3?dest-id=90171" length="19144711" type="audio/mpeg" />
      <itunes:duration>19:51</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/d/6/6/ed669a37f2f6eef1/jai_450px.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Lowering Cost and Increasing Access to Drugs Without Hurting Innovation</title>
      <itunes:title>Lowering Cost and Increasing Access to Drugs Without Hurting Innovation</itunes:title>
      <pubDate>Tue, 23 Apr 2019 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[03fcd1de41ab429abd4f2e59538bae7b]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/lowering-cost-and-increasing-access-to-drugs-without-hurting-innovation]]></link>
      <description><![CDATA[<p>Interview with Robert M. Califf, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.3846"> Lowering Cost and Increasing Access to Drugs Without Jeopardizing Innovation</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Robert M. Califf, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.3846"> Lowering Cost and Increasing Access to Drugs Without Jeopardizing Innovation</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Lowering_Cost_and_Increasing_Access_to_Drugs_Without_Hurting_Innovation.mp3?dest-id=90171" length="28625899" type="audio/mpeg" />
      <itunes:duration>29:44</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/a/4/b/6a4b17a8b884ab9f/-CDB450x.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Screening for Elevated Blood Lead Levels in Children and Pregnancy</title>
      <itunes:title>USPSTF Recommendation: Screening for Elevated Blood Lead Levels in Children and Pregnancy</itunes:title>
      <pubDate>Tue, 16 Apr 2019 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[66b5577076934ae4b46129a5da4d9f66]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/uspstf-recommendation-screening-for-elevated-blood-lead-levels-in-children-and-pregnancy]]></link>
      <description><![CDATA[<p>Interview with Michael Silverstein, MD, MPH, USPSTF member and coauthor of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.3326"> Screening for Elevated Blood Lead Levels in Children and Pregnant Women: US Preventive Services Task Force Recommendation Statement</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Michael Silverstein, MD, MPH, USPSTF member and coauthor of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.3326"> Screening for Elevated Blood Lead Levels in Children and Pregnant Women: US Preventive Services Task Force Recommendation Statement</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation__Screening_for_Elevated_Blood_Lead_Levels_in_Children_and_Pregnancy.mp3?dest-id=90171" length="20622294" type="audio/mpeg" />
      <itunes:duration>21:09</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/9/d/d/19dddf8072861248/JMI190016.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Insights From 2 New Trials on Vitamin D as Cancer Therapy</title>
      <itunes:title>Insights From 2 New Trials on Vitamin D as Cancer Therapy</itunes:title>
      <pubDate>Tue, 09 Apr 2019 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[5e1c81a9120c4c5cafe927bb2b43e8ee]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/insights-from-2-new-trials-on-vitamin-d-as-cancer-therapy]]></link>
      <description><![CDATA[<p>Interview with John A. Baron, M.D., author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.2589"> Vitamin D as Cancer Therapy?: Insights From 2 New Trials</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with John A. Baron, M.D., author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.2589"> Vitamin D as Cancer Therapy?: Insights From 2 New Trials</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Insights_From_2_New_Trials_on_Vitamin_D_as_Cancer_Therapy.mp3?dest-id=90171" length="18051530" type="audio/mpeg" />
      <itunes:duration>18:43</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/f/1/6/3/f16342e121dd282e/1_jai_450px.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>The Implications of "Medicare for All" for US Hospitals</title>
      <itunes:title>The Implications of "Medicare for All" for US Hospitals</itunes:title>
      <pubDate>Thu, 04 Apr 2019 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[8a009992064c4dc3a8593408cddc78db]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/the-implications-of-medicare-for-all-for-us-hospitals]]></link>
      <description><![CDATA[<p>Interview with Kevin A. Schulman, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.3134"> The Implications of "Medicare for All" for US Hospitals</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Kevin A. Schulman, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.3134"> The Implications of "Medicare for All" for US Hospitals</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/The_Implications_of__Medicare_for_All__for_US_Hospitals.mp3?dest-id=90171" length="21367204" type="audio/mpeg" />
      <itunes:duration>22:10</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/f/7/0/1f70c66be3e767ec/1_jai_450px.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>The Uncertain Effect of Financial Incentives to Improve Health Behaviors</title>
      <itunes:title>The Uncertain Effect of Financial Incentives to Improve Health Behaviors</itunes:title>
      <pubDate>Mon, 25 Mar 2019 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[09fcdbe22cc449d2ad6e4a0d0607d832]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/the-uncertain-effect-of-financial-incentives-to-improve-health-behaviors]]></link>
      <description><![CDATA[<p>Interview with David A. Asch, MD, MBA, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.2560"> The Uncertain Effect of Financial Incentives to Improve Health Behaviors</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with David A. Asch, MD, MBA, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.2560"> The Uncertain Effect of Financial Incentives to Improve Health Behaviors</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/The_Uncertain_Effect_of_Financial_Incentives_to_Improve_Health_Behaviors.mp3?dest-id=90171" length="20163062" type="audio/mpeg" />
      <itunes:duration>20:55</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/b/3/6/d/b36d724f10e6417f/-CDB450x.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Recommendations for Treatment of Hypercholesterolemia in Older Adults</title>
      <itunes:title>Recommendations for Treatment of Hypercholesterolemia in Older Adults</itunes:title>
      <pubDate>Mon, 11 Mar 2019 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[99328c0b43f74fd5a1aba486f9d9285d]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/recommendations-for-treatment-of-hypercholesterolemia-in-older-adults]]></link>
      <description><![CDATA[<p>Interview with Neil Skolnik, M.D., author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.1676"> Reexamining Recommendations for Treatment of Hypercholesterolemia in Older Adults</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Neil Skolnik, M.D., author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.1676"> Reexamining Recommendations for Treatment of Hypercholesterolemia in Older Adults</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/recommendations-for-treatment-of-hypercholesterolemia-in-older-adults.mp3?dest-id=90171" length="20596068" type="audio/mpeg" />
      <itunes:duration>21:22</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/5/b/1/a/5b1a1a193f4591ab/-CDB450x.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Next Phase in Effective Cost Control in Health Care</title>
      <itunes:title>Next Phase in Effective Cost Control in Health Care</itunes:title>
      <pubDate>Thu, 07 Mar 2019 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[8d65f6eb4d6b43aca053b8b6320a23c7]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/next-phase-in-effective-cost-control-in-health-care]]></link>
      <description><![CDATA[<p>Interview with Ezekiel J. Emanuel, M.D., Ph.D., author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.1608"> Next Phase in Effective Cost Control in Health Care</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Ezekiel J. Emanuel, M.D., Ph.D., author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.1608"> Next Phase in Effective Cost Control in Health Care</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Next_Phase_in_Effective_Cost_Control_in_Health_Care.mp3?dest-id=90171" length="27864598" type="audio/mpeg" />
      <itunes:duration>28:56</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/f/3/b/6f3b58d549d016d1/JVP200156.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Interventions to Prevent Perinatal Depression</title>
      <itunes:title>USPSTF Recommendation: Interventions to Prevent Perinatal Depression</itunes:title>
      <pubDate>Tue, 12 Feb 2019 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[a7a482a99ff44cccad0bc498124a0b5a]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/uspstf-recommendation-interventions-to-prevent-perinatal-depression]]></link>
      <description><![CDATA[<p>Interview with Elizabeth O'Connor, PHD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.20865"> Interventions to Prevent Perinatal Depression: Evidence Report and Systematic Review for the US Preventive Services Task Force</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Elizabeth O'Connor, PHD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.20865"> Interventions to Prevent Perinatal Depression: Evidence Report and Systematic Review for the US Preventive Services Task Force</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation__Interventions_to_Prevent_Perinatal_Depression.mp3?dest-id=90171" length="19542418" type="audio/mpeg" />
      <itunes:duration>20:07</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/6/6/5/e665e6009ee8d396/JMI180106.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Humanizing Artificial Intelligence</title>
      <itunes:title>Humanizing Artificial Intelligence</itunes:title>
      <pubDate>Mon, 10 Dec 2018 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[62c8645ac9d04b2692ad8fb1b06600cf]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/humanizing-artificial-intelligence-through-a-glass-differently]]></link>
      <description><![CDATA[<p>Interview with Sonoo Thadaney-Israni, MBA, and Abraham Verghese, MD, MACP, authors of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.19398"> Humanizing Artificial Intelligence</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Sonoo Thadaney-Israni, MBA, and Abraham Verghese, MD, MACP, authors of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.19398"> Humanizing Artificial Intelligence</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Humanizing_Artificial_Intelligence.mp3?dest-id=90171" length="24572117" type="audio/mpeg" />
      <itunes:duration>25:24</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/f/4/3/3/f433a1b2352a6776/JVP180159.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Screening for Child Maltreatment</title>
      <itunes:title>USPSTF Recommendation: Screening for Child Maltreatment</itunes:title>
      <pubDate>Tue, 27 Nov 2018 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[62d60b2f526c4683a0e605df7ac2bd7c]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/uspstf-recommendation-screening-for-child-maltreatment]]></link>
      <description><![CDATA[<p>Interview with Alex R Kemper, MD, MPH, MS, Task Force member and co-author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.17772"> Interventions to Prevent Child Maltreatment: US Preventive Services Task Force Recommendation Statement</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Alex R Kemper, MD, MPH, MS, Task Force member and co-author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.17772"> Interventions to Prevent Child Maltreatment: US Preventive Services Task Force Recommendation Statement</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation__Screening_for_Child_Maltreatment.mp3?dest-id=90171" length="12875739" type="audio/mpeg" />
      <itunes:duration>13:21</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/f/1/e/3f1e4dcbf22f2e00/JMI180093.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Screening and Interventions for Unhealthy Alcohol Use</title>
      <itunes:title>USPSTF Recommendation: Screening and Interventions for Unhealthy Alcohol Use</itunes:title>
      <pubDate>Tue, 13 Nov 2018 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[8c3fd76c37f74c9e89c310d55008bb51]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/uspstf-recommendation-screening-and-interventions-for-unhealthy-alcohol-use]]></link>
      <description><![CDATA[<p>Interview with Susan J. Curry, PhD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.16789"> Screening and Behavioral Counseling Interventions to Reduce Unhealthy Alcohol Use in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Susan J. Curry, PhD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.16789"> Screening and Behavioral Counseling Interventions to Reduce Unhealthy Alcohol Use in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation__Screening_and_Interventions_for_Unhealthy_Alcohol_Use.mp3?dest-id=90171" length="19423377" type="audio/mpeg" />
      <itunes:duration>20:12</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/b/b/b/c/bbbc884a17e70f43/JUS180025.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Screening for Intimate Partner Violence</title>
      <itunes:title>USPSTF Recommendation: Screening for Intimate Partner Violence</itunes:title>
      <pubDate>Tue, 23 Oct 2018 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[3181f85b4aef4f6c870e564278a7548b]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/uspstf-recommendation-screening-for-intimate-partner-violence]]></link>
      <description><![CDATA[<p>Interview with John W Epling, MD, MSEd, Task Force member and co-author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.14741"> Screening for Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: US Preventive Services Task Force Final Recommendation Statement</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with John W Epling, MD, MSEd, Task Force member and co-author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.14741"> Screening for Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: US Preventive Services Task Force Final Recommendation Statement</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation__Screening_for_Intimate_Partner_Violence.mp3?dest-id=90171" length="18662557" type="audio/mpeg" />
      <itunes:duration>19:07</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/b/8/b/2/b8b2f8417c1dd318/JMI180081.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Behavioral Interventions to Prevent Adult Obesity-Related Outcomes</title>
      <itunes:title>USPSTF Recommendation: Behavioral Interventions to Prevent Adult Obesity-Related Outcomes</itunes:title>
      <pubDate>Tue, 18 Sep 2018 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[eb424148adfd469fa9ceaca7c7b1b738]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/uspstf-recommendation-behavioral-interventions-to-prevent-adult-obesity-related-outcomes]]></link>
      <description><![CDATA[<p>Interview with Chyke A Doubeni, M.D., F.R.C.S., M.P.H., Task Force member and co-author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.13022"> Behavioral Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: US Preventive Services Task Force Recommendation Statement</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Chyke A Doubeni, M.D., F.R.C.S., M.P.H., Task Force member and co-author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.13022"> Behavioral Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: US Preventive Services Task Force Recommendation Statement</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation__Behavioral_Interventions_to_Prevent_Adult_Obesity-Related_Outcomes.mp3?dest-id=90171" length="14204120" type="audio/mpeg" />
      <itunes:duration>14:37</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/c/b/3/acb3801c88166add/JMI180072.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Screening for Cervical Cancer</title>
      <itunes:title>USPSTF Recommendation: Screening for Cervical Cancer</itunes:title>
      <pubDate>Tue, 21 Aug 2018 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[071457dfcc4e4419988d59e9b5c34f84]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/uspstf-recommendation-screening-for-cervical-cancer]]></link>
      <description><![CDATA[<p>Interview with Carol M Mangione, MD MSPH, Task Force member and co-author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.10897"> Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Carol M Mangione, MD MSPH, Task Force member and co-author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.10897"> Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation__Screening_for_Cervical_Cancer.mp3?dest-id=90171" length="21991787" type="audio/mpeg" />
      <itunes:duration>22:48</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/c/d/d/2cdd917cddc857e5/JMI180064.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Screening for Atrial Fibrillation With Electrocardiography</title>
      <itunes:title>USPSTF Recommendation: Screening for Atrial Fibrillation With Electrocardiography</itunes:title>
      <pubDate>Tue, 07 Aug 2018 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[e34a190382e54deca5468e920cc366f9]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/uspstf-recommendation-screening-for-atrial-fibrillation-with-electrocardiography]]></link>
      <description><![CDATA[<p>Interview with Seth Landefeld, MD, member of the US Preventative Services Task Force, on  <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.10321"> Screening for Atrial Fibrillation With Electrocardiography: US Preventive Services Task Force Recommendation Statement</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Seth Landefeld, MD, member of the US Preventative Services Task Force, on <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.10321"> Screening for Atrial Fibrillation With Electrocardiography: US Preventive Services Task Force Recommendation Statement</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation__Screening_for_Atrial_Fibrillation_With_Electrocardiography.mp3?dest-id=90171" length="16361208" type="audio/mpeg" />
      <itunes:duration>16:50</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/b/2/e/2b2e373255132e55/JMI180065.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Nontraditional Risk Factors and Peripheral Artery Disease</title>
      <itunes:title>USPSTF Recommendation: Nontraditional Risk Factors and Peripheral Artery Disease</itunes:title>
      <pubDate>Tue, 10 Jul 2018 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[7ba901a44f484a40878e830cfbdf309c]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/uspstf-recommendation-nontraditional-risk-factors-and-peripheral-artery-disease]]></link>
      <description><![CDATA[<p>Interview with Michael J. Barry, MD, Task Force member and co-author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.8357"> Screening for Peripheral Artery Disease and Cardiovascular Disease Risk Assessment With the Ankle-Brachial Index: US Preventive Services Task Force Recommendation Statement</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Michael J. Barry, MD, Task Force member and co-author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.8357"> Screening for Peripheral Artery Disease and Cardiovascular Disease Risk Assessment With the Ankle-Brachial Index: US Preventive Services Task Force Recommendation Statement</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation__Nontraditional_Risk_Factors_and_Peripheral_Artery_Disease.mp3?dest-id=90171" length="20644868" type="audio/mpeg" />
      <itunes:duration>21:20</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/8/f/9/98f9d39b49a37950/JMI180056.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation Statement: Screening for Osteoporosis to Prevent Fractures</title>
      <itunes:title>USPSTF Recommendation Statement: Screening for Osteoporosis to Prevent Fractures</itunes:title>
      <pubDate>Tue, 26 Jun 2018 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[ac61ae845a51468c94b71a3ccb6ec503]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/uspstf-recommendation-statement-screening-for-osteoporosis-to-prevent-fractures]]></link>
      <description><![CDATA[<p>Interview with Chien-Wen Tseng, MD, MPH, Task Force member and co-author of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.7498"> Screening for Osteoporosis to Prevent Fractures: US Preventive Services Task Force Recommendation Statement</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Chien-Wen Tseng, MD, MPH, Task Force member and co-author of <a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.7498"> Screening for Osteoporosis to Prevent Fractures: US Preventive Services Task Force Recommendation Statement</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation_Statement__Screening_for_Osteoporosis_to_Prevent_Fractures.mp3?dest-id=90171" length="16814651" type="audio/mpeg" />
      <itunes:duration>17:22</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/2/9/a/329af67bde4e7fc0/JMI180053.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Screening for Cardiovascular Disease Risk With Electrocardiography</title>
      <itunes:title>USPSTF Recommendation: Screening for Cardiovascular Disease Risk With Electrocardiography</itunes:title>
      <pubDate>Tue, 12 Jun 2018 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[05dc5bc1c3b6451e8c8b9218d09ecd90]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/uspstf-recommendation-screening-for-cardiovascular-disease-risk-with-electrocardiography]]></link>
      <description><![CDATA[<p>Interview with Seth Landefeld, MD, Task Force member and co-author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.6848"> Screening for Cardiovascular Disease Risk With Electrocardiography: US Preventive Services Task Force Recommendation Statement</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Seth Landefeld, MD, Task Force member and co-author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.6848"> Screening for Cardiovascular Disease Risk With Electrocardiography: US Preventive Services Task Force Recommendation Statement</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation__Screening_for_Cardiovascular_Disease_Risk_With_Electrocardiography.mp3?dest-id=90171" length="15715650" type="audio/mpeg" />
      <itunes:duration>16:10</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/b/f/c/1/bfc1515cec316692/JMI180051.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Screening for Prostate Cancer</title>
      <itunes:title>USPSTF Recommendation: Screening for Prostate Cancer</itunes:title>
      <pubDate>Tue, 08 May 2018 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[2f99a557a8ef532b07133f967f59b2af]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/uspstf-recommendation-screening-for-prostate-cancer]]></link>
      <description><![CDATA[<p>Interview with Alex H Krist, MD, MPH, Task Force member and co-author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.3710"> Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Alex H Krist, MD, MPH, Task Force member and co-author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.3710"> Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation__Screening_for_Prostate_Cancer.mp3?dest-id=90171" length="35486767" type="audio/mpeg" />
      <itunes:duration>36:43</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/2/0/6/1206d3b7900abd8a/180508-jama-jai-krist-prostate-thumb-v3.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Calcium and Vitamin D to Prevent Fractures and Interventions to Prevent Falls in Community-Dwelling Adults</title>
      <itunes:title>USPSTF Recommendation: Calcium and Vitamin D to Prevent Fractures and Interventions to Prevent Falls in Community-Dwelling Adults</itunes:title>
      <pubDate>Tue, 17 Apr 2018 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[0d6d4df1e03f3b5f11be35b2c19ee007]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/uspstf-recommendation-calcium-and-vitamin-d-to-prevent-fractures-and-interventions-to-prevent-falls-in-community-dwelling-adults]]></link>
      <description><![CDATA[<p>Interview with Alex H Krist, MD, MPH, Task Force member and co-author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.3185"> Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: US Preventive Services Task Force Recommendation Statement</a>, and <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.3097"> Interventions to Prevent Falls in Community-Dwelling Older Adults: US Preventive Services Task Force Recommendation Statement</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Alex H Krist, MD, MPH, Task Force member and co-author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.3185"> Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: US Preventive Services Task Force Recommendation Statement</a>, and <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.3097"> Interventions to Prevent Falls in Community-Dwelling Older Adults: US Preventive Services Task Force Recommendation Statement</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation__Calcium_and_Vitamin_D_to_Prevent_Fractures_and_Interventions_to_Prevent_Falls_in_Community-Dwelling_Adults.mp3?dest-id=90171" length="23565717" type="audio/mpeg" />
      <itunes:duration>24:21</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/d/b/2/cdb24a0373d6327f/JMI180006.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>US Burden of Diseases, Injuries, and Disease Risk Factors, 1990-2016</title>
      <itunes:title>US Burden of Diseases, Injuries, and Disease Risk Factors, 1990-2016</itunes:title>
      <pubDate>Tue, 10 Apr 2018 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[71428cd5f2cfe34d5fb94016e680c3a5]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/us-burden-of-diseases-injuries-and-disease-risk-factors-1990-2016]]></link>
      <description><![CDATA[<p>Interview with Christopher JL. Murray, MD, DPhil, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.0158"> The State of US Health, 1990-2016: Burden of Diseases, Injuries, and Risk Factors Among US States</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Christopher JL. Murray, MD, DPhil, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.0158"> The State of US Health, 1990-2016: Burden of Diseases, Injuries, and Risk Factors Among US States</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/US_Burden_of_Diseases_Injuries_and_Disease_Risk_Factors_1990-2016.mp3?dest-id=90171" length="51412359" type="audio/mpeg" />
      <itunes:duration>53:27</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/d/6/3/d/d63dce54cb8fac97/JOI180029.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Behavioral Counseling to Prevent Skin Cancer</title>
      <itunes:title>USPSTF Recommendation: Behavioral Counseling to Prevent Skin Cancer</itunes:title>
      <pubDate>Tue, 20 Mar 2018 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[c82154ae55c43ca9614f6292eca3eef8]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/uspstf-recommendation-behavioral-counseling-to-prevent-skin-cancer]]></link>
      <description><![CDATA[<p>Interview with John W Epling, MD, MSEd, Task Force member and co-author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.1623"> Behavioral Counseling to Prevent Skin Cancer: US Preventive Services Task Force Recommendation Statement</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with John W Epling, MD, MSEd, Task Force member and co-author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.1623"> Behavioral Counseling to Prevent Skin Cancer: US Preventive Services Task Force Recommendation Statement</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation__Behavioral_Counseling_to_Prevent_Skin_Cancer.mp3?dest-id=90171" length="21236963" type="audio/mpeg" />
      <itunes:duration>21:34</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/d/7/8/3d780211657a0f43/JMI180005.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Health Care Spending in the United States and Other High-Income Countries</title>
      <itunes:title>Health Care Spending in the United States and Other High-Income Countries</itunes:title>
      <pubDate>Tue, 13 Mar 2018 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[7e6ceb4a4115d7d4132b55baff377937]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/health-care-spending-in-the-united-states-and-other-high-income-countries]]></link>
      <description><![CDATA[<p>Interview with Dr. Ashish Jha, MD, MPH, about his <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.1150"> study</a> using Organization for Economic Cooperation and Development (OECD) data to compare health care infrastructure, outcomes, and prices in the US and other high-income countries to identify the sources of spending that make US health care so expensive.</p> <p> </p> <p> </p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Dr. Ashish Jha, MD, MPH, about his <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.1150"> study</a> using Organization for Economic Cooperation and Development (OECD) data to compare health care infrastructure, outcomes, and prices in the US and other high-income countries to identify the sources of spending that make US health care so expensive.</p> <p> </p> <p> </p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Health_Care_Spending_in_the_United_States_and_Other_High-Income_Countries.mp3?dest-id=90171" length="17693227" type="audio/mpeg" />
      <itunes:duration>18:22</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/4/b/9/e4b9b33f5a3e0a87/180313-jai-jama-jmi180003-jha.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Screening for Ovarian Cancer</title>
      <itunes:title>USPSTF Recommendation: Screening for Ovarian Cancer</itunes:title>
      <pubDate>Tue, 13 Feb 2018 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[cbd95376a2342b56250b9751779c2ecf]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/uspstf-recommendation-screening-for-ovarian-cancer]]></link>
      <description><![CDATA[<p>Interview with Michael J. Barry, MD, Task Force member and co-author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2017.21926"> Screening for Ovarian Cancer: US Preventive Services Task Force Recommendation Statement</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Michael J. Barry, MD, Task Force member and co-author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2017.21926"> Screening for Ovarian Cancer: US Preventive Services Task Force Recommendation Statement</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation__Screening_for_Ovarian_Cancer.mp3?dest-id=90171" length="19074331" type="audio/mpeg" />
      <itunes:duration>19:37</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/b/6/1/8/b6185ebb4008b378/JUS170020-thumb.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Screening for Adolescent Idiopathic Scoliosis</title>
      <itunes:title>USPSTF Recommendation: Screening for Adolescent Idiopathic Scoliosis</itunes:title>
      <pubDate>Tue, 09 Jan 2018 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[6ce6ff29b846470bc362e6e60973ac00]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/uspstf-recommendation-screening-for-adolescent-idiopathic-scoliosis]]></link>
      <description><![CDATA[<p>Interview with Alex R Kemper, MD, MPH, MS, Task Force member and co-author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2017.19342"> Screening for Adolescent Idiopathic Scoliosis: US Preventive Services Task Force Recommendation Statement</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Alex R Kemper, MD, MPH, MS, Task Force member and co-author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2017.19342"> Screening for Adolescent Idiopathic Scoliosis: US Preventive Services Task Force Recommendation Statement</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation__Screening_for_Adolescent_Idiopathic_Scoliosis.mp3?dest-id=90171" length="22993590" type="audio/mpeg" />
      <itunes:duration>23:55</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/e/5/7/2e57fb339345d1d5/JUS170015.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Deep Learning Algorithms for Detection of Lymph Node Metastases From Breast Cancer</title>
      <itunes:title>Deep Learning Algorithms for Detection of Lymph Node Metastases From Breast Cancer</itunes:title>
      <pubDate>Tue, 12 Dec 2017 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[b80faf5f6e7ad90aaaaff9b92915f275]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/deep-learning-algorithms-for-detection-of-lymph-node-metastases-from-breast-cancer]]></link>
      <description><![CDATA[<p>Interview with Jeffrey Alan. Golden, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2017.14580"> Deep Learning Algorithms for Detection of Lymph Node Metastases From Breast Cancer: Helping Artificial Intelligence Be Seen</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Jeffrey Alan. Golden, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2017.14580"> Deep Learning Algorithms for Detection of Lymph Node Metastases From Breast Cancer: Helping Artificial Intelligence Be Seen</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Deep_Learning_Algorithms_for_Detection_of_Lymph_Node_Metastases_From_Breast_Cancer.mp3?dest-id=90171" length="4186955" type="audio/mpeg" />
      <itunes:duration>04:17</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/3/0/3/c30355ec64fc044a/171212-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation Statement: Hormone Therapy After Menopause</title>
      <itunes:title>USPSTF Recommendation Statement: Hormone Therapy After Menopause</itunes:title>
      <pubDate>Tue, 12 Dec 2017 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[91bd7a64c1c4080b91083caee71306f7]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/uspstf-recommendation-statement-hormone-therapy-after-menopause]]></link>
      <description><![CDATA[<p>Interview with Maureen Phipps, MD, Task Force member and co-author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2017.18261"> Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women: US Preventive Services Task Force Recommendation Statement</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Maureen Phipps, MD, Task Force member and co-author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2017.18261"> Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women: US Preventive Services Task Force Recommendation Statement</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation_Statement__Hormone_Therapy_After_Menopause.mp3?dest-id=90171" length="7860382" type="audio/mpeg" />
      <itunes:duration>16:19</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/5/f/0/e5f0e79d76c6fc26/171212-jama-jai-phipps-thumb.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality</title>
      <itunes:title>Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality</itunes:title>
      <pubDate>Tue, 12 Sep 2017 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[3924a0fb6d54bf20f6716c7297b91282]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/menopausal-hormone-therapy-and-long-term-all-cause-and-cause-specific-mortality]]></link>
      <description><![CDATA[<p>Interview with JoAnn E. Manson, MD, DrPH, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2017.11217"> Menopausal Hormone Therapy and Long-Term All-Cause and Cause-Specific Mortality: The Women's Health Initiative Randomized Trials</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with JoAnn E. Manson, MD, DrPH, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2017.11217"> Menopausal Hormone Therapy and Long-Term All-Cause and Cause-Specific Mortality: The Women's Health Initiative Randomized Trials</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Menopausal_Hormone_Therapy_and_Long-Term_All-Cause_and_Cause-Specific_Mortality.mp3?dest-id=90171" length="6209803" type="audio/mpeg" />
      <itunes:duration>06:26</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/8/a/6/88a6b039ac54c351/170912-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Vision Screening in Children</title>
      <itunes:title>USPSTF Recommendation: Vision Screening in Children</itunes:title>
      <pubDate>Tue, 05 Sep 2017 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[682049231c51045e85ec2c56db3c4031]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/uspstf-recommendation-vision-screening-in-children]]></link>
      <description><![CDATA[<p>Interview with Alex R Kemper, MD, MPH, MS, Task Force member and co-author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2017.11260"> Vision Screening in Children Aged 6 Months to 5 Years: US Preventive Services Task Force Recommendation Statement</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Alex R Kemper, MD, MPH, MS, Task Force member and co-author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2017.11260"> Vision Screening in Children Aged 6 Months to 5 Years: US Preventive Services Task Force Recommendation Statement</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation__Vision_Screening_in_Children.mp3?dest-id=90171" length="12285133" type="audio/mpeg" />
      <itunes:duration>25:06</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/4/8/1/f/481fd3765274892c/170905-jama-jai-kemper-thumb.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>State Flexibility for Medicaid: How Much and Who Decides?</title>
      <itunes:title>State Flexibility for Medicaid: How Much and Who Decides?</itunes:title>
      <pubDate>Tue, 01 Aug 2017 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[c6e7c5f599b5e85401eb1d9d55f20e68]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/state-flexibility-for-medicaid-how-much-and-who-decides]]></link>
      <description><![CDATA[<p>Interview with Stuart M. Butler, PhD, MA, BSc, author of <a href="http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2017.8758"> State Flexibility for Medicaid: How Much?</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Stuart M. Butler, PhD, MA, BSc, author of <a href="http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2017.8758"> State Flexibility for Medicaid: How Much?</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/State_Flexibility_for_Medicaid__How_Much_and_Who_Decides_.mp3?dest-id=90171" length="24143887" type="audio/mpeg" />
      <itunes:duration>25:09</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/6/4/4/26444bd705100449/JJF170017.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Evaluation of Chronic Traumatic Encephalopathy in Football Players</title>
      <itunes:title>Evaluation of Chronic Traumatic Encephalopathy in Football Players</itunes:title>
      <pubDate>Tue, 25 Jul 2017 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[517f59adda937500dbfa089114926924]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/evaluation-of-chronic-traumatic-encephalopathy-in-football-players]]></link>
      <description><![CDATA[<p>Interview with Ann C. McKee, M.D., author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2017.8334"> Clinicopathological Evaluation of Chronic Traumatic Encephalopathy in Players of American Football</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Ann C. McKee, M.D., author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2017.8334"> Clinicopathological Evaluation of Chronic Traumatic Encephalopathy in Players of American Football</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Evaluation_of_Chronic_Traumatic_Encephalopathy_in_Football_Players.mp3?dest-id=90171" length="5635395" type="audio/mpeg" />
      <itunes:duration>05:49</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/7/9/8/c7980a7767ae4499/170725-jama-avi-2.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Behavioral Counseling for CVD Prevention</title>
      <itunes:title>USPSTF Recommendation: Behavioral Counseling for CVD Prevention</itunes:title>
      <pubDate>Tue, 11 Jul 2017 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[6027b20a4ee21f4c0d899dc7ba487ceb]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/uspstf-recommendation-behavioral-counseling-for-cvd-prevention]]></link>
      <description><![CDATA[<p>Interview with Susan J. Curry, PhD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2017.7171"> Behavioral Counseling to Promote a Healthful Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Risk Factors: US Preventive Services Task Force Recommendation Statement</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Susan J. Curry, PhD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2017.7171"> Behavioral Counseling to Promote a Healthful Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Risk Factors: US Preventive Services Task Force Recommendation Statement</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation__Behavioral_Counseling_for_CVD_Prevention.mp3?dest-id=90171" length="18105436" type="audio/mpeg" />
      <itunes:duration>18:33</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/f/8/a/a/f8aa2aae32f19a98/JUS170009.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Screening for Obesity in Children and Adolescents</title>
      <itunes:title>USPSTF Recommendation: Screening for Obesity in Children and Adolescents</itunes:title>
      <pubDate>Tue, 20 Jun 2017 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[1e6742ced76fc2b6389625a53b4be482]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/uspstf-recommendation-screening-for-obesity-in-children-and-adolescents]]></link>
      <description><![CDATA[<p>Interview with David C. Grossman, MD, MPH, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2017.6803"> Screening for Obesity in Children and Adolescents: US Preventive Services Task Force Recommendation Statement</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with David C. Grossman, MD, MPH, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2017.6803"> Screening for Obesity in Children and Adolescents: US Preventive Services Task Force Recommendation Statement</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation__Screening_for_Obesity_in_Children_and_Adolescents.mp3?dest-id=90171" length="26736552" type="audio/mpeg" />
      <itunes:duration>27:37</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/7/d/f/9/7df95a621883f9ba/JUS170008.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Comparison of Intra-articular Triamcinolone vs Saline for Knee Osteoarthritis</title>
      <itunes:title>Comparison of Intra-articular Triamcinolone vs Saline for Knee Osteoarthritis</itunes:title>
      <pubDate>Tue, 16 May 2017 14:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[efa2e0631d56f5577ad33921e72a32ef]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/comparison-of-intra-articular-triamcinolone-vs-saline-for-knee-osteoarthritis]]></link>
      <description><![CDATA[<p>Interview with Timothy E. McAlindon, MD,MPH, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2017.5283"> Effect of Intra-articular Triamcinolone vs Saline on Knee Cartilage Volume and Pain in Patients With Knee Osteoarthritis: A Randomized Clinical Trial</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Timothy E. McAlindon, MD,MPH, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2017.5283"> Effect of Intra-articular Triamcinolone vs Saline on Knee Cartilage Volume and Pain in Patients With Knee Osteoarthritis: A Randomized Clinical Trial</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Comparison_of_Intra-articular_Triamcinolone_vs_Saline_for_Knee_Osteoarthritis.mp3?dest-id=90171" length="3722118" type="audio/mpeg" />
      <itunes:duration>03:51</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/0/f/c/00fc0570615a1769/170516-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Genomics and Precision Health</title>
      <itunes:title>Genomics and Precision Health</itunes:title>
      <pubDate>Tue, 09 May 2017 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[a12bb48ac3a6ced868dde178f52ef6be]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/genomics-and-precision-health]]></link>
      <description><![CDATA[<p>Whole-genome sequencing is now easily done for very little cost. It is not known how to interpret the results of this testing. Healthy individuals should not have this performed. If someone has a reason to suspect a particular disease with a known genetic association, then whole-genome or targeted sequencing is reasonable to pursue.</p>]]></description>
      
      <content:encoded><![CDATA[<p>Whole-genome sequencing is now easily done for very little cost. It is not known how to interpret the results of this testing. Healthy individuals should not have this performed. If someone has a reason to suspect a particular disease with a known genetic association, then whole-genome or targeted sequencing is reasonable to pursue.</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/170509-jama-jai-feero.mp3?dest-id=90171" length="8953917" type="audio/mpeg" />
      <itunes:duration>09:17</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/f/8/1/7/f8178652007ef172/170509-jama-jai-feero.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Screening for Thyroid Cancer</title>
      <itunes:title>Screening for Thyroid Cancer</itunes:title>
      <pubDate>Tue, 09 May 2017 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[3a3d8a9a6a789f66bff1a76da4304b17]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2017.4011]]></link>
      <description><![CDATA[<p>Interview with Charles Landefeld, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2017.4011"> Screening for Thyroid Cancer: US Preventive Services Task Force Recommendation Statement</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Charles Landefeld, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2017.4011"> Screening for Thyroid Cancer: US Preventive Services Task Force Recommendation Statement</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation__Screening_for_Thyroid_Cancer.mp3?dest-id=90171" length="8122815" type="audio/mpeg" />
      <itunes:duration>16:38</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/4/f/b/4/4fb4d017201feb21/JUS170007.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Screening for Preeclampsia</title>
      <itunes:title>Screening for Preeclampsia</itunes:title>
      <pubDate>Tue, 25 Apr 2017 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[0811c05e2cc305573c6e710a3ccec7a8]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2017.3439]]></link>
      <description><![CDATA[<p>Interview with Maureen G. Phipps, MD, MPH, Task Force member and co-author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2017.3439"> Screening for Preeclampsia: US Preventive Services Task Force Recommendation Statement</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Maureen G. Phipps, MD, MPH, Task Force member and co-author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2017.3439"> Screening for Preeclampsia: US Preventive Services Task Force Recommendation Statement</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation__Screening_for_Preeclampsia.mp3?dest-id=90171" length="9799312" type="audio/mpeg" />
      <itunes:duration>19:38</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/4/5/f/c45f1aff3d0aff0f/170425-jama-jai-phipps-thumb-v2.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Dexamethasone Without Antibiotics vs Placebo on Acute Sore Throat</title>
      <itunes:title>Dexamethasone Without Antibiotics vs Placebo on Acute Sore Throat</itunes:title>
      <pubDate>Tue, 18 Apr 2017 14:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[92e15c8aa50e7b91fccb2fc43ecdeec2]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2017.3417]]></link>
      <description><![CDATA[<p>Interview with Gail Hayward, MA (Oxon) D.Phil MRCP MRCGP, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2017.3417"> Effect of Oral Dexamethasone Without Immediate Antibiotics vs Placebo on Acute Sore Throat in Adults: A Randomized Clinical Trial</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Gail Hayward, MA (Oxon) D.Phil MRCP MRCGP, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2017.3417"> Effect of Oral Dexamethasone Without Immediate Antibiotics vs Placebo on Acute Sore Throat in Adults: A Randomized Clinical Trial</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Dexamethasone_Without_Antibiotics_vs_Placebo_on_Acute_Sore_Throat.mp3?dest-id=90171" length="3827453" type="audio/mpeg" />
      <itunes:duration>03:57</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/3/c/c/a3cc9a2997bb08af/170418-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>JAMA Medical News: The Nature of Lung Microbiome Research</title>
      <itunes:title>JAMA Medical News: The Nature of Lung Microbiome Research</itunes:title>
      <pubDate>Wed, 12 Apr 2017 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[5f4713e448ea46dbde7ac9eafb3e2014]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2017.3023]]></link>
      <description><![CDATA[<p>This podcast discusses the latest research into the workings of the lung microbiome and how it will affect future diagnosis and treatment of respiratory diseases. Related article: <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2017.3023"> The Lung Microbiome: Key to Respiratory Ills?</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>This podcast discusses the latest research into the workings of the lung microbiome and how it will affect future diagnosis and treatment of respiratory diseases. Related article: <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2017.3023"> The Lung Microbiome: Key to Respiratory Ills?</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/QA_with_Drs_Jack_Gilbert_and_Steve_White_of_the_University_of_Chicago_on_the_nature_of_lung_microbiome_research.mp3?dest-id=90171" length="12159331" type="audio/mpeg" />
      <itunes:duration>25:17</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/d/7/0/5/d705db4c650b7070/JMN170016.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Barry Marshall, MD: H pylori 35 Years Later</title>
      <itunes:title>Barry Marshall, MD: H pylori 35 Years Later</itunes:title>
      <pubDate>Tue, 11 Apr 2017 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[b91abbea19b76e2a22577d94d546e660]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2017.2629]]></link>
      <description><![CDATA[<p>This Medical News podcast features an interview with Barry Marshall, MD, who codiscovered the stomach bug H pylori in 1982.</p>]]></description>
      
      <content:encoded><![CDATA[<p>This Medical News podcast features an interview with Barry Marshall, MD, who codiscovered the stomach bug H pylori in 1982.</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Barry_Marshall_MD__H_pylori_35_Years_Later.mp3?dest-id=90171" length="8369892" type="audio/mpeg" />
      <itunes:duration>17:14</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/5/f/b/5/5fb5855895ea0eb1/170222-mednews-marshall.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Screening for Celiac Disease</title>
      <itunes:title>Screening for Celiac Disease</itunes:title>
      <pubDate>Tue, 28 Mar 2017 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[5d4d07d790bb28638a7800e5f5eb739b]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2017.1462]]></link>
      <description><![CDATA[<p>Interview with Alex H Krist, MD, MPH, Task Force member and co-author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2017.1462"> Screening for Celiac Disease: US Preventive Services Task Force Recommendation Statement</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Alex H Krist, MD, MPH, Task Force member and co-author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2017.1462"> Screening for Celiac Disease: US Preventive Services Task Force Recommendation Statement</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation_-_Screening_for_Celiac_Disease.mp3?dest-id=90171" length="12330596" type="audio/mpeg" />
      <itunes:duration>25:20</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/b/a/1/7/ba17cf85e28c64d2/170328-jama-jai-krist-thumb.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer</title>
      <itunes:title>Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer</itunes:title>
      <pubDate>Tue, 21 Mar 2017 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[8d848e34eb4493e8d2321e82985bc46e]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2017.1703]]></link>
      <description><![CDATA[<p>Interview with Freddie C. Hamdy, MD, FRCSEd(Urol), and Jenny L Donovan, PhD, FMedSci, authors of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2017.1703"> Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer: Helping Decision Making for Patients and Their Physicians</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Freddie C. Hamdy, MD, FRCSEd(Urol), and Jenny L Donovan, PhD, FMedSci, authors of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2017.1703"> Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer: Helping Decision Making for Patients and Their Physicians</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Patient-Reported_Outcomes_Following_Treatment_for_Localized_Prostate_Cancer.mp3?dest-id=90171" length="14293284" type="audio/mpeg" />
      <itunes:duration>29:35</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/b/a/1/9ba104426d250d64/170321-jama-jai-hamdy-thumb.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Why the New Sepsis Guideline Changed</title>
      <itunes:title>Why the New Sepsis Guideline Changed</itunes:title>
      <pubDate>Tue, 07 Mar 2017 20:54:40 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[7e49004b0eb35570bdd24b2a24ae3b9f]]></guid>
      <link><![CDATA[https://jamaauthorinterviews.libsyn.com/why-the-new-sepsis-guideline-changed]]></link>
      <description><![CDATA[<p>Recent guidelines for how to best manage septic shock have changed. Gone are recommendations for central venous oxygen saturation monitoring and goal-directed therapy. In is the concept that septic shock be treated as an emergency with rapid administration of antibiotics and large amounts of fluids. Our discussants Derek C. Angus, MD, MPH, and Michael D. Howell, MD, MPH, discuss why these recommendations have changed. This is the second podcast in the Surviving Sepsis guideline series. <a href= "http://jamanetwork.com/learning/audio-player/14166547">The first podcast</a> reviewed what recommendations are in the <a href= "%E2%80%9Chttp:/www.sccm.org/Research/Quality/Pages/Surviving-Sepsis-Campaign.aspx%E2%80%9D"> guideline</a> itself.</p> <p>Article discussed in this episode: <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2017.0131"> Management of Sepsis and Septic Shock</a></p> <p>Speakers: JAMA Associate Editor Derek C. Angus, MD, MPH, University of Pittsburgh, and Michael D. Howell, MD, MPH, University of Chicago.</p>]]></description>
      
      <content:encoded><![CDATA[<p>Recent guidelines for how to best manage septic shock have changed. Gone are recommendations for central venous oxygen saturation monitoring and goal-directed therapy. In is the concept that septic shock be treated as an emergency with rapid administration of antibiotics and large amounts of fluids. Our discussants Derek C. Angus, MD, MPH, and Michael D. Howell, MD, MPH, discuss why these recommendations have changed. This is the second podcast in the Surviving Sepsis guideline series. <a href= "http://jamanetwork.com/learning/audio-player/14166547">The first podcast</a> reviewed what recommendations are in the <a href= "%E2%80%9Chttp:/www.sccm.org/Research/Quality/Pages/Surviving-Sepsis-Campaign.aspx%E2%80%9D"> guideline</a> itself.</p> <p>Article discussed in this episode: <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2017.0131"> Management of Sepsis and Septic Shock</a></p> <p>Speakers: JAMA Associate Editor Derek C. Angus, MD, MPH, University of Pittsburgh, and Michael D. Howell, MD, MPH, University of Chicago.</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/170228-jama-jcr-sepsis-pt2.mp3?dest-id=90171" length="32222338" type="audio/mpeg" />
      <itunes:duration>33:32</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/1/1/5/6115b60b8de9cfa4/170228-jama-jcr-sepsis-guideline-synopsis-pt2.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: The Screening Pelvic Examination</title>
      <itunes:title>USPSTF Recommendation: The Screening Pelvic Examination</itunes:title>
      <pubDate>Tue, 07 Mar 2017 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[1534bfcd65114590b5f684f1c1759bd9]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2017.0807]]></link>
      <description><![CDATA[<p>Interview with Maureen G. Phipps, MD, MPH, Task Force member and co-author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2017.0807"> Screening for Gynecologic Conditions With Pelvic Examination: US Preventive Services Task Force Recommendation Statement</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Maureen G. Phipps, MD, MPH, Task Force member and co-author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2017.0807"> Screening for Gynecologic Conditions With Pelvic Examination: US Preventive Services Task Force Recommendation Statement</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation_The_Screening_Pelvic_Examination.mp3?dest-id=90171" length="6864107" type="audio/mpeg" />
      <itunes:duration>13:39</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/f/f/1/0/ff10cfba58e97b05/170307-jama-jai-phipps-thumb.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Updated Guidelines for Sepsis Management</title>
      <itunes:title>Updated Guidelines for Sepsis Management</itunes:title>
      <pubDate>Tue, 28 Feb 2017 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[33cd4a88ffa005c0755aa2ac5000f5b4]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2017.0131]]></link>
      <description><![CDATA[<p>In 2017 the Society for Critical Care Medicine updated its <a href= "http://www.sccm.org/Research/Quality/Pages/Surviving-Sepsis-Campaign.aspx"> guidelines for sepsis management</a>. These new guidelines differ significantly from ones in the past in that they no longer recommend protocolized resuscitation and emphasize early and aggressive fluid resuscitation when patients present with septic shock. This is the first podcast in the Surviving Sepsis guideline series. <a href= "http://jamanetwork.com/learning/audio-player/14182864">The next episode</a> discusses why the new sepsis guideline changed.</p> <p>Article discussed in this episode: <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2017.0131"> Management of Sepsis and Septic Shock</a></p> <p>Speakers:</p> <p>Laura Evans, MD, MSc, of Bellevue Hospital and NYU Medical Center</p> <p>Andrew Rhodes, MBBS, MD, of St George's University Hospitals NHS Trust and co-chair of the Surviving Sepsis guideline panel</p> <p>Mitchell M. Levy, MD, of the Alpert Medical School of Brown University and Rhode Island Hospital</p> <p> </p>]]></description>
      
      <content:encoded><![CDATA[<p>In 2017 the Society for Critical Care Medicine updated its <a href= "http://www.sccm.org/Research/Quality/Pages/Surviving-Sepsis-Campaign.aspx"> guidelines for sepsis management</a>. These new guidelines differ significantly from ones in the past in that they no longer recommend protocolized resuscitation and emphasize early and aggressive fluid resuscitation when patients present with septic shock. This is the first podcast in the Surviving Sepsis guideline series. <a href= "http://jamanetwork.com/learning/audio-player/14182864">The next episode</a> discusses why the new sepsis guideline changed.</p> <p>Article discussed in this episode: <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2017.0131"> Management of Sepsis and Septic Shock</a></p> <p>Speakers:</p> <p>Laura Evans, MD, MSc, of Bellevue Hospital and NYU Medical Center</p> <p>Andrew Rhodes, MBBS, MD, of St George's University Hospitals NHS Trust and co-chair of the Surviving Sepsis guideline panel</p> <p>Mitchell M. Levy, MD, of the Alpert Medical School of Brown University and Rhode Island Hospital</p> <p> </p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/New_Guidelines_for_Sepsis_Management.mp3?dest-id=90171" length="14987384" type="audio/mpeg" />
      <itunes:duration>15:36</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/8/d/4/38d4e7d7a0fc1afa/170228-jama-jcr-sepsis-guideline-synopsis-pt1.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>The Effects of Testosterone Gel on Health Outcomes</title>
      <itunes:title>The Effects of Testosterone Gel on Health Outcomes</itunes:title>
      <pubDate>Tue, 21 Feb 2017 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[9dd7feecb4d2920777ac2e9f5dae0971]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.21043]]></link>
      <description><![CDATA[<p>Can testosterone gel improve memory, correct anemia, increase bone density or prevent the growth of coronary artery plaque in older men with low testosterone levels? Four new studies in JAMA and JAMA Internal Medicine found improvement in some of these measures.</p> <p>Articles discussed in this episode:</p> <p>• <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2016.21043"> Testosterone Treatment and Coronary Artery Plaque Volume in Older Men With Low Testosterone</a></p> <p>• <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2016.21044"> Testosterone Treatment and Cognitive Function in Older Men With Low Testosterone and Age-Associated Memory Impairment</a></p> <p>• <a href= "http://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2016.9539"> Effect of Testosterone Treatment on Volumetric Bone Density and Strength in Older Men With Low Testosterone: A Controlled Clinical Trial</a></p> <p>• <a href= "http://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2016.9540"> Association of Testosterone Levels With Anemia in Older Men: A Controlled Clinical Trial</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Can testosterone gel improve memory, correct anemia, increase bone density or prevent the growth of coronary artery plaque in older men with low testosterone levels? Four new studies in JAMA and JAMA Internal Medicine found improvement in some of these measures.</p> <p>Articles discussed in this episode:</p> <p>• <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2016.21043"> Testosterone Treatment and Coronary Artery Plaque Volume in Older Men With Low Testosterone</a></p> <p>• <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2016.21044"> Testosterone Treatment and Cognitive Function in Older Men With Low Testosterone and Age-Associated Memory Impairment</a></p> <p>• <a href= "http://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2016.9539"> Effect of Testosterone Treatment on Volumetric Bone Density and Strength in Older Men With Low Testosterone: A Controlled Clinical Trial</a></p> <p>• <a href= "http://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2016.9540"> Association of Testosterone Levels With Anemia in Older Men: A Controlled Clinical Trial</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/The_Effects_of_Testosterone_Gel_on_Health_Outcomes.mp3?dest-id=90171" length="3076038" type="audio/mpeg" />
      <itunes:duration>03:10</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/5/8/5/e585902a9bfdc3eb/170221-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Alzheimer Outlook Far From Bleak</title>
      <itunes:title>Alzheimer Outlook Far From Bleak</itunes:title>
      <pubDate>Wed, 15 Feb 2017 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[009cc676104dc62e47eb24075922084a]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2017.0276]]></link>
      <description><![CDATA[<p>Rudolph Tanzi, PhD, of Harvard University, and Berislav Zlokovic, MD, PhD, of the University of Southern California, discuss what the future holds for Alzheimer Disease research and treatment.</p>]]></description>
      
      <content:encoded><![CDATA[<p>Rudolph Tanzi, PhD, of Harvard University, and Berislav Zlokovic, MD, PhD, of the University of Southern California, discuss what the future holds for Alzheimer Disease research and treatment.</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Alzheimer_Outlook_Far_From_Bleak.mp3?dest-id=90171" length="17744581" type="audio/mpeg" />
      <itunes:duration>36:38</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/5/b/0/65b0938fd1435733/161104-jama-mednews-alzheimer." />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Effect of Scalp Cooling for Chemotherapy-Induced Alopecia in Women With Breast Cancer</title>
      <itunes:title>Effect of Scalp Cooling for Chemotherapy-Induced Alopecia in Women With Breast Cancer</itunes:title>
      <pubDate>Tue, 14 Feb 2017 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[0268da858f330ae7fbf26a58e6108a8d]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.20939]]></link>
      <description><![CDATA[<p>Interview with Julie Rani Nangia, BA, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2016.20939"> Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial</a>, and Hope S. Rugo, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2016.21038"> Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Julie Rani Nangia, BA, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2016.20939"> Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial</a>, and Hope S. Rugo, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2016.21038"> Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Effect_of_Scalp_Cooling_for_Chemotherapy-Induced_Alopecia_in_Women_With_Breast_Cancer.mp3?dest-id=90171" length="13136141" type="audio/mpeg" />
      <itunes:duration>26:52</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/5/c/1/5/5c150943343f2262/170214-jama-jai-nangia." />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Managing Violent Patients in Health Care Settings</title>
      <itunes:title>Managing Violent Patients in Health Care Settings</itunes:title>
      <pubDate>Mon, 30 Jan 2017 19:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[917d46681f6f63b7c7c04ede3ec532af]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.18260]]></link>
      <description><![CDATA[<p>Workplace violence–related injuries occur disproportionately in health care settings. In this podcast, we discuss how individual clinicians should manage violent patients who might attack them. Article discussed in this episode: <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2016.18260"> Ensuring Staff Safety When Treating Potentially Violent Patients</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Workplace violence–related injuries occur disproportionately in health care settings. In this podcast, we discuss how individual clinicians should manage violent patients who might attack them. Article discussed in this episode: <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2016.18260"> Ensuring Staff Safety When Treating Potentially Violent Patients</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Managing_Violent_Patients_in_Health_Care_Settings.mp3?dest-id=90171" length="21059840" type="audio/mpeg" />
      <itunes:duration>21:55</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/7/6/2/27623f2eeda153c6/170117-jama-jcr-staffsafetyjpg." />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Screening for Obstructive Sleep Apnea in Adults</title>
      <itunes:title>Screening for Obstructive Sleep Apnea in Adults</itunes:title>
      <pubDate>Tue, 24 Jan 2017 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[e63c748db21a1391bd997e6452a0e4d4]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.20325]]></link>
      <description><![CDATA[<p>Interview with Alex H. Krist, MD, MPH, Task Force member and co-author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2016.20325"> Screening for Obstructive Sleep Apnea in Adults: US Preventive Services Task Force Recommendation Statement</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Alex H. Krist, MD, MPH, Task Force member and co-author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2016.20325"> Screening for Obstructive Sleep Apnea in Adults: US Preventive Services Task Force Recommendation Statement</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation_-_Screening_for_Obstructive_Sleep_Apnea_in_Adults.mp3?dest-id=90171" length="11776989" type="audio/mpeg" />
      <itunes:duration>24:08</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/9/8/4/3984e95476c9e1ca/170124-jama-jai-krist-thumb2.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Folic Acid to Prevent Neural Tube Defects</title>
      <itunes:title>USPSTF Recommendation: Folic Acid to Prevent Neural Tube Defects</itunes:title>
      <pubDate>Tue, 10 Jan 2017 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[8e56c8cef20252ee8b8039a1a639bc73]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.19438]]></link>
      <description><![CDATA[<p>Interview with Alex R. Kemper, MD, MPH, MS, Task Force member and co-author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2016.19438"> Folic Acid Supplementation for the Prevention of Neural Tube Defects: US Preventive Services Task Force Recommendation Statement</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Alex R. Kemper, MD, MPH, MS, Task Force member and co-author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2016.19438"> Folic Acid Supplementation for the Prevention of Neural Tube Defects: US Preventive Services Task Force Recommendation Statement</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation_-_Folic_Acid_to_Prevent_Neural_Tube_Defects.mp3?dest-id=90171" length="6891871" type="audio/mpeg" />
      <itunes:duration>14:03</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/5/c/f/4/5cf4cadb514ea9c5/170110-jama-jai-kemper-thumb.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>JAMA Performance Improvement: Do No Harm — Ensuring Staff Safety Against Violent Patients</title>
      <itunes:title>JAMA Performance Improvement: Do No Harm — Ensuring Staff Safety Against Violent Patients</itunes:title>
      <pubDate>Tue, 27 Dec 2016 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[a4e5593dd794c5032e494f1f486b52dd]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.18260]]></link>
      <description><![CDATA[<p>Violence against health care workers is increasing. With fewer mental health services available, health care workers have disproportionate exposure to potentially dangerous patients. This article reviews the experience of one nurse who was severely injured by a patient and the lessons learned by the hospital where the incident occurred regarding minimizing the risk of staff injury when providing care for potentially violent patients. We interview Robert P. Roca, MD, MPH, MBA; Antonio DePaolo, PhD; Ernestine Cosby, RN; and Bolarin Kehinde, RN, to shed light on this serious issue.</p> <p>Article discussed in this episode: <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2016.18260"> Ensuring Staff Safety When Treating Potentially Violent Patients</a></p> <p> </p>]]></description>
      
      <content:encoded><![CDATA[<p>Violence against health care workers is increasing. With fewer mental health services available, health care workers have disproportionate exposure to potentially dangerous patients. This article reviews the experience of one nurse who was severely injured by a patient and the lessons learned by the hospital where the incident occurred regarding minimizing the risk of staff injury when providing care for potentially violent patients. We interview Robert P. Roca, MD, MPH, MBA; Antonio DePaolo, PhD; Ernestine Cosby, RN; and Bolarin Kehinde, RN, to shed light on this serious issue.</p> <p>Article discussed in this episode: <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2016.18260"> Ensuring Staff Safety When Treating Potentially Violent Patients</a></p> <p> </p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Ensuring_Staff_Safety_Against_Violent_Patientsx.mp3?dest-id=90171" length="14974446" type="audio/mpeg" />
      <itunes:duration>30:51</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/7/5/1/6751c02114765446/160715-jama-jpi-staffsafety-EL-161102.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Systematic Approach to a New Onset Seizure</title>
      <itunes:title>Systematic Approach to a New Onset Seizure</itunes:title>
      <pubDate>Tue, 27 Dec 2016 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[ecace967629c98bfcb7de875a6435e4f]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.18625]]></link>
      <description><![CDATA[<p>Between 8% and 10% of the population will have a seizure at one point in life. It's important to distinguish seizures from other entities that can look like them and, once a diagnosis of a seizure is established, know how to treat them. In this JAMA Clinical Review podcast, we discuss seizures and epilepsy with Jay Gavvala, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2016.18625"> New-Onset Seizure in Adults and Adolescents: A Review.</a></p> <p>Article discussed in this episode:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2016.18625"> New-Onset Seizure in Adults and Adolescents: A Review</a></p> <p> </p>]]></description>
      
      <content:encoded><![CDATA[<p>Between 8% and 10% of the population will have a seizure at one point in life. It's important to distinguish seizures from other entities that can look like them and, once a diagnosis of a seizure is established, know how to treat them. In this JAMA Clinical Review podcast, we discuss seizures and epilepsy with Jay Gavvala, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2016.18625"> New-Onset Seizure in Adults and Adolescents: A Review.</a></p> <p>Article discussed in this episode:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2016.18625"> New-Onset Seizure in Adults and Adolescents: A Review</a></p> <p> </p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Systematic_approach_to_a_new_onset_seizure.mp3?dest-id=90171" length="13727079" type="audio/mpeg" />
      <itunes:duration>28:14</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/e/b/7/6eb7a1e64d9442cf/161227-jama-jcr-epilepsy-new-with-narration.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Serologic Screening for Genital Herpes Infection</title>
      <itunes:title>Serologic Screening for Genital Herpes Infection</itunes:title>
      <pubDate>Tue, 20 Dec 2016 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[5aba24a5b50caed259da7c9a9ba2b470]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.16776]]></link>
      <description><![CDATA[<p>Interview with Ann E. Kurth, PhD, RN, MSN, MPH, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2016.16776"> Serologic Screening for Genital Herpes Infection: US Preventive Services Task Force Recommendation Statement</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Ann E. Kurth, PhD, RN, MSN, MPH, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2016.16776"> Serologic Screening for Genital Herpes Infection: US Preventive Services Task Force Recommendation Statement</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation_Serologic_Screening_for_Genital_Herpes_Infection.mp3?dest-id=90171" length="6453963" type="audio/mpeg" />
      <itunes:duration>13:12</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/7/4/d/e74dbbc82fcfe054/161220-jama-jai-kurth-thumb.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Early Physical Activity and Persistent and Postconcussive symptoms in Children and Adolescents</title>
      <itunes:title>Early Physical Activity and Persistent and Postconcussive symptoms in Children and Adolescents</itunes:title>
      <pubDate>Tue, 20 Dec 2016 15:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[65cb367ddd04b846e3a9b35ba878f280]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.17396]]></link>
      <description><![CDATA[<p>Interview with Roger L. Zemek, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2016.17396"> Association Between Early Participation in Physical Activity Following Acute Concussion and Persistent Postconcussive Symptoms in Children and Adolescents</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Roger L. Zemek, MD, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2016.17396"> Association Between Early Participation in Physical Activity Following Acute Concussion and Persistent Postconcussive Symptoms in Children and Adolescents</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Early_Physical_Activity_and_Persistent_and_Postconcussive_symptoms_in_Children_and_Adolescents.mp3?dest-id=90171" length="2786474" type="audio/mpeg" />
      <itunes:duration>02:53</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/f/8/b/3/f8b316e1dfbf3a4c/161220-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>NIH Charts a Path for Nutrition Science</title>
      <itunes:title>NIH Charts a Path for Nutrition Science</itunes:title>
      <pubDate>Wed, 14 Dec 2016 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[45f9ddb05211ce23676aa750670e3088]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.18217]]></link>
      <description><![CDATA[<p>Interview with Jennifer Abbasi, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2016.18217"> NIH Charts a Path for Nutrition Science</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Jennifer Abbasi, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2016.18217"> NIH Charts a Path for Nutrition Science</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/NIH_Charts_a_Path_for_Nutrition_Science.mp3?dest-id=90171" length="6353894" type="audio/mpeg" />
      <itunes:duration>12:53</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/4/3/c/a43c180104fd7b8b/1612-jama-mednews-rodgers-final-edit.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>US County-Level Trends in Mortality Rates for Major Causes of Death</title>
      <itunes:title>US County-Level Trends in Mortality Rates for Major Causes of Death</itunes:title>
      <pubDate>Tue, 13 Dec 2016 15:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[08db50abea722914509c3f12fe222b0d]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.13645]]></link>
      <description><![CDATA[<p>Interview with Christopher JL. Murray, MD, DPhil, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2016.13645"> US County-Level Trends in Mortality Rates for Major Causes of Death, 1980-2014</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Christopher JL. Murray, MD, DPhil, author of <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2016.13645"> US County-Level Trends in Mortality Rates for Major Causes of Death, 1980-2014</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/US_County-Level_Trends_in_Mortality_Rates_for_Major_Causes_of_Death.mp3?dest-id=90171" length="3762472" type="audio/mpeg" />
      <itunes:duration>03:52</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/4/b/9/04b9c1bf1b9ec910/161213-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>What Should Students or Residents Do When Abused by Faculty</title>
      <itunes:title>What Should Students or Residents Do When Abused by Faculty</itunes:title>
      <pubDate>Tue, 06 Dec 2016 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[63903db80173dfbd94bde94d24004d35]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.17752]]></link>
      <description><![CDATA[<p>Approximately one-third of all medical school graduates report having been abused as students. Medical student and resident abuse has long been considered unacceptable behavior but still persists in the teaching environment. In this podcast we discuss how students and residents might respond to these events. We interview Geoffrey Young, MD, from the Association of American Medical Colleges and Thomas J. Nasca, MD, from the Accreditation Council for Graduate Medical Education, who discuss how they expect medical schools to respond to abusive behaviors and what resources are available to students and residents who have been abused to report those experiences without fearing retribution.</p> <p>Article discussed in this episode:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2016.17752"> Medical Student Mistreatment</a></p> <p> </p>]]></description>
      
      <content:encoded><![CDATA[<p>Approximately one-third of all medical school graduates report having been abused as students. Medical student and resident abuse has long been considered unacceptable behavior but still persists in the teaching environment. In this podcast we discuss how students and residents might respond to these events. We interview Geoffrey Young, MD, from the Association of American Medical Colleges and Thomas J. Nasca, MD, from the Accreditation Council for Graduate Medical Education, who discuss how they expect medical schools to respond to abusive behaviors and what resources are available to students and residents who have been abused to report those experiences without fearing retribution.</p> <p>Article discussed in this episode:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2016.17752"> Medical Student Mistreatment</a></p> <p> </p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/What_Should_Students_or_Residents_Do_When_Abused_by_Faculty.mp3?dest-id=90171" length="29487182" type="audio/mpeg" />
      <itunes:duration>30:41</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/e/a/8/cea888e0637409ab/161206-jama-jpr-bullying.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Statin Use for Primary Prevention of Cardiovascular Disease in Adults</title>
      <itunes:title>Statin Use for Primary Prevention of Cardiovascular Disease in Adults</itunes:title>
      <pubDate>Sun, 13 Nov 2016 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[07955efdea7bda9a97618f9832f23e91]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.15450]]></link>
      <description><![CDATA[<p>Interview with Douglas K. Owens, MD, MS, USPSTF Task Force member and coauthor of <a href= "jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2016.15450"> Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Douglas K. Owens, MD, MS, USPSTF Task Force member and coauthor of <a href= "jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2016.15450"> Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Statin_Use_for_Primary_Prevention_of_Cardiovascular_Disease_in_Adults.mp3?dest-id=90171" length="13525612" type="audio/mpeg" />
      <itunes:duration>27:56</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/d/e/3/ede34a4bd31c789e/161115-jama-jai-owens-thumb-v2.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Using Medicare Star Ratings to Select Hospitals</title>
      <itunes:title>Using Medicare Star Ratings to Select Hospitals</itunes:title>
      <pubDate>Tue, 01 Nov 2016 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[73141ab06ade4c1de60c51233392c9da]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.13679]]></link>
      <description><![CDATA[<p>Medicare recently developed a star rating system to help consumers determine the quality of care delivered at various hospitals. This rating system was considered controversial by many. In this podcast we discuss the rating system with one of its critics, Karl Y. Bilimoria, MD, MS, and with Kate Goodrich, MD, the Director of the Center for Clinical Standards and Quality at Medicare.</p> <p>Article discussed in this episode:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2016.13679"> The New CMS Hospital Quality Star Ratings: The Stars Are Not Aligned</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Medicare recently developed a star rating system to help consumers determine the quality of care delivered at various hospitals. This rating system was considered controversial by many. In this podcast we discuss the rating system with one of its critics, Karl Y. Bilimoria, MD, MS, and with Kate Goodrich, MD, the Director of the Center for Clinical Standards and Quality at Medicare.</p> <p>Article discussed in this episode:</p> <p><a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2016.13679"> The New CMS Hospital Quality Star Ratings: The Stars Are Not Aligned</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Using_Medicare_Star_Ratings_to_Select_Hospitals.mp3?dest-id=90171" length="25860451" type="audio/mpeg" />
      <itunes:duration>26:54</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/4/3/7/84374970139eb2f9/160510-jama-jai-bilimoria.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Pioneering Geneticist Explains Ambitious Plan to "Write" the Human Genome</title>
      <itunes:title>Pioneering Geneticist Explains Ambitious Plan to "Write" the Human Genome</itunes:title>
      <pubDate>Wed, 26 Oct 2016 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[361c4d6fe158d1e2eb99a34ec4048f70]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.10673]]></link>
      <description><![CDATA[<p>This Medical News podcast discusses the Human Genome Project-write with Harvard geneticist, George Church, PhD.</p>]]></description>
      
      <content:encoded><![CDATA[<p>This Medical News podcast discusses the Human Genome Project-write with Harvard geneticist, George Church, PhD.</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/160621-jama-mednews-church.mp3?dest-id=90171" length="6957196" type="audio/mpeg" />
      <itunes:duration>14:23</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/d/9/7/ed97594987d6174b/160621-jama-mednews-church.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Interventions to Support Breastfeeding</title>
      <itunes:title>USPSTF Recommendation: Interventions to Support Breastfeeding</itunes:title>
      <pubDate>Tue, 25 Oct 2016 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[8f665d649f27a59a7753aaeacdf8b881]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.14697]]></link>
      <description><![CDATA[<p>Interview with Ann E. Kurth, PhD, RN, MSN, MPH, Task Force member and co-author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.14697"> Primary Care Interventions to Support Breastfeeding: US Preventive Services Task Force Recommendation Statement</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Ann E. Kurth, PhD, RN, MSN, MPH, Task Force member and co-author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.14697"> Primary Care Interventions to Support Breastfeeding: US Preventive Services Task Force Recommendation Statement</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation__Interventions_to_Support_Breastfeeding.mp3?dest-id=90171" length="6124125" type="audio/mpeg" />
      <itunes:duration>12:26</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/b/4/5/3/b453b24e05cbadb6/161025-jama-jai-kurth.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Professional Boundaries: What to Do When Clinicians Ask Other Clinicians to Prescribe Medications for Them</title>
      <itunes:title>Professional Boundaries: What to Do When Clinicians Ask Other Clinicians to Prescribe Medications for Them</itunes:title>
      <pubDate>Tue, 25 Oct 2016 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[2bb122cc8df899ffd900f01a30409314]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.15753]]></link>
      <description><![CDATA[<p>In this episode of JAMA Professionalism: Best Practice, Edward H. Livingston, MD looks at the case of a physician requesting prescription medication from a colleague to examine professional boundaries between physicians and options for managing those boundaries. Shiphra Ginsburg, MD and Wendy Levinson, MD, authors of the <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2016.15753"> related article</a>, join Dr Livingston to discuss the best options for handling this challenging situation. Arthur S. Hengerer, MD, chair of the Federation of State Medical Boards discusses the legal and licensure ramifications of physicians prescribing for other clinicians and Kate E. Engelhardt, MD, and D. Brock Hewitt, MD, MPH, practicing physicians, relate their experience with other clinicians asking them to prescribe medications.</p>]]></description>
      
      <content:encoded><![CDATA[<p>In this episode of JAMA Professionalism: Best Practice, Edward H. Livingston, MD looks at the case of a physician requesting prescription medication from a colleague to examine professional boundaries between physicians and options for managing those boundaries. Shiphra Ginsburg, MD and Wendy Levinson, MD, authors of the <a href= "http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2016.15753"> related article</a>, join Dr Livingston to discuss the best options for handling this challenging situation. Arthur S. Hengerer, MD, chair of the Federation of State Medical Boards discusses the legal and licensure ramifications of physicians prescribing for other clinicians and Kate E. Engelhardt, MD, and D. Brock Hewitt, MD, MPH, practicing physicians, relate their experience with other clinicians asking them to prescribe medications.</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/160802-jama-jpr-boundaries.mp3?dest-id=90171" length="26410118" type="audio/mpeg" />
      <itunes:duration>27:29</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/2/4/b/e24bee26352fd51d/160802-jama-jpr-boundaries.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>On CDC's 70th Anniversary, Director Tom Frieden, MD, Looks Ahead</title>
      <itunes:title>On CDC's 70th Anniversary, Director Tom Frieden, MD, Looks Ahead</itunes:title>
      <pubDate>Thu, 13 Oct 2016 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[09128ae0e0c60d5889462c6b523b7439]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.12699]]></link>
      <description><![CDATA[<p>This Medical News podcast features a Q&A with CDC Director Tom Frieden, MD, commemorating the agency's historic 70th anniversary. The interview was recorded on August 8th, 2016.</p>]]></description>
      
      <content:encoded><![CDATA[<p>This Medical News podcast features a Q&A with CDC Director Tom Frieden, MD, commemorating the agency's historic 70th anniversary. The interview was recorded on August 8th, 2016.</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/On_CDCs_70th_Anniversary_Director_Tom_Frieden_MD_Looks_Ahead.mp3?dest-id=90171" length="5221370" type="audio/mpeg" />
      <itunes:duration>10:49</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/b/9/3/4/b934d324cbda9753/160808-mednews-frieden.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>The Supplement Paradox</title>
      <itunes:title>The Supplement Paradox</itunes:title>
      <pubDate>Tue, 11 Oct 2016 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[e9a6170782875e56125c64df1a01c04e]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.14252]]></link>
      <description><![CDATA[<p>Interview with Pieter A. Cohen, MD, author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.14252"> The Supplement Paradox: Negligible Benefits, Robust Consumption</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Pieter A. Cohen, MD, author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.14252"> The Supplement Paradox: Negligible Benefits, Robust Consumption</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/The_Supplement_Paradox.mp3?dest-id=90171" length="4467005" type="audio/mpeg" />
      <itunes:duration>04:38</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/a/e/7/cae76e4b733fab88/161011-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Treatments for Hyperemesis and Nausea and Vomiting in Pregnancy</title>
      <itunes:title>Treatments for Hyperemesis and Nausea and Vomiting in Pregnancy</itunes:title>
      <pubDate>Tue, 04 Oct 2016 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[113cec9004246400276d74f63ac0ffdd]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.14337]]></link>
      <description><![CDATA[<p>Nearly all women experience some element of nausea and vomiting during their pregnancies. In this podcast we review the entire spectrum of disease all the way up to hyperemesis gravidarum and how to provide care for women experiencing these problems.</p> <p>Article discussed in this episode:</p> <p><a href="http://dx.doi.org/10.1001/jama.2016.14337">Treatments for Hyperemesis Gravidarum and Nausea and Vomiting in Pregnancy</a></p> <p> </p>]]></description>
      
      <content:encoded><![CDATA[<p>Nearly all women experience some element of nausea and vomiting during their pregnancies. In this podcast we review the entire spectrum of disease all the way up to hyperemesis gravidarum and how to provide care for women experiencing these problems.</p> <p>Article discussed in this episode:</p> <p><a href="http://dx.doi.org/10.1001/jama.2016.14337">Treatments for Hyperemesis Gravidarum and Nausea and Vomiting in Pregnancy</a></p> <p> </p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Treatments_for_Hyperemesis_Gravidarum_and_Nausea_and_Vomiting_in_Pregnancy.mp3?dest-id=90171" length="8896221" type="audio/mpeg" />
      <itunes:duration>18:05</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/1/a/6/21a62ba6be5807b5/160928-jama-jcr-moore-finalfinal." />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Fluid Resuscitation for Patients in Septic Shock</title>
      <itunes:title>Fluid Resuscitation for Patients in Septic Shock</itunes:title>
      <pubDate>Tue, 27 Sep 2016 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[15ad3c6a1674e37eee24e12ecf8a2694]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.12310]]></link>
      <description><![CDATA[<p>When managing septic shock, passive leg raising is the best test to determine if a patient is likely to respond to a fluid bolus, better than CVP lines or even bedside ultrasound. Dr Najib Ayas, Associate professor of Critical Care Medicine at the University of British Columbia, discusses shock management from the context of his Rational Clinical examination article in the September 27, 2016 issue of JAMA, entitled "<a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.12310">Will This Hemodynamically Unstable Patient Respond to a Bolus of Intravenous Fluids?</a>"</p>]]></description>
      
      <content:encoded><![CDATA[<p>When managing septic shock, passive leg raising is the best test to determine if a patient is likely to respond to a fluid bolus, better than CVP lines or even bedside ultrasound. Dr Najib Ayas, Associate professor of Critical Care Medicine at the University of British Columbia, discusses shock management from the context of his Rational Clinical examination article in the September 27, 2016 issue of JAMA, entitled "<a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.12310">Will This Hemodynamically Unstable Patient Respond to a Bolus of Intravenous Fluids?</a>"</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Fluid_Resuscitation_for_Patients_in_Septic_Shock.mp3?dest-id=90171" length="14848450" type="audio/mpeg" />
      <itunes:duration>30:40</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/4/3/7/84375aef90d8ed4d/JRC160002.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Endovascular Thrombectomy and Outcomes in Ischemic Stroke</title>
      <itunes:title>Endovascular Thrombectomy and Outcomes in Ischemic Stroke</itunes:title>
      <pubDate>Tue, 27 Sep 2016 14:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[5740b376f2b0bac7f7f427ef8687dbea]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.13647]]></link>
      <description><![CDATA[<p>Interview with Jeffrey L Saver, M.D., author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.13647"> Time to Treatment With Endovascular Thrombectomy and Outcomes From Ischemic Stroke: A Meta-analysis</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Jeffrey L Saver, M.D., author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.13647"> Time to Treatment With Endovascular Thrombectomy and Outcomes From Ischemic Stroke: A Meta-analysis</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Endovascular_Thrombectomy_and_Outcomes_in_Ischemic_Stroke.mp3?dest-id=90171" length="3024442" type="audio/mpeg" />
      <itunes:duration>03:07</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/b/c/8/3bc8f5ef992a98d3/160927-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>JAMA Performance Improvement: Do No Harm — Performing the Wrong Procedure</title>
      <itunes:title>JAMA Performance Improvement: Do No Harm — Performing the Wrong Procedure</itunes:title>
      <pubDate>Tue, 20 Sep 2016 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[8f4679807633af9ea3ae021265abc938]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.9134]]></link>
      <description><![CDATA[<p>What to do when the wrong procedure is performed? In this first installment of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.9134"> JAMA Performance Improvement: Do No Harm</a> we explore the options for dealing with this very difficult problem with Tami Minnier, RN, MSN, Paul Phrampus, MD, Linda Waddell, RN, MSN, and David Baker, MD, MPH, FACP. Air traffic audio courtesy of LiveATC.net, used with permission.</p> <p> </p>]]></description>
      
      <content:encoded><![CDATA[<p>What to do when the wrong procedure is performed? In this first installment of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.9134"> JAMA Performance Improvement: Do No Harm</a> we explore the options for dealing with this very difficult problem with Tami Minnier, RN, MSN, Paul Phrampus, MD, Linda Waddell, RN, MSN, and David Baker, MD, MPH, FACP. Air traffic audio courtesy of LiveATC.net, used with permission.</p> <p> </p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Performing_the_Wrong_Procedure.mp3?dest-id=90171" length="18833615" type="audio/mpeg" />
      <itunes:duration>19:35</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/7/c/7/e7c7cb7bdfa9607e/160113-jama-jpi-wrongprocedure.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Monitoring and Feedback for Long-term Weight Loss</title>
      <itunes:title>Monitoring and Feedback for Long-term Weight Loss</itunes:title>
      <pubDate>Tue, 20 Sep 2016 14:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[2dc3071c87731996ba880e1a43031751]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.12858]]></link>
      <description><![CDATA[<p>Interview with John M. Jakicic, PhD, author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.12858"> Effect of Wearable Technology Combined With a Lifestyle Intervention on Long-term Weight Loss: The IDEA Randomized Clinical Trial</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with John M. Jakicic, PhD, author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.12858"> Effect of Wearable Technology Combined With a Lifestyle Intervention on Long-term Weight Loss: The IDEA Randomized Clinical Trial</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Monitoring_and_Feedback_for_Long-term_Weight_Loss.mp3?dest-id=90171" length="2372526" type="audio/mpeg" />
      <itunes:duration>02:27</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/9/a/c/39ac640eda3d9e5e/JOI160104.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Value-Driven Outcomes Program and Health Care Cost and Quality</title>
      <itunes:title>Value-Driven Outcomes Program and Health Care Cost and Quality</itunes:title>
      <pubDate>Tue, 13 Sep 2016 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[fc3c0a1fd5e78b2df09f735bad63eab4]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.12226]]></link>
      <description><![CDATA[<p>Interview with Vivian S. Lee, MD, PhD, MBA;, author of Implementation of a Value-Driven Outcomes Program to Identify High Variability in Clinical Costs and Outcomes: Association With Reduced Cost and Improved Quality, and Michael E. Porter, PhD, author of From Volume to Value in Health Care: The Work Begins</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Vivian S. Lee, MD, PhD, MBA;, author of Implementation of a Value-Driven Outcomes Program to Identify High Variability in Clinical Costs and Outcomes: Association With Reduced Cost and Improved Quality, and Michael E. Porter, PhD, author of From Volume to Value in Health Care: The Work Begins</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Value-Driven_Outcomes_Program_and_Health_Care_Cost_and_Quality.mp3?dest-id=90171" length="14800920" type="audio/mpeg" />
      <itunes:duration>30:46</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/9/a/e/69ae7ced656632fc/160913-joi160099-350x350.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>A Surgeon-scientist and Entrepreneur Fights Against Cancer</title>
      <itunes:title>A Surgeon-scientist and Entrepreneur Fights Against Cancer</itunes:title>
      <pubDate>Wed, 07 Sep 2016 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[68acb03005d0bdc5eecd93d77a67cc5b]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.9304]]></link>
      <description><![CDATA[<p>Patrick Soon-Shiong, MD, physician-scientist and entrepreneur, talks about the National MoonShot Initiative, his MoonShot 2020 Program, as well as promising approaches in cancer immunotherapy. This podcast was originally recorded on June 3, 2016</p>]]></description>
      
      <content:encoded><![CDATA[<p>Patrick Soon-Shiong, MD, physician-scientist and entrepreneur, talks about the National MoonShot Initiative, his MoonShot 2020 Program, as well as promising approaches in cancer immunotherapy. This podcast was originally recorded on June 3, 2016</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/A_Surgeon-scientist_and_Entrepreneur_Fights_Against_Cancer.mp3?dest-id=90171" length="11192961" type="audio/mpeg" />
      <itunes:duration>23:15</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/4/2/a/a42aed23615bbe46/160603-mednews-soon-shiong.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>MRI Exposure During Pregnancy and Offspring Outcomes</title>
      <itunes:title>MRI Exposure During Pregnancy and Offspring Outcomes</itunes:title>
      <pubDate>Tue, 06 Sep 2016 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[4956bef74e19a0d79284f8dc07e4820c]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.12126]]></link>
      <description><![CDATA[<p>Interview with Joel G. Ray, MD, MSc, FRCPC, author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.12126"> Association Between MRI Exposure During Pregnancy and Fetal and Childhood Outcomes</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Joel G. Ray, MD, MSc, FRCPC, author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.12126"> Association Between MRI Exposure During Pregnancy and Fetal and Childhood Outcomes</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/160906-jama-avi.mp3?dest-id=90171" length="3447790" type="audio/mpeg" />
      <itunes:duration>03:33</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/4/1/9/5/41955981e9bfc222/160906-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Screening for Latent Tuberculosis in Adults</title>
      <itunes:title>USPSTF Recommendation: Screening for Latent Tuberculosis in Adults</itunes:title>
      <pubDate>Tue, 06 Sep 2016 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[5ec35c80e73aa2b04e145b5d1445d307]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.11046]]></link>
      <description><![CDATA[<p>Interview with Francisco A.R. García, MD, MPH, author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.11046"> Screening for Latent Tuberculosis Infection in Adults: US Preventive Services Task Force Recommendation Statement</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Francisco A.R. García, MD, MPH, author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.11046"> Screening for Latent Tuberculosis Infection in Adults: US Preventive Services Task Force Recommendation Statement</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation__Screening_for_Latent_Tuberculosis_in_Adults.mp3?dest-id=90171" length="11531210" type="audio/mpeg" />
      <itunes:duration>23:44</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/e/8/e/1e8e00afc005835c/160906-jama-jai-garcia-thumb.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>The High Cost of Pharmaceuticals in the United States</title>
      <itunes:title>The High Cost of Pharmaceuticals in the United States</itunes:title>
      <pubDate>Fri, 26 Aug 2016 20:32:49 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[25000fc358dbdeb0656c7e017284fb43]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.11237]]></link>
      <description><![CDATA[<p>Drug prices continue to rise in the US. Many solutions have been proposed but few have been implemented. Drs. Janet Woodcock from the FDA and Aaron Kesselheim, author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.11237"> The High Cost of Prescription Drugs in the United States</a> from the Harvard Medical School discuss the role of brand name drugs and generics and how they influence the cost of pharmaceuticals.</p> <p>Also see <a href="http://www.nber.org/papers/w11114">The Cost of US Pharmaceutical Price Reductions: A Financial Simulation Model of R&D Decisions</a> by Thomas A. Abbott and John A. Vernon.</p>]]></description>
      
      <content:encoded><![CDATA[<p>Drug prices continue to rise in the US. Many solutions have been proposed but few have been implemented. Drs. Janet Woodcock from the FDA and Aaron Kesselheim, author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.11237"> The High Cost of Prescription Drugs in the United States</a> from the Harvard Medical School discuss the role of brand name drugs and generics and how they influence the cost of pharmaceuticals.</p> <p>Also see <a href="http://www.nber.org/papers/w11114">The Cost of US Pharmaceutical Price Reductions: A Financial Simulation Model of R&D Decisions</a> by Thomas A. Abbott and John A. Vernon.</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/The_High_Cost_of_Prescription_Drugs_in_the_United_States.mp3?dest-id=90171" length="15921887" type="audio/mpeg" />
      <itunes:duration>32:46</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/5/c/5/6/5c56a0f6bf45fb9b/Generic_Drugs.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>JAMA Professionalism: Best Practice--Disclosure of Medical Error</title>
      <itunes:title>JAMA Professionalism: Best Practice--Disclosure of Medical Error</itunes:title>
      <pubDate>Tue, 16 Aug 2016 15:01:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[2efb747758f515b87169bb0948a51dd3]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.9136]]></link>
      <description><![CDATA[<p>Introducing a new series of JAMA articles on professionalism, discussed from the perspective of how clinicians should address challenging clinical situations and adverse events in their medical practice. In the first episode of the accompanying podcast, JAMA Professionalism: Best Practice, we interview Wendy Levinson, MD, and Jensen Yeung, MD, authors of <a href= ""http:/jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.9136%E2%80%9D"> Disclosure of Medical Error</a>, which appeared in the August 16, 2016 issue of JAMA, as well as Thomas H. Gallagher, MD.</p>]]></description>
      
      <content:encoded><![CDATA[<p>Introducing a new series of JAMA articles on professionalism, discussed from the perspective of how clinicians should address challenging clinical situations and adverse events in their medical practice. In the first episode of the accompanying podcast, JAMA Professionalism: Best Practice, we interview Wendy Levinson, MD, and Jensen Yeung, MD, authors of <a href= ""http:/jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.9136%E2%80%9D"> Disclosure of Medical Error</a>, which appeared in the August 16, 2016 issue of JAMA, as well as Thomas H. Gallagher, MD.</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_Professionalism__Best_Practice-Disclosure_of_Medical_Error.mp3?dest-id=90171" length="10510728" type="audio/mpeg" />
      <itunes:duration>21:29</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/e/f/b/3efbfb7b436ccb96/1607-professionalism-disclosure.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Cost-effectiveness of PCSK9 Inhibitors for Heterozygous FH or ASCVD</title>
      <itunes:title>Cost-effectiveness of PCSK9 Inhibitors for Heterozygous FH or ASCVD</itunes:title>
      <pubDate>Tue, 16 Aug 2016 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[b8332c588feb04d45bf3fda83e04848f]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.11004]]></link>
      <description><![CDATA[<p>Interview with Dhruv S. Kazi, MD, MSc, MS, author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.11004"> Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Dhruv S. Kazi, MD, MSc, MS, author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.11004"> Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Cost-effectiveness_of_PCSK9_Inhibitors_for_Heterozygous_FH_or_ASCVD.mp3?dest-id=90171" length="3530563" type="audio/mpeg" />
      <itunes:duration>03:39</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/6/8/e/068ed7c08f4c031e/160816-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Opioid Use Disorder</title>
      <itunes:title>Opioid Use Disorder</itunes:title>
      <pubDate>Thu, 11 Aug 2016 19:34:12 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[119674e8be663aa986d84050478e9259]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.9795]]></link>
      <description><![CDATA[<p>Edward H. Livingston, MD, discusses the British Columbia Ministry of Health's 2015 guidelines on clinical management of opioid use disorder in adults with Keith Ahamad, MD,  Evan Wood, MD, PhD, ABIM, FRCPC, Tony L. Yaksh, PhD, and Humayun J. Chaudhry, DO, MS, MACP, FACOI.</p> <p class="p2">Articles and resources discussed in this episode: </p> <ul> <li class="p1"><a href= "http://sites.jamanetwork.com/opioids/">Opioid Use and Addiction Microsite</a>,</li> <li class="p1"><a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.9795"> Clinical Management of Opioid Use Disorder (JAMA Clinical Guidelines Synopsis)</a>,</li> <li class="p1"><a href= "http://www.vch.ca/media/Opioid-Addiction-Guideline.pdf">The Vancouver Opioid Use Disorder Guideline</a>,</li> <li class="p1"><a href= "http://www.fsmb.org/Media/Default/PDF/FSMB/Advocacy/2013_model_policy_treatment_opioid_addiction.pdf"> Model Policy on DATA 2000 And Treatment of Opioid Addiction in the Medical Office</a></li> </ul> <p> </p>]]></description>
      
      <content:encoded><![CDATA[<p>Edward H. Livingston, MD, discusses the British Columbia Ministry of Health's 2015 guidelines on clinical management of opioid use disorder in adults with Keith Ahamad, MD, Evan Wood, MD, PhD, ABIM, FRCPC, Tony L. Yaksh, PhD, and Humayun J. Chaudhry, DO, MS, MACP, FACOI.</p> <p class="p2">Articles and resources discussed in this episode: </p> <ul> <li class="p1"><a href= "http://sites.jamanetwork.com/opioids/">Opioid Use and Addiction Microsite</a>,</li> <li class="p1"><a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.9795"> Clinical Management of Opioid Use Disorder (JAMA Clinical Guidelines Synopsis)</a>,</li> <li class="p1"><a href= "http://www.vch.ca/media/Opioid-Addiction-Guideline.pdf">The Vancouver Opioid Use Disorder Guideline</a>,</li> <li class="p1"><a href= "http://www.fsmb.org/Media/Default/PDF/FSMB/Advocacy/2013_model_policy_treatment_opioid_addiction.pdf"> Model Policy on DATA 2000 And Treatment of Opioid Addiction in the Medical Office</a></li> </ul> <p> </p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Clinical_Management_of_Opioid_Use_Disorder.mp3?dest-id=90171" length="33538910" type="audio/mpeg" />
      <itunes:duration>34:55</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/3/b/1/23b1809e5660b1c6/160719-jama-cre-opioidaddiction.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Screening for Lipid Disorders in Youth</title>
      <itunes:title>USPSTF Recommendation: Screening for Lipid Disorders in Youth</itunes:title>
      <pubDate>Tue, 09 Aug 2016 15:02:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[82231cc41aa77c5f72bd5bee9ec46e70]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.9852]]></link>
      <description><![CDATA[<p>Interview with David Grossman, MD, author of <a href= ""http:/archderm.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.9852%E2%80%9D"> Screening for Lipid Disorders in Children and Adolescents: US Preventive Services Task Force Recommendation Statement</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with David Grossman, MD, author of <a href= ""http:/archderm.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.9852%E2%80%9D"> Screening for Lipid Disorders in Children and Adolescents: US Preventive Services Task Force Recommendation Statement</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation__Screening_for_Lipid_Disorders_in_Youth.mp3?dest-id=90171" length="11453425" type="audio/mpeg" />
      <itunes:duration>23:30</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/d/c/4/b/dc4b3c8bbd5d5ce5/160809-jama-jai-grossman.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Cerebral Protection Device Effects on Brain Lesions After TAVI</title>
      <itunes:title>Cerebral Protection Device Effects on Brain Lesions After TAVI</itunes:title>
      <pubDate>Tue, 09 Aug 2016 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[7847183e96bbaeea0f8ff2879f4d3abe]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.10302]]></link>
      <description><![CDATA[<p>Interview with Axel Linke, MD, author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.10302"> Effect of a Cerebral Protection Device on Brain Lesions Following Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis: The CLEAN-TAVI Randomized Clinical Trial</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Axel Linke, MD, author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.10302"> Effect of a Cerebral Protection Device on Brain Lesions Following Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis: The CLEAN-TAVI Randomized Clinical Trial</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Cerebral_Protection_Device_Effects_on_Brain_Lesions_After_TAVI.mp3?dest-id=90171" length="2637573" type="audio/mpeg" />
      <itunes:duration>02:43</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/4/1/c/1/41c1060d093c6db6/160809-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Threat From Colistin-Resistant Superbug</title>
      <itunes:title>Threat From Colistin-Resistant Superbug</itunes:title>
      <pubDate>Wed, 27 Jul 2016 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[68d7946b08f08d79d72806fd670c4ee1]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.9690]]></link>
      <description><![CDATA[<p>Interview with Barbara E. Murray, MD, author of <a href= "http://archderm.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.9690"> Infectious Disease Expert Sees Threat From Colistin-Resistant Superbug</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Barbara E. Murray, MD, author of <a href= "http://archderm.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.9690"> Infectious Disease Expert Sees Threat From Colistin-Resistant Superbug</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Threat_From_Colistin-Resistant_Superbug.mp3?dest-id=90171" length="6185427" type="audio/mpeg" />
      <itunes:duration>12:49</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/b/3/0/8b3086a9ed29700d/160727-jama-news-murray-thumb.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Screening for Skin Cancer</title>
      <itunes:title>Screening for Skin Cancer</itunes:title>
      <pubDate>Tue, 26 Jul 2016 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[486100c338094ef258bffc55f40b3701]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.8465]]></link>
      <description><![CDATA[<p>Interview with Michael P. Pignone, MD, MPH, author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.8465"> Screening for Skin Cancer: US Preventive Services Task Force Recommendation Statement</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Michael P. Pignone, MD, MPH, author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.8465"> Screening for Skin Cancer: US Preventive Services Task Force Recommendation Statement</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation_Statement__Screening_for_Skin_Cancer.mp3?dest-id=90171" length="10696875" type="audio/mpeg" />
      <itunes:duration>22:13</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/9/8/3/3983a35b3ee336ce/160615-task-force-logo-350x350.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Treating Opioid Use Disorder Using Buprenorphine Implants</title>
      <itunes:title>Treating Opioid Use Disorder Using Buprenorphine Implants</itunes:title>
      <pubDate>Tue, 19 Jul 2016 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[1ee651f9a3d84258e83fe29e87db9d7a]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.9382]]></link>
      <description><![CDATA[<p>Richard N. Rosenthal, MD discusses a <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.9382"> randomized clinical trial demonstrating the efficacy of an implantable buprenorphine-releasing device for treating opioid use disorder.</a></p> <p> </p>]]></description>
      
      <content:encoded><![CDATA[<p>Richard N. Rosenthal, MD discusses a <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.9382"> randomized clinical trial demonstrating the efficacy of an implantable buprenorphine-releasing device for treating opioid use disorder.</a></p> <p> </p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Treating_Opioid_Use_Disorder_Using_Implantable_Devices.mp3?dest-id=90171" length="17959115" type="audio/mpeg" />
      <itunes:duration>18:41</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/8/b/e/88be58a5279caa03/160719-jama-jai-rosenthal.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Review of Lyme Disease</title>
      <itunes:title>Review of Lyme Disease</itunes:title>
      <pubDate>Tue, 12 Jul 2016 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[51122902ae9f3e30ce7fe45d1642b68e]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.2884]]></link>
      <description><![CDATA[<p>Lyme disease is very common in certain regions of the country and is caused by the spirochete <em>Borrelia bergdorferi</em>. Lyme disease is transmitted by tick bites and in this podcast we review the discovery of Lyme disease, its major clinical features, and how to diagnose and treat it, as told by Dr Alan Steere, Dr Lyndon Hu, and Dr Paul Auerwerter.</p> <p>Related article: <a href= ""http:/jama.jamanetwork.com/article.aspx?doi=xxx%E2%80%9D">Review of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis</a></p> <p> </p>]]></description>
      
      <content:encoded><![CDATA[<p>Lyme disease is very common in certain regions of the country and is caused by the spirochete <em>Borrelia bergdorferi</em>. Lyme disease is transmitted by tick bites and in this podcast we review the discovery of Lyme disease, its major clinical features, and how to diagnose and treat it, as told by Dr Alan Steere, Dr Lyndon Hu, and Dr Paul Auerwerter.</p> <p>Related article: <a href= ""http:/jama.jamanetwork.com/article.aspx?doi=xxx%E2%80%9D">Review of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis</a></p> <p> </p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Review_of_Lyme_Disease.mp3?dest-id=90171" length="18551530" type="audio/mpeg" />
      <itunes:duration>38:26</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/8/c/0/28c00c024dc17650/jrc70005f3.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>HIV and Transplantation: New Reasons for HOPE</title>
      <itunes:title>HIV and Transplantation: New Reasons for HOPE</itunes:title>
      <pubDate>Tue, 12 Jul 2016 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[d765541d5b2fd145ec6d9a14a8bc05bd]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.8158]]></link>
      <description><![CDATA[<p>Interview with Dorry Segev, MD, PhD, author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.8158"> HIV and Transplantation: New Reasons for HOPE</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Dorry Segev, MD, PhD, author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.8158"> HIV and Transplantation: New Reasons for HOPE</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/HIV_and_Transplantation__New_Reasons_for_HOPE.mp3?dest-id=90171" length="10667488" type="audio/mpeg" />
      <itunes:duration>22:09</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/f/5/d/a/f5da0f8b05a835be/ThinkstockPhotos-167612910.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Attitudes and Practices of Euthanasia and Physician-Assisted Suicide</title>
      <itunes:title>Attitudes and Practices of Euthanasia and Physician-Assisted Suicide</itunes:title>
      <pubDate>Tue, 05 Jul 2016 14:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[282983574bf26245fe2568e730c0a0cd]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.8499]]></link>
      <description><![CDATA[<p>Interview with Ezekiel J. Emanuel, MD, PhD, author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.8499"> Attitudes and Practices of Euthanasia and Physician-Assisted Suicide in the United States, Canada, and Europe</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Ezekiel J. Emanuel, MD, PhD, author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.8499"> Attitudes and Practices of Euthanasia and Physician-Assisted Suicide in the United States, Canada, and Europe</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Attitudes_and_Practices_of_Euthanasia_and_Physician-Assisted_Suicide.mp3?dest-id=90171" length="4240908" type="audio/mpeg" />
      <itunes:duration>04:24</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/f/0/9/2f095166deed1879/ThinkstockPhotos-496824824.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Managing Persistent Diarrhea</title>
      <itunes:title>Managing Persistent Diarrhea</itunes:title>
      <pubDate>Tue, 28 Jun 2016 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[a04328739dfc5530e184617a06420b42]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.7833]]></link>
      <description><![CDATA[<p>Persistent diarrhea is a poorly recognized syndrome in all populations that requires proper assessment and diagnosis to ensure that affected individuals receive the treatment needed to experience improvement of clinical symptoms. Listen to Drs Herbert DuPont and Annie Feagins discuss how to diagnose and treat diarrhea. Related article: <a href= ""http:/jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.7833%E2%80%9D"> Persistent Diarrhea</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Persistent diarrhea is a poorly recognized syndrome in all populations that requires proper assessment and diagnosis to ensure that affected individuals receive the treatment needed to experience improvement of clinical symptoms. Listen to Drs Herbert DuPont and Annie Feagins discuss how to diagnose and treat diarrhea. Related article: <a href= ""http:/jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.7833%E2%80%9D"> Persistent Diarrhea</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Persistent_Diarrhea.mp3?dest-id=90171" length="18074856" type="audio/mpeg" />
      <itunes:duration>37:25</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/b/4/5/8/b458145face44d70/160518-jama-cre-diarrhea.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Intensive Blood Pressure Control in Adults Aged 75 Years or Older</title>
      <itunes:title>Intensive Blood Pressure Control in Adults Aged 75 Years or Older</itunes:title>
      <pubDate>Tue, 28 Jun 2016 14:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[690f8590c206fdaa44976bf058ae5708]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.7050]]></link>
      <description><![CDATA[<p>Interview with Jeff D. Williamson, MD, MHS, author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.7050"> Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Jeff D. Williamson, MD, MHS, author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.7050"> Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Intensive_Blood_Pressure_Control_in_Adults_Aged_75_Years_or_Older.mp3?dest-id=90171" length="4216672" type="audio/mpeg" />
      <itunes:duration>04:22</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/8/4/6/684684233f268fd5/160628-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Gun Law Reforms and Firearm Deaths in Australia</title>
      <itunes:title>Gun Law Reforms and Firearm Deaths in Australia</itunes:title>
      <pubDate>Wed, 22 Jun 2016 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[abd0ee08515b158f27fb0e6e575515d0]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.8752]]></link>
      <description><![CDATA[<p>Howard Bauchner, MD, Editor in Chief of JAMA, interviews Simon Chapman, MD, author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.8752"> Association Between Gun Law Reforms and Intentional Firearm Deaths in Australia, 1979-2013</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Howard Bauchner, MD, Editor in Chief of JAMA, interviews Simon Chapman, MD, author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.8752"> Association Between Gun Law Reforms and Intentional Firearm Deaths in Australia, 1979-2013</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Gun_Law_Reforms_and_Firearm_Deaths_in_Australia.mp3?dest-id=90171" length="10936513" type="audio/mpeg" />
      <itunes:duration>22:39</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/b/d/6/8bd6448efd2f1ef2/160622-jama-jai-chapman." />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Screening for Colorectal Cancer</title>
      <itunes:title>Screening for Colorectal Cancer</itunes:title>
      <pubDate>Wed, 15 Jun 2016 14:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[4dc8b58cbd38f12b76e2c1655d4a9cf9]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.5989]]></link>
      <description><![CDATA[<p>Interview with Douglas K. Owens, MD, MS, author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.5989"> Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Douglas K. Owens, MD, MS, author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.5989"> Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation_Statement__Screening_for_Colorectal_Cancer.mp3?dest-id=90171" length="9252611" type="audio/mpeg" />
      <itunes:duration>18:57</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/0/d/a/80da5127556ec8c1/ThinkstockPhotos-505751042.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>The Discovery of Lyme Disease with Dr Allen Steere</title>
      <itunes:title>The Discovery of Lyme Disease with Dr Allen Steere</itunes:title>
      <pubDate>Tue, 14 Jun 2016 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[24b1f826c9add12762ae02590b59d4f3]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.2884]]></link>
      <description><![CDATA[<p>Dr Allen Steere discovered Lyme disease and discusses what he saw and did when confronted early in his career with a previously undescribed disease. Late stage disease, a form not commonly seen today, is discussed in detail since that is how the disease presented before its cause was determined.</p> <p>Related article:<br /> <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.2884"> Review of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis</a></p> <p> </p>]]></description>
      
      <content:encoded><![CDATA[<p>Dr Allen Steere discovered Lyme disease and discusses what he saw and did when confronted early in his career with a previously undescribed disease. Late stage disease, a form not commonly seen today, is discussed in detail since that is how the disease presented before its cause was determined.</p> <p>Related article: <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.2884"> Review of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis</a></p> <p> </p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Interview_with_Allen_Steere_MD_on_Lyme_Disease.mp3?dest-id=90171" length="11223181" type="audio/mpeg" />
      <itunes:duration>23:03</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/b/2/7/1b27d310e3b87fcd/m_jpg0620f1.jpeg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>USPSTF Recommendation: Screening for Syphilis Infection</title>
      <itunes:title>USPSTF Recommendation: Screening for Syphilis Infection</itunes:title>
      <pubDate>Tue, 07 Jun 2016 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[65f060300c6dde60e46729483e344f54]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.5824]]></link>
      <description><![CDATA[<p>Interview with Ann E. Kurth, PhD, RN, MSN, MPH, author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.5824"> Screening for Syphilis Infection in Nonpregnant Adults and Adolescents: US Preventive Services Task Force Recommendation Statement</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Ann E. Kurth, PhD, RN, MSN, MPH, author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.5824"> Screening for Syphilis Infection in Nonpregnant Adults and Adolescents: US Preventive Services Task Force Recommendation Statement</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation__Screening_for_Syphilis_Infection.mp3?dest-id=90171" length="6136725" type="audio/mpeg" />
      <itunes:duration>11:57</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/7/a/e/87aecb372376adc9/JUS160001.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Trends in Obesity Among Adults in the United States, 2005 to 2014</title>
      <itunes:title>Trends in Obesity Among Adults in the United States, 2005 to 2014</itunes:title>
      <pubDate>Tue, 07 Jun 2016 14:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[494aa384a74765ee8fa554bcbff60b5c]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.6458]]></link>
      <description><![CDATA[<p>Interview with Cynthia L. Ogden, PhD, author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.6458"> Trends in Obesity Among Adults in the United States, 2005 to 2014</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Cynthia L. Ogden, PhD, author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.6458"> Trends in Obesity Among Adults in the United States, 2005 to 2014</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Trends_in_Obesity_Among_Adults_in_the_United_States_2005_to_2014.mp3?dest-id=90171" length="3115108" type="audio/mpeg" />
      <itunes:duration>03:13</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/8/5/c/985ca4153e7a161e/160607-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Neighborhood Walkability, Weight, and Diabetes</title>
      <itunes:title>Neighborhood Walkability, Weight, and Diabetes</itunes:title>
      <pubDate>Tue, 24 May 2016 13:44:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[ed0eb8d6a59733443372113b532e7549]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.5898]]></link>
      <description><![CDATA[<p>Interview with Gillian L. Booth, MD, author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.5898"> Association of Neighborhood Walkability With Change in Overweight, Obesity, and Diabetes</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Gillian L. Booth, MD, author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.5898"> Association of Neighborhood Walkability With Change in Overweight, Obesity, and Diabetes</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Neighborhood_Walkability_Weight_and_Diabetes.mp3?dest-id=90171" length="2593972" type="audio/mpeg" />
      <itunes:duration>02:41</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/4/0/5/9/4059d333d1466da9/160524-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Histologic Changes in the Esophagus in Patients With GERD</title>
      <itunes:title>Histologic Changes in the Esophagus in Patients With GERD</itunes:title>
      <pubDate>Tue, 17 May 2016 15:02:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[2219289199b176b2eef51826cfaad52d]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.5657]]></link>
      <description><![CDATA[<p>Drs Stuart Spechler and Peter Kahrilis discuss GERD and esophagitis--how they occur and how they are treated. Dr Spechler also discusses a new hypothesis regarding how reflux esophagitis is caused that differs from the traditional teaching that acid and pepsin reflux into the esophagus and burn the mucosa layers.</p> <p>Related articles:<br /> <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.5657"> Association of Acute Gastroesophageal Reflux Disease With Esophageal Histologic Changes</a><br /> <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.5827"> Turning the Pathogenesis of Acute Peptic Esophagitis Inside Out</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Drs Stuart Spechler and Peter Kahrilis discuss GERD and esophagitis--how they occur and how they are treated. Dr Spechler also discusses a new hypothesis regarding how reflux esophagitis is caused that differs from the traditional teaching that acid and pepsin reflux into the esophagus and burn the mucosa layers.</p> <p>Related articles: <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.5657"> Association of Acute Gastroesophageal Reflux Disease With Esophageal Histologic Changes</a> <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.5827"> Turning the Pathogenesis of Acute Peptic Esophagitis Inside Out</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Histologic_Changes_in_the_Esophagus_in_Patients_With_GERD.mp3?dest-id=90171" length="14354084" type="audio/mpeg" />
      <itunes:duration>29:31</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/4/d/4/94d404aa9ed99fcd/160517-jama-cre-gerd-spechler.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Physician-Surrogate Discordance in Prognosis of Critically Ill Patients</title>
      <itunes:title>Physician-Surrogate Discordance in Prognosis of Critically Ill Patients</itunes:title>
      <pubDate>Tue, 17 May 2016 14:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[3c4217a7f2db53f182180db5b70379e5]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.5351]]></link>
      <description><![CDATA[<p>Interview with Douglas B. White, MD, MAS, author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.5351"> Prevalence of and Factors Related to Discordance About Prognosis Between Physicians and Surrogate Decision Makers of Critically Ill Patients</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Douglas B. White, MD, MAS, author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.5351"> Prevalence of and Factors Related to Discordance About Prognosis Between Physicians and Surrogate Decision Makers of Critically Ill Patients</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Physician-Surrogate_Discordance_in_Prognosis_of_Critically_Ill_Patients.mp3?dest-id=90171" length="2808098" type="audio/mpeg" />
      <itunes:duration>02:54</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/9/4/3/3943044c52c6f655/160517-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Treating ADHD in Adolescents</title>
      <itunes:title>Treating ADHD in Adolescents</itunes:title>
      <pubDate>Tue, 10 May 2016 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[49f1a2756a1ce630ab494dd398a048c4]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.5453]]></link>
      <description><![CDATA[<p>Attention-Deficit/Hyperactivity Disorder, or ADHD is a very common problem affecting about 10% of all adolescents. Children with ADHD have short attention spans, are hyperactive, talk a great deal, can be disruptive in the classroom etc.-features that are common in many adolescents. However, to have true ADHD, children must be significantly impaired by these problems. An array of medical and behavioral treatments can successfully help manage ADHD. These are reviewed in a series of articles appearing in the May 10, 2016, issue of JAMA. In this podcast, we discuss ADHD with the authors of some of those papers, Eugenia Chan, MD, MPH from Harvard and Philip Shaw, MD, PhD from the National Human Genome Research Institute.</p> <p>Articles discussed in this episode:</p> <ul> <li><a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.5453"> Treatment of Attention-Deficit/Hyperactivity Disorder in Adolescents: A Systematic Review</a></li> <li><a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.3427"> Quantifying the Benefits and Risks of Methylphenidate as Treatment for Childhood Attention-Deficit/Hyperactivity Disorder</a></li> <li><a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.3611"> Methylphenidate for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents</a></li> </ul> <p> </p>]]></description>
      
      <content:encoded><![CDATA[<p>Attention-Deficit/Hyperactivity Disorder, or ADHD is a very common problem affecting about 10% of all adolescents. Children with ADHD have short attention spans, are hyperactive, talk a great deal, can be disruptive in the classroom etc.-features that are common in many adolescents. However, to have true ADHD, children must be significantly impaired by these problems. An array of medical and behavioral treatments can successfully help manage ADHD. These are reviewed in a series of articles appearing in the May 10, 2016, issue of JAMA. In this podcast, we discuss ADHD with the authors of some of those papers, Eugenia Chan, MD, MPH from Harvard and Philip Shaw, MD, PhD from the National Human Genome Research Institute.</p> <p>Articles discussed in this episode:</p> <ul> <li><a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.5453"> Treatment of Attention-Deficit/Hyperactivity Disorder in Adolescents: A Systematic Review</a></li> <li><a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.3427"> Quantifying the Benefits and Risks of Methylphenidate as Treatment for Childhood Attention-Deficit/Hyperactivity Disorder</a></li> <li><a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.3611"> Methylphenidate for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents</a></li> </ul> <p> </p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Treatment_of_Attention-Deficit_Hyperactivity_Disorder_in_Adolescents.mp3?dest-id=90171" length="24392720" type="audio/mpeg" />
      <itunes:duration>25:12</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/4/b/7/94b768249d58967b/160510-jama-cre-adhd.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Chemoradiotherapy vs Chemotherapy for Pancreatic Cancer</title>
      <itunes:title>Chemoradiotherapy vs Chemotherapy for Pancreatic Cancer</itunes:title>
      <pubDate>Tue, 03 May 2016 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[3f9caa5d1ddb7ad58f37fc639fc9309d]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.4324]]></link>
      <description><![CDATA[<p>Interview with Pascal Hammel, MD, author of <a href=
"http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.4324">
Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients
With Locally Advanced Pancreatic Cancer Controlled After 4 Months
of Gemcitabine With or Without Erlotinib: The LAP07 Randomized
Clinical Trial</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Pascal Hammel, MD, author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.4324"> Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical Trial</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Chemoradiotherapy_vs_Chemotherapy_on_for_Pancreatic_Cancer.mp3?dest-id=90171" length="6410275" type="audio/mpeg" />
      <itunes:duration>13:18</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/7/f/3/2/7f32fbcf0f24134e/joi160039f2.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Quelling Zika Fears With Evidence</title>
      <itunes:title>Quelling Zika Fears With Evidence</itunes:title>
      <pubDate>Wed, 27 Apr 2016 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[7985f0d51a76dba2a3fc4d16457885d5]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.4069]]></link>
      <description><![CDATA[<p>Christine Curry, MD, PhD, assistant professor of obstetrics and
gynecology at the University of Miami, discusses the challenges of
keeping pregnant patients and her colleagues well-informed of the
facts as Zika virus fears circulate.</p>]]></description>
      
      <content:encoded><![CDATA[<p>Christine Curry, MD, PhD, assistant professor of obstetrics and gynecology at the University of Miami, discusses the challenges of keeping pregnant patients and her colleagues well-informed of the facts as Zika virus fears circulate.</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Quelling_Zika_Fears_With_Evidence.mp3?dest-id=90171" length="3950631" type="audio/mpeg" />
      <itunes:duration>08:10</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/d/a/8/ada80760f3cc530f/ThinkstockPhotos-480292112.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Review of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis</title>
      <itunes:title>Review of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis</itunes:title>
      <pubDate>Tue, 26 Apr 2016 17:16:29 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[34f8019faa9459e536d99c87c1f8e066]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.2884]]></link>
      <description><![CDATA[<p>Interview with Linden Hu, MD, author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.2884"> Diagnosis, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: A Review</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Linden Hu, MD, author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.2884"> Diagnosis, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: A Review</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Review_of_Lyme_Disease_Human_Granulocytic_Anaplasmosis_and_Babesiosis.mp3?dest-id=90171" length="7025129" type="audio/mpeg" />
      <itunes:duration>14:15</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/6/9/7/1697be7fc714dc36/jrv160005f3.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Rotating Night Shift Work and Risk of CHD Among Women</title>
      <itunes:title>Rotating Night Shift Work and Risk of CHD Among Women</itunes:title>
      <pubDate>Tue, 26 Apr 2016 14:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[40aabd1030297c056f3f71beb58af3f9]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.4454]]></link>
      <description><![CDATA[<p>Interview with Céline Vetter, PhD, author of <a href="http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.4454">Association Between Rotating Night Shift Work and Risk of Coronary Heart Disease Among Women</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Céline Vetter, PhD, author of <a href="http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.4454">Association Between Rotating Night Shift Work and Risk of Coronary Heart Disease Among Women</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Rotating_Night_Shift_Work_and_Risk_of_CHD_Among_Women.mp3?dest-id=90171" length="3371546" type="audio/mpeg" />
      <itunes:duration>03:29</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/a/b/0/aab0de7b3187584d/160426-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Pembrolizumab, Tumor Response, and Survival in Advanced Melanoma</title>
      <itunes:title>Pembrolizumab, Tumor Response, and Survival in Advanced Melanoma</itunes:title>
      <pubDate>Tue, 19 Apr 2016 14:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[3e12221ea5fb6550a08a4748e472859f]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.4059]]></link>
      <description><![CDATA[<p>Interview with Antoni Ribas, MD, PhD, author of <a href="http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.4059">Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Antoni Ribas, MD, PhD, author of <a href="http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.4059">Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Pembrolizumab_Tumor_Response_and_Survival_in_Advanced_Melanoma.mp3?dest-id=90171" length="2904901" type="audio/mpeg" />
      <itunes:duration>03:00</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/2/6/4/0264cf7e4a495126/160419-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Diagnosing Infectious Mononucleosis</title>
      <itunes:title>Diagnosing Infectious Mononucleosis</itunes:title>
      <pubDate>Tue, 12 Apr 2016 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[ff0a797407bc1c113e5765eb767de951]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.2111]]></link>
      <description><![CDATA[<p>Mononucleosis is a common disease of young adults manifested by lethargy, fever, pharyngitis, lymphadenopathy and splenomegaly. In this podcast, we review the clinical features of the disease and how good each of them is at establishing a diagnosis of mononucleosis. We also review how Epstein Barr virus was discovered as the cause of mononucleosis and talk to Mark H. Ebell, MD, MS, author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.2111"> <span class="s1">Does This Patient Have Infectious Mononucleosis?</span> The Rational Clinical Examination Systematic Review</a>.</p> <p class="p1">Articles discussed in this episode:</p> <ul> <li><a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.2111"> <span class="s1">Does This Patient Have Infectious Mononucleosis?</span> The Rational Clinical Examination Systematic Review</a> (2016)</li> <li class="p3"><a href= "http://jama.jamanetwork.com/article.aspx?articleid=246689">Acute Lymphatic Leukemia and Infectious Mononucleosis</a> (1931)</li> <li class="p1"><span class="s1"><a href= "http://jama.jamanetwork.com/article.aspx?articleid=1154475">Infectious Mononucleosis:</a></span> <a href= "http://jama.jamanetwork.com/article.aspx?articleid=1154475">Part I. Clinical Aspects</a> (1935) </li> <li class="p2"><span class="s1"><a href= "http://jama.jamanetwork.com/article.aspx?articleid=337384">Infectious Mononucleosis:</a></span> <a href= "http://jama.jamanetwork.com/article.aspx?articleid=337384">Clinical Manifestations in Relation to EB Virus Antibodies</a> (1968)</li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Mononucleosis is a common disease of young adults manifested by lethargy, fever, pharyngitis, lymphadenopathy and splenomegaly. In this podcast, we review the clinical features of the disease and how good each of them is at establishing a diagnosis of mononucleosis. We also review how Epstein Barr virus was discovered as the cause of mononucleosis and talk to Mark H. Ebell, MD, MS, author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.2111"> Does This Patient Have Infectious Mononucleosis? The Rational Clinical Examination Systematic Review</a>.</p> <p class="p1">Articles discussed in this episode:</p> <ul> <li><a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.2111"> Does This Patient Have Infectious Mononucleosis? The Rational Clinical Examination Systematic Review</a> (2016)</li> <li class="p3"><a href= "http://jama.jamanetwork.com/article.aspx?articleid=246689">Acute Lymphatic Leukemia and Infectious Mononucleosis</a> (1931)</li> <li class="p1"><a href= "http://jama.jamanetwork.com/article.aspx?articleid=1154475">Infectious Mononucleosis:</a> <a href= "http://jama.jamanetwork.com/article.aspx?articleid=1154475">Part I. Clinical Aspects</a> (1935) </li> <li class="p2"><a href= "http://jama.jamanetwork.com/article.aspx?articleid=337384">Infectious Mononucleosis:</a> <a href= "http://jama.jamanetwork.com/article.aspx?articleid=337384">Clinical Manifestations in Relation to EB Virus Antibodies</a> (1968)</li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Diagnosing_Infectious_Mononucleosis.mp3?dest-id=90171" length="32441634" type="audio/mpeg" />
      <itunes:duration>33:33</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/d/5/f/5/d5f5502fe8d4165b/160412-jama-cre-mono-v2.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Air Quality and Bronchitic Symptoms in Children</title>
      <itunes:title>Air Quality and Bronchitic Symptoms in Children</itunes:title>
      <pubDate>Tue, 12 Apr 2016 14:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[815ac20836bc47a1aa6d28121d22d2c5]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.3444]]></link>
      <description><![CDATA[<p>Interview with Kiros Berhane, PhD, author of <a href="http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.3444">Association of Changes in Air Quality With Bronchitic Symptoms in Children in California, 1993-2012</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Kiros Berhane, PhD, author of <a href="http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.3444">Association of Changes in Air Quality With Bronchitic Symptoms in Children in California, 1993-2012</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Air_Quality_and_Bronchitic_Symptoms_in_Children.mp3?dest-id=90171" length="3708235" type="audio/mpeg" />
      <itunes:duration>03:50</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/2/5/3/c253455c27abe7a7/160412-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Association Between Income and Life Expectancy in the United States</title>
      <itunes:title>Association Between Income and Life Expectancy in the United States</itunes:title>
      <pubDate>Mon, 11 Apr 2016 03:55:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[2822c33e234307bb43c2226a04205f1f]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.4226]]></link>
      <description><![CDATA[<p>Interview with Raj Chetty, PhD, author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.4226"> The Association Between Income and Life Expectancy in the United States, 2001-2014</a>, and Angus Deaton, PhD, author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.4072"> On Death and Money: History, Facts, and Explanations</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Raj Chetty, PhD, author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.4226"> The Association Between Income and Life Expectancy in the United States, 2001-2014</a>, and Angus Deaton, PhD, author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.4072"> On Death and Money: History, Facts, and Explanations</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Association_Between_Income_and_Life_Expectancy_in_the_United_States.mp3?dest-id=90171" length="15934372" type="audio/mpeg" />
      <itunes:duration>32:49</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/9/4/f/194fd7c592e75a5b/160411-jama-jai-chetty.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Screening for Chronic Obstructive Pulmonary Disease</title>
      <itunes:title>Screening for Chronic Obstructive Pulmonary Disease</itunes:title>
      <pubDate>Tue, 05 Apr 2016 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[dbbf4779f7d81e7fbc54b317c25937e9]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.2638]]></link>
      <description><![CDATA[<p>Interview with William R. Phillips, MD, MPH, author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.2638"> Screening for Chronic Obstructive Pulmonary Disease: US Preventive Services Task Force Recommendation Statement</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with William R. Phillips, MD, MPH, author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.2638"> Screening for Chronic Obstructive Pulmonary Disease: US Preventive Services Task Force Recommendation Statement</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation__Screening_for_Chronic_Obstructive_Pulmonary_Disease.mp3?dest-id=90171" length="10610539" type="audio/mpeg" />
      <itunes:duration>21:51</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/7/4/c/d/74cd56191f02bb29/160405-jama-jai-phillips.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Pain and Physical Function After Bariatric Surgery</title>
      <itunes:title>Pain and Physical Function After Bariatric Surgery</itunes:title>
      <pubDate>Tue, 05 Apr 2016 14:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[4f7f53f0800a28d9ef0bbae035d5297a]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.3010]]></link>
      <description><![CDATA[<p>Interview with Wendy C. King, PhD, author of <a href="http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.3010">Change in Pain and Physical Function Following Bariatric Surgery for Severe Obesity</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Wendy C. King, PhD, author of <a href="http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.3010">Change in Pain and Physical Function Following Bariatric Surgery for Severe Obesity</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Pain_and_Physical_Function_After_Bariatric_Surgery.mp3?dest-id=90171" length="3727724" type="audio/mpeg" />
      <itunes:duration>03:51</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/1/6/e/016e975d85d3c336/160405-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Mindfulness-Based Stress Reduction vs Cognitive Behavioral Therapy for Chronic Low Back Pain</title>
      <itunes:title>Mindfulness-Based Stress Reduction vs Cognitive Behavioral Therapy for Chronic Low Back Pain</itunes:title>
      <pubDate>Tue, 22 Mar 2016 14:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[810a6a7bdf558b6a82112d00ae5c4642]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.2323]]></link>
      <description><![CDATA[<p>Interview with Daniel C. Cherkin, PhD, author of <a href="http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.2323">Effect of Mindfulness-Based Stress Reduction vs Cognitive Behavioral Therapy or Usual Care on Back Pain and Functional Limitations in Adults With Chronic Low Back Pain: A Randomized Clinical Trial</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Daniel C. Cherkin, PhD, author of <a href="http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.2323">Effect of Mindfulness-Based Stress Reduction vs Cognitive Behavioral Therapy or Usual Care on Back Pain and Functional Limitations in Adults With Chronic Low Back Pain: A Randomized Clinical Trial</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Mindfulness-Based_Stress_Reduction_vs_Cognitive_Behavioral_Therapy.mp3?dest-id=90171" length="3365751" type="audio/mpeg" />
      <itunes:duration>03:29</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/7/1/e/171e28c01a153fc3/160322-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Opioid Prescribing: Rising to the Challenge</title>
      <itunes:title>Opioid Prescribing: Rising to the Challenge</itunes:title>
      <pubDate>Tue, 15 Mar 2016 17:30:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[1a299df6b22d090e2c1263f766afe97a]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.1464]]></link>
      <description><![CDATA[<p>An opioid abuse epidemic now plagues US healthcare. It was caused, in part, by overzealous advocacy for controlling chronic pain resulting in overuse of narcotics. There are now 2 million Americans addicted to opioids. The approach for treating chronic pain must change. In this podcast, we summarize recent CDC guidelines for the proper use of opioids for treating chronic pain.</p>
<p>Articles discussed in this episode:</p>
<ul>
<li><a href="http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.1464">CDC Guideline for Prescribing Opioids for Chronic Pain— United States, 2016</a>,</li>
<li><a href="http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.1910">The CDC Guideline on Opioid Prescribing: Rising to the Challenge</a> (Yngvild Olsen, MD, MPH),</li>
<li><a href="http://pcssmat.org/wp-content/uploads/2014/02/5B-DSM-5-Opioid-Use-Disorder-Diagnostic-Criteria.pdf">The DSM-V definition for opioid use disorder and 11 point checklist</a></li>
</ul>]]></description>
      
      <content:encoded><![CDATA[<p>An opioid abuse epidemic now plagues US healthcare. It was caused, in part, by overzealous advocacy for controlling chronic pain resulting in overuse of narcotics. There are now 2 million Americans addicted to opioids. The approach for treating chronic pain must change. In this podcast, we summarize recent CDC guidelines for the proper use of opioids for treating chronic pain.</p> <p>Articles discussed in this episode:</p> <ul> <li><a href="http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.1464">CDC Guideline for Prescribing Opioids for Chronic Pain— United States, 2016</a>,</li> <li><a href="http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.1910">The CDC Guideline on Opioid Prescribing: Rising to the Challenge</a> (Yngvild Olsen, MD, MPH),</li> <li><a href="http://pcssmat.org/wp-content/uploads/2014/02/5B-DSM-5-Opioid-Use-Disorder-Diagnostic-Criteria.pdf">The DSM-V definition for opioid use disorder and 11 point checklist</a></li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Opioid_Prescribing_Rising_to_the_Challenge.mp3?dest-id=90171" length="22116971" type="audio/mpeg" />
      <itunes:duration>23:00</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/b/e/f/4/bef402fba9ba2a96/160315-jama-cre-opioids.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Causes of Outbreaks of Vaccine-Preventable Diseases in the United States</title>
      <itunes:title>Causes of Outbreaks of Vaccine-Preventable Diseases in the United States</itunes:title>
      <pubDate>Tue, 15 Mar 2016 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[f27f8aa3ff6cda68ea01e496a35872f9]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.1353]]></link>
      <description><![CDATA[<p>Interview with Saad B. Omer, MBBS, MPH, PhD, author of <a href="http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.1353">Association Between Vaccine Refusal and Vaccine-Preventable Diseases in the United States A Review of Measles and Pertussis</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Saad B. Omer, MBBS, MPH, PhD, author of <a href="http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.1353">Association Between Vaccine Refusal and Vaccine-Preventable Diseases in the United States A Review of Measles and Pertussis</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Causes_of_Outbreaks_of_Vaccine-Preventable_Diseases_in_the_United_States.mp3?dest-id=90171" length="7670952" type="audio/mpeg" />
      <itunes:duration>15:54</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/4/2/6/2426a5af0595d472/160315-jama-jai-omer.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Treating Geriatric Polypharmacy by Deintensifying Unnecessary Diabetes Treatment</title>
      <itunes:title>Treating Geriatric Polypharmacy by Deintensifying Unnecessary Diabetes Treatment</itunes:title>
      <pubDate>Tue, 08 Mar 2016 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[ec6bb6adba49fee67fc9bdf13ef8aece]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.0299]]></link>
      <description><![CDATA[<p>Polypharmacy is a rapidly worsening problem that hits elderly patients particularly hard.  As patients grow older, they need more medications but at the same time become less capable of managing the complexity of drug treatments.  In order to simplify treatment regimens for older patients, it is necessary to consider the evidence supporting treatment of various conditions and when the evidence is not particularly strong, reduce or eliminate medications accordingly.  Diabetes management in the elderly is highlighted in this podcast with specific attention given to deintensifying diabetes treatment in the elderly.</p> <p class="p1">Articles discussed in this episode:</p> <ul> <li class="p2"><a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.0299"> Polypharmacy in the Aging Patient: Glycemic Control in Older Adults With Type 2 Diabetes: A Review</a> (Kasia J. Lipska, MD, MHS)</li> <li class="p3"><a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2014.10924"> Evaluation and Treatment of Older Patients With Hypercholesterolemia: A Clinical Review</a> (T<span class="s1">imo E. Strandberg, MD, PhD</span>)</li> <li class="p4"><a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2015.13766"> Trends in Prescription Drug Use Among Adults in the United States From 1999-2012</a> (<span class="s2">Elizabeth D. Kantor, PhD, MPH</span>)</li> </ul>]]></description>
      
      <content:encoded><![CDATA[<p>Polypharmacy is a rapidly worsening problem that hits elderly patients particularly hard. As patients grow older, they need more medications but at the same time become less capable of managing the complexity of drug treatments. In order to simplify treatment regimens for older patients, it is necessary to consider the evidence supporting treatment of various conditions and when the evidence is not particularly strong, reduce or eliminate medications accordingly. Diabetes management in the elderly is highlighted in this podcast with specific attention given to deintensifying diabetes treatment in the elderly.</p> <p class="p1">Articles discussed in this episode:</p> <ul> <li class="p2"><a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.0299"> Polypharmacy in the Aging Patient: Glycemic Control in Older Adults With Type 2 Diabetes: A Review</a> (Kasia J. Lipska, MD, MHS)</li> <li class="p3"><a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2014.10924"> Evaluation and Treatment of Older Patients With Hypercholesterolemia: A Clinical Review</a> (Timo E. Strandberg, MD, PhD)</li> <li class="p4"><a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2015.13766"> Trends in Prescription Drug Use Among Adults in the United States From 1999-2012</a> (Elizabeth D. Kantor, PhD, MPH)</li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/160308-jama-cre-polypharmacy.mp3?dest-id=90171" length="26518438" type="audio/mpeg" />
      <itunes:duration>27:28</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/b/d/2/6bd2e75b51741ad3/160308-jama-cre-polypharmacy.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Children With Acute Concussion Presenting to the Emergency Department</title>
      <itunes:title>Children With Acute Concussion Presenting to the Emergency Department</itunes:title>
      <pubDate>Tue, 08 Mar 2016 15:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[796648fd58febdf4eb7739ee81e9d3a9]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.1276]]></link>
      <description><![CDATA[<p>Interview with Lynn Babcock, MD, MS, author of <a href="http://dx.doi.org/10.1001/jama.2016.1276">Identifying Children and Adolescents at Risk for Persistent Postconcussion Symptoms</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Lynn Babcock, MD, MS, author of <a href="http://dx.doi.org/10.1001/jama.2016.1276">Identifying Children and Adolescents at Risk for Persistent Postconcussion Symptoms</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Children_With_Acute_Concussion_Presenting_to_the_Emergency_Department.mp3?dest-id=90171" length="2349935" type="audio/mpeg" />
      <itunes:duration>02:26</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/f/2/9/2f292d2523922f90/160308-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Screening for Impaired Visual Acuity in Older Adults</title>
      <itunes:title>Screening for Impaired Visual Acuity in Older Adults</itunes:title>
      <pubDate>Tue, 01 Mar 2016 15:30:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[12a3e93ad1fa350cec39a6792cce7c66]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.0763]]></link>
      <description><![CDATA[<p>Interview with Michael P. Pignone, MD, MPH, author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.0763"> Screening for Impaired Visual Acuity in Older Adults: US Preventive Services Task Force Recommendation Statement</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Michael P. Pignone, MD, MPH, author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.0763"> Screening for Impaired Visual Acuity in Older Adults: US Preventive Services Task Force Recommendation Statement</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/USPSTF_Recommendation__Screening_for_Impaired_Visual_Acuity_in_Older_Adults.mp3?dest-id=90171" length="6414411" type="audio/mpeg" />
      <itunes:duration>13:13</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/7/a/f/f/7aff06abb7c7421c/160301-jama-jai-pignone.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Interview with Robert O. Bonow, MD, MS</title>
      <itunes:title>Interview with Robert O. Bonow, MD, MS</itunes:title>
      <pubDate>Tue, 01 Mar 2016 15:29:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[4cf77e0039b42e4c4338ddfad12a72a1]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.18368]]></link>
      <description><![CDATA[<p>Robert O. Bonow, MD, the editor-in-chief of JAMA Cardiology, the JAMA Network’s newest addition, discusses his editorial vision for the journal, as well as his insights on advances in the prevention and treatment of cardiovascular disease.  </p>]]></description>
      
      <content:encoded><![CDATA[<p>Robert O. Bonow, MD, the editor-in-chief of JAMA Cardiology, the JAMA Network’s newest addition, discusses his editorial vision for the journal, as well as his insights on advances in the prevention and treatment of cardiovascular disease. </p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Interview_with_Robert_O._Bonow_MD_MS.mp3?dest-id=90171" length="5832067" type="audio/mpeg" />
      <itunes:duration>12:07</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/2/c/e/62ce01cf68440c94/151215-mednews-bonow.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Consensus Definitions for Sepsis and Septic Shock</title>
      <itunes:title>Consensus Definitions for Sepsis and Septic Shock</itunes:title>
      <pubDate>Mon, 22 Feb 2016 20:15:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[747902c8c4d0e85c6d7ffdd899c5218f]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.0287]]></link>
      <description><![CDATA[<p>Interview with Clifford Deutschman, MD, MS, Mervyn Singer, MD and Derek Angus, MD, MPH, authors of <a href="http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.0287">The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Clifford Deutschman, MD, MS, Mervyn Singer, MD and Derek Angus, MD, MPH, authors of <a href="http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.0287">The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Consensus_Definitions_for_Sepsis_and_Septic_Shock.mp3?dest-id=90171" length="19204474" type="audio/mpeg" />
      <itunes:duration>39:40</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/0/4/4/8044cf0edd8b7c5b/1602-sepsis.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Trends in Acute Respiratory Distress Syndrome in 50 Countries</title>
      <itunes:title>Trends in Acute Respiratory Distress Syndrome in 50 Countries</itunes:title>
      <pubDate>Mon, 22 Feb 2016 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[95a2fdc401d17822309aa018b8aee6b4]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.0291]]></link>
      <description><![CDATA[<p>Interview with John G. Laffey, MD, MA, author of <a href="http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.0291">Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with John G. Laffey, MD, MA, author of <a href="http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.0291">Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Trends_in_Acute_Respiratory_Distress_Syndrome_in_50_Countries.mp3?dest-id=90171" length="8511287" type="audio/mpeg" />
      <itunes:duration>17:35</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/1/7/4/21741f61ec6dba7e/JOI160008audio1_thumb-cropped.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Screening for Autism Spectrum Disorder in Young Children</title>
      <itunes:title>Screening for Autism Spectrum Disorder in Young Children</itunes:title>
      <pubDate>Tue, 16 Feb 2016 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[533f105d1a6a66a2ec035fdc23e3b5de]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.0018]]></link>
      <description><![CDATA[<p>Interview with David C. Grossman, MD, MPH, author of <a href="http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.0018">Screening for Autism Spectrum Disorder in Young Children: US Preventive Services Task Force Recommendation Statement</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with David C. Grossman, MD, MPH, author of <a href="http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.0018">Screening for Autism Spectrum Disorder in Young Children: US Preventive Services Task Force Recommendation Statement</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Screening_for_Autism_Spectrum_Disorder_in_Young_Children.mp3?dest-id=90171" length="10560815" type="audio/mpeg" />
      <itunes:duration>21:58</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/6/4/8/8648aa12db33b5d5/160216-jama-jai-grossman.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Antibiotic Therapy for Community-Acquired Pneumonia in Adults</title>
      <itunes:title>Antibiotic Therapy for Community-Acquired Pneumonia in Adults</itunes:title>
      <pubDate>Tue, 09 Feb 2016 16:03:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[4edb7e8e6924d01c8e5c657b8a3f7142]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2016.0115]]></link>
      <description><![CDATA[<p>Community acquired pneumonia accounts for 600,000 hospital admissions a year. Many patients with this disease are quite ill and have a very high mortality. To save lives, the appropriate antibiotics should be given in a timely basis, but it is not clear what the best antibiotics are and how long they should be given. In this podcast we interview the author of a JAMA review on community acquired pneumonia, Dr Jonathan Lee, author of <a href= "http://dx.doi.org/10.1001/jama.2016.0115">Antibiotic Therapy for Adults Hospitalized With Community-Acquired Pneumonia</a>, who performed a systematic review of the literature to determine the best way to treat community acquired pneumonia.</p>]]></description>
      
      <content:encoded><![CDATA[<p>Community acquired pneumonia accounts for 600,000 hospital admissions a year. Many patients with this disease are quite ill and have a very high mortality. To save lives, the appropriate antibiotics should be given in a timely basis, but it is not clear what the best antibiotics are and how long they should be given. In this podcast we interview the author of a JAMA review on community acquired pneumonia, Dr Jonathan Lee, author of <a href= "http://dx.doi.org/10.1001/jama.2016.0115">Antibiotic Therapy for Adults Hospitalized With Community-Acquired Pneumonia</a>, who performed a systematic review of the literature to determine the best way to treat community acquired pneumonia.</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_Clinical_Review__Antibiotic_Therapy_for_Community-Acquired_Pneumonia_in_Adults.mp3?dest-id=90171" length="9202513" type="audio/mpeg" />
      <itunes:duration>18:42</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/1/9/8/21984870aca08169/160209-jama-cre-pneumonia-comp.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>New Dietary Guidelines</title>
      <itunes:title>New Dietary Guidelines</itunes:title>
      <pubDate>Tue, 02 Feb 2016 16:06:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[ceea22de6dbbab2c06f33d6f2dd82c97]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.18396]]></link>
      <description><![CDATA[<p>The 2015-2020 US Dietary Guidelines for Americans were recently released. They are intended to provide guidance for health policy officials and clinicians regarding healthy diets and establishing goals for improving nutrition. These are important since bad eating habits are the underlying cause for a great deal of disease in the US and that these guidelines influence the operations of programs such as school lunch assistance, meals on wheels etc. Because these guidelines influence policy, they have been criticized by various investigators and special interest groups. Karen DeSalvo, MD, Acting Assistant Secretary for Health at HHS and author of <a href="http://dx.doi.org/ 10.1001/jama.2015.18396">Dietary Guidelines for Americans</a> responds to some of these criticisms and explains how the guideline was created and what it is intended to do. Implementation of the guidelines dietary advice may be challenging and Deborah Clegg, RD, PhD, Professor of Internal Medicine at UCLA discusses how the various recommendations can be followed.</p>]]></description>
      
      <content:encoded><![CDATA[<p>The 2015-2020 US Dietary Guidelines for Americans were recently released. They are intended to provide guidance for health policy officials and clinicians regarding healthy diets and establishing goals for improving nutrition. These are important since bad eating habits are the underlying cause for a great deal of disease in the US and that these guidelines influence the operations of programs such as school lunch assistance, meals on wheels etc. Because these guidelines influence policy, they have been criticized by various investigators and special interest groups. Karen DeSalvo, MD, Acting Assistant Secretary for Health at HHS and author of <a href="http://dx.doi.org/ 10.1001/jama.2015.18396">Dietary Guidelines for Americans</a> responds to some of these criticisms and explains how the guideline was created and what it is intended to do. Implementation of the guidelines dietary advice may be challenging and Deborah Clegg, RD, PhD, Professor of Internal Medicine at UCLA discusses how the various recommendations can be followed.</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Dietary_Guidelines_for_Americans2.mp3?dest-id=90171" length="12344334" type="audio/mpeg" />
      <itunes:duration>25:19</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/7/6/5/6765ffafbc2ed4f4/160202-jama-cre-desalvo.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Seafood Consumption, Mercury, and Brain Neuropathology in Older Adults</title>
      <itunes:title>Seafood Consumption, Mercury, and Brain Neuropathology in Older Adults</itunes:title>
      <pubDate>Tue, 02 Feb 2016 15:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[90efca8ccb21d0502b7fef21a4119be3]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.19451]]></link>
      <description><![CDATA[<p>Interview with Martha Clare Morris, ScD, author of <a href="http://dx.doi.org/10.1001/jama.2015.19451">Association of Seafood Consumption, Brain Mercury Level, and APOE ε4 Status With Brain Neuropathology in Older Adults</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Martha Clare Morris, ScD, author of <a href="http://dx.doi.org/10.1001/jama.2015.19451">Association of Seafood Consumption, Brain Mercury Level, and APOE ε4 Status With Brain Neuropathology in Older Adults</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Seafood_Consumption_Mercury_and_Brain_Neuropathology_in_Older_Adults.mp3?dest-id=90171" length="4311204" type="audio/mpeg" />
      <itunes:duration>04:28</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/6/1/1/c611c0651f6e5e48/160202-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Screening for Depression in Adults</title>
      <itunes:title>Screening for Depression in Adults</itunes:title>
      <pubDate>Tue, 26 Jan 2016 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[f9dbfa78e5938082d787723dc7cc9af7]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.18392]]></link>
      <description><![CDATA[<p>Interview with Michael P. Pignone, MD, MPH, author of <a href="http://dx.doi.org/10.1001/jama.2015.18392">Screening for Depression in Adults: US Preventive Services Task Force Recommendation Statement</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Michael P. Pignone, MD, MPH, author of <a href="http://dx.doi.org/10.1001/jama.2015.18392">Screening for Depression in Adults: US Preventive Services Task Force Recommendation Statement</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Screening_for_Depression_in_Adults.mp3?dest-id=90171" length="10535109" type="audio/mpeg" />
      <itunes:duration>21:26</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/1/5/9/6159b78bb6b18c3b/JSC150011audioa_thumb-cropped.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Peripheral Neuropathy</title>
      <itunes:title>Peripheral Neuropathy</itunes:title>
      <pubDate>Tue, 19 Jan 2016 16:05:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[97b64ec190d65a5d665ba4310d0ccf17]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.16832]]></link>
      <description><![CDATA[<p>Peripheral neuropathy is a highly prevalent and morbid condition affecting 2% to 7% of the population. Patients frequently experience pain and are at risk of falls, ulcerations, and amputations. It is most commonly occurs in patients with diabetes. For most cases, the diagnosis and treatment of neuropathy can be made without complex testing or referral to specialists. Drs. Eva Feldman and Brian Callaghan from the University of Michigan Department of Neurology, authors of <a href= "http://dx.doi.org/10.1001/jama.2015.13611">Distal Symmetric Polyneuropathy</a> and <a href= "http://dx.doi.org/10.1001/jama.2015.16832">Electrodiagnostic Tests in Polyneuropathy and Radiculopathy</a>, explain how to manage neuropathy.</p>]]></description>
      
      <content:encoded><![CDATA[<p>Peripheral neuropathy is a highly prevalent and morbid condition affecting 2% to 7% of the population. Patients frequently experience pain and are at risk of falls, ulcerations, and amputations. It is most commonly occurs in patients with diabetes. For most cases, the diagnosis and treatment of neuropathy can be made without complex testing or referral to specialists. Drs. Eva Feldman and Brian Callaghan from the University of Michigan Department of Neurology, authors of <a href= "http://dx.doi.org/10.1001/jama.2015.13611">Distal Symmetric Polyneuropathy</a> and <a href= "http://dx.doi.org/10.1001/jama.2015.16832">Electrodiagnostic Tests in Polyneuropathy and Radiculopathy</a>, explain how to manage neuropathy.</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Peripheral_Neuropathy.mp3?dest-id=90171" length="13007526" type="audio/mpeg" />
      <itunes:duration>26:43</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/b/a/7/0ba7379dce824993/151124-jama-cre-neuropathy-ed-final.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Health Care and Costs Related to Cancer Deaths in 7 Countries</title>
      <itunes:title>Health Care and Costs Related to Cancer Deaths in 7 Countries</itunes:title>
      <pubDate>Tue, 19 Jan 2016 15:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[c4775aab34620fe75aac1fb743366ce3]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.18603]]></link>
      <description><![CDATA[<p>Interview with Justin E. Bekelman, MD, author of <a href="http://dx.doi.org/10.1001/jama.2015.18603">Comparison of Site of Death, Health Care Utilization, and Hospital Expenditures for Patients Dying With Cancer in 7 Developed Countries</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Justin E. Bekelman, MD, author of <a href="http://dx.doi.org/10.1001/jama.2015.18603">Comparison of Site of Death, Health Care Utilization, and Hospital Expenditures for Patients Dying With Cancer in 7 Developed Countries</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Health_Care_and_Costs_Related_to_Cancer_Deaths_in_7_Countries.mp3?dest-id=90171" length="3998949" type="audio/mpeg" />
      <itunes:duration>04:04</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/c/7/0/ec700af1440e673a/160119-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Advances in Diagnosis and Treatment of Constipation</title>
      <itunes:title>Advances in Diagnosis and Treatment of Constipation</itunes:title>
      <pubDate>Tue, 12 Jan 2016 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[bee993f423f125aeb62922d41d565b4c]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.16994]]></link>
      <description><![CDATA[<p>Constipation is one of the most frequent problems clinicians are asked to deal with. Despite how common it is, constipation is frequently not treated adequately. In this podcast, Arnold Wald, MD, explains a <a href="http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2015.16994">stepwise approach to the management of constipation</a> ranging from very simple measures to the most novel and complicated new medical therapies.</p>]]></description>
      
      <content:encoded><![CDATA[<p>Constipation is one of the most frequent problems clinicians are asked to deal with. Despite how common it is, constipation is frequently not treated adequately. In this podcast, Arnold Wald, MD, explains a <a href="http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2015.16994">stepwise approach to the management of constipation</a> ranging from very simple measures to the most novel and complicated new medical therapies.</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Advances_in_Diagnosis_and_Treatment_of_Constipation.mp3?dest-id=90171" length="13433671" type="audio/mpeg" />
      <itunes:duration>27:57</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/d/a/9/f/da9fbf9a855320fd/1601-jama-cre-constipation.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Lung Volume Reduction Coil Treatment for Patients With Severe Emphysema</title>
      <itunes:title>Lung Volume Reduction Coil Treatment for Patients With Severe Emphysema</itunes:title>
      <pubDate>Tue, 12 Jan 2016 15:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[ad640a064cd0a110f4596f159e7fd3d2]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.17821]]></link>
      <description><![CDATA[<p>Interview with Gaëtan Deslée, MD, PhD, author of <a href="http://dx.doi.org/10.1001/jama.2015.17821">Lung Volume Reduction Coil Treatment vs Usual Care in Patients With Severe Emphysema: The REVOLENS Randomized Clinical Trial</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Gaëtan Deslée, MD, PhD, author of <a href="http://dx.doi.org/10.1001/jama.2015.17821">Lung Volume Reduction Coil Treatment vs Usual Care in Patients With Severe Emphysema: The REVOLENS Randomized Clinical Trial</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Lung_Volume_Reduction_Coil_Treatment_for_Patients_With_Severe_Emphysema.mp3?dest-id=90171" length="4461434" type="audio/mpeg" />
      <itunes:duration>04:38</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/d/7/6/2d769214511ef232/160112-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>New Dietary Guidelines</title>
      <itunes:title>New Dietary Guidelines</itunes:title>
      <pubDate>Thu, 07 Jan 2016 19:44:41 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[7917567a580b2047cf78f5ab41ced9bb]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.18396]]></link>
      <description><![CDATA[<p>Interview with Karen DeSalvo, MD, MPH, MSc, author of <a href= "http://jama.jamanetwork.com/article.aspx?articleid=2481221">Dietary Guidelines for Americans</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Karen DeSalvo, MD, MPH, MSc, author of <a href= "http://jama.jamanetwork.com/article.aspx?articleid=2481221">Dietary Guidelines for Americans</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Dietary_Guidelines_for_Americans.mp3?dest-id=90171" length="3295550" type="audio/mpeg" />
      <itunes:duration>06:28</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/d/2/4/ad249bde786e8cc4/160202-jama-cre-desalvo.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Diet vs Exercise in Obese Older Patients With HFPEF</title>
      <itunes:title>Diet vs Exercise in Obese Older Patients With HFPEF</itunes:title>
      <pubDate>Tue, 05 Jan 2016 15:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[75b7d547120ef1b5378ce6d77c64ab6e]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.17346]]></link>
      <description><![CDATA[<p>Interview with Dalane W. Kitzman, MD, author of <a href="http://dx.doi.org/10.1001/jama.2015.17346">Effect of Caloric Restriction or Aerobic Exercise Training on Peak Oxygen Consumption and Quality of Life in Obese Older Patients With Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Dalane W. Kitzman, MD, author of <a href="http://dx.doi.org/10.1001/jama.2015.17346">Effect of Caloric Restriction or Aerobic Exercise Training on Peak Oxygen Consumption and Quality of Life in Obese Older Patients With Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Diet_vs_Exercise_in_Obese_Older_Patients_With_HFPEF.mp3?dest-id=90171" length="4844265" type="audio/mpeg" />
      <itunes:duration>05:02</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/9/4/7/6947e0fcb96d1d1c/160105-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Head Trauma</title>
      <itunes:title>Head Trauma</itunes:title>
      <pubDate>Tue, 22 Dec 2015 16:12:39 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[42318e69254367b1b97b1a7ca69456f1]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.16316]]></link>
      <description><![CDATA[<p>Minor head trauma usually does not cause significant brain injury. To be safe, clinicians often obtain head CT scans to ensure no major injury is present. For minor head trauma (Glascow coma scale 13-15), the risk to benefit ratio for head CT is usually not in favor of getting CT scans. When the Canadian head CT rule or New Orleans Criteria are negative, there is a very small risk for missing a significant brain injury. Joshua Easter, MD from the Department of Emergency Medicine at the University of Virginia who authored a <a href="http://dx.doi.org/10.1001/jama.2015.16316">JAMA Rational Clinical Examination article</a> on this topic is interviewed as is Frederick Rivara, from the Department of Pediatrics at the University of Washington who wrote <a href= "http://dx.doi.org/10.1001/jama.2015.17298">an accompanying editorial</a>. Michelle Mello, a Law Professor at Stanford, discusses the medical liability associated with not obtaining neuroimaging for minor head trauma.</p>]]></description>
      
      <content:encoded><![CDATA[<p>Minor head trauma usually does not cause significant brain injury. To be safe, clinicians often obtain head CT scans to ensure no major injury is present. For minor head trauma (Glascow coma scale 13-15), the risk to benefit ratio for head CT is usually not in favor of getting CT scans. When the Canadian head CT rule or New Orleans Criteria are negative, there is a very small risk for missing a significant brain injury. Joshua Easter, MD from the Department of Emergency Medicine at the University of Virginia who authored a <a href="http://dx.doi.org/10.1001/jama.2015.16316">JAMA Rational Clinical Examination article</a> on this topic is interviewed as is Frederick Rivara, from the Department of Pediatrics at the University of Washington who wrote <a href= "http://dx.doi.org/10.1001/jama.2015.17298">an accompanying editorial</a>. Michelle Mello, a Law Professor at Stanford, discusses the medical liability associated with not obtaining neuroimaging for minor head trauma.</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/The_JAMA_Clinical_Review__Head_Trauma.mp3?dest-id=90171" length="12440210" type="audio/mpeg" />
      <itunes:duration>25:35</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/f/b/f/afbf1e98af5bf71a/frederick-rivara.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Live-Birth Rate and Repeat In Vitro Fertilization Treatment</title>
      <itunes:title>Live-Birth Rate and Repeat In Vitro Fertilization Treatment</itunes:title>
      <pubDate>Tue, 22 Dec 2015 15:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[6b79dc5ecb2209c6d3b37b3ab15dd1ba]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.17296]]></link>
      <description><![CDATA[<p>Interview with Debbie A. Lawlor, PhD, author of <a href="http://dx.doi.org/10.1001/jama.2015.17296">Live-Birth Rate Associated With Repeat In Vitro Fertilization Treatment Cycles</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Debbie A. Lawlor, PhD, author of <a href="http://dx.doi.org/10.1001/jama.2015.17296">Live-Birth Rate Associated With Repeat In Vitro Fertilization Treatment Cycles</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Live-Birth_Rate_and_Repeat_In_Vitro_Fertilization_Treatment.mp3?dest-id=90171" length="5026530" type="audio/mpeg" />
      <itunes:duration>05:13</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/8/c/c/98cc57f5065a8a89/151222-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Graves Disease</title>
      <itunes:title>Graves Disease</itunes:title>
      <pubDate>Tue, 15 Dec 2015 16:10:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[88967d8fe8edac42fb8b29c7bc478256]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.16535]]></link>
      <description><![CDATA[<p>Edward H. Livingston, MD discusses Graves disease with David Cooper, MD, author of <a href= "http://dx.doi.org/10.1001/jama.2015.16535">Management of Graves Disease: A Review</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Edward H. Livingston, MD discusses Graves disease with David Cooper, MD, author of <a href= "http://dx.doi.org/10.1001/jama.2015.16535">Management of Graves Disease: A Review</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/The_JAMA_Clinical_Review__Graves_Disease.mp3?dest-id=90171" length="12087642" type="audio/mpeg" />
      <itunes:duration>24:49</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/2/a/6/32a6774cb035ed72/151215-jama-cre-cooper." />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Alternating Electric Fields for the Treatment of Glioblastoma</title>
      <itunes:title>Alternating Electric Fields for the Treatment of Glioblastoma</itunes:title>
      <pubDate>Tue, 15 Dec 2015 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[3fff2245b39b40de42eb5c596a65a507]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.16701]]></link>
      <description><![CDATA[<p>Interview with John H. Sampson, MD, PhD, MHSc, MBA, author of <a href="http://dx.doi.org/10.1001/jama.2015.16701">Alternating Electric Fields for the Treatment of Glioblastoma</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with John H. Sampson, MD, PhD, MHSc, MBA, author of <a href="http://dx.doi.org/10.1001/jama.2015.16701">Alternating Electric Fields for the Treatment of Glioblastoma</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Alternating_Electric_Fields_for_the_Treatment_of_Glioblastoma.mp3?dest-id=90171" length="6701326" type="audio/mpeg" />
      <itunes:duration>13:55</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/f/a/8/7/fa87f6ca971b2395/151215-jama-jai-sampson.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Maintenance Therapy After Chemoradiation in Patients With Glioblastoma</title>
      <itunes:title>Maintenance Therapy After Chemoradiation in Patients With Glioblastoma</itunes:title>
      <pubDate>Tue, 15 Dec 2015 15:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[c7dff1d1e8e82089406d91c42b63e81a]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.16669]]></link>
      <description><![CDATA[<p>Interview with Roger Stupp, MD, author of <a href="http://dx.doi.org/10.1001/jama.2015.16669">Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Roger Stupp, MD, author of <a href="http://dx.doi.org/10.1001/jama.2015.16669">Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Maintenance_Therapy_After_Chemoradiation_in_Patients_With_Glioblastoma.mp3?dest-id=90171" length="3565411" type="audio/mpeg" />
      <itunes:duration>03:42</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/f/3/0/c/f30c0eb8bd757054/151215-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Resident Depression and Graduate Medical Education</title>
      <itunes:title>Resident Depression and Graduate Medical Education</itunes:title>
      <pubDate>Tue, 08 Dec 2015 15:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[2e0ebcaac370ff799d08bb732d9d8f48]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.15408]]></link>
      <description><![CDATA[<p>Interview with Thomas L. Schwenk, MD, author of <a href="http://dx.doi.org/10.1001/jama.2015.15408">Resident Depression: The Tip of a Graduate Medical Education Iceberg</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Thomas L. Schwenk, MD, author of <a href="http://dx.doi.org/10.1001/jama.2015.15408">Resident Depression: The Tip of a Graduate Medical Education Iceberg</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Resident_Depression_and_Graduate_Medical_Education.mp3?dest-id=90171" length="6569442" type="audio/mpeg" />
      <itunes:duration>06:50</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/2/a/3/e2a32be4687ac04c/151208-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Metformin for Adolescents With Type 1 Diabetes</title>
      <itunes:title>Metformin for Adolescents With Type 1 Diabetes</itunes:title>
      <pubDate>Tue, 01 Dec 2015 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[c089c84526d07690926d6d73c673b67c]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.16174]]></link>
      <description><![CDATA[<p>Interview with Ingrid M. Libman, MD, PhD, author of Effect of Metformin Added to Insulin on Glycemic Control Among Overweight/Obese Adolescents With Type 1 Diabetes</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Ingrid M. Libman, MD, PhD, author of Effect of Metformin Added to Insulin on Glycemic Control Among Overweight/Obese Adolescents With Type 1 Diabetes</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Metformin_for_Adolescents_With_Type_1_Diabetes.mp3?dest-id=90171" length="4789281" type="audio/mpeg" />
      <itunes:duration>09:54</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/b/4/a/1/b4a17be7c49f0f79/Libman_Ingrid_5216_thumb_cropped.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Cesarean Delivery Rate and Maternal and Neonatal Mortality</title>
      <itunes:title>Cesarean Delivery Rate and Maternal and Neonatal Mortality</itunes:title>
      <pubDate>Tue, 01 Dec 2015 15:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[7ab0bf396f7f36c990443e1cad30dbf3]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.15553]]></link>
      <description><![CDATA[<p>Interview with Alex B. Haynes, MD, MPH, author of <a href="http://dx.doi.org/10.1001/jama.2015.15553">Relationship Between Cesarean Delivery Rate and Maternal and Neonatal Mortality</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Alex B. Haynes, MD, MPH, author of <a href="http://dx.doi.org/10.1001/jama.2015.15553">Relationship Between Cesarean Delivery Rate and Maternal and Neonatal Mortality</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Cesarean_Delivery_Rate_and_Maternal_and_Neonatal_Mortality.mp3?dest-id=90171" length="4178264" type="audio/mpeg" />
      <itunes:duration>04:20</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/5/6/3/15633f25904c71ad/151201-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Prostate Cancer Screening</title>
      <itunes:title>Prostate Cancer Screening</itunes:title>
      <pubDate>Tue, 17 Nov 2015 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[503d16eb6ccaa92e619a088f3fc155b0]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.14905]]></link>
      <description><![CDATA[<p>Edward H. Livingston MD, explores the topic of prostate cancer screening in author interviews with:</p>
<ul>
<li>Dan Merenstein about losing a <a href="http://jama.jamanetwork.com/article.aspx?articleid=197947">malpractice</a> case despite following evidence-based medicine guidelines (<a href="http://archinte.jamanetwork.com/article.aspx?articleid=1921755">PSA Screening — I Finally Won!</a>).</li>
<li>Otis Brawley about <a href="http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2015.14905">Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations</a>.</li>
<li>David F. Penson about <a href="http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2015.13775">The Pendulum of Prostate Cancer Screening</a>.</li>
<li>Victor M. Montori about <a href="http:/jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2014.10186">The Connection Between Evidence-Based Medicine and Shared Decision Making</a>.</li>
</ul>]]></description>
      
      <content:encoded><![CDATA[<p>Edward H. Livingston MD, explores the topic of prostate cancer screening in author interviews with:</p> <ul> <li>Dan Merenstein about losing a <a href="http://jama.jamanetwork.com/article.aspx?articleid=197947">malpractice</a> case despite following evidence-based medicine guidelines (<a href="http://archinte.jamanetwork.com/article.aspx?articleid=1921755">PSA Screening — I Finally Won!</a>).</li> <li>Otis Brawley about <a href="http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2015.14905">Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations</a>.</li> <li>David F. Penson about <a href="http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2015.13775">The Pendulum of Prostate Cancer Screening</a>.</li> <li>Victor M. Montori about <a href="http:/jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2014.10186">The Connection Between Evidence-Based Medicine and Shared Decision Making</a>.</li> </ul>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Prostate_Cancer_Screening.mp3?dest-id=90171" length="18124339" type="audio/mpeg" />
      <itunes:duration>18:52</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/4/b/4/c4b40742e7f7cd1a/151117-jama-cre-PSAscreening.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Prostate Cancer Incidence and PSA Screening</title>
      <itunes:title>Prostate Cancer Incidence and PSA Screening</itunes:title>
      <pubDate>Tue, 17 Nov 2015 15:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[320171223cba2da875741621c48eca26]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.13775]]></link>
      <description><![CDATA[<p>Edward H. Livingston, MD, Deputy Editor of Clinical Reviews and Education discusses prostate cancer screening with Otis Brawley, MD, author of <a href="http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2015.14905">Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations</a> and David F. Penson, MD, MPH, author of a related editorial entitled <a href="http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2015.13775">The Pendulum of Prostate Cancer Screening.</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Edward H. Livingston, MD, Deputy Editor of Clinical Reviews and Education discusses prostate cancer screening with Otis Brawley, MD, author of <a href="http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2015.14905">Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations</a> and David F. Penson, MD, MPH, author of a related editorial entitled <a href="http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2015.13775">The Pendulum of Prostate Cancer Screening.</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Prostate_Cancer_Incidence_and_PSA_Screening.mp3?dest-id=90171" length="4185479" type="audio/mpeg" />
      <itunes:duration>08:41</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/4/c/b/c4cb8f6245abb6f1/151117-jama-jai-PSAscreening.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>For Patients: Prostate Cancer Screening</title>
      <itunes:title>For Patients: Prostate Cancer Screening</itunes:title>
      <pubDate>Tue, 17 Nov 2015 15:58:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[756da3191d1b10c4aa5e4c1046569d7c]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.15295]]></link>
      <description><![CDATA[<p>Edward H. Livingston, MD, Deputy Editor of Clinical Reviews and Education and Jon Tilburt, MD, from the Mayo Clinic explain prostate cancer screening. For more information, read the <a href="http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2015.15295">JAMA Patient Page</a> on this topic.</p>]]></description>
      
      <content:encoded><![CDATA[<p>Edward H. Livingston, MD, Deputy Editor of Clinical Reviews and Education and Jon Tilburt, MD, from the Mayo Clinic explain prostate cancer screening. For more information, read the <a href="http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2015.15295">JAMA Patient Page</a> on this topic.</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/For_Patients-Prostate_Cancer_Screening.mp3?dest-id=90171" length="3165473" type="audio/mpeg" />
      <itunes:duration>06:33</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/0/5/b/105be56ea99452a9/151117-jama-patientpage-PSAscreening.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Early Azithromycin Treatment to Prevent Respiratory Illness in Children</title>
      <itunes:title>Early Azithromycin Treatment to Prevent Respiratory Illness in Children</itunes:title>
      <pubDate>Tue, 17 Nov 2015 15:57:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[6c7ea7787f7128d3320a6eeeb7e3407b]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.13896]]></link>
      <description><![CDATA[<p>Interview with Leonard B. Bacharier, MD, author of <a href="http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2015.13896">Early Administration of Azithromycin and Prevention of Severe Lower Respiratory Tract Illnesses in Preschool Children With a History of Such Illnesses: A Randomized Clinical Trial</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Leonard B. Bacharier, MD, author of <a href="http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2015.13896">Early Administration of Azithromycin and Prevention of Severe Lower Respiratory Tract Illnesses in Preschool Children With a History of Such Illnesses: A Randomized Clinical Trial</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Early_Azithromycin_Treatment_to_Prevent_Respiratory_Illness_in_Children.mp3?dest-id=90171" length="4405120" type="audio/mpeg" />
      <itunes:duration>04:34</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/b/7/f/3/b7f3ead5b904cbd1/151117-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy</title>
      <itunes:title>Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy</itunes:title>
      <pubDate>Fri, 13 Nov 2015 22:49:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[f2200e91e8eb0c6691ef1347e20953a3]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.15217]]></link>
      <description><![CDATA[<p>Interview with Lee M. Jampol, MD, author of <a href="http://dx.doi.org/10.1001/jama.2015.15217">Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Lee M. Jampol, MD, author of <a href="http://dx.doi.org/10.1001/jama.2015.15217">Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Intravitreous_Ranibizumab_for_Proliferative_Diabetic_Retinopathy.mp3?dest-id=90171" length="4345403" type="audio/mpeg" />
      <itunes:duration>04:31</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/5/5/d/7/55d73ae397f76b1e/151113-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Ruling Out Acute Coronary Syndrome in Patients With Chest Pain</title>
      <itunes:title>Ruling Out Acute Coronary Syndrome in Patients With Chest Pain</itunes:title>
      <pubDate>Sun, 08 Nov 2015 16:06:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[de097fa413410276493a3db084cdd77e]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.12735]]></link>
      <description><![CDATA[<p>ACS is a common and potentially lethal problem. However, only about 10% of patients who present to an emergency department with chest pain actually have ACS. In this JAMA Clinical Reviews podcast, we discuss which signs, symptoms and tests used to make the diagnosis of ACS are reliable.</p> <p>Edward H. Livingston MD, speaks with Alexander Fanaroff, MD, author of <a href="http://dx.doi.org/10.1001/jama.2015.12735">Does This Patient With Chest Pain Have Acute Coronary Syndrome? The Rational Clinical Examination Systematic Review</a> as well as a patient who was diagnosed with myocardial infarction.</p>]]></description>
      
      <content:encoded><![CDATA[<p>ACS is a common and potentially lethal problem. However, only about 10% of patients who present to an emergency department with chest pain actually have ACS. In this JAMA Clinical Reviews podcast, we discuss which signs, symptoms and tests used to make the diagnosis of ACS are reliable.</p> <p>Edward H. Livingston MD, speaks with Alexander Fanaroff, MD, author of <a href="http://dx.doi.org/10.1001/jama.2015.12735">Does This Patient With Chest Pain Have Acute Coronary Syndrome? The Rational Clinical Examination Systematic Review</a> as well as a patient who was diagnosed with myocardial infarction.</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Does_This_Patient_With_Chest_Pain_Have_Acute_Coronary_Syndrome.mp3?dest-id=90171" length="8522328" type="audio/mpeg" />
      <itunes:duration>17:30</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/0/8/d/808d9452985c8ee3/151110-jama-jai-fanaroff-tanksley." />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Using Likelihood Ratios to Understand How Chest Pain Predicts Acute Coronary Syndrome</title>
      <itunes:title>Using Likelihood Ratios to Understand How Chest Pain Predicts Acute Coronary Syndrome</itunes:title>
      <pubDate>Sun, 08 Nov 2015 16:02:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[58a7cf42760eea5395912816ba69f07f]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.15085]]></link>
      <description><![CDATA[<p>Interview with David Simel, MD, author of <a href= "http://dx.doi.org/10.1001/jama.2015.12735">Does This Patient With Chest Pain Have Acute Coronary Syndrome? The Rational Clinical Examination Systematic Review</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with David Simel, MD, author of <a href= "http://dx.doi.org/10.1001/jama.2015.12735">Does This Patient With Chest Pain Have Acute Coronary Syndrome? The Rational Clinical Examination Systematic Review</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Does_This_Patient_With_Chest_Pain_Have_Acute_Coronary_Syndrome_.mp3?dest-id=90171" length="7338411" type="audio/mpeg" />
      <itunes:duration>14:58</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/5/d/8/4/5d8459ff354395f1/151110-jama-jai-simel-jama.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Effect of Financial Incentives on Lipid Levels</title>
      <itunes:title>Effect of Financial Incentives on Lipid Levels</itunes:title>
      <pubDate>Sun, 08 Nov 2015 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[e1b053f29f733ad6f2889a37a9805fd6]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.14850]]></link>
      <description><![CDATA[<p>Interview with David A. Asch, MD and Kevin G. Volpp, MD, PhD, authors of <a href="http://dx.doi.org/10.1001/jama.2015.14850">Effect of Financial Incentives to Physicians, Patients, or Both on Lipid Levels: A Randomized Clinical Trial</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with David A. Asch, MD and Kevin G. Volpp, MD, PhD, authors of <a href="http://dx.doi.org/10.1001/jama.2015.14850">Effect of Financial Incentives to Physicians, Patients, or Both on Lipid Levels: A Randomized Clinical Trial</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Effect_of_Financial_Incentives_on_Lipid_Levels.mp3?dest-id=90171" length="6462545" type="audio/mpeg" />
      <itunes:duration>06:43</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/f/4/e/1f4e50c5701841fa/151108-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Prescription Drug Use in US Adults 1999-2012</title>
      <itunes:title>Prescription Drug Use in US Adults 1999-2012</itunes:title>
      <pubDate>Tue, 03 Nov 2015 15:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[2d67893e8746929dacaefbfb7f6df7bf]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.13766]]></link>
      <description><![CDATA[<p>Interview with Elizabeth D. Kantor, PhD, MPH, author of <a href="http://dx.doi.org/10.1001/jama.2015.13766">Trends in Prescription Drug Use Among Adults in the United States From 1999-2012</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Elizabeth D. Kantor, PhD, MPH, author of <a href="http://dx.doi.org/10.1001/jama.2015.13766">Trends in Prescription Drug Use Among Adults in the United States From 1999-2012</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Prescription_Drug_Use_in_US_Adults_1999-2012.mp3?dest-id=90171" length="3090727" type="audio/mpeg" />
      <itunes:duration>03:12</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/b/c/6/3bc69e0baba56123/151103-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Explaining the Improved Health of the US: Mortality Trends 1969-2013</title>
      <itunes:title>Explaining the Improved Health of the US: Mortality Trends 1969-2013</itunes:title>
      <pubDate>Tue, 27 Oct 2015 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[be71d57598a22c3468ddf007c76d71c7]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.12391]]></link>
      <description><![CDATA[<p>Interview with Ahmedin Jemal, DVM, PhD, author of <a href="http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2015.12319">Temporal Trends in Mortality in the United States, 1969-2013</a>, and J. Michael McGinnis, MD, MPP, author of <a href="http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2015.12391">Mortality Trends and Signs of Health Progress</a>. Also in this episode is a conversation with Christopher J.L. Murray, MD, DPhil, a Professor of Global Health at the University of Washington and Institute Director of the Institute for Health Metrics and Evaluation.</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Ahmedin Jemal, DVM, PhD, author of <a href="http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2015.12319">Temporal Trends in Mortality in the United States, 1969-2013</a>, and J. Michael McGinnis, MD, MPP, author of <a href="http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2015.12391">Mortality Trends and Signs of Health Progress</a>. Also in this episode is a conversation with Christopher J.L. Murray, MD, DPhil, a Professor of Global Health at the University of Washington and Institute Director of the Institute for Health Metrics and Evaluation.</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Explaining_the_Improved_Health_of_the_US__Mortality_Trends_1969-2013.mp3?dest-id=90171" length="8951864" type="audio/mpeg" />
      <itunes:duration>18:37</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/7/9/1/07917bf2cc19b41a/151027-jama-jai-TrendsInMortality.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Trends in US Mortality, 1969-2013</title>
      <itunes:title>Trends in US Mortality, 1969-2013</itunes:title>
      <pubDate>Tue, 27 Oct 2015 14:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[265dafed59a7c7156ac208e2b625cd95]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.12319]]></link>
      <description><![CDATA[<p>Interview with Ahmedin Jemal, DVM, PhD, author of <a href="http://dx.doi.org/10.1001/jama.2015.12319">Temporal Trends in Mortality in the United States, 1969-2013</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Ahmedin Jemal, DVM, PhD, author of <a href="http://dx.doi.org/10.1001/jama.2015.12319">Temporal Trends in Mortality in the United States, 1969-2013</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Trends_in_US_Mortality_1969-2013.mp3?dest-id=90171" length="3470109" type="audio/mpeg" />
      <itunes:duration>03:36</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/a/6/b/0a6b9cf2945334aa/151027-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Breast Cancer Screening Guidelines</title>
      <itunes:title>Breast Cancer Screening Guidelines</itunes:title>
      <pubDate>Tue, 20 Oct 2015 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[4e8bef9c0cd8b94578b25519d14a44b4]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.13086]]></link>
      <description><![CDATA[<p>Interview with Elizabeth T. H. Fontham, MPH, DrPH, author of <a href="http://dx.doi.org/10.1001/jama.2015.12783">Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society</a>, Nancy L. Keating, MD, MPH, author of <a href="http://dx.doi.org/10.1001/jama.2015.13086">New Guidelines for Breast Cancer Screening in US Women</a>, and Evan R. Myers, MD, MPH, author of <a href= "http://dx.doi.org/10.1001/jama.2015.13183">Benefits and Harms of Breast Cancer Screening: A Systematic Review</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Elizabeth T. H. Fontham, MPH, DrPH, author of <a href="http://dx.doi.org/10.1001/jama.2015.12783">Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society</a>, Nancy L. Keating, MD, MPH, author of <a href="http://dx.doi.org/10.1001/jama.2015.13086">New Guidelines for Breast Cancer Screening in US Women</a>, and Evan R. Myers, MD, MPH, author of <a href= "http://dx.doi.org/10.1001/jama.2015.13183">Benefits and Harms of Breast Cancer Screening: A Systematic Review</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/2015_Breast_Cancer_Screening_Recommendations_for_Women_at_Average_Risk_Artist.mp3?dest-id=90171" length="10950479" type="audio/mpeg" />
      <itunes:duration>22:39</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/8/1/9/e8191254e44b959c/JMI150001audioA_thumb-240x240.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>2015 Breast Cancer Screening Recommendations for Women at Average Risk</title>
      <itunes:title>2015 Breast Cancer Screening Recommendations for Women at Average Risk</itunes:title>
      <pubDate>Tue, 20 Oct 2015 14:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[b6560c69e9df557739235ea18d83d828]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.12783]]></link>
      <description><![CDATA[<p>Interview with Kevin C. Oeffinger, MD, author of <a href="http://dx.doi.org/10.1001/jama.2015.12783">Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Kevin C. Oeffinger, MD, author of <a href="http://dx.doi.org/10.1001/jama.2015.12783">Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/2015_Breast_Cancer_Screening_Recommendations_for_Women_at_Average_Risk.mp3?dest-id=90171" length="5090069" type="audio/mpeg" />
      <itunes:duration>05:17</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/4/2/7/a/427a45f4b2054232/151020-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Laparoscopic vs Open Resection for Rectal Cancer</title>
      <itunes:title>Laparoscopic vs Open Resection for Rectal Cancer</itunes:title>
      <pubDate>Tue, 06 Oct 2015 14:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[6a45490184ed8d6a6fd65cc3421b8bc8]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.10529]]></link>
      <description><![CDATA[<p>Interview with James Fleshman, MD, author of <a href="http://dx.doi.org/10.1001/jama.2015.10529">Effect of Laparoscopic-Assisted Resection vs Open Resection of Stage II or III Rectal Cancer on Pathologic Outcomes: The ACOSOG Z6051 Randomized Clinical Trial</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with James Fleshman, MD, author of <a href="http://dx.doi.org/10.1001/jama.2015.10529">Effect of Laparoscopic-Assisted Resection vs Open Resection of Stage II or III Rectal Cancer on Pathologic Outcomes: The ACOSOG Z6051 Randomized Clinical Trial</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Laparoscopic_vs_Open_Resection_for_Rectal_Cancer.mp3?dest-id=90171" length="4853297" type="audio/mpeg" />
      <itunes:duration>05:02</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/b/c/0/d/bc0d483209434309/151006-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Influenza Pneumonia Hospitalization and Prior Influenza Vaccination</title>
      <itunes:title>Influenza Pneumonia Hospitalization and Prior Influenza Vaccination</itunes:title>
      <pubDate>Mon, 05 Oct 2015 14:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[c0983b132421797ca18d431f2042309b]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.12160]]></link>
      <description><![CDATA[<p>Interview with Carlos G. Grijalva, MD, MPH, author of <a href="http://dx.doi.org/10.1001/jama.2015.12160">Association Between Hospitalization With Community-Acquired Laboratory-Confirmed Influenza Pneumonia and Prior Receipt of Influenza Vaccination</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Carlos G. Grijalva, MD, MPH, author of <a href="http://dx.doi.org/10.1001/jama.2015.12160">Association Between Hospitalization With Community-Acquired Laboratory-Confirmed Influenza Pneumonia and Prior Receipt of Influenza Vaccination</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Influenza_Pneumonia_Hospitalization_and_Prior_Influenza_Vaccination.mp3?dest-id=90171" length="3117831" type="audio/mpeg" />
      <itunes:duration>03:14</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/d/4/c/b/d4cbfacdc328e387/151013-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>DNR Status and Neurological Prognosis After In-Hospital Cardiac Arrest</title>
      <itunes:title>DNR Status and Neurological Prognosis After In-Hospital Cardiac Arrest</itunes:title>
      <pubDate>Tue, 22 Sep 2015 15:32:14 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[1b926145df702155fc502fb81e086c99]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.11069]]></link>
      <description><![CDATA[<p>Interview with Timothy Fendler, MD, MS, author of Alignment of Do-Not-Resuscitate Status With Patients' Likelihood of Favorable Neurological Survival After In-Hospital Cardiac Arrest</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Timothy Fendler, MD, MS, author of Alignment of Do-Not-Resuscitate Status With Patients' Likelihood of Favorable Neurological Survival After In-Hospital Cardiac Arrest</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/DNR_Status_and_Neurological_Prognosis_After_In-Hospital_Cardiac_Arrest.mp3?dest-id=90171" length="8222083" type="audio/mpeg" />
      <itunes:duration>16:47</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/3/2/c/c32c0b811b097c40/150922-jama-jai-fendler.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Dextromethorphan-Quinidine for Agitation in Patients With Alzheimer Disease</title>
      <itunes:title>Dextromethorphan-Quinidine for Agitation in Patients With Alzheimer Disease</itunes:title>
      <pubDate>Tue, 22 Sep 2015 14:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[5725b77cb7fc4772a7cd783336bc17b6]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.10214]]></link>
      <description><![CDATA[<p>Interview with Jeffrey L. Cummings, MD, ScD, author of <a href="http://dx.doi.org/10.1001/jama.2015.10214">Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia: A Randomized Clinical Trial</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Jeffrey L. Cummings, MD, ScD, author of <a href="http://dx.doi.org/10.1001/jama.2015.10214">Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia: A Randomized Clinical Trial</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Dextromethorphan-Quinidine_for_Agitation_in_Patients_With_Alzheimer_Disease.mp3?dest-id=90171" length="3748641" type="audio/mpeg" />
      <itunes:duration>03:53</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/7/c/5/3/7c53fd21433c602c/150922-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Doing Field Work With Doctors Without Borders</title>
      <itunes:title>Doing Field Work With Doctors Without Borders</itunes:title>
      <pubDate>Tue, 15 Sep 2015 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[2f04ef3a7450a6f4937fa90ef0c933aa]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.10442]]></link>
      <description><![CDATA[<p>Adi Nadimpalli, MD, the Doctors Without Borders/Médecins Sans Frontières (MSF) Head of Mission in Nepal, and the former vice president of the US board of directors, talks about MSF's mission and the challenges he has faced serving in countries where access to health care is insufficient or strained due to natural or manmade disasters, violent conflicts, epidemics, and population displacement.</p>]]></description>
      
      <content:encoded><![CDATA[<p>Adi Nadimpalli, MD, the Doctors Without Borders/Médecins Sans Frontières (MSF) Head of Mission in Nepal, and the former vice president of the US board of directors, talks about MSF's mission and the challenges he has faced serving in countries where access to health care is insufficient or strained due to natural or manmade disasters, violent conflicts, epidemics, and population displacement.</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Interview_with_Adi_Nadimpalli.mp3?dest-id=90171" length="11216019" type="audio/mpeg" />
      <itunes:duration>23:19</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/0/3/a/903a8a8d655f0967/150729-mednews-docswithoutborders.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Sex Differences in Academic Rank in US Medical Schools</title>
      <itunes:title>Sex Differences in Academic Rank in US Medical Schools</itunes:title>
      <pubDate>Tue, 15 Sep 2015 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[01ba2330d74ee97dc9bdd705ba139080]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.10680]]></link>
      <description><![CDATA[<p>Interview with Anupam Jena, MD, PhD, author of Sex Differences in Academic Rank in US Medical Schools in 2014</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Anupam Jena, MD, PhD, author of Sex Differences in Academic Rank in US Medical Schools in 2014</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/01_Sex_Differences_in_Academic_Rank_in_US_Medical_Schools.mp3?dest-id=90171" length="30280402" type="audio/mpeg" />
      <itunes:duration>10:59</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/7/2/c/9/72c9de1d4bbda0b3/150915_jama_jai_jena.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Prevalence of and Trends in Diabetes Among US Adults</title>
      <itunes:title>Prevalence of and Trends in Diabetes Among US Adults</itunes:title>
      <pubDate>Tue, 08 Sep 2015 14:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[4bfa0d35cf92fd409731eaaee7af2868]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.10029]]></link>
      <description><![CDATA[<p>Interview with Andy Menke, PhD, author of <a href="http://dx.doi.org/10.1001/jama.2015.10029">Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Andy Menke, PhD, author of <a href="http://dx.doi.org/10.1001/jama.2015.10029">Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Prevalence_of_and_Trends_in_Diabetes_Among_US_Adults.mp3?dest-id=90171" length="2047177" type="audio/mpeg" />
      <itunes:duration>02:07</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/c/7/d/1c7d61f753dcaed9/150908-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Treating Chronic Sinusitis in Adults</title>
      <itunes:title>Treating Chronic Sinusitis in Adults</itunes:title>
      <pubDate>Tue, 01 Sep 2015 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[03c5d65bd25817e0eab3c72a40afd24e]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.7544]]></link>
      <description><![CDATA[<p>Interview with Luke Rudmik, MD, MSc, author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2015.7544"> Medical Therapies for Adult Chronic Sinusitis: A Systematic Review.</a> This systematic review summarizes the evidence-based medical treatment of adult chronic sinusitis and proposes a treatment algorithm.</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Luke Rudmik, MD, MSc, author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2015.7544"> Medical Therapies for Adult Chronic Sinusitis: A Systematic Review.</a> This systematic review summarizes the evidence-based medical treatment of adult chronic sinusitis and proposes a treatment algorithm.</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Medical_Therapies_for_Adult_Chronic_Sinusitis.mp3?dest-id=90171" length="24138018" type="audio/mpeg" />
      <itunes:duration>24:55</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/b/4/a/ab4abfcf246b78a1/150901-jama-cre-sinusitis.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Molecular Diagnostic Tests in Children With Autism Spectrum Disorder</title>
      <itunes:title>Molecular Diagnostic Tests in Children With Autism Spectrum Disorder</itunes:title>
      <pubDate>Tue, 01 Sep 2015 14:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[02c8a2780efb550c9494368507432cf2]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.10078]]></link>
      <description><![CDATA[<p>Interview with Bridget A. Fernandez, MD, author of <a href="http://dx.doi.org/10.1001/jama.2015.10078">Molecular Diagnostic Yield of Chromosomal Microarray Analysis and Whole-Exome Sequencing in Children With Autism Spectrum Disorder</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Bridget A. Fernandez, MD, author of <a href="http://dx.doi.org/10.1001/jama.2015.10078">Molecular Diagnostic Yield of Chromosomal Microarray Analysis and Whole-Exome Sequencing in Children With Autism Spectrum Disorder</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Molecular_Diagnostic_Tests_in_Children_With_Autism_Spectrum_Disorder.mp3?dest-id=90171" length="2963869" type="audio/mpeg" />
      <itunes:duration>03:04</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/3/a/d/e3ad1806bfc45038/150901-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Mutation Clearance After Chemotherapy and Outcomes in AML</title>
      <itunes:title>Mutation Clearance After Chemotherapy and Outcomes in AML</itunes:title>
      <pubDate>Tue, 25 Aug 2015 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[ff566d908682347fd8ed6848594775c7]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.9643]]></link>
      <description><![CDATA[<p>Interview with Timothy Ley, MD, author of <a href= "http://dx.doi.org/10.1001/jama.2015.9643">Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid Leukemia</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Timothy Ley, MD, author of <a href= "http://dx.doi.org/10.1001/jama.2015.9643">Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid Leukemia</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Mutation_Clearance_After_Chemotherapy_and_Outcomes_in_AML.mp3?dest-id=90171" length="5543826" type="audio/mpeg" />
      <itunes:duration>11:08</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/4/3/8/3/43836737cf3d0012/150825-jama-jai-ley.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Activity Intervention vs Health Education in Sedentary Older Adults</title>
      <itunes:title>Activity Intervention vs Health Education in Sedentary Older Adults</itunes:title>
      <pubDate>Tue, 25 Aug 2015 14:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[ab535de2b49f5be2282d9ca80296e3f9]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.9617]]></link>
      <description><![CDATA[<p>Interview with Kaycee M. Sink, MD, MAS, author of <a href="http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2015.9617">Effect of a 24-Month Physical Activity Intervention vs Health Education on Cognitive Outcomes in Sedentary Older Adults: The LIFE Randomized Trial</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Kaycee M. Sink, MD, MAS, author of <a href="http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2015.9617">Effect of a 24-Month Physical Activity Intervention vs Health Education on Cognitive Outcomes in Sedentary Older Adults: The LIFE Randomized Trial</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Activity_Intervention_vs_Health_Education_in_Sedentary_Older_Adults.mp3?dest-id=90171" length="3186752" type="audio/mpeg" />
      <itunes:duration>03:18</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/f/3/f/6/f3f6654b736f1bdf/150825-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>e-Cigarette Use and Subsequent Tobacco Use by Adolescents</title>
      <itunes:title>e-Cigarette Use and Subsequent Tobacco Use by Adolescents</itunes:title>
      <pubDate>Tue, 18 Aug 2015 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[bde38a6bb73ee86416d0ccf3e785e818]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.8382]]></link>
      <description><![CDATA[<p>Interview with Nancy A. Rigotti, MD, author of <a href="http://dx.doi.org/10.1001/jama.2015.8382">e-Cigarette Use and Subsequent Tobacco Use by Adolescents: New Evidence About a Potential Risk of e-Cigarettes</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Nancy A. Rigotti, MD, author of <a href="http://dx.doi.org/10.1001/jama.2015.8382">e-Cigarette Use and Subsequent Tobacco Use by Adolescents: New Evidence About a Potential Risk of e-Cigarettes</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/e-Cigarette_Use_and_Subsequent_Tobacco_Use_by_Adolescents.mp3?dest-id=90171" length="19440873" type="audio/mpeg" />
      <itunes:duration>20:08</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/8/0/9/280924c341546960/150818-jama-jai-rigotti.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Electronic Cigarette Use and Smoking During Early Adolescence</title>
      <itunes:title>Electronic Cigarette Use and Smoking During Early Adolescence</itunes:title>
      <pubDate>Tue, 18 Aug 2015 14:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[28da35ffe28939fa2e9114d351dc6f70]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.8950]]></link>
      <description><![CDATA[<p>Interview with Adam M. Leventhal, PhD, author of <a href="http:/jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2015.8950">Association of Electronic Cigarette Use With Initiation of Combustible Tobacco Product Smoking in Early Adolescence</a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Adam M. Leventhal, PhD, author of <a href="http:/jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2015.8950">Association of Electronic Cigarette Use With Initiation of Combustible Tobacco Product Smoking in Early Adolescence</a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Electronic_Cigarette_Use_and_Smoking_During_Early_Adolescence.mp3?dest-id=90171" length="4085788" type="audio/mpeg" />
      <itunes:duration>04:14</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/c/b/4/3cb4a9231818e6ba/150818-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Referrals From Dialysis Facilities for Kidney Transplantation</title>
      <itunes:title>Referrals From Dialysis Facilities for Kidney Transplantation</itunes:title>
      <pubDate>Tue, 11 Aug 2015 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[2cc491f07a074f28375cf6a5dce65981]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.8897]]></link>
      <description><![CDATA[<p>Interview with Rachel E. Patzer, PhD, MPH, author of Variation in Dialysis Facility Referral for Kidney Transplantation Among Patients With End-Stage Renal Disease in Georgia. This population epidemiology study uses United States Renal Data System data to characterize dialysis facility–level referral for kidney transplant evaluation in Georgia, the US state with the lowest transplantation rates, and patient and facility factors associated with referral and waitlisting.</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Rachel E. Patzer, PhD, MPH, author of Variation in Dialysis Facility Referral for Kidney Transplantation Among Patients With End-Stage Renal Disease in Georgia. This population epidemiology study uses United States Renal Data System data to characterize dialysis facility–level referral for kidney transplant evaluation in Georgia, the US state with the lowest transplantation rates, and patient and facility factors associated with referral and waitlisting.</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Referrals_From_Dialysis_Facilities_for_Kidney_Transplantation.mp3?dest-id=90171" length="4493336" type="audio/mpeg" />
      <itunes:duration>09:19</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/a/e/8/aae860aff80051ad/150811-jama-jai-patzer.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Testosterone and Atherosclerosis in Older Men</title>
      <itunes:title>Testosterone and Atherosclerosis in Older Men</itunes:title>
      <pubDate>Tue, 11 Aug 2015 14:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[6d805c0c7c12981b89fd835133e2aab4]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.8881]]></link>
      <description><![CDATA[<p>Interview with Shalender Bhasin, MBBS, author of Effects of Testosterone Administration for 3 Years on Subclinical Atherosclerosis Progression in Older Men With Low or Low-Normal Testosterone Levels: A Randomized Clinical Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Shalender Bhasin, MBBS, author of Effects of Testosterone Administration for 3 Years on Subclinical Atherosclerosis Progression in Older Men With Low or Low-Normal Testosterone Levels: A Randomized Clinical Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Testosterone_and_Atherosclerosis_in_Older_Men.mp3?dest-id=90171" length="4009183" type="audio/mpeg" />
      <itunes:duration>04:10</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/3/4/d/334d71f640f3f072/150811-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Posttraumatic Stress Disorder</title>
      <itunes:title>Posttraumatic Stress Disorder</itunes:title>
      <pubDate>Tue, 04 Aug 2015 15:36:44 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[147f389af215d197069602813d5c2374]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.8370]]></link>
      <description><![CDATA[<p>Edward H. Livingston, MD, interviews a war veteran and discusses PTSD with Maria Steenkamp, PhD, author of <a href= "http://jama.jamanetwork.com/article.aspx?articleid=2422548">Psychotherapy for Military-Related PTSD</a>, and Michele Spoont, PhD, author of <a href= "http://jama.jamanetwork.com/article.aspx?articleid=2422547">Rational Clinical Exam: Does This Patient Have Posttraumatic Stress Disorder?</a> The article by Dr Steenkamp reports that many military personnel and veterans with posttraumatic stress disorder achieve clinically meaningful improvement with use of the first-line trauma-focused interventions cognitive processing therapy and prolonged exposure.  The Rational Clinical Examination Systematic Review by Dr Spoont examines the utility of self-report screening instruments for posttraumatic stress disorder among primary care and high-risk populations.</p>]]></description>
      
      <content:encoded><![CDATA[<p>Edward H. Livingston, MD, interviews a war veteran and discusses PTSD with Maria Steenkamp, PhD, author of <a href= "http://jama.jamanetwork.com/article.aspx?articleid=2422548">Psychotherapy for Military-Related PTSD</a>, and Michele Spoont, PhD, author of <a href= "http://jama.jamanetwork.com/article.aspx?articleid=2422547">Rational Clinical Exam: Does This Patient Have Posttraumatic Stress Disorder?</a> The article by Dr Steenkamp reports that many military personnel and veterans with posttraumatic stress disorder achieve clinically meaningful improvement with use of the first-line trauma-focused interventions cognitive processing therapy and prolonged exposure. The Rational Clinical Examination Systematic Review by Dr Spoont examines the utility of self-report screening instruments for posttraumatic stress disorder among primary care and high-risk populations.</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/The_JAMA_Clinical_Review__Posttraumatic_Stress_Disorder.mp3?dest-id=90171" length="11228993" type="audio/mpeg" />
      <itunes:duration>23:11</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/7/2/7/1/7271c877cd9e0293/150728-jama-cre-ptsd-ed.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Mindfulness-Based Stress Reduction for PTSD Among Veterans</title>
      <itunes:title>Mindfulness-Based Stress Reduction for PTSD Among Veterans</itunes:title>
      <pubDate>Tue, 04 Aug 2015 14:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[b7a61ee358e642eea255ee7df45493e6]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.8361]]></link>
      <description><![CDATA[<p>Interview with Melissa A. Polusny, PhD, author of Mindfulness-Based Stress Reduction for Posttraumatic Stress Disorder Among Veterans: A Randomized Clinical Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Melissa A. Polusny, PhD, author of Mindfulness-Based Stress Reduction for Posttraumatic Stress Disorder Among Veterans: A Randomized Clinical Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Mindfulness-Based_Stress_Reduction_for_PTSD_Among_Veterans.mp3?dest-id=90171" length="3075759" type="audio/mpeg" />
      <itunes:duration>03:11</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/f/7/c/2f7c58889ba457fd/150804-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Medicare and Medicaid at 50 Years</title>
      <itunes:title>Medicare and Medicaid at 50 Years</itunes:title>
      <pubDate>Tue, 28 Jul 2015 15:02:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[555a02702eed6c7851023ad172db0292]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.7811]]></link>
      <description><![CDATA[<p>Interview with Drew Altman, PhD and William Frist, MD, authors of Medicare and Medicaid at 50 Years: Perspectives of Beneficiaries, Health Care Professionals and Institutions, and Policy Makers</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Drew Altman, PhD and William Frist, MD, authors of Medicare and Medicaid at 50 Years: Perspectives of Beneficiaries, Health Care Professionals and Institutions, and Policy Makers</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Medicare_and_Medicaid_at_50_Years.mp3?dest-id=90171" length="15289994" type="audio/mpeg" />
      <itunes:duration>31:40</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/8/e/f/a8efef3bba5ef26c/150728-jama-jai-altman.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Donald M. Berwick Reflects on Medicare at 50</title>
      <itunes:title>Donald M. Berwick Reflects on Medicare at 50</itunes:title>
      <pubDate>Tue, 28 Jul 2015 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[d15ebe182382ca73464a9ee69c876dd3]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.7842]]></link>
      <description><![CDATA[<p>Medicare at 50: Reflections From Former CMS Administrator Donald M. Berwick, MD</p>]]></description>
      
      <content:encoded><![CDATA[<p>Medicare at 50: Reflections From Former CMS Administrator Donald M. Berwick, MD</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Donald_M._Berwick_Reflects_on_Medicare_at_50.mp3?dest-id=90171" length="9117866" type="audio/mpeg" />
      <itunes:duration>18:53</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/a/2/f/ea2f02eb21882998/150728-jai-berwick.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Mortality, Hospitalizations, and Expenditures for the Medicare Population</title>
      <itunes:title>Mortality, Hospitalizations, and Expenditures for the Medicare Population</itunes:title>
      <pubDate>Tue, 28 Jul 2015 14:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[fd21d49698f82c93fb7b3b4b6aa9b898]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.8035]]></link>
      <description><![CDATA[<p>Interview with Harlan M. Krumholz, MD, SM, author of Mortality, Hospitalizations, and Expenditures for the Medicare Population Aged 65 Years or Older, 1999-2013</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Harlan M. Krumholz, MD, SM, author of Mortality, Hospitalizations, and Expenditures for the Medicare Population Aged 65 Years or Older, 1999-2013</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Mortality_Hospitalizations_and_Expenditures_for_the_Medicare_Population.mp3?dest-id=90171" length="3464048" type="audio/mpeg" />
      <itunes:duration>03:36</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/f/5/4/ef548f8f02be50fa/150728-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Managing Atrial Fibrillation</title>
      <itunes:title>Managing Atrial Fibrillation</itunes:title>
      <pubDate>Tue, 21 Jul 2015 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[9eee0684e4501c7970e356db7e8c3486]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.7505]]></link>
      <description><![CDATA[<p>Edward H. Livingston, MD discusses atrial fibrillation with Eric N. Prystowsky, MD, author of Treatment of Atrial Fibrillation. This review article reports that therapy for atrial fibrillation should include rate control for all patients, but maintenance of sinus rhythm with drugs or catheter ablation should be considered on an individual patient basis. Also on the program is a conversation about new technologies to facilitate screening for atrial fibrillation with Leslie Saxon, MD.</p>]]></description>
      
      <content:encoded><![CDATA[<p>Edward H. Livingston, MD discusses atrial fibrillation with Eric N. Prystowsky, MD, author of Treatment of Atrial Fibrillation. This review article reports that therapy for atrial fibrillation should include rate control for all patients, but maintenance of sinus rhythm with drugs or catheter ablation should be considered on an individual patient basis. Also on the program is a conversation about new technologies to facilitate screening for atrial fibrillation with Leslie Saxon, MD.</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Treatment_of_Atrial_Fibrillation.mp3?dest-id=90171" length="10819980" type="audio/mpeg" />
      <itunes:duration>22:30</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/3/7/c/a37c083c26548dfb/150721-jama-cre-afib.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Cardiac Survival After Bystander and First-Responder CPR Intervention</title>
      <itunes:title>Cardiac Survival After Bystander and First-Responder CPR Intervention</itunes:title>
      <pubDate>Tue, 21 Jul 2015 14:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[75ce5af25e8b8cf814ea613d5ccfe5b4]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.7938]]></link>
      <description><![CDATA[<p>Interview with Carolina Malta Hansen, MD, author of Association of Bystander and First-Responder Intervention With Survival After Out-of-Hospital Cardiac Arrest in North Carolina, 2010-2013</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Carolina Malta Hansen, MD, author of Association of Bystander and First-Responder Intervention With Survival After Out-of-Hospital Cardiac Arrest in North Carolina, 2010-2013</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Cardiac_Survival_After_Bystander_and_First-Responder_CPR_Intervention.mp3?dest-id=90171" length="3584765" type="audio/mpeg" />
      <itunes:duration>03:43</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/7/1/0/3710f3041ca14503/150721-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Cost-effectiveness of Varying 10-Year Risk Statin Treatment Thresholds</title>
      <itunes:title>Cost-effectiveness of Varying 10-Year Risk Statin Treatment Thresholds</itunes:title>
      <pubDate>Tue, 14 Jul 2015 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[5fad25d3881c0ca761387f9ca214af42]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.6822]]></link>
      <description><![CDATA[<p>Interview with Thomas A. Gaziano, MD, MSc, author of Cost-effectiveness of 10-Year Risk Thresholds for Initiation of Statin Therapy for Primary Prevention of Cardiovascular Disease</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Thomas A. Gaziano, MD, MSc, author of Cost-effectiveness of 10-Year Risk Thresholds for Initiation of Statin Therapy for Primary Prevention of Cardiovascular Disease</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Cost-effectiveness_of_Varying_10-Year_Risk_Statin_Treatment_Thresholds.mp3?dest-id=90171" length="6956597" type="audio/mpeg" />
      <itunes:duration>14:27</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/f/e/5/e/fe5ec5a58b9c6d9d/150714-jama-jai-gaziano.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Maternal Malignancy and Noninvasive Prenatal Testing</title>
      <itunes:title>Maternal Malignancy and Noninvasive Prenatal Testing</itunes:title>
      <pubDate>Mon, 13 Jul 2015 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[253dddd1465dc9123c77b9eefeb58485]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.7120]]></link>
      <description><![CDATA[<p>Interview with Diana W. Bianchi, MD, author of Noninvasive Prenatal Testing and Incidental Detection of Occult Maternal Malignancies</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Diana W. Bianchi, MD, author of Noninvasive Prenatal Testing and Incidental Detection of Occult Maternal Malignancies</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Maternal_Malignancy_and_Noninvasive_Prenatal_Testing.mp3?dest-id=90171" length="4772695" type="audio/mpeg" />
      <itunes:duration>04:57</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/b/0/a/3b0ac09fd85b13b4/150713-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Duration of Oral Anticoagulation After PE</title>
      <itunes:title>Duration of Oral Anticoagulation After PE</itunes:title>
      <pubDate>Tue, 07 Jul 2015 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[1ddc7e92637bf8a4e83a7639cf977c38]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.7046]]></link>
      <description><![CDATA[<p>Interview with Francis Couturaud, MD, PhD, author of Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism: The PADIS-PE Randomized Clinical Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Francis Couturaud, MD, PhD, author of Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism: The PADIS-PE Randomized Clinical Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Duration_of_Oral_Anticoagulation_After_PE.mp3?dest-id=90171" length="6255260" type="audio/mpeg" />
      <itunes:duration>13:00</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/3/4/d/e34daa1933e55fc6/150707-jama-jai-couturaud.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Trajectory of Cognitive Decline After Incident Stroke</title>
      <itunes:title>Trajectory of Cognitive Decline After Incident Stroke</itunes:title>
      <pubDate>Tue, 07 Jul 2015 14:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[96df19b95e5ceff094baaa75184e743f]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.6968]]></link>
      <description><![CDATA[<p>Interview with Deborah A. Levine, MD, MPH, author of Trajectory of Cognitive Decline After Incident Stroke</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Deborah A. Levine, MD, MPH, author of Trajectory of Cognitive Decline After Incident Stroke</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Trajectory_of_Cognitive_Decline_After_Incident_Stroke.mp3?dest-id=90171" length="3257402" type="audio/mpeg" />
      <itunes:duration>03:23</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/f/1/b/c/f1bc95fe762abb7b/150707-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Interview with Harold Varmus, MD</title>
      <itunes:title>Interview with Harold Varmus, MD</itunes:title>
      <pubDate>Tue, 07 Jul 2015 14:58:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[68ef00ff6711025d71ab00a673880369]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.4231]]></link>
      <description><![CDATA[<p>Harold Varmus, MD, former director of the National Cancer Institute, talks about his career and his ideas for improving the biomedical research enterprise.</p>]]></description>
      
      <content:encoded><![CDATA[<p>Harold Varmus, MD, former director of the National Cancer Institute, talks about his career and his ideas for improving the biomedical research enterprise.</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/150406-jama-mednews-varmus.mp3?dest-id=90171" length="5432118" type="audio/mpeg" />
      <itunes:duration>11:16</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/c/0/0/2c0044e65e37ea66/150406-jama-mednews-varmus.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Medical Marijuana for Treatment of Chronic Pain and Other Problems</title>
      <itunes:title>Medical Marijuana for Treatment of Chronic Pain and Other Problems</itunes:title>
      <pubDate>Tue, 23 Jun 2015 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[eabb5f88c43806514d4cb3829278907f]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.6199]]></link>
      <description><![CDATA[<p>Interview with Kevin P. Hill, MD, MHS, author of Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review, and Deepak Cyril D'Souza, MBBS, MD, author of Medical Marijuana: Is the Cart Before the Horse?</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Kevin P. Hill, MD, MHS, author of Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review, and Deepak Cyril D'Souza, MBBS, MD, author of Medical Marijuana: Is the Cart Before the Horse?</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Medical_Marijuana_for_Treatment_of_Chronic_Pain_and_Other_Problems.mp3?dest-id=90171" length="18657503" type="audio/mpeg" />
      <itunes:duration>19:25</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/1/f/7/91f752b14b883187/150623-jai-hill.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>ICD Use Among Medicare Patients After Acute MI</title>
      <itunes:title>ICD Use Among Medicare Patients After Acute MI</itunes:title>
      <pubDate>Tue, 23 Jun 2015 14:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[eaf8dfa36154b205b8eb332f7e546a9a]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.6409]]></link>
      <description><![CDATA[<p>Interview with Tracy Y. Wang, MD, MHS, MSc, author of Implantable Cardioverter-Defibrillator Use Among Medicare Patients With Low Ejection Fraction After Acute Myocardial Infarction</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Tracy Y. Wang, MD, MHS, MSc, author of Implantable Cardioverter-Defibrillator Use Among Medicare Patients With Low Ejection Fraction After Acute Myocardial Infarction</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/ICD_Use_Among_Medicare_Patients_After_Acute_MI.mp3?dest-id=90171" length="3904198" type="audio/mpeg" />
      <itunes:duration>04:03</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/a/7/6/1a7600ec624dbf07/150623-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Antibiotics vs Appendectomy for Uncomplicated Appendicitis Treatment</title>
      <itunes:title>Antibiotics vs Appendectomy for Uncomplicated Appendicitis Treatment</itunes:title>
      <pubDate>Tue, 16 Jun 2015 15:06:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[6386fb0a8517ef0358435637fb9c6659]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.6154]]></link>
      <description><![CDATA[<p>JAMA Topic Review: Edward Livingston, MD, FACS, AGAF, Deputy Editor of JAMA, explores how the study by Paulina Salminen, MD, PhD, supports treating appendicitis without surgery</p>]]></description>
      
      <content:encoded><![CDATA[<p>JAMA Topic Review: Edward Livingston, MD, FACS, AGAF, Deputy Editor of JAMA, explores how the study by Paulina Salminen, MD, PhD, supports treating appendicitis without surgery</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Antibiotics_vs_Appendectomy_for_Uncomplicated_Appendicitis_Treatment.mp3?dest-id=90171" length="9337947" type="audio/mpeg" />
      <itunes:duration>19:21</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/8/a/b/88aba954237fab58/150616-jama-jai-salminen-compiled.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Lifetime Benefits and Costs of Colorectal Cancer Screening</title>
      <itunes:title>Lifetime Benefits and Costs of Colorectal Cancer Screening</itunes:title>
      <pubDate>Tue, 16 Jun 2015 14:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[b7ab6af219e2b87e9481787676052600]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.6251]]></link>
      <description><![CDATA[<p>Interview with Chyke A. Doubeni, MD, MPH, author of Variation in Adenoma Detection Rate and the Lifetime Benefits and Cost of Colorectal Cancer Screening: A Microsimulation Model</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Chyke A. Doubeni, MD, MPH, author of Variation in Adenoma Detection Rate and the Lifetime Benefits and Cost of Colorectal Cancer Screening: A Microsimulation Model</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Lifetime_Benefits_and_Costs_of_Colorectal_Cancer_Screening.mp3?dest-id=90171" length="2269753" type="audio/mpeg" />
      <itunes:duration>02:20</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/8/1/f/e81fde82392d3946/150616-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Why the Americans With Disabilities Act Matters for Genetics</title>
      <itunes:title>Why the Americans With Disabilities Act Matters for Genetics</itunes:title>
      <pubDate>Tue, 09 Jun 2015 15:05:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[dbb32ad86a5cb7059fac2109f6be3b62]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.3419]]></link>
      <description><![CDATA[<p>Interview with Ellen Wright Clayton, MD, JD , author of Why the Americans With Disabilities Act Matters for Genetics</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Ellen Wright Clayton, MD, JD , author of Why the Americans With Disabilities Act Matters for Genetics</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Why_the_Americans_With_Disabilities_Act_Matters_for_Genetics.mp3?dest-id=90171" length="7638090" type="audio/mpeg" />
      <itunes:duration>15:48</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/f/a/e/c/faec1dda51b592e9/150609-jai-clayton.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>The ADA, Disability, and Identity</title>
      <itunes:title>The ADA, Disability, and Identity</itunes:title>
      <pubDate>Tue, 09 Jun 2015 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[5b22b5a25b9ed39ec098e649bda0a1c7]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.4936]]></link>
      <description><![CDATA[<p>Interview with Eve Hill, JD, author of The ADA, Disability, and Identity</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Eve Hill, JD, author of The ADA, Disability, and Identity</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/The_ADA_Disability_and_Identity.mp3?dest-id=90171" length="10249178" type="audio/mpeg" />
      <itunes:duration>21:15</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/1/9/9/8199c8fa20939919/150609-jai-hill.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>The ADA and the Supreme Court</title>
      <itunes:title>The ADA and the Supreme Court</itunes:title>
      <pubDate>Tue, 09 Jun 2015 14:58:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[c385092e7ad4553f0dbe179cdccc2d2f]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.4268]]></link>
      <description><![CDATA[<p>Interview with Samuel R. Bagenstos, JD, author of The ADA and the Supreme Court: A Mixed Record</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Samuel R. Bagenstos, JD, author of The ADA and the Supreme Court: A Mixed Record</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/The_ADA_and_the_Supreme_Court.mp3?dest-id=90171" length="12864399" type="audio/mpeg" />
      <itunes:duration>26:46</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/d/4/7/4/d4748cb2b72833f4/150609-jama-jai-bagenstos.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Intuitive Control of a Powered Prosthetic Leg</title>
      <itunes:title>Intuitive Control of a Powered Prosthetic Leg</itunes:title>
      <pubDate>Tue, 09 Jun 2015 14:57:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[cbaa36a84b5a79568d3774896898b102]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.4527]]></link>
      <description><![CDATA[<p>Interview with Levi J. Hargrove, PhD, author of Intuitive Control of a Powered Prosthetic Leg During Ambulation: A Randomized Clinical Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Levi J. Hargrove, PhD, author of Intuitive Control of a Powered Prosthetic Leg During Ambulation: A Randomized Clinical Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Intuitive_Control_of_a_Powered_Prosthetic_Leg.mp3?dest-id=90171" length="2575197" type="audio/mpeg" />
      <itunes:duration>02:40</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/8/6/3/9863f303089adfb3/150609-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Outcomes for ACOs vs Traditional Medicare Fee for Service</title>
      <itunes:title>Outcomes for ACOs vs Traditional Medicare Fee for Service</itunes:title>
      <pubDate>Tue, 02 Jun 2015 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[bf14c18ab0afd11ffca24e135b7463f8]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.4930]]></link>
      <description><![CDATA[<p>Interview with Patrick H. Conway, MD, MSc, author of Association of Pioneer Accountable Care Organizations vs Traditional Medicare Fee for Service With Spending, Utilization, and Patient Experience</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Patrick H. Conway, MD, MSc, author of Association of Pioneer Accountable Care Organizations vs Traditional Medicare Fee for Service With Spending, Utilization, and Patient Experience</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Outcomes_for_ACOs_vs_Traditional_Medicare_Fee_for_Service.mp3?dest-id=90171" length="2093903" type="audio/mpeg" />
      <itunes:duration>04:19</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/3/2/4/132410437ddf9b78/150602-jama-jai-conway.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Antidepressant Use Late in Pregnancy and Effects on Newborn</title>
      <itunes:title>Antidepressant Use Late in Pregnancy and Effects on Newborn</itunes:title>
      <pubDate>Tue, 02 Jun 2015 14:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[0f071207f561a92e92de5e01b7340853]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.5605]]></link>
      <description><![CDATA[<p>Interview with Krista F. Huybrechts, MS, PhD, author of Antidepressant Use Late in Pregnancy and Risk of Persistent Pulmonary Hypertension of the Newborn</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Krista F. Huybrechts, MS, PhD, author of Antidepressant Use Late in Pregnancy and Risk of Persistent Pulmonary Hypertension of the Newborn</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Antidepressant_Use_Late_in_Pregnancy_and_Effects_on_Newborn.mp3?dest-id=90171" length="5890336" type="audio/mpeg" />
      <itunes:duration>06:07</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/9/3/d/293dd78fe0bd8b1f/150602-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Subclinical Thyroid Dysfunction and Fracture Risk</title>
      <itunes:title>Subclinical Thyroid Dysfunction and Fracture Risk</itunes:title>
      <pubDate>Tue, 26 May 2015 14:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[8d5de059ab76ad8f4969cac389d99e3c]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.5161]]></link>
      <description><![CDATA[<p>Interview with Anne R. Cappola, MD, ScM, author of Subclinical Thyroid Dysfunction and Fracture Risk: A Meta-analysis</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Anne R. Cappola, MD, ScM, author of Subclinical Thyroid Dysfunction and Fracture Risk: A Meta-analysis</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Subclinical_Thyroid_Dysfunction_and_Fracture_Risk.mp3?dest-id=90171" length="3017487" type="audio/mpeg" />
      <itunes:duration>03:07</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/f/6/3/cf63600978afd75a/150526-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Oral Steroids for Acute Sciatica Due to Herniated Lumbar Disk</title>
      <itunes:title>Oral Steroids for Acute Sciatica Due to Herniated Lumbar Disk</itunes:title>
      <pubDate>Tue, 19 May 2015 14:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[22ed6ba99f6a96ee43e33009914faa93]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.4468]]></link>
      <description><![CDATA[<p>Interview with Harley Goldberg, DO, author of Oral Steroids for Acute Radiculopathy Due to a Herniated Lumbar Disk: A Randomized Clinical Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Harley Goldberg, DO, author of Oral Steroids for Acute Radiculopathy Due to a Herniated Lumbar Disk: A Randomized Clinical Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Oral_Steroids_for_Acute_Sciatica_Due_to_Herniated_Lumbar_Disk.mp3?dest-id=90171" length="3175580" type="audio/mpeg" />
      <itunes:duration>03:17</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/5/f/d/3/5fd3028ac1ac9ea4/150519-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>DCV/ASV/BCV for HCV Infection With Cirrhosis</title>
      <itunes:title>DCV/ASV/BCV for HCV Infection With Cirrhosis</itunes:title>
      <pubDate>Tue, 05 May 2015 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[fca8878efbd36c57bd237c1259b44cc0]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.3868]]></link>
      <description><![CDATA[<p>Interview with Andrew J. Muir, MD, author of Daclatasvir in Combination With Asunaprevir and Beclabuvir for Hepatitis C Virus Genotype 1 Infection With Compensated Cirrhosis</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Andrew J. Muir, MD, author of Daclatasvir in Combination With Asunaprevir and Beclabuvir for Hepatitis C Virus Genotype 1 Infection With Compensated Cirrhosis</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/DCV_ASV_BCV_for_HCV_Infection_With_Cirrhosis.mp3?dest-id=90171" length="2381591" type="audio/mpeg" />
      <itunes:duration>04:55</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/a/f/2/9af2ded49ac2965e/150505-jama-jai-muir.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Nontoxigenic Clostridium difficile for Prevention of Recurrent Infection</title>
      <itunes:title>Nontoxigenic Clostridium difficile for Prevention of Recurrent Infection</itunes:title>
      <pubDate>Tue, 05 May 2015 14:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[c76d50d8787812f050f87092cb617418]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.3725]]></link>
      <description><![CDATA[<p>Interview with Dale N. Gerding, MD, author of Administration of Spores of Nontoxigenic Clostridium difficile Strain M3 for Prevention of Recurrent C difficile Infection: A Randomized Clinical Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Dale N. Gerding, MD, author of Administration of Spores of Nontoxigenic Clostridium difficile Strain M3 for Prevention of Recurrent C difficile Infection: A Randomized Clinical Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Nontoxigenic_Clostridium_difficile_for_Prevention_of_Recurrent_Infection.mp3?dest-id=90171" length="4486200" type="audio/mpeg" />
      <itunes:duration>04:39</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/b/d/3/4/bd34921d5f4f1b25/150505-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>ED-Initiated Treatment for Opioid Dependence</title>
      <itunes:title>ED-Initiated Treatment for Opioid Dependence</itunes:title>
      <pubDate>Tue, 28 Apr 2015 14:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[4f10af526730787c6f4c849bddb16128]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.3474]]></link>
      <description><![CDATA[<p>Interview with Gail D'Onofrio, MD, MS, author of Emergency Department-Initiated Buprenorphine/Naloxone Treatment for Opioid Dependence: A Randomized Clinical Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Gail D'Onofrio, MD, MS, author of Emergency Department-Initiated Buprenorphine/Naloxone Treatment for Opioid Dependence: A Randomized Clinical Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/ED-Initiated_Treatment_for_Opioid_Dependence.mp3?dest-id=90171" length="4290558" type="audio/mpeg" />
      <itunes:duration>04:27</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/6/0/3/e603f3ecfe01385f/150428-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Oral Insulin and Immune Responses in Children at Risk for Diabetes</title>
      <itunes:title>Oral Insulin and Immune Responses in Children at Risk for Diabetes</itunes:title>
      <pubDate>Tue, 21 Apr 2015 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[b1ad5bbe3bb276f3c7404e9e5789f48d]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.2928]]></link>
      <description><![CDATA[<p>Interview with Ezio Bonifacio, PhD, author of Effects of High-Dose Oral Insulin on Immune Responses in Children at High Risk for Type 1 Diabetes: The Pre-POINT Randomized Clinical Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Ezio Bonifacio, PhD, author of Effects of High-Dose Oral Insulin on Immune Responses in Children at High Risk for Type 1 Diabetes: The Pre-POINT Randomized Clinical Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Oral_Insulin_and_Immune_Responses_in_Children_at_Risk_for_Diabetes.mp3?dest-id=90171" length="3713846" type="audio/mpeg" />
      <itunes:duration>07:42</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/f/a/5/9fa58cb92b8625d7/150421-jama-jai-bonifacio.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Autism Occurrence by MMR Vaccine Status Among US Children</title>
      <itunes:title>Autism Occurrence by MMR Vaccine Status Among US Children</itunes:title>
      <pubDate>Tue, 21 Apr 2015 14:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[b5a3ef4d9f110fdeda70ce4c665569fa]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.3077]]></link>
      <description><![CDATA[<p>Interview with Anjali Jain, MD, author of Autism Occurrence by MMR Vaccine Status Among US Children With Older Siblings With and Without Autism</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Anjali Jain, MD, author of Autism Occurrence by MMR Vaccine Status Among US Children With Older Siblings With and Without Autism</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Autism_Occurrence_by_MMR_Vaccine_Status_Among_US_Children.mp3?dest-id=90171" length="3390727" type="audio/mpeg" />
      <itunes:duration>03:31</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/f/1/a/0f1a212ee62d98df/150421-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Maternal Diabetes and Autism in Offspring</title>
      <itunes:title>Maternal Diabetes and Autism in Offspring</itunes:title>
      <pubDate>Tue, 14 Apr 2015 14:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[c50c57b5d27d94afc2f23ddf8c1b77ef]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.2707]]></link>
      <description><![CDATA[<p>Interview with Anny H. Xiang, PhD, author of Association of Maternal Diabetes With Autism in Offspring</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Anny H. Xiang, PhD, author of Association of Maternal Diabetes With Autism in Offspring</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Maternal_Diabetes_and_Autism_in_Offspring.mp3?dest-id=90171" length="3765422" type="audio/mpeg" />
      <itunes:duration>03:54</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/7/e/c/1/7ec13b8836c3d6f9/150414-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Hospital Credentialing and Privileging of Surgeons</title>
      <itunes:title>Hospital Credentialing and Privileging of Surgeons</itunes:title>
      <pubDate>Tue, 07 Apr 2015 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[bd2a4a17bb58a11e5330896562e8afd3]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.1943]]></link>
      <description><![CDATA[<p>Interview with Justin B. Dimick, MD, MPH, author of Hospital Credentialing and Privileging of Surgeons: A Potential Safety Blind Spot</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Justin B. Dimick, MD, MPH, author of Hospital Credentialing and Privileging of Surgeons: A Potential Safety Blind Spot</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Hospital_Credentialing_and_Privileging_of_Surgeons.mp3?dest-id=90171" length="5509468" type="audio/mpeg" />
      <itunes:duration>11:26</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/b/2/3/0/b230890ec764f77a/150407-jama-jai-dimick.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Ebola Vaccine After Needlestick</title>
      <itunes:title>Ebola Vaccine After Needlestick</itunes:title>
      <pubDate>Tue, 24 Mar 2015 14:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[acd738cd78ab61024a125b4b3885f7fe]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.1995]]></link>
      <description><![CDATA[<p>Interview with Mark J. Mulligan, MD, author of Emergency Postexposure Vaccination With Vesicular Stomatitis Virus-Vectored Ebola Vaccine After Needlestick</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Mark J. Mulligan, MD, author of Emergency Postexposure Vaccination With Vesicular Stomatitis Virus-Vectored Ebola Vaccine After Needlestick</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Ebola_Vaccine_After_Needlestick.mp3?dest-id=90171" length="5922647" type="audio/mpeg" />
      <itunes:duration>06:09</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/b/7/9/d/b79d66c8d8ca45f4/150324-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Early Imaging for Back Pain in Older Adults</title>
      <itunes:title>Early Imaging for Back Pain in Older Adults</itunes:title>
      <pubDate>Tue, 17 Mar 2015 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[02a259fcfde6aaecb469ece959bad59a]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.1871]]></link>
      <description><![CDATA[<p>Interview with Jeffrey G. Jarvik, MD, MPH, author of Association of Early Imaging for Back Pain With Clinical Outcomes in Older Adults</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Jeffrey G. Jarvik, MD, MPH, author of Association of Early Imaging for Back Pain With Clinical Outcomes in Older Adults</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Early_Imaging_for_Back_Pain_in_Older_Adults.mp3?dest-id=90171" length="3590844" type="audio/mpeg" />
      <itunes:duration>07:27</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/a/1/6/ea16ff59d7ab6b98/150317-jama-jai-jarvik.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Diagnostic Concordance in Interpreting Breast Biopsies</title>
      <itunes:title>Diagnostic Concordance in Interpreting Breast Biopsies</itunes:title>
      <pubDate>Tue, 17 Mar 2015 14:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[2737612c11efa23468503a8ddf8b905a]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.1405]]></link>
      <description><![CDATA[<p>Interview with Joann G. Elmore, MD, MPH, author of Diagnostic Concordance Among Pathologists Interpreting Breast Biopsy Specimens</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Joann G. Elmore, MD, MPH, author of Diagnostic Concordance Among Pathologists Interpreting Breast Biopsy Specimens</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Diagnostic_Concordance_in_Interpreting_Breast_Biopsies.mp3?dest-id=90171" length="3772967" type="audio/mpeg" />
      <itunes:duration>03:55</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/7/7/a/c77a6d36884a63a1/150317-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Folic Acid for Stroke Prevention in Hypertension</title>
      <itunes:title>Folic Acid for Stroke Prevention in Hypertension</itunes:title>
      <pubDate>Sun, 15 Mar 2015 17:45:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[8be7ad6e7ddb684752cde33898f08d05]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.2274]]></link>
      <description><![CDATA[<p>Interview with Xiaobin Wang, MD, ScD, author of Efficacy of Folic Acid Therapy in Primary Prevention of Stroke Among Adults With Hypertension in China: The CSPPT Randomized Clinical Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Xiaobin Wang, MD, ScD, author of Efficacy of Folic Acid Therapy in Primary Prevention of Stroke Among Adults With Hypertension in China: The CSPPT Randomized Clinical Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Folic_Acid_for_Stroke_Prevention_in_Hypertension.mp3?dest-id=90171" length="4956168" type="audio/mpeg" />
      <itunes:duration>05:09</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/5/f/8/35f8e877bfb94cc3/150315-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Outcomes After Transcatheter Aortic Valve Replacement</title>
      <itunes:title>Outcomes After Transcatheter Aortic Valve Replacement</itunes:title>
      <pubDate>Tue, 10 Mar 2015 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[dbef26fa7b33197332c65385cd01ed37]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.1474]]></link>
      <description><![CDATA[<p>Interview with David R. Holmes Jr, MD, author of Clinical Outcomes at 1 Year Following Transcatheter Aortic Valve Replacement</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with David R. Holmes Jr, MD, author of Clinical Outcomes at 1 Year Following Transcatheter Aortic Valve Replacement</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Outcomes_After_Transcatheter_Aortic_Valve_Replacement.mp3?dest-id=90171" length="3884337" type="audio/mpeg" />
      <itunes:duration>04:02</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/b/b/0/6/bb06a53556a4a802/150310-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Natural History of Benign Thyroid Nodules</title>
      <itunes:title>Natural History of Benign Thyroid Nodules</itunes:title>
      <pubDate>Tue, 03 Mar 2015 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[52dba4b10a31f033175f1cf748b14e42]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.0956]]></link>
      <description><![CDATA[<p>Interview with Sebastiano Filetti, MD, author of The Natural History of Benign Thyroid Nodules</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Sebastiano Filetti, MD, author of The Natural History of Benign Thyroid Nodules</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Natural_History_of_Benign_Thyroid_Nodules.mp3?dest-id=90171" length="3191678" type="audio/mpeg" />
      <itunes:duration>06:37</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/0/0/7/3007a12e54efbf9a/150303-jama-jai-filetti.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Housing Stability Among Homeless Adults With Mental Illness</title>
      <itunes:title>Housing Stability Among Homeless Adults With Mental Illness</itunes:title>
      <pubDate>Tue, 03 Mar 2015 15:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[3cd7d5ca3fe1ea9bdc646ba75cae6ca6]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.1163]]></link>
      <description><![CDATA[<p>Interview with Vicky Stergiopoulos, MD, author of Effect of Scattered-Site Housing Using Rent Supplements and Intensive Case Management on Housing Stability Among Homeless Adults With Mental Illness</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Vicky Stergiopoulos, MD, author of Effect of Scattered-Site Housing Using Rent Supplements and Intensive Case Management on Housing Stability Among Homeless Adults With Mental Illness</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Housing_Stability_Among_Homeless_Adults_With_Mental_Illness.mp3?dest-id=90171" length="3415268" type="audio/mpeg" />
      <itunes:duration>03:33</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/b/0/f/6b0f03c095f396c1/150303-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Genetic Variant and Vincristine Peripheral Neuropathy in ALL</title>
      <itunes:title>Genetic Variant and Vincristine Peripheral Neuropathy in ALL</itunes:title>
      <pubDate>Tue, 24 Feb 2015 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[b2aa3302ed7473cfff5958f5930b65a6]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.0894]]></link>
      <description><![CDATA[<p>Interview with William E. Evans, PharmD, author of Association of an Inherited Genetic Variant With Vincristine-Related Peripheral Neuropathy in Children With Acute Lymphoblastic Leukemia</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with William E. Evans, PharmD, author of Association of an Inherited Genetic Variant With Vincristine-Related Peripheral Neuropathy in Children With Acute Lymphoblastic Leukemia</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Genetic_Variant_and_Vincristine_Peripheral_Neuropathy_in_ALL.mp3?dest-id=90171" length="5156159" type="audio/mpeg" />
      <itunes:duration>05:21</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/a/7/8/0a780975161c6779/150224-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Corticosteroids for Severe Community-Acquired Pneumonia</title>
      <itunes:title>Corticosteroids for Severe Community-Acquired Pneumonia</itunes:title>
      <pubDate>Tue, 17 Feb 2015 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[8076bf3b10ec2eb42eef7c08f287597f]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.88]]></link>
      <description><![CDATA[<p>Interview with Antoni Torres, MD, PhD, author of Effect of Corticosteroids on Treatment Failure Among Hospitalized Patients With Severe Community-Acquired Pneumonia and High Inflammatory Response: A Randomized Clinical Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Antoni Torres, MD, PhD, author of Effect of Corticosteroids on Treatment Failure Among Hospitalized Patients With Severe Community-Acquired Pneumonia and High Inflammatory Response: A Randomized Clinical Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Corticosteroids_for_Severe_Community-Acquired_Pneumonia.mp3?dest-id=90171" length="1774326" type="audio/mpeg" />
      <itunes:duration>03:40</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/7/3/7/c737b7d2b070d2af/150217-jama-jai-torres.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Varenicline for Smoking Cessation Through Smoking Reduction</title>
      <itunes:title>Varenicline for Smoking Cessation Through Smoking Reduction</itunes:title>
      <pubDate>Tue, 17 Feb 2015 15:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[d45a0eb9ba50e8653dab73595405c86d]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.280]]></link>
      <description><![CDATA[<p>Interview with Jon O. Ebbert, MD, MSc, author of Effect of Varenicline on Smoking Cessation Through Smoking Reduction</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Jon O. Ebbert, MD, MSc, author of Effect of Varenicline on Smoking Cessation Through Smoking Reduction</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Varenicline_for_Smoking_Cessation_Through_Smoking_Reduction.mp3?dest-id=90171" length="2464043" type="audio/mpeg" />
      <itunes:duration>02:33</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/b/e/d/3bed1e57f89877a2/150217-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Oral Iron Supplementation After Blood Donation</title>
      <itunes:title>Oral Iron Supplementation After Blood Donation</itunes:title>
      <pubDate>Tue, 10 Feb 2015 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[bfbfa291dc08cf00373c597d1150035e]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.119]]></link>
      <description><![CDATA[<p>Interview with Joseph E. Kiss, MD, author of Oral Iron Supplementation After Blood Donation</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Joseph E. Kiss, MD, author of Oral Iron Supplementation After Blood Donation</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Oral_Iron_Supplementation_After_Blood_Donation.mp3?dest-id=90171" length="5501055" type="audio/mpeg" />
      <itunes:duration>05:43</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/4/a/d/4/4ad4295fdbc82985/150210-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Measuring Surgical Outcomes</title>
      <itunes:title>Measuring Surgical Outcomes</itunes:title>
      <pubDate>Tue, 03 Feb 2015 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[c6100520cb8ae90c854368b98158f086]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2015.4]]></link>
      <description><![CDATA[<p>Interview with Donald M. Berwick, MD, MPP, author of Measuring Surgical Outcomes for Improvement: Was Codman Wrong?</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Donald M. Berwick, MD, MPP, author of Measuring Surgical Outcomes for Improvement: Was Codman Wrong?</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Measuring_Surgical_Outcomes.mp3?dest-id=90171" length="4239759" type="audio/mpeg" />
      <itunes:duration>08:48</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/9/3/c/093ca2e19904d11f/150203-jama-jai-berwick.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Reasons Associated With Readmission After Surgery</title>
      <itunes:title>Reasons Associated With Readmission After Surgery</itunes:title>
      <pubDate>Tue, 03 Feb 2015 15:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[a3e0ead0034ad2e3e643e7ec7f86339a]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.18614]]></link>
      <description><![CDATA[<p>Interview with Karl Y. Bilimoria, MD, MS, author of Underlying Reasons Associated With Hospital Readmission Following Surgery in the United States</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Karl Y. Bilimoria, MD, MS, author of Underlying Reasons Associated With Hospital Readmission Following Surgery in the United States</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Reasons_Associated_With_Readmission_After_Surgery.mp3?dest-id=90171" length="3000480" type="audio/mpeg" />
      <itunes:duration>03:07</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/5/1/2/0/512084b5e3a96ba4/150203-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>MR/Ultrasound Fusion Biopsy for Prostate Cancer</title>
      <itunes:title>MR/Ultrasound Fusion Biopsy for Prostate Cancer</itunes:title>
      <pubDate>Tue, 27 Jan 2015 16:11:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[97281a716c3ee1de8effab5af7979d0b]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.17942]]></link>
      <description><![CDATA[<p>Interview with Peter A. Pinto, MD, author of Comparison of MR/Ultrasound Fusion-Guided Biopsy With Ultrasound-Guided Biopsy for the Diagnosis of Prostate Cancer</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Peter A. Pinto, MD, author of Comparison of MR/Ultrasound Fusion-Guided Biopsy With Ultrasound-Guided Biopsy for the Diagnosis of Prostate Cancer</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/MR_Ultrasound_Fusion_Biopsy_for_Prostate_Cancer.mp3?dest-id=90171" length="3478936" type="audio/mpeg" />
      <itunes:duration>03:37</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/7/7/5/b/775b50d4bc920066/150127-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Hematopoietic Stem Cell Transplantation for Multiple Sclerosis</title>
      <itunes:title>Hematopoietic Stem Cell Transplantation for Multiple Sclerosis</itunes:title>
      <pubDate>Tue, 20 Jan 2015 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[cd7257b2dab4d8e9be44f94116daa081]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.17986]]></link>
      <description><![CDATA[<p>Interview with Richard K. Burt, MD, author of Association of Nonmyeloablative Hematopoietic Stem Cell Transplantation With Neurological Disability in Patients With Relapsing-Remitting Multiple Sclerosis</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Richard K. Burt, MD, author of Association of Nonmyeloablative Hematopoietic Stem Cell Transplantation With Neurological Disability in Patients With Relapsing-Remitting Multiple Sclerosis</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Hematopoietic_Stem_Cell_Transplantation_for_Multiple_Sclerosis.mp3?dest-id=90171" length="6693678" type="audio/mpeg" />
      <itunes:duration>13:55</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/f/4/d/0/f4d009456899522a/150120-jama-jai-burt.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Trends and Outcomes of Intracytoplasmic Sperm Injection</title>
      <itunes:title>Trends and Outcomes of Intracytoplasmic Sperm Injection</itunes:title>
      <pubDate>Tue, 20 Jan 2015 15:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[a1cf91f6fef9866b69b12149bfadb37c]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.17985]]></link>
      <description><![CDATA[<p>Interview with Sheree L. Boulet, DrPH, MPH, author of Trends in Use of and Reproductive Outcomes Associated With Intracytoplasmic Sperm Injection</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Sheree L. Boulet, DrPH, MPH, author of Trends in Use of and Reproductive Outcomes Associated With Intracytoplasmic Sperm Injection</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Trends_and_Outcomes_of_Intracytoplasmic_Sperm_Injection.mp3?dest-id=90171" length="4138194" type="audio/mpeg" />
      <itunes:duration>04:18</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/5/7/0/f/570fce43900c5509/150120-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Breast Cancer Stage at Diagnosis and Survival</title>
      <itunes:title>Breast Cancer Stage at Diagnosis and Survival</itunes:title>
      <pubDate>Tue, 13 Jan 2015 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[3cd4baee7b8e0d5871cf2ac43ac89bf2]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.17322]]></link>
      <description><![CDATA[<p>Interview with Steven A. Narod, MD, FRCPC, author of Differences in Breast Cancer Stage at Diagnosis and Cancer-Specific Survival by Race and Ethnicity in the United States</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Steven A. Narod, MD, FRCPC, author of Differences in Breast Cancer Stage at Diagnosis and Cancer-Specific Survival by Race and Ethnicity in the United States</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Breast_Cancer_Stage_at_Diagnosis_and_Survival.mp3?dest-id=90171" length="4516146" type="audio/mpeg" />
      <itunes:duration>04:41</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/d/5/3/0d53fe9f1dcf5df0/150113-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Association Between Bariatric Surgery and Long-term Survival</title>
      <itunes:title>Association Between Bariatric Surgery and Long-term Survival</itunes:title>
      <pubDate>Tue, 06 Jan 2015 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[7b33956cd82fb96d50f3886f1df77289]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.16968]]></link>
      <description><![CDATA[<p>Interview with David E. Arterburn, MD, MPH and Matthew L. Maciejewski, PhD, authors of Association Between Bariatric Surgery and Long-term Survival</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with David E. Arterburn, MD, MPH and Matthew L. Maciejewski, PhD, authors of Association Between Bariatric Surgery and Long-term Survival</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Association_Between_Bariatric_Surgery_and_Long-term_Survival.mp3?dest-id=90171" length="3194983" type="audio/mpeg" />
      <itunes:duration>06:38</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/6/c/3/c6c37c4795645b8f/150105-jama-jai-arterburn.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Treatment of Diabetes and Long-term Mortality</title>
      <itunes:title>Treatment of Diabetes and Long-term Mortality</itunes:title>
      <pubDate>Tue, 06 Jan 2015 15:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[5a9859975bef67388c96dccbd6b130a2]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.16107]]></link>
      <description><![CDATA[<p>Interview with David M. Nathan, MD, author of Association Between 7 Years of Intensive Treatment of Type 1 Diabetes and Long-term Mortality</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with David M. Nathan, MD, author of Association Between 7 Years of Intensive Treatment of Type 1 Diabetes and Long-term Mortality</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Treatment_of_Diabetes_and_Long-term_Mortality.mp3?dest-id=90171" length="4264568" type="audio/mpeg" />
      <itunes:duration>04:25</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/5/b/b/e/5bbeb8e8d5bd153a/150106-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Effect of Depth and Duration of Cooling on Neonates With HIE</title>
      <itunes:title>Effect of Depth and Duration of Cooling on Neonates With HIE</itunes:title>
      <pubDate>Tue, 23 Dec 2014 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[dfebe783f95b26cf5d70fa964a462ae2]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.16058]]></link>
      <description><![CDATA[<p>Interview with Seetha Shankaran, MD, author of Effect of Depth and Duration of Cooling on Deaths in the NICU Among Neonates With Hypoxic Ischemic Encephalopathy: A Randomized Clinical Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Seetha Shankaran, MD, author of Effect of Depth and Duration of Cooling on Deaths in the NICU Among Neonates With Hypoxic Ischemic Encephalopathy: A Randomized Clinical Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Effect_of_Depth_and_Duration_of_Cooling_on_Neonates_With_HIE.mp3?dest-id=90171" length="5593864" type="audio/mpeg" />
      <itunes:duration>11:37</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/8/9/a/189a38c3d76c0d2f/141223-jama-jai-shankaran.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>High-Risk Children With Chronic Illness</title>
      <itunes:title>High-Risk Children With Chronic Illness</itunes:title>
      <pubDate>Tue, 23 Dec 2014 20:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[01fbe2ff0925428fe7c47e89672fc913]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.16419]]></link>
      <description><![CDATA[<p>Interview with Ricardo A. Mosquera, MD, author of Effect of an Enhanced Medical Home on Serious Illness and Cost of Care Among High-Risk Children With Chronic Illness</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Ricardo A. Mosquera, MD, author of Effect of an Enhanced Medical Home on Serious Illness and Cost of Care Among High-Risk Children With Chronic Illness</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/High-Risk_Children_With_Chronic_Illness.mp3?dest-id=90171" length="1980584" type="audio/mpeg" />
      <itunes:duration>02:03</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/7/6/5/2/7652bb66b3dcc216/141223-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Interview with Dr Aiah A. Gbakima</title>
      <itunes:title>Interview with Dr Aiah A. Gbakima</itunes:title>
      <pubDate>Tue, 23 Dec 2014 20:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[22d816d4529fb96e09630e6ac2a8b879]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.13382]]></link>
      <description><![CDATA[<p>Dr Aiah A. Gbakima, editor in chief of the <em>Sierra Leone Journal of Biomedical Research,</em> talks about confronting the Ebola outbreak in Sierra Leone (originally posted on 10-2-2014).</p>]]></description>
      
      <content:encoded><![CDATA[<p>Dr Aiah A. Gbakima, editor in chief of the <em>Sierra Leone Journal of Biomedical Research,</em> talks about confronting the Ebola outbreak in Sierra Leone (originally posted on 10-2-2014).</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-10-02_Interview_with_Dr_Aiah_A._Gbakima.mp3?dest-id=90171" length="5537766" type="audio/mpeg" />
      <itunes:duration>11:30</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/b/2/5/eb251ac61d78896a/140923-special-gbakima.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Interview with Tom Frieden, MD, MPH</title>
      <itunes:title>Interview with Tom Frieden, MD, MPH</itunes:title>
      <pubDate>Tue, 23 Dec 2014 20:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[945ae044e6f9cdfcc0dc86c92e697d11]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.13382]]></link>
      <description><![CDATA[<p>Tom Frieden, MD, MPH, Director, Centers for Disease Control and Prevention, talks with Howard Bauchner, MD, Editor in Chief of JAMA, about the Ebola crisis and the CDC's response (originally posted on 10-23-2014).</p>]]></description>
      
      <content:encoded><![CDATA[<p>Tom Frieden, MD, MPH, Director, Centers for Disease Control and Prevention, talks with Howard Bauchner, MD, Editor in Chief of JAMA, about the Ebola crisis and the CDC's response (originally posted on 10-23-2014).</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-10-23_Interview_with_Tom_Frieden_MD_MPH.mp3?dest-id=90171" length="5660503" type="audio/mpeg" />
      <itunes:duration>11:46</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/d/1/d/e/d1de85b17a01493f/141022-jama-jai-frieden.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Glycemic Index, Cardiovascular Disease, and Insulin Sensitivity</title>
      <itunes:title>Glycemic Index, Cardiovascular Disease, and Insulin Sensitivity</itunes:title>
      <pubDate>Tue, 16 Dec 2014 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[95b5b94ab0036940e62fe69ecf7d25a7]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.16658]]></link>
      <description><![CDATA[<p>Interview with Frank M. Sacks, MD, author of Effects of High vs Low Glycemic Index of Dietary Carbohydrate on Cardiovascular Disease Risk Factors and Insulin Sensitivity</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Frank M. Sacks, MD, author of Effects of High vs Low Glycemic Index of Dietary Carbohydrate on Cardiovascular Disease Risk Factors and Insulin Sensitivity</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Glycemic_Index_Cardiovascular_Disease_and_Insulin_Sensitivity.mp3?dest-id=90171" length="2493594" type="audio/mpeg" />
      <itunes:duration>02:35</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/2/8/5/0285a5758c308335/141216-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Imposition of a MOC Requirement and Outcomes of Care</title>
      <itunes:title>Imposition of a MOC Requirement and Outcomes of Care</itunes:title>
      <pubDate>Tue, 09 Dec 2014 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[85595ea16c3bd0b45d90459dbfacb9c8]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.12716]]></link>
      <description><![CDATA[<p>Interview with Bradley M. Gray, PhD, author of Association Between Imposition of a Maintenance of Certification Requirement and Ambulatory Care-Sensitive Hospitalizations and Health Care Costs</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Bradley M. Gray, PhD, author of Association Between Imposition of a Maintenance of Certification Requirement and Ambulatory Care-Sensitive Hospitalizations and Health Care Costs</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Imposition_of_a_MOC_Requirement_and_Outcomes_of_Care.mp3?dest-id=90171" length="4076840" type="audio/mpeg" />
      <itunes:duration>08:28</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/2/1/f/921fc0b616840d02/141209-jama-jai-gray.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Resident Duty Hour Reforms and Patient Outcomes</title>
      <itunes:title>Resident Duty Hour Reforms and Patient Outcomes</itunes:title>
      <pubDate>Tue, 09 Dec 2014 20:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[3180ab55043eead32f072cb1da785779]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.15273]]></link>
      <description><![CDATA[<p>Interview with Mitesh S. Patel, MD, MBA, MS, author of Association of the 2011 ACGME Resident Duty Hour Reforms With Mortality and Readmissions Among Hospitalized Medicare Patients</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Mitesh S. Patel, MD, MBA, MS, author of Association of the 2011 ACGME Resident Duty Hour Reforms With Mortality and Readmissions Among Hospitalized Medicare Patients</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Resident_Duty_Hour_Reforms_and_Patient_Outcomes.mp3?dest-id=90171" length="3317619" type="audio/mpeg" />
      <itunes:duration>03:27</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/5/2/b/c52bb8ebb34c3b77/141209-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>CAD Screening in Patients With Diabetes Mellitus</title>
      <itunes:title>CAD Screening in Patients With Diabetes Mellitus</itunes:title>
      <pubDate>Tue, 02 Dec 2014 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[c707583e88fc3bb0065f667693c4b99a]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.15825]]></link>
      <description><![CDATA[<p>Interview with Joseph B. Muhlestein, MD, author of Effect of Screening for Coronary Artery Disease Using CT Angiography on Mortality and Cardiac Events in High-Risk Patients With Diabetes</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Joseph B. Muhlestein, MD, author of Effect of Screening for Coronary Artery Disease Using CT Angiography on Mortality and Cardiac Events in High-Risk Patients With Diabetes</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/CAD_Screening_in_Patients_With_Diabetes_Mellitus.mp3?dest-id=90171" length="3471801" type="audio/mpeg" />
      <itunes:duration>03:36</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/b/0/1/7/b017cc7b50725d3a/141202-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Medical Liability and Reform</title>
      <itunes:title>Medical Liability and Reform</itunes:title>
      <pubDate>Tue, 25 Nov 2014 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[8d31cce1059bdf498d16689869c86977]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.10705]]></link>
      <description><![CDATA[<p>Interview with Michelle M. Mello, JD, PhD, MPhil, author of The Medical Liability Climate and Prospects for Reform</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Michelle M. Mello, JD, PhD, MPhil, author of The Medical Liability Climate and Prospects for Reform</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Medical_Liability_and_Reform.mp3?dest-id=90171" length="4589065" type="audio/mpeg" />
      <itunes:duration>09:32</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/c/8/9/2c89eaa7cb85ff1e/141125-jama-jai-mello.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Preschool Full or Half Days and School Readiness</title>
      <itunes:title>Preschool Full or Half Days and School Readiness</itunes:title>
      <pubDate>Tue, 25 Nov 2014 20:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[9ce58761aa29b1aa90ec2962fb072def]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.15376]]></link>
      <description><![CDATA[<p>Interview with Arthur J. Reynolds, PhD, author of Association of a Full-Day vs Part-Day Preschool Intervention With School Readiness, Attendance, and Parent Involvement</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Arthur J. Reynolds, PhD, author of Association of a Full-Day vs Part-Day Preschool Intervention With School Readiness, Attendance, and Parent Involvement</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Preschool_Full_or_Half_Days_and_School_Readiness.mp3?dest-id=90171" length="3799476" type="audio/mpeg" />
      <itunes:duration>03:57</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/0/5/e/905e3f524286eb84/141125-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Vascular Closure Devices vs Manual Compression</title>
      <itunes:title>Vascular Closure Devices vs Manual Compression</itunes:title>
      <pubDate>Sun, 16 Nov 2014 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[84c79a21724e69a66e399b8544d8b4fa]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.15305]]></link>
      <description><![CDATA[<p>Interview with Stefanie Schulz-Schüpke, MD, author of Comparison of Vascular Closure Devices vs Manual Compression After Femoral Artery Puncture: The ISAR-CLOSURE Randomized Clinical Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Stefanie Schulz-Schüpke, MD, author of Comparison of Vascular Closure Devices vs Manual Compression After Femoral Artery Puncture: The ISAR-CLOSURE Randomized Clinical Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Vascular_Closure_Devices_vs_Manual_Compression.mp3?dest-id=90171" length="3919645" type="audio/mpeg" />
      <itunes:duration>08:08</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/3/2/7/9327105494a5803c/141118-jama-jai-schulz.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Inpatient STEMI and Treatment and Clinical Outcomes</title>
      <itunes:title>Inpatient STEMI and Treatment and Clinical Outcomes</itunes:title>
      <pubDate>Sun, 16 Nov 2014 15:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[fa04d89da96aa7e9628f6cd41ca6f19f]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.15236]]></link>
      <description><![CDATA[<p>Interview with George A. Stouffer, MD, author of Association of Inpatient vs Outpatient Onset of ST-Elevation Myocardial Infarction With Treatment and Clinical Outcomes</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with George A. Stouffer, MD, author of Association of Inpatient vs Outpatient Onset of ST-Elevation Myocardial Infarction With Treatment and Clinical Outcomes</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Inpatient_STEMI_and_Treatment_and_Clinical_Outcomes.mp3?dest-id=90171" length="3284577" type="audio/mpeg" />
      <itunes:duration>03:25</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/c/3/3/0c33557da75caec5/141116-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Medicare Hospice Benefit and Poor-Prognosis Cancer</title>
      <itunes:title>Medicare Hospice Benefit and Poor-Prognosis Cancer</itunes:title>
      <pubDate>Tue, 11 Nov 2014 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[9e0c11598f550dc9bbdb42738b2ed2af]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.14950]]></link>
      <description><![CDATA[<p>Interview with Ziad Obermeyer, MD, MPhil, author of Association Between the Medicare Hospice Benefit and Health Care Utilization and Costs for Patients With Poor-Prognosis Cancer</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Ziad Obermeyer, MD, MPhil, author of Association Between the Medicare Hospice Benefit and Health Care Utilization and Costs for Patients With Poor-Prognosis Cancer</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Medicare_Hospice_Benefit_and_Poor-Prognosis_Cancer.mp3?dest-id=90171" length="4671682" type="audio/mpeg" />
      <itunes:duration>04:52</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/4/b/5/4/4b54c200ffae95ee/141111-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Frozen Fecal Microbiota for C difficile Infection</title>
      <itunes:title>Frozen Fecal Microbiota for C difficile Infection</itunes:title>
      <pubDate>Tue, 04 Nov 2014 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[08ce00223efa314ec1910d89e38d69f4]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.13875]]></link>
      <description><![CDATA[<p>Interview with Ilan Youngster, MD, MMSc, author of Oral, Capsulized, Frozen Fecal Microbiota Transplantation for Relapsing <em>Clostridium difficile</em> Infection</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Ilan Youngster, MD, MMSc, author of Oral, Capsulized, Frozen Fecal Microbiota Transplantation for Relapsing <em>Clostridium difficile</em> Infection</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Frozen_Fecal_Microbiota_for_C_difficile_Infection.mp3?dest-id=90171" length="3279952" type="audio/mpeg" />
      <itunes:duration>06:48</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/d/8/6/4/d86468214308c621/141104-jama-jai-youngster.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Nonobstructive Coronary Artery Disease and MI</title>
      <itunes:title>Nonobstructive Coronary Artery Disease and MI</itunes:title>
      <pubDate>Tue, 04 Nov 2014 20:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[5cc4adcda0b27a00f3c64d135d66f05a]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.14681]]></link>
      <description><![CDATA[<p>Interview with Thomas M. Maddox, MD, MSc, author of Nonobstructive Coronary Artery Disease and Risk of Myocardial Infarction</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Thomas M. Maddox, MD, MSc, author of Nonobstructive Coronary Artery Disease and Risk of Myocardial Infarction</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/Nonobstructive_Coronary_Artery_Disease_and_MI.mp3?dest-id=90171" length="3091254" type="audio/mpeg" />
      <itunes:duration>03:13</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/e/b/7/aeb7f401becee630/141104-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>For-Profit Status and Clinical and Economic Outcomes</title>
      <itunes:title>For-Profit Status and Clinical and Economic Outcomes</itunes:title>
      <pubDate>Tue, 21 Oct 2014 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[1a291e657ebdd41c0feb1c070112c67f]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.13336]]></link>
      <description><![CDATA[<p>Interview with Ashish K. Jha, MD, MPH, author of Association Between Hospital Conversions to For-Profit Status and Clinical and Economic Outcomes</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Ashish K. Jha, MD, MPH, author of Association Between Hospital Conversions to For-Profit Status and Clinical and Economic Outcomes</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/For-Profit_Status_and_Clinical_and_Economic_Outcomes.mp3?dest-id=90171" length="3498635" type="audio/mpeg" />
      <itunes:duration>03:38</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/5/c/7/e5c7380d51ee07ce/141021-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Climate Change and Global Health Challenges</title>
      <itunes:title>Climate Change and Global Health Challenges</itunes:title>
      <pubDate>Tue, 14 Oct 2014 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[494b93df3a63ed123c448c9f2d187862]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.13186]]></link>
      <description><![CDATA[<p>Interview with Jonathan A. Patz, MD, MPH, author of Climate Change: Challenges and Opportunities for Global Health</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Jonathan A. Patz, MD, MPH, author of Climate Change: Challenges and Opportunities for Global Health</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-10-14_Vol._312_No._15_Author_Interview.mp3?dest-id=90171" length="4600969" type="audio/mpeg" />
      <itunes:duration>09:33</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/d/b/6/0db6c7fe15291e2b/141015-jai-jama-patz.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Obstetric Quality Indicators and Morbidity</title>
      <itunes:title>Obstetric Quality Indicators and Morbidity</itunes:title>
      <pubDate>Tue, 14 Oct 2014 19:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[913f3bc7346ccf604a182728e8488e25]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.13381]]></link>
      <description><![CDATA[<p>Interview with Elizabeth A Howell, MD, MPP, author of Durability of Benefits of an Outpatient Antimicrobial Stewardship Intervention After Discontinuation of Audit and Feedback</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Elizabeth A Howell, MD, MPP, author of Durability of Benefits of an Outpatient Antimicrobial Stewardship Intervention After Discontinuation of Audit and Feedback</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-10-14_Vol._312_No._15_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="4374365" type="audio/mpeg" />
      <itunes:duration>04:33</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/0/5/2/00526a3462bc9315/141014-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Prevalence of Antimicrobial Use in US Acute Care Hospitals, May-September 2011</title>
      <itunes:title>Prevalence of Antimicrobial Use in US Acute Care Hospitals, May-September 2011</itunes:title>
      <pubDate>Tue, 07 Oct 2014 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[65d4f08a7b723d6d412942002f242f47]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.12923]]></link>
      <description><![CDATA[<p>Interview with Shelley S. Magill, MD, PhD, author of Prevalence of Antimicrobial Use in US Acute Care Hospitals, May-September 2011</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Shelley S. Magill, MD, PhD, author of Prevalence of Antimicrobial Use in US Acute Care Hospitals, May-September 2011</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-10-07_Vol._312_No._14_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="5225670" type="audio/mpeg" />
      <itunes:duration>05:26</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/d/d/9/b/dd9be67da53a6619/141007-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Acupuncture for Chronic Knee Pain: A Randomized Clinical Trial</title>
      <itunes:title>Acupuncture for Chronic Knee Pain: A Randomized Clinical Trial</itunes:title>
      <pubDate>Tue, 30 Sep 2014 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[a819dc2ee1563f1696b0be9eb896463f]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.12660]]></link>
      <description><![CDATA[<p>Interview with Kim L. Bennell, PhD, author of Acupuncture for Chronic Knee Pain: A Randomized Clinical Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Kim L. Bennell, PhD, author of Acupuncture for Chronic Knee Pain: A Randomized Clinical Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-09-30_Vol._312_No._13_Author_Interview.mp3?dest-id=90171" length="3092226" type="audio/mpeg" />
      <itunes:duration>06:25</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/a/9/d/ca9d8fb9c2c4a3f8/140930-jama-jai-bennell.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Effect of a Postdischarge Virtual Ward on Readmission or Death for High-Risk Patients</title>
      <itunes:title>Effect of a Postdischarge Virtual Ward on Readmission or Death for High-Risk Patients</itunes:title>
      <pubDate>Tue, 30 Sep 2014 19:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[24715c1deb329426548e42cd102bdeb5]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.11492]]></link>
      <description><![CDATA[<p>Interview with Irfan A. Dhalla, MD, MSc, author of Effect of a Postdischarge Virtual Ward on Readmission or Death for High-Risk Patients</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Irfan A. Dhalla, MD, MSc, author of Effect of a Postdischarge Virtual Ward on Readmission or Death for High-Risk Patients</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-09-30_Vol._312_No._13_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="3434253" type="audio/mpeg" />
      <itunes:duration>03:34</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/8/7/a/c87a59a967236a16/140930-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Effect of Enhanced Information, Values Clarification, and Removal of Financial Barriers on Use of Prenatal Genetic Testing</title>
      <itunes:title>Effect of Enhanced Information, Values Clarification, and Removal of Financial Barriers on Use of Prenatal Genetic Testing</itunes:title>
      <pubDate>Tue, 23 Sep 2014 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[e886d4c375f371734dd352884d746a36]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.11479]]></link>
      <description><![CDATA[<p>Interview with Miriam Kuppermann, PhD, MPH, author of Effect of Enhanced Information, Values Clarification, and Removal of Financial Barriers on Use of Prenatal Genetic Testing</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Miriam Kuppermann, PhD, MPH, author of Effect of Enhanced Information, Values Clarification, and Removal of Financial Barriers on Use of Prenatal Genetic Testing</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-09-23_Vol._312_No._12_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="3929332" type="audio/mpeg" />
      <itunes:duration>04:05</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/7/3/0/373076898d61eabd/140923-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Clinical and Safety Outcomes Associated With Treatment of Acute Venous Thromboembolism: A Systematic Review and Meta-analysis</title>
      <itunes:title>Clinical and Safety Outcomes Associated With Treatment of Acute Venous Thromboembolism: A Systematic Review and Meta-analysis</itunes:title>
      <pubDate>Tue, 16 Sep 2014 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[0609dc21bad3dfa8407c4f67d4e7081b]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.10538]]></link>
      <description><![CDATA[<p>Interview with Marc Carrier, MD, MSc, author of Clinical and Safety Outcomes Associated With Treatment of Acute Venous Thromboembolism: A Systematic Review and Meta-analysis</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Marc Carrier, MD, MSc, author of Clinical and Safety Outcomes Associated With Treatment of Acute Venous Thromboembolism: A Systematic Review and Meta-analysis</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-09-16_Vol._312_No._11_Author_Interview.mp3?dest-id=90171" length="2155790" type="audio/mpeg" />
      <itunes:duration>04:28</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/5/d/c/85dc685cec7cbe71/140916-jama-jai-carrier.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Combination Long-Acting β-Agonists and Inhaled Corticosteroids Compared With Long-Acting β-Agonists Alone in Older Adults With Chronic Obstructive Pulmonary Disease</title>
      <itunes:title>Combination Long-Acting β-Agonists and Inhaled Corticosteroids Compared With Long-Acting β-Agonists Alone in Older Adults With Chronic Obstructive Pulmonary Disease</itunes:title>
      <pubDate>Tue, 16 Sep 2014 19:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[fd8376d8b26be66a08717c7c87d41bd1]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.11432]]></link>
      <description><![CDATA[<p>Interview with Andrea S. Gershon, MD, MSc, author of Combination Long-Acting β-Agonists and Inhaled Corticosteroids Compared With Long-Acting β-Agonists Alone in Older Adults With Chronic Obstructive Pulmonary Disease</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Andrea S. Gershon, MD, MSc, author of Combination Long-Acting β-Agonists and Inhaled Corticosteroids Compared With Long-Acting β-Agonists Alone in Older Adults With Chronic Obstructive Pulmonary Disease</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-09-16_Vol._312_No._11_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="3746089" type="audio/mpeg" />
      <itunes:duration>03:53</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/6/8/4/a684e3d7db8e0390/140916-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Management of Sickle Cell Disease</title>
      <itunes:title>Management of Sickle Cell Disease</itunes:title>
      <pubDate>Tue, 09 Sep 2014 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[bfc038409d2daf7a0419c2a899109056]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.10517]]></link>
      <description><![CDATA[<p>Interview with George R. Buchanan, MD, author of Management of Sickle Cell Disease</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with George R. Buchanan, MD, author of Management of Sickle Cell Disease</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-09-09_Vol._312_No._10_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="3885298" type="audio/mpeg" />
      <itunes:duration>04:02</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/c/0/7/0c07534cfc91805a/140909-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Comparison of Weight Loss Among Named Diet Programs in Overweight and Obese Adults: A Meta-analysis</title>
      <itunes:title>Comparison of Weight Loss Among Named Diet Programs in Overweight and Obese Adults: A Meta-analysis</itunes:title>
      <pubDate>Tue, 02 Sep 2014 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[ace0fc02cf1055ed49ee1ea214861c28]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.10397]]></link>
      <description><![CDATA[<p>Interview with Bradley C. Johnston, PhD, author of Comparison of Weight Loss Among Named Diet Programs in Overweight and Obese Adults: A Meta-analysis</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Bradley C. Johnston, PhD, author of Comparison of Weight Loss Among Named Diet Programs in Overweight and Obese Adults: A Meta-analysis</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-09-02_Vol._312_No._9_Author_Interview.mp3?dest-id=90171" length="4445278" type="audio/mpeg" />
      <itunes:duration>09:14</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/5/a/0/4/5a0414594390897c/140902-jama-jai-johnston.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Use of and Mortality After Bilateral Mastectomy Compared With Other Surgical Treatments for Breast Cancer in California, 1998-2011</title>
      <itunes:title>Use of and Mortality After Bilateral Mastectomy Compared With Other Surgical Treatments for Breast Cancer in California, 1998-2011</itunes:title>
      <pubDate>Tue, 02 Sep 2014 19:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[585b5c6c3715eb73cd352bdca922accd]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.10707]]></link>
      <description><![CDATA[<p>Interview with Allison W. Kurian, MD, MSc, author of Use of and Mortality After Bilateral Mastectomy Compared With Other Surgical Treatments for Breast Cancer in California, 1998-2011</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Allison W. Kurian, MD, MSc, author of Use of and Mortality After Bilateral Mastectomy Compared With Other Surgical Treatments for Breast Cancer in California, 1998-2011</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-09-02_Vol._312_No._9_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="3613292" type="audio/mpeg" />
      <itunes:duration>03:45</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/4/4/b/244b47eb34112be0/140902-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Collaborative Care for Adolescents With Depression in Primary Care</title>
      <itunes:title>Collaborative Care for Adolescents With Depression in Primary Care</itunes:title>
      <pubDate>Tue, 26 Aug 2014 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[2dd24e77930def62c2464f8e5f39ff3f]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.9259]]></link>
      <description><![CDATA[<p>Interview with Laura P. Richardson, MD, MPH, author of Collaborative Care for Adolescents With Depression in Primary Care</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Laura P. Richardson, MD, MPH, author of Collaborative Care for Adolescents With Depression in Primary Care</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-08-26_Vol._312_No._8_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="4551409" type="audio/mpeg" />
      <itunes:duration>04:44</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/d/a/a/9daa5a06e648b57d/140826-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Effect of Providing Conditional Economic Compensation on Uptake of Voluntary Medical Male Circumcision in Kenya: A Randomized Clinical Trial</title>
      <itunes:title>Effect of Providing Conditional Economic Compensation on Uptake of Voluntary Medical Male Circumcision in Kenya: A Randomized Clinical Trial</itunes:title>
      <pubDate>Tue, 19 Aug 2014 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[3746314546219a966f5493608f390c3f]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.9087]]></link>
      <description><![CDATA[<p>Interview with Harsha Thirumurthy, PhD, author of Effect of Providing Conditional Economic Compensation on Uptake of Voluntary Medical Male Circumcision in Kenya: A Randomized Clinical Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Harsha Thirumurthy, PhD, author of Effect of Providing Conditional Economic Compensation on Uptake of Voluntary Medical Male Circumcision in Kenya: A Randomized Clinical Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-08-19_Vol._312_No._7_Author_Interview.mp3?dest-id=90171" length="4909222" type="audio/mpeg" />
      <itunes:duration>10:12</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/f/8/a/7/f8a7632a416cef6d/140819-jama-jai-thirumurthy.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Sustained Care Intervention and Postdischarge Smoking Cessation Among Hospitalized Adults</title>
      <itunes:title>Sustained Care Intervention and Postdischarge Smoking Cessation Among Hospitalized Adults</itunes:title>
      <pubDate>Tue, 19 Aug 2014 19:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[86c2e16c5e4e3c5c30a316a54ba85115]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.9237]]></link>
      <description><![CDATA[<p>Interview with Nancy A. Rigotti, MD, author of Sustained Care Intervention and Postdischarge Smoking Cessation Among Hospitalized Adults</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Nancy A. Rigotti, MD, author of Sustained Care Intervention and Postdischarge Smoking Cessation Among Hospitalized Adults</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-08-19_Vol._312_No._7_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="3611954" type="audio/mpeg" />
      <itunes:duration>03:45</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/a/b/b/8abb200b444fa1f1/140819-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Perioperative Atrial Fibrillation and the Long-term Risk of Ischemic Stroke</title>
      <itunes:title>Perioperative Atrial Fibrillation and the Long-term Risk of Ischemic Stroke</itunes:title>
      <pubDate>Tue, 12 Aug 2014 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[3b78304e8f4e83640dce786d9aef488a]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.9143]]></link>
      <description><![CDATA[<p>Interview with Hooman Kamel, MD, author of Perioperative Atrial Fibrillation and the Long-term Risk of Ischemic Stroke</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Hooman Kamel, MD, author of Perioperative Atrial Fibrillation and the Long-term Risk of Ischemic Stroke</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-08-12_Vol._312_No._6_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="3209953" type="audio/mpeg" />
      <itunes:duration>03:20</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/c/f/e/6cfeb8c2d1ea60ac/140812-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Does This Man With Lower Urinary Tract Symptoms Have Bladder Outlet Obstruction? The Rational Clinical Examination: A Systematic Review</title>
      <itunes:title>Does This Man With Lower Urinary Tract Symptoms Have Bladder Outlet Obstruction? The Rational Clinical Examination: A Systematic Review</itunes:title>
      <pubDate>Tue, 05 Aug 2014 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[e80079b7192c3224ead0fc6f08e42067]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.5555]]></link>
      <description><![CDATA[<p>Interview with Karen A. D'Silva, MD, MS, author of Does This Man With Lower Urinary Tract Symptoms Have Bladder Outlet Obstruction? The Rational Clinical Examination: A Systematic Review</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Karen A. D'Silva, MD, MS, author of Does This Man With Lower Urinary Tract Symptoms Have Bladder Outlet Obstruction? The Rational Clinical Examination: A Systematic Review</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-08-05_Vol._312_No._5_Author_Interview.mp3?dest-id=90171" length="4434803" type="audio/mpeg" />
      <itunes:duration>09:13</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/2/b/6/02b67b528801d865/140805-jama-jai-dsilva.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Screening and Brief Intervention for Drug Use in Primary Care</title>
      <itunes:title>Screening and Brief Intervention for Drug Use in Primary Care</itunes:title>
      <pubDate>Tue, 05 Aug 2014 19:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[382c4ef4491a17188368a4db0ac8f5ad]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.7862]]></link>
      <description><![CDATA[<p>Interview with Richard Saitz, MD, MPH, author of Screening and Brief Intervention for Drug Use in Primary Care</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Richard Saitz, MD, MPH, author of Screening and Brief Intervention for Drug Use in Primary Care</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-08-05_Vol._312_No._5_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="3501490" type="audio/mpeg" />
      <itunes:duration>03:38</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/4/5/9/a/459a1700c300fc05/140805-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Sofosbuvir and Ribavirin for Hepatitis C in Patients With HIV Coinfection</title>
      <itunes:title>Sofosbuvir and Ribavirin for Hepatitis C in Patients With HIV Coinfection</itunes:title>
      <pubDate>Sat, 19 Jul 2014 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[a4993584f22bbec33d19aeb95e8066c7]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.7734]]></link>
      <description><![CDATA[<p>Interview with Mark S. Sulkowski, MD, author of Sofosbuvir and Ribavirin for Hepatitis C in Patients With HIV Coinfection</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Mark S. Sulkowski, MD, author of Sofosbuvir and Ribavirin for Hepatitis C in Patients With HIV Coinfection</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-07-19_Vol._312_No._4_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="5125298" type="audio/mpeg" />
      <itunes:duration>05:20</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/f/2/4/7/f247382dd0359a41/140719-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Time Elapsed After Ischemic Stroke and Risk of Adverse Cardiovascular Events and Mortality Following Elective Noncardiac Surgery</title>
      <itunes:title>Time Elapsed After Ischemic Stroke and Risk of Adverse Cardiovascular Events and Mortality Following Elective Noncardiac Surgery</itunes:title>
      <pubDate>Tue, 15 Jul 2014 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[894d3757dca4b91ab23c0d07812566df]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.8165]]></link>
      <description><![CDATA[<p>Interview with Mads E. Jørgensen, MB, author of Time Elapsed After Ischemic Stroke and Risk of Adverse Cardiovascular Events and Mortality Following Elective Noncardiac Surgery</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Mads E. Jørgensen, MB, author of Time Elapsed After Ischemic Stroke and Risk of Adverse Cardiovascular Events and Mortality Following Elective Noncardiac Surgery</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-07-15_Vol._312_No._3_Author_Interview.mp3?dest-id=90171" length="2364744" type="audio/mpeg" />
      <itunes:duration>04:54</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/f/a/4/9/fa49d705f81f55b5/140715-jama-jai-joergensen.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Telecare Collaborative Management of Chronic Pain in Primary Care</title>
      <itunes:title>Telecare Collaborative Management of Chronic Pain in Primary Care</itunes:title>
      <pubDate>Tue, 15 Jul 2014 19:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[062d3e23a3cbd8dde752842f2816b45f]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.7689]]></link>
      <description><![CDATA[<p>Interview with Kurt Kroenke, MD, author of Telecare Collaborative Management of Chronic Pain in Primary Care</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Kurt Kroenke, MD, author of Telecare Collaborative Management of Chronic Pain in Primary Care</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-07-15_Vol._312_No._3_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="4154246" type="audio/mpeg" />
      <itunes:duration>04:19</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/b/a/8/b/ba8bfc7e139c3ff4/140715-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Transcatheter Aortic Valve Implantation in Failed Bioprosthetic Surgical Valves</title>
      <itunes:title>Transcatheter Aortic Valve Implantation in Failed Bioprosthetic Surgical Valves</itunes:title>
      <pubDate>Tue, 08 Jul 2014 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[627a5c21eb5913caafad4bef783efbd4]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.7246]]></link>
      <description><![CDATA[<p>Interview with Danny Dvir, MD, author of Transcatheter Aortic Valve Implantation in Failed Bioprosthetic Surgical Valves</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Danny Dvir, MD, author of Transcatheter Aortic Valve Implantation in Failed Bioprosthetic Surgical Valves</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-07-08_Vol._312_No._2_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="4025575" type="audio/mpeg" />
      <itunes:duration>04:09</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/4/a/4/94a4eef927c23e59/140708-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>of Effect of Erythropoietin and Transfusion Threshold on Neurological Recovery After Traumatic Brain Injury: A Randomized Clinical Trial</title>
      <itunes:title>of Effect of Erythropoietin and Transfusion Threshold on Neurological Recovery After Traumatic Brain Injury: A Randomized Clinical Trial</itunes:title>
      <pubDate>Tue, 01 Jul 2014 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[b2292eec362324c02c6748ba381edc7d]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.6490]]></link>
      <description><![CDATA[<p>Interview with Claudia S. Robertson, MD, author of Effect of Erythropoietin and Transfusion Threshold on Neurological Recovery After Traumatic Brain Injury: A Randomized Clinical Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Claudia S. Robertson, MD, author of Effect of Erythropoietin and Transfusion Threshold on Neurological Recovery After Traumatic Brain Injury: A Randomized Clinical Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-07-01_Vol._312_No._1_Author_Interview.mp3?dest-id=90171" length="2447816" type="audio/mpeg" />
      <itunes:duration>05:04</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/5/2/8/1/528175c09963bf83/140701-jama-jai-robertson.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Nonmyeloablative HLA-Matched Sibling Allogeneic Hematopoietic Stem Cell Transplantation for Severe Sickle Cell Phenotype</title>
      <itunes:title>Nonmyeloablative HLA-Matched Sibling Allogeneic Hematopoietic Stem Cell Transplantation for Severe Sickle Cell Phenotype</itunes:title>
      <pubDate>Tue, 01 Jul 2014 19:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[9a4b71653a8867b70e1d2a218beb5692]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.7192]]></link>
      <description><![CDATA[<p>Interview with John F. Tisdale, MD, author of Nonmyeloablative HLA-Matched Sibling Allogeneic Hematopoietic Stem Cell Transplantation for Severe Sickle Cell Phenotype</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with John F. Tisdale, MD, author of Nonmyeloablative HLA-Matched Sibling Allogeneic Hematopoietic Stem Cell Transplantation for Severe Sickle Cell Phenotype</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-07-01_Vol._312_No._1_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="3907753" type="audio/mpeg" />
      <itunes:duration>04:04</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/b/f/1/1bf15e30ad45cdda/140701-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Breast Cancer Screening Using Tomosynthesis in Combination With Digital Mammography</title>
      <itunes:title>Breast Cancer Screening Using Tomosynthesis in Combination With Digital Mammography</itunes:title>
      <pubDate>Tue, 24 Jun 2014 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[bab610cd1739bce3826ac56c7f6d4604]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.6095]]></link>
      <description><![CDATA[<p>Interview with Sarah M. Friedewald, MD, author of Breast Cancer Screening Using Tomosynthesis in Combination With Digital Mammography</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Sarah M. Friedewald, MD, author of Breast Cancer Screening Using Tomosynthesis in Combination With Digital Mammography</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-06-24_Vol._311_No._24_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="2924822" type="audio/mpeg" />
      <itunes:duration>03:02</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/4/b/f/2/4bf2845e86432e69/140624-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Association Between Tumor Necrosis Factor-α Antagonists and Risk of Cancer in Patients With Inflammatory Bowel Disease</title>
      <itunes:title>Association Between Tumor Necrosis Factor-α Antagonists and Risk of Cancer in Patients With Inflammatory Bowel Disease</itunes:title>
      <pubDate>Tue, 17 Jun 2014 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[0da0ab1b591accbe4b429760c607ae3f]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.5613]]></link>
      <description><![CDATA[<p>Interview with Nynne Nyboe Andersen, MD, author of Association Between Tumor Necrosis Factor-α Antagonists and Risk of Cancer in Patients With Inflammatory Bowel Disease</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Nynne Nyboe Andersen, MD, author of Association Between Tumor Necrosis Factor-α Antagonists and Risk of Cancer in Patients With Inflammatory Bowel Disease</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-06-17_Vol._311_No._23_Author_Interview.mp3?dest-id=90171" length="2929298" type="audio/mpeg" />
      <itunes:duration>06:05</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/f/8/4/cf848fe4b4e601b3/140617-jama-jai-andersen.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Association Between Intensification of Metformin Treatment With Insulin vs Sulfonylureas and Cardiovascular Events and All-Cause Mortality Among Patients With Diabetes</title>
      <itunes:title>Association Between Intensification of Metformin Treatment With Insulin vs Sulfonylureas and Cardiovascular Events and All-Cause Mortality Among Patients With Diabetes</itunes:title>
      <pubDate>Tue, 10 Jun 2014 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[880fad4c2e7aa518487b1b7f8d5c41c7]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.4312]]></link>
      <description><![CDATA[<p>Interview with Christianne L. Roumie, MD, MPH, author of Association Between Intensification of Metformin Treatment With Insulin vs Sulfonylureas and Cardiovascular Events and All-Cause Mortality Among Patients With Diabetes</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Christianne L. Roumie, MD, MPH, author of Association Between Intensification of Metformin Treatment With Insulin vs Sulfonylureas and Cardiovascular Events and All-Cause Mortality Among Patients With Diabetes</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-06-10_Vol._311_No._22_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="4204636" type="audio/mpeg" />
      <itunes:duration>04:22</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/a/2/7/9a27034c5d098c3d/140610-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Effect of a Perioperative, Cardiac Output-Guided Hemodynamic Therapy Algorithm on Outcomes Following Major Gastrointestinal Surgery: A Randomized Clinical Trial and Systematic Review</title>
      <itunes:title>Effect of a Perioperative, Cardiac Output-Guided Hemodynamic Therapy Algorithm on Outcomes Following Major Gastrointestinal Surgery: A Randomized Clinical Trial and Systematic Review</itunes:title>
      <pubDate>Tue, 03 Jun 2014 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[79062c1fbbf4de68b2f6798cff223ff9]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.5305]]></link>
      <description><![CDATA[<p>Interview with Rupert M. Pearse, MD, author of Effect of a Perioperative, Cardiac Output-Guided Hemodynamic Therapy Algorithm on Outcomes Following Major Gastrointestinal Surgery: A Randomized Clinical Trial and Systematic Review</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Rupert M. Pearse, MD, author of Effect of a Perioperative, Cardiac Output-Guided Hemodynamic Therapy Algorithm on Outcomes Following Major Gastrointestinal Surgery: A Randomized Clinical Trial and Systematic Review</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-06-03_Vol._311_No._21_Author_Interview.mp3?dest-id=90171" length="2582356" type="audio/mpeg" />
      <itunes:duration>05:21</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/5/4/0/9540ee36d121eebf/140603-jama-jai-pearse.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Association of Azithromycin With Mortality and Cardiovascular Events Among Older Patients Hospitalized With Pneumoniaew</title>
      <itunes:title>Association of Azithromycin With Mortality and Cardiovascular Events Among Older Patients Hospitalized With Pneumoniaew</itunes:title>
      <pubDate>Tue, 03 Jun 2014 19:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[28e69833bf542207407276f1bc5a860b]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.4304]]></link>
      <description><![CDATA[<p>Interview with Eric M. Mortensen, MD, MSc, author of Association of Azithromycin With Mortality and Cardiovascular Events Among Older Patients Hospitalized With Pneumonia</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Eric M. Mortensen, MD, MSc, author of Association of Azithromycin With Mortality and Cardiovascular Events Among Older Patients Hospitalized With Pneumonia</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-06-03_Vol._311_No._21_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="2470817" type="audio/mpeg" />
      <itunes:duration>02:34</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/0/7/8/80787a18ced68644/140603-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Effect of Structured Physical Activity on Prevention of Major Mobility Disability in Older Adults: The LIFE Study Randomized Clinical Trial</title>
      <itunes:title>Effect of Structured Physical Activity on Prevention of Major Mobility Disability in Older Adults: The LIFE Study Randomized Clinical Trial</itunes:title>
      <pubDate>Tue, 27 May 2014 17:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[c68a9b74af68ad0f8129ff9e934a6e01]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.5616]]></link>
      <description><![CDATA[<p>Interview with Marco Pahor, MD, author of Effect of Structured Physical Activity on Prevention of Major Mobility Disability in Older Adults: The LIFE Study Randomized Clinical Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Marco Pahor, MD, author of Effect of Structured Physical Activity on Prevention of Major Mobility Disability in Older Adults: The LIFE Study Randomized Clinical Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-05-27_Online_First_Audio_from_Author_Video_Interview.mp3?dest-id=90171" length="3396919" type="audio/mpeg" />
      <itunes:duration>03:32</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/1/b/5/c1b5d228e1893dd3/140527-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Effect of Physical Therapy on Pain and Function in Patients With Hip Osteoarthritis: A Randomized Clinical Trial</title>
      <itunes:title>Effect of Physical Therapy on Pain and Function in Patients With Hip Osteoarthritis: A Randomized Clinical Trial</itunes:title>
      <pubDate>Tue, 20 May 2014 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[e9a105c14cde244503f79f7e94feefb0]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.4591]]></link>
      <description><![CDATA[<p>Interview with Kim L. Bennell, PhD, author of Effect of Physical Therapy on Pain and Function in Patients With Hip Osteoarthritis: A Randomized Clinical Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Kim L. Bennell, PhD, author of Effect of Physical Therapy on Pain and Function in Patients With Hip Osteoarthritis: A Randomized Clinical Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-05-20_Vol._311_No._19_Author_Interview.mp3?dest-id=90171" length="3260737" type="audio/mpeg" />
      <itunes:duration>06:46</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/6/d/f/16dfa7b1c32f8084/140520-jama-jai-bennell.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs</title>
      <itunes:title>Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs</itunes:title>
      <pubDate>Tue, 20 May 2014 19:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[5231635c552bbc82537a7281a96b74e2]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.3741]]></link>
      <description><![CDATA[<p>Interview with Mark G. Kris, MD, author of Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Mark G. Kris, MD, author of Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-05-20_Vol._311_No._19_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="4101891" type="audio/mpeg" />
      <itunes:duration>04:16</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/7/7/2/07722b9efdaf1e8a/140520-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Effect of Vitamin D3 on Asthma Treatment Failures in Adults With Symptomatic Asthma and Lower Vitamin D Levels</title>
      <itunes:title>Effect of Vitamin D3 on Asthma Treatment Failures in Adults With Symptomatic Asthma and Lower Vitamin D Levels</itunes:title>
      <pubDate>Sun, 18 May 2014 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[a55740bed858d73a1dbc29e6b4ae82f4]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.5052]]></link>
      <description><![CDATA[<p>Interview with Mario Castro, MD, author of Effect of Vitamin D<sub>3</sub> on Asthma Treatment Failures in Adults With Symptomatic Asthma and Lower Vitamin D Levels</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Mario Castro, MD, author of Effect of Vitamin D3 on Asthma Treatment Failures in Adults With Symptomatic Asthma and Lower Vitamin D Levels</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-05-18_Online_First_Audio_from_Author_Video_Interview.mp3?dest-id=90171" length="4546877" type="audio/mpeg" />
      <itunes:duration>04:44</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/4/1/3/0/413043a292af95ee/140518-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Medical and legalized marijuana in Colorado</title>
      <itunes:title>Medical and legalized marijuana in Colorado</itunes:title>
      <pubDate>Wed, 14 May 2014 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[100f0fcf89b6cb768b631de6faf7a875]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.4370]]></link>
      <description><![CDATA[<p>Interview with Larry Wolk, MD, MSPH, chief medical officer for the Colorado Department of Public Health, about medical and legalized marijuana in Colorado.</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Larry Wolk, MD, MSPH, chief medical officer for the Colorado Department of Public Health, about medical and legalized marijuana in Colorado.</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-05-14_Vol._311_No._20_Author_Interview.mp3?dest-id=90171" length="5387410" type="audio/mpeg" />
      <itunes:duration>11:12</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/9/5/d/395d264abd615085/140410-special-wolk.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>The Pathophysiology and Treatment of Glaucoma</title>
      <itunes:title>The Pathophysiology and Treatment of Glaucoma</itunes:title>
      <pubDate>Tue, 13 May 2014 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[ad6dc4eb2b28d6ebf4130af3f25bca05]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.3192]]></link>
      <description><![CDATA[<p>Interview with Robert N. Weinreb, MD, author of The Pathophysiology and Treatment of Glaucoma</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Robert N. Weinreb, MD, author of The Pathophysiology and Treatment of Glaucoma</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-05-13_Vol._311_No._18_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="4828659" type="audio/mpeg" />
      <itunes:duration>05:01</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/5/9/a/c59ab4110d30aaeb/140513-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>The Familial Risk of Autism</title>
      <itunes:title>The Familial Risk of Autism</itunes:title>
      <pubDate>Sat, 03 May 2014 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[eb961365ea14ea82bccfd71c7c1e895f]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.4144]]></link>
      <description><![CDATA[<p>Interview with Sven Sandin, MSc, author of The Familial Risk of Autism</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Sven Sandin, MSc, author of The Familial Risk of Autism</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-05-03_Vol._311_No._17_Author_Interview.mp3?dest-id=90171" length="3556956" type="audio/mpeg" />
      <itunes:duration>07:23</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/4/6/a/2/46a253c36a8b6c64/140502-jama-jai-sandin.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Prevalence of Type 1 and Type 2 Diabetes Among Children and Adolescents From 2001 to 2009</title>
      <itunes:title>Prevalence of Type 1 and Type 2 Diabetes Among Children and Adolescents From 2001 to 2009</itunes:title>
      <pubDate>Sat, 03 May 2014 19:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[8f785d7f96ada631eb363af995f1ad92]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.3201]]></link>
      <description><![CDATA[<p>Interview with Dana Dabelea, MD, PhD, author of Prevalence of Type 1 and Type 2 Diabetes Among Children and Adolescents From 2001 to 2009</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Dana Dabelea, MD, PhD, author of Prevalence of Type 1 and Type 2 Diabetes Among Children and Adolescents From 2001 to 2009</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-05-03_Vol._311_No._17_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="4849919" type="audio/mpeg" />
      <itunes:duration>05:02</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/a/8/3/1a838bc8eca2bcc5/140503-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Door-to-Needle Times for Tissue Plasminogen Activator Administration and Clinical Outcomes in Acute Ischemic Stroke Before and After a Quality Improvement Initiative</title>
      <itunes:title>Door-to-Needle Times for Tissue Plasminogen Activator Administration and Clinical Outcomes in Acute Ischemic Stroke Before and After a Quality Improvement Initiative</itunes:title>
      <pubDate>Tue, 22 Apr 2014 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[bd724ea5f1c3644e031b1bec3699a941]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.3203]]></link>
      <description><![CDATA[<p>Interview with Gregg C. Fonarow, MD, author of Door-to-Needle Times for Tissue Plasminogen Activator Administration and Clinical Outcomes in Acute Ischemic Stroke Before and After a Quality Improvement Initiative</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Gregg C. Fonarow, MD, author of Door-to-Needle Times for Tissue Plasminogen Activator Administration and Clinical Outcomes in Acute Ischemic Stroke Before and After a Quality Improvement Initiative</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-04-22_Vol._311_No._16_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="5807555" type="audio/mpeg" />
      <itunes:duration>06:05</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/5/0/1/7/50179e0f24bdfea5/140422-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Comparison of Balloon-Expandable vs Self-expandable Valves in Patients Undergoing Transcatheter Aortic Valve Replacement: The CHOICE Randomized Clinical Trial</title>
      <itunes:title>Comparison of Balloon-Expandable vs Self-expandable Valves in Patients Undergoing Transcatheter Aortic Valve Replacement: The CHOICE Randomized Clinical Trial</itunes:title>
      <pubDate>Tue, 15 Apr 2014 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[7454edeeb3a2a568146e9508a6bf173d]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.3316]]></link>
      <description><![CDATA[<p>Interview with Mohamed Abdel-Wahab, MD, author of Comparison of Balloon-Expandable vs Self-expandable Valves in Patients Undergoing Transcatheter Aortic Valve Replacement: The CHOICE Randomized Clinical Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Mohamed Abdel-Wahab, MD, author of Comparison of Balloon-Expandable vs Self-expandable Valves in Patients Undergoing Transcatheter Aortic Valve Replacement: The CHOICE Randomized Clinical Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-04-15_Vol._311_No._15_Author_Interview.mp3?dest-id=90171" length="3928942" type="audio/mpeg" />
      <itunes:duration>08:09</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/e/7/3/ce7399722f55ed17/140415-jama-jai-abdel-wahab.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Fibromyalgia: A Clinical Review</title>
      <itunes:title>Fibromyalgia: A Clinical Review</itunes:title>
      <pubDate>Tue, 15 Apr 2014 19:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[ec3ba38fa3de5c13ec75eee24e259e92]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.3266]]></link>
      <description><![CDATA[<p>Interview with Daniel J. Clauw, MD, author of Fibromyalgia: A Clinical Review</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Daniel J. Clauw, MD, author of Fibromyalgia: A Clinical Review</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-04-15_Vol._311_No._15_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="3743272" type="audio/mpeg" />
      <itunes:duration>04:11</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/b/5/d/7/b5d7d871bf244801/140415-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>of Screening Mammography in Older Women: A Review</title>
      <itunes:title>of Screening Mammography in Older Women: A Review</itunes:title>
      <pubDate>Tue, 01 Apr 2014 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[e5c573a6a27fc4d15f69ddcc75135f2c]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.2834]]></link>
      <description><![CDATA[<p>Interview with Louise C. Walter, MD and Mara A. Schonberg, MD, MPH, authors of Screening Mammography in Older Women: A Review</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Louise C. Walter, MD and Mara A. Schonberg, MD, MPH, authors of Screening Mammography in Older Women: A Review</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-04-01_Vol._311_No._13_Author_Interview.mp3?dest-id=90171" length="5013245" type="audio/mpeg" />
      <itunes:duration>10:25</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/f/e/3/9fe331b9121b0b2d/140401-jama-jai-walter.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>A Systematic Assessment of Benefits and Risks to Guide Breast Cancer Screening Decisions</title>
      <itunes:title>A Systematic Assessment of Benefits and Risks to Guide Breast Cancer Screening Decisions</itunes:title>
      <pubDate>Tue, 01 Apr 2014 19:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[d0e5f4bace276fa7c63d6c1475d4ba3f]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.1398]]></link>
      <description><![CDATA[<p>Interview with Nancy L. Keating, MD, MPH, author of A Systematic Assessment of Benefits and Risks to Guide Breast Cancer Screening Decisions</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Nancy L. Keating, MD, MPH, author of A Systematic Assessment of Benefits and Risks to Guide Breast Cancer Screening Decisions</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-04-01_Vol._311_No._13_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="3907224" type="audio/mpeg" />
      <itunes:duration>04:04</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/5/7/c/2/57c2a7bc8e39eb8d/140401-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Proportion of US Adults Potentially Affected by the 2014 Hypertension Guideline</title>
      <itunes:title>Proportion of US Adults Potentially Affected by the 2014 Hypertension Guideline</itunes:title>
      <pubDate>Sat, 29 Mar 2014 18:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[10c8dc41b2b65838ed7784fd2626d824]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.2531]]></link>
      <description><![CDATA[<p>Interview with Ann Marie Navar-Boggan, MD, PhD, author of Proportion of US Adults Potentially Affected by the 2014 Hypertension Guideline</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Ann Marie Navar-Boggan, MD, PhD, author of Proportion of US Adults Potentially Affected by the 2014 Hypertension Guideline</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-03-29_Online_First_Audio_from_Author_Video_Interview.mp3?dest-id=90171" length="3643020" type="audio/mpeg" />
      <itunes:duration>03:47</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/6/5/b/165b75d615263e81/140329-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Interview with Henry Waxman (D, Calif), retiring from Congress after 20 terms.</title>
      <itunes:title>Interview with Henry Waxman (D, Calif), retiring from Congress after 20 terms.</itunes:title>
      <pubDate>Wed, 26 Mar 2014 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[7eac313c8fdea1402b4a515782db0d3e]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.1827]]></link>
      <description><![CDATA[<p>Interview with Henry Waxman (D, Calif) who is retiring from Congress after 20 terms.</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Henry Waxman (D, Calif) who is retiring from Congress after 20 terms.</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-03-26_Vol._311_No._14_Author_Interview.mp3?dest-id=90171" length="7546867" type="audio/mpeg" />
      <itunes:duration>15:41</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/7/4/d/6/74d61c22c0d94e2b/140213-special-waxman-cuts.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Web-Based Alcohol Screening and Brief Intervention for University Students: A Randomized Trial</title>
      <itunes:title>Web-Based Alcohol Screening and Brief Intervention for University Students: A Randomized Trial</itunes:title>
      <pubDate>Tue, 25 Mar 2014 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[4b4c04f5a628129dfb044f03802cf075]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.2138]]></link>
      <description><![CDATA[<p>Interview with Nicholas J. Horton, ScD, author of Web-Based Alcohol Screening and Brief Intervention for University Students: A Randomized Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Nicholas J. Horton, ScD, author of Web-Based Alcohol Screening and Brief Intervention for University Students: A Randomized Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-03-25_Vol._311_No._12_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="2650842" type="audio/mpeg" />
      <itunes:duration>02:45</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/d/5/e/1d5e71db12e2c34c/140325-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Screening for Prostate Cancer With the Prostate-Specific Antigen Test: A Review of Current Evidence</title>
      <itunes:title>Screening for Prostate Cancer With the Prostate-Specific Antigen Test: A Review of Current Evidence</itunes:title>
      <pubDate>Tue, 18 Mar 2014 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[e2956b6eaf75d55ea5061c4c63cc562f]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.2085]]></link>
      <description><![CDATA[<p>Interview with Michael J. Barry, MD, author of Screening for Prostate Cancer With the Prostate-Specific Antigen Test: A Review of Current Evidence</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Michael J. Barry, MD, author of Screening for Prostate Cancer With the Prostate-Specific Antigen Test: A Review of Current Evidence</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-03-18_Vol._311_No._11_Author_Interview.mp3?dest-id=90171" length="4117194" type="audio/mpeg" />
      <itunes:duration>08:33</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/b/d/f/1/bdf18bb2e1c587ac/140318-jama-jai-barry.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Psychiatric Diagnoses and Psychoactive Medication Use Among Nonsurgical Critically Ill Patients Receiving Mechanical Ventilation</title>
      <itunes:title>Psychiatric Diagnoses and Psychoactive Medication Use Among Nonsurgical Critically Ill Patients Receiving Mechanical Ventilation</itunes:title>
      <pubDate>Tue, 18 Mar 2014 19:58:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[47cc2744bac6ad81ec0ad91eaeea4f33]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.2137]]></link>
      <description><![CDATA[<p>Interview with Derek C. Angus, MD, MPH, author of Psychiatric Diagnoses and Psychoactive Medication Use Among Nonsurgical Critically Ill Patients Receiving Mechanical Ventilation</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Derek C. Angus, MD, MPH, author of Psychiatric Diagnoses and Psychoactive Medication Use Among Nonsurgical Critically Ill Patients Receiving Mechanical Ventilation</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-03-18_Vol._311_No._11_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="4548460" type="audio/mpeg" />
      <itunes:duration>04:44</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/7/0/6/1/706185ba0da7c989/140318-jama-avi.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Comparison of 2 Transvaginal Surgical Approaches and Perioperative Behavioral Therapy for Apical Vaginal Prolapse</title>
      <itunes:title>Comparison of 2 Transvaginal Surgical Approaches and Perioperative Behavioral Therapy for Apical Vaginal Prolapse</itunes:title>
      <pubDate>Tue, 11 Mar 2014 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[47df311b44f1ea8f7df950cd2760cd4d]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.1719]]></link>
      <description><![CDATA[<p>Interview with Matthew D. Barber, MD, MHS, author of Comparison of 2 Transvaginal Surgical Approaches and Perioperative Behavioral Therapy for Apical Vaginal Prolapse</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Matthew D. Barber, MD, MHS, author of Comparison of 2 Transvaginal Surgical Approaches and Perioperative Behavioral Therapy for Apical Vaginal Prolapse</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-03-11_Vol._311_No._10_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="4068060" type="audio/mpeg" />
      <itunes:duration>04:14</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/e/b/d/cebdb23b3e71b49e/140311-jama-avi.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Warfarin, Kidney Dysfunction, and Outcomes Following Acute Myocardial Infarction in Patients With Atrial Fibrillation</title>
      <itunes:title>Warfarin, Kidney Dysfunction, and Outcomes Following Acute Myocardial Infarction in Patients With Atrial Fibrillation</itunes:title>
      <pubDate>Tue, 04 Mar 2014 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[6e68d2b7d71deca517386b8069b28de9]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.1334]]></link>
      <description><![CDATA[<p>Interview with Juan Jesús Carrero, PhD(Pharm and Med), author of Warfarin, Kidney Dysfunction, and Outcomes Following Acute Myocardial Infarction in Patients With Atrial Fibrillation</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Juan Jesús Carrero, PhD(Pharm and Med), author of Warfarin, Kidney Dysfunction, and Outcomes Following Acute Myocardial Infarction in Patients With Atrial Fibrillation</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-03-04_Vol._311_No._9_Author_Interview.mp3?dest-id=90171" length="1912054" type="audio/mpeg" />
      <itunes:duration>03:57</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/9/f/3/89f3b0760f3547d1/140305-jama-jai-carrero.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Associations of Housing Mobility Interventions for Children in High-Poverty Neighborhoods With Subsequent Mental Disorders During Adolescence</title>
      <itunes:title>Associations of Housing Mobility Interventions for Children in High-Poverty Neighborhoods With Subsequent Mental Disorders During Adolescence</itunes:title>
      <pubDate>Tue, 04 Mar 2014 20:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[7b596561df0d6d03c920c32dcf11ee74]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.607]]></link>
      <description><![CDATA[<p>Interview with Ronald C. Kessler, PhD, author of Associations of Housing Mobility Interventions for Children in High-Poverty Neighborhoods With Subsequent Mental Disorders During Adolescence</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Ronald C. Kessler, PhD, author of Associations of Housing Mobility Interventions for Children in High-Poverty Neighborhoods With Subsequent Mental Disorders During Adolescence</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-03-04_Vol._311_No._9_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="4477396" type="audio/mpeg" />
      <itunes:duration>04:39</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/7/e/d/4/7ed47349c139de3c/140304-jama-avi.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Association Between Participation in a Multipayer Medical Home Intervention and Changes in Quality, Utilization, and Costs of Care</title>
      <itunes:title>Association Between Participation in a Multipayer Medical Home Intervention and Changes in Quality, Utilization, and Costs of Care</itunes:title>
      <pubDate>Tue, 25 Feb 2014 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[8a3357b1ac9180c1da319094fa64fd6b]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.353]]></link>
      <description><![CDATA[<p>Interview with Mark W. Friedberg, MD, MPP, author of Association Between Participation in a Multipayer Medical Home Intervention and Changes in Quality, Utilization, and Costs of Care</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Mark W. Friedberg, MD, MPP, author of Association Between Participation in a Multipayer Medical Home Intervention and Changes in Quality, Utilization, and Costs of Care</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-02-25_Vol._311_No._8_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="3961674" type="audio/mpeg" />
      <itunes:duration>04:05</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/7/f/5/6/7f56c5a2f7a7a99f/140225-jama-avi.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Surgical Site Infections Following Ambulatory Surgery Procedures</title>
      <itunes:title>Surgical Site Infections Following Ambulatory Surgery Procedures</itunes:title>
      <pubDate>Tue, 18 Feb 2014 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[ad29b4f588c320e99bd6666f8235fb16]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.4]]></link>
      <description><![CDATA[<p>Interview with Claudia A. Steiner, MD, MPH, author of Surgical Site Infections Following Ambulatory Surgery Procedures</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Claudia A. Steiner, MD, MPH, author of Surgical Site Infections Following Ambulatory Surgery Procedures</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-02-18_Vol._311_No._7_Author_Interview.mp3?dest-id=90171" length="4312748" type="audio/mpeg" />
      <itunes:duration>08:57</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/b/c/5/abc5daf28eda6142/140218-jama-jai-steiner.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Effect of Citalopram on Agitation in Alzheimer Disease</title>
      <itunes:title>Effect of Citalopram on Agitation in Alzheimer Disease</itunes:title>
      <pubDate>Tue, 18 Feb 2014 20:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[10d92ad341307d3a71f9677852fc320f]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.93]]></link>
      <description><![CDATA[<p>Interview with Constantine G. Lyketsos, MD, MHS, author of Effect of Citalopram on Agitation in Alzheimer Disease</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Constantine G. Lyketsos, MD, MHS, author of Effect of Citalopram on Agitation in Alzheimer Disease</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-02-18_Vol._311_No._7_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="4798821" type="audio/mpeg" />
      <itunes:duration>04:59</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/4/a/a/7/4aa7fecacf256daf/140218-jama-avi.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Association of Varying Number of Doses of Quadrivalent Human Papillomavirus Vaccine With Incidence of Condyloma</title>
      <itunes:title>Association of Varying Number of Doses of Quadrivalent Human Papillomavirus Vaccine With Incidence of Condyloma</itunes:title>
      <pubDate>Tue, 11 Feb 2014 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[67e6b54c2c7bb632fcb7cba9c3d121cd]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.95]]></link>
      <description><![CDATA[<p>Interview with Lisen Arnheim-Dahlström, PhD, author of Association of Varying Number of Doses of Quadrivalent Human Papillomavirus Vaccine With Incidence of Condyloma</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Lisen Arnheim-Dahlström, PhD, author of Association of Varying Number of Doses of Quadrivalent Human Papillomavirus Vaccine With Incidence of Condyloma</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-02-11_Vol._311_No._6_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="3820244" type="audio/mpeg" />
      <itunes:duration>03:58</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/4/a/c/c/4acc67df86fd9416/140211-jama-avi.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Ending Sales of Tobacco Products in Pharmacies</title>
      <itunes:title>Ending Sales of Tobacco Products in Pharmacies</itunes:title>
      <pubDate>Wed, 05 Feb 2014 11:45:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[ee7a0f8264cea1baa4204551b3ed7313]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2014.686]]></link>
      <description><![CDATA[<p>Interview with Troyen A. Brennan, MD, MPH, author of Ending Sales of Tobacco Products in Pharmacies</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Troyen A. Brennan, MD, MPH, author of Ending Sales of Tobacco Products in Pharmacies</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-02-05_Vol._311_No._11_Author_Interview.mp3?dest-id=90171" length="4292471" type="audio/mpeg" />
      <itunes:duration>08:55</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/9/0/f/890f17508e6c7de2/140205-jama-jai-brennan.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Blood Pressure Trajectories in Early Adulthood and Subclinical Atherosclerosis in Middle Age</title>
      <itunes:title>Blood Pressure Trajectories in Early Adulthood and Subclinical Atherosclerosis in Middle Age</itunes:title>
      <pubDate>Tue, 04 Feb 2014 20:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[5c700d6a9a0726bd33acd0a74d75e6e4]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.285122]]></link>
      <description><![CDATA[<p>Interview with Norrina B. Allen, PhD, MPH, author of Blood Pressure Trajectories in Early Adulthood and Subclinical Atherosclerosis in Middle Age</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Norrina B. Allen, PhD, MPH, author of Blood Pressure Trajectories in Early Adulthood and Subclinical Atherosclerosis in Middle Age</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-02-04_Vol._311_No._5_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="3937944" type="audio/mpeg" />
      <itunes:duration>04:04</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/6/3/5/963536d61b0758e3/140204-jama-avi.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Clinical Trial Evidence Supporting FDA Approval of Novel Therapeutic Agents, 2005-2012</title>
      <itunes:title>Clinical Trial Evidence Supporting FDA Approval of Novel Therapeutic Agents, 2005-2012</itunes:title>
      <pubDate>Tue, 21 Jan 2014 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[1beeb9519f500de0ce0c2546bbae7196]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.282034]]></link>
      <description><![CDATA[<p>Interview with Joseph S. Ross, MD, MHS, author of Clinical Trial Evidence Supporting FDA Approval of Novel Therapeutic Agents, 2005-2012</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Joseph S. Ross, MD, MHS, author of Clinical Trial Evidence Supporting FDA Approval of Novel Therapeutic Agents, 2005-2012</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-01-21_Vol._311_No._4_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="5071328" type="audio/mpeg" />
      <itunes:duration>05:14</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/7/6/6/6/76668cbb80e60041/140121-jama-avi.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Effect of 3 to 5 Years of Scheduled CEA and CT Follow-up to Detect Recurrence of Colorectal Cancer: The FACS Randomized Clinical Trial</title>
      <itunes:title>Effect of 3 to 5 Years of Scheduled CEA and CT Follow-up to Detect Recurrence of Colorectal Cancer: The FACS Randomized Clinical Trial</itunes:title>
      <pubDate>Tue, 14 Jan 2014 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[98985e979f47c1ec2d698e7e5febfdbd]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.285718]]></link>
      <description><![CDATA[<p>Interview with John N. Primrose, MD, FRCS, author of Effect of 3 to 5 Years of Scheduled CEA and CT Follow-up to Detect Recurrence of Colorectal Cancer: The FACS Randomized Clinical Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with John N. Primrose, MD, FRCS, author of Effect of 3 to 5 Years of Scheduled CEA and CT Follow-up to Detect Recurrence of Colorectal Cancer: The FACS Randomized Clinical Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-01-14_Vol._311_No._3_Author_Interview.mp3?dest-id=90171" length="2784851" type="audio/mpeg" />
      <itunes:duration>05:46</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/d/a/2/3/da23ae716d7280a3/140114-jama-jai-primrose.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Calcium Density of Coronary Artery Plaque and Risk of Incident Cardiovascular Events</title>
      <itunes:title>Calcium Density of Coronary Artery Plaque and Risk of Incident Cardiovascular Events</itunes:title>
      <pubDate>Tue, 14 Jan 2014 20:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[e51ebd345523b9a4ed1f71ac5aa76da4]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.282535]]></link>
      <description><![CDATA[<p>Interview with Michael H. Criqui, MD, MPH, author of Calcium Density of Coronary Artery Plaque and Risk of Incident Cardiovascular Events</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Michael H. Criqui, MD, MPH, author of Calcium Density of Coronary Artery Plaque and Risk of Incident Cardiovascular Events</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-01-14_Vol._311_No._3_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="4154721" type="audio/mpeg" />
      <itunes:duration>04:17</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/7/4/8/9748a61a044275f9/140114-jama-avi.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Tobacco Control and the Reduction in Smoking-Related Premature Deaths in the United States, 1964-2012</title>
      <itunes:title>Tobacco Control and the Reduction in Smoking-Related Premature Deaths in the United States, 1964-2012</itunes:title>
      <pubDate>Tue, 07 Jan 2014 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[998b7b4c4bda956c42caf04e17ac4f09]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.285112]]></link>
      <description><![CDATA[<p>Interview with Theodore R. Holford, PhD, author of Tobacco Control and the Reduction in Smoking-Related Premature Deaths in the United States, 1964-2012</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Theodore R. Holford, PhD, author of Tobacco Control and the Reduction in Smoking-Related Premature Deaths in the United States, 1964-2012</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2014-01-07_Vol._311_No._2_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="5110977" type="audio/mpeg" />
      <itunes:duration>05:16</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/f/0/0/7/f007a8eafe5f80b6/140107-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Long-term Drug Treatment for Obesity: A Systematic and Clinical Review</title>
      <itunes:title>Long-term Drug Treatment for Obesity: A Systematic and Clinical Review</itunes:title>
      <pubDate>Tue, 31 Dec 2013 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[6c156538c04f32fd4f77aadda6342ffb]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.281361]]></link>
      <description><![CDATA[<p>Interview with Susan Z. Yanovski, MD, author of Long-term Drug Treatment for Obesity: A Systematic and Clinical Review</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Susan Z. Yanovski, MD, author of Long-term Drug Treatment for Obesity: A Systematic and Clinical Review</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-12-31_Vol._311_No._1_Author_Interview.mp3?dest-id=90171" length="3235444" type="audio/mpeg" />
      <itunes:duration>06:43</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/2/4/d/024dbf2d98fabbe6/131231-jama-jai-yanovski.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Effect of Vitamin E and Memantine on Functional Decline in Alzheimer Disease: The TEAM-AD VA Cooperative Randomized Trial</title>
      <itunes:title>Effect of Vitamin E and Memantine on Functional Decline in Alzheimer Disease: The TEAM-AD VA Cooperative Randomized Trial</itunes:title>
      <pubDate>Tue, 31 Dec 2013 20:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[0ec9ac5a57d1aa60503c3eeb8cd985b7]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.282834]]></link>
      <description><![CDATA[<p>Interview with Maurice W. Dysken, MD, author of Effect of Vitamin E and Memantine on Functional Decline in Alzheimer Disease: The TEAM-AD VA Cooperative Randomized Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Maurice W. Dysken, MD, author of Effect of Vitamin E and Memantine on Functional Decline in Alzheimer Disease: The TEAM-AD VA Cooperative Randomized Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-12-31_Vol._311_No._1_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="5512554" type="audio/mpeg" />
      <itunes:duration>05:41</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/0/8/3/9083a636cca01bd3/131231-jama-avi.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Cognitive Behavioral Therapy Plus Amitriptyline for Chronic Migraine in Children and Adolescents</title>
      <itunes:title>Cognitive Behavioral Therapy Plus Amitriptyline for Chronic Migraine in Children and Adolescents</itunes:title>
      <pubDate>Tue, 24 Dec 2013 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[4794d3c893803731a992e93cebbadcc0]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.282533]]></link>
      <description><![CDATA[<p>Interview with Scott W. Powers, PhD, author of Cognitive Behavioral Therapy Plus Amitriptyline for Chronic Migraine in Children and Adolescents</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Scott W. Powers, PhD, author of Cognitive Behavioral Therapy Plus Amitriptyline for Chronic Migraine in Children and Adolescents</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-12-24_Vol._310_No._24_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="4960330" type="audio/mpeg" />
      <itunes:duration>05:07</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/d/f/3/8df32d64d5c01041/131224-jama-avi.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8)</title>
      <itunes:title>2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8)</itunes:title>
      <pubDate>Wed, 18 Dec 2013 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[e1dac98b7ba48b60f01a1e1d2021d216]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.284427]]></link>
      <description><![CDATA[<p>Interview with Paul A. James, MD, author of 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8)</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Paul A. James, MD, author of 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8)</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-12-18_Vol._311_No._5_Author_Interview.mp3?dest-id=90171" length="11061096" type="audio/mpeg" />
      <itunes:duration>22:57</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/8/a/a/18aa1e984c81589e/140204-jama-jai-james.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Calcium-Channel Blocker-Clarithromycin Drug Interactions and Acute Kidney Injury</title>
      <itunes:title>Calcium-Channel Blocker-Clarithromycin Drug Interactions and Acute Kidney Injury</itunes:title>
      <pubDate>Tue, 17 Dec 2013 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[b12e52cfab0c5601ad9a8b6c87f1b1fa]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.282426]]></link>
      <description><![CDATA[<p>Interview with Amit X. Garg, MD, PhD, author of Calcium-Channel Blocker-Clarithromycin Drug Interactions and Acute Kidney Injury</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Amit X. Garg, MD, PhD, author of Calcium-Channel Blocker-Clarithromycin Drug Interactions and Acute Kidney Injury</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-12-17_Vol._310_No._23_Author_Interview.mp3?dest-id=90171" length="2202616" type="audio/mpeg" />
      <itunes:duration>04:34</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/f/b/8/1/fb8142804c890fd7/131218-jama-jai-garg.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Three vs Twelve Months of Dual Antiplatelet Therapy After Zotarolimus-Eluting Stents</title>
      <itunes:title>Three vs Twelve Months of Dual Antiplatelet Therapy After Zotarolimus-Eluting Stents</itunes:title>
      <pubDate>Tue, 17 Dec 2013 20:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[640911333eed67054a875f8ca9b29af2]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.282183]]></link>
      <description><![CDATA[<p>Interview with Deepak L. Bhatt, MD, MPH, author of Three vs Twelve Months of Dual Antiplatelet Therapy After Zotarolimus-Eluting Stents</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Deepak L. Bhatt, MD, MPH, author of Three vs Twelve Months of Dual Antiplatelet Therapy After Zotarolimus-Eluting Stents</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-12-17_Vol._310_No._23_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="4754531" type="audio/mpeg" />
      <itunes:duration>04:54</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/9/6/8/89685d55a36ee714/131217-jama-avi.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Weight Change and Health Outcomes at 3 Years After Bariatric Surgery Among Individuals With Severe Obesity</title>
      <itunes:title>Weight Change and Health Outcomes at 3 Years After Bariatric Surgery Among Individuals With Severe Obesity</itunes:title>
      <pubDate>Tue, 10 Dec 2013 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[b253768392eaf3c963cab7d1ec381379]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.280928]]></link>
      <description><![CDATA[<p>Interview with Anita P. Courcoulas, MD, MPH, author of Weight Change and Health Outcomes at 3 Years After Bariatric Surgery Among Individuals With Severe Obesity</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Anita P. Courcoulas, MD, MPH, author of Weight Change and Health Outcomes at 3 Years After Bariatric Surgery Among Individuals With Severe Obesity</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-12-10_Vol._310_No._22_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="5645074" type="audio/mpeg" />
      <itunes:duration>05:50</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/d/1/2/3d127d47ebd03abe/131210-jama-avi.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Effect of Communication Skills Training for Residents and Nurse Practitioners on Quality of Communication With Patients With Serious Illness: A Randomized Trial</title>
      <itunes:title>Effect of Communication Skills Training for Residents and Nurse Practitioners on Quality of Communication With Patients With Serious Illness: A Randomized Trial</itunes:title>
      <pubDate>Tue, 03 Dec 2013 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[567ac9c5ac03cb5e3c95a907aa8d5fd0]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.282081]]></link>
      <description><![CDATA[<p>Interview with J. Randall Curtis, MD, MPH, author of Effect of Communication Skills Training for Residents and Nurse Practitioners on Quality of Communication With Patients With Serious Illness: A Randomized Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with J. Randall Curtis, MD, MPH, author of Effect of Communication Skills Training for Residents and Nurse Practitioners on Quality of Communication With Patients With Serious Illness: A Randomized Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-12-03_Vol._310_No._21_Author_Interview.mp3?dest-id=90171" length="3202164" type="audio/mpeg" />
      <itunes:duration>06:39</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/7/c/1/37c146fb23ade7a1/131204-jama-jai-curtis.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Rates of Medical Errors and Preventable Adverse Events Among Hospitalized Children Following Implementation of a Resident Handoff Bundle</title>
      <itunes:title>Rates of Medical Errors and Preventable Adverse Events Among Hospitalized Children Following Implementation of a Resident Handoff Bundle</itunes:title>
      <pubDate>Tue, 03 Dec 2013 20:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[db8c3c56fb6c9216a25ba38fb947e6ab]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.281961]]></link>
      <description><![CDATA[<p>Interview with Amy J. Starmer, MD, MPH, author of Rates of Medical Errors and Preventable Adverse Events Among Hospitalized Children Following Implementation of a Resident Handoff Bundle</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Amy J. Starmer, MD, MPH, author of Rates of Medical Errors and Preventable Adverse Events Among Hospitalized Children Following Implementation of a Resident Handoff Bundle</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-12-03_Vol._310_No._21_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="4325532" type="audio/mpeg" />
      <itunes:duration>04:28</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/4/9/8/0/498063947b062ffa/131203-jama-avi.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Effect of Micronutrient Supplementation on Disease Progression in Asymptomatic, Antiretroviral-Naive, HIV-Infected Adults in Botswana</title>
      <itunes:title>Effect of Micronutrient Supplementation on Disease Progression in Asymptomatic, Antiretroviral-Naive, HIV-Infected Adults in Botswana</itunes:title>
      <pubDate>Tue, 26 Nov 2013 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[cf05361300eb3c95b5c33776ad0a6885]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.280923]]></link>
      <description><![CDATA[<p>Interview with Marianna K Baum, PhD, author of Effect of Micronutrient Supplementation on Disease Progression in Asymptomatic, Antiretroviral-Naive, HIV-Infected Adults in Botswana</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Marianna K Baum, PhD, author of Effect of Micronutrient Supplementation on Disease Progression in Asymptomatic, Antiretroviral-Naive, HIV-Infected Adults in Botswana</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-11-26_Vol._310_No._20_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="4583866" type="audio/mpeg" />
      <itunes:duration>04:44</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/d/3/7/a/d37ad6d148114e0e/131126-jama-avi.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>JEffect of Weight Reduction and Cardiometabolic Risk Factor Management on Symptom Burden and Severity in Patients With Atrial Fibrillation: A Randomized Clinical Trial</title>
      <itunes:title>JEffect of Weight Reduction and Cardiometabolic Risk Factor Management on Symptom Burden and Severity in Patients With Atrial Fibrillation: A Randomized Clinical Trial</itunes:title>
      <pubDate>Sun, 17 Nov 2013 17:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[56919072f5b941474d0cc90012d13dec]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.280521]]></link>
      <description><![CDATA[<p>Interview with Prashanthan Sanders, MBBS, PhD, author of Effect of Weight Reduction and Cardiometabolic Risk Factor Management on Symptom Burden and Severity in Patients With Atrial Fibrillation: A Randomized Clinical Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Prashanthan Sanders, MBBS, PhD, author of Effect of Weight Reduction and Cardiometabolic Risk Factor Management on Symptom Burden and Severity in Patients With Atrial Fibrillation: A Randomized Clinical Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-11-17_Vol._310_No._19_Author_Interview.mp3?dest-id=90171" length="3231094" type="audio/mpeg" />
      <itunes:duration>06:42</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/d/c/9/edc9e111d1f5c19f/131119-jama-jai-sanders.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Outcomes Following Transcatheter Aortic Valve Replacement in the United States</title>
      <itunes:title>Outcomes Following Transcatheter Aortic Valve Replacement in the United States</itunes:title>
      <pubDate>Sun, 17 Nov 2013 16:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[fff463a94d4cfbcf9ddff1637dca8112]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.282043]]></link>
      <description><![CDATA[<p>Interview with Michael J. Mack, MD, author of Outcomes Following Transcatheter Aortic Valve Replacement in the United States</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Michael J. Mack, MD, author of Outcomes Following Transcatheter Aortic Valve Replacement in the United States</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-11-17_Vol._310_No._19_Audio_from_Weekly_Author_Video_Interview_JAMA_2013-11-17_Vol._310_No._19_Audio_from_Weekly_Author_Video_Interview_JAMA_2013-11-17_Vol._310_No._19_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="4433292" type="audio/mpeg" />
      <itunes:duration>04:34</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/a/d/d/8adda68863819ef6/131117-jama-avi.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>The Anatomy of Health Care in the United States</title>
      <itunes:title>The Anatomy of Health Care in the United States</itunes:title>
      <pubDate>Tue, 12 Nov 2013 14:30:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[cbf5b3095031d604b463196df99c119a]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.281425]]></link>
      <description><![CDATA[<p>Interview with Hamilton Moses III, MD, author of The Anatomy of Health Care in the United States</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Hamilton Moses III, MD, author of The Anatomy of Health Care in the United States</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-11-12_Vol._310_No._18_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="7843391" type="audio/mpeg" />
      <itunes:duration>08:07</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/3/0/e/930ea367880a772b/131112-jama-avi.png" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Complications of Daytime Elective Laparoscopic Cholecystectomies Performed by Surgeons Who Operated the Night Before</title>
      <itunes:title>Complications of Daytime Elective Laparoscopic Cholecystectomies Performed by Surgeons Who Operated the Night Before</itunes:title>
      <pubDate>Tue, 05 Nov 2013 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[d834f13c738d630639949374457da938]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.280372]]></link>
      <description><![CDATA[<p>Interview with Christopher Vinden, MD, author of Complications of Daytime Elective Laparoscopic Cholecystectomies Performed by Surgeons Who Operated the Night Before</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Christopher Vinden, MD, author of Complications of Daytime Elective Laparoscopic Cholecystectomies Performed by Surgeons Who Operated the Night Before</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-11-05_Vol._310_No._17_Author_Interview.mp3?dest-id=90171" length="3138641" type="audio/mpeg" />
      <itunes:duration>06:31</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/9/e/4/09e45c70ef29ab56/131105-jama-jai-vinden.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Association of Testosterone Therapy With Mortality, Myocardial Infarction, and Stroke in Men With Low Testosterone Levels</title>
      <itunes:title>Association of Testosterone Therapy With Mortality, Myocardial Infarction, and Stroke in Men With Low Testosterone Levels</itunes:title>
      <pubDate>Tue, 05 Nov 2013 20:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[6465b27bcbec74030947912ef0a5e126]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.280386]]></link>
      <description><![CDATA[<p>Interview with Michael Ho, MD, PhD, author of Association of Testosterone Therapy With Mortality, Myocardial Infarction, and Stroke in Men With Low Testosterone Levels</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Michael Ho, MD, PhD, author of Association of Testosterone Therapy With Mortality, Myocardial Infarction, and Stroke in Men With Low Testosterone Levels</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-11-05_Vol._310_No._17_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="4496882" type="audio/mpeg" />
      <itunes:duration>04:38</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/f/5/8/d/f58d4009f4a5b1dd/131105-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Association Between Influenza Vaccination and Cardiovascular Outcomes in High-Risk Patients: A Meta-analysis</title>
      <itunes:title>Association Between Influenza Vaccination and Cardiovascular Outcomes in High-Risk Patients: A Meta-analysis</itunes:title>
      <pubDate>Tue, 22 Oct 2013 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[d99580653e2c140ee8a72a510b49767d]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.279206]]></link>
      <description><![CDATA[<p>Interview with Jacob A. Udell, MD, MPH, FRCPC, author of Association Between Influenza Vaccination and Cardiovascular Outcomes in High-Risk Patients: A Meta-analysis</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Jacob A. Udell, MD, MPH, FRCPC, author of Association Between Influenza Vaccination and Cardiovascular Outcomes in High-Risk Patients: A Meta-analysis</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-10-22_Vol._310_No._16_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="5044038" type="audio/mpeg" />
      <itunes:duration>05:15</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/f/9/6/9/f969c7bbcb2910ee/131022-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>World Medical Association's Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects</title>
      <itunes:title>World Medical Association's Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects</itunes:title>
      <pubDate>Sat, 19 Oct 2013 18:30:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[77c1cd50baf7f32d7c94f9efbb1466cf]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.281053]]></link>
      <description><![CDATA[<p>Howard Bauchner, MD interviews Ramin W. Parsa-Parsi, MD, MPH and Heikki Pälve, MD, PhD about the World Medical Association's Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects</p>]]></description>
      
      <content:encoded><![CDATA[<p>Howard Bauchner, MD interviews Ramin W. Parsa-Parsi, MD, MPH and Heikki Pälve, MD, PhD about the World Medical Association's Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-10-19_Vol._310_No._20_Author_Interview.mp3?dest-id=90171" length="11859427" type="audio/mpeg" />
      <itunes:duration>24:41</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/6/c/c/36ccd007ff9896ad/131019-jama-jai-palve.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Metoclopramide in Pregnancy and Risk of Major Congenital Malformations and Fetal Death</title>
      <itunes:title>Metoclopramide in Pregnancy and Risk of Major Congenital Malformations and Fetal Death</itunes:title>
      <pubDate>Tue, 15 Oct 2013 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[373f8b0ff4db1f8650817099a68dddaa]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.278343]]></link>
      <description><![CDATA[<p>Interview with Björn Pasternak, MD, PhD, author of Metoclopramide in Pregnancy and Risk of Major Congenital Malformations and Fetal Death</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Björn Pasternak, MD, PhD, author of Metoclopramide in Pregnancy and Risk of Major Congenital Malformations and Fetal Death</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-10-15_Vol._310_No._15_Author_Interview.mp3?dest-id=90171" length="3304601" type="audio/mpeg" />
      <itunes:duration>06:51</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/f/7/c/4/f7c4af3b90799cf9/131016-jama-jai-pasternak.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Evaluation of Surveillance Bias and the Validity of the Venous Thromboembolism Quality Measure</title>
      <itunes:title>Evaluation of Surveillance Bias and the Validity of the Venous Thromboembolism Quality Measure</itunes:title>
      <pubDate>Mon, 07 Oct 2013 15:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[03b2355fc604d8ad48f558be8ee91228]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.280048]]></link>
      <description><![CDATA[<p>Interview with Karl Y. Bilimoria, MD, author of Evaluation of Surveillance Bias and the Validity of the Venous Thromboembolism Quality Measure</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Karl Y. Bilimoria, MD, author of Evaluation of Surveillance Bias and the Validity of the Venous Thromboembolism Quality Measure</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-10-07_Vol._310_No._14_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="2663586" type="audio/mpeg" />
      <itunes:duration>02:46</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/5/0/7/2/507230aa90f669f2/131007-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Universal Glove and Gown Use and Acquisition of Antibiotic-Resistant Bacteria in the ICU: A Randomized Trial</title>
      <itunes:title>Universal Glove and Gown Use and Acquisition of Antibiotic-Resistant Bacteria in the ICU: A Randomized Trial</itunes:title>
      <pubDate>Fri, 04 Oct 2013 23:15:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[553a35bb7ddeb98d6661c05fa2f92570]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.277815]]></link>
      <description><![CDATA[<p>Interview with Anthony D. Harris, MD, author of Universal Glove and Gown Use and Acquisition of Antibiotic-Resistant Bacteria in the ICU: A Randomized Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Anthony D. Harris, MD, author of Universal Glove and Gown Use and Acquisition of Antibiotic-Resistant Bacteria in the ICU: A Randomized Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-10-04_Vol._310_No._15_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="4153027" type="audio/mpeg" />
      <itunes:duration>04:19</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/9/5/3/a953f786482ad9bc/131004-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Association of National Initiatives to Improve Cardiac Arrest Management With Rates of Bystander Intervention and Patient Survival After Out-of-Hospital Cardiac Arrest</title>
      <itunes:title>Association of National Initiatives to Improve Cardiac Arrest Management With Rates of Bystander Intervention and Patient Survival After Out-of-Hospital Cardiac Arrest</itunes:title>
      <pubDate>Tue, 01 Oct 2013 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[3d014d52f91ff93811943eafd7aaf9ad]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.278483]]></link>
      <description><![CDATA[<p>Interview with Christian Torp-Pedersen, MD, DSc, author of Association of National Initiatives to Improve Cardiac Arrest Management With Rates of Bystander Intervention and Patient Survival After Out-of-Hospital Cardiac Arrest</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Christian Torp-Pedersen, MD, DSc, author of Association of National Initiatives to Improve Cardiac Arrest Management With Rates of Bystander Intervention and Patient Survival After Out-of-Hospital Cardiac Arrest</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-10-01_Vol._310_No._13_Author_Interview.mp3?dest-id=90171" length="2689296" type="audio/mpeg" />
      <itunes:duration>05:35</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/7/2/b/672b4d8bf018c33f/131002-jama-jai-torp-pedersen.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Menopausal Hormone Therapy and Health Outcomes During the Intervention and Extended Poststopping Phases of the Women's Health Initiative Randomized Trials</title>
      <itunes:title>Menopausal Hormone Therapy and Health Outcomes During the Intervention and Extended Poststopping Phases of the Women's Health Initiative Randomized Trials</itunes:title>
      <pubDate>Tue, 01 Oct 2013 19:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[b0216f34e514d6c309db46da7b540b5c]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.278040]]></link>
      <description><![CDATA[<p>Interview with JoAnn E. Manson, MD, author of Menopausal Hormone Therapy and Health Outcomes During the Intervention and Extended Poststopping Phases of the Women's Health Initiative Randomized Trials</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with JoAnn E. Manson, MD, author of Menopausal Hormone Therapy and Health Outcomes During the Intervention and Extended Poststopping Phases of the Women's Health Initiative Randomized Trials</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-10-01_Vol._310_No._13_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="6779973" type="audio/mpeg" />
      <itunes:duration>07:03</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/a/b/1/cab13967153b1be6/131001-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Repeat Bone Mineral Density Screening and Prediction of Hip and Major Osteoporotic Fracture</title>
      <itunes:title>Repeat Bone Mineral Density Screening and Prediction of Hip and Major Osteoporotic Fracture</itunes:title>
      <pubDate>Tue, 24 Sep 2013 19:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[073c9564020b3ea6c13bd6c9cd5fba96]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.277817]]></link>
      <description><![CDATA[<p>Interview with Sarah D. Berry, MD, author of Repeat Bone Mineral Density Screening and Prediction of Hip and Major Osteoporotic Fracture</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Sarah D. Berry, MD, author of Repeat Bone Mineral Density Screening and Prediction of Hip and Major Osteoporotic Fracture</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-09-24_Vol._310_No._12_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="4445674" type="audio/mpeg" />
      <itunes:duration>04:37</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/e/a/e/aeaed3d7fac017a7/130924-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Mobility Limitation in the Older Patient: A Clinical Review</title>
      <itunes:title>Mobility Limitation in the Older Patient: A Clinical Review</itunes:title>
      <pubDate>Tue, 17 Sep 2013 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[7e10f67930bdf21f663bb0fdb0a7a8d8]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.276566]]></link>
      <description><![CDATA[<p>Interview with Cynthia J. Brown, MD, author of Mobility Limitation in the Older Patient: A Clinical Review</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Cynthia J. Brown, MD, author of Mobility Limitation in the Older Patient: A Clinical Review</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-09-17_Vol._310_No._11_Author_Interview.mp3?dest-id=90171" length="4191187" type="audio/mpeg" />
      <itunes:duration>08:42</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/c/8/7/2c87f1e36ec48f24/130917-jama-jai-brown.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Chronic Care Management for Dependence on Alcohol and Other Drugs</title>
      <itunes:title>Chronic Care Management for Dependence on Alcohol and Other Drugs</itunes:title>
      <pubDate>Tue, 17 Sep 2013 19:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[b76898380badbb1769e5b0e35b331d8a]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.277609]]></link>
      <description><![CDATA[<p>Interview with Richard Saitz, MD, MPH, author of Chronic Care Management for Dependence on Alcohol and Other Drugs</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Richard Saitz, MD, MPH, author of Chronic Care Management for Dependence on Alcohol and Other Drugs</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-09-17_Vol._310_No._11_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="2994628" type="audio/mpeg" />
      <itunes:duration>03:07</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/0/3/a/903aa3bf494dafeb/130917-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Effects of Individual Physician-Level and Practice-Level Financial Incentives on Hypertension Care</title>
      <itunes:title>Effects of Individual Physician-Level and Practice-Level Financial Incentives on Hypertension Care</itunes:title>
      <pubDate>Tue, 10 Sep 2013 19:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[85676a5729e294827e8a10800c041176]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.276303]]></link>
      <description><![CDATA[<p>Interview with Laura A. Petersen, MD, MPH, author of Effects of Individual Physician-Level and Practice-Level Financial Incentives on Hypertension Care</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Laura A. Petersen, MD, MPH, author of Effects of Individual Physician-Level and Practice-Level Financial Incentives on Hypertension Care</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-09-10_Vol._310_No._10_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="5538650" type="audio/mpeg" />
      <itunes:duration>05:45</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/9/7/0/897034bf7860d0f5/130910-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>The Evolving Science of Cochlear Implants</title>
      <itunes:title>The Evolving Science of Cochlear Implants</itunes:title>
      <pubDate>Mon, 09 Sep 2013 12:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[7d81fedbf5f0eb127a1db8e75424c2db]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.278142]]></link>
      <description><![CDATA[<p>Interview with Graeme M. Clark, AC, FRS, FAA, author of The Evolving Science of Cochlear Implants</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Graeme M. Clark, AC, FRS, FAA, author of The Evolving Science of Cochlear Implants</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-09-09_Vol._310_No._12_Author_Interview.mp3?dest-id=90171" length="3948342" type="audio/mpeg" />
      <itunes:duration>08:12</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/d/e/f/7/def7a50896ef5d88/130909-jama-jai-clark.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Industry-Sponsored Clinical Trials in Emerging Markets: Time to Review the Terms of Engagement</title>
      <itunes:title>Industry-Sponsored Clinical Trials in Emerging Markets: Time to Review the Terms of Engagement</itunes:title>
      <pubDate>Tue, 03 Sep 2013 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[67c2bc2c72d4a4acf48235a0301eee6f]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.276913]]></link>
      <description><![CDATA[<p>Interview with Stephen MacMahon, DSc, FMedSci, author of Industry-Sponsored Clinical Trials in Emerging Markets: Time to Review the Terms of Engagement</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Stephen MacMahon, DSc, FMedSci, author of Industry-Sponsored Clinical Trials in Emerging Markets: Time to Review the Terms of Engagement</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-09-03_Vol._310_No._9_Author_Interview.mp3?dest-id=90171" length="4480900" type="audio/mpeg" />
      <itunes:duration>09:17</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/c/7/0/1c707b9afef4e676/130903-jama-jai-macmahon.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Effects of a Fixed-Dose Combination Strategy on Adherence and Risk Factors in Patients With or at High Risk of CVD: The UMPIRE Randomized Clinical Trial</title>
      <itunes:title>Effects of a Fixed-Dose Combination Strategy on Adherence and Risk Factors in Patients With or at High Risk of CVD: The UMPIRE Randomized Clinical Trial</itunes:title>
      <pubDate>Tue, 03 Sep 2013 19:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[29e9dd3d835f2994506e355f5269b6b2]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.277064]]></link>
      <description><![CDATA[<p>Interview with Simon Thom, MB,BS, MD, author of Effects of a Fixed-Dose Combination Strategy on Adherence and Risk Factors in Patients With or at High Risk of CVD: The UMPIRE Randomized Clinical Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Simon Thom, MB,BS, MD, author of Effects of a Fixed-Dose Combination Strategy on Adherence and Risk Factors in Patients With or at High Risk of CVD: The UMPIRE Randomized Clinical Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-09-03_Vol._310_No._9_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="4315617" type="audio/mpeg" />
      <itunes:duration>04:29</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/f/2/0/7/f20719fbf9311c51/130903-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Sofosbuvir and Ribavirin for Hepatitis C Genotype 1 in Patients With Unfavorable Treatment Characteristics: A Randomized Clinical Trial</title>
      <itunes:title>Sofosbuvir and Ribavirin for Hepatitis C Genotype 1 in Patients With Unfavorable Treatment Characteristics: A Randomized Clinical Trial</itunes:title>
      <pubDate>Tue, 27 Aug 2013 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[74c26d50ac9abd3acb50f12040aa82ac]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.109309]]></link>
      <description><![CDATA[<p>Interview with Anthony S. Fauci, MD, author of Sofosbuvir and Ribavirin for Hepatitis C Genotype 1 in Patients With Unfavorable Treatment Characteristics: A Randomized Clinical Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Anthony S. Fauci, MD, author of Sofosbuvir and Ribavirin for Hepatitis C Genotype 1 in Patients With Unfavorable Treatment Characteristics: A Randomized Clinical Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-08-27_Vol._310_No._8_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="3858689" type="audio/mpeg" />
      <itunes:duration>04:01</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/8/a/0/08a08bf7a05b3603/130827-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>The Regulatory Challenge of Electronic Cigarettes</title>
      <itunes:title>The Regulatory Challenge of Electronic Cigarettes</itunes:title>
      <pubDate>Tue, 20 Aug 2013 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[ed1e8c5d5ebc73ada45cbdb5df8f060a]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.109501]]></link>
      <description><![CDATA[<p>Interview with Neal L. Benowitz, MD, author of The Regulatory Challenge of Electronic Cigarettes</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Neal L. Benowitz, MD, author of The Regulatory Challenge of Electronic Cigarettes</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-08-20_Vol._310_No._7_Author_Interview.mp3?dest-id=90171" length="5794114" type="audio/mpeg" />
      <itunes:duration>12:03</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/6/6/9/2669f7ec391cea30/130820-jama-jai-benowitz.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Improved Blood Pressure Control Associated With a Large-Scale Hypertension Program</title>
      <itunes:title>Improved Blood Pressure Control Associated With a Large-Scale Hypertension Program</itunes:title>
      <pubDate>Tue, 20 Aug 2013 19:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[142afb91637f9986f3721c451e0ca785]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.108769]]></link>
      <description><![CDATA[<p>Interview with Marc G. Jaffe, MD, author of Improved Blood Pressure Control Associated With a Large-Scale Hypertension Program</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Marc G. Jaffe, MD, author of Improved Blood Pressure Control Associated With a Large-Scale Hypertension Program</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-08-20_Vol._310_No._7_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="3722092" type="audio/mpeg" />
      <itunes:duration>03:52</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/a/a/9/aaa94f2adf7b86ce/130820-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Concurrent Naltrexone and Prolonged Exposure Therapy for Patients With Comorbid Alcohol Dependence and PTSD: A Randomized Clinical Trial</title>
      <itunes:title>Concurrent Naltrexone and Prolonged Exposure Therapy for Patients With Comorbid Alcohol Dependence and PTSD: A Randomized Clinical Trial</itunes:title>
      <pubDate>Tue, 06 Aug 2013 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[48153b8c1d192cfbd64d95738b64bfda]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.8268]]></link>
      <description><![CDATA[<p>Interview with Edna B. Foa, PhD, author of Concurrent Naltrexone and Prolonged Exposure Therapy for Patients With Comorbid Alcohol Dependence and PTSD: A Randomized Clinical Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Edna B. Foa, PhD, author of Concurrent Naltrexone and Prolonged Exposure Therapy for Patients With Comorbid Alcohol Dependence and PTSD: A Randomized Clinical Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-08-06_Vol._310_No._5_Author_Interview.mp3?dest-id=90171" length="4750507" type="audio/mpeg" />
      <itunes:duration>09:52</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/b/9/7/9b975cad76c1f28a/130806-jama-jai-foa.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Risk Factors Associated With Suicide in Current and Former US Military Personnel</title>
      <itunes:title>Risk Factors Associated With Suicide in Current and Former US Military Personnel</itunes:title>
      <pubDate>Tue, 06 Aug 2013 19:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[2283e2a375572fc2ed5add86f5db5dbc]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.65164]]></link>
      <description><![CDATA[<p>Interview with Cynthia A. LeardMann, MPH, author of Risk Factors Associated With Suicide in Current and Former US Military Personnel</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Cynthia A. LeardMann, MPH, author of Risk Factors Associated With Suicide in Current and Former US Military Personnel</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-08-06_Vol._310_No._5_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="3819455" type="audio/mpeg" />
      <itunes:duration>03:58</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/5/8/d/158d25769bc18f45/130806-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Views of US Physicians About Controlling Health Care Costs</title>
      <itunes:title>Views of US Physicians About Controlling Health Care Costs</itunes:title>
      <pubDate>Tue, 23 Jul 2013 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[f39ca04f92c4d74c2a40d6666272f331]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.8278]]></link>
      <description><![CDATA[<p>Interview with Jon C. Tilburt, MD, MPH, author of Views of US Physicians About Controlling Health Care Costs</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Jon C. Tilburt, MD, MPH, author of Views of US Physicians About Controlling Health Care Costs</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-07-23_Vol._310_No._4_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="4867023" type="audio/mpeg" />
      <itunes:duration>05:04</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/6/b/b/e6bb3e3f4da7ae01/130723-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Association Between Duration of Overall and Abdominal Obesity Beginning in Young Adulthood and Coronary Artery Calcification in Middle Age</title>
      <itunes:title>Association Between Duration of Overall and Abdominal Obesity Beginning in Young Adulthood and Coronary Artery Calcification in Middle Age</itunes:title>
      <pubDate>Tue, 16 Jul 2013 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[4e5c2463aee4929b0e45dbcd200f3a96]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.7833]]></link>
      <description><![CDATA[<p>Interview with Jared P. Reis, PhD, author of Association Between Duration of Overall and Abdominal Obesity Beginning in Young Adulthood and Coronary Artery Calcification in Middle Age</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Jared P. Reis, PhD, author of Association Between Duration of Overall and Abdominal Obesity Beginning in Young Adulthood and Coronary Artery Calcification in Middle Age</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-07-16_Vol._310_No._3_Author_Interview.mp3?dest-id=90171" length="2578290" type="audio/mpeg" />
      <itunes:duration>05:21</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/0/9/0/80902e75b63eb35c/130716-jama-jas-reis.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>The 2012 West Nile Encephalitis Epidemic in Dallas, Texas</title>
      <itunes:title>The 2012 West Nile Encephalitis Epidemic in Dallas, Texas</itunes:title>
      <pubDate>Tue, 16 Jul 2013 19:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[84df38a6bc5702a64badac8a7385ea91]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.8267]]></link>
      <description><![CDATA[<p>Interview with Wendy M. Chung, MD, SM, author of The 2012 West Nile Encephalitis Epidemic in Dallas, Texas</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Wendy M. Chung, MD, SM, author of The 2012 West Nile Encephalitis Epidemic in Dallas, Texas</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-07-16_Vol._310_No._3_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="3882383" type="audio/mpeg" />
      <itunes:duration>04:02</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/8/f/0/68f02b576c80064a/130716-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>The State of US Health, 1990-2010: Burden of Diseases, Injuries, and Risk Factors</title>
      <itunes:title>The State of US Health, 1990-2010: Burden of Diseases, Injuries, and Risk Factors</itunes:title>
      <pubDate>Wed, 10 Jul 2013 14:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[b803a9a64cab2bdb24e5dbbeb97039b8]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.13805]]></link>
      <description><![CDATA[<p>Interview with Christopher J. L. Murray, MD, DPhil, author of The State of US Health, 1990-2010: Burden of Diseases, Injuries, and Risk Factors</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Christopher J. L. Murray, MD, DPhil, author of The State of US Health, 1990-2010: Burden of Diseases, Injuries, and Risk Factors</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-07-10_Online_First_Audio_from_Author_Video_Interview.mp3?dest-id=90171" length="7427558" type="audio/mpeg" />
      <itunes:duration>07:44</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/d/9/3/1/d931d1d81788d327/130710-jama-olf-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Geographic Variation in Cardiovascular Procedure Use Among Medicare Fee-for-Service vs Medicare Advantage Beneficiaries</title>
      <itunes:title>Geographic Variation in Cardiovascular Procedure Use Among Medicare Fee-for-Service vs Medicare Advantage Beneficiaries</itunes:title>
      <pubDate>Tue, 09 Jul 2013 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[8fab64dad1cada315ebb0b31c32de37b]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.7837]]></link>
      <description><![CDATA[<p>Interview with Daniel D. Matlock, MD, MPH, author of Geographic Variation in Cardiovascular Procedure Use Among Medicare Fee-for-Service vs Medicare Advantage Beneficiaries</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Daniel D. Matlock, MD, MPH, author of Geographic Variation in Cardiovascular Procedure Use Among Medicare Fee-for-Service vs Medicare Advantage Beneficiaries</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-07-09_Vol._310_No._2_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="4707147" type="audio/mpeg" />
      <itunes:duration>04:54</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/6/8/d/868d7818d3afb3d2/130709-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>The Paradox of Disease Prevention: Celebrated in Principle, Resisted in Practice</title>
      <itunes:title>The Paradox of Disease Prevention: Celebrated in Principle, Resisted in Practice</itunes:title>
      <pubDate>Tue, 02 Jul 2013 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[8aba974401b045dfe25dd0f00b2fa158]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.7518]]></link>
      <description><![CDATA[<p>Interview with Harvey V. Fineberg, MD, PhD, author of The Paradox of Disease Prevention: Celebrated in Principle, Resisted in Practice</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Harvey V. Fineberg, MD, PhD, author of The Paradox of Disease Prevention: Celebrated in Principle, Resisted in Practice</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-07-02_Vol._310_No._1_Author_Interview.mp3?dest-id=90171" length="4170763" type="audio/mpeg" />
      <itunes:duration>08:40</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/7/f/1/97f1c095efced95c/130703-jama-jai-fineberg.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Effect of Home Blood Pressure Telemonitoring and Pharmacist Management on Blood Pressure Control: A Cluster Randomized Clinical Trial</title>
      <itunes:title>Effect of Home Blood Pressure Telemonitoring and Pharmacist Management on Blood Pressure Control: A Cluster Randomized Clinical Trial</itunes:title>
      <pubDate>Tue, 02 Jul 2013 19:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[ca9ac2caf60913515e19e345fff9554b]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.6549]]></link>
      <description><![CDATA[<p>Interview with Karen L. Margolis, MD, MPH, author of Effect of Home Blood Pressure Telemonitoring and Pharmacist Management on Blood Pressure Control: A Cluster Randomized Clinical Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Karen L. Margolis, MD, MPH, author of Effect of Home Blood Pressure Telemonitoring and Pharmacist Management on Blood Pressure Control: A Cluster Randomized Clinical Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-07-02_Vol._310_No._1_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="3654737" type="audio/mpeg" />
      <itunes:duration>03:48</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/7/6/0/c/760c6b9d1957143e/130702-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Use of Advanced Treatment Technologies Among Men at Low Risk of Dying From Prostate Cancer</title>
      <itunes:title>Use of Advanced Treatment Technologies Among Men at Low Risk of Dying From Prostate Cancer</itunes:title>
      <pubDate>Tue, 25 Jun 2013 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[e7fc9bb808e277eb9c9489489109236a]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.6882]]></link>
      <description><![CDATA[<p>Interview with Brent K. Hollenbeck, MD, MS, author of Use of Advanced Treatment Technologies Among Men at Low Risk of Dying From Prostate Cancer</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Brent K. Hollenbeck, MD, MS, author of Use of Advanced Treatment Technologies Among Men at Low Risk of Dying From Prostate Cancer</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-06-25_Vol._309_No._24_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="2899912" type="audio/mpeg" />
      <itunes:duration>03:01</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/7/2/f/e/72fe88d3b4f23382/130625-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Time to Treatment With Intravenous Tissue Plasminogen Activator and Outcome From Acute Ischemic Stroke</title>
      <itunes:title>Time to Treatment With Intravenous Tissue Plasminogen Activator and Outcome From Acute Ischemic Stroke</itunes:title>
      <pubDate>Tue, 18 Jun 2013 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[f7bd3e5b38392f900534090c2198c07f]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.6959]]></link>
      <description><![CDATA[<p>Interview with Jeffrey L. Saver, MD, author of Time to Treatment With Intravenous Tissue Plasminogen Activator and Outcome From Acute Ischemic Stroke</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Jeffrey L. Saver, MD, author of Time to Treatment With Intravenous Tissue Plasminogen Activator and Outcome From Acute Ischemic Stroke</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-06-18_Vol._309_No._23_Author_Interview.mp3?dest-id=90171" length="3081531" type="audio/mpeg" />
      <itunes:duration>06:22</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/3/4/6/3346c2c72518515b/130618-jama-jai-saver.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Magnetic Resonance Imaging Screening to Identify Spinal and Paraspinal Infections Associated With Injections of Contaminated Methylprednisolone Acetate</title>
      <itunes:title>Magnetic Resonance Imaging Screening to Identify Spinal and Paraspinal Infections Associated With Injections of Contaminated Methylprednisolone Acetate</itunes:title>
      <pubDate>Tue, 18 Jun 2013 19:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[10dbd05f6d4f99f18eb3485c080209e2]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.6293]]></link>
      <description><![CDATA[<p>Interview with Anurag N. Malani, MD, author of Magnetic Resonance Imaging Screening to Identify Spinal and Paraspinal Infections Associated With Injections of Contaminated Methylprednisolone Acetate</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Anurag N. Malani, MD, author of Magnetic Resonance Imaging Screening to Identify Spinal and Paraspinal Infections Associated With Injections of Contaminated Methylprednisolone Acetate</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-06-18_Vol._309_No._23_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="5986794" type="audio/mpeg" />
      <itunes:duration>06:14</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/5/c/4/9/5c49137f67be22c5/130618-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Effect of an Outpatient Antimicrobial Stewardship Intervention on Broad-Spectrum Antibiotic Prescribing by Primary Care Pediatricians: A Randomized Trial</title>
      <itunes:title>Effect of an Outpatient Antimicrobial Stewardship Intervention on Broad-Spectrum Antibiotic Prescribing by Primary Care Pediatricians: A Randomized Trial</itunes:title>
      <pubDate>Tue, 11 Jun 2013 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[21cfc43eaed8668337ee9009332c26c1]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.6287]]></link>
      <description><![CDATA[<p>Interview with Jeffrey S. Gerber, MD, PhD, author of Effect of an Outpatient Antimicrobial Stewardship Intervention on Broad-Spectrum Antibiotic Prescribing by Primary Care Pediatricians: A Randomized Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Jeffrey S. Gerber, MD, PhD, author of Effect of an Outpatient Antimicrobial Stewardship Intervention on Broad-Spectrum Antibiotic Prescribing by Primary Care Pediatricians: A Randomized Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-06-11_Vol._309_No._22_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="3254230" type="audio/mpeg" />
      <itunes:duration>03:23</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/1/d/b/91db9ab811db5f9a/130611-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Short-term vs Conventional Glucocorticoid Therapy in Acute Exacerbations of Chronic Obstructive Pulmonary Disease: The REDUCE Randomized Clinical Trial</title>
      <itunes:title>Short-term vs Conventional Glucocorticoid Therapy in Acute Exacerbations of Chronic Obstructive Pulmonary Disease: The REDUCE Randomized Clinical Trial</itunes:title>
      <pubDate>Tue, 04 Jun 2013 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[083c4c1250ffdf6865590893c2b08e3d]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.5023]]></link>
      <description><![CDATA[<p>Interview with Jonas Rutishauser, MD, author of Short-term vs Conventional Glucocorticoid Therapy in Acute Exacerbations of Chronic Obstructive Pulmonary Disease: The REDUCE Randomized Clinical Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Jonas Rutishauser, MD, author of Short-term vs Conventional Glucocorticoid Therapy in Acute Exacerbations of Chronic Obstructive Pulmonary Disease: The REDUCE Randomized Clinical Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-06-04_Vol._309_No._21_Author_Interview.mp3?dest-id=90171" length="5485268" type="audio/mpeg" />
      <itunes:duration>11:24</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/b/a/b/6/bab63b929c261597/130604-jama-jai-rutishauser.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Roux-en-Y Gastric Bypass vs Intensive Medical Management for the Control of Type 2 Diabetes, Hypertension, and Hyperlipidemia: The Diabetes Surgery Study Randomized Clinical Trial</title>
      <itunes:title>Roux-en-Y Gastric Bypass vs Intensive Medical Management for the Control of Type 2 Diabetes, Hypertension, and Hyperlipidemia: The Diabetes Surgery Study Randomized Clinical Trial</itunes:title>
      <pubDate>Tue, 04 Jun 2013 19:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[20f6a25ddfaec1a5de7d4e869858953d]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.5835]]></link>
      <description><![CDATA[<p>Interview with Sayeed Ikramuddin, MD, author of Roux-en-Y Gastric Bypass vs Intensive Medical Management for the Control of Type 2 Diabetes, Hypertension, and Hyperlipidemia: The Diabetes Surgery Study Randomized Clinical Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Sayeed Ikramuddin, MD, author of Roux-en-Y Gastric Bypass vs Intensive Medical Management for the Control of Type 2 Diabetes, Hypertension, and Hyperlipidemia: The Diabetes Surgery Study Randomized Clinical Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-06-04_Vol._309_No._21_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="6259315" type="audio/mpeg" />
      <itunes:duration>06:31</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/1/e/8/61e8640d09eb1e47/130604-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Effect of Escitalopram on Mental Stress-Induced Myocardial Ischemia: Results of the REMIT Trial</title>
      <itunes:title>Effect of Escitalopram on Mental Stress-Induced Myocardial Ischemia: Results of the REMIT Trial</itunes:title>
      <pubDate>Tue, 21 May 2013 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[b0fafdf67701ea08fcaa7bafa80377ed]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.5566]]></link>
      <description><![CDATA[<p>Interview with Christopher O'Connor, MD, author of Effect of Escitalopram on Mental Stress-Induced Myocardial Ischemia: Results of the REMIT Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Christopher O'Connor, MD, author of Effect of Escitalopram on Mental Stress-Induced Myocardial Ischemia: Results of the REMIT Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-05-21_Vol._309_No._20_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="6073238" type="audio/mpeg" />
      <itunes:duration>06:19</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/7/d/b/c7dbb5548a7b673c/130521-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Long-term Outcomes Following Abdominal Sacrocolpopexy for Pelvic Organ Prolapse</title>
      <itunes:title>Long-term Outcomes Following Abdominal Sacrocolpopexy for Pelvic Organ Prolapse</itunes:title>
      <pubDate>Tue, 14 May 2013 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[e5f0294d23451817dec4d5cc98a5e6c8]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.4919]]></link>
      <description><![CDATA[<p>Interview with Linda Brubaker, MD, author of Long-term Outcomes Following Abdominal Sacrocolpopexy for Pelvic Organ Prolapse</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Linda Brubaker, MD, author of Long-term Outcomes Following Abdominal Sacrocolpopexy for Pelvic Organ Prolapse</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-05-14_Vol._309_No._19_Author_Interview.mp3?dest-id=90171" length="2564539" type="audio/mpeg" />
      <itunes:duration>05:19</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/2/9/e/e29e31d39e38cae8/130514-jama-jai-brubaker.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Lutein + Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration: The Age-Related Eye Disease Study 2 (AREDS2) Randomized Clinical Trial</title>
      <itunes:title>Lutein + Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration: The Age-Related Eye Disease Study 2 (AREDS2) Randomized Clinical Trial</itunes:title>
      <pubDate>Tue, 14 May 2013 19:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[60ece2344a6cf3d41646b57dec0d2d14]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.4997]]></link>
      <description><![CDATA[<p>Interview with Emily Y. Chew, MD, author of Lutein + Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration: The Age-Related Eye Disease Study 2 (AREDS2) Randomized Clinical Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Emily Y. Chew, MD, author of Lutein + Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration: The Age-Related Eye Disease Study 2 (AREDS2) Randomized Clinical Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-05-14_Vol._309_No._19_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="4580148" type="audio/mpeg" />
      <itunes:duration>04:45</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/1/3/2/e1320cfc8de039fa/130514-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Elective Cesarean Delivery on Maternal Request</title>
      <itunes:title>Elective Cesarean Delivery on Maternal Request</itunes:title>
      <pubDate>Tue, 07 May 2013 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[c8c59f61f40db14f5a5866ccfc6fd72f]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.3982]]></link>
      <description><![CDATA[<p>Interview with Jeffrey Ecker, MD, author of Elective Cesarean Delivery on Maternal Request</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Jeffrey Ecker, MD, author of Elective Cesarean Delivery on Maternal Request</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-05-07_Vol._309_No._18_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="4214909" type="audio/mpeg" />
      <itunes:duration>04:23</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/5/2/6/8526064bdaeb9f10/130507-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Effect of Different Dosages of Oral Vitamin D Supplementation on Vitamin D Status in Healthy, Breastfed Infants: A Randomized Trial</title>
      <itunes:title>Effect of Different Dosages of Oral Vitamin D Supplementation on Vitamin D Status in Healthy, Breastfed Infants: A Randomized Trial</itunes:title>
      <pubDate>Tue, 30 Apr 2013 14:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[337dc7edd3ec92872b54b631ffa120dd]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.3404]]></link>
      <description><![CDATA[<p>Interview with Hope Weiler, RD, PhD, author of Effect of Different Dosages of Oral Vitamin D Supplementation on Vitamin D Status in Healthy, Breastfed Infants: A Randomized Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Hope Weiler, RD, PhD, author of Effect of Different Dosages of Oral Vitamin D Supplementation on Vitamin D Status in Healthy, Breastfed Infants: A Randomized Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-04-30_Vol._309_No._17_Author_Interview.mp3?dest-id=90171" length="3979815" type="audio/mpeg" />
      <itunes:duration>08:16</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/b/b/8/3bb83a8f12a910ef/130430-jama-jai-weiler.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Immunogenicity of 2 Doses of Human Papillomavirus Vaccine in Younger Adolescents Versus 3 Doses in Young Women: A Randomized Clinical Trial</title>
      <itunes:title>Immunogenicity of 2 Doses of Human Papillomavirus Vaccine in Younger Adolescents Versus 3 Doses in Young Women: A Randomized Clinical Trial</itunes:title>
      <pubDate>Tue, 30 Apr 2013 13:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[d86b8f47430defbe3491fd679e84801f]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.1625]]></link>
      <description><![CDATA[<p>Interview with Simon R. M. Dobson, MD, author of Immunogenicity of 2 Doses of Human Papillomavirus Vaccine in Younger Adolescents Versus 3 Doses in Young Women: A Randomized Clinical Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Simon R. M. Dobson, MD, author of Immunogenicity of 2 Doses of Human Papillomavirus Vaccine in Younger Adolescents Versus 3 Doses in Young Women: A Randomized Clinical Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-04-30_Vol._309_No._17_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="5384901" type="audio/mpeg" />
      <itunes:duration>05:36</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/8/9/c/c89c221759aea7f7/130430-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Prenatal Valproate Exposure and Risk of Autism Spectrum Disorders and Childhood Autism</title>
      <itunes:title>Prenatal Valproate Exposure and Risk of Autism Spectrum Disorders and Childhood Autism</itunes:title>
      <pubDate>Tue, 23 Apr 2013 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[3ca258445f294a0e131a29d9cc7a92b5]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.2270]]></link>
      <description><![CDATA[<p>Interview with Jakob Christensen, PhD, author of Prenatal Valproate Exposure and Risk of Autism Spectrum Disorders and Childhood Autism</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Jakob Christensen, PhD, author of Prenatal Valproate Exposure and Risk of Autism Spectrum Disorders and Childhood Autism</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-04-23_Vol._309_No._16_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="3507366" type="audio/mpeg" />
      <itunes:duration>03:36</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/4/f/7/04f73773a6ddd643/130423-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Prevalence of a Healthy Lifestyle Among Individuals With Cardiovascular Disease in High-, Middle- and Low-Income Countries: The Prospective Urban Rural Epidemiology (PURE) Studyterview</title>
      <itunes:title>Prevalence of a Healthy Lifestyle Among Individuals With Cardiovascular Disease in High-, Middle- and Low-Income Countries: The Prospective Urban Rural Epidemiology (PURE) Studyterview</itunes:title>
      <pubDate>Tue, 16 Apr 2013 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[e2dc1bb122d765aa6665b8dc0a948178]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.3519]]></link>
      <description><![CDATA[<p>Interview with Koon Teo, MB, PhD, author of Prevalence of a Healthy Lifestyle Among Individuals With Cardiovascular Disease in High-, Middle- and Low-Income Countries: The Prospective Urban Rural Epidemiology (PURE) Study</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Koon Teo, MB, PhD, author of Prevalence of a Healthy Lifestyle Among Individuals With Cardiovascular Disease in High-, Middle- and Low-Income Countries: The Prospective Urban Rural Epidemiology (PURE) Study</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-04-16_Vol._309_No._15_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="4986265" type="audio/mpeg" />
      <itunes:duration>05:11</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/7/4/b/c74b0b33e9809cd6/130416-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Relationship Between Occurrence of Surgical Complications and Hospital Finances, and Uwe E. Reinhardt, PhD, author of Making Surgical Complications Pay</title>
      <itunes:title>Relationship Between Occurrence of Surgical Complications and Hospital Finances, and Uwe E. Reinhardt, PhD, author of Making Surgical Complications Pay</itunes:title>
      <pubDate>Tue, 16 Apr 2013 19:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[3ce11b0117b67ddb6020b44318a7d61b]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.2773]]></link>
      <description><![CDATA[<p>Interview with Atul A. Gawande, MD, MPH, author of Relationship Between Occurrence of Surgical Complications and Hospital Finances, and Uwe E. Reinhardt, PhD, author of Making Surgical Complications Pay</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Atul A. Gawande, MD, MPH, author of Relationship Between Occurrence of Surgical Complications and Hospital Finances, and Uwe E. Reinhardt, PhD, author of Making Surgical Complications Pay</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-04-16_Vol._309_No._15_Author_Interview_Part_I.mp3?dest-id=90171" length="10998323" type="audio/mpeg" />
      <itunes:duration>22:50</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/4/3/c/4/43c47c884f27d2a5/130416-jai-gawande-Part01.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Relationship Between Occurrence of Surgical Complications and Hospital Finances, and Uwe E. Reinhardt, PhD, author of Making Surgical Complications Pay</title>
      <itunes:title>Relationship Between Occurrence of Surgical Complications and Hospital Finances, and Uwe E. Reinhardt, PhD, author of Making Surgical Complications Pay</itunes:title>
      <pubDate>Tue, 16 Apr 2013 19:58:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[468b0ca3b98fa596001e47076a905003]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.3451]]></link>
      <description><![CDATA[<p>Interview with Atul A. Gawande, MD, MPH, author of Relationship Between Occurrence of Surgical Complications and Hospital Finances, and Uwe E. Reinhardt, PhD, author of Making Surgical Complications Pay</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Atul A. Gawande, MD, MPH, author of Relationship Between Occurrence of Surgical Complications and Hospital Finances, and Uwe E. Reinhardt, PhD, author of Making Surgical Complications Pay</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-04-16_Vol._309_No._15_Author_Interview_Part_II.mp3?dest-id=90171" length="7131463" type="audio/mpeg" />
      <itunes:duration>14:50</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/a/0/5/8a054d7989342638/130416-jai-gawande-Part02.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Variants in the ATP-Binding Cassette Transporter (ABCA7), Apolipoprotein E ε4, and the Risk of Late-Onset Alzheimer Disease in African Americans</title>
      <itunes:title>Variants in the ATP-Binding Cassette Transporter (ABCA7), Apolipoprotein E ε4, and the Risk of Late-Onset Alzheimer Disease in African Americans</itunes:title>
      <pubDate>Tue, 09 Apr 2013 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[b33eb60a501b4eb6fbfeedbc7e38e1be]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.2973]]></link>
      <description><![CDATA[<p>Interview with Richard Mayeux, MD, MSc, author of Variants in the ATP-Binding Cassette Transporter (<em>ABCA7</em>), Apolipoprotein E ε4, and the Risk of Late-Onset Alzheimer Disease in African Americans</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Richard Mayeux, MD, MSc, author of Variants in the ATP-Binding Cassette Transporter (<em>ABCA7</em>), Apolipoprotein E ε4, and the Risk of Late-Onset Alzheimer Disease in African Americans</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-04-09_Vol._309_No._14_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="4299932" type="audio/mpeg" />
      <itunes:duration>04:28</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/e/0/f/6e0f832c48e1ca84/130409-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Melatonin Secretion and the Incidence of Type 2 Diabetes</title>
      <itunes:title>Melatonin Secretion and the Incidence of Type 2 Diabetes</itunes:title>
      <pubDate>Tue, 02 Apr 2013 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[d5b398a47ef09e2f1d7acf2b8e1f613a]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.2710]]></link>
      <description><![CDATA[<p>Interview with Ciaran J. McMullan, MD, author of Melatonin Secretion and the Incidence of Type 2 Diabetes</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Ciaran J. McMullan, MD, author of Melatonin Secretion and the Incidence of Type 2 Diabetes</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-04-02_Vol._309_No._13_Author_Interview.mp3?dest-id=90171" length="5327820" type="audio/mpeg" />
      <itunes:duration>11:04</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/0/b/e/c0be4c2bf5b04d04/130402-jai-jama-mcmullan.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy: A Randomized Clinical Trial</title>
      <itunes:title>Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy: A Randomized Clinical Trial</itunes:title>
      <pubDate>Tue, 02 Apr 2013 19:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[1a59c6f8ccf92ce35b492e49c9980d6a]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.2813]]></link>
      <description><![CDATA[<p>Interview with Ellen M. Lavoie Smith, PhD, author of Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy: A Randomized Clinical Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Ellen M. Lavoie Smith, PhD, author of Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy: A Randomized Clinical Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-04-02_Vol._309_No._13_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="6099193" type="audio/mpeg" />
      <itunes:duration>06:18</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/9/e/4/69e4e15a8fd60b86/130402-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Effect of Disodium EDTA Chelation Regimen on Cardiovascular Events in Patients With Previous Myocardial Infarction: The TACT Randomized Trial</title>
      <itunes:title>Effect of Disodium EDTA Chelation Regimen on Cardiovascular Events in Patients With Previous Myocardial Infarction: The TACT Randomized Trial</itunes:title>
      <pubDate>Tue, 26 Mar 2013 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[4ee239b37fca7d0034adbd8083eec9a9]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.2107]]></link>
      <description><![CDATA[<p>Interview with Gervasio A. Lamas, MD, author of Effect of Disodium EDTA Chelation Regimen on Cardiovascular Events in Patients With Previous Myocardial Infarction: The TACT Randomized Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Gervasio A. Lamas, MD, author of Effect of Disodium EDTA Chelation Regimen on Cardiovascular Events in Patients With Previous Myocardial Infarction: The TACT Randomized Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-03-26_Vol._309_No._12_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="5396074" type="audio/mpeg" />
      <itunes:duration>05:37</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/f/8/e/af8ea0acec325422/130326-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Long-term Mortality After Stroke Among Adults Aged 18 to 50 Years</title>
      <itunes:title>Long-term Mortality After Stroke Among Adults Aged 18 to 50 Years</itunes:title>
      <pubDate>Tue, 19 Mar 2013 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[303219e82e6968887cbc8d22f62fb7a9]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.842]]></link>
      <description><![CDATA[<p>Interview with Frank-Erik de Leeuw, MD, PhD and Loes C. A. Rutten-Jacobs, MSc, authors of Long-term Mortality After Stroke Among Adults Aged 18 to 50 Years</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Frank-Erik de Leeuw, MD, PhD and Loes C. A. Rutten-Jacobs, MSc, authors of Long-term Mortality After Stroke Among Adults Aged 18 to 50 Years</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-03-19_Vol._309_No._11_Author_Interview.mp3?dest-id=90171" length="3518825" type="audio/mpeg" />
      <itunes:duration>07:18</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/4/9/3/1493b709c656cdeb/130319-jai-jama-deLeeuw.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Comparison of Presenting Complaint vs Discharge Diagnosis for Identifying "Nonemergency" Emergency Department Visits</title>
      <itunes:title>Comparison of Presenting Complaint vs Discharge Diagnosis for Identifying "Nonemergency" Emergency Department Visits</itunes:title>
      <pubDate>Tue, 19 Mar 2013 19:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[d814e840e6029055073501d992014e9f]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.1948]]></link>
      <description><![CDATA[<p>Interview with Maria C. Raven, MD, MPH, MSc, author of Comparison of Presenting Complaint vs Discharge Diagnosis for Identifying "Nonemergency" Emergency Department Visits</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Maria C. Raven, MD, MPH, MSc, author of Comparison of Presenting Complaint vs Discharge Diagnosis for Identifying "Nonemergency" Emergency Department Visits</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-03-19_Vol._309_No._11_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="6739980" type="audio/mpeg" />
      <itunes:duration>06:58</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/8/9/2/a8925b4dbe96d399/130319-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Association of Smoking Cessation and Weight Change With Cardiovascular Disease Among People With and Without Diabetes</title>
      <itunes:title>Association of Smoking Cessation and Weight Change With Cardiovascular Disease Among People With and Without Diabetes</itunes:title>
      <pubDate>Tue, 12 Mar 2013 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[ab3c17b90d59a5c621659085ad220c67]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.1644]]></link>
      <description><![CDATA[<p>Interview with James B. Meigs, MD, MPH, author of Association of Smoking Cessation and Weight Change With Cardiovascular Disease Among People With and Without Diabetes</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with James B. Meigs, MD, MPH, author of Association of Smoking Cessation and Weight Change With Cardiovascular Disease Among People With and Without Diabetes</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-03-12_Vol._309_No._10_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="4958966" type="audio/mpeg" />
      <itunes:duration>05:07</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/c/f/8/1cf8439b9b915283/130312-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Keeping an Eye on Distracted Driving</title>
      <itunes:title>Keeping an Eye on Distracted Driving</itunes:title>
      <pubDate>Tue, 05 Mar 2013 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[f5fd97b66621743931ced78c82f0e821]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.491]]></link>
      <description><![CDATA[<p>Interview with Jeffrey H. Coben, MD, author of Keeping an Eye on Distracted Driving</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Jeffrey H. Coben, MD, author of Keeping an Eye on Distracted Driving</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-03-05_Vol._309_No._9_Author_Interview.mp3?dest-id=90171" length="3264914" type="audio/mpeg" />
      <itunes:duration>06:46</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/4/f/6/9/4f69b03ff1a94826/130305-jai-jama-coben.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Association Between the Initiation of Anti-Tumor Necrosis Factor Therapy and the Risk of Herpes Zoster</title>
      <itunes:title>Association Between the Initiation of Anti-Tumor Necrosis Factor Therapy and the Risk of Herpes Zoster</itunes:title>
      <pubDate>Tue, 05 Mar 2013 20:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[827e4ac41a235a53bb7da6cfb07782c2]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.1099]]></link>
      <description><![CDATA[<p>Interview with Kevin L Winthrop, MD, MPH, author of Association Between the Initiation of Anti-Tumor Necrosis Factor Therapy and the Risk of Herpes Zoster</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Kevin L Winthrop, MD, MPH, author of Association Between the Initiation of Anti-Tumor Necrosis Factor Therapy and the Risk of Herpes Zoster</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-03-05_Vol._309_No._9_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="5847160" type="audio/mpeg" />
      <itunes:duration>06:02</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/0/5/d/c05d572cdc8a50ad/130305-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Bariatric Surgery Complications Before vs After Implementation of a National Policy Restricting Coverage to Centers of Excellence</title>
      <itunes:title>Bariatric Surgery Complications Before vs After Implementation of a National Policy Restricting Coverage to Centers of Excellence</itunes:title>
      <pubDate>Tue, 26 Feb 2013 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[8a1d91980dbe5a58d6720ea6029d3fff]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.755]]></link>
      <description><![CDATA[<p>Interview with Justin B. Dimick, MD, MPH, author of Bariatric Surgery Complications Before vs After Implementation of a National Policy Restricting Coverage to Centers of Excellence</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Justin B. Dimick, MD, MPH, author of Bariatric Surgery Complications Before vs After Implementation of a National Policy Restricting Coverage to Centers of Excellence</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-02-26_Vol._309_No._8_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="3100741" type="audio/mpeg" />
      <itunes:duration>03:13</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/d/e/f/adef3da1312e7658/130226-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Reengineering US Health Care</title>
      <itunes:title>Reengineering US Health Care</itunes:title>
      <pubDate>Tue, 19 Feb 2013 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[f7dcca389e0b29233c624af23c16cfed]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.214571]]></link>
      <description><![CDATA[<p>Interview with Ezekiel J. Emanuel, MD, PhD, author of Reengineering US Health Care</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Ezekiel J. Emanuel, MD, PhD, author of Reengineering US Health Care</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-02-19_Vol._309_No._7_Author_Interview.mp3?dest-id=90171" length="7698360" type="audio/mpeg" />
      <itunes:duration>16:00</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/e/f/9/eef9fe73ea819de0/130219-jai-jama-emanuel.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Robotically Assisted vs Laparoscopic Hysterectomy Among Women With Benign Gynecologic Disease</title>
      <itunes:title>Robotically Assisted vs Laparoscopic Hysterectomy Among Women With Benign Gynecologic Disease</itunes:title>
      <pubDate>Tue, 19 Feb 2013 20:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[c886a53d86fed7cdd5e636b3bba46c5e]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2013.186]]></link>
      <description><![CDATA[<p>Interview with Jason D. Wright, MD, author of Robotically Assisted vs Laparoscopic Hysterectomy Among Women With Benign Gynecologic Disease</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Jason D. Wright, MD, author of Robotically Assisted vs Laparoscopic Hysterectomy Among Women With Benign Gynecologic Disease</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-02-19_Vol._309_No._7_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="4284536" type="audio/mpeg" />
      <itunes:duration>04:25</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/d/1/e/b/d1ebddfb498b4d95/130219-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Association Between Maternal Use of Folic Acid Supplements and Risk of Autism Spectrum Disorders in Children</title>
      <itunes:title>Association Between Maternal Use of Folic Acid Supplements and Risk of Autism Spectrum Disorders in Children</itunes:title>
      <pubDate>Tue, 12 Feb 2013 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[afdad83f78ba7040facd74484ac6779b]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.155925]]></link>
      <description><![CDATA[<p>Interview with Pål Surén, author of Association Between Maternal Use of Folic Acid Supplements and Risk of Autism Spectrum Disorders in Children</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Pål Surén, author of Association Between Maternal Use of Folic Acid Supplements and Risk of Autism Spectrum Disorders in Children</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-02-12_Vol._309_No._6_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="4923207" type="audio/mpeg" />
      <itunes:duration>05:05</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/d/f/9/adf9ba325d64ff37/130212-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Change in End-of-Life Care for Medicare Beneficiaries: Site of Death, Place of Care, and Health Care Transitions in 2000, 2005, and 2009</title>
      <itunes:title>Change in End-of-Life Care for Medicare Beneficiaries: Site of Death, Place of Care, and Health Care Transitions in 2000, 2005, and 2009</itunes:title>
      <pubDate>Tue, 05 Feb 2013 20:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[3dfc06350122c29895263e74debb4175]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.207624]]></link>
      <description><![CDATA[<p>Interview with Joan M. Teno, MD, MS, author of Change in End-of-Life Care for Medicare Beneficiaries: Site of Death, Place of Care, and Health Care Transitions in 2000, 2005, and 2009</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Joan M. Teno, MD, MS, author of Change in End-of-Life Care for Medicare Beneficiaries: Site of Death, Place of Care, and Health Care Transitions in 2000, 2005, and 2009</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-02-05_Vol._309_No._5_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="4007610" type="audio/mpeg" />
      <itunes:duration>04:10</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/b/8/3/1/b83164274630a223/130205-jama-avi.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Diagnoses and Timing of 30-Day Readmissions After Hospitalization for Heart Failure, Acute Myocardial Infarction, or Pneumonia</title>
      <itunes:title>Diagnoses and Timing of 30-Day Readmissions After Hospitalization for Heart Failure, Acute Myocardial Infarction, or Pneumonia</itunes:title>
      <pubDate>Tue, 22 Jan 2013 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[10a067ffe7d5e827a2149127257ed16d]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.216476]]></link>
      <description><![CDATA[<p>Interview with Harlan M. Krumholz, MD, SM, author of Diagnoses and Timing of 30-Day Readmissions After Hospitalization for Heart Failure, Acute Myocardial Infarction, or Pneumonia</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Harlan M. Krumholz, MD, SM, author of Diagnoses and Timing of 30-Day Readmissions After Hospitalization for Heart Failure, Acute Myocardial Infarction, or Pneumonia</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-01-22_Vol._309_No._4_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="7431731" type="audio/mpeg" />
      <itunes:duration>07:42</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/f/b/5/2fb5c5a887c99410/jama-avi-012213.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Bacterial Coinfection in Influenza: A Grand Rounds Review</title>
      <itunes:title>Bacterial Coinfection in Influenza: A Grand Rounds Review</itunes:title>
      <pubDate>Tue, 15 Jan 2013 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[34dcec97858da5845828c202ed483c6c]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.194139]]></link>
      <description><![CDATA[<p>Interview with Daniel S. Chertow, MD, MPH, author of Bacterial Coinfection in Influenza: A Grand Rounds Review</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Daniel S. Chertow, MD, MPH, author of Bacterial Coinfection in Influenza: A Grand Rounds Review</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-01-15_Vol._309_No._3_Author_Interview.mp3?dest-id=90171" length="3167209" type="audio/mpeg" />
      <itunes:duration>06:34</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/7/d/e/e/7dee8e156313b985/011513Chertow.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Association Between Medicare Advantage Plan Star Ratings and Enrollment</title>
      <itunes:title>Association Between Medicare Advantage Plan Star Ratings and Enrollment</itunes:title>
      <pubDate>Tue, 15 Jan 2013 20:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[21c9fd58fb9c3c68b1ef30b45a28cb64]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.173925]]></link>
      <description><![CDATA[<p>Interview with William H. Shrank, MD, MSHS, author of Association Between Medicare Advantage Plan Star Ratings and Enrollment</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with William H. Shrank, MD, MSHS, author of Association Between Medicare Advantage Plan Star Ratings and Enrollment</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-01-15_Vol._309_No._3_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="6799506" type="audio/mpeg" />
      <itunes:duration>07:02</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/b/9/0/d/b90d9d3f6905cf75/jama-avi-011513.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Effect of Vitamin D Supplementation on Progression of Knee Pain and Cartilage Volume Loss in Patients With Symptomatic Osteoarthritis: A Randomized Controlled Trial</title>
      <itunes:title>Effect of Vitamin D Supplementation on Progression of Knee Pain and Cartilage Volume Loss in Patients With Symptomatic Osteoarthritis: A Randomized Controlled Trial</itunes:title>
      <pubDate>Tue, 08 Jan 2013 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[19c141910e783e5e9692f26d87176e6c]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.164487]]></link>
      <description><![CDATA[<p>Interview with Timothy McAlindon, DM, MPH, author of Effect of Vitamin D Supplementation on Progression of Knee Pain and Cartilage Volume Loss in Patients With Symptomatic Osteoarthritis: A Randomized Controlled Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Timothy McAlindon, DM, MPH, author of Effect of Vitamin D Supplementation on Progression of Knee Pain and Cartilage Volume Loss in Patients With Symptomatic Osteoarthritis: A Randomized Controlled Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-01-08_Vol._309_No._2_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="5912853" type="audio/mpeg" />
      <itunes:duration>06:06</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/d/f/8/8/df880e6a01e6d073/jama-avi-010813.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>How and Why US Health Care Differs From That in Other OECD Countries</title>
      <itunes:title>How and Why US Health Care Differs From That in Other OECD Countries</itunes:title>
      <pubDate>Tue, 01 Jan 2013 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[75ff5bd73463caa6d40092cbfa99cd69]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.125458]]></link>
      <description><![CDATA[<p>Interview with Victor R. Fuchs, PhD, author of How and Why US Health Care Differs From That in Other OECD Countries</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Victor R. Fuchs, PhD, author of How and Why US Health Care Differs From That in Other OECD Countries</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-01-01_Vol._309_No._1_Author_Interview.mp3?dest-id=90171" length="9251703" type="audio/mpeg" />
      <itunes:duration>19:15</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/d/0/3/9/d0391d4c1427d9ff/010113Fuchs.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Association of All-Cause Mortality With Overweight and Obesity Using Standard Body Mass Index Categories: A Systematic Review and Meta-analysis</title>
      <itunes:title>Association of All-Cause Mortality With Overweight and Obesity Using Standard Body Mass Index Categories: A Systematic Review and Meta-analysis</itunes:title>
      <pubDate>Tue, 01 Jan 2013 20:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[5fdd38b827f904403f1630a5d5dda514]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.113905]]></link>
      <description><![CDATA[<p>Interview with Katherine M. Flegal, PhD, author of Association of All-Cause Mortality With Overweight and Obesity Using Standard Body Mass Index Categories: A Systematic Review and Meta-analysis</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Katherine M. Flegal, PhD, author of Association of All-Cause Mortality With Overweight and Obesity Using Standard Body Mass Index Categories: A Systematic Review and Meta-analysis</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2013-01-01_Vol._309_No._1_Audio_from_Weekly_Author_Video_Interview.mp3?dest-id=90171" length="3728056" type="audio/mpeg" />
      <itunes:duration>03:50</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/d/6/0/4/d604d625cc2ff5da/jama-avi-010113.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Prevalence of and Risk Factors for Autopsy-Determined Atherosclerosis Among US Service Members, 2001-2011</title>
      <itunes:title>Prevalence of and Risk Factors for Autopsy-Determined Atherosclerosis Among US Service Members, 2001-2011</itunes:title>
      <pubDate>Tue, 25 Dec 2012 20:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[8d362c258500f67c57649acf85dfa4e0]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.70830]]></link>
      <description><![CDATA[<p>Interview with Bryant J. Webber, MD, author of Prevalence of and Risk Factors for Autopsy-Determined Atherosclerosis Among US Service Members, 2001-2011</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Bryant J. Webber, MD, author of Prevalence of and Risk Factors for Autopsy-Determined Atherosclerosis Among US Service Members, 2001-2011</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2012-12-25_Vol._308_No._24_Author_Interview.mp3?dest-id=90171" length="4924636" type="audio/mpeg" />
      <itunes:duration>05:07</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/4/5/c/e/45ceaa01740565c1/jama-avi-122512.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Association of Clopidogrel Pretreatment With Mortality, Cardiovascular Events, and Major Bleeding Among Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis</title>
      <itunes:title>Association of Clopidogrel Pretreatment With Mortality, Cardiovascular Events, and Major Bleeding Among Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis</itunes:title>
      <pubDate>Tue, 18 Dec 2012 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[d4edbcee89bb161950c9444d11d1f571]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.50788]]></link>
      <description><![CDATA[<p>Interview with Gilles Montalescot, MD, PhD, author of Association of Clopidogrel Pretreatment With Mortality, Cardiovascular Events, and Major Bleeding Among Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Gilles Montalescot, MD, PhD, author of Association of Clopidogrel Pretreatment With Mortality, Cardiovascular Events, and Major Bleeding Among Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2012-12-18_Vol_308_No_23_Author_Interview.mp3?dest-id=90171" length="4250797" type="audio/mpeg" />
      <itunes:duration>08:50</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/3/f/2/23f2a17894e77bea/121812Montalescot.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Association Between World Trade Center Exposure and Excess Cancer Risk</title>
      <itunes:title>Association Between World Trade Center Exposure and Excess Cancer Risk</itunes:title>
      <pubDate>Tue, 18 Dec 2012 20:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[017bebe90ae4071524d73b4d7215e0e4]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.110980]]></link>
      <description><![CDATA[<p>Interview with Steven D. Stellman, PhD, MPH, author of Association Between World Trade Center Exposure and Excess Cancer Risk</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Steven D. Stellman, PhD, MPH, author of Association Between World Trade Center Exposure and Excess Cancer Risk</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2012-12-18_Vol._308_No._23_Author_Interview.mp3?dest-id=90171" length="6036110" type="audio/mpeg" />
      <itunes:duration>06:17</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/9/3/d/693d389e915626e0/jama-avi-121812.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Prevalence of Nonrefractive Visual Impairment in US Adults and Associated Risk Factors, 1999-2002 and 2005-2008</title>
      <itunes:title>Prevalence of Nonrefractive Visual Impairment in US Adults and Associated Risk Factors, 1999-2002 and 2005-2008</itunes:title>
      <pubDate>Tue, 11 Dec 2012 20:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[4541b5645303a34b02a7c467c5d33010]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.85685]]></link>
      <description><![CDATA[<p>Interview with David S. Friedman, MD, MPH, PhD, author of Prevalence of Nonrefractive Visual Impairment in US Adults and Associated Risk Factors, 1999-2002 and 2005-2008</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with David S. Friedman, MD, MPH, PhD, author of Prevalence of Nonrefractive Visual Impairment in US Adults and Associated Risk Factors, 1999-2002 and 2005-2008</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2012-12-11_Vol._308_No._22_Author_Interview.mp3?dest-id=90171" length="5474222" type="audio/mpeg" />
      <itunes:duration>05:41</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/3/0/1/2301d8c251c97249/jama-avi-121112.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>General Medicine vs Subspecialty Career Plans Among Internal Medicine Residents</title>
      <itunes:title>General Medicine vs Subspecialty Career Plans Among Internal Medicine Residents</itunes:title>
      <pubDate>Tue, 04 Dec 2012 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[4895134959d190710ee0e7011819151b]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.47535]]></link>
      <description><![CDATA[<p>Interview with Colin P. West, MD, PhD, author of General Medicine vs Subspecialty Career Plans Among Internal Medicine Residents</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Colin P. West, MD, PhD, author of General Medicine vs Subspecialty Career Plans Among Internal Medicine Residents</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2012-12-04_Vol_308_No_21_Author_Interview.mp3?dest-id=90171" length="3848084" type="audio/mpeg" />
      <itunes:duration>07:59</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/c/7/d/6c7d62c28371277b/120412west.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Effect of a Protected Sleep Period on Hours Slept During Extended Overnight In-hospital Duty Hours Among Medical Interns: A Randomized Trial</title>
      <itunes:title>Effect of a Protected Sleep Period on Hours Slept During Extended Overnight In-hospital Duty Hours Among Medical Interns: A Randomized Trial</itunes:title>
      <pubDate>Tue, 04 Dec 2012 20:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[656686c8d4ce8e74ebb7ded2e16580e9]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.34490]]></link>
      <description><![CDATA[<p>Interview with Kevin G. Volpp, MD, PhD, author of Effect of a Protected Sleep Period on Hours Slept During Extended Overnight In-hospital Duty Hours Among Medical Interns: A Randomized Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Kevin G. Volpp, MD, PhD, author of Effect of a Protected Sleep Period on Hours Slept During Extended Overnight In-hospital Duty Hours Among Medical Interns: A Randomized Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2012-12-4_Vol._308_No._21_Author_Interview.mp3?dest-id=90171" length="6205960" type="audio/mpeg" />
      <itunes:duration>06:27</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/7/0/0/c7002be9ad618efc/jama-avi-120412.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Association of Childhood Pertussis With Receipt of 5 Doses of Pertussis Vaccine by Time Since Last Vaccine Dose, California, 2010</title>
      <itunes:title>Association of Childhood Pertussis With Receipt of 5 Doses of Pertussis Vaccine by Time Since Last Vaccine Dose, California, 2010</itunes:title>
      <pubDate>Tue, 27 Nov 2012 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[7f80355a7d30b931c6ab68868a7f55ea]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.14939]]></link>
      <description><![CDATA[<p>Interview with Lara K. Misegades, PhD, MS, author of Association of Childhood Pertussis With Receipt of 5 Doses of Pertussis Vaccine by Time Since Last Vaccine Dose, California, 2010</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Lara K. Misegades, PhD, MS, author of Association of Childhood Pertussis With Receipt of 5 Doses of Pertussis Vaccine by Time Since Last Vaccine Dose, California, 2010</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/joc120116audio.mp3?dest-id=90171" length="7647685" type="audio/mpeg" />
      <itunes:duration>06:22</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/7/b/5/07b5c2ce9005e474/jama-avi-112712.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Daily Sedation Interruption in Mechanically Ventilated Critically Ill Patients Cared for With a Sedation Protocol</title>
      <itunes:title>Daily Sedation Interruption in Mechanically Ventilated Critically Ill Patients Cared for With a Sedation Protocol</itunes:title>
      <pubDate>Tue, 20 Nov 2012 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[0cba5a510a81d294776b644e14d1719d]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.13872]]></link>
      <description><![CDATA[<p>Interview with Sangeeta Mehta, MD, author of Daily Sedation Interruption in Mechanically Ventilated Critically Ill Patients Cared for With a Sedation Protocol</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Sangeeta Mehta, MD, author of Daily Sedation Interruption in Mechanically Ventilated Critically Ill Patients Cared for With a Sedation Protocol</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2012-11-20_Vol._308_No._19_Author_Interview.mp3?dest-id=90171" length="3133030" type="audio/mpeg" />
      <itunes:duration>06:30</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/0/0/5/200551ea39d59f43/mehta.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Association of Online Patient Access to Clinicians and Medical Records With Use of Clinical Services</title>
      <itunes:title>Association of Online Patient Access to Clinicians and Medical Records With Use of Clinical Services</itunes:title>
      <pubDate>Tue, 20 Nov 2012 20:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[c6ea6f42ffd4939f2778797589ba5826]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.14126]]></link>
      <description><![CDATA[<p>Interview with Ted E. Palen, MD, PhD, MSPH, author of Association of Online Patient Access to Clinicians and Medical Records With Use of Clinical Services</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Ted E. Palen, MD, PhD, MSPH, author of Association of Online Patient Access to Clinicians and Medical Records With Use of Clinical Services</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/joc120103audio.mp3?dest-id=90171" length="10790588" type="audio/mpeg" />
      <itunes:duration>08:59</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/e/a/7/0ea7ba924a4b44eb/jama-avi-112012.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Structural Brain Changes in Migraine</title>
      <itunes:title>Structural Brain Changes in Migraine</itunes:title>
      <pubDate>Tue, 13 Nov 2012 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[6747a07a9c2084795369fc2f3e4da7fc]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.14276]]></link>
      <description><![CDATA[<p>Interview with Lenore J. Launer, PhD, author of Structural Brain Changes in Migraine</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Lenore J. Launer, PhD, author of Structural Brain Changes in Migraine</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/joc120097audio.mp3?dest-id=90171" length="4661120" type="audio/mpeg" />
      <itunes:duration>03:53</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/5/6/e/a56e2f1dda0d9715/jama-avi-111312.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Lifetime Risk and Years Lived Free of Total Cardiovascular Disease</title>
      <itunes:title>Lifetime Risk and Years Lived Free of Total Cardiovascular Disease</itunes:title>
      <pubDate>Mon, 05 Nov 2012 17:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[596f44a291899685903ae97c7834fa64]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.14312]]></link>
      <description><![CDATA[<p>Interview with Donald M. Lloyd-Jones, MD, ScM, author of Lifetime Risk and Years Lived Free of Total Cardiovascular Disease</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Donald M. Lloyd-Jones, MD, ScM, author of Lifetime Risk and Years Lived Free of Total Cardiovascular Disease</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2012-11-05_Author_Interview.mp3?dest-id=90171" length="3226591" type="audio/mpeg" />
      <itunes:duration>06:42</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/b/1/c/3/b1c3117e7089baaf/110612Lloyd-Jones.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Prevention of Cardiovascular Disease in Men: The Physicians' Health Study II Randomized Controlled Trial</title>
      <itunes:title>Prevention of Cardiovascular Disease in Men: The Physicians' Health Study II Randomized Controlled Trial</itunes:title>
      <pubDate>Mon, 05 Nov 2012 16:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[6b9dba25f83a34cbfe1a8ad1a8200266]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.14805]]></link>
      <description><![CDATA[<p>Interview with J. Michael Gaziano, MD, MPH, author of Multivitamins in the Prevention of Cardiovascular Disease in Men: The Physicians' Health Study II Randomized Controlled Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with J. Michael Gaziano, MD, MPH, author of Multivitamins in the Prevention of Cardiovascular Disease in Men: The Physicians' Health Study II Randomized Controlled Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/joc120113audio.mp3?dest-id=90171" length="3936144" type="audio/mpeg" />
      <itunes:duration>03:16</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/7/7/f/c/77fc84582f6649d4/jama-avi-110512.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Hospitalizations and Mortality Associated With Norovirus Outbreaks in Nursing Homes, 2009-2010</title>
      <itunes:title>Hospitalizations and Mortality Associated With Norovirus Outbreaks in Nursing Homes, 2009-2010</itunes:title>
      <pubDate>Thu, 18 Oct 2012 16:15:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[af550263d552cf5ab413f46eb7d6fb58]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.14023]]></link>
      <description><![CDATA[<p>Interview with Tarak K. Trivedi, BS, author of Hospitalizations and Mortality Associated With Norovirus Outbreaks in Nursing Homes, 2009-2010</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Tarak K. Trivedi, BS, author of Hospitalizations and Mortality Associated With Norovirus Outbreaks in Nursing Homes, 2009-2010</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/joc120102audio.mp3?dest-id=90171" length="4203545" type="audio/mpeg" />
      <itunes:duration>02:55</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/5/2/e/252e4b7f15445942/jama-avi-101812.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>The Problem With Peripherally Inserted Central Catheters</title>
      <itunes:title>The Problem With Peripherally Inserted Central Catheters</itunes:title>
      <pubDate>Tue, 16 Oct 2012 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[3f17a105beed2adda2f42cafd9cdfe66]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.12704]]></link>
      <description><![CDATA[<p>Interview with Vineet Chopra, MD, MSc and Scott A Flanders, MD, authors of The Problem With Peripherally Inserted Central Catheters</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Vineet Chopra, MD, MSc and Scott A Flanders, MD, authors of The Problem With Peripherally Inserted Central Catheters</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA__2012-10-16_Author_Interview.mp3?dest-id=90171" length="5189670" type="audio/mpeg" />
      <itunes:duration>10:47</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/7/1/e/371eea0c1e683abe/101712chopra.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Trends in Lipids and Lipoproteins in US Adults, 1988-2010</title>
      <itunes:title>Trends in Lipids and Lipoproteins in US Adults, 1988-2010</itunes:title>
      <pubDate>Tue, 16 Oct 2012 19:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[f9d484e4ed5f9da08d6696a612fe0a61]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.13260]]></link>
      <description><![CDATA[<p>Interview with Margaret D. Carroll, MSPH, author of Trends in Lipids and Lipoproteins in US Adults, 1988-2010</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Margaret D. Carroll, MSPH, author of Trends in Lipids and Lipoproteins in US Adults, 1988-2010</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/joc120099audio.mp3?dest-id=90171" length="4125634" type="audio/mpeg" />
      <itunes:duration>03:26</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/7/0/6/b/706b78f513a21016/jama-avi-101612.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Association of Public Reporting for Percutaneous Coronary Intervention With Utilization and Outcomes Among Medicare Beneficiaries With Acute Myocardial Infarction</title>
      <itunes:title>Association of Public Reporting for Percutaneous Coronary Intervention With Utilization and Outcomes Among Medicare Beneficiaries With Acute Myocardial Infarction</itunes:title>
      <pubDate>Tue, 09 Oct 2012 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[943c89ec2edbb450607641182522778d]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.12922]]></link>
      <description><![CDATA[<p>Interview with Karen E. Joynt, MD, MPH, author of Association of Public Reporting for Percutaneous Coronary Intervention With Utilization and Outcomes Among Medicare Beneficiaries With Acute Myocardial Infarction</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Karen E. Joynt, MD, MPH, author of Association of Public Reporting for Percutaneous Coronary Intervention With Utilization and Outcomes Among Medicare Beneficiaries With Acute Myocardial Infarction</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/joc120093audio.mp3?dest-id=90171" length="7271347" type="audio/mpeg" />
      <itunes:duration>06:03</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/6/6/9/66696274d328178c/jama-avi-101012.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Challenges at the Intersection of Team-Based and Patient-Centered Health Care: Insights From an IOM Working Group</title>
      <itunes:title>Challenges at the Intersection of Team-Based and Patient-Centered Health Care: Insights From an IOM Working Group</itunes:title>
      <pubDate>Tue, 02 Oct 2012 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[88c869321e841afb9b80762368625abf]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.12601]]></link>
      <description><![CDATA[<p>Interview with Matthew K. Wynia, MD, MPH, author of Challenges at the Intersection of Team-Based and Patient-Centered Health Care: Insights From an IOM Working Group</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Matthew K. Wynia, MD, MPH, author of Challenges at the Intersection of Team-Based and Patient-Centered Health Care: Insights From an IOM Working Group</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/100312wynia.mp3?dest-id=90171" length="6126246" type="audio/mpeg" />
      <itunes:duration>12:44</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/5/5/1/6/5516fd225cd08bbb/wynia-libsyn.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Effect of Vitamin D3 Supplementation on Upper Respiratory Tract Infections in Healthy Adults: The VIDARIS Randomized Controlled Trial</title>
      <itunes:title>Effect of Vitamin D3 Supplementation on Upper Respiratory Tract Infections in Healthy Adults: The VIDARIS Randomized Controlled Trial</itunes:title>
      <pubDate>Tue, 02 Oct 2012 19:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[ef88647706619a9cea3a75dc4e346098]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.12505]]></link>
      <description><![CDATA[<p>Interview with Carlos A. Camargo, MD, author of Effect of Vitamin D<sub>3</sub> Supplementation on Upper Respiratory Tract Infections in Healthy Adults: The VIDARIS Randomized Controlled Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Carlos A. Camargo, MD, author of Effect of Vitamin D3 Supplementation on Upper Respiratory Tract Infections in Healthy Adults: The VIDARIS Randomized Controlled Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/joc120088audio.mp3?dest-id=90171" length="3838301" type="audio/mpeg" />
      <itunes:duration>03:12</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/e/4/0/3e407bf9929ebae0/jama-avi-100312.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Total Knee Arthroplasty Volume, Utilization, and Outcomes Among Medicare Beneficiaries, 1991-2010</title>
      <itunes:title>Total Knee Arthroplasty Volume, Utilization, and Outcomes Among Medicare Beneficiaries, 1991-2010</itunes:title>
      <pubDate>Tue, 25 Sep 2012 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[9bf7c81d11d603ddb6f9f4b1c759a4f7]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/2012.jama.11153]]></link>
      <description><![CDATA[<p>Interview with Peter Cram, MD, MBA, author of Total Knee Arthroplasty Volume, Utilization, and Outcomes Among Medicare Beneficiaries, 1991-2010</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Peter Cram, MD, MBA, author of Total Knee Arthroplasty Volume, Utilization, and Outcomes Among Medicare Beneficiaries, 1991-2010</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/joc120077audio.mp3?dest-id=90171" length="9364960" type="audio/mpeg" />
      <itunes:duration>07:48</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/e/7/f/ce7f54b8cb0a4bc3/jama-avi-092612.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>The Next Generation of Obesity Research: No Time to Waste</title>
      <itunes:title>The Next Generation of Obesity Research: No Time to Waste</itunes:title>
      <pubDate>Tue, 18 Sep 2012 14:01:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[8fc700c114d175961cfbe1915c6db71b]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/2012.jama.11853]]></link>
      <description><![CDATA[<p>Interview with Griffin P. Rodgers, MD, author of The Next Generation of Obesity Research: No Time to Waste</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Griffin P. Rodgers, MD, author of The Next Generation of Obesity Research: No Time to Waste</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_2012-09-19_Vol._308_No._11_Author_Interview.mp3?dest-id=90171" length="6676106" type="audio/mpeg" />
      <itunes:duration>13:52</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/7/f/f/1/7ff1341153534fe3/091912rodgers.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Health Benefits of Gastric Bypass Surgery After 6 Years</title>
      <itunes:title>Health Benefits of Gastric Bypass Surgery After 6 Years</itunes:title>
      <pubDate>Tue, 18 Sep 2012 14:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[1b818af182c134a097ac06f5a0f6c731]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/2012.jama.11164]]></link>
      <description><![CDATA[<p>Interview with Ted D. Adams, PhD, MPH, author of Health Benefits of Gastric Bypass Surgery After 6 Years</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Ted D. Adams, PhD, MPH, author of Health Benefits of Gastric Bypass Surgery After 6 Years</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/joc120072audio.mp3?dest-id=90171" length="7716103" type="audio/mpeg" />
      <itunes:duration>06:25</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/5/8/5/d/585da8dc3336cc84/jama-avi-091912.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>The Attending Physician on the Wards: Finding a New Homeostasis</title>
      <itunes:title>The Attending Physician on the Wards: Finding a New Homeostasis</itunes:title>
      <pubDate>Tue, 11 Sep 2012 21:46:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[5274eacbdc0c99d326c394eb04cca2de]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/2012.jama.10476]]></link>
      <description><![CDATA[<p>Special interview by Howard Bauchner, MD, Editor in Chief of JAMA, with Robert M. Wachter, MD, and Abraham Verghese, MD, MACP, authors of The Attending Physician on the Wards: Finding a New Homeostasis</p>]]></description>
      
      <content:encoded><![CDATA[<p>Special interview by Howard Bauchner, MD, Editor in Chief of JAMA, with Robert M. Wachter, MD, and Abraham Verghese, MD, MACP, authors of The Attending Physician on the Wards: Finding a New Homeostasis</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA__2012-09-12_Author_Interview.mp3?dest-id=90171" length="12547392" type="audio/mpeg" />
      <itunes:duration>26:06</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/d/5/d/0d5db3629a64a947/091212bauchner.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Comparison of Physician-, Biomarker-, and Symptom-Based Strategies for Adjustment of Inhaled Corticosteroid Therapy in Adults With Asthma: The BASALT Randomized Controlled Trial</title>
      <itunes:title>Comparison of Physician-, Biomarker-, and Symptom-Based Strategies for Adjustment of Inhaled Corticosteroid Therapy in Adults With Asthma: The BASALT Randomized Controlled Trial</itunes:title>
      <pubDate>Tue, 11 Sep 2012 19:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[697b18f5f9d1864dccf8d991b4ab388b]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/2012.jama.10893]]></link>
      <description><![CDATA[<p>Interview with William J. Calhoun, MD, author of Comparison of Physician-, Biomarker-, and Symptom-Based Strategies for Adjustment of Inhaled Corticosteroid Therapy in Adults With Asthma: The BASALT Randomized Controlled Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with William J. Calhoun, MD, author of Comparison of Physician-, Biomarker-, and Symptom-Based Strategies for Adjustment of Inhaled Corticosteroid Therapy in Adults With Asthma: The BASALT Randomized Controlled Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/joc120069audio.mp3?dest-id=90171" length="8349118" type="audio/mpeg" />
      <itunes:duration>06:57</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/e/1/5/ae157c42e7de79b1/jama-avi-091212.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Risk of Malignancies in Patients with Rheumatoid Arthritis Treated with Biologic Therapy: A Meta-analysis</title>
      <itunes:title>Risk of Malignancies in Patients with Rheumatoid Arthritis Treated with Biologic Therapy: A Meta-analysis</itunes:title>
      <pubDate>Tue, 04 Sep 2012 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[421c73d1bdc0656182e9dcda581b0b94]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/2012.jama.10857]]></link>
      <description><![CDATA[<p>Interview with Maria E Suarez-Almazor, MD, PhD, author of Risk of Malignancies in Patients with Rheumatoid Arthritis Treated with Biologic Therapy: A Meta-analysis</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Maria E Suarez-Almazor, MD, PhD, author of Risk of Malignancies in Patients with Rheumatoid Arthritis Treated with Biologic Therapy: A Meta-analysis</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA__2012-09-04_Author_Interview.mp3?dest-id=90171" length="4666016" type="audio/mpeg" />
      <itunes:duration>09:42</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/d/4/9/1d49a2313d00ad18/090512suarez.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Aortic Stiffness, Blood Pressure Progression, and Incident Hypertension</title>
      <itunes:title>Aortic Stiffness, Blood Pressure Progression, and Incident Hypertension</itunes:title>
      <pubDate>Tue, 04 Sep 2012 19:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[87338c7763eb58faace4a2dcf2422b7b]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/2012.jama.10503]]></link>
      <description><![CDATA[<p>Interview with Gary F. Mitchell, MD, author of Aortic Stiffness, Blood Pressure Progression, and Incident Hypertension</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Gary F. Mitchell, MD, author of Aortic Stiffness, Blood Pressure Progression, and Incident Hypertension</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/joc120066audio.mp3?dest-id=90171" length="3819218" type="audio/mpeg" />
      <itunes:duration>03:10</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/c/4/f/2c4fd97025b5ad47/jama-avi-090512.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Effect of Biolimus-Eluting Stents With Biodegradable Polymer vs Bare-Metal Stents on Cardiovascular Events Among Patients With Acute Myocardial Infarction: The COMFORTABLE AMI Randomized Trial</title>
      <itunes:title>Effect of Biolimus-Eluting Stents With Biodegradable Polymer vs Bare-Metal Stents on Cardiovascular Events Among Patients With Acute Myocardial Infarction: The COMFORTABLE AMI Randomized Trial</itunes:title>
      <pubDate>Tue, 21 Aug 2012 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[7dd1ba15be90a17a803aa7f8eed9ad31]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.10065]]></link>
      <description><![CDATA[<p>Interview with Stephan Windecker, MD, author of Effect of Biolimus-Eluting Stents With Biodegradable Polymer vs Bare-Metal Stents on Cardiovascular Events Among Patients With Acute Myocardial Infarction: The COMFORTABLE AMI Randomized Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Stephan Windecker, MD, author of Effect of Biolimus-Eluting Stents With Biodegradable Polymer vs Bare-Metal Stents on Cardiovascular Events Among Patients With Acute Myocardial Infarction: The COMFORTABLE AMI Randomized Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/joc120065audio.mp3?dest-id=90171" length="5686379" type="audio/mpeg" />
      <itunes:duration>04:44</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/f/d/9/4/fd9456eff801bfa2/jama-avi-082212.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>The State of the World's Refugees: Adapting Health Responses to Urban Environments</title>
      <itunes:title>The State of the World's Refugees: Adapting Health Responses to Urban Environments</itunes:title>
      <pubDate>Tue, 14 Aug 2012 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[4d9e4e7f9afc62aa64044b9b04b12e3d]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/2012.jama.10161]]></link>
      <description><![CDATA[<p>Interview with Paul Spiegel, MD, author of The State of the World's Refugees: Adapting Health Responses to Urban Environments</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Paul Spiegel, MD, author of The State of the World's Refugees: Adapting Health Responses to Urban Environments</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/081512spiegel.mp3?dest-id=90171" length="3752352" type="audio/mpeg" />
      <itunes:duration>07:47</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/f/f/b/3ffbd674be1a1707/spiegel.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Effect of Screening for Partner Violence on Women's Quality of Life: A Randomized Controlled Trial</title>
      <itunes:title>Effect of Screening for Partner Violence on Women's Quality of Life: A Randomized Controlled Trial</itunes:title>
      <pubDate>Tue, 14 Aug 2012 19:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[7a6ef783e2b6f2bcc001db4a8d72ddf8]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.6434]]></link>
      <description><![CDATA[<p>Interview with Joanne Klevens, MD, PhD, author of Effect of Screening for Partner Violence on Women's Quality of Life: A Randomized Controlled Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Joanne Klevens, MD, PhD, author of Effect of Screening for Partner Violence on Women's Quality of Life: A Randomized Controlled Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/joc120034audio.mp3?dest-id=90171" length="4255755" type="audio/mpeg" />
      <itunes:duration>03:32</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/7/4/a/074acec04e7ecde7/jama-avi-081512.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Trends in Serum Lipids Among US Youths Aged 6 to 19 Years, 1988-2010</title>
      <itunes:title>Trends in Serum Lipids Among US Youths Aged 6 to 19 Years, 1988-2010</itunes:title>
      <pubDate>Tue, 07 Aug 2012 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[678b58e7aaf25a1c0ee4890b7e2caf45]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.9136]]></link>
      <description><![CDATA[<p>Interview with Brian K. Kit, MD, MPH, author of Trends in Serum Lipids Among US Youths Aged 6 to 19 Years, 1988-2010</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Brian K. Kit, MD, MPH, author of Trends in Serum Lipids Among US Youths Aged 6 to 19 Years, 1988-2010</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/joc120062audio.mp3?dest-id=90171" length="4831774" type="audio/mpeg" />
      <itunes:duration>04:01</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/5/1/1/c51152652f9810ad/jama-avi-080812.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Effects of Exercise Training on Depressive Symptoms in Patients With Chronic Heart Failure: The HF-ACTION Randomized Trial</title>
      <itunes:title>Effects of Exercise Training on Depressive Symptoms in Patients With Chronic Heart Failure: The HF-ACTION Randomized Trial</itunes:title>
      <pubDate>Tue, 31 Jul 2012 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[a5a74d4556e57e31959ee5705b78fa6f]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.8720]]></link>
      <description><![CDATA[<p>Interview with James A. Blumenthal, PhD, author of Effects of Exercise Training on Depressive Symptoms in Patients With Chronic Heart Failure: The HF-ACTION Randomized Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with James A. Blumenthal, PhD, author of Effects of Exercise Training on Depressive Symptoms in Patients With Chronic Heart Failure: The HF-ACTION Randomized Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA__2012-08-01_Author_Interview.mp3?dest-id=90171" length="3615344" type="audio/mpeg" />
      <itunes:duration>07:30</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/b/2/c/1/b2c147bd4cf1ae0b/080112blumenthal.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Risk of Fractures Following Cataract Surgery in Medicare Beneficiaries</title>
      <itunes:title>Risk of Fractures Following Cataract Surgery in Medicare Beneficiaries</itunes:title>
      <pubDate>Tue, 31 Jul 2012 19:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[e6c881f96260d1accb40232021c31347]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.9014]]></link>
      <description><![CDATA[<p>Interview with Anne L. Coleman, MD, PhD, author of Risk of Fractures Following Cataract Surgery in Medicare Beneficiaries</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Anne L. Coleman, MD, PhD, author of Risk of Fractures Following Cataract Surgery in Medicare Beneficiaries</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/joc120058audio.mp3?dest-id=90171" length="4129669" type="audio/mpeg" />
      <itunes:duration>03:26</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/f/8/8/a/f88a715dbb9d3bfe/jama-avi-080112.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>HIV in Persons Born Outside the United States, 2007-2010</title>
      <itunes:title>HIV in Persons Born Outside the United States, 2007-2010</itunes:title>
      <pubDate>Sun, 22 Jul 2012 14:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[bad4d34d67a2d90bd28f9c0ad25f2e96]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.9046]]></link>
      <description><![CDATA[<p>Interview with Adria Tassy Prosser, PhD, author of HIV in Persons Born Outside the United States, 2007-2010</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Adria Tassy Prosser, PhD, author of HIV in Persons Born Outside the United States, 2007-2010</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/joc120052audio.mp3?dest-id=90171" length="4701701" type="audio/mpeg" />
      <itunes:duration>03:55</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/0/f/8/80f8bf4897b9588f/jama-avi-072512.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Marshaling Leadership for High-Value Health Care</title>
      <itunes:title>Marshaling Leadership for High-Value Health Care</itunes:title>
      <pubDate>Tue, 17 Jul 2012 20:01:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[3ec82c60d028366b87946af99ea2cd95]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.7081]]></link>
      <description><![CDATA[<p>Interview with Gary S. Kaplan, MD, author of Marshaling Leadership for High-Value Health Care</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Gary S. Kaplan, MD, author of Marshaling Leadership for High-Value Health Care</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA__2012-07-18_Author_Interview.mp3?dest-id=90171" length="4623151" type="audio/mpeg" />
      <itunes:duration>09:36</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/4/f/f/d/4ffd26ef8450c4e7/Kaplan-headshot.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Association Between Use of Interferon Beta and Progression of Disability in Patients With Relapsing-Remitting Multiple Sclerosis</title>
      <itunes:title>Association Between Use of Interferon Beta and Progression of Disability in Patients With Relapsing-Remitting Multiple Sclerosis</itunes:title>
      <pubDate>Tue, 17 Jul 2012 19:59:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[f04ce86ce742d3d8c5f134b6b859dcb8]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.7625]]></link>
      <description><![CDATA[<p>Interview with Helen Tremlett, PhD, author of Association Between Use of Interferon Beta and Progression of Disability in Patients With Relapsing-Remitting Multiple Sclerosis</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Helen Tremlett, PhD, author of Association Between Use of Interferon Beta and Progression of Disability in Patients With Relapsing-Remitting Multiple Sclerosis</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/joc120048audio.mp3?dest-id=90171" length="6010569" type="audio/mpeg" />
      <itunes:duration>05:00</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/2/f/b/82fb95aa5e1d01bd/jama-avi-071812.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Risk of Adverse Fetal Outcomes Following Administration of a Pandemic Influenza A(H1N1) Vaccine During Pregnancy</title>
      <itunes:title>Risk of Adverse Fetal Outcomes Following Administration of a Pandemic Influenza A(H1N1) Vaccine During Pregnancy</itunes:title>
      <pubDate>Tue, 10 Jul 2012 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[601475b3b20ab239fbfbc35793827ba9]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.6131]]></link>
      <description><![CDATA[<p>Interview with Björn Pasternak, MD, PhD, author of Risk of Adverse Fetal Outcomes Following Administration of a Pandemic Influenza A(H1N1) Vaccine During Pregnancy</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Björn Pasternak, MD, PhD, author of Risk of Adverse Fetal Outcomes Following Administration of a Pandemic Influenza A(H1N1) Vaccine During Pregnancy</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/joc120035audio.mp3?dest-id=90171" length="8138189" type="audio/mpeg" />
      <itunes:duration>06:47</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/d/8/e/5/d8e5a3fd57cdcc58/jama-avi-071112.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Association Between Vaccination for Herpes Zoster and Risk of Herpes Zoster Infection Among Older Patients With Selected Immune-Mediated Diseases: Herpes Zoster and Immune-Mediated Diseases</title>
      <itunes:title>Association Between Vaccination for Herpes Zoster and Risk of Herpes Zoster Infection Among Older Patients With Selected Immune-Mediated Diseases: Herpes Zoster and Immune-Mediated Diseases</itunes:title>
      <pubDate>Tue, 03 Jul 2012 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[c584052dfbfc9d37f332639cb6995b44]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.7304]]></link>
      <description><![CDATA[<p>Interview with Jeffrey R. Curtis, MD, MS, author of Association Between Vaccination for Herpes Zoster and Risk of Herpes Zoster Infection Among Older Patients With Selected Immune-Mediated Diseases: Herpes Zoster and Immune-Mediated Diseases<br /> <a id= "sitemasterMainContent_siteMasterLeftPanelContent_rptUnpublishedIssues_rptIssueArticles_0_hlArticleTitle_23" href= "http://jama.jamanetwork.com/article.aspx?preview=true&articleid=1209423" target="_blank" name= "sitemasterMainContent_siteMasterLeftPanelContent_rptUnpublishedIssues_rptIssueArticles_0_hlArticleTitle_23"> </a></p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Jeffrey R. Curtis, MD, MS, author of Association Between Vaccination for Herpes Zoster and Risk of Herpes Zoster Infection Among Older Patients With Selected Immune-Mediated Diseases: Herpes Zoster and Immune-Mediated Diseases <a id= "sitemasterMainContent_siteMasterLeftPanelContent_rptUnpublishedIssues_rptIssueArticles_0_hlArticleTitle_23" href= "http://jama.jamanetwork.com/article.aspx?preview=true&articleid=1209423" target="_blank" name= "sitemasterMainContent_siteMasterLeftPanelContent_rptUnpublishedIssues_rptIssueArticles_0_hlArticleTitle_23"> </a></p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA__2012-07-04_Author_Interview.mp3?dest-id=90171" length="4638245" type="audio/mpeg" />
      <itunes:duration>09:38</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/c/e/b/9ceb8e5f9a8c917d/Curtis-headshot.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Epidemiology of Staphylococcus aureus Blood and Skin and Soft Tissue Infections in the US Military Health System, 2005-2010</title>
      <itunes:title>Epidemiology of Staphylococcus aureus Blood and Skin and Soft Tissue Infections in the US Military Health System, 2005-2010</itunes:title>
      <pubDate>Tue, 03 Jul 2012 19:58:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[42dfd79d3527df3a8c8908093b9e4b89]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.7139]]></link>
      <description><![CDATA[<p>Interview with Clinton K. Murray, MD, author of Epidemiology of <em>Staphylococcus aureus</em> Blood and Skin and Soft Tissue Infections in the US Military Health System, 2005-2010</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Clinton K. Murray, MD, author of Epidemiology of <em>Staphylococcus aureus</em> Blood and Skin and Soft Tissue Infections in the US Military Health System, 2005-2010</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/joc120046audio.mp3?dest-id=90171" length="7055582" type="audio/mpeg" />
      <itunes:duration>05:52</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/7/8/d/a78df87ab7d1d258/jama-avi-070412.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Effect of a Stepped-Care Intervention Approach on Weight Loss in Adults: A Randomized Clinical Trial</title>
      <itunes:title>Effect of a Stepped-Care Intervention Approach on Weight Loss in Adults: A Randomized Clinical Trial</itunes:title>
      <pubDate>Tue, 26 Jun 2012 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[3f2082f442663f9976645c417bc7333d]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.6866]]></link>
      <description><![CDATA[<p>Interview with John M. Jakicic, PhD, author of Effect of a Stepped-Care Intervention Approach on Weight Loss in Adults: A Randomized Clinical Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with John M. Jakicic, PhD, author of Effect of a Stepped-Care Intervention Approach on Weight Loss in Adults: A Randomized Clinical Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/joc120038audio.mp3?dest-id=90171" length="9896135" type="audio/mpeg" />
      <itunes:duration>08:14</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/2/8/1/e281aa7dd6c81abb/jama-avi-062712.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Lipid-Related Markers and Cardiovascular Disease Prediction</title>
      <itunes:title>Lipid-Related Markers and Cardiovascular Disease Prediction</itunes:title>
      <pubDate>Tue, 19 Jun 2012 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[223406fa5e3d896d85166a0276c78436]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.6571]]></link>
      <description><![CDATA[<p>Interview with Emanuele Di Angelantonio, MD, author of Lipid-Related Markers and Cardiovascular Disease Prediction</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Emanuele Di Angelantonio, MD, author of Lipid-Related Markers and Cardiovascular Disease Prediction</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/062012diangelantonio.mp3?dest-id=90171" length="3101276" type="audio/mpeg" />
      <itunes:duration>06:26</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/1/b/7/c1b73541a1aa262a/di-angelantonio-libsyn.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Prevalence of Alcohol Use Disorders Before and After Bariatric Surgery</title>
      <itunes:title>Prevalence of Alcohol Use Disorders Before and After Bariatric Surgery</itunes:title>
      <pubDate>Mon, 18 Jun 2012 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[5a36cb455bbe83a3bfa40993c0d51b62]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.6147]]></link>
      <description><![CDATA[<p>Interview with Wendy C. King, PhD, author of Prevalence of Alcohol Use Disorders Before and After Bariatric Surgery</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Wendy C. King, PhD, author of Prevalence of Alcohol Use Disorders Before and After Bariatric Surgery</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/joc120031audio.mp3?dest-id=90171" length="10278857" type="audio/mpeg" />
      <itunes:duration>07:08</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/d/f/4/f/df4fdab43b84ddd4/jama-avi-062012.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Use of Diagnostic Imaging Studies and Associated Radiation Exposure for Patients Enrolled in Large Integrated Health Care Systems, 1996-2010</title>
      <itunes:title>Use of Diagnostic Imaging Studies and Associated Radiation Exposure for Patients Enrolled in Large Integrated Health Care Systems, 1996-2010</itunes:title>
      <pubDate>Tue, 12 Jun 2012 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[75a0577a44d1ec550e385bf50e8f1e0d]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.5960]]></link>
      <description><![CDATA[<p>Interview with Rebecca Smith-Bindman, MD, author of Use of Diagnostic Imaging Studies and Associated Radiation Exposure for Patients Enrolled in Large Integrated Health Care Systems, 1996-2010</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Rebecca Smith-Bindman, MD, author of Use of Diagnostic Imaging Studies and Associated Radiation Exposure for Patients Enrolled in Large Integrated Health Care Systems, 1996-2010</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/joc120030audio.mp3?dest-id=90171" length="12034470" type="audio/mpeg" />
      <itunes:duration>10:01</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/1/4/5/314556c8accb70a1/jama-avi-061312.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>If Accountable Care Organizations Are the Answer, Who Should Create Them?</title>
      <itunes:title>If Accountable Care Organizations Are the Answer, Who Should Create Them?</itunes:title>
      <pubDate>Wed, 06 Jun 2012 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[e31024f8260f8b975725daf1be35ce1b]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.5564]]></link>
      <description><![CDATA[<p>Interview with Victor R. Fuchs, PhD, author of If Accountable Care Organizations Are the Answer, Who Should Create Them?</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Victor R. Fuchs, PhD, author of If Accountable Care Organizations Are the Answer, Who Should Create Them?</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/060612fuchs.mp3?dest-id=90171" length="6217296" type="audio/mpeg" />
      <itunes:duration>12:55</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/4/d/5/94d5c5e462b17a5d/Fuchs-libsyn.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Effect of Telephone-Administered vs Face-to-face Cognitive Behavioral Therapy on Adherence to Therapy and Depression Outcomes Among Primary Care Patients: A Randomized Trial</title>
      <itunes:title>Effect of Telephone-Administered vs Face-to-face Cognitive Behavioral Therapy on Adherence to Therapy and Depression Outcomes Among Primary Care Patients: A Randomized Trial</itunes:title>
      <pubDate>Tue, 05 Jun 2012 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[bf567ab31fa3268f52661963b252e638]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.5588]]></link>
      <description><![CDATA[<p>Interview with David C. Mohr, PhD, author of Effect of Telephone-Administered vs Face-to-face Cognitive Behavioral Therapy on Adherence to Therapy and Depression Outcomes Among Primary Care Patients: A Randomized Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with David C. Mohr, PhD, author of Effect of Telephone-Administered vs Face-to-face Cognitive Behavioral Therapy on Adherence to Therapy and Depression Outcomes Among Primary Care Patients: A Randomized Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/JAMA_3839_Author_Audio_1-2.mp3?dest-id=90171" length="10768239" type="audio/mpeg" />
      <itunes:duration>08:58</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/4/2/8/64284a9e3810d9db/jama-avi-060612.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Effect of Continuous Positive Airway Pressure on the Incidence of Hypertension and Cardiovascular Events in Nonsleepy Patients With Obstructive Sleep Apnea: A Randomized Controlled Trial</title>
      <itunes:title>Effect of Continuous Positive Airway Pressure on the Incidence of Hypertension and Cardiovascular Events in Nonsleepy Patients With Obstructive Sleep Apnea: A Randomized Controlled Trial</itunes:title>
      <pubDate>Tue, 22 May 2012 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[3a9c838969c699aa3fb87b1fba7539f5]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.4366]]></link>
      <description><![CDATA[<p>Interview with Ferran Barbé, MD, author of Effect of Continuous Positive Airway Pressure on the Incidence of Hypertension and Cardiovascular Events in Nonsleepy Patients With Obstructive Sleep Apnea: A Randomized Controlled Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Ferran Barbé, MD, author of Effect of Continuous Positive Airway Pressure on the Incidence of Hypertension and Cardiovascular Events in Nonsleepy Patients With Obstructive Sleep Apnea: A Randomized Controlled Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/joc120016audio.mp3?dest-id=90171" length="2513824" type="audio/mpeg" />
      <itunes:duration>02:05</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/f/1/d/0f1dba6dc1a56407/ferran-barbe-author-index.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>HIV Development Assistance and Adult Mortality in Africa</title>
      <itunes:title>HIV Development Assistance and Adult Mortality in Africa</itunes:title>
      <pubDate>Tue, 15 May 2012 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[cdd7aa9e7f03bd3df1051b85ad9b0bdf]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.2001]]></link>
      <description><![CDATA[<p>Interview with Eran Bendavid, MD, MS, author of HIV Development Assistance and Adult Mortality in Africa</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Eran Bendavid, MD, MS, author of HIV Development Assistance and Adult Mortality in Africa</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/joc120003audio.mp3?dest-id=90171" length="6499486" type="audio/mpeg" />
      <itunes:duration>05:25</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/5/2/4/a/524ac788328b2a02/bendavid-author-index.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Primary Health Care in Low-Income Countries: Building on Recent Achievements</title>
      <itunes:title>Primary Health Care in Low-Income Countries: Building on Recent Achievements</itunes:title>
      <pubDate>Tue, 15 May 2012 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[3c7b625f6b5b4981897682aa019b5b16]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.4438]]></link>
      <description><![CDATA[<p>Interview with Jeffrey D. Sachs, PhD, author of Primary Health Care in Low-Income Countries: Building on Recent Achievements</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Jeffrey D. Sachs, PhD, author of Primary Health Care in Low-Income Countries: Building on Recent Achievements</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/051612sachs.mp3?dest-id=90171" length="5416978" type="audio/mpeg" />
      <itunes:duration>11:15</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/7/2/6/f/726f5f19361bcbb0/sachs-author-index.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Neonatal Abstinence Syndrome and Associated Health Care Expenditures: United States, 2000-2009</title>
      <itunes:title>Neonatal Abstinence Syndrome and Associated Health Care Expenditures: United States, 2000-2009</itunes:title>
      <pubDate>Tue, 08 May 2012 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[93d0cf381310f7bf01fa4de6c934fc56]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.3951]]></link>
      <description><![CDATA[<p>Interview with Stephen W. Patrick, MD, MPH, MS, author of Neonatal Abstinence Syndrome and Associated Health Care Expenditures: United States, 2000-2009</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Stephen W. Patrick, MD, MPH, MS, author of Neonatal Abstinence Syndrome and Associated Health Care Expenditures: United States, 2000-2009</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/20123951-patrick.mp3?dest-id=90171" length="5123902" type="audio/mpeg" />
      <itunes:duration>04:16</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/a/d/d/9add5dd865d86c92/patrick-author-index.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Studying Complementary and Alternative Therapies</title>
      <itunes:title>Studying Complementary and Alternative Therapies</itunes:title>
      <pubDate>Tue, 01 May 2012 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[5e66123622efd9e54a63e5bcc82478e3]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.518]]></link>
      <description><![CDATA[<p>Interview with Paul A. Offit, MD, author of Studying Complementary and Alternative Therapies</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Paul A. Offit, MD, author of Studying Complementary and Alternative Therapies</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/050212offit.mp3?dest-id=90171" length="4072249" type="audio/mpeg" />
      <itunes:duration>08:27</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/b/3/6/d/b36d3d51052be271/offit-author-index.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Association Between Treatment With Brachytherapy vs Whole-Breast Irradiation and Subsequent Mastectomy, Complications, and Survival Among Older Women With Invasive Breast Cancer</title>
      <itunes:title>Association Between Treatment With Brachytherapy vs Whole-Breast Irradiation and Subsequent Mastectomy, Complications, and Survival Among Older Women With Invasive Breast Cancer</itunes:title>
      <pubDate>Tue, 01 May 2012 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[27f1b977df34524f63a738d39963f224]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.3481]]></link>
      <description><![CDATA[<p>Interview with Benjamin D. Smith, MD, author of Association Between Treatment With Brachytherapy vs Whole-Breast Irradiation and Subsequent Mastectomy, Complications, and Survival Among Older Women With Invasive Breast Cancer</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Benjamin D. Smith, MD, author of Association Between Treatment With Brachytherapy vs Whole-Breast Irradiation and Subsequent Mastectomy, Complications, and Survival Among Older Women With Invasive Breast Cancer</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/307171827-smith.mp3?dest-id=90171" length="7580961" type="audio/mpeg" />
      <itunes:duration>06:19</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/a/b/7/aab787085f5a51dd/smith-author-index.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Association Between Hospital Recognition for Nursing Excellence and Outcomes of Very Low-Birth-Weight Infants</title>
      <itunes:title>Association Between Hospital Recognition for Nursing Excellence and Outcomes of Very Low-Birth-Weight Infants</itunes:title>
      <pubDate>Tue, 24 Apr 2012 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[b1a940c0db27cff0649b9dd55d72886b]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.504]]></link>
      <description><![CDATA[<p>Interview with Eileen T. Lake, PhD, RN, author of Association Between Hospital Recognition for Nursing Excellence and Outcomes of Very Low-Birth-Weight Infants</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Eileen T. Lake, PhD, RN, author of Association Between Hospital Recognition for Nursing Excellence and Outcomes of Very Low-Birth-Weight Infants</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/042512lake.mp3?dest-id=90171" length="4780943" type="audio/mpeg" />
      <itunes:duration>09:56</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/4/6/2/a462ccaf7a22a423/lake-author-index.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Effect of a Text Messaging Intervention on Influenza Vaccination in an Urban, Low-Income Pediatric and Adolescent Population: A Randomized Controlled Trial</title>
      <itunes:title>Effect of a Text Messaging Intervention on Influenza Vaccination in an Urban, Low-Income Pediatric and Adolescent Population: A Randomized Controlled Trial</itunes:title>
      <pubDate>Tue, 24 Apr 2012 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[ef0057954eb1259102e3a39a363f14a2]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.502]]></link>
      <description><![CDATA[<p>Interview with Melissa S. Stockwell, MD, MPH, author of Effect of a Text Messaging Intervention on Influenza Vaccination in an Urban, Low-Income Pediatric and Adolescent Population: A Randomized Controlled Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Melissa S. Stockwell, MD, MPH, author of Effect of a Text Messaging Intervention on Influenza Vaccination in an Urban, Low-Income Pediatric and Adolescent Population: A Randomized Controlled Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/307161702-stockwell.mp3?dest-id=90171" length="4525589" type="audio/mpeg" />
      <itunes:duration>03:46</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/5/f/2/7/5f276d0bfaa42792/stockwell-author-index.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Association Between Helicopter vs Ground Emergency Medical Services and Survival for Adults With Major Trauma</title>
      <itunes:title>Association Between Helicopter vs Ground Emergency Medical Services and Survival for Adults With Major Trauma</itunes:title>
      <pubDate>Tue, 17 Apr 2012 14:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[8e2cd4df0a7577cb60b85a5e65cac63a]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.467]]></link>
      <description><![CDATA[<p>Interview with Samuel M. Galvagno Jr, DO, PhD, author of Association Between Helicopter vs Ground Emergency Medical Services and Survival for Adults With Major Trauma</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Samuel M. Galvagno Jr, DO, PhD, author of Association Between Helicopter vs Ground Emergency Medical Services and Survival for Adults With Major Trauma</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/307151602-galvagno.mp3?dest-id=90171" length="5651014" type="audio/mpeg" />
      <itunes:duration>04:41</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/b/e/d/abedf9d420d20042/galvagno-author-index.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>JAMA: 2012-04-11, Vol. 307, No. 14, Author Interview</title>
      <itunes:title>JAMA: 2012-04-11, Vol. 307, No. 14, Author Interview</itunes:title>
      <pubDate>Tue, 10 Apr 2012 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[f1cb250b4fce84450d36ecf7c2580595]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.362]]></link>
      <description><![CDATA[<p>Interview with Donald M. Berwick, MD, MPP, author of Eliminating Waste in US Health Care</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Donald M. Berwick, MD, MPP, author of Eliminating Waste in US Health Care</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/307141513-berwick.mp3?dest-id=90171" length="10591402" type="audio/mpeg" />
      <itunes:duration>08:49</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/d/9/c/0/d9c0f38691bc705c/berwick-author-index.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Healthy Men Should Not Take Statins</title>
      <itunes:title>Healthy Men Should Not Take Statins</itunes:title>
      <pubDate>Tue, 10 Apr 2012 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[c6d89e9020c5ddf5cc7f5337b017f9f9]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.423]]></link>
      <description><![CDATA[<p>Interview with Rita F. Redberg, MD, author of Healthy Men Should Not Take Statins</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Rita F. Redberg, MD, author of Healthy Men Should Not Take Statins</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/041112blumenthal.mp3?dest-id=90171" length="6921961" type="audio/mpeg" />
      <itunes:duration>14:23</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/a/5/7/6a5720024c0d3d96/redberg-author-index.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Detection of Breast Cancer With Addition of Annual Screening Ultrasound or a Single Screening MRI to Mammography in Women With Elevated Breast Cancer Risk</title>
      <itunes:title>Detection of Breast Cancer With Addition of Annual Screening Ultrasound or a Single Screening MRI to Mammography in Women With Elevated Breast Cancer Risk</itunes:title>
      <pubDate>Tue, 03 Apr 2012 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[98723c800cc1a91b827cb9676b369b4b]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.388]]></link>
      <description><![CDATA[<p>Interview with Wendie A. Berg, MD, PhD, author of Detection of Breast Cancer With Addition of Annual Screening Ultrasound or a Single Screening MRI to Mammography in Women With Elevated Breast Cancer Risk</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Wendie A. Berg, MD, PhD, author of Detection of Breast Cancer With Addition of Annual Screening Ultrasound or a Single Screening MRI to Mammography in Women With Elevated Breast Cancer Risk</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/307131394-berg.mp3?dest-id=90171" length="6469966" type="audio/mpeg" />
      <itunes:duration>05:23</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/b/f/c/6bfcd12e60cd7fcb/berg-author-index.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Out-of-Pocket Medication Costs and Use of Medications and Health Care Services Among Children With Asthma</title>
      <itunes:title>Out-of-Pocket Medication Costs and Use of Medications and Health Care Services Among Children With Asthma</itunes:title>
      <pubDate>Tue, 27 Mar 2012 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[2fa517fa51eedf4a3e7ec39baa939aa8]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.340]]></link>
      <description><![CDATA[<p>Interview with Dana P. Goldman, PhD, author of Out-of-Pocket Medication Costs and Use of Medications and Health Care Services Among Children With Asthma</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Dana P. Goldman, PhD, author of Out-of-Pocket Medication Costs and Use of Medications and Health Care Services Among Children With Asthma</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/307121284-goldman.mp3?dest-id=90171" length="3897198" type="audio/mpeg" />
      <itunes:duration>03:14</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/4/e/c/94ec18f7597a461f/goldman-author-index.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Utilization of Anesthesia Services During Outpatient Endoscopies and Colonoscopies and Associated Spending in 2003-2009</title>
      <itunes:title>Utilization of Anesthesia Services During Outpatient Endoscopies and Colonoscopies and Associated Spending in 2003-2009</itunes:title>
      <pubDate>Tue, 20 Mar 2012 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[76be19287e6c53e3a3d86b0a04d7a96a]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.270]]></link>
      <description><![CDATA[<p>Interview with Soeren Mattke, MD, DSc, author of Utilization of Anesthesia Services During Outpatient Endoscopies and Colonoscopies and Associated Spending in 2003-2009</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Soeren Mattke, MD, DSc, author of Utilization of Anesthesia Services During Outpatient Endoscopies and Colonoscopies and Associated Spending in 2003-2009</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/307111178-mattke.mp3?dest-id=90171" length="8200199" type="audio/mpeg" />
      <itunes:duration>06:50</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/b/7/0/d/b70dee78ecfab4cb/mattke-author-index.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Questioning the Use of Epinephrine to Treat Cardiac Arrest</title>
      <itunes:title>Questioning the Use of Epinephrine to Treat Cardiac Arrest</itunes:title>
      <pubDate>Tue, 20 Mar 2012 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[46902ef1743804979bff69f9cc21f27b]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.313]]></link>
      <description><![CDATA[<p>Interview with Clifton W. Callaway, MD, PhD, author of Questioning the Use of Epinephrine to Treat Cardiac Arrest</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Clifton W. Callaway, MD, PhD, author of Questioning the Use of Epinephrine to Treat Cardiac Arrest</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/032112callaway.mp3?dest-id=90171" length="3909276" type="audio/mpeg" />
      <itunes:duration>06:30</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/4/1/7/1417e4ed7764702f/callaway-author-index.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Association of Hospital Spending Intensity With Mortality and Readmission Rates in Ontario Hospitals</title>
      <itunes:title>Association of Hospital Spending Intensity With Mortality and Readmission Rates in Ontario Hospitals</itunes:title>
      <pubDate>Tue, 13 Mar 2012 20:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[1764cb3c77fb0c23b001002d8bade222]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.265]]></link>
      <description><![CDATA[<p>Interview with Therese A. Stukel, PhD, author of Association of Hospital Spending Intensity With Mortality and Readmission Rates in Ontario Hospitals</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Therese A. Stukel, PhD, author of Association of Hospital Spending Intensity With Mortality and Readmission Rates in Ontario Hospitals</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/307101037-stukel.mp3?dest-id=90171" length="8201427" type="audio/mpeg" />
      <itunes:duration>06:50</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/d/6/b/a/d6ba8513394a4c68/stukel-author-index.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>The Retreat From Advanced Care Planning</title>
      <itunes:title>The Retreat From Advanced Care Planning</itunes:title>
      <pubDate>Tue, 06 Mar 2012 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[d54c2d82097bc0a769a4b43f140b9bd1]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.229]]></link>
      <description><![CDATA[<p>Interview with Mary E. Tinetti, MD, author of The Retreat From Advanced Care Planning</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Mary E. Tinetti, MD, author of The Retreat From Advanced Care Planning</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/022012tinetti.mp3?dest-id=90171" length="6052128" type="audio/mpeg" />
      <itunes:duration>10:04</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/4/6/c/4/46c42f729de52a3a/tinetti-author-index.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Association of Mental Health Disorders With Prescription Opioids and High-Risk Opioid Use in US Veterans of Iraq and Afghanistan</title>
      <itunes:title>Association of Mental Health Disorders With Prescription Opioids and High-Risk Opioid Use in US Veterans of Iraq and Afghanistan</itunes:title>
      <pubDate>Tue, 06 Mar 2012 16:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[deba68479631bdf1883de81260bc518b]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.234]]></link>
      <description><![CDATA[<p>Interview with Karen H. Seal, MD, MPH, author of Association of Mental Health Disorders With Prescription Opioids and High-Risk Opioid Use in US Veterans of Iraq and Afghanistan</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Karen H. Seal, MD, MPH, author of Association of Mental Health Disorders With Prescription Opioids and High-Risk Opioid Use in US Veterans of Iraq and Afghanistan</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/30709940-seal.mp3?dest-id=90171" length="5291045" type="audio/mpeg" />
      <itunes:duration>04:24</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/f/2/2/9/f2292fef3cd51173/seal-author-index.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Association of Age and Sex With Myocardial Infarction Symptom Presentation and In-Hospital Mortality</title>
      <itunes:title>Association of Age and Sex With Myocardial Infarction Symptom Presentation and In-Hospital Mortality</itunes:title>
      <pubDate>Tue, 21 Feb 2012 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[201b1903e83cefb9d924ce6b929c157b]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.199]]></link>
      <description><![CDATA[<p>Interview with John G. Canto, MD, MSPH, author of Association of Age and Sex With Myocardial Infarction Symptom Presentation and In-Hospital Mortality</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with John G. Canto, MD, MSPH, author of Association of Age and Sex With Myocardial Infarction Symptom Presentation and In-Hospital Mortality</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/30708813-canto.mp3?dest-id=90171" length="5213783" type="audio/mpeg" />
      <itunes:duration>04:20</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/4/f/8/e4f8faced60b7292/canto.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Amoxicillin for Acute Rhinosinusitis: A Randomized Controlled Trial</title>
      <itunes:title>Amoxicillin for Acute Rhinosinusitis: A Randomized Controlled Trial</itunes:title>
      <pubDate>Tue, 14 Feb 2012 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[f79a82e6297b71f780873f06ce1c7fb7]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.138]]></link>
      <description><![CDATA[<p>Interview with Jay F. Piccirillo, MD, author of Amoxicillin for Acute Rhinosinusitis: A Randomized Controlled Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Jay F. Piccirillo, MD, author of Amoxicillin for Acute Rhinosinusitis: A Randomized Controlled Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/30707685-piccirillo.mp3?dest-id=90171" length="2838643" type="audio/mpeg" />
      <itunes:duration>02:21</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/7/1/4/0/714021d2bff07f65/piccirillo.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Moderate to Vigorous Physical Activity and Sedentary Time and Cardiometabolic Risk Factors in Children and Adolescents</title>
      <itunes:title>Moderate to Vigorous Physical Activity and Sedentary Time and Cardiometabolic Risk Factors in Children and Adolescents</itunes:title>
      <pubDate>Tue, 14 Feb 2012 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[6776a0e938cda4dbababbac055535f4b]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.156]]></link>
      <description><![CDATA[<p>Interview with Ulf Ekelund, PhD, author of Moderate to Vigorous Physical Activity and Sedentary Time and Cardiometabolic Risk Factors in Children and Adolescents</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Ulf Ekelund, PhD, author of Moderate to Vigorous Physical Activity and Sedentary Time and Cardiometabolic Risk Factors in Children and Adolescents</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/021512ekelund.mp3?dest-id=90171" length="3388228" type="audio/mpeg" />
      <itunes:duration>05:38</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/d/c/4/adc45e9f28d7cc57/ekuland.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Risk of Intussusception Following Administration of a Pentavalent Rotavirus Vaccine in US Infants</title>
      <itunes:title>Risk of Intussusception Following Administration of a Pentavalent Rotavirus Vaccine in US Infants</itunes:title>
      <pubDate>Tue, 07 Feb 2012 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[ce33766dc8dec0ff264012f7c3abbde9]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.97]]></link>
      <description><![CDATA[<p>Interview with Irene M. Shui, ScD, author of Risk of Intussusception Following Administration of a Pentavalent Rotavirus Vaccine in US Infants</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Irene M. Shui, ScD, author of Risk of Intussusception Following Administration of a Pentavalent Rotavirus Vaccine in US Infants</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/30706598-shui.mp3?dest-id=90171" length="5803639" type="audio/mpeg" />
      <itunes:duration>04:50</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/7/3/2/9/732950b97491d216/shui.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Variability in Reexcision Following Breast Conservation Surgery</title>
      <itunes:title>Variability in Reexcision Following Breast Conservation Surgery</itunes:title>
      <pubDate>Tue, 31 Jan 2012 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[4d704e80397a449040ee4f2888718463]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.43]]></link>
      <description><![CDATA[<p>Interview with Laurence E. McCahill, MD, author of Variability in Reexcision Following Breast Conservation Surgery</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Laurence E. McCahill, MD, author of Variability in Reexcision Following Breast Conservation Surgery</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/30705467-mccahill.mp3?dest-id=90171" length="8789335" type="audio/mpeg" />
      <itunes:duration>07:19</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/0/4/d/6/04d6636226922d5e/mccahill.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Physician Medical Identity Theft</title>
      <itunes:title>Physician Medical Identity Theft</itunes:title>
      <pubDate>Tue, 31 Jan 2012 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[b47dee7e2c57d435de57c84afe131953]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2012.78]]></link>
      <description><![CDATA[<p>Interview with Peter Budetti, MD, JD, author of Physician Medical Identity Theft</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Peter Budetti, MD, JD, author of Physician Medical Identity Theft</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/020112budetti.mp3?dest-id=90171" length="6034065" type="audio/mpeg" />
      <itunes:duration>10:02</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/4/e/5/9/4e59a53d1d991ba7/budetti.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Lansoprazole for Children With Poorly Controlled Asthma: A Randomized Controlled Trial</title>
      <itunes:title>Lansoprazole for Children With Poorly Controlled Asthma: A Randomized Controlled Trial</itunes:title>
      <pubDate>Tue, 24 Jan 2012 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[8cdee216100278f3a52f9320792a818c]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2011.2035]]></link>
      <description><![CDATA[<p>Interview with Janet T. Holbrook, MPH, PhD, author of Lansoprazole for Children With Poorly Controlled Asthma: A Randomized Controlled Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Janet T. Holbrook, MPH, PhD, author of Lansoprazole for Children With Poorly Controlled Asthma: A Randomized Controlled Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/30704373-holbrook.mp3?dest-id=90171" length="4328813" type="audio/mpeg" />
      <itunes:duration>03:36</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/4/7/6/0/476013eccf03891e/holbrook.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Antiplatelet Therapy With Cangrelor in Patients Undergoing Cardiac Surgery: A Randomized Controlled Trial</title>
      <itunes:title>Antiplatelet Therapy With Cangrelor in Patients Undergoing Cardiac Surgery: A Randomized Controlled Trial</itunes:title>
      <pubDate>Tue, 17 Jan 2012 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[be4b4b49363b0b535a74851535b7ae7e]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2011.2002]]></link>
      <description><![CDATA[<p>Interview with Eric J. Topol, MD, author of Bridging Antiplatelet Therapy With Cangrelor in Patients Undergoing Cardiac Surgery: A Randomized Controlled Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Eric J. Topol, MD, author of Bridging Antiplatelet Therapy With Cangrelor in Patients Undergoing Cardiac Surgery: A Randomized Controlled Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/30703265-topol.mp3?dest-id=90171" length="6388110" type="audio/mpeg" />
      <itunes:duration>04:26</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/e/1/8/9e188b87462196e2/30703265-topol.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Universal Screening and Drug Treatment of Dyslipidemia in Children and Adolescents</title>
      <itunes:title>Universal Screening and Drug Treatment of Dyslipidemia in Children and Adolescents</itunes:title>
      <pubDate>Tue, 17 Jan 2012 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[a295a545a7df46a79b3c96565dc8603a]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2011.1916]]></link>
      <description><![CDATA[<p>Interview with Frederick P. Rivara, MD, MPH, author of Universal Screening and Drug Treatment of Dyslipidemia in Children and Adolescents</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Frederick P. Rivara, MD, MPH, author of Universal Screening and Drug Treatment of Dyslipidemia in Children and Adolescents</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/011812rivara.mp3?dest-id=90171" length="3594451" type="audio/mpeg" />
      <itunes:duration>05:58</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/1/2/7/91279728ddbd23a2/011812rivara.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Association Between Marijuana Exposure and Pulmonary Function Over 20 Years</title>
      <itunes:title>Association Between Marijuana Exposure and Pulmonary Function Over 20 Years</itunes:title>
      <pubDate>Tue, 03 Jan 2012 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[6c34ff26ff37b0ce3f97eeabad605206]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2011.1961]]></link>
      <description><![CDATA[<p>Interview with Stefan Kertesz, MD, author of Association Between Marijuana Exposure and Pulmonary Function Over 20 Years</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Stefan Kertesz, MD, author of Association Between Marijuana Exposure and Pulmonary Function Over 20 Years</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/30702173-kertesz.mp3?dest-id=90171" length="7434415" type="audio/mpeg" />
      <itunes:duration>06:11</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/7/2/3/87239a5a8701a869/30702173-kertesz.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Effect of Dietary Protein Content on Weight Gain, Energy Expenditure, and Body Composition During Overeating: A Randomized Controlled Trial</title>
      <itunes:title>Effect of Dietary Protein Content on Weight Gain, Energy Expenditure, and Body Composition During Overeating: A Randomized Controlled Trial</itunes:title>
      <pubDate>Tue, 03 Jan 2012 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[67928a0e3766685b4a76ea605dd6697c]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2011.1918]]></link>
      <description><![CDATA[<p>Interview with George A. Bray, MD, author of Effect of Dietary Protein Content on Weight Gain, Energy Expenditure, and Body Composition During Overeating: A Randomized Controlled Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with George A. Bray, MD, author of Effect of Dietary Protein Content on Weight Gain, Energy Expenditure, and Body Composition During Overeating: A Randomized Controlled Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/3070147-bray.mp3?dest-id=90171" length="7905083" type="audio/mpeg" />
      <itunes:duration>06:35</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/3/f/f/e3ffaeef6a882f24/3070147-bray.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Where Are the Health Care Cost Savings?</title>
      <itunes:title>Where Are the Health Care Cost Savings?</itunes:title>
      <pubDate>Tue, 03 Jan 2012 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[d27c22c59cc8ef7b1d881633ff011f2d]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2011.1927]]></link>
      <description><![CDATA[<p>Interview with Ezekiel J. Emanuel, MD, PhD, author of Where Are the Health Care Cost Savings?</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Ezekiel J. Emanuel, MD, PhD, author of Where Are the Health Care Cost Savings?</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/010412emanuel.mp3?dest-id=90171" length="5177421" type="audio/mpeg" />
      <itunes:duration>08:37</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/4/a/f/a/4afa362fe730fa98/010412emanuel.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults</title>
      <itunes:title>ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults</itunes:title>
      <pubDate>Tue, 27 Dec 2011 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[772c2ecc5714d6aca0aeb47d5120c306]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2011.1830]]></link>
      <description><![CDATA[<p>Interview with Laurel A. Habel, PhD, author of ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Laurel A. Habel, PhD, author of ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/306242673-habel.mp3?dest-id=90171" length="4278036" type="audio/mpeg" />
      <itunes:duration>03:33</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/7/6/5/3/76536abac9cea8bf/306242673-habel.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Prostate Cancer Screening-The Evidence, the Recommendations, and the Clinical Implications</title>
      <itunes:title>Prostate Cancer Screening-The Evidence, the Recommendations, and the Clinical Implications</itunes:title>
      <pubDate>Tue, 27 Dec 2011 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[f468897d355320be649edffde51b545d]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2011.1891]]></link>
      <description><![CDATA[<p>Interview with Roger Chou, MD, author of Prostate Cancer Screening-The Evidence, the Recommendations, and the Clinical Implications</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Roger Chou, MD, author of Prostate Cancer Screening-The Evidence, the Recommendations, and the Clinical Implications</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/chou122811.mp3?dest-id=90171" length="5226737" type="audio/mpeg" />
      <itunes:duration>08:41</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/d/9/d/b/d9db2f25ed319bcd/chou122811.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Sleep Disorders, Health, and Safety in Police Officers</title>
      <itunes:title>Sleep Disorders, Health, and Safety in Police Officers</itunes:title>
      <pubDate>Tue, 13 Dec 2011 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[9731b2845f347690b8a2352a2bbbd9c3]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2011.1851]]></link>
      <description><![CDATA[<p>Interview with Charles A. Czeisler, PhD, MD, FRCP, author of Sleep Disorders, Health, and Safety in Police Officers</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Charles A. Czeisler, PhD, MD, FRCP, author of Sleep Disorders, Health, and Safety in Police Officers</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/306232567-czeisler.mp3?dest-id=90171" length="5970836" type="audio/mpeg" />
      <itunes:duration>04:58</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/a/3/1/5/a315722220479b76/306232567-czeisler.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Causes of Death Among Stillbirths</title>
      <itunes:title>Causes of Death Among Stillbirths</itunes:title>
      <pubDate>Tue, 13 Dec 2011 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[e66630451bcd37f1d134c7b3bcc5f66d]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2011.1823]]></link>
      <description><![CDATA[<p>Interview with Robert M. Silver, MD, author of Causes of Death Among Stillbirths</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Robert M. Silver, MD, author of Causes of Death Among Stillbirths</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/306222459-silver.mp3?dest-id=90171" length="5103704" type="audio/mpeg" />
      <itunes:duration>08:29</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/2/b/9/82b935f5b7b2457a/306222459-silver.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>What Patients Really Want From Health Care</title>
      <itunes:title>What Patients Really Want From Health Care</itunes:title>
      <pubDate>Tue, 13 Dec 2011 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[754789b1046ade75b0033344e84a4127]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2011.1819]]></link>
      <description><![CDATA[<p>Interview with Allan S. Detsky, MD, PhD, author of What Patients Really Want From Health Care</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Allan S. Detsky, MD, PhD, author of What Patients Really Want From Health Care</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/detsky121411.mp3?dest-id=90171" length="3954564" type="audio/mpeg" />
      <itunes:duration>06:34</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/b/e/4/1be40e77c85e9089/detsky121411.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Association of Antenatal Corticosteroids With Mortality and Neurodevelopmental Outcomes Among Infants Born at 22 to 25 Weeks' Gestation</title>
      <itunes:title>Association of Antenatal Corticosteroids With Mortality and Neurodevelopmental Outcomes Among Infants Born at 22 to 25 Weeks' Gestation</itunes:title>
      <pubDate>Tue, 06 Dec 2011 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[23fe0fbe7cc68a89439415bec1e0a346]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2011.1752]]></link>
      <description><![CDATA[<p>Interview with Waldemar A. Carlo, MD, author of Association of Antenatal Corticosteroids With Mortality and Neurodevelopmental Outcomes Among Infants Born at 22 to 25 Weeks' Gestation</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Waldemar A. Carlo, MD, author of Association of Antenatal Corticosteroids With Mortality and Neurodevelopmental Outcomes Among Infants Born at 22 to 25 Weeks' Gestation</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/306212348-carlo.mp3?dest-id=90171" length="5090928" type="audio/mpeg" />
      <itunes:duration>03:32</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/b/a/2/8/ba287e8d85295f60/306212348-carlo.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Association Between Valvular Surgery and Mortality Among Patients With Infective Endocarditis Complicated by Heart</title>
      <itunes:title>Association Between Valvular Surgery and Mortality Among Patients With Infective Endocarditis Complicated by Heart</itunes:title>
      <pubDate>Tue, 22 Nov 2011 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[56469db744de40426e3295bc3c6dc607]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2011.1701]]></link>
      <description><![CDATA[<p>Interview with Andrew Wang, MD, author of Association Between Valvular Surgery and Mortality Among Patients With Infective Endocarditis Complicated by Heart Failure</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Andrew Wang, MD, author of Association Between Valvular Surgery and Mortality Among Patients With Infective Endocarditis Complicated by Heart Failure</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/306202239-wang.mp3?dest-id=90171" length="6793068" type="audio/mpeg" />
      <itunes:duration>03:32</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/b/9/f/eb9fbd54f5013b9c/306202239-wang.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Urinary Sodium and Potassium Excretion and Risk of Cardiovascular Events</title>
      <itunes:title>Urinary Sodium and Potassium Excretion and Risk of Cardiovascular Events</itunes:title>
      <pubDate>Tue, 22 Nov 2011 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[79e8fcb46e7623e18c821ad311744d71]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2011.1729]]></link>
      <description><![CDATA[<p>Interview with Martin J. O'Donnell, MB, PhD, author of Urinary Sodium and Potassium Excretion and Risk of Cardiovascular Events</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Martin J. O'Donnell, MB, PhD, author of Urinary Sodium and Potassium Excretion and Risk of Cardiovascular Events</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/odonnell_112311.mp3?dest-id=90171" length="3945480" type="audio/mpeg" />
      <itunes:duration>06:33</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/2/f/1/62f16aa34a0f2ca6/odonnell_112311.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Effects of the CETP Inhibitor Evacetrapib Administered as Monotherapy or in Combination With Statins on HDL and LDL Cholesterol: A Randomized Controlled Trial</title>
      <itunes:title>Effects of the CETP Inhibitor Evacetrapib Administered as Monotherapy or in Combination With Statins on HDL and LDL Cholesterol: A Randomized Controlled Trial</itunes:title>
      <pubDate>Tue, 15 Nov 2011 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[faa668a10bad4da3119dd7e01c794612]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2011.1649]]></link>
      <description><![CDATA[<p>Interview with Steven E. Nissen, MD, author of Effects of the CETP Inhibitor Evacetrapib Administered as Monotherapy or in Combination With Statins on HDL and LDL Cholesterol: A Randomized Controlled Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Steven E. Nissen, MD, author of Effects of the CETP Inhibitor Evacetrapib Administered as Monotherapy or in Combination With Statins on HDL and LDL Cholesterol: A Randomized Controlled Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/306192099-nissen.mp3?dest-id=90171" length="3593582" type="audio/mpeg" />
      <itunes:duration>02:59</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/b/a/2/b/ba2b3e1bc6f319e8/306192099-nissen.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Effect of Intracoronary Delivery of Autologous Bone Marrow Mononuclear Cells 2 to 3 Weeks Following Acute Myocardial Infarction on Left Ventricular Function: The LateTIME Randomized Trial</title>
      <itunes:title>Effect of Intracoronary Delivery of Autologous Bone Marrow Mononuclear Cells 2 to 3 Weeks Following Acute Myocardial Infarction on Left Ventricular Function: The LateTIME Randomized Trial</itunes:title>
      <pubDate>Tue, 15 Nov 2011 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[95c438a57282beaed9f6bbde2cc98ccf]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2011.1670]]></link>
      <description><![CDATA[<p>Interview with Jay H. Traverse, MD, author of Effect of Intracoronary Delivery of Autologous Bone Marrow Mononuclear Cells 2 to 3 Weeks Following Acute Myocardial Infarction on Left Ventricular Function: The LateTIME Randomized Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Jay H. Traverse, MD, author of Effect of Intracoronary Delivery of Autologous Bone Marrow Mononuclear Cells 2 to 3 Weeks Following Acute Myocardial Infarction on Left Ventricular Function: The LateTIME Randomized Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/traverse111611.mp3?dest-id=90171" length="3888896" type="audio/mpeg" />
      <itunes:duration>06:27</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/7/c/c/c7cc3b547519bd63/traverse111611.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Association Between Physician Billing and Cardiac Stress Testing Patterns Following Coronary Revascularization</title>
      <itunes:title>Association Between Physician Billing and Cardiac Stress Testing Patterns Following Coronary Revascularization</itunes:title>
      <pubDate>Tue, 08 Nov 2011 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[01b77e5a29c4bb964d4d6b3ded8f3c9e]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2011.1604]]></link>
      <description><![CDATA[<p>Interview with Bimal R. Shah, MD, MB, author of Association Between Physician Billing and Cardiac Stress Testing Patterns Following Coronary Revascularization</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Bimal R. Shah, MD, MB, author of Association Between Physician Billing and Cardiac Stress Testing Patterns Following Coronary Revascularization</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/306181993-shah.mp3?dest-id=90171" length="8134900" type="audio/mpeg" />
      <itunes:duration>04:14</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/4/5/6/e/456eebbda41bb550/306181993-shah.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Neuron Number and Size in Prefrontal Cortex of Children With Autism</title>
      <itunes:title>Neuron Number and Size in Prefrontal Cortex of Children With Autism</itunes:title>
      <pubDate>Tue, 08 Nov 2011 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[a4c55cdc6f90015ec13d4055920c1ce9]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2011.1638]]></link>
      <description><![CDATA[<p>Interview with Eric Courchesne, PhD, author of Neuron Number and Size in Prefrontal Cortex of Children With Autism</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Eric Courchesne, PhD, author of Neuron Number and Size in Prefrontal Cortex of Children With Autism</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/courchesne110911.mp3?dest-id=90171" length="7437168" type="audio/mpeg" />
      <itunes:duration>12:23</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/1/3/f/113f396f97a2bcaf/courchesne110911.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Moderate Alcohol Consumption During Adult Life, Drinking Patterns, and Breast Cancer Risk</title>
      <itunes:title>Moderate Alcohol Consumption During Adult Life, Drinking Patterns, and Breast Cancer Risk</itunes:title>
      <pubDate>Tue, 01 Nov 2011 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[691560d12648185397f8267c46ef97e3]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2011.1590]]></link>
      <description><![CDATA[<p>Interview with Wendy Y. Chen, MD, MPH, author of Moderate Alcohol Consumption During Adult Life, Drinking Patterns, and Breast Cancer Risk</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Wendy Y. Chen, MD, MPH, author of Moderate Alcohol Consumption During Adult Life, Drinking Patterns, and Breast Cancer Risk</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/306171884-chen.mp3?dest-id=90171" length="3407805" type="audio/mpeg" />
      <itunes:duration>02:50</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/0/a/c/c0ac8578957930c2/306171884-chen.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Identification of Chronic Obstructive Pulmonary Disease in Lung Cancer Screening Computed Tomographic Scans</title>
      <itunes:title>Identification of Chronic Obstructive Pulmonary Disease in Lung Cancer Screening Computed Tomographic Scans</itunes:title>
      <pubDate>Tue, 25 Oct 2011 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[16caa33fd4f4680e84abae8c038aff59]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2011.1531]]></link>
      <description><![CDATA[<p>Interview with Pim A. de Jong, MD, PhD, author of Identification of Chronic Obstructive Pulmonary Disease in Lung Cancer Screening Computed Tomographic Scans</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Pim A. de Jong, MD, PhD, author of Identification of Chronic Obstructive Pulmonary Disease in Lung Cancer Screening Computed Tomographic Scans</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/306161775-dejong.mp3?dest-id=90171" length="3982315" type="audio/mpeg" />
      <itunes:duration>02:04</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/d/9/8/5/d985f6bf546d468e/306161775-dejong.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>National and Regional Trends in Heart Failure Hospitalization and Mortality Rates for Medicare Beneficiaries, 1998-2008</title>
      <itunes:title>National and Regional Trends in Heart Failure Hospitalization and Mortality Rates for Medicare Beneficiaries, 1998-2008</itunes:title>
      <pubDate>Tue, 18 Oct 2011 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[61bbb2666dd1b679f7ca9bee6172697d]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2011.1474]]></link>
      <description><![CDATA[<p>Interview with Jersey Chen, MD, MPH, author of National and Regional Trends in Heart Failure Hospitalization and Mortality Rates for Medicare Beneficiaries, 1998-2008</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Jersey Chen, MD, MPH, author of National and Regional Trends in Heart Failure Hospitalization and Mortality Rates for Medicare Beneficiaries, 1998-2008</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/306151669-chen.mp3?dest-id=90171" length="3991407" type="audio/mpeg" />
      <itunes:duration>05:32</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/d/2/0/c/d20c5f8dd6897109/306151669-chen.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Use of Electron-Beam Sterilized Hemodialysis Membranes and Risk of Thrombocytopenia</title>
      <itunes:title>Use of Electron-Beam Sterilized Hemodialysis Membranes and Risk of Thrombocytopenia</itunes:title>
      <pubDate>Tue, 18 Oct 2011 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[87133c3cc52c4e5b489a3f37330137c5]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2011.1499]]></link>
      <description><![CDATA[<p>Interview with Mercedeh Kiaii, MD, author of Use of Electron-Beam Sterilized Hemodialysis Membranes and Risk of Thrombocytopenia</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Mercedeh Kiaii, MD, author of Use of Electron-Beam Sterilized Hemodialysis Membranes and Risk of Thrombocytopenia</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/kiaii101911.mp3?dest-id=90171" length="5837817" type="audio/mpeg" />
      <itunes:duration>09:43</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/4/f/f/d/4ffdfa2855c461ae/kiaii101911.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Vitamin E and the Risk of Prostate Cancer: The Selenium and Vitamin E Cancer Prevention Trial (SELECT</title>
      <itunes:title>Vitamin E and the Risk of Prostate Cancer: The Selenium and Vitamin E Cancer Prevention Trial (SELECT</itunes:title>
      <pubDate>Tue, 11 Oct 2011 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[ebedacf74ebba1b36c9612c95480fc7e]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2011.1437]]></link>
      <description><![CDATA[<p>Interview with Eric A. Klein, MD, author of Vitamin E and the Risk of Prostate Cancer: The Selenium and Vitamin E Cancer Prevention Trial (SELECT)</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Eric A. Klein, MD, author of Vitamin E and the Risk of Prostate Cancer: The Selenium and Vitamin E Cancer Prevention Trial (SELECT)</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/306141549-klein.mp3?dest-id=90171" length="4544779" type="audio/mpeg" />
      <itunes:duration>03:47</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/7/6/a/7/76a7d7672a253085/306141549-klein.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Regional Variation in the Association Between Advance Directives and End-of-Life Medicare Expenditures</title>
      <itunes:title>Regional Variation in the Association Between Advance Directives and End-of-Life Medicare Expenditures</itunes:title>
      <pubDate>Tue, 04 Oct 2011 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[b9c3c2aef4a0202838208e61654e3902]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2011.1410]]></link>
      <description><![CDATA[<p>Interview with Lauren Hersch Nicholas, PhD, MPP, author of Regional Variation in the Association Between Advance Directives and End-of-Life Medicare Expenditures</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Lauren Hersch Nicholas, PhD, MPP, author of Regional Variation in the Association Between Advance Directives and End-of-Life Medicare Expenditures</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/306131447-nicholas.mp3?dest-id=90171" length="14938204" type="audio/mpeg" />
      <itunes:duration>07:47</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/2/3/5/6235c742fe13a679/306131447-nicholas.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Prevalence and Outcomes of Same-Day Discharge After Elective Percutaneous Coronary Intervention Among Older Patients</title>
      <itunes:title>Prevalence and Outcomes of Same-Day Discharge After Elective Percutaneous Coronary Intervention Among Older Patients</itunes:title>
      <pubDate>Tue, 04 Oct 2011 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[7eca20ab20809083dc92626aad0d630c]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2011.1409]]></link>
      <description><![CDATA[<p>Interview with Sunil V. Rao, MD, author of Prevalence and Outcomes of Same-Day Discharge After Elective Percutaneous Coronary Intervention Among Older Patients</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Sunil V. Rao, MD, author of Prevalence and Outcomes of Same-Day Discharge After Elective Percutaneous Coronary Intervention Among Older Patients</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/rao_100511.mp3?dest-id=90171" length="4882724" type="audio/mpeg" />
      <itunes:duration>08:07</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/0/1/c/901c63b165111822/rao_100511.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Effect of Increasing Doses of Saw Palmetto Extract on Lower Urinary Tract Symptoms: A Randomized Trial</title>
      <itunes:title>Effect of Increasing Doses of Saw Palmetto Extract on Lower Urinary Tract Symptoms: A Randomized Trial</itunes:title>
      <pubDate>Tue, 27 Sep 2011 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[5049ace3dbc62251324d0855bd3b1d4c]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2011.1364]]></link>
      <description><![CDATA[<p>Interview with Kevin T. McVary, MD, author of Effect of Increasing Doses of Saw Palmetto Extract on Lower Urinary Tract Symptoms: A Randomized Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Kevin T. McVary, MD, author of Effect of Increasing Doses of Saw Palmetto Extract on Lower Urinary Tract Symptoms: A Randomized Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/mcvary-306121344.mp3?dest-id=90171" length="5753709" type="audio/mpeg" />
      <itunes:duration>04:47</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/d/3/8/1d38b05cff30b3d5/mcvary-306121344.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Prediction of Erectile Function Following Treatment for Prostate Cancer</title>
      <itunes:title>Prediction of Erectile Function Following Treatment for Prostate Cancer</itunes:title>
      <pubDate>Tue, 20 Sep 2011 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[ef12cdb4fc0cef585a49f683d8f7e7e6]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2011.1333]]></link>
      <description><![CDATA[<p>Interview with Martin G. Sanda, MD, author of Prediction of Erectile Function Following Treatment for Prostate Cancer</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Martin G. Sanda, MD, author of Prediction of Erectile Function Following Treatment for Prostate Cancer</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/sanda-306111205.mp3?dest-id=90171" length="6966473" type="audio/mpeg" />
      <itunes:duration>04:50</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/d/0/2/8/d0281b571bb3f309/sanda-306111205.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Cognitive Behavior Therapy Augmentation of Pharmacotherapy in Pediatric Obsessive-Compulsive Disorder: The Pediatric OCD Treatment Study II (POTS II) Randomized Controlled Trial</title>
      <itunes:title>Cognitive Behavior Therapy Augmentation of Pharmacotherapy in Pediatric Obsessive-Compulsive Disorder: The Pediatric OCD Treatment Study II (POTS II) Randomized Controlled Trial</itunes:title>
      <pubDate>Tue, 20 Sep 2011 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[d6a5c16eda8d45cd308b2f854fc3b24b]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2011.1344]]></link>
      <description><![CDATA[<p>Interview with Martin E. Franklin, PhD, author of Cognitive Behavior Therapy Augmentation of Pharmacotherapy in Pediatric Obsessive-Compulsive Disorder: The Pediatric OCD Treatment Study II (POTS II) Randomized Controlled Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Martin E. Franklin, PhD, author of Cognitive Behavior Therapy Augmentation of Pharmacotherapy in Pediatric Obsessive-Compulsive Disorder: The Pediatric OCD Treatment Study II (POTS II) Randomized Controlled Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/franklin_092111.mp3?dest-id=90171" length="4771478" type="audio/mpeg" />
      <itunes:duration>07:56</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/7/6/7/2767c77c243f0622/franklin_092111.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Graduated Driver Licensing and Fatal Crashes Involving 16- to 19-Year-Old Drivers</title>
      <itunes:title>Graduated Driver Licensing and Fatal Crashes Involving 16- to 19-Year-Old Drivers</itunes:title>
      <pubDate>Tue, 13 Sep 2011 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[0bf1080ad968203f69965b9a879a7b62]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2011.1277]]></link>
      <description><![CDATA[<p>Interview with Scott V. Masten, PhD, author of Graduated Driver Licensing and Fatal Crashes Involving 16- to 19-Year-Old Drivers</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Scott V. Masten, PhD, author of Graduated Driver Licensing and Fatal Crashes Involving 16- to 19-Year-Old Drivers</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/masten-306101098.mp3?dest-id=90171" length="4885639" type="audio/mpeg" />
      <itunes:duration>04:05</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/5/8/a/e/58ae9b6c78891efd/masten-306101098.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Association of Unconscious Race and Social Class Bias With Vignette-Based Clinical Assessments by Medical Students</title>
      <itunes:title>Association of Unconscious Race and Social Class Bias With Vignette-Based Clinical Assessments by Medical Students</itunes:title>
      <pubDate>Tue, 06 Sep 2011 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[3215845ea79b086f491fd33f2b64ff16]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2011.1248]]></link>
      <description><![CDATA[<p>Interview with Julie A. Freischlag, MD, author of Association of Unconscious Race and Social Class Bias With Vignette-Based Clinical Assessments by Medical Students</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Julie A. Freischlag, MD, author of Association of Unconscious Race and Social Class Bias With Vignette-Based Clinical Assessments by Medical Students</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/freischlag-30609942.mp3?dest-id=90171" length="15671635" type="audio/mpeg" />
      <itunes:duration>08:10</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/1/4/c/914c84f6affcaeb6/freischlag-30609942.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Quality of Life, Burnout, Educational Debt, and Medical Knowledge Among Internal Medicine Residents</title>
      <itunes:title>Quality of Life, Burnout, Educational Debt, and Medical Knowledge Among Internal Medicine Residents</itunes:title>
      <pubDate>Tue, 06 Sep 2011 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[50021520350df226b0d25f661ca6882e]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2011.1247]]></link>
      <description><![CDATA[<p>Interview with Colin P. West, MD, PhD, author of Quality of Life, Burnout, Educational Debt, and Medical Knowledge Among Internal Medicine Residents</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Colin P. West, MD, PhD, author of Quality of Life, Burnout, Educational Debt, and Medical Knowledge Among Internal Medicine Residents</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/west_090711.mp3?dest-id=90171" length="5853969" type="audio/mpeg" />
      <itunes:duration>09:44</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/3/5/d/835d41e1af3f0b75/west_090711.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Effect of a Dietary Portfolio of Cholesterol-Lowering Foods Given at 2 Levels of Intensity of Dietary Advice on Serum Lipids in Hyperlipidemia: A Randomized Controlled Trial</title>
      <itunes:title>Effect of a Dietary Portfolio of Cholesterol-Lowering Foods Given at 2 Levels of Intensity of Dietary Advice on Serum Lipids in Hyperlipidemia: A Randomized Controlled Trial</itunes:title>
      <pubDate>Tue, 23 Aug 2011 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[7310cd5d5f2328938d08a66d6f5e2ae3]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2011.1202]]></link>
      <description><![CDATA[<p>Interview with David J. A. Jenkins, MD, author of Effect of a Dietary Portfolio of Cholesterol-Lowering Foods Given at 2 Levels of Intensity of Dietary Advice on Serum Lipids in Hyperlipidemia: A Randomized Controlled Trial</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with David J. A. Jenkins, MD, author of Effect of a Dietary Portfolio of Cholesterol-Lowering Foods Given at 2 Levels of Intensity of Dietary Advice on Serum Lipids in Hyperlipidemia: A Randomized Controlled Trial</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/jenkins-30608831.mp3?dest-id=90171" length="14690264" type="audio/mpeg" />
      <itunes:duration>07:39</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/8/6/2/386250e10f68ec8e/jenkins-30608831.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Implementing Accountable Care Organizations: Ten Potential Mistakes and How to Learn From Them</title>
      <itunes:title>Implementing Accountable Care Organizations: Ten Potential Mistakes and How to Learn From Them</itunes:title>
      <pubDate>Tue, 16 Aug 2011 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[258a6b833136d29ad70bdceda4b08222]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2011.1180]]></link>
      <description><![CDATA[<p>Interview with Stephen M. Shortell, PhD, MPH, MBA, author of Implementing Accountable Care Organizations: Ten Potential Mistakes and How to Learn From Them</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Stephen M. Shortell, PhD, MPH, MBA, author of Implementing Accountable Care Organizations: Ten Potential Mistakes and How to Learn From Them</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/shortell081711.mp3?dest-id=90171" length="6000867" type="audio/mpeg" />
      <itunes:duration>09:59</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/a/8/f/2a8f2ec41e6c6fcb/shortell081711.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Use of Radioactive Iodine for Thyroid Cancer</title>
      <itunes:title>Use of Radioactive Iodine for Thyroid Cancer</itunes:title>
      <pubDate>Tue, 16 Aug 2011 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[63186fe634459455ae2003926374aefb]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2011.1139]]></link>
      <description><![CDATA[<p>Interview with Megan R. Haymart, MD, author of Use of Radioactive Iodine for Thyroid Cancer</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Megan R. Haymart, MD, author of Use of Radioactive Iodine for Thyroid Cancer</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/haymart-30607721.mp3?dest-id=90171" length="3726167" type="audio/mpeg" />
      <itunes:duration>01:57</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/b/9/7/b/b97bf9be1007d3a1/haymart-30607721.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Sleep-Disordered Breathing, Hypoxia, and Risk of Mild Cognitive Impairment and Dementia in Older Women</title>
      <itunes:title>Sleep-Disordered Breathing, Hypoxia, and Risk of Mild Cognitive Impairment and Dementia in Older Women</itunes:title>
      <pubDate>Fri, 12 Aug 2011 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[56c89a4a127d12b97be84ec2219fcc84]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2011.1115]]></link>
      <description><![CDATA[<p>Interview with Katie L. Stone, PhD, author of Sleep-Disordered Breathing, Hypoxia, and Risk of Mild Cognitive Impairment and Dementia in Older Women</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Katie L. Stone, PhD, author of Sleep-Disordered Breathing, Hypoxia, and Risk of Mild Cognitive Impairment and Dementia in Older Women</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/stone-30606613.mp3?dest-id=90171" length="4891211" type="audio/mpeg" />
      <itunes:duration>02:33</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/6/6/8/166880e70e817704/stone-30606613.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Adjunctive Risperidone Treatment for Antidepressant-Resistant Symptoms of Chronic Military Service-Related PTSD</title>
      <itunes:title>Adjunctive Risperidone Treatment for Antidepressant-Resistant Symptoms of Chronic Military Service-Related PTSD</itunes:title>
      <pubDate>Fri, 12 Aug 2011 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[8a53341309ee02e0ab62aa70eee13701]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2011.1080]]></link>
      <description><![CDATA[<p>Interview with John H. Krystal, MD, author of Adjunctive Risperidone Treatment for Antidepressant-Resistant Symptoms of Chronic Military Service-Related PTSD</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with John H. Krystal, MD, author of Adjunctive Risperidone Treatment for Antidepressant-Resistant Symptoms of Chronic Military Service-Related PTSD</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/3799jamaauthoraudiointerview.mp3?dest-id=90171" length="12406858" type="audio/mpeg" />
      <itunes:duration>06:28</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/c/f/d/ccfd1e0e6fcdb5fe/krystal-author-index.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Implementation of Medicare Part D and Nondrug Medical Spending for Elderly Adults With Limited Prior Drug Coverage</title>
      <itunes:title>Implementation of Medicare Part D and Nondrug Medical Spending for Elderly Adults With Limited Prior Drug Coverage</itunes:title>
      <pubDate>Fri, 12 Aug 2011 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[f1ec8f738fa7a1b6b3b906d289e5bf86]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2011.1026]]></link>
      <description><![CDATA[<p>Interview with J. Michael McWilliams, MD, Phd, author of Implementation of Medicare Part D and Nondrug Medical Spending for Elderly Adults With Limited Prior Drug Coverage</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with J. Michael McWilliams, MD, Phd, author of Implementation of Medicare Part D and Nondrug Medical Spending for Elderly Adults With Limited Prior Drug Coverage</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/3798jamaauthoraudiointerview.mp3?dest-id=90171" length="13033547" type="audio/mpeg" />
      <itunes:duration>06:48</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/5/e/b/7/5eb7f63c2b284c48/mcwilliams-author-index.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Interventions for War-Related Posttraumatic Stress Disorder: Meeting Veterans Where They Are</title>
      <itunes:title>Interventions for War-Related Posttraumatic Stress Disorder: Meeting Veterans Where They Are</itunes:title>
      <pubDate>Tue, 02 Aug 2011 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[afc434a50559b66179bdf71dc0c0b138]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2011.1096]]></link>
      <description><![CDATA[<p>Interview with Charles Hoge, MD, author of Interventions for War-Related Posttraumatic Stress Disorder: Meeting Veterans Where They Are</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Charles Hoge, MD, author of Interventions for War-Related Posttraumatic Stress Disorder: Meeting Veterans Where They Are</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/hoge080311.mp3?dest-id=90171" length="4499376" type="audio/mpeg" />
      <itunes:duration>07:29</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/f/7/8/a/f78acbe3a3f86f06/hoge080311.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Prevention of Melanoma With Regular Sunscreen Use</title>
      <itunes:title>Prevention of Melanoma With Regular Sunscreen Use</itunes:title>
      <pubDate>Tue, 19 Jul 2011 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[45eb245f0f8a7507525512798a7d315d]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2011.990]]></link>
      <description><![CDATA[<p>Interview with June K. Robinson, MD, author of Prevention of Melanoma With Regular Sunscreen Use</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with June K. Robinson, MD, author of Prevention of Melanoma With Regular Sunscreen Use</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/robinson072011.mp3?dest-id=90171" length="6367217" type="audio/mpeg" />
      <itunes:duration>10:36</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/2/1/d/121dad759b99dbbd/robinson072011.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Application of Electronic Health Records to the Joint Commission's 2011 National Patient Safety Goals</title>
      <itunes:title>Application of Electronic Health Records to the Joint Commission's 2011 National Patient Safety Goals</itunes:title>
      <pubDate>Tue, 05 Jul 2011 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[6c2944f8a17e5627414e34dbfc530a12]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2011.937]]></link>
      <description><![CDATA[<p>Interview with Ryan Radecki, MD, author of Application of Electronic Health Records to the Joint Commission's 2011 National Patient Safety Goals</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Ryan Radecki, MD, author of Application of Electronic Health Records to the Joint Commission's 2011 National Patient Safety Goals</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/radecki070611.mp3?dest-id=90171" length="3606159" type="audio/mpeg" />
      <itunes:duration>05:59</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/5/e/7/b/5e7bb27c9ff71e0f/radecki070611.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Improving Postdischarge Outcomes in Patients Hospitalized for Acute Heart Failure Syndromes</title>
      <itunes:title>Improving Postdischarge Outcomes in Patients Hospitalized for Acute Heart Failure Syndromes</itunes:title>
      <pubDate>Tue, 14 Jun 2011 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[ec4bd3722fe760e632fed80938468420]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2011.836]]></link>
      <description><![CDATA[<p>Interview with Mihai Gheorghiade, MD, author of Improving Postdischarge Outcomes in Patients Hospitalized for Acute Heart Failure Syndromes</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Mihai Gheorghiade, MD, author of Improving Postdischarge Outcomes in Patients Hospitalized for Acute Heart Failure Syndromes</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/gheorghiade_061511.mp3?dest-id=90171" length="5070205" type="audio/mpeg" />
      <itunes:duration>08:27</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/b/7/f/d/b7fd3ced9a6e796b/gheorghiade_061511.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>A New Frontier in Patient Safety</title>
      <itunes:title>A New Frontier in Patient Safety</itunes:title>
      <pubDate>Tue, 31 May 2011 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[6d6bf1db4e8fe7aba9676c3ee507c61f]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2011.742]]></link>
      <description><![CDATA[<p>Interview with Don Berwick, MD, author of A New Frontier in Patient Safety</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Don Berwick, MD, author of A New Frontier in Patient Safety</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/berwick060111.mp3?dest-id=90171" length="4963899" type="audio/mpeg" />
      <itunes:duration>08:15</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/e/b/3/3eb3817598e9a3f0/berwick060111.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>From Efficacy to Effectiveness in the Face of Uncertainty: Indication Creep and Prevention Creep</title>
      <itunes:title>From Efficacy to Effectiveness in the Face of Uncertainty: Indication Creep and Prevention Creep</itunes:title>
      <pubDate>Tue, 17 May 2011 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[ede0fcd0b8c4b01751eb0400cd4ff726]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2011.650]]></link>
      <description><![CDATA[<p>Interview with Benjamin Djulbegovic, MD, PhD, author of From Efficacy to Effectiveness in the Face of Uncertainty: Indication Creep and Prevention Creep</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Benjamin Djulbegovic, MD, PhD, author of From Efficacy to Effectiveness in the Face of Uncertainty: Indication Creep and Prevention Creep</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/djulbegovic051811.mp3?dest-id=90171" length="4131985" type="audio/mpeg" />
      <itunes:duration>08:33</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/0/0/b/100b1a1cb5e67196/djulbegovic051811.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Patient-Physican Communication: It's About Time</title>
      <itunes:title>Patient-Physican Communication: It's About Time</itunes:title>
      <pubDate>Tue, 03 May 2011 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[9f640b38d55b88014f8a701acd0cb87e]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2011.556]]></link>
      <description><![CDATA[<p>Interview with Wendy Levinson, MD, author of Patient-Physican Communication: It's About Time</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Wendy Levinson, MD, author of Patient-Physican Communication: It's About Time</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/levinson050411.mp3?dest-id=90171" length="4584198" type="audio/mpeg" />
      <itunes:duration>09:30</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/6/c/d/26cda136a4cbb1fa/levinson050411.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>How to Enroll Participants in Research Ethically</title>
      <itunes:title>How to Enroll Participants in Research Ethically</itunes:title>
      <pubDate>Tue, 19 Apr 2011 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[bc58f8697e3bc91394b9432f93a6c5f7]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2011.421]]></link>
      <description><![CDATA[<p>Interview with David Wendler, PhD, author of How to Enroll Participants in Research Ethically</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with David Wendler, PhD, author of How to Enroll Participants in Research Ethically</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/wendler042011.mp3?dest-id=90171" length="3557635" type="audio/mpeg" />
      <itunes:duration>07:21</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/a/1/2/9a12c7ee32bff25c/wendler042011.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Curtailing Diversion and Abuse of Opioid Analgesics Without Jeopardizing Pain Treatment</title>
      <itunes:title>Curtailing Diversion and Abuse of Opioid Analgesics Without Jeopardizing Pain Treatment</itunes:title>
      <pubDate>Tue, 05 Apr 2011 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[abfb90b53d9aa70ca83513ae08ba5133]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2011.369]]></link>
      <description><![CDATA[<p>Interview with Nora D. Volkow, MD, author of Curtailing Diversion and Abuse of Opioid Analgesics Without Jeopardizing Pain Treatment</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Nora D. Volkow, MD, author of Curtailing Diversion and Abuse of Opioid Analgesics Without Jeopardizing Pain Treatment</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/volkow040611.mp3?dest-id=90171" length="5075707" type="audio/mpeg" />
      <itunes:duration>10:31</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/8/8/4/2/8842ccc19aa6ef10/volkow040611.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Physician Communication in the 21st Century</title>
      <itunes:title>Physician Communication in the 21st Century</itunes:title>
      <pubDate>Tue, 15 Mar 2011 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[13a62d9466c325f220b23f652aba6b17]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2011.324]]></link>
      <description><![CDATA[<p>Interview with Allan S. Detsky, MD, PhD, author of Physician Communication in the 21st Century</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Allan S. Detsky, MD, PhD, author of Physician Communication in the 21st Century</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/detsky031611.mp3?dest-id=90171" length="4101522" type="audio/mpeg" />
      <itunes:duration>08:27</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/b/3/d/eb3d202513f0f9aa/detsky031611.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Biosafety Concerns Involving Genetically Modified Mosquitoes to Combat Malaria and Dengue in Developing Countries</title>
      <itunes:title>Biosafety Concerns Involving Genetically Modified Mosquitoes to Combat Malaria and Dengue in Developing Countries</itunes:title>
      <pubDate>Tue, 01 Mar 2011 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[047b8653b3eb8c5f0ef3d12b9028c07d]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2011.246]]></link>
      <description><![CDATA[<p>Interview with Lawrence O. Gostin, JD, author of Biosafety Concerns Involving Genetically Modified Mosquitoes to Combat Malaria and Dengue in Developing Countries</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Lawrence O. Gostin, JD, author of Biosafety Concerns Involving Genetically Modified Mosquitoes to Combat Malaria and Dengue in Developing Countries</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/gostin030211.mp3?dest-id=90171" length="3900920" type="audio/mpeg" />
      <itunes:duration>08:03</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/1/c/c/9/1cc9c0a2de3dbf08/gostin030211.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Damage Prevention and Control for Financial Incapacity</title>
      <itunes:title>Damage Prevention and Control for Financial Incapacity</itunes:title>
      <pubDate>Tue, 15 Feb 2011 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[ae5833f1a6fba80d4ca5c877d850af25]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2011.187]]></link>
      <description><![CDATA[<p>Interview with Charles Sabatino, JD, author of Damage Prevention and Control for Financial Incapacity</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Charles Sabatino, JD, author of Damage Prevention and Control for Financial Incapacity</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/sabatino021611.mp3?dest-id=90171" length="3687761" type="audio/mpeg" />
      <itunes:duration>07:35</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/7/2/5/3/7253eace7ebae8e3/sabatino021611.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>A Physician Management Infrastructure</title>
      <itunes:title>A Physician Management Infrastructure</itunes:title>
      <pubDate>Tue, 01 Feb 2011 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[8fecf954ab3c88da8bf88dc3a74a6221]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2011.71]]></link>
      <description><![CDATA[<p>Interview with Peter J. Pronovost, MD, PhD, author of A Physician Management Infrastructure</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Peter J. Pronovost, MD, PhD, author of A Physician Management Infrastructure</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/pronovost020211.mp3?dest-id=90171" length="4817190" type="audio/mpeg" />
      <itunes:duration>10:01</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/7/9/a/979a18ffb70c5265/pronovost020211.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>A Vision for Patient-Centered Health Information Systems</title>
      <itunes:title>A Vision for Patient-Centered Health Information Systems</itunes:title>
      <pubDate>Tue, 18 Jan 2011 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[5e7530d30e7133b279746648e7c5514a]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2010.2011]]></link>
      <description><![CDATA[<p>Interview with Alex H. Krist, MD, MPH, author of A Vision for Patient-Centered Health Information Systems</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Alex H. Krist, MD, MPH, author of A Vision for Patient-Centered Health Information Systems</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/krist011911.mp3?dest-id=90171" length="7421499" type="audio/mpeg" />
      <itunes:duration>15:04</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/e/1/a/7/e1a7abfacc7114d0/krist011911.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Re"evolutionary" Regenerative Medicine</title>
      <itunes:title>Re"evolutionary" Regenerative Medicine</itunes:title>
      <pubDate>Tue, 21 Dec 2010 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[d9b68714608001c171fad8bc2255ff3a]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2010.1938]]></link>
      <description><![CDATA[<p>Interview with Helen M. Blau, PhD, author of Re"evolutionary" Regenerative Medicine</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Helen M. Blau, PhD, author of Re"evolutionary" Regenerative Medicine</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/blau122110.mp3?dest-id=90171" length="5785844" type="audio/mpeg" />
      <itunes:duration>11:59</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/f/9/8/2f98d58fdf7e7c4a/blau122110.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>he United States' Engagement in Global Tobacco Control</title>
      <itunes:title>he United States' Engagement in Global Tobacco Control</itunes:title>
      <pubDate>Tue, 14 Dec 2010 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[705d93a66abacfb92892cf748e108e09]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2010.1842]]></link>
      <description><![CDATA[<p>Interview with Lawrence O. Gostin, JD, author of The United States' Engagement in Global Tobacco Control</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Lawrence O. Gostin, JD, author of The United States' Engagement in Global Tobacco Control</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/gostin121510.mp3?dest-id=90171" length="3768136" type="audio/mpeg" />
      <itunes:duration>07:48</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/d/d/9/3dd9f0faa4dfd53c/gostin030211.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Active Surveillance for Prostate Cancer</title>
      <itunes:title>Active Surveillance for Prostate Cancer</itunes:title>
      <pubDate>Tue, 30 Nov 2010 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[9d2acd771d47a58a50a6d9c5ac638915]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2010.1761]]></link>
      <description><![CDATA[<p>Interview with Ian M. Thompson, MD, author of Active Surveillance for Prostate Cancer</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Ian M. Thompson, MD, author of Active Surveillance for Prostate Cancer</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/thompson120110.mp3?dest-id=90171" length="4211291" type="audio/mpeg" />
      <itunes:duration>08:43</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/4/3/a/f/43af6e79bb7c1d56/thompson120110.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Discussing Radiation Risks Associated With CT Scans With Patients</title>
      <itunes:title>Discussing Radiation Risks Associated With CT Scans With Patients</itunes:title>
      <pubDate>Tue, 16 Nov 2010 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[e3b1eae99da12f40259442cdf53ad177]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2010.1591]]></link>
      <description><![CDATA[<p>Interview with Mark Otto Baerlocher, MD, author of Discussing Radiation Risks Associated With CT Scans With Patients</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Mark Otto Baerlocher, MD, author of Discussing Radiation Risks Associated With CT Scans With Patients</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/baerlocher111710.mp3?dest-id=90171" length="4713589" type="audio/mpeg" />
      <itunes:duration>09:46</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/9/e/a/4/9ea4956ddc54c559/baerlocher111710.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Substituted Interests and Best Judgments: An Integrated Model of Surrogate Decision Making</title>
      <itunes:title>Substituted Interests and Best Judgments: An Integrated Model of Surrogate Decision Making</itunes:title>
      <pubDate>Tue, 02 Nov 2010 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[578fedf50eebd4378540e1e785021c71]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2010.1595]]></link>
      <description><![CDATA[<p>Interview with Daniel P. Sulmasy, MD, PhD, author of Substituted Interests and Best Judgments: An Integrated Model of Surrogate Decision Making</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Daniel P. Sulmasy, MD, PhD, author of Substituted Interests and Best Judgments: An Integrated Model of Surrogate Decision Making</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/sulmasy110310.mp3?dest-id=90171" length="2706627" type="audio/mpeg" />
      <itunes:duration>05:35</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/c/5/f/a/c5fa8dd4d4dea20f/sulmasy110310.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Putting the Public Back in Public Reporting of Health Care Quality</title>
      <itunes:title>Putting the Public Back in Public Reporting of Health Care Quality</itunes:title>
      <pubDate>Tue, 19 Oct 2010 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[9cdd7321ee661e926f40d0ac228773b0]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2010.1499]]></link>
      <description><![CDATA[<p>Interview with Tara Lagu, MD, MPH, author of Putting the Public Back in Public Reporting of Health Care Quality</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Tara Lagu, MD, MPH, author of Putting the Public Back in Public Reporting of Health Care Quality</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/lagu102010.mp3?dest-id=90171" length="3894464" type="audio/mpeg" />
      <itunes:duration>08:03</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/2/e/b/7/2eb78d8288f3188d/lagu102010.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>What If Physicians Actually Had to Control Medical Costs?</title>
      <itunes:title>What If Physicians Actually Had to Control Medical Costs?</itunes:title>
      <pubDate>Tue, 05 Oct 2010 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[30b84bf1c3ea654db0dd370b426bd719]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2010.1426]]></link>
      <description><![CDATA[<p>Interview with Robert H. Brook, MD, ScD, author of What If Physicians Actually Had to Control Medical Costs?</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Robert H. Brook, MD, ScD, author of What If Physicians Actually Had to Control Medical Costs?</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/brook100610.mp3?dest-id=90171" length="2736426" type="audio/mpeg" />
      <itunes:duration>05:39</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/6/a/5/e/6a5e78bce6ced160/brook100610.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Understanding Depression and Distress Among Medical Students</title>
      <itunes:title>Understanding Depression and Distress Among Medical Students</itunes:title>
      <pubDate>Tue, 14 Sep 2010 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[c6d47b1f3d612e8af99a751d3682fbc9]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2010.1347]]></link>
      <description><![CDATA[<p>Interview with Laura Weiss Roberts, MD, MA, author of Understanding Depression and Distress Among Medical Students</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Laura Weiss Roberts, MD, MA, author of Understanding Depression and Distress Among Medical Students</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/roberts091510.mp3?dest-id=90171" length="4822126" type="audio/mpeg" />
      <itunes:duration>09:59</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/3/4/c/4/34c4ccdf32626563/roberts091510.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
    <item>
      <title>Societal Perceptions of Physicians: Knights, Knaves, or Pawns?</title>
      <itunes:title>Societal Perceptions of Physicians: Knights, Knaves, or Pawns?</itunes:title>
      <pubDate>Tue, 31 Aug 2010 21:00:00 +0000</pubDate>
      <guid isPermaLink="false"><![CDATA[36c9bc446117a17661be797f327e439d]]></guid>
      <link><![CDATA[http://dx.doi.org/10.1001/jama.2010.1250]]></link>
      <description><![CDATA[<p>Interview with Sachin H. Jain, MD, MBA and Christine K. Cassel, MD, authors of Societal Perceptions of Physicians: Knights, Knaves, or Pawns?</p>]]></description>
      
      <content:encoded><![CDATA[<p>Interview with Sachin H. Jain, MD, MBA and Christine K. Cassel, MD, authors of Societal Perceptions of Physicians: Knights, Knaves, or Pawns?</p>]]></content:encoded>
      
      
      <enclosure url="https://traffic.libsyn.com/secure/jamaauthorinterviews/jain-cassel090110.mp3?dest-id=90171" length="4165935" type="audio/mpeg" />
      <itunes:duration>08:37</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      
      <itunes:keywords />
      
      
      
      <itunes:image href="https://static.libsyn.com/p/assets/d/0/0/0/d0003e2da283012b/jain-cassel090110.jpg" />
      
      <itunes:episodeType>full</itunes:episodeType>
      
      
      
    </item>
    
  </channel>
</rss>
